,GO_ID,GO_Term,Depth,Propagated_Enrichment,Original_Enrichment,P_Value,Child_Count
163,GO:0008150,biological_process,0,6727.26,1.17,2.692439202452234e-06,18
198,GO:0003674,molecular_function,0,5255.67,1.12,6.939099568020262e-05,31
157,GO:0005575,cellular_component,0,692.51,1.18,1.0397480552014307e-06,3
66,GO:0032501,multicellular organismal process,1,6727.26,8.88,1.3501425383394808e-16,61
128,GO:0009987,cellular process,1,6727.26,1.27,2.3669946514660603e-09,60
56,GO:0003824,catalytic activity,1,5255.67,1.76,2.11756532870043e-19,15
375,GO:0065007,biological regulation,1,3669.41,0.85,0.7807975377379582,7
304,GO:0005488,binding,1,2242.42,0.84,0.9790250934483647,27
121,GO:0110165,cellular anatomical structure,1,692.51,1.32,1.3743524130640556e-09,431
245,GO:0050896,response to stimulus,1,611.57,1.9,0.0052659093420743,15
360,GO:0032502,developmental process,1,517.48,1.38,0.2655844745472318,22
386,GO:0051179,localization,1,368.62,1.08,0.4770523290684353,9
353,GO:0032991,protein-containing complex,1,352.38,0.8,0.8838971878204434,280
97,GO:0042592,homeostatic process,1,307.18,10.98,7.260771489844011e-12,3
344,GO:0022414,reproductive process,1,82.37,1.71,0.2554633010750833,20
79,GO:0044419,biological process involved in interspecies interaction between organisms,1,29.58,7.91,3.2339846797098816e-14,5
374,GO:0060090,molecular adaptor activity,1,22.88,1.14,0.5875230237794908,3
338,GO:0048511,rhythmic process,1,6.66,4.05,0.2193238602930991,4
348,GO:0040007,growth,1,3.62,2.89,0.2929567243720946,6
352,GO:0090729,toxin activity,1,1.72,1.72,0.3240135272718293,0
15255,GO:0002376,immune system process,1,0.0,1.0,1.0,19
15256,GO:0003774,cytoskeletal motor activity,1,0.0,1.0,1.0,4
15257,GO:0005198,structural molecule activity,1,0.0,1.0,1.0,23
15258,GO:0005215,transporter activity,1,0.0,1.0,1.0,4
15259,GO:0009055,electron transfer activity,1,0.0,1.0,1.0,10
15260,GO:0016032,viral process,1,0.0,1.0,1.0,46
15261,GO:0016209,antioxidant activity,1,0.0,1.0,1.0,7
15262,GO:0038024,cargo receptor activity,1,0.0,1.0,1.0,12
15263,GO:0040011,locomotion,1,0.0,1.0,1.0,6
15264,GO:0043473,pigmentation,1,0.0,1.0,1.0,4
15265,GO:0044183,protein folding chaperone,1,0.0,1.0,1.0,1
15266,GO:0044423,virion component,1,0.0,1.0,1.0,23
15267,GO:0044848,biological phase,1,0.0,1.0,1.0,6
15268,GO:0045182,translation regulator activity,1,0.0,1.0,1.0,3
15269,GO:0051703,biological process involved in intraspecies interaction between organisms,1,0.0,1.0,1.0,9
15270,GO:0060089,molecular transducer activity,1,0.0,1.0,1.0,4
15271,GO:0098754,detoxification,1,0.0,1.0,1.0,8
15272,GO:0098772,molecular function regulator activity,1,0.0,1.0,1.0,9
15273,GO:0140104,molecular carrier activity,1,0.0,1.0,1.0,7
15274,GO:0140110,transcription regulator activity,1,0.0,1.0,1.0,8
15275,GO:0140223,general transcription initiation factor activity,1,0.0,1.0,1.0,3
15276,GO:0140313,molecular sequestering activity,1,0.0,1.0,1.0,5
15277,GO:0140489,molecular template activity,1,0.0,1.0,1.0,2
15278,GO:0140522,fusogenic activity,1,0.0,1.0,1.0,1
15279,GO:0140657,ATP-dependent activity,1,0.0,1.0,1.0,20
15280,GO:0140776,protein-containing complex destabilizing activity,1,0.0,1.0,1.0,4
15281,GO:0140777,protein-containing complex stabilizing activity,1,0.0,1.0,1.0,1
15282,GO:0141047,molecular tag activity,1,0.0,1.0,1.0,2
247,GO:0071840,cellular component organization or biogenesis,2,6727.26,1.85,0.006849158944882,2
14,GO:0016787,hydrolase activity,2,5255.67,5.82,2.7543085834460743e-61,22
68,GO:0008152,metabolic process,2,4484.84,1.56,1.1920144436949903e-16,88
367,GO:0050789,regulation of biological process,2,3669.41,0.82,0.8111575015561117,24
148,GO:0044877,protein-containing complex binding,2,2242.42,6.29,4.6013467860655427e-07,70
251,GO:0005515,protein binding,2,1382.31,1.97,0.0079786832945606,109
32,GO:1901681,sulfur compound binding,2,704.76,49.33,7.814719086236846e-34,25
298,GO:0097367,carbohydrate derivative binding,2,704.76,1.45,0.0317116088656343,28
223,GO:0016020,membrane,2,692.51,1.68,0.0012496946676515,16
141,GO:0042221,response to chemical,2,611.57,5.48,2.9476306214458697e-08,58
307,GO:0003008,system process,2,576.62,3.1,0.0732178508355826,9
257,GO:0022611,dormancy process,2,517.48,67.95,0.0146108641305427,15
279,GO:0007586,digestion,2,448.48,29.0,0.0339081427775884,3
376,GO:0051234,establishment of localization,2,368.62,1.17,0.3890184838573894,6
35,GO:0032994,protein-lipid complex,2,352.38,223.31,3.555096770801921e-33,2
82,GO:0048878,chemical homeostasis,2,307.18,15.16,7.681198689701325e-14,7
347,GO:0008289,lipid binding,2,280.3,1.87,0.2892501286085216,12
362,GO:0051716,cellular response to stimulus,2,211.55,1.32,0.3017436760209215,13
211,GO:0034381,plasma lipoprotein particle clearance,2,172.49,65.95,0.0004432199178856,5
328,GO:0006950,response to stress,2,168.18,0.45,0.9673978893287642,30
118,GO:0031667,response to nutrient levels,2,106.44,15.64,1.05557321194767e-09,11
390,GO:0065009,regulation of molecular function,2,105.11,0.84,0.6997884525307811,10
310,GO:0003006,developmental process involved in reproduction,2,82.37,3.01,0.078495568650014,151
382,GO:0048856,anatomical structure development,2,57.5,1.23,0.4411191679565509,202
5,GO:0005615,extracellular space,2,52.77,52.77,9.223167247456196e-126,0
241,GO:0009719,response to endogenous stimulus,2,31.53,5.63,0.005767245404232,4
67,GO:0001906,cell killing,2,29.58,28.05,1.3964337997987692e-16,3
71,GO:0141060,disruption of anatomical structure in another organism,2,29.58,26.23,3.4832244033836686e-16,4
246,GO:0043226,organelle,2,26.49,0.41,0.99828571111966,5
389,GO:0099080,supramolecular complex,2,26.49,1.0,0.633396542443961,7
187,GO:0042995,cell projection,2,24.73,6.03,5.750813812531505e-05,6
366,GO:0030674,protein-macromolecule adaptor activity,2,22.88,1.28,0.5437219136072767,19
359,GO:0036094,small molecule binding,2,21.71,0.89,0.8317754118703046,22
129,GO:0009986,cell surface,2,16.84,16.84,4.022028830464228e-09,0
217,GO:0009607,response to biotic stimulus,2,10.96,3.92,0.0010133841384821,6
219,GO:0009605,response to external stimulus,2,10.96,3.67,0.0015520787849134,12
258,GO:0009791,post-embryonic development,2,10.85,10.85,0.014887556984116,16
370,GO:0031974,membrane-enclosed lumen,2,7.37,1.23,0.5587437726751305,2
323,GO:0007623,circadian rhythm,2,6.66,6.66,0.139536568763624,7
393,GO:0009628,response to abiotic stimulus,2,4.4,0.59,0.8179317581547156,15
175,GO:0005576,extracellular region,2,3.63,3.63,1.3455364389584616e-05,4
343,GO:0048589,developmental growth,2,3.62,3.62,0.2417001521874383,21
385,GO:1902494,catalytic complex,2,1.02,1.02,0.5410984983271115,119
153,GO:0016740,transferase activity,2,0.46,0.06,0.9999999801525052,16
14908,GO:0000133,polarisome,2,0.0,1.0,1.0,4
14909,GO:0000146,microfilament motor activity,2,0.0,1.0,1.0,2
14910,GO:0000399,cellular bud neck septin structure,2,0.0,1.0,1.0,3
14911,GO:0000785,chromatin,2,0.0,1.0,1.0,4
14912,GO:0000808,origin recognition complex,2,0.0,1.0,1.0,2
14913,GO:0000922,spindle pole,2,0.0,1.0,1.0,2
14914,GO:0000930,gamma-tubulin complex,2,0.0,1.0,1.0,2
14915,GO:0000940,outer kinetochore,2,0.0,1.0,1.0,1
14916,GO:0001114,protein-DNA-RNA complex,2,0.0,1.0,1.0,1
14917,GO:0001503,ossification,2,0.0,1.0,1.0,6
14918,GO:0001534,radial spoke,2,0.0,1.0,1.0,3
14919,GO:0001535,radial spoke head,2,0.0,1.0,1.0,3
14920,GO:0001750,photoreceptor outer segment,2,0.0,1.0,1.0,2
14921,GO:0001775,cell activation,2,0.0,1.0,1.0,13
14922,GO:0002139,stereocilia coupling link,2,0.0,1.0,1.0,2
14923,GO:0002200,somatic diversification of immune receptors,2,0.0,1.0,1.0,10
14924,GO:0002252,immune effector process,2,0.0,1.0,1.0,13
14925,GO:0002339,B cell selection,2,0.0,1.0,1.0,4
14926,GO:0002404,antigen sampling in mucosal-associated lymphoid tissue,2,0.0,1.0,1.0,2
14927,GO:0002507,tolerance induction,2,0.0,1.0,1.0,9
14928,GO:0002532,production of molecular mediator involved in inflammatory response,2,0.0,1.0,1.0,8
14929,GO:0003682,chromatin binding,2,0.0,1.0,1.0,4
14930,GO:0003700,DNA-binding transcription factor activity,2,0.0,1.0,1.0,5
14931,GO:0003777,microtubule motor activity,2,0.0,1.0,1.0,2
14932,GO:0003823,antigen binding,2,0.0,1.0,1.0,3
14933,GO:0005199,structural constituent of cell wall,2,0.0,1.0,1.0,1
14934,GO:0005200,structural constituent of cytoskeleton,2,0.0,1.0,1.0,3
14935,GO:0005201,extracellular matrix structural constituent,2,0.0,1.0,1.0,6
14936,GO:0005319,lipid transporter activity,2,0.0,1.0,1.0,5
14937,GO:0005549,odorant binding,2,0.0,1.0,1.0,1
14938,GO:0005581,collagen trimer,2,0.0,1.0,1.0,10
14939,GO:0005622,intracellular anatomical structure,2,0.0,1.0,1.0,6
14940,GO:0005657,replication fork,2,0.0,1.0,1.0,2
14941,GO:0005663,DNA replication factor C complex,2,0.0,1.0,1.0,2
14942,GO:0005667,transcription regulator complex,2,0.0,1.0,1.0,12
14943,GO:0005713,recombination nodule,2,0.0,1.0,1.0,2
14944,GO:0005737,cytoplasm,2,0.0,1.0,1.0,5
14945,GO:0005815,microtubule organizing center,2,0.0,1.0,1.0,5
14946,GO:0005821,intermediate layer of spindle pole body,2,0.0,1.0,1.0,1
14947,GO:0005822,inner plaque of spindle pole body,2,0.0,1.0,1.0,1
14948,GO:0005823,central plaque of spindle pole body,2,0.0,1.0,1.0,1
14949,GO:0005824,outer plaque of spindle pole body,2,0.0,1.0,1.0,1
14950,GO:0005825,half bridge of spindle pole body,2,0.0,1.0,1.0,1
14951,GO:0005829,cytosol,2,0.0,1.0,1.0,1
14952,GO:0005838,proteasome regulatory particle,2,0.0,1.0,1.0,2
14953,GO:0005852,eukaryotic translation initiation factor 3 complex,2,0.0,1.0,1.0,2
14954,GO:0005861,troponin complex,2,0.0,1.0,1.0,1
14955,GO:0005875,microtubule associated complex,2,0.0,1.0,1.0,7
14956,GO:0006276,plasmid maintenance,2,0.0,1.0,1.0,2
14957,GO:0006457,protein folding,2,0.0,1.0,1.0,7
14958,GO:0006903,vesicle targeting,2,0.0,1.0,1.0,5
14959,GO:0006955,immune response,2,0.0,1.0,1.0,9
14960,GO:0007017,microtubule-based process,2,0.0,1.0,1.0,9
14961,GO:0007049,cell cycle,2,0.0,1.0,1.0,2
14962,GO:0007117,budding cell bud growth,2,0.0,1.0,1.0,2
14963,GO:0007154,cell communication,2,0.0,1.0,1.0,12
14964,GO:0007155,cell adhesion,2,0.0,1.0,1.0,7
14965,GO:0007163,establishment or maintenance of cell polarity,2,0.0,1.0,1.0,11
14966,GO:0007272,ensheathment of neurons,2,0.0,1.0,1.0,2
14967,GO:0007389,pattern specification process,2,0.0,1.0,1.0,16
14968,GO:0007610,behavior,2,0.0,1.0,1.0,29
14969,GO:0007624,ultradian rhythm,2,0.0,1.0,1.0,1
14970,GO:0008037,cell recognition,2,0.0,1.0,1.0,5
14971,GO:0008186,"ATP-dependent activity, acting on RNA",2,0.0,1.0,1.0,3
14972,GO:0008219,cell death,2,0.0,1.0,1.0,1
14973,GO:0008278,cohesin complex,2,0.0,1.0,1.0,2
14974,GO:0008283,cell population proliferation,2,0.0,1.0,1.0,31
14975,GO:0008290,F-actin capping protein complex,2,0.0,1.0,1.0,1
14976,GO:0008540,"proteasome regulatory particle, base subcomplex",2,0.0,1.0,1.0,2
14977,GO:0008541,"proteasome regulatory particle, lid subcomplex",2,0.0,1.0,1.0,2
14978,GO:0009292,horizontal gene transfer,2,0.0,1.0,1.0,3
14979,GO:0009295,nucleoid,2,0.0,1.0,1.0,3
14980,GO:0009532,plastid stroma,2,0.0,1.0,1.0,8
14981,GO:0009566,fertilization,2,0.0,1.0,1.0,3
14982,GO:0009653,anatomical structure morphogenesis,2,0.0,1.0,1.0,88
14983,GO:0009838,abscission,2,0.0,1.0,1.0,4
14984,GO:0009845,seed germination,2,0.0,1.0,1.0,1
14985,GO:0009975,cyclase activity,2,0.0,1.0,1.0,20
14986,GO:0010014,meristem initiation,2,0.0,1.0,1.0,2
14987,GO:0010022,meristem determinacy,2,0.0,1.0,1.0,1
14988,GO:0010118,stomatal movement,2,0.0,1.0,1.0,2
14989,GO:0010339,external side of cell wall,2,0.0,1.0,1.0,1
14990,GO:0014823,response to activity,2,0.0,1.0,1.0,2
14991,GO:0014854,response to inactivity,2,0.0,1.0,1.0,2
14992,GO:0014874,response to stimulus involved in regulation of muscle adaptation,2,0.0,1.0,1.0,4
14993,GO:0016037,light absorption,2,0.0,1.0,1.0,2
14994,GO:0016049,cell growth,2,0.0,1.0,1.0,6
14995,GO:0016459,myosin complex,2,0.0,1.0,1.0,3
14996,GO:0016491,oxidoreductase activity,2,0.0,1.0,1.0,55
14997,GO:0016530,metallochaperone activity,2,0.0,1.0,1.0,5
14998,GO:0016597,amino acid binding,2,0.0,1.0,1.0,12
14999,GO:0016604,nuclear body,2,0.0,1.0,1.0,12
15000,GO:0016829,lyase activity,2,0.0,1.0,1.0,13
15001,GO:0016853,isomerase activity,2,0.0,1.0,1.0,16
15002,GO:0016874,ligase activity,2,0.0,1.0,1.0,10
15003,GO:0018995,host cellular component,2,0.0,1.0,1.0,3
15004,GO:0019028,viral capsid,2,0.0,1.0,1.0,2
15005,GO:0019043,establishment of viral latency,2,0.0,1.0,1.0,2
15006,GO:0019046,release from viral latency,2,0.0,1.0,1.0,1
15007,GO:0019069,viral capsid assembly,2,0.0,1.0,1.0,2
15008,GO:0019072,viral genome packaging,2,0.0,1.0,1.0,2
15009,GO:0019079,viral genome replication,2,0.0,1.0,1.0,2
15010,GO:0019081,viral translation,2,0.0,1.0,1.0,1
15011,GO:0019083,viral transcription,2,0.0,1.0,1.0,5
15012,GO:0019215,intermediate filament binding,2,0.0,1.0,1.0,1
15013,GO:0019725,cellular homeostasis,2,0.0,1.0,1.0,8
15014,GO:0019773,"proteasome core complex, alpha-subunit complex",2,0.0,1.0,1.0,2
15015,GO:0019774,"proteasome core complex, beta-subunit complex",2,0.0,1.0,1.0,2
15016,GO:0019814,immunoglobulin complex,2,0.0,1.0,1.0,12
15017,GO:0019835,cytolysis,2,0.0,1.0,1.0,1
15018,GO:0019882,antigen processing and presentation,2,0.0,1.0,1.0,14
15019,GO:0019898,extrinsic component of membrane,2,0.0,1.0,1.0,4
15020,GO:0019953,sexual reproduction,2,0.0,1.0,1.0,2
15021,GO:0019954,asexual reproduction,2,0.0,1.0,1.0,3
15022,GO:0020023,kinetoplast,2,0.0,1.0,1.0,1
15023,GO:0021700,developmental maturation,2,0.0,1.0,1.0,7
15024,GO:0022402,cell cycle process,2,0.0,1.0,1.0,50
15025,GO:0022403,cell cycle phase,2,0.0,1.0,1.0,11
15026,GO:0022404,molting cycle process,2,0.0,1.0,1.0,7
15027,GO:0022406,membrane docking,2,0.0,1.0,1.0,3
15028,GO:0022413,reproductive process in single-celled organism,2,0.0,1.0,1.0,8
15029,GO:0022601,menstrual cycle phase,2,0.0,1.0,1.0,3
15030,GO:0022602,ovulation cycle process,2,0.0,1.0,1.0,16
15031,GO:0022608,multicellular organism adhesion,2,0.0,1.0,1.0,1
15032,GO:0022857,transmembrane transporter activity,2,0.0,1.0,1.0,49
15033,GO:0030029,actin filament-based process,2,0.0,1.0,1.0,4
15034,GO:0030054,cell junction,2,0.0,1.0,1.0,3
15035,GO:0030076,light-harvesting complex,2,0.0,1.0,1.0,3
15036,GO:0030226,apolipoprotein receptor activity,2,0.0,1.0,1.0,1
15037,GO:0030228,lipoprotein particle receptor activity,2,0.0,1.0,1.0,4
15038,GO:0030234,enzyme regulator activity,2,0.0,1.0,1.0,23
15039,GO:0030246,carbohydrate binding,2,0.0,1.0,1.0,4
15040,GO:0030312,external encapsulating structure,2,0.0,1.0,1.0,6
15041,GO:0030371,translation repressor activity,2,0.0,1.0,1.0,4
15042,GO:0030427,site of polarized growth,2,0.0,1.0,1.0,7
15043,GO:0030428,cell septum,2,0.0,1.0,1.0,3
15044,GO:0030431,sleep,2,0.0,1.0,1.0,1
15045,GO:0030447,filamentous growth,2,0.0,1.0,1.0,4
15046,GO:0030545,signaling receptor regulator activity,2,0.0,1.0,1.0,3
15047,GO:0030588,pseudocleavage,2,0.0,1.0,1.0,2
15048,GO:0031074,nucleocytoplasmic transport complex,2,0.0,1.0,1.0,2
15049,GO:0031105,septin complex,2,0.0,1.0,1.0,2
15050,GO:0031128,developmental induction,2,0.0,1.0,1.0,5
15051,GO:0031252,cell leading edge,2,0.0,1.0,1.0,2
15052,GO:0031256,leading edge membrane,2,0.0,1.0,1.0,3
15053,GO:0031257,cell trailing edge membrane,2,0.0,1.0,1.0,1
15054,GO:0031409,pigment binding,2,0.0,1.0,1.0,1
15055,GO:0031503,protein-containing complex localization,2,0.0,1.0,1.0,27
15056,GO:0031967,organelle envelope,2,0.0,1.0,1.0,4
15057,GO:0031977,thylakoid lumen,2,0.0,1.0,1.0,3
15058,GO:0031984,organelle subcompartment,2,0.0,1.0,1.0,3
15059,GO:0031987,locomotion involved in locomotory behavior,2,0.0,1.0,1.0,1
15060,GO:0031992,energy transducer activity,2,0.0,1.0,1.0,1
15061,GO:0032158,septin band,2,0.0,1.0,1.0,2
15062,GO:0032161,cleavage apparatus septin structure,2,0.0,1.0,1.0,5
15063,GO:0032196,transposition,2,0.0,1.0,1.0,2
15064,GO:0032300,mismatch repair complex,2,0.0,1.0,1.0,7
15065,GO:0032432,actin filament bundle,2,0.0,1.0,1.0,4
15066,GO:0032451,demethylase activity,2,0.0,1.0,1.0,6
15067,GO:0032777,piccolo histone acetyltransferase complex,2,0.0,1.0,1.0,1
15068,GO:0032898,neurotrophin production,2,0.0,1.0,1.0,1
15069,GO:0032992,protein-carbohydrate complex,2,0.0,1.0,1.0,1
15070,GO:0032993,protein-DNA complex,2,0.0,1.0,1.0,16
15071,GO:0033036,macromolecule localization,2,0.0,1.0,1.0,5
15072,GO:0033058,directional locomotion,2,0.0,1.0,1.0,2
15073,GO:0033059,cellular pigmentation,2,0.0,1.0,1.0,1
15074,GO:0033061,DNA recombinase mediator complex,2,0.0,1.0,1.0,5
15075,GO:0033218,amide binding,2,0.0,1.0,1.0,22
15076,GO:0034337,RNA folding,2,0.0,1.0,1.0,1
15077,GO:0034646,organelle-enclosing lipid monolayer,2,0.0,1.0,1.0,2
15078,GO:0034992,microtubule organizing center attachment site,2,0.0,1.0,1.0,1
15079,GO:0035821,modulation of process of another organism,2,0.0,1.0,1.0,11
15080,GO:0035869,ciliary transition zone,2,0.0,1.0,1.0,1
15081,GO:0036166,phenotypic switching,2,0.0,1.0,1.0,2
15082,GO:0036284,tubulobulbar complex,2,0.0,1.0,1.0,2
15083,GO:0036338,viral membrane,2,0.0,1.0,1.0,2
15084,GO:0036379,myofilament,2,0.0,1.0,1.0,2
15085,GO:0036452,ESCRT complex,2,0.0,1.0,1.0,5
15086,GO:0036454,growth factor complex,2,0.0,1.0,1.0,3
15087,GO:0038023,signaling receptor activity,2,0.0,1.0,1.0,24
15088,GO:0039663,membrane fusion involved in viral entry into host cell,2,0.0,1.0,1.0,2
15089,GO:0039664,lysis of host organelle involved in viral entry into host cell,2,0.0,1.0,1.0,2
15090,GO:0039665,permeabilization of host organelle membrane involved in viral entry into host cell,2,0.0,1.0,1.0,2
15091,GO:0039678,symbiont genome ejection through host cell envelope,2,0.0,1.0,1.0,3
15092,GO:0042277,peptide binding,2,0.0,1.0,1.0,4
15093,GO:0042302,structural constituent of cuticle,2,0.0,1.0,1.0,2
15094,GO:0042303,molting cycle,2,0.0,1.0,1.0,3
15095,GO:0042330,taxis,2,0.0,1.0,1.0,5
15096,GO:0042555,MCM complex,2,0.0,1.0,1.0,1
15097,GO:0042562,hormone binding,2,0.0,1.0,1.0,15
15098,GO:0042597,periplasmic space,2,0.0,1.0,1.0,3
15099,GO:0042641,actomyosin,2,0.0,1.0,1.0,1
15100,GO:0042716,plasma membrane-derived chromatophore,2,0.0,1.0,1.0,1
15101,GO:0042763,intracellular immature spore,2,0.0,1.0,1.0,2
15102,GO:0043036,starch grain,2,0.0,1.0,1.0,2
15103,GO:0043176,amine binding,2,0.0,1.0,1.0,4
15104,GO:0043235,receptor complex,2,0.0,1.0,1.0,17
15105,GO:0043256,laminin complex,2,0.0,1.0,1.0,16
15106,GO:0043511,inhibin complex,2,0.0,1.0,1.0,2
15107,GO:0043696,dedifferentiation,2,0.0,1.0,1.0,1
15108,GO:0043934,sporulation,2,0.0,1.0,1.0,4
15109,GO:0044111,formation of structure involved in a symbiotic process,2,0.0,1.0,1.0,5
15110,GO:0044217,other organism part,2,0.0,1.0,1.0,2
15111,GO:0044232,organelle membrane contact site,2,0.0,1.0,1.0,10
15112,GO:0044292,dendrite terminus,2,0.0,1.0,1.0,4
15113,GO:0044297,cell body,2,0.0,1.0,1.0,2
15114,GO:0044298,cell body membrane,2,0.0,1.0,1.0,1
15115,GO:0044303,axon collateral,2,0.0,1.0,1.0,2
15116,GO:0044306,neuron projection terminus,2,0.0,1.0,1.0,1
15117,GO:0044403,biological process involved in symbiotic interaction,2,0.0,1.0,1.0,5
15118,GO:0044703,multi-organism reproductive process,2,0.0,1.0,1.0,5
15119,GO:0044706,multi-multicellular organism process,2,0.0,1.0,1.0,7
15120,GO:0044851,hair cycle phase,2,0.0,1.0,1.0,4
15121,GO:0045058,T cell selection,2,0.0,1.0,1.0,5
15122,GO:0045103,intermediate filament-based process,2,0.0,1.0,1.0,1
15123,GO:0045171,intercellular bridge,2,0.0,1.0,1.0,2
15124,GO:0045183,"translation factor activity, non-nucleic acid binding",2,0.0,1.0,1.0,1
15125,GO:0045251,electron transfer flavoprotein complex,2,0.0,1.0,1.0,2
15126,GO:0046727,capsomere,2,0.0,1.0,1.0,2
15127,GO:0046755,viral budding,2,0.0,1.0,1.0,5
15128,GO:0046794,transport of virus,2,0.0,1.0,1.0,3
15129,GO:0046812,host cell surface binding,2,0.0,1.0,1.0,1
15130,GO:0048066,developmental pigmentation,2,0.0,1.0,1.0,3
15131,GO:0048180,activin complex,2,0.0,1.0,1.0,3
15132,GO:0048471,perinuclear region of cytoplasm,2,0.0,1.0,1.0,1
15133,GO:0048532,anatomical structure arrangement,2,0.0,1.0,1.0,26
15134,GO:0048609,multicellular organismal reproductive process,2,0.0,1.0,1.0,26
15135,GO:0048646,anatomical structure formation involved in morphogenesis,2,0.0,1.0,1.0,105
15136,GO:0048647,polyphenic determination,2,0.0,1.0,1.0,3
15137,GO:0048771,tissue remodeling,2,0.0,1.0,1.0,8
15138,GO:0048869,cellular developmental process,2,0.0,1.0,1.0,18
15139,GO:0048870,cell motility,2,0.0,1.0,1.0,12
15140,GO:0048871,multicellular organismal-level homeostasis,2,0.0,1.0,1.0,7
15141,GO:0050817,coagulation,2,0.0,1.0,1.0,2
15142,GO:0050840,extracellular matrix binding,2,0.0,1.0,1.0,5
15143,GO:0050879,multicellular organismal movement,2,0.0,1.0,1.0,3
15144,GO:0051192,prosthetic group binding,2,0.0,1.0,1.0,1
15145,GO:0051233,spindle midzone,2,0.0,1.0,1.0,2
15146,GO:0051235,maintenance of location,2,0.0,1.0,1.0,7
15147,GO:0051301,cell division,2,0.0,1.0,1.0,18
15148,GO:0051410,detoxification of nitrogen compound,2,0.0,1.0,1.0,4
15149,GO:0051606,detection of stimulus,2,0.0,1.0,1.0,7
15150,GO:0051640,organelle localization,2,0.0,1.0,1.0,14
15151,GO:0051641,cellular localization,2,0.0,1.0,1.0,7
15152,GO:0051674,localization of cell,2,0.0,1.0,1.0,2
15153,GO:0051775,response to redox state,2,0.0,1.0,1.0,3
15154,GO:0060033,anatomical structure regression,2,0.0,1.0,1.0,6
15155,GO:0060187,cell pole,2,0.0,1.0,1.0,6
15156,GO:0060206,estrous cycle phase,2,0.0,1.0,1.0,4
15157,GO:0060361,flight,2,0.0,1.0,1.0,1
15158,GO:0060590,ATPase regulator activity,2,0.0,1.0,1.0,4
15159,GO:0061645,endocytic patch,2,0.0,1.0,1.0,1
15160,GO:0061687,detoxification of inorganic compound,2,0.0,1.0,1.0,10
15161,GO:0061696,pituitary gonadotropin complex,2,0.0,1.0,1.0,1
15162,GO:0061702,canonical inflammasome complex,2,0.0,1.0,1.0,6
15163,GO:0061783,peptidoglycan muralytic activity,2,0.0,1.0,1.0,5
15164,GO:0061842,microtubule organizing center localization,2,0.0,1.0,1.0,2
15165,GO:0061845,neuron projection branch point,2,0.0,1.0,1.0,1
15166,GO:0061919,process utilizing autophagic mechanism,2,0.0,1.0,1.0,2
15167,GO:0065008,regulation of biological quality,2,0.0,1.0,1.0,39
15168,GO:0070701,mucus layer,2,0.0,1.0,1.0,2
15169,GO:0070938,contractile ring,2,0.0,1.0,1.0,1
15170,GO:0071141,SMAD protein complex,2,0.0,1.0,1.0,2
15171,GO:0071554,cell wall organization or biogenesis,2,0.0,1.0,1.0,4
15172,GO:0071684,organism emergence from protective structure,2,0.0,1.0,1.0,2
15173,GO:0072341,modified amino acid binding,2,0.0,1.0,1.0,7
15174,GO:0072379,ER membrane insertion complex,2,0.0,1.0,1.0,3
15175,GO:0072562,blood microparticle,2,0.0,1.0,1.0,1
15176,GO:0080190,lateral growth,2,0.0,1.0,1.0,4
15177,GO:0090130,tissue migration,2,0.0,1.0,1.0,3
15178,GO:0090665,glycoprotein complex,2,0.0,1.0,1.0,3
15179,GO:0090693,plant organ senescence,2,0.0,1.0,1.0,2
15180,GO:0090713,immunological memory process,2,0.0,1.0,1.0,3
15181,GO:0090734,site of DNA damage,2,0.0,1.0,1.0,1
15182,GO:0097071,interferon regulatory factor complex,2,0.0,1.0,1.0,5
15183,GO:0097136,Bcl-2 family protein complex,2,0.0,1.0,1.0,12
15184,GO:0097159,organic cyclic compound binding,2,0.0,1.0,1.0,53
15185,GO:0097218,sieve plate,2,0.0,1.0,1.0,2
15186,GO:0097242,amyloid-beta clearance,2,0.0,1.0,1.0,2
15187,GO:0097243,flavonoid binding,2,0.0,1.0,1.0,4
15188,GO:0097427,microtubule bundle,2,0.0,1.0,1.0,4
15189,GO:0097493,structural molecule activity conferring elasticity,2,0.0,1.0,1.0,1
15190,GO:0097574,lateral part of cell,2,0.0,1.0,1.0,2
15191,GO:0097610,cell surface furrow,2,0.0,1.0,1.0,3
15192,GO:0097683,dinoflagellate apex,2,0.0,1.0,1.0,1
15193,GO:0097684,dinoflagellate antapex,2,0.0,1.0,1.0,1
15194,GO:0098021,"viral capsid, decoration",2,0.0,1.0,1.0,2
15195,GO:0098552,side of membrane,2,0.0,1.0,1.0,9
15196,GO:0098636,protein complex involved in cell adhesion,2,0.0,1.0,1.0,3
15197,GO:0098687,chromosomal region,2,0.0,1.0,1.0,6
15198,GO:0098727,maintenance of cell number,2,0.0,1.0,1.0,2
15199,GO:0098733,hemidesmosome associated protein complex,2,0.0,1.0,1.0,1
15200,GO:0098743,cell aggregation,2,0.0,1.0,1.0,2
15201,GO:0098793,presynapse,2,0.0,1.0,1.0,2
15202,GO:0098794,postsynapse,2,0.0,1.0,1.0,2
15203,GO:0098796,membrane protein complex,2,0.0,1.0,1.0,92
15204,GO:0098798,mitochondrial protein-containing complex,2,0.0,1.0,1.0,23
15205,GO:0098803,respiratory chain complex,2,0.0,1.0,1.0,8
15206,GO:0098862,cluster of actin-based cell projections,2,0.0,1.0,1.0,2
15207,GO:0098918,structural constituent of synapse,2,0.0,1.0,1.0,3
15208,GO:0099023,vesicle tethering complex,2,0.0,1.0,1.0,8
15209,GO:0099086,synaptonemal structure,2,0.0,1.0,1.0,2
15210,GO:0120082,smooth endoplasmic reticulum cisterna,2,0.0,1.0,1.0,2
15211,GO:0120114,Sm-like protein family complex,2,0.0,1.0,1.0,7
15212,GO:0120339,radial spoke base,2,0.0,1.0,1.0,3
15213,GO:0140029,exocytic process,2,0.0,1.0,1.0,15
15214,GO:0140096,"catalytic activity, acting on a protein",2,0.0,1.0,1.0,91
15215,GO:0140142,nucleocytoplasmic carrier activity,2,0.0,1.0,1.0,2
15216,GO:0140253,cell-cell fusion,2,0.0,1.0,1.0,1
15217,GO:0140299,molecular sensor activity,2,0.0,1.0,1.0,14
15218,GO:0140318,protein transporter activity,2,0.0,1.0,1.0,3
15219,GO:0140319,receptor decoy activity,2,0.0,1.0,1.0,1
15220,GO:0140414,phosphopantetheine-dependent carrier activity,2,0.0,1.0,1.0,2
15221,GO:0140487,metal ion sequestering activity,2,0.0,1.0,1.0,3
15222,GO:0140513,nuclear protein-containing complex,2,0.0,1.0,1.0,171
15223,GO:0140534,endoplasmic reticulum protein-containing complex,2,0.0,1.0,1.0,38
15224,GO:0140535,intracellular protein-containing complex,2,0.0,1.0,1.0,95
15225,GO:0140597,protein carrier chaperone,2,0.0,1.0,1.0,3
15226,GO:0140640,"catalytic activity, acting on a nucleic acid",2,0.0,1.0,1.0,3
15227,GO:0140659,cytoskeletal motor regulator activity,2,0.0,1.0,1.0,2
15228,GO:0140677,molecular function activator activity,2,0.0,1.0,1.0,7
15229,GO:0140678,molecular function inhibitor activity,2,0.0,1.0,1.0,9
15230,GO:0141108,transporter regulator activity,2,0.0,1.0,1.0,3
15231,GO:0150005,enzyme activator complex,2,0.0,1.0,1.0,5
15232,GO:0160065,SIN/MEN signaling complex,2,0.0,1.0,1.0,2
15233,GO:0160215,deacylase activity,2,0.0,1.0,1.0,4
15234,GO:0170060,microtubule destablizing activity,2,0.0,1.0,1.0,1
15235,GO:1902695,metallochaperone complex,2,0.0,1.0,1.0,1
15236,GO:1903502,translation repressor complex,2,0.0,1.0,1.0,1
15237,GO:1903503,ATPase inhibitor complex,2,0.0,1.0,1.0,1
15238,GO:1904090,peptidase inhibitor complex,2,0.0,1.0,1.0,1
15239,GO:1904091,non-ribosomal peptide synthetase activity,2,0.0,1.0,1.0,2
15240,GO:1990015,ensheathing process,2,0.0,1.0,1.0,1
15241,GO:1990078,replication inhibiting complex,2,0.0,1.0,1.0,4
15242,GO:1990104,DNA bending complex,2,0.0,1.0,1.0,3
15243,GO:1990229,iron-sulfur cluster assembly complex,2,0.0,1.0,1.0,5
15244,GO:1990249,"nucleotide-excision repair, DNA damage recognition complex",2,0.0,1.0,1.0,1
15245,GO:1990351,transporter complex,2,0.0,1.0,1.0,9
15246,GO:1990427,stereocilia tip-link density,2,0.0,1.0,1.0,2
15247,GO:1990563,extracellular exosome complex,2,0.0,1.0,1.0,1
15248,GO:1990586,divisome complex,2,0.0,1.0,1.0,2
15249,GO:1990636,reproductive senescence,2,0.0,1.0,1.0,1
15250,GO:1990684,protein-lipid-RNA complex,2,0.0,1.0,1.0,2
15251,GO:1990748,cellular detoxification,2,0.0,1.0,1.0,8
15252,GO:1990752,microtubule end,2,0.0,1.0,1.0,4
15253,GO:1990904,ribonucleoprotein complex,2,0.0,1.0,1.0,20
15254,GO:1990923,PET complex,2,0.0,1.0,1.0,1
237,GO:0016043,cellular component organization,3,6727.26,1.98,0.0033533277725857,34
8,GO:0016788,"hydrolase activity, acting on ester bonds",3,5255.67,17.7,1.1936778482832903e-93,9
10,GO:0009056,catabolic process,3,4484.84,10.48,8.242950986824714e-78,74
47,GO:0044238,primary metabolic process,3,4484.84,1.9,1.3947193829322565e-23,7
358,GO:0050794,regulation of cellular process,3,3669.41,0.76,0.8553441384864442,59
38,GO:0071814,protein-lipid complex binding,3,2242.42,507.72,1.7499181697141197e-29,1
177,GO:0051239,regulation of multicellular organismal process,3,2242.42,5.42,1.6131974304602507e-05,58
297,GO:0048518,positive regulation of biological process,3,2242.42,1.94,0.0424455933797153,34
387,GO:1901135,carbohydrate derivative metabolic process,3,1922.07,0.89,0.6843983991368264,33
171,GO:0032879,regulation of localization,3,1441.55,6.77,7.804821587261797e-06,19
28,GO:0034185,apolipoprotein binding,3,1382.31,1382.31,1.4130648178428157e-43,1
265,GO:0050793,regulation of developmental process,3,1223.14,2.6,0.0184583199891074,78
43,GO:0043394,proteoglycan binding,3,704.76,435.29,2.3516807353728048e-26,3
268,GO:0031090,organelle membrane,3,692.51,2.09,0.0155839189027411,13
116,GO:1901700,response to oxygen-containing compound,3,611.57,9.96,6.660020292448042e-10,142
220,GO:0097006,regulation of plasma lipoprotein particle levels,3,611.57,611.57,0.0016339392088922,0
179,GO:0022600,digestive system process,3,576.62,59.01,2.017182063274357e-05,11
222,GO:0042750,hibernation,3,517.48,517.48,0.0019307356006364,0
331,GO:0006793,phosphorus metabolic process,3,509.64,1.41,0.105495876420887,12
227,GO:0044241,lipid digestion,3,448.48,448.48,0.0022274448356881,0
364,GO:0006810,transport,3,368.62,1.23,0.343475196200673,46
350,GO:0006575,modified amino acid metabolic process,3,354.07,1.83,0.2980358095527972,32
34,GO:1990777,lipoprotein particle,3,352.38,229.99,2.205012217381771e-33,1
42,GO:0055088,lipid homeostasis,3,307.18,109.8,1.694336624477919e-26,8
235,GO:0017129,triglyceride binding,3,280.3,280.3,0.0035615585094532,0
134,GO:0033993,response to lipid,3,211.55,14.64,1.3273683392462125e-08,36
218,GO:0070887,cellular response to chemical stimulus,3,211.55,5.01,0.0013223887406178,37
23,GO:0005539,glycosaminoglycan binding,3,201.31,141.25,8.956469803588899e-45,6
242,GO:0034383,low-density lipoprotein particle clearance,3,172.49,172.49,0.0057811666393194,0
378,GO:0006952,defense response,3,168.18,1.07,0.5624397065116045,7
192,GO:0071830,triglyceride-rich lipoprotein particle clearance,3,156.45,151.17,8.475926944626512e-05,2
89,GO:0007584,response to nutrient,3,106.44,62.07,1.1597376563530205e-12,3
182,GO:0031669,cellular response to nutrient levels,3,106.44,14.77,2.50058648722424e-05,6
356,GO:0044093,positive regulation of molecular function,3,105.11,1.98,0.3977050238958924,9
373,GO:0050790,regulation of catalytic activity,3,105.11,1.14,0.5860327401091856,11
238,GO:0009058,biosynthetic process,3,92.79,0.57,0.998907545287323,74
264,GO:1901376,organic heteropentacyclic compound metabolic process,3,90.91,56.53,0.0175368480220157,9
354,GO:0019748,secondary metabolic process,3,90.91,2.11,0.3776521234641672,41
169,GO:0007548,sex differentiation,3,82.37,82.37,7.467329926628248e-06,2
351,GO:0010038,response to metal ion,3,73.93,2.64,0.3157037742651732,19
81,GO:0043170,macromolecule metabolic process,3,73.12,0.04,0.9999999999999988,17
365,GO:0006790,sulfur compound metabolic process,3,73.12,0.4,0.9223092231690372,57
332,GO:0048583,regulation of response to stimulus,3,65.82,1.87,0.130019610313318,38
339,GO:0048513,animal organ development,3,57.5,2.25,0.223073362524907,32
267,GO:0032094,response to food,3,50.2,50.2,0.0197257021975797,1
303,GO:0048519,negative regulation of biological process,3,42.05,0.2,0.9944138499668732,41
325,GO:1901615,organic hydroxy compound metabolic process,3,31.69,1.95,0.1493949653278337,33
388,GO:0044281,small molecule metabolic process,3,31.69,0.97,0.6022042822487901,19
233,GO:0009725,response to hormone,3,31.53,6.88,0.0028497210064305,19
260,GO:0014070,response to organic cyclic compound,3,31.53,5.69,0.0161049092640505,123
63,GO:0141061,disruption of cell in another organism,3,29.58,29.58,6.754554960403066e-17,1
239,GO:0043229,intracellular organelle,3,26.49,0.35,0.9993046647734232,2
314,GO:0043228,membraneless organelle,3,26.49,0.22,0.991385986599503,4
180,GO:0120025,plasma membrane bounded cell projection,3,24.73,6.95,2.1330408581218715e-05,23
291,GO:0043495,protein-membrane adaptor activity,3,22.88,22.88,0.0427758289369522,15
381,GO:0043167,ion binding,3,21.71,0.95,0.6825846505887079,2
287,GO:0043227,membrane-bounded organelle,3,21.07,0.43,0.9930503266347636,5
231,GO:1901698,response to nitrogen compound,3,20.75,6.91,0.0028083885490711,115
216,GO:0043207,response to external biotic stimulus,3,10.96,4.13,0.0007257052197271,6
167,GO:0017171,serine hydrolase activity,3,10.26,10.26,6.043781773948854e-06,1
330,GO:0001101,response to acid chemical,3,10.19,5.41,0.1688897403607205,4
262,GO:0009410,response to xenobiotic stimulus,3,10.1,10.1,0.0170295722218987,1
230,GO:0042802,identical protein binding,3,8.36,3.79,0.0025413171921103,1
234,GO:0046983,protein dimerization activity,3,8.36,4.11,0.0035155869076917,2
369,GO:0043233,organelle lumen,3,7.37,1.23,0.5586775128989351,4
345,GO:0007275,multicellular organism development,3,5.51,3.22,0.2672794697556709,5
226,GO:0005102,signaling receptor binding,3,4.52,4.52,0.0021933392080123,55
349,GO:0071495,cellular response to endogenous stimulus,3,4.44,2.88,0.2935897701264675,5
341,GO:0070482,response to oxygen levels,3,4.4,3.81,0.231108542195207,4
236,GO:0005886,plasma membrane,3,1.92,1.92,0.0027757821352907,4
380,GO:0016746,acyltransferase activity,3,0.46,0.46,0.8889576977571905,3
13929,GO:0000109,nucleotide-excision repair complex,3,0.0,1.0,1.0,9
13930,GO:0000118,histone deacetylase complex,3,0.0,1.0,1.0,7
13931,GO:0000120,RNA polymerase I transcription regulator complex,3,0.0,1.0,1.0,3
13932,GO:0000149,SNARE binding,3,0.0,1.0,1.0,1
13933,GO:0000278,mitotic cell cycle,3,0.0,1.0,1.0,4
13934,GO:0000279,M phase,3,0.0,1.0,1.0,2
13935,GO:0000320,re-entry into mitotic cell cycle,3,0.0,1.0,1.0,1
13936,GO:0000347,THO complex,3,0.0,1.0,1.0,2
13937,GO:0000775,"chromosome, centromeric region",3,0.0,1.0,1.0,1
13938,GO:0000781,"chromosome, telomeric region",3,0.0,1.0,1.0,2
13939,GO:0000782,telomere cap complex,3,0.0,1.0,1.0,2
13940,GO:0000786,nucleosome,3,0.0,1.0,1.0,2
13941,GO:0000792,heterochromatin,3,0.0,1.0,1.0,9
13942,GO:0000902,cell morphogenesis,3,0.0,1.0,1.0,21
13943,GO:0000910,cytokinesis,3,0.0,1.0,1.0,4
13944,GO:0000934,porous cell septum,3,0.0,1.0,1.0,1
13945,GO:0000935,division septum,3,0.0,1.0,1.0,2
13946,GO:0000981,"DNA-binding transcription factor activity, RNA polymerase II-specific",3,0.0,1.0,1.0,3
13947,GO:0001098,basal transcription machinery binding,3,0.0,1.0,1.0,2
13948,GO:0001216,DNA-binding transcription activator activity,3,0.0,1.0,1.0,2
13949,GO:0001217,DNA-binding transcription repressor activity,3,0.0,1.0,1.0,3
13950,GO:0001525,angiogenesis,3,0.0,1.0,1.0,5
13951,GO:0001539,cilium or flagellum-dependent cell motility,3,0.0,1.0,1.0,2
13952,GO:0001545,primary ovarian follicle growth,3,0.0,1.0,1.0,2
13953,GO:0001548,follicular fluid formation in ovarian follicle antrum,3,0.0,1.0,1.0,3
13954,GO:0001565,phorbol ester receptor activity,3,0.0,1.0,1.0,1
13955,GO:0001568,blood vessel development,3,0.0,1.0,1.0,5
13956,GO:0001653,peptide receptor activity,3,0.0,1.0,1.0,3
13957,GO:0001659,temperature homeostasis,3,0.0,1.0,1.0,5
13958,GO:0001671,ATPase activator activity,3,0.0,1.0,1.0,1
13959,GO:0001704,formation of primary germ layer,3,0.0,1.0,1.0,3
13960,GO:0001708,cell fate specification,3,0.0,1.0,1.0,23
13961,GO:0001709,cell fate determination,3,0.0,1.0,1.0,21
13962,GO:0001763,morphogenesis of a branching structure,3,0.0,1.0,1.0,4
13963,GO:0001846,opsonin binding,3,0.0,1.0,1.0,6
13964,GO:0001848,complement binding,3,0.0,1.0,1.0,8
13965,GO:0001887,selenium compound metabolic process,3,0.0,1.0,1.0,2
13966,GO:0001974,blood vessel remodeling,3,0.0,1.0,1.0,1
13967,GO:0002118,aggressive behavior,3,0.0,1.0,1.0,6
13968,GO:0002249,lymphocyte anergy,3,0.0,1.0,1.0,2
13969,GO:0002250,adaptive immune response,3,0.0,1.0,1.0,5
13970,GO:0002251,organ or tissue specific immune response,3,0.0,1.0,1.0,3
13971,GO:0002263,cell activation involved in immune response,3,0.0,1.0,1.0,4
13972,GO:0002266,follicular dendritic cell activation,3,0.0,1.0,1.0,2
13973,GO:0002340,central B cell selection,3,0.0,1.0,1.0,2
13974,GO:0002343,peripheral B cell selection,3,0.0,1.0,1.0,3
13975,GO:0002346,B cell positive selection,3,0.0,1.0,1.0,2
13976,GO:0002347,response to tumor cell,3,0.0,1.0,1.0,4
13977,GO:0002352,B cell negative selection,3,0.0,1.0,1.0,2
13978,GO:0002387,immune response in gut-associated lymphoid tissue,3,0.0,1.0,1.0,3
13979,GO:0002434,immune complex clearance,3,0.0,1.0,1.0,2
13980,GO:0002443,leukocyte mediated immunity,3,0.0,1.0,1.0,4
13981,GO:0002450,B cell antigen processing and presentation,3,0.0,1.0,1.0,2
13982,GO:0002468,dendritic cell antigen processing and presentation,3,0.0,1.0,1.0,2
13983,GO:0002475,antigen processing and presentation via MHC class Ib,3,0.0,1.0,1.0,2
13984,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,3,0.0,1.0,1.0,2
13985,GO:0002508,central tolerance induction,3,0.0,1.0,1.0,4
13986,GO:0002513,tolerance induction to self antigen,3,0.0,1.0,1.0,2
13987,GO:0002514,B cell tolerance induction,3,0.0,1.0,1.0,3
13988,GO:0002517,T cell tolerance induction,3,0.0,1.0,1.0,3
13989,GO:0002538,arachidonate metabolite production involved in inflammatory response,3,0.0,1.0,1.0,2
13990,GO:0002563,somatic diversification of immune receptors via alternate splicing,3,0.0,1.0,1.0,1
13991,GO:0002566,somatic diversification of immune receptors via somatic mutation,3,0.0,1.0,1.0,1
13992,GO:0002568,somatic diversification of T cell receptor genes,3,0.0,1.0,1.0,2
13993,GO:0002569,somatic diversification of immune receptors by N region addition,3,0.0,1.0,1.0,2
13994,GO:0002682,regulation of immune system process,3,0.0,1.0,1.0,16
13995,GO:0002745,antigen processing and presentation initiated by receptor mediated uptake of antigen,3,0.0,1.0,1.0,2
13996,GO:0002746,antigen processing and presentation following pinocytosis,3,0.0,1.0,1.0,2
13997,GO:0003002,regionalization,3,0.0,1.0,1.0,41
13998,GO:0003012,muscle system process,3,0.0,1.0,1.0,4
13999,GO:0003013,circulatory system process,3,0.0,1.0,1.0,5
14000,GO:0003014,renal system process,3,0.0,1.0,1.0,9
14001,GO:0003016,respiratory system process,3,0.0,1.0,1.0,2
14002,GO:0003170,heart valve development,3,0.0,1.0,1.0,5
14003,GO:0003179,heart valve morphogenesis,3,0.0,1.0,1.0,6
14004,GO:0003188,heart valve formation,3,0.0,1.0,1.0,6
14005,GO:0003205,cardiac chamber development,3,0.0,1.0,1.0,5
14006,GO:0003206,cardiac chamber morphogenesis,3,0.0,1.0,1.0,5
14007,GO:0003207,cardiac chamber formation,3,0.0,1.0,1.0,5
14008,GO:0003279,cardiac septum development,3,0.0,1.0,1.0,2
14009,GO:0003392,cell adhesion involved in retrograde extension,3,0.0,1.0,1.0,1
14010,GO:0003676,nucleic acid binding,3,0.0,1.0,1.0,6
14011,GO:0003712,transcription coregulator activity,3,0.0,1.0,1.0,2
14012,GO:0004325,ferrochelatase activity,3,0.0,1.0,1.0,1
14013,GO:0004386,helicase activity,3,0.0,1.0,1.0,3
14014,GO:0004497,monooxygenase activity,3,0.0,1.0,1.0,58
14015,GO:0004857,enzyme inhibitor activity,3,0.0,1.0,1.0,30
14016,GO:0004888,transmembrane signaling receptor activity,3,0.0,1.0,1.0,36
14017,GO:0005030,neurotrophin receptor activity,3,0.0,1.0,1.0,2
14018,GO:0005048,signal sequence binding,3,0.0,1.0,1.0,8
14019,GO:0005214,structural constituent of chitin-based cuticle,3,0.0,1.0,1.0,3
14020,GO:0005275,amine transmembrane transporter activity,3,0.0,1.0,1.0,2
14021,GO:0005326,neurotransmitter transmembrane transporter activity,3,0.0,1.0,1.0,2
14022,GO:0005342,organic acid transmembrane transporter activity,3,0.0,1.0,1.0,4
14023,GO:0005496,steroid binding,3,0.0,1.0,1.0,10
14024,GO:0005518,collagen binding,3,0.0,1.0,1.0,2
14025,GO:0005527,macrolide binding,3,0.0,1.0,1.0,2
14026,GO:0005543,phospholipid binding,3,0.0,1.0,1.0,9
14027,GO:0005548,phospholipid transporter activity,3,0.0,1.0,1.0,9
14028,GO:0005583,fibrillar collagen trimer,3,0.0,1.0,1.0,7
14029,GO:0005593,FACIT collagen trimer,3,0.0,1.0,1.0,8
14030,GO:0005598,short-chain collagen trimer,3,0.0,1.0,1.0,2
14031,GO:0005618,cell wall,3,0.0,1.0,1.0,5
14032,GO:0005677,chromatin silencing complex,3,0.0,1.0,1.0,3
14033,GO:0005681,spliceosomal complex,3,0.0,1.0,1.0,10
14034,GO:0005697,telomerase holoenzyme complex,3,0.0,1.0,1.0,1
14035,GO:0005727,extrachromosomal circular DNA,3,0.0,1.0,1.0,2
14036,GO:0005732,sno(s)RNA-containing ribonucleoprotein complex,3,0.0,1.0,1.0,3
14037,GO:0005813,centrosome,3,0.0,1.0,1.0,1
14038,GO:0005816,spindle pole body,3,0.0,1.0,1.0,2
14039,GO:0005826,actomyosin contractile ring,3,0.0,1.0,1.0,2
14040,GO:0005839,proteasome core complex,3,0.0,1.0,1.0,2
14041,GO:0005849,mRNA cleavage factor complex,3,0.0,1.0,1.0,2
14042,GO:0005871,kinesin complex,3,0.0,1.0,1.0,4
14043,GO:0005938,cell cortex,3,0.0,1.0,1.0,1
14044,GO:0006081,aldehyde metabolic process,3,0.0,1.0,1.0,17
14045,GO:0006091,generation of precursor metabolites and energy,3,0.0,1.0,1.0,12
14046,GO:0006403,RNA localization,3,0.0,1.0,1.0,7
14047,GO:0006413,translational initiation,3,0.0,1.0,1.0,2
14048,GO:0006450,regulation of translational fidelity,3,0.0,1.0,1.0,4
14049,GO:0006458,'de novo' protein folding,3,0.0,1.0,1.0,2
14050,GO:0006518,peptide metabolic process,3,0.0,1.0,1.0,5
14051,GO:0006805,xenobiotic metabolic process,3,0.0,1.0,1.0,27
14052,GO:0006910,"phagocytosis, recognition",3,0.0,1.0,1.0,1
14053,GO:0006935,chemotaxis,3,0.0,1.0,1.0,9
14054,GO:0006949,syncytium formation,3,0.0,1.0,1.0,2
14055,GO:0006959,humoral immune response,3,0.0,1.0,1.0,4
14056,GO:0006970,response to osmotic stress,3,0.0,1.0,1.0,6
14057,GO:0006979,response to oxidative stress,3,0.0,1.0,1.0,5
14058,GO:0006991,response to sterol depletion,3,0.0,1.0,1.0,1
14059,GO:0007018,microtubule-based movement,3,0.0,1.0,1.0,8
14060,GO:0007059,chromosome segregation,3,0.0,1.0,1.0,1
14061,GO:0007114,cell budding,3,0.0,1.0,1.0,2
14062,GO:0007164,establishment of tissue polarity,3,0.0,1.0,1.0,1
14063,GO:0007204,positive regulation of cytosolic calcium ion concentration,3,0.0,1.0,1.0,5
14064,GO:0007276,gamete generation,3,0.0,1.0,1.0,2
14065,GO:0007349,cellularization,3,0.0,1.0,1.0,5
14066,GO:0007379,segment specification,3,0.0,1.0,1.0,4
14067,GO:0007487,analia development,3,0.0,1.0,1.0,2
14068,GO:0007530,sex determination,3,0.0,1.0,1.0,7
14069,GO:0007535,donor selection,3,0.0,1.0,1.0,2
14070,GO:0007588,excretion,3,0.0,1.0,1.0,4
14071,GO:0007591,"molting cycle, chitin-based cuticle",3,0.0,1.0,1.0,1
14072,GO:0007622,rhythmic behavior,3,0.0,1.0,1.0,1
14073,GO:0007626,locomotory behavior,3,0.0,1.0,1.0,7
14074,GO:0007631,feeding behavior,3,0.0,1.0,1.0,7
14075,GO:0007635,chemosensory behavior,3,0.0,1.0,1.0,4
14076,GO:0007638,mechanosensory behavior,3,0.0,1.0,1.0,1
14077,GO:0008023,transcription elongation factor complex,3,0.0,1.0,1.0,8
14078,GO:0008038,neuron recognition,3,0.0,1.0,1.0,5
14079,GO:0008047,enzyme activator activity,3,0.0,1.0,1.0,28
14080,GO:0008092,cytoskeletal protein binding,3,0.0,1.0,1.0,20
14081,GO:0008093,cytoskeletal anchor activity,3,0.0,1.0,1.0,2
14082,GO:0008134,transcription factor binding,3,0.0,1.0,1.0,3
14083,GO:0008217,regulation of blood pressure,3,0.0,1.0,1.0,5
14084,GO:0008233,peptidase activity,3,0.0,1.0,1.0,11
14085,GO:0008356,asymmetric cell division,3,0.0,1.0,1.0,5
14086,GO:0008366,axon ensheathment,3,0.0,1.0,1.0,5
14087,GO:0008514,organic anion transmembrane transporter activity,3,0.0,1.0,1.0,42
14088,GO:0008608,attachment of spindle microtubules to kinetochore,3,0.0,1.0,1.0,3
14089,GO:0009266,response to temperature stimulus,3,0.0,1.0,1.0,8
14090,GO:0009268,response to pH,3,0.0,1.0,1.0,5
14091,GO:0009289,pilus,3,0.0,1.0,1.0,3
14092,GO:0009291,unidirectional conjugation,3,0.0,1.0,1.0,1
14093,GO:0009308,amine metabolic process,3,0.0,1.0,1.0,9
14094,GO:0009314,response to radiation,3,0.0,1.0,1.0,3
14095,GO:0009317,acetyl-CoA carboxylase complex,3,0.0,1.0,1.0,1
14096,GO:0009330,"DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex",3,0.0,1.0,1.0,2
14097,GO:0009368,endopeptidase Clp complex,3,0.0,1.0,1.0,2
14098,GO:0009453,energy taxis,3,0.0,1.0,1.0,7
14099,GO:0009521,photosystem,3,0.0,1.0,1.0,2
14100,GO:0009526,plastid envelope,3,0.0,1.0,1.0,5
14101,GO:0009581,detection of external stimulus,3,0.0,1.0,1.0,6
14102,GO:0009582,detection of abiotic stimulus,3,0.0,1.0,1.0,7
14103,GO:0009593,detection of chemical stimulus,3,0.0,1.0,1.0,21
14104,GO:0009595,detection of biotic stimulus,3,0.0,1.0,1.0,4
14105,GO:0009606,tropism,3,0.0,1.0,1.0,6
14106,GO:0009611,response to wounding,3,0.0,1.0,1.0,7
14107,GO:0009612,response to mechanical stimulus,3,0.0,1.0,1.0,6
14108,GO:0009629,response to gravity,3,0.0,1.0,1.0,4
14109,GO:0009636,response to toxic substance,3,0.0,1.0,1.0,7
14110,GO:0009798,axis specification,3,0.0,1.0,1.0,12
14111,GO:0009799,specification of symmetry,3,0.0,1.0,1.0,3
14112,GO:0009812,flavonoid metabolic process,3,0.0,1.0,1.0,9
14113,GO:0009820,alkaloid metabolic process,3,0.0,1.0,1.0,9
14114,GO:0009847,spore germination,3,0.0,1.0,1.0,2
14115,GO:0009875,pollen-pistil interaction,3,0.0,1.0,1.0,2
14116,GO:0009880,embryonic pattern specification,3,0.0,1.0,1.0,4
14117,GO:0009881,photoreceptor activity,3,0.0,1.0,1.0,3
14118,GO:0009886,post-embryonic animal morphogenesis,3,0.0,1.0,1.0,40
14119,GO:0009887,animal organ morphogenesis,3,0.0,1.0,1.0,28
14120,GO:0009888,tissue development,3,0.0,1.0,1.0,27
14121,GO:0009897,external side of plasma membrane,3,0.0,1.0,1.0,2
14122,GO:0009900,dehiscence,3,0.0,1.0,1.0,2
14123,GO:0009988,cell-cell recognition,3,0.0,1.0,1.0,4
14124,GO:0009989,cell-matrix recognition,3,0.0,1.0,1.0,1
14125,GO:0010016,shoot system morphogenesis,3,0.0,1.0,1.0,3
14126,GO:0010036,response to boron-containing substance,3,0.0,1.0,1.0,1
14127,GO:0010162,seed dormancy process,3,0.0,1.0,1.0,2
14128,GO:0010171,body morphogenesis,3,0.0,1.0,1.0,2
14129,GO:0010191,mucilage metabolic process,3,0.0,1.0,1.0,5
14130,GO:0010269,response to selenium ion,3,0.0,1.0,1.0,1
14131,GO:0010273,detoxification of copper ion,3,0.0,1.0,1.0,1
14132,GO:0010463,mesenchymal cell proliferation,3,0.0,1.0,1.0,7
14133,GO:0010598,NAD(P)H dehydrogenase complex (plastoquinone),3,0.0,1.0,1.0,1
14134,GO:0010644,cell communication by electrical coupling,3,0.0,1.0,1.0,1
14135,GO:0010817,regulation of hormone levels,3,0.0,1.0,1.0,6
14136,GO:0010851,cyclase regulator activity,3,0.0,1.0,1.0,4
14137,GO:0010876,lipid localization,3,0.0,1.0,1.0,2
14138,GO:0012501,programmed cell death,3,0.0,1.0,1.0,12
14139,GO:0014009,glial cell proliferation,3,0.0,1.0,1.0,2
14140,GO:0014719,skeletal muscle satellite cell activation,3,0.0,1.0,1.0,1
14141,GO:0014834,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,3,0.0,1.0,1.0,1
14142,GO:0014850,response to muscle activity,3,0.0,1.0,1.0,2
14143,GO:0014863,detection of inactivity,3,0.0,1.0,1.0,1
14144,GO:0014865,detection of activity,3,0.0,1.0,1.0,1
14145,GO:0014870,response to muscle inactivity,3,0.0,1.0,1.0,2
14146,GO:0015075,monoatomic ion transmembrane transporter activity,3,0.0,1.0,1.0,4
14147,GO:0015101,organic cation transmembrane transporter activity,3,0.0,1.0,1.0,42
14148,GO:0015110,cyanate transmembrane transporter activity,3,0.0,1.0,1.0,1
14149,GO:0015144,carbohydrate transmembrane transporter activity,3,0.0,1.0,1.0,18
14150,GO:0015171,amino acid transmembrane transporter activity,3,0.0,1.0,1.0,15
14151,GO:0015203,polyamine transmembrane transporter activity,3,0.0,1.0,1.0,5
14152,GO:0015205,nucleobase transmembrane transporter activity,3,0.0,1.0,1.0,3
14153,GO:0015232,heme transmembrane transporter activity,3,0.0,1.0,1.0,2
14154,GO:0015318,inorganic molecular entity transmembrane transporter activity,3,0.0,1.0,1.0,7
14155,GO:0015343,siderophore-iron transmembrane transporter activity,3,0.0,1.0,1.0,7
14156,GO:0015562,efflux transmembrane transporter activity,3,0.0,1.0,1.0,7
14157,GO:0015603,iron chelate transmembrane transporter activity,3,0.0,1.0,1.0,6
14158,GO:0015605,organophosphate ester transmembrane transporter activity,3,0.0,1.0,1.0,17
14159,GO:0015621,ferric triacetylfusarinine C transmembrane transporter activity,3,0.0,1.0,1.0,1
14160,GO:0015932,nucleobase-containing compound transmembrane transporter activity,3,0.0,1.0,1.0,8
14161,GO:0015977,carbon fixation,3,0.0,1.0,1.0,5
14162,GO:0016229,steroid dehydrogenase activity,3,0.0,1.0,1.0,2
14163,GO:0016234,inclusion body,3,0.0,1.0,1.0,14
14164,GO:0016247,channel regulator activity,3,0.0,1.0,1.0,3
14165,GO:0016332,establishment or maintenance of polarity of embryonic epithelium,3,0.0,1.0,1.0,1
14166,GO:0016334,establishment or maintenance of polarity of follicular epithelium,3,0.0,1.0,1.0,4
14167,GO:0016336,establishment or maintenance of polarity of larval imaginal disc epithelium,3,0.0,1.0,1.0,1
14168,GO:0016445,somatic diversification of immunoglobulins,3,0.0,1.0,1.0,6
14169,GO:0016460,myosin II complex,3,0.0,1.0,1.0,1
14170,GO:0016461,unconventional myosin complex,3,0.0,1.0,1.0,17
14171,GO:0016469,proton-transporting two-sector ATPase complex,3,0.0,1.0,1.0,3
14172,GO:0016472,sodium ion-transporting two-sector ATPase complex,3,0.0,1.0,1.0,2
14173,GO:0016477,cell migration,3,0.0,1.0,1.0,35
14174,GO:0016500,protein-hormone receptor activity,3,0.0,1.0,1.0,9
14175,GO:0016531,copper chaperone activity,3,0.0,1.0,1.0,1
14176,GO:0016607,nuclear speck,3,0.0,1.0,1.0,1
14177,GO:0016614,"oxidoreductase activity, acting on CH-OH group of donors",3,0.0,1.0,1.0,38
14178,GO:0016627,"oxidoreductase activity, acting on the CH-CH group of donors",3,0.0,1.0,1.0,22
14179,GO:0016638,"oxidoreductase activity, acting on the CH-NH2 group of donors",3,0.0,1.0,1.0,14
14180,GO:0016645,"oxidoreductase activity, acting on the CH-NH group of donors",3,0.0,1.0,1.0,15
14181,GO:0016651,"oxidoreductase activity, acting on NAD(P)H",3,0.0,1.0,1.0,12
14182,GO:0016661,"oxidoreductase activity, acting on other nitrogenous compounds as donors",3,0.0,1.0,1.0,8
14183,GO:0016667,"oxidoreductase activity, acting on a sulfur group of donors",3,0.0,1.0,1.0,18
14184,GO:0016675,"oxidoreductase activity, acting on a heme group of donors",3,0.0,1.0,1.0,5
14185,GO:0016679,"oxidoreductase activity, acting on diphenols and related substances as donors",3,0.0,1.0,1.0,5
14186,GO:0016684,"oxidoreductase activity, acting on peroxide as acceptor",3,0.0,1.0,1.0,2
14187,GO:0016695,"oxidoreductase activity, acting on hydrogen as donor",3,0.0,1.0,1.0,6
14188,GO:0016701,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen",3,0.0,1.0,1.0,5
14189,GO:0016705,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",3,0.0,1.0,1.0,71
14190,GO:0016721,"oxidoreductase activity, acting on superoxide radicals as acceptor",3,0.0,1.0,1.0,2
14191,GO:0016722,"oxidoreductase activity, acting on metal ions",3,0.0,1.0,1.0,4
14192,GO:0016725,"oxidoreductase activity, acting on CH or CH2 groups",3,0.0,1.0,1.0,11
14193,GO:0016730,"oxidoreductase activity, acting on iron-sulfur proteins as donors",3,0.0,1.0,1.0,3
14194,GO:0016737,"oxidoreductase activity, acting on reduced flavodoxin as donor",3,0.0,1.0,1.0,1
14195,GO:0016741,"transferase activity, transferring one-carbon groups",3,0.0,1.0,1.0,4
14196,GO:0016744,transketolase or transaldolase activity,3,0.0,1.0,1.0,10
14197,GO:0016757,glycosyltransferase activity,3,0.0,1.0,1.0,8
14198,GO:0016765,"transferase activity, transferring alkyl or aryl (other than methyl) groups",3,0.0,1.0,1.0,63
14199,GO:0016769,"transferase activity, transferring nitrogenous groups",3,0.0,1.0,1.0,7
14200,GO:0016772,"transferase activity, transferring phosphorus-containing groups",3,0.0,1.0,1.0,12
14201,GO:0016782,"transferase activity, transferring sulphur-containing groups",3,0.0,1.0,1.0,5
14202,GO:0016785,selenotransferase activity,3,0.0,1.0,1.0,3
14203,GO:0016798,"hydrolase activity, acting on glycosyl bonds",3,0.0,1.0,1.0,3
14204,GO:0016801,"hydrolase activity, acting on ether bonds",3,0.0,1.0,1.0,2
14205,GO:0016810,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",3,0.0,1.0,1.0,18
14206,GO:0016817,"hydrolase activity, acting on acid anhydrides",3,0.0,1.0,1.0,2
14207,GO:0016822,"hydrolase activity, acting on acid carbon-carbon bonds",3,0.0,1.0,1.0,2
14208,GO:0016824,"hydrolase activity, acting on acid halide bonds",3,0.0,1.0,1.0,2
14209,GO:0016825,"hydrolase activity, acting on acid phosphorus-nitrogen bonds",3,0.0,1.0,1.0,3
14210,GO:0016826,"hydrolase activity, acting on acid sulfur-nitrogen bonds",3,0.0,1.0,1.0,2
14211,GO:0016827,"hydrolase activity, acting on acid carbon-phosphorus bonds",3,0.0,1.0,1.0,3
14212,GO:0016828,"hydrolase activity, acting on acid sulfur-sulfur bonds",3,0.0,1.0,1.0,1
14213,GO:0016830,carbon-carbon lyase activity,3,0.0,1.0,1.0,12
14214,GO:0016835,carbon-oxygen lyase activity,3,0.0,1.0,1.0,10
14215,GO:0016840,carbon-nitrogen lyase activity,3,0.0,1.0,1.0,5
14216,GO:0016846,carbon-sulfur lyase activity,3,0.0,1.0,1.0,30
14217,GO:0016848,carbon-halide lyase activity,3,0.0,1.0,1.0,8
14218,GO:0016849,phosphorus-oxygen lyase activity,3,0.0,1.0,1.0,9
14219,GO:0016854,racemase and epimerase activity,3,0.0,1.0,1.0,9
14220,GO:0016859,cis-trans isomerase activity,3,0.0,1.0,1.0,12
14221,GO:0016860,intramolecular oxidoreductase activity,3,0.0,1.0,1.0,16
14222,GO:0016866,intramolecular transferase activity,3,0.0,1.0,1.0,23
14223,GO:0016872,intramolecular lyase activity,3,0.0,1.0,1.0,16
14224,GO:0016875,"ligase activity, forming carbon-oxygen bonds",3,0.0,1.0,1.0,1
14225,GO:0016877,"ligase activity, forming carbon-sulfur bonds",3,0.0,1.0,1.0,3
14226,GO:0016879,"ligase activity, forming carbon-nitrogen bonds",3,0.0,1.0,1.0,28
14227,GO:0016885,"ligase activity, forming carbon-carbon bonds",3,0.0,1.0,1.0,4
14228,GO:0016886,"ligase activity, forming phosphoric ester bonds",3,0.0,1.0,1.0,4
14229,GO:0016903,"oxidoreductase activity, acting on the aldehyde or oxo group of donors",3,0.0,1.0,1.0,14
14230,GO:0016942,insulin-like growth factor binding protein complex,3,0.0,1.0,1.0,2
14231,GO:0016999,antibiotic metabolic process,3,0.0,1.0,1.0,10
14232,GO:0017046,peptide hormone binding,3,0.0,1.0,1.0,8
14233,GO:0017053,transcription repressor complex,3,0.0,1.0,1.0,8
14234,GO:0017145,stem cell division,3,0.0,1.0,1.0,4
14235,GO:0018835,carbon phosphorus lyase activity,3,0.0,1.0,1.0,1
14236,GO:0018884,carbazole metabolic process,3,0.0,1.0,1.0,1
14237,GO:0018930,3-methylquinoline metabolic process,3,0.0,1.0,1.0,1
14238,GO:0018933,nicotine metabolic process,3,0.0,1.0,1.0,2
14239,GO:0018942,organometal metabolic process,3,0.0,1.0,1.0,4
14240,GO:0019030,icosahedral viral capsid,3,0.0,1.0,1.0,17
14241,GO:0019073,viral DNA genome packaging,3,0.0,1.0,1.0,2
14242,GO:0019098,reproductive behavior,3,0.0,1.0,1.0,3
14243,GO:0019207,kinase regulator activity,3,0.0,1.0,1.0,6
14244,GO:0019208,phosphatase regulator activity,3,0.0,1.0,1.0,3
14245,GO:0019213,deacetylase activity,3,0.0,1.0,1.0,25
14246,GO:0019236,response to pheromone,3,0.0,1.0,1.0,3
14247,GO:0019330,aldoxime metabolic process,3,0.0,1.0,1.0,1
14248,GO:0019499,cyanide metabolic process,3,0.0,1.0,1.0,2
14249,GO:0019534,toxin transmembrane transporter activity,3,0.0,1.0,1.0,1
14250,GO:0019808,polyamine binding,3,0.0,1.0,1.0,2
14251,GO:0019827,stem cell population maintenance,3,0.0,1.0,1.0,4
14252,GO:0019838,growth factor binding,3,0.0,1.0,1.0,19
14253,GO:0019840,isoprenoid binding,3,0.0,1.0,1.0,5
14254,GO:0019842,vitamin binding,3,0.0,1.0,1.0,12
14255,GO:0019865,immunoglobulin binding,3,0.0,1.0,1.0,6
14256,GO:0019867,outer membrane,3,0.0,1.0,1.0,3
14257,GO:0019883,antigen processing and presentation of endogenous antigen,3,0.0,1.0,1.0,2
14258,GO:0019884,antigen processing and presentation of exogenous antigen,3,0.0,1.0,1.0,2
14259,GO:0019897,extrinsic component of plasma membrane,3,0.0,1.0,1.0,3
14260,GO:0019899,enzyme binding,3,0.0,1.0,1.0,28
14261,GO:0019904,protein domain specific binding,3,0.0,1.0,1.0,74
14262,GO:0019915,lipid storage,3,0.0,1.0,1.0,2
14263,GO:0019955,cytokine binding,3,0.0,1.0,1.0,35
14264,GO:0021546,rhombomere development,3,0.0,1.0,1.0,8
14265,GO:0021593,rhombomere morphogenesis,3,0.0,1.0,1.0,8
14266,GO:0021594,rhombomere formation,3,0.0,1.0,1.0,8
14267,GO:0021595,rhombomere structural organization,3,0.0,1.0,1.0,8
14268,GO:0021602,cranial nerve morphogenesis,3,0.0,1.0,1.0,12
14269,GO:0021603,cranial nerve formation,3,0.0,1.0,1.0,12
14270,GO:0021604,cranial nerve structural organization,3,0.0,1.0,1.0,12
14271,GO:0021675,nerve development,3,0.0,1.0,1.0,1
14272,GO:0021869,forebrain ventricular zone progenitor cell division,3,0.0,1.0,1.0,1
14273,GO:0022405,hair cycle process,3,0.0,1.0,1.0,3
14274,GO:0022412,cellular process involved in reproduction in multicellular organism,3,0.0,1.0,1.0,23
14275,GO:0022605,mammalian oogenesis stage,3,0.0,1.0,1.0,9
14276,GO:0022609,multicellular organism adhesion to substrate,3,0.0,1.0,1.0,1
14277,GO:0022615,protein to membrane docking,3,0.0,1.0,1.0,1
14278,GO:0022803,passive transmembrane transporter activity,3,0.0,1.0,1.0,1
14279,GO:0022804,active transmembrane transporter activity,3,0.0,1.0,1.0,8
14280,GO:0022884,macromolecule transmembrane transporter activity,3,0.0,1.0,1.0,6
14281,GO:0023023,MHC protein complex binding,3,0.0,1.0,1.0,3
14282,GO:0023051,regulation of signaling,3,0.0,1.0,1.0,11
14283,GO:0023052,signaling,3,0.0,1.0,1.0,5
14284,GO:0030008,TRAPP complex,3,0.0,1.0,1.0,3
14285,GO:0030010,establishment of cell polarity,3,0.0,1.0,1.0,9
14286,GO:0030011,maintenance of cell polarity,3,0.0,1.0,1.0,2
14287,GO:0030021,extracellular matrix structural constituent conferring compression resistance,3,0.0,1.0,1.0,1
14288,GO:0030048,actin filament-based movement,3,0.0,1.0,1.0,4
14289,GO:0030077,plasma membrane light-harvesting complex,3,0.0,1.0,1.0,2
14290,GO:0030112,glycocalyx,3,0.0,1.0,1.0,7
14291,GO:0030117,membrane coat,3,0.0,1.0,1.0,2
14292,GO:0030119,AP-type membrane coat adaptor complex,3,0.0,1.0,1.0,4
14293,GO:0030154,cell differentiation,3,0.0,1.0,1.0,79
14294,GO:0030235,nitric-oxide synthase regulator activity,3,0.0,1.0,1.0,1
14295,GO:0030247,polysaccharide binding,3,0.0,1.0,1.0,17
14296,GO:0030276,clathrin binding,3,0.0,1.0,1.0,2
14297,GO:0030286,dynein complex,3,0.0,1.0,1.0,2
14298,GO:0030426,growth cone,3,0.0,1.0,1.0,2
14299,GO:0030435,sporulation resulting in formation of a cellular spore,3,0.0,1.0,1.0,2
14300,GO:0030436,asexual sporulation,3,0.0,1.0,1.0,5
14301,GO:0030492,hemoglobin binding,3,0.0,1.0,1.0,2
14302,GO:0030532,small nuclear ribonucleoprotein complex,3,0.0,1.0,1.0,3
14303,GO:0030534,adult behavior,3,0.0,1.0,1.0,6
14304,GO:0030537,larval behavior,3,0.0,1.0,1.0,3
14305,GO:0030541,plasmid partitioning,3,0.0,1.0,1.0,1
14306,GO:0030546,signaling receptor activator activity,3,0.0,1.0,1.0,3
14307,GO:0030547,signaling receptor inhibitor activity,3,0.0,1.0,1.0,3
14308,GO:0030594,neurotransmitter receptor activity,3,0.0,1.0,1.0,5
14309,GO:0030611,arsenate reductase activity,3,0.0,1.0,1.0,2
14310,GO:0030613,"oxidoreductase activity, acting on phosphorus or arsenic in donors",3,0.0,1.0,1.0,4
14311,GO:0030684,preribosome,3,0.0,1.0,1.0,4
14312,GO:0030689,Noc complex,3,0.0,1.0,1.0,3
14313,GO:0030703,eggshell formation,3,0.0,1.0,1.0,1
14314,GO:0030728,ovulation,3,0.0,1.0,1.0,1
14315,GO:0030874,nucleolar chromatin,3,0.0,1.0,1.0,2
14316,GO:0030882,lipid antigen binding,3,0.0,1.0,1.0,2
14317,GO:0030894,replisome,3,0.0,1.0,1.0,2
14318,GO:0030897,HOPS complex,3,0.0,1.0,1.0,2
14319,GO:0030929,ADPG pyrophosphorylase complex,3,0.0,1.0,1.0,2
14320,GO:0030934,anchoring collagen complex,3,0.0,1.0,1.0,3
14321,GO:0030984,kininogen binding,3,0.0,1.0,1.0,2
14322,GO:0031002,actin rod,3,0.0,1.0,1.0,1
14323,GO:0031012,extracellular matrix,3,0.0,1.0,1.0,8
14324,GO:0031072,heat shock protein binding,3,0.0,1.0,1.0,3
14325,GO:0031082,BLOC complex,3,0.0,1.0,1.0,3
14326,GO:0031099,regeneration,3,0.0,1.0,1.0,6
14327,GO:0031129,inductive cell-cell signaling,3,0.0,1.0,1.0,3
14328,GO:0031201,SNARE complex,3,0.0,1.0,1.0,18
14329,GO:0031240,external side of cell outer membrane,3,0.0,1.0,1.0,1
14330,GO:0031244,extrinsic component of cell outer membrane,3,0.0,1.0,1.0,3
14331,GO:0031261,DNA replication preinitiation complex,3,0.0,1.0,1.0,2
14332,GO:0031312,extrinsic component of organelle membrane,3,0.0,1.0,1.0,12
14333,GO:0031332,RNAi effector complex,3,0.0,1.0,1.0,3
14334,GO:0031369,translation initiation factor binding,3,0.0,1.0,1.0,3
14335,GO:0031491,nucleosome binding,3,0.0,1.0,1.0,2
14336,GO:0031519,PcG protein complex,3,0.0,1.0,1.0,3
14337,GO:0031589,cell-substrate adhesion,3,0.0,1.0,1.0,7
14338,GO:0031647,regulation of protein stability,3,0.0,1.0,1.0,3
14339,GO:0031978,plastid thylakoid lumen,3,0.0,1.0,1.0,2
14340,GO:0032045,guanyl-nucleotide exchange factor complex,3,0.0,1.0,1.0,3
14341,GO:0032098,regulation of appetite,3,0.0,1.0,1.0,2
14342,GO:0032116,SMC loading complex,3,0.0,1.0,1.0,2
14343,GO:0032182,ubiquitin-like protein binding,3,0.0,1.0,1.0,2
14344,GO:0032259,methylation,3,0.0,1.0,1.0,1
14345,GO:0032404,mismatch repair complex binding,3,0.0,1.0,1.0,4
14346,GO:0032409,regulation of transporter activity,3,0.0,1.0,1.0,4
14347,GO:0032506,cytokinetic process,3,0.0,1.0,1.0,10
14348,GO:0032835,glomerulus development,3,0.0,1.0,1.0,3
14349,GO:0032963,collagen metabolic process,3,0.0,1.0,1.0,2
14350,GO:0033002,muscle cell proliferation,3,0.0,1.0,1.0,2
14351,GO:0033013,tetrapyrrole metabolic process,3,0.0,1.0,1.0,7
14352,GO:0033037,polysaccharide localization,3,0.0,1.0,1.0,2
14353,GO:0033177,"proton-transporting two-sector ATPase complex, proton-transporting domain",3,0.0,1.0,1.0,2
14354,GO:0033178,"proton-transporting two-sector ATPase complex, catalytic domain",3,0.0,1.0,1.0,2
14355,GO:0033202,DNA helicase complex,3,0.0,1.0,1.0,8
14356,GO:0033256,I-kappaB/NF-kappaB complex,3,0.0,1.0,1.0,1
14357,GO:0033500,carbohydrate homeostasis,3,0.0,1.0,1.0,1
14358,GO:0033554,cellular response to stress,3,0.0,1.0,1.0,28
14359,GO:0033555,multicellular organismal response to stress,3,0.0,1.0,1.0,3
14360,GO:0033566,gamma-tubulin complex localization,3,0.0,1.0,1.0,1
14361,GO:0033627,cell adhesion mediated by integrin,3,0.0,1.0,1.0,1
14362,GO:0033643,host cell part,3,0.0,1.0,1.0,23
14363,GO:0033750,ribosome localization,3,0.0,1.0,1.0,1
14364,GO:0034072,squalene cyclase activity,3,0.0,1.0,1.0,2
14365,GO:0034081,polyketide synthase complex,3,0.0,1.0,1.0,2
14366,GO:0034085,establishment of sister chromatid cohesion,3,0.0,1.0,1.0,2
14367,GO:0034086,maintenance of sister chromatid cohesion,3,0.0,1.0,1.0,2
14368,GO:0034293,sexual sporulation,3,0.0,1.0,1.0,3
14369,GO:0034357,photosynthetic membrane,3,0.0,1.0,1.0,2
14370,GO:0034405,response to fluid shear stress,3,0.0,1.0,1.0,4
14371,GO:0034510,centromere separation,3,0.0,1.0,1.0,1
14372,GO:0034518,RNA cap binding complex,3,0.0,1.0,1.0,2
14373,GO:0034617,tetrahydrobiopterin binding,3,0.0,1.0,1.0,1
14374,GO:0034719,SMN-Sm protein complex,3,0.0,1.0,1.0,2
14375,GO:0034751,aryl hydrocarbon receptor complex,3,0.0,1.0,1.0,2
14376,GO:0035010,encapsulation of foreign target,3,0.0,1.0,1.0,1
14377,GO:0035033,histone deacetylase regulator activity,3,0.0,1.0,1.0,1
14378,GO:0035094,response to nicotine,3,0.0,1.0,1.0,1
14379,GO:0035107,appendage morphogenesis,3,0.0,1.0,1.0,6
14380,GO:0035145,exon-exon junction complex,3,0.0,1.0,1.0,1
14381,GO:0035148,tube formation,3,0.0,1.0,1.0,5
14382,GO:0035152,"regulation of tube architecture, open tracheal system",3,0.0,1.0,1.0,3
14383,GO:0035161,imaginal disc lineage restriction,3,0.0,1.0,1.0,2
14384,GO:0035188,hatching,3,0.0,1.0,1.0,1
14385,GO:0035239,tube morphogenesis,3,0.0,1.0,1.0,12
14386,GO:0035265,organ growth,3,0.0,1.0,1.0,4
14387,GO:0035266,meristem growth,3,0.0,1.0,1.0,4
14388,GO:0035287,head segmentation,3,0.0,1.0,1.0,2
14389,GO:0035295,tube development,3,0.0,1.0,1.0,25
14390,GO:0035371,microtubule plus-end,3,0.0,1.0,1.0,1
14391,GO:0035448,extrinsic component of thylakoid membrane,3,0.0,1.0,1.0,1
14392,GO:0035591,signaling adaptor activity,3,0.0,1.0,1.0,3
14393,GO:0035640,exploration behavior,3,0.0,1.0,1.0,1
14394,GO:0035738,envenomation resulting in modulation of process in another organism,3,0.0,1.0,1.0,15
14395,GO:0035806,perturbation of blood coagulation in another organism,3,0.0,1.0,1.0,3
14396,GO:0035900,response to isolation stress,3,0.0,1.0,1.0,1
14397,GO:0035902,response to immobilization stress,3,0.0,1.0,1.0,3
14398,GO:0035966,response to topologically incorrect protein,3,0.0,1.0,1.0,3
14399,GO:0036022,limb joint morphogenesis,3,0.0,1.0,1.0,1
14400,GO:0036064,ciliary basal body,3,0.0,1.0,1.0,9
14401,GO:0036072,direct ossification,3,0.0,1.0,1.0,2
14402,GO:0036075,replacement ossification,3,0.0,1.0,1.0,1
14403,GO:0036093,germ cell proliferation,3,0.0,1.0,1.0,1
14404,GO:0036276,response to antidepressant,3,0.0,1.0,1.0,1
14405,GO:0036387,pre-replicative complex,3,0.0,1.0,1.0,2
14406,GO:0036449,microtubule minus-end,3,0.0,1.0,1.0,1
14407,GO:0038187,pattern recognition receptor activity,3,0.0,1.0,1.0,5
14408,GO:0038199,ethylene receptor activity,3,0.0,1.0,1.0,1
14409,GO:0038201,TOR complex,3,0.0,1.0,1.0,2
14410,GO:0039654,fusion of virus membrane with host endosome membrane,3,0.0,1.0,1.0,1
14411,GO:0039696,RNA-templated viral transcription,3,0.0,1.0,1.0,1
14412,GO:0039709,cytoplasmic capsid assembly,3,0.0,1.0,1.0,2
14413,GO:0040008,regulation of growth,3,0.0,1.0,1.0,9
14414,GO:0040012,regulation of locomotion,3,0.0,1.0,1.0,7
14415,GO:0042030,ATPase inhibitor activity,3,0.0,1.0,1.0,2
14416,GO:0042118,endothelial cell activation,3,0.0,1.0,1.0,1
14417,GO:0042123,glucanosyltransferase activity,3,0.0,1.0,1.0,1
14418,GO:0042180,ketone metabolic process,3,0.0,1.0,1.0,54
14419,GO:0042335,cuticle development,3,0.0,1.0,1.0,2
14420,GO:0042391,regulation of membrane potential,3,0.0,1.0,1.0,20
14421,GO:0042393,histone binding,3,0.0,1.0,1.0,3
14422,GO:0042430,indole-containing compound metabolic process,3,0.0,1.0,1.0,10
14423,GO:0042440,pigment metabolic process,3,0.0,1.0,1.0,9
14424,GO:0042465,kinesis,3,0.0,1.0,1.0,3
14425,GO:0042537,benzene-containing compound metabolic process,3,0.0,1.0,1.0,51
14426,GO:0042558,pteridine-containing compound metabolic process,3,0.0,1.0,1.0,9
14427,GO:0042571,"immunoglobulin complex, circulating",3,0.0,1.0,1.0,5
14428,GO:0042594,response to starvation,3,0.0,1.0,1.0,14
14429,GO:0042620,poly(3-hydroxyalkanoate) metabolic process,3,0.0,1.0,1.0,1
14430,GO:0042698,ovulation cycle,3,0.0,1.0,1.0,2
14431,GO:0042726,flavin-containing compound metabolic process,3,0.0,1.0,1.0,5
14432,GO:0042752,regulation of circadian rhythm,3,0.0,1.0,1.0,6
14433,GO:0042887,amide transmembrane transporter activity,3,0.0,1.0,1.0,28
14434,GO:0042910,xenobiotic transmembrane transporter activity,3,0.0,1.0,1.0,6
14435,GO:0042923,neuropeptide binding,3,0.0,1.0,1.0,1
14436,GO:0042979,ornithine decarboxylase regulator activity,3,0.0,1.0,1.0,2
14437,GO:0043021,ribonucleoprotein complex binding,3,0.0,1.0,1.0,6
14438,GO:0043028,cysteine-type endopeptidase regulator activity involved in apoptotic process,3,0.0,1.0,1.0,2
14439,GO:0043033,isoamylase complex,3,0.0,1.0,1.0,2
14440,GO:0043094,cellular metabolic compound salvage,3,0.0,1.0,1.0,9
14441,GO:0043177,organic acid binding,3,0.0,1.0,1.0,3
14442,GO:0043178,alcohol binding,3,0.0,1.0,1.0,16
14443,GO:0043195,terminal bouton,3,0.0,1.0,1.0,10
14444,GO:0043230,extracellular organelle,3,0.0,1.0,1.0,2
14445,GO:0043236,laminin binding,3,0.0,1.0,1.0,2
14446,GO:0043364,glycyl-radical enzyme activating activity,3,0.0,1.0,1.0,2
14447,GO:0043368,positive T cell selection,3,0.0,1.0,1.0,2
14448,GO:0043383,negative T cell selection,3,0.0,1.0,1.0,2
14449,GO:0043462,regulation of ATP-dependent activity,3,0.0,1.0,1.0,10
14450,GO:0043476,pigment accumulation,3,0.0,1.0,1.0,4
14451,GO:0043548,phosphatidylinositol 3-kinase binding,3,0.0,1.0,1.0,2
14452,GO:0043603,amide metabolic process,3,0.0,1.0,1.0,52
14453,GO:0043679,axon terminus,3,0.0,1.0,1.0,4
14454,GO:0043697,cell dedifferentiation,3,0.0,1.0,1.0,3
14455,GO:0043903,regulation of biological process involved in symbiotic interaction,3,0.0,1.0,1.0,7
14456,GO:0044085,cellular component biogenesis,3,0.0,1.0,1.0,9
14457,GO:0044092,negative regulation of molecular function,3,0.0,1.0,1.0,12
14458,GO:0044114,development of symbiont in host,3,0.0,1.0,1.0,6
14459,GO:0044145,modulation of formation of structure involved in a symbiotic process,3,0.0,1.0,1.0,7
14460,GO:0044182,filamentous growth of a population of unicellular organisms,3,0.0,1.0,1.0,6
14461,GO:0044359,modulation of molecular function in another organism,3,0.0,1.0,1.0,4
14462,GO:0044391,ribosomal subunit,3,0.0,1.0,1.0,2
14463,GO:0044537,regulation of circulating fibrinogen levels,3,0.0,1.0,1.0,2
14464,GO:0044553,modulation of biological quality in another organism,3,0.0,1.0,1.0,3
14465,GO:0044620,ACP phosphopantetheine attachment site binding,3,0.0,1.0,1.0,1
14466,GO:0044770,cell cycle phase transition,3,0.0,1.0,1.0,5
14467,GO:0044796,DNA polymerase processivity factor complex,3,0.0,1.0,1.0,2
14468,GO:0045061,thymic T cell selection,3,0.0,1.0,1.0,2
14469,GO:0045062,extrathymic T cell selection,3,0.0,1.0,1.0,2
14470,GO:0045136,development of secondary sexual characteristics,3,0.0,1.0,1.0,2
14471,GO:0045137,development of primary sexual characteristics,3,0.0,1.0,1.0,2
14472,GO:0045165,cell fate commitment,3,0.0,1.0,1.0,35
14473,GO:0045172,germline ring canal,3,0.0,1.0,1.0,2
14474,GO:0045185,maintenance of protein location,3,0.0,1.0,1.0,3
14475,GO:0045196,establishment or maintenance of neuroblast polarity,3,0.0,1.0,1.0,2
14476,GO:0045202,synapse,3,0.0,1.0,1.0,16
14477,GO:0045239,tricarboxylic acid cycle heteromeric enzyme complex,3,0.0,1.0,1.0,3
14478,GO:0045293,mRNA editing complex,3,0.0,1.0,1.0,3
14479,GO:0045321,leukocyte activation,3,0.0,1.0,1.0,6
14480,GO:0045468,regulation of R8 cell spacing in compound eye,3,0.0,1.0,1.0,2
14481,GO:0045495,pole plasm,3,0.0,1.0,1.0,1
14482,GO:0045730,respiratory burst,3,0.0,1.0,1.0,2
14483,GO:0046332,SMAD binding,3,0.0,1.0,1.0,3
14484,GO:0046453,dipyrrin metabolic process,3,0.0,1.0,1.0,1
14485,GO:0046484,oxazole or thiazole metabolic process,3,0.0,1.0,1.0,2
14486,GO:0046508,"hydrolase activity, acting on carbon-sulfur bonds",3,0.0,1.0,1.0,3
14487,GO:0046536,dosage compensation complex,3,0.0,1.0,1.0,1
14488,GO:0046624,sphingolipid transporter activity,3,0.0,1.0,1.0,3
14489,GO:0046625,sphingolipid binding,3,0.0,1.0,1.0,2
14490,GO:0046677,response to antibiotic,3,0.0,1.0,1.0,8
14491,GO:0046683,response to organophosphorus,3,0.0,1.0,1.0,8
14492,GO:0046685,response to arsenic-containing substance,3,0.0,1.0,1.0,4
14493,GO:0046692,sperm competition,3,0.0,1.0,1.0,3
14494,GO:0046765,viral budding from nuclear membrane,3,0.0,1.0,1.0,2
14495,GO:0046906,tetrapyrrole binding,3,0.0,1.0,1.0,3
14496,GO:0046930,pore complex,3,0.0,1.0,1.0,3
14497,GO:0046977,TAP binding,3,0.0,1.0,1.0,2
14498,GO:0046992,"oxidoreductase activity, acting on X-H and Y-H to form an X-Y bond",3,0.0,1.0,1.0,8
14499,GO:0048002,antigen processing and presentation of peptide antigen,3,0.0,1.0,1.0,5
14500,GO:0048029,monosaccharide binding,3,0.0,1.0,1.0,9
14501,GO:0048038,quinone binding,3,0.0,1.0,1.0,1
14502,GO:0048067,cuticle pigmentation,3,0.0,1.0,1.0,1
14503,GO:0048069,eye pigmentation,3,0.0,1.0,1.0,1
14504,GO:0048071,sex-specific pigmentation,3,0.0,1.0,1.0,2
14505,GO:0048134,germ-line cyst formation,3,0.0,1.0,1.0,2
14506,GO:0048138,germ-line cyst encapsulation,3,0.0,1.0,1.0,2
14507,GO:0048144,fibroblast proliferation,3,0.0,1.0,1.0,3
14508,GO:0048199,"vesicle targeting, to, from or within Golgi",3,0.0,1.0,1.0,5
14509,GO:0048266,behavioral response to pain,3,0.0,1.0,1.0,1
14510,GO:0048306,calcium-dependent protein binding,3,0.0,1.0,1.0,1
14511,GO:0048338,mesoderm structural organization,3,0.0,1.0,1.0,4
14512,GO:0048438,floral whorl development,3,0.0,1.0,1.0,5
14513,GO:0048468,cell development,3,0.0,1.0,1.0,42
14514,GO:0048492,ribulose bisphosphate carboxylase complex,3,0.0,1.0,1.0,2
14515,GO:0048500,signal recognition particle,3,0.0,1.0,1.0,3
14516,GO:0048544,recognition of pollen,3,0.0,1.0,1.0,3
14517,GO:0048588,developmental cell growth,3,0.0,1.0,1.0,12
14518,GO:0048598,embryonic morphogenesis,3,0.0,1.0,1.0,63
14519,GO:0048608,reproductive structure development,3,0.0,1.0,1.0,15
14520,GO:0048645,animal organ formation,3,0.0,1.0,1.0,7
14521,GO:0048648,caste determination,3,0.0,1.0,1.0,2
14522,GO:0048651,"polyphenic determination, influence by environmental factors",3,0.0,1.0,1.0,1
14523,GO:0048652,"polyphenic determination, influence by genetic factors",3,0.0,1.0,1.0,1
14524,GO:0048729,tissue morphogenesis,3,0.0,1.0,1.0,13
14525,GO:0048731,system development,3,0.0,1.0,1.0,27
14526,GO:0048736,appendage development,3,0.0,1.0,1.0,3
14527,GO:0048839,inner ear development,3,0.0,1.0,1.0,1
14528,GO:0048857,neural nucleus development,3,0.0,1.0,1.0,30
14529,GO:0048859,formation of anatomical boundary,3,0.0,1.0,1.0,9
14530,GO:0048860,glioblast division,3,0.0,1.0,1.0,2
14531,GO:0048872,homeostasis of number of cells,3,0.0,1.0,1.0,9
14532,GO:0048887,cupula development,3,0.0,1.0,1.0,2
14533,GO:0050000,chromosome localization,3,0.0,1.0,1.0,7
14534,GO:0050673,epithelial cell proliferation,3,0.0,1.0,1.0,18
14535,GO:0050792,regulation of viral process,3,0.0,1.0,1.0,8
14536,GO:0050801,monoatomic ion homeostasis,3,0.0,1.0,1.0,3
14537,GO:0050839,cell adhesion molecule binding,3,0.0,1.0,1.0,3
14538,GO:0050877,nervous system process,3,0.0,1.0,1.0,14
14539,GO:0050878,regulation of body fluid levels,3,0.0,1.0,1.0,10
14540,GO:0050886,endocrine process,3,0.0,1.0,1.0,1
14541,GO:0050898,nitrile metabolic process,3,0.0,1.0,1.0,8
14542,GO:0050906,detection of stimulus involved in sensory perception,3,0.0,1.0,1.0,7
14543,GO:0050997,quaternary ammonium group binding,3,0.0,1.0,1.0,3
14544,GO:0051002,"ligase activity, forming nitrogen-metal bonds",3,0.0,1.0,1.0,1
14545,GO:0051014,actin filament severing,3,0.0,1.0,1.0,1
14546,GO:0051018,protein kinase A binding,3,0.0,1.0,1.0,2
14547,GO:0051021,GDP-dissociation inhibitor binding,3,0.0,1.0,1.0,1
14548,GO:0051087,protein-folding chaperone binding,3,0.0,1.0,1.0,1
14549,GO:0051098,regulation of binding,3,0.0,1.0,1.0,12
14550,GO:0051189,prosthetic group metabolic process,3,0.0,1.0,1.0,4
14551,GO:0051213,dioxygenase activity,3,0.0,1.0,1.0,7
14552,GO:0051219,phosphoprotein binding,3,0.0,1.0,1.0,1
14553,GO:0051231,spindle elongation,3,0.0,1.0,1.0,2
14554,GO:0051236,establishment of RNA localization,3,0.0,1.0,1.0,3
14555,GO:0051237,maintenance of RNA location,3,0.0,1.0,1.0,1
14556,GO:0051238,sequestering of metal ion,3,0.0,1.0,1.0,5
14557,GO:0051286,cell tip,3,0.0,1.0,1.0,5
14558,GO:0051299,centrosome separation,3,0.0,1.0,1.0,1
14559,GO:0051304,chromosome separation,3,0.0,1.0,1.0,2
14560,GO:0051318,G1 phase,3,0.0,1.0,1.0,2
14561,GO:0051319,G2 phase,3,0.0,1.0,1.0,2
14562,GO:0051320,S phase,3,0.0,1.0,1.0,2
14563,GO:0051321,meiotic cell cycle,3,0.0,1.0,1.0,1
14564,GO:0051322,anaphase,3,0.0,1.0,1.0,1
14565,GO:0051324,prophase,3,0.0,1.0,1.0,3
14566,GO:0051325,interphase,3,0.0,1.0,1.0,2
14567,GO:0051326,telophase,3,0.0,1.0,1.0,3
14568,GO:0051409,response to nitrosative stress,3,0.0,1.0,1.0,1
14569,GO:0051450,myoblast proliferation,3,0.0,1.0,1.0,2
14570,GO:0051481,negative regulation of cytosolic calcium ion concentration,3,0.0,1.0,1.0,2
14571,GO:0051540,metal cluster binding,3,0.0,1.0,1.0,2
14572,GO:0051597,response to methylmercury,3,0.0,1.0,1.0,1
14573,GO:0051601,exocyst localization,3,0.0,1.0,1.0,1
14574,GO:0051602,response to electrical stimulus,3,0.0,1.0,1.0,4
14575,GO:0051642,centrosome localization,3,0.0,1.0,1.0,2
14576,GO:0051643,endoplasmic reticulum localization,3,0.0,1.0,1.0,3
14577,GO:0051644,plastid localization,3,0.0,1.0,1.0,3
14578,GO:0051645,Golgi localization,3,0.0,1.0,1.0,3
14579,GO:0051646,mitochondrion localization,3,0.0,1.0,1.0,3
14580,GO:0051647,nucleus localization,3,0.0,1.0,1.0,4
14581,GO:0051648,vesicle localization,3,0.0,1.0,1.0,6
14582,GO:0051649,establishment of localization in cell,3,0.0,1.0,1.0,38
14583,GO:0051651,maintenance of location in cell,3,0.0,1.0,1.0,10
14584,GO:0051653,spindle localization,3,0.0,1.0,1.0,2
14585,GO:0051656,establishment of organelle localization,3,0.0,1.0,1.0,13
14586,GO:0051668,localization within membrane,3,0.0,1.0,1.0,8
14587,GO:0051701,biological process involved in interaction with host,3,0.0,1.0,1.0,10
14588,GO:0051702,biological process involved in interaction with symbiont,3,0.0,1.0,1.0,8
14589,GO:0051780,behavioral response to nutrient,3,0.0,1.0,1.0,1
14590,GO:0051861,glycolipid binding,3,0.0,1.0,1.0,3
14591,GO:0052093,formation of specialized structure for nutrient acquisition,3,0.0,1.0,1.0,5
14592,GO:0052111,symbiont-mediated disruption of host anatomical structure,3,0.0,1.0,1.0,4
14593,GO:0052575,carbohydrate localization,3,0.0,1.0,1.0,1
14594,GO:0052803,imidazole-containing compound metabolic process,3,0.0,1.0,1.0,5
14595,GO:0055017,cardiac muscle tissue growth,3,0.0,1.0,1.0,1
14596,GO:0055057,neuroblast division,3,0.0,1.0,1.0,5
14597,GO:0055082,intracellular chemical homeostasis,3,0.0,1.0,1.0,19
14598,GO:0055103,ligase regulator activity,3,0.0,1.0,1.0,4
14599,GO:0055106,ubiquitin-protein transferase regulator activity,3,0.0,1.0,1.0,2
14600,GO:0055115,entry into diapause,3,0.0,1.0,1.0,2
14601,GO:0060004,reflex,3,0.0,1.0,1.0,8
14602,GO:0060021,roof of mouth development,3,0.0,1.0,1.0,3
14603,GO:0060061,Spemann organizer formation,3,0.0,1.0,1.0,3
14604,GO:0060135,maternal process involved in female pregnancy,3,0.0,1.0,1.0,2
14605,GO:0060151,peroxisome localization,3,0.0,1.0,1.0,2
14606,GO:0060184,cell cycle switching,3,0.0,1.0,1.0,1
14607,GO:0060249,anatomical structure homeostasis,3,0.0,1.0,1.0,2
14608,GO:0060274,maintenance of stationary phase,3,0.0,1.0,1.0,2
14609,GO:0060322,head development,3,0.0,1.0,1.0,1
14610,GO:0060343,trabecula formation,3,0.0,1.0,1.0,4
14611,GO:0060378,regulation of brood size,3,0.0,1.0,1.0,2
14612,GO:0060411,cardiac septum morphogenesis,3,0.0,1.0,1.0,3
14613,GO:0060432,lung pattern specification process,3,0.0,1.0,1.0,1
14614,GO:0060465,pharynx development,3,0.0,1.0,1.0,3
14615,GO:0060560,developmental growth involved in morphogenesis,3,0.0,1.0,1.0,24
14616,GO:0060589,nucleoside-triphosphatase regulator activity,3,0.0,1.0,1.0,1
14617,GO:0060592,mammary gland formation,3,0.0,1.0,1.0,1
14618,GO:0060722,cell proliferation involved in embryonic placenta development,3,0.0,1.0,1.0,1
14619,GO:0060756,foraging behavior,3,0.0,1.0,1.0,3
14620,GO:0060788,ectodermal placode formation,3,0.0,1.0,1.0,9
14621,GO:0060794,leaflet morphogenesis,3,0.0,1.0,1.0,3
14622,GO:0060896,neural plate pattern specification,3,0.0,1.0,1.0,1
14623,GO:0061004,pattern specification involved in kidney development,3,0.0,1.0,1.0,8
14624,GO:0061061,muscle structure development,3,0.0,1.0,1.0,2
14625,GO:0061077,chaperone-mediated protein folding,3,0.0,1.0,1.0,2
14626,GO:0061134,peptidase regulator activity,3,0.0,1.0,1.0,3
14627,GO:0061245,establishment or maintenance of bipolar cell polarity,3,0.0,1.0,1.0,2
14628,GO:0061299,retina vasculature morphogenesis in camera-type eye,3,0.0,1.0,1.0,1
14629,GO:0061303,cornea development in camera-type eye,3,0.0,1.0,1.0,1
14630,GO:0061323,cell proliferation involved in heart morphogenesis,3,0.0,1.0,1.0,6
14631,GO:0061339,establishment or maintenance of monopolar cell polarity,3,0.0,1.0,1.0,2
14632,GO:0061343,cell adhesion involved in heart morphogenesis,3,0.0,1.0,1.0,2
14633,GO:0061351,neural precursor cell proliferation,3,0.0,1.0,1.0,8
14634,GO:0061383,trabecula morphogenesis,3,0.0,1.0,1.0,2
14635,GO:0061439,kidney vasculature morphogenesis,3,0.0,1.0,1.0,1
14636,GO:0061554,ganglion formation,3,0.0,1.0,1.0,1
14637,GO:0061555,ganglion structural organization,3,0.0,1.0,1.0,1
14638,GO:0061744,motor behavior,3,0.0,1.0,1.0,1
14639,GO:0061771,response to caloric restriction,3,0.0,1.0,1.0,1
14640,GO:0061850,growth cone leading edge,3,0.0,1.0,1.0,2
14641,GO:0061900,glial cell activation,3,0.0,1.0,1.0,2
14642,GO:0061968,maintenance of left/right asymmetry,3,0.0,1.0,1.0,2
14643,GO:0062137,cargo receptor complex,3,0.0,1.0,1.0,1
14644,GO:0065001,specification of axis polarity,3,0.0,1.0,1.0,6
14645,GO:0070050,neuron cellular homeostasis,3,0.0,1.0,1.0,2
14646,GO:0070069,cytochrome complex,3,0.0,1.0,1.0,4
14647,GO:0070085,glycosylation,3,0.0,1.0,1.0,5
14648,GO:0070161,anchoring junction,3,0.0,1.0,1.0,3
14649,GO:0070314,G1 to G0 transition,3,0.0,1.0,1.0,1
14650,GO:0070341,fat cell proliferation,3,0.0,1.0,1.0,2
14651,GO:0070358,actin polymerization-dependent cell motility,3,0.0,1.0,1.0,1
14652,GO:0070492,oligosaccharide binding,3,0.0,1.0,1.0,9
14653,GO:0070631,spindle pole body localization,3,0.0,1.0,1.0,1
14654,GO:0070661,leukocyte proliferation,3,0.0,1.0,1.0,5
14655,GO:0070727,cellular macromolecule localization,3,0.0,1.0,1.0,3
14656,GO:0070848,response to growth factor,3,0.0,1.0,1.0,9
14657,GO:0070988,demethylation,3,0.0,1.0,1.0,2
14658,GO:0070992,translation initiation complex,3,0.0,1.0,1.0,1
14659,GO:0070993,translation preinitiation complex,3,0.0,1.0,1.0,2
14660,GO:0071000,response to magnetism,3,0.0,1.0,1.0,1
14661,GO:0071159,NF-kappaB complex,3,0.0,1.0,1.0,1
14662,GO:0071216,cellular response to biotic stimulus,3,0.0,1.0,1.0,7
14663,GO:0071256,translocon complex,3,0.0,1.0,1.0,2
14664,GO:0071402,cellular response to lipoprotein particle stimulus,3,0.0,1.0,1.0,3
14665,GO:0071496,cellular response to external stimulus,3,0.0,1.0,1.0,2
14666,GO:0071585,detoxification of cadmium ion,3,0.0,1.0,1.0,1
14667,GO:0071625,vocalization behavior,3,0.0,1.0,1.0,2
14668,GO:0071664,catenin-TCF7L2 complex,3,0.0,1.0,1.0,2
14669,GO:0071669,plant-type cell wall organization or biogenesis,3,0.0,1.0,1.0,2
14670,GO:0071695,anatomical structure maturation,3,0.0,1.0,1.0,23
14671,GO:0071696,ectodermal placode development,3,0.0,1.0,1.0,2
14672,GO:0071697,ectodermal placode morphogenesis,3,0.0,1.0,1.0,1
14673,GO:0071723,lipopeptide binding,3,0.0,1.0,1.0,2
14674,GO:0071735,IgG immunoglobulin complex,3,0.0,1.0,1.0,2
14675,GO:0071738,IgD immunoglobulin complex,3,0.0,1.0,1.0,3
14676,GO:0071742,IgE immunoglobulin complex,3,0.0,1.0,1.0,2
14677,GO:0071745,IgA immunoglobulin complex,3,0.0,1.0,1.0,2
14678,GO:0071753,IgM immunoglobulin complex,3,0.0,1.0,1.0,2
14679,GO:0071852,fungal-type cell wall organization or biogenesis,3,0.0,1.0,1.0,2
14680,GO:0071871,response to epinephrine,3,0.0,1.0,1.0,1
14681,GO:0071941,nitrogen cycle metabolic process,3,0.0,1.0,1.0,4
14682,GO:0071975,cell swimming,3,0.0,1.0,1.0,2
14683,GO:0071976,cell gliding,3,0.0,1.0,1.0,2
14684,GO:0071981,exit from diapause,3,0.0,1.0,1.0,2
14685,GO:0071982,maintenance of diapause,3,0.0,1.0,1.0,2
14686,GO:0072003,kidney rudiment formation,3,0.0,1.0,1.0,1
14687,GO:0072006,nephron development,3,0.0,1.0,1.0,5
14688,GO:0072022,descending thin limb development,3,0.0,1.0,1.0,3
14689,GO:0072028,nephron morphogenesis,3,0.0,1.0,1.0,3
14690,GO:0072033,renal vesicle formation,3,0.0,1.0,1.0,2
14691,GO:0072048,renal system pattern specification,3,0.0,1.0,1.0,2
14692,GO:0072049,comma-shaped body morphogenesis,3,0.0,1.0,1.0,2
14693,GO:0072050,S-shaped body morphogenesis,3,0.0,1.0,1.0,2
14694,GO:0072051,juxtaglomerular apparatus development,3,0.0,1.0,1.0,2
14695,GO:0072055,renal cortex development,3,0.0,1.0,1.0,1
14696,GO:0072056,pyramid development,3,0.0,1.0,1.0,1
14697,GO:0072059,cortical collecting duct development,3,0.0,1.0,1.0,1
14698,GO:0072089,stem cell proliferation,3,0.0,1.0,1.0,2
14699,GO:0072102,glomerulus morphogenesis,3,0.0,1.0,1.0,3
14700,GO:0072111,cell proliferation involved in kidney development,3,0.0,1.0,1.0,6
14701,GO:0072118,pronephros structural organization,3,0.0,1.0,1.0,1
14702,GO:0072129,renal capsule formation,3,0.0,1.0,1.0,2
14703,GO:0072187,metanephric cap formation,3,0.0,1.0,1.0,1
14704,GO:0072328,alkene binding,3,0.0,1.0,1.0,1
14705,GO:0072349,modified amino acid transmembrane transporter activity,3,0.0,1.0,1.0,17
14706,GO:0072521,purine-containing compound metabolic process,3,0.0,1.0,1.0,13
14707,GO:0072524,pyridine-containing compound metabolic process,3,0.0,1.0,1.0,13
14708,GO:0072527,pyrimidine-containing compound metabolic process,3,0.0,1.0,1.0,7
14709,GO:0072537,fibroblast activation,3,0.0,1.0,1.0,1
14710,GO:0072586,"DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) regulator activity",3,0.0,1.0,1.0,2
14711,GO:0072593,reactive oxygen species metabolic process,3,0.0,1.0,1.0,4
14712,GO:0072700,response to bismuth,3,0.0,1.0,1.0,1
14713,GO:0072718,response to cisplatin,3,0.0,1.0,1.0,1
14714,GO:0072728,response to Gentian violet,3,0.0,1.0,1.0,1
14715,GO:0072739,response to anisomycin,3,0.0,1.0,1.0,1
14716,GO:0072758,response to topoisomerase inhibitor,3,0.0,1.0,1.0,1
14717,GO:0072765,centromere localization,3,0.0,1.0,1.0,1
14718,GO:0075015,formation of infection structure,3,0.0,1.0,1.0,8
14719,GO:0075283,sporulation resulting in formation of a multicellular or syncytial spore,3,0.0,1.0,1.0,2
14720,GO:0075720,establishment of episomal latency,3,0.0,1.0,1.0,2
14721,GO:0075733,intracellular transport of virus,3,0.0,1.0,1.0,4
14722,GO:0080161,auxin transmembrane transporter activity,3,0.0,1.0,1.0,3
14723,GO:0080186,developmental vegetative growth,3,0.0,1.0,1.0,1
14724,GO:0085035,haustorium,3,0.0,1.0,1.0,1
14725,GO:0086065,cell communication involved in cardiac conduction,3,0.0,1.0,1.0,7
14726,GO:0090066,regulation of anatomical structure size,3,0.0,1.0,1.0,7
14727,GO:0090131,mesenchyme migration,3,0.0,1.0,1.0,1
14728,GO:0090132,epithelium migration,3,0.0,1.0,1.0,2
14729,GO:0090345,organohalogen metabolic process,3,0.0,1.0,1.0,18
14730,GO:0090395,plant cell papilla,3,0.0,1.0,1.0,3
14731,GO:0090398,cellular senescence,3,0.0,1.0,1.0,2
14732,GO:0090421,embryonic meristem initiation,3,0.0,1.0,1.0,2
14733,GO:0090482,vitamin transmembrane transporter activity,3,0.0,1.0,1.0,11
14734,GO:0090559,regulation of membrane permeability,3,0.0,1.0,1.0,4
14735,GO:0090575,RNA polymerase II transcription regulator complex,3,0.0,1.0,1.0,38
14736,GO:0090576,RNA polymerase III transcription regulator complex,3,0.0,1.0,1.0,6
14737,GO:0090598,male anatomical structure morphogenesis,3,0.0,1.0,1.0,2
14738,GO:0090626,plant epidermis morphogenesis,3,0.0,1.0,1.0,1
14739,GO:0090698,post-embryonic plant morphogenesis,3,0.0,1.0,1.0,11
14740,GO:0090715,immunological memory formation process,3,0.0,1.0,1.0,2
14741,GO:0097009,energy homeostasis,3,0.0,1.0,1.0,1
14742,GO:0097094,craniofacial suture morphogenesis,3,0.0,1.0,1.0,3
14743,GO:0097120,receptor localization to synapse,3,0.0,1.0,1.0,7
14744,GO:0097164,ammonium ion metabolic process,3,0.0,1.0,1.0,3
14745,GO:0097179,protease inhibitor complex,3,0.0,1.0,1.0,1
14746,GO:0097354,prenylation,3,0.0,1.0,1.0,1
14747,GO:0097437,maintenance of dormancy,3,0.0,1.0,1.0,1
14748,GO:0097438,exit from dormancy,3,0.0,1.0,1.0,1
14749,GO:0097439,acquisition of desiccation tolerance,3,0.0,1.0,1.0,1
14750,GO:0097517,contractile actin filament bundle,3,0.0,1.0,1.0,1
14751,GO:0097518,parallel actin filament bundle,3,0.0,1.0,1.0,2
14752,GO:0097612,dinoflagellate sulcus,3,0.0,1.0,1.0,1
14753,GO:0097709,connective tissue replacement,3,0.0,1.0,1.0,1
14754,GO:0097714,response to viscosity,3,0.0,1.0,1.0,1
14755,GO:0097722,sperm motility,3,0.0,1.0,1.0,2
14756,GO:0098022,"viral capsid, fiber",3,0.0,1.0,1.0,2
14757,GO:0098531,ligand-activated transcription factor activity,3,0.0,1.0,1.0,3
14758,GO:0098544,maintenance of protein complex location,3,0.0,1.0,1.0,1
14759,GO:0098562,cytoplasmic side of membrane,3,0.0,1.0,1.0,7
14760,GO:0098576,lumenal side of membrane,3,0.0,1.0,1.0,6
14761,GO:0098590,plasma membrane region,3,0.0,1.0,1.0,18
14762,GO:0098599,palmitoyl hydrolase activity,3,0.0,1.0,1.0,1
14763,GO:0098609,cell-cell adhesion,3,0.0,1.0,1.0,20
14764,GO:0098630,aggregation of unicellular organisms,3,0.0,1.0,1.0,1
14765,GO:0098635,protein complex involved in cell-cell adhesion,3,0.0,1.0,1.0,2
14766,GO:0098637,protein complex involved in cell-matrix adhesion,3,0.0,1.0,1.0,4
14767,GO:0098642,network-forming collagen trimer,3,0.0,1.0,1.0,2
14768,GO:0098644,complex of collagen trimers,3,0.0,1.0,1.0,3
14769,GO:0098651,basement membrane collagen trimer,3,0.0,1.0,1.0,5
14770,GO:0098665,serotonin receptor complex,3,0.0,1.0,1.0,1
14771,GO:0098725,symmetric cell division,3,0.0,1.0,1.0,1
14772,GO:0098762,meiotic cell cycle phase,3,0.0,1.0,1.0,5
14773,GO:0098763,mitotic cell cycle phase,3,0.0,1.0,1.0,2
14774,GO:0098771,inorganic ion homeostasis,3,0.0,1.0,1.0,16
14775,GO:0098791,Golgi apparatus subcompartment,3,0.0,1.0,1.0,3
14776,GO:0098797,plasma membrane protein complex,3,0.0,1.0,1.0,168
14777,GO:0098799,outer mitochondrial membrane protein complex,3,0.0,1.0,1.0,3
14778,GO:0098800,inner mitochondrial membrane protein complex,3,0.0,1.0,1.0,14
14779,GO:0098807,chloroplast thylakoid membrane protein complex,3,0.0,1.0,1.0,6
14780,GO:0098827,endoplasmic reticulum subcompartment,3,0.0,1.0,1.0,4
14781,GO:0098857,membrane microdomain,3,0.0,1.0,1.0,3
14782,GO:0098869,cellular oxidant detoxification,3,0.0,1.0,1.0,2
14783,GO:0099072,regulation of postsynaptic membrane neurotransmitter receptor levels,3,0.0,1.0,1.0,5
14784,GO:0099081,supramolecular polymer,3,0.0,1.0,1.0,2
14785,GO:0099120,socially cooperative development,3,0.0,1.0,1.0,7
14786,GO:0099181,structural constituent of presynapse,3,0.0,1.0,1.0,1
14787,GO:0099186,structural constituent of postsynapse,3,0.0,1.0,1.0,3
14788,GO:0099402,plant organ development,3,0.0,1.0,1.0,6
14789,GO:0099522,cytosolic region,3,0.0,1.0,1.0,2
14790,GO:0099568,cytoplasmic region,3,0.0,1.0,1.0,2
14791,GO:0099572,postsynaptic specialization,3,0.0,1.0,1.0,3
14792,GO:0099602,neurotransmitter receptor regulator activity,3,0.0,1.0,1.0,1
14793,GO:0101031,protein folding chaperone complex,3,0.0,1.0,1.0,6
14794,GO:0104004,cellular response to environmental stimulus,3,0.0,1.0,1.0,1
14795,GO:0106083,nuclear membrane protein complex,3,0.0,1.0,1.0,1
14796,GO:0106254,lipid sensor activity,3,0.0,1.0,1.0,2
14797,GO:0110051,metabolite repair,3,0.0,1.0,1.0,1
14798,GO:0110095,cellular detoxification of aldehyde,3,0.0,1.0,1.0,2
14799,GO:0110100,spindle pole body separation,3,0.0,1.0,1.0,2
14800,GO:0120013,lipid transfer activity,3,0.0,1.0,1.0,8
14801,GO:0120246,acetylenic compound metabolic process,3,0.0,1.0,1.0,4
14802,GO:0120252,hydrocarbon metabolic process,3,0.0,1.0,1.0,11
14803,GO:0120254,olefinic compound metabolic process,3,0.0,1.0,1.0,30
14804,GO:0120305,regulation of pigmentation,3,0.0,1.0,1.0,2
14805,GO:0140030,modification-dependent protein binding,3,0.0,1.0,1.0,7
14806,GO:0140056,organelle localization by membrane tethering,3,0.0,1.0,1.0,10
14807,GO:0140097,"catalytic activity, acting on DNA",3,0.0,1.0,1.0,25
14808,GO:0140098,"catalytic activity, acting on RNA",3,0.0,1.0,1.0,24
14809,GO:0140103,"catalytic activity, acting on a glycoprotein",3,0.0,1.0,1.0,20
14810,GO:0140272,exogenous protein binding,3,0.0,1.0,1.0,2
14811,GO:0140274,repair of kinetochore microtubule attachment defect,3,0.0,1.0,1.0,2
14812,GO:0140303,intramembrane lipid transporter activity,3,0.0,1.0,1.0,2
14813,GO:0140312,cargo adaptor activity,3,0.0,1.0,1.0,1
14814,GO:0140375,immune receptor activity,3,0.0,1.0,1.0,7
14815,GO:0140457,protein demethylase activity,3,0.0,1.0,1.0,1
14816,GO:0140463,chromatin-protein adaptor activity,3,0.0,1.0,1.0,2
14817,GO:0140517,protein-RNA adaptor activity,3,0.0,1.0,1.0,5
14818,GO:0140612,DNA damage sensor activity,3,0.0,1.0,1.0,1
14819,GO:0140713,histone chaperone activity,3,0.0,1.0,1.0,4
14820,GO:0140767,enzyme-substrate adaptor activity,3,0.0,1.0,1.0,2
14821,GO:0140784,metal ion sensor activity,3,0.0,1.0,1.0,5
14822,GO:0140785,amino acid sensor activity,3,0.0,1.0,1.0,3
14823,GO:0140961,cellular detoxification of metal ion,3,0.0,1.0,1.0,2
14824,GO:0140962,multicellular organismal-level chemical homeostasis,3,0.0,1.0,1.0,3
14825,GO:0140975,disruption of cellular anatomical structure in another organism,3,0.0,1.0,1.0,3
14826,GO:0140993,histone modifying activity,3,0.0,1.0,1.0,17
14827,GO:0140994,RNA polymerase II CTD heptapeptide repeat modifying activity,3,0.0,1.0,1.0,3
14828,GO:0141062,disruption of tissue in another organism,3,0.0,1.0,1.0,1
14829,GO:0141107,methyltransferase regulator activity,3,0.0,1.0,1.0,1
14830,GO:0141109,transporter activator activity,3,0.0,1.0,1.0,1
14831,GO:0141110,transporter inhibitor activity,3,0.0,1.0,1.0,2
14832,GO:0141122,nitrogen-oxygen hydrolyase activity,3,0.0,1.0,1.0,3
14833,GO:0170055,lipid transmembrane transporter activity,3,0.0,1.0,1.0,11
14834,GO:1900558,austinol metabolic process,3,0.0,1.0,1.0,2
14835,GO:1900619,acetate ester metabolic process,3,0.0,1.0,1.0,7
14836,GO:1900629,methanophenazine metabolic process,3,0.0,1.0,1.0,1
14837,GO:1900750,oligopeptide binding,3,0.0,1.0,1.0,2
14838,GO:1901125,candicidin metabolic process,3,0.0,1.0,1.0,2
14839,GO:1901160,primary amino compound metabolic process,3,0.0,1.0,1.0,12
14840,GO:1901265,nucleoside phosphate binding,3,0.0,1.0,1.0,5
14841,GO:1901275,tartrate metabolic process,3,0.0,1.0,1.0,2
14842,GO:1901286,iron-sulfur-molybdenum cofactor metabolic process,3,0.0,1.0,1.0,2
14843,GO:1901334,lactone metabolic process,3,0.0,1.0,1.0,11
14844,GO:1901338,catecholamine binding,3,0.0,1.0,1.0,3
14845,GO:1901363,heterocyclic compound binding,3,0.0,1.0,1.0,33
14846,GO:1901375,acetate ester transmembrane transporter activity,3,0.0,1.0,1.0,1
14847,GO:1901440,poly(hydroxyalkanoate) metabolic process,3,0.0,1.0,1.0,3
14848,GO:1901474,azole transmembrane transporter activity,3,0.0,1.0,1.0,10
14849,GO:1901505,carbohydrate derivative transmembrane transporter activity,3,0.0,1.0,1.0,26
14850,GO:1901513,lipo-chitin oligosaccharide transmembrane transporter activity,3,0.0,1.0,1.0,1
14851,GO:1901562,response to paraquat,3,0.0,1.0,1.0,1
14852,GO:1901567,fatty acid derivative binding,3,0.0,1.0,1.0,4
14853,GO:1901618,organic hydroxy compound transmembrane transporter activity,3,0.0,1.0,1.0,18
14854,GO:1901652,response to peptide,3,0.0,1.0,1.0,2
14855,GO:1901682,sulfur compound transmembrane transporter activity,3,0.0,1.0,1.0,19
14856,GO:1901683,arsenate ion transmembrane transporter activity,3,0.0,1.0,1.0,1
14857,GO:1901702,salt transmembrane transporter activity,3,0.0,1.0,1.0,2
14858,GO:1901764,phosphinothricin metabolic process,3,0.0,1.0,1.0,2
14859,GO:1901850,"7,8-didemethyl-8-hydroxy-5-deazariboflavin metabolic process",3,0.0,1.0,1.0,2
14860,GO:1901902,tyrocidine metabolic process,3,0.0,1.0,1.0,2
14861,GO:1902061,betaine aldehyde metabolic process,3,0.0,1.0,1.0,2
14862,GO:1902074,response to salt,3,0.0,1.0,1.0,3
14863,GO:1902421,hydrogen metabolic process,3,0.0,1.0,1.0,2
14864,GO:1902495,transmembrane transporter complex,3,0.0,1.0,1.0,21
14865,GO:1902610,response to N-phenylthiourea,3,0.0,1.0,1.0,1
14866,GO:1902617,response to fluoride,3,0.0,1.0,1.0,1
14867,GO:1902687,glucosidase complex,3,0.0,1.0,1.0,2
14868,GO:1902710,GABA receptor complex,3,0.0,1.0,1.0,2
14869,GO:1902773,GTPase activator complex,3,0.0,1.0,1.0,2
14870,GO:1902778,response to alkane,3,0.0,1.0,1.0,7
14871,GO:1903046,meiotic cell cycle process,3,0.0,1.0,1.0,58
14872,GO:1903047,mitotic cell cycle process,3,0.0,1.0,1.0,52
14873,GO:1903293,phosphatase complex,3,0.0,1.0,1.0,5
14874,GO:1903768,taste receptor complex,3,0.0,1.0,1.0,1
14875,GO:1903867,extraembryonic membrane development,3,0.0,1.0,1.0,2
14876,GO:1903927,response to cyanide,3,0.0,1.0,1.0,1
14877,GO:1904010,response to Aroclor 1254,3,0.0,1.0,1.0,1
14878,GO:1904016,response to Thyroglobulin triiodothyronine,3,0.0,1.0,1.0,1
14879,GO:1904147,response to nonylphenol,3,0.0,1.0,1.0,1
14880,GO:1904311,response to gold(3+),3,0.0,1.0,1.0,1
14881,GO:1904619,response to dimethyl sulfoxide,3,0.0,1.0,1.0,1
14882,GO:1904680,peptide transmembrane transporter activity,3,0.0,1.0,1.0,2
14883,GO:1904817,serous membrane development,3,0.0,1.0,1.0,1
14884,GO:1904880,response to hydrogen sulfide,3,0.0,1.0,1.0,1
14885,GO:1904949,ATPase complex,3,0.0,1.0,1.0,6
14886,GO:1905328,plant septum development,3,0.0,1.0,1.0,3
14887,GO:1905348,endonuclease complex,3,0.0,1.0,1.0,2
14888,GO:1905354,exoribonuclease complex,3,0.0,1.0,1.0,4
14889,GO:1905360,GTPase complex,3,0.0,1.0,1.0,8
14890,GO:1905368,peptidase complex,3,0.0,1.0,1.0,8
14891,GO:1905392,plant organ morphogenesis,3,0.0,1.0,1.0,5
14892,GO:1905393,plant organ formation,3,0.0,1.0,1.0,5
14893,GO:1990039,hypolemmal cisterna,3,0.0,1.0,1.0,1
14894,GO:1990077,primosome complex,3,0.0,1.0,1.0,5
14895,GO:1990204,oxidoreductase complex,3,0.0,1.0,1.0,44
14896,GO:1990233,intramolecular phosphotransferase complex,3,0.0,1.0,1.0,1
14897,GO:1990234,transferase complex,3,0.0,1.0,1.0,44
14898,GO:1990267,response to transition metal nanoparticle,3,0.0,1.0,1.0,1
14899,GO:1990391,DNA repair complex,3,0.0,1.0,1.0,3
14900,GO:1990531,phospholipid-translocating ATPase complex,3,0.0,1.0,1.0,1
14901,GO:1990840,response to lectin,3,0.0,1.0,1.0,1
14902,GO:1990845,adaptive thermogenesis,3,0.0,1.0,1.0,2
14903,GO:1990849,vacuolar localization,3,0.0,1.0,1.0,4
14904,GO:2000241,regulation of reproductive process,3,0.0,1.0,1.0,58
14905,GO:2000793,cell proliferation involved in heart valve development,3,0.0,1.0,1.0,1
14906,GO:2001057,reactive nitrogen species metabolic process,3,0.0,1.0,1.0,2
14907,GO:2001119,methanofuran metabolic process,3,0.0,1.0,1.0,1
117,GO:0043933,protein-containing complex organization,4,6727.26,6.06,7.290552091249141e-10,10
0,GO:0016298,lipase activity,4,5255.67,299.33,4.476244929683989e-190,6
7,GO:0006629,lipid metabolic process,4,4484.84,17.5,1.0520675900729097e-102,15
326,GO:0007165,signal transduction,4,3669.41,1.78,0.1203127934543066,30
39,GO:0071813,lipoprotein particle binding,4,2242.42,507.72,1.7499181697141197e-29,5
150,GO:0051240,positive regulation of multicellular organismal process,4,2242.42,9.16,6.738787631363272e-07,124
161,GO:0010984,regulation of lipoprotein particle clearance,4,2242.42,123.06,2.245555914905283e-06,6
140,GO:0052689,carboxylic ester hydrolase activity,4,2087.77,10.99,2.9014582308807825e-08,88
240,GO:1901136,carbohydrate derivative catabolic process,4,1922.07,3.8,0.0051239605949848,21
75,GO:1905952,regulation of lipid localization,4,1441.55,79.25,4.790105333778781e-15,3
95,GO:0010883,regulation of lipid storage,4,1441.55,168.18,2.1691194810358295e-12,4
65,GO:1904177,regulation of adipose tissue development,4,1223.14,823.75,1.2448656778542115e-16,2
202,GO:0051094,positive regulation of developmental process,4,1223.14,7.47,0.0001627865737906,104
361,GO:0048522,positive regulation of cellular process,4,820.4,1.38,0.267740393806996,63
371,GO:0019222,regulation of metabolic process,4,820.4,1.18,0.3532744363996238,38
40,GO:0043395,heparan sulfate proteoglycan binding,4,704.76,704.76,9.569142946972855e-29,0
113,GO:0012506,vesicle membrane,4,692.51,14.52,3.1883865646238575e-10,1
195,GO:0098588,bounding membrane of organelle,4,692.51,3.97,0.0001003056771749,29
207,GO:0045595,regulation of cell differentiation,4,672.73,6.94,0.0002420368018795,41
221,GO:0010034,response to acetate,4,611.57,611.57,0.0016339392088922,1
155,GO:0050892,intestinal absorption,4,576.62,161.45,9.927321244387329e-07,4
277,GO:0019637,organophosphate metabolic process,4,509.64,1.71,0.0264512449301557,31
324,GO:0006796,phosphate-containing compound metabolic process,4,509.64,1.41,0.1032127755230999,32
105,GO:0015850,organic hydroxy compound transport,4,368.62,51.58,1.1347869161708848e-10,41
149,GO:0006869,lipid transport,4,368.62,15.08,4.849286033390524e-07,21
33,GO:0034358,plasma lipoprotein particle,4,352.38,230.48,2.1298671709558176e-33,4
51,GO:0055090,acylglycerol homeostasis,4,307.18,282.66,3.842149235046586e-22,1
37,GO:0055092,sterol homeostasis,4,260.75,249.77,6.856655527298311e-32,1
108,GO:0070542,response to fatty acid,4,211.55,78.22,2.1450932096450584e-10,11
168,GO:0071396,cellular response to lipid,4,211.55,19.14,7.255913646616782e-06,32
208,GO:1901701,cellular response to oxygen-containing compound,4,211.55,8.52,0.0003243450608996,123
19,GO:0008201,heparin binding,4,201.31,201.31,1.6937129163630178e-48,0
151,GO:0055091,phospholipid homeostasis,4,177.03,177.03,7.521585330373868e-07,0
189,GO:0006968,cellular defense response,4,168.18,168.18,6.845563263731395e-05,0
191,GO:0034382,chylomicron remnant clearance,4,156.45,156.45,7.913302363618088e-05,0
315,GO:0051049,regulation of transport,4,134.55,2.81,0.0918988880767077,36
119,GO:0031670,cellular response to nutrient,4,106.44,106.44,1.572521749448813e-09,5
346,GO:0043085,positive regulation of catalytic activity,4,105.11,3.03,0.2813583441551247,9
355,GO:0051336,regulation of hydrolase activity,4,105.11,2.03,0.3903636929354288,18
319,GO:0009404,toxin metabolic process,4,90.91,9.33,0.1017024536439825,8
253,GO:0032026,response to magnesium ion,4,73.93,73.93,0.0134380618376785,1
166,GO:0019538,protein metabolic process,4,73.12,0.07,0.999999774388452,20
188,GO:0009059,macromolecule biosynthetic process,4,73.12,0.08,0.9999980372593722,25
292,GO:1901137,carbohydrate derivative biosynthetic process,4,73.12,0.18,0.9963643741822726,28
379,GO:0044272,sulfur compound biosynthetic process,4,73.12,0.48,0.8791052750698966,35
96,GO:0009743,response to carbohydrate,4,72.56,52.4,4.432819034702679e-12,9
215,GO:0032101,regulation of response to external stimulus,4,65.82,7.54,0.0005613986144884,22
228,GO:0080134,regulation of response to stress,4,65.82,5.49,0.0022687974221839,12
252,GO:0048584,positive regulation of response to stimulus,4,65.82,3.57,0.0133320095748397,51
263,GO:0031016,pancreas development,4,57.5,57.5,0.0172446362656153,0
296,GO:1900076,regulation of cellular response to insulin stimulus,4,42.05,20.08,0.0485957289461304,2
317,GO:0048523,negative regulation of cellular process,4,42.05,0.21,0.9930028900669589,73
392,GO:0048585,negative regulation of response to stimulus,4,42.05,1.01,0.6322914950603311,53
285,GO:0006066,alcohol metabolic process,4,31.69,3.21,0.0367459905964882,15
210,GO:0048545,response to steroid hormone,4,31.53,20.96,0.0004237892655263,4
64,GO:0031640,killing of cells of another organism,4,29.58,29.58,6.754554960403066e-17,3
313,GO:0043232,intracellular membraneless organelle,4,26.49,0.22,0.991041462991622,39
318,GO:0098858,actin-based cell projection,4,24.73,9.84,0.096741492808912,3
293,GO:0046688,response to copper ion,4,22.2,22.2,0.0440563729903722,2
249,GO:0043169,cation binding,4,21.71,1.53,0.0056555066674467,28
270,GO:0043231,intracellular membrane-bounded organelle,4,21.07,0.36,0.997138456740195,36
272,GO:0031982,vesicle,4,21.07,3.12,0.0224995594228564,2
184,GO:0043434,response to peptide hormone,4,20.75,20.75,4.597909896618032e-05,15
372,GO:2000026,regulation of multicellular organismal development,4,18.23,1.16,0.5801444106526304,21
276,GO:0006082,organic acid metabolic process,4,17.18,1.71,0.0178529541802352,13
306,GO:0044283,small molecule biosynthetic process,4,17.18,1.6,0.0507751674646816,10
327,GO:0048732,gland development,4,13.11,5.85,0.1571686591467817,24
309,GO:0051592,response to calcium ion,4,12.37,12.37,0.0777241441826299,2
213,GO:0051707,response to other organism,4,10.96,4.42,0.0004715994498642,13
316,GO:0043200,response to amino acid,4,10.19,10.19,0.0935091116435438,19
170,GO:0043005,neuron projection,4,9.92,9.92,7.518941321384742e-06,17
194,GO:0042803,protein homodimerization activity,4,8.36,8.36,8.869865054351787e-05,0
368,GO:0070013,intracellular organelle lumen,4,7.37,1.23,0.5583460665473505,19
335,GO:0009790,embryo development,4,5.51,4.27,0.2092492562881664,2
333,GO:0032870,cellular response to hormone stimulus,4,4.44,4.44,0.2019066073235025,15
336,GO:0036293,response to decreased oxygen levels,4,4.4,4.19,0.2124259662101409,4
12031,GO:0000087,mitotic M phase,4,0.0,1.0,1.0,1
12032,GO:0000090,mitotic anaphase,4,0.0,1.0,1.0,2
12033,GO:0000095,S-adenosyl-L-methionine transmembrane transporter activity,4,0.0,1.0,1.0,1
12034,GO:0000103,sulfate assimilation,4,0.0,1.0,1.0,3
12035,GO:0000104,succinate dehydrogenase activity,4,0.0,1.0,1.0,2
12036,GO:0000126,transcription factor TFIIIB complex,4,0.0,1.0,1.0,2
12037,GO:0000151,ubiquitin ligase complex,4,0.0,1.0,1.0,11
12038,GO:0000166,nucleotide binding,4,0.0,1.0,1.0,9
12039,GO:0000178,exosome (RNase complex),4,0.0,1.0,1.0,2
12040,GO:0000255,allantoin metabolic process,4,0.0,1.0,1.0,2
12041,GO:0000268,peroxisome targeting sequence binding,4,0.0,1.0,1.0,3
12042,GO:0000282,cellular bud site selection,4,0.0,1.0,1.0,2
12043,GO:0000293,ferric-chelate reductase activity,4,0.0,1.0,1.0,2
12044,GO:0000302,response to reactive oxygen species,4,0.0,1.0,1.0,6
12045,GO:0000439,transcription factor TFIIH core complex,4,0.0,1.0,1.0,2
12046,GO:0000510,H3-H4 histone complex chaperone activity,4,0.0,1.0,1.0,1
12047,GO:0000578,embryonic axis specification,4,0.0,1.0,1.0,6
12048,GO:0000768,syncytium formation by plasma membrane fusion,4,0.0,1.0,1.0,3
12049,GO:0000783,nuclear telomere cap complex,4,0.0,1.0,1.0,2
12050,GO:0000911,cytokinesis by cell plate formation,4,0.0,1.0,1.0,2
12051,GO:0001067,transcription regulatory region nucleic acid binding,4,0.0,1.0,1.0,2
12052,GO:0001099,basal RNA polymerase II transcription machinery binding,4,0.0,1.0,1.0,2
12053,GO:0001221,transcription coregulator binding,4,0.0,1.0,1.0,2
12054,GO:0001501,skeletal system development,4,0.0,1.0,1.0,1
12055,GO:0001508,action potential,4,0.0,1.0,1.0,5
12056,GO:0001555,oocyte growth,4,0.0,1.0,1.0,1
12057,GO:0001570,vasculogenesis,4,0.0,1.0,1.0,2
12058,GO:0001664,G protein-coupled receptor binding,4,0.0,1.0,1.0,43
12059,GO:0001667,ameboidal-type cell migration,4,0.0,1.0,1.0,6
12060,GO:0001707,mesoderm formation,4,0.0,1.0,1.0,4
12061,GO:0001736,establishment of planar polarity,4,0.0,1.0,1.0,8
12062,GO:0001739,sex chromatin,4,0.0,1.0,1.0,1
12063,GO:0001743,lens placode formation,4,0.0,1.0,1.0,1
12064,GO:0001764,neuron migration,4,0.0,1.0,1.0,8
12065,GO:0001767,establishment of lymphocyte polarity,4,0.0,1.0,1.0,3
12066,GO:0001776,leukocyte homeostasis,4,0.0,1.0,1.0,8
12067,GO:0001822,kidney development,4,0.0,1.0,1.0,3
12068,GO:0001847,opsonin receptor activity,4,0.0,1.0,1.0,7
12069,GO:0001873,polysaccharide immune receptor activity,4,0.0,1.0,1.0,1
12070,GO:0001882,nucleoside binding,4,0.0,1.0,1.0,4
12071,GO:0001894,tissue homeostasis,4,0.0,1.0,1.0,10
12072,GO:0001909,leukocyte mediated cytotoxicity,4,0.0,1.0,1.0,5
12073,GO:0001935,endothelial cell proliferation,4,0.0,1.0,1.0,2
12074,GO:0001944,vasculature development,4,0.0,1.0,1.0,4
12075,GO:0001957,intramembranous ossification,4,0.0,1.0,1.0,1
12076,GO:0001976,nervous system process involved in regulation of systemic arterial blood pressure,4,0.0,1.0,1.0,11
12077,GO:0002007,detection of hypoxic conditions in blood by chemoreceptor signaling,4,0.0,1.0,1.0,2
12078,GO:0002009,morphogenesis of an epithelium,4,0.0,1.0,1.0,22
12079,GO:0002020,protease binding,4,0.0,1.0,1.0,2
12080,GO:0002054,nucleobase binding,4,0.0,1.0,1.0,2
12081,GO:0002062,chondrocyte differentiation,4,0.0,1.0,1.0,1
12082,GO:0002063,chondrocyte development,4,0.0,1.0,1.0,1
12083,GO:0002064,epithelial cell development,4,0.0,1.0,1.0,10
12084,GO:0002164,larval development,4,0.0,1.0,1.0,3
12085,GO:0002165,instar larval or pupal development,4,0.0,1.0,1.0,3
12086,GO:0002178,palmitoyltransferase complex,4,0.0,1.0,1.0,4
12087,GO:0002183,cytoplasmic translational initiation,4,0.0,1.0,1.0,3
12088,GO:0002208,somatic diversification of immunoglobulins involved in immune response,4,0.0,1.0,1.0,3
12089,GO:0002209,behavioral defense response,4,0.0,1.0,1.0,3
12090,GO:0002237,response to molecule of bacterial origin,4,0.0,1.0,1.0,6
12091,GO:0002238,response to molecule of fungal origin,4,0.0,1.0,1.0,2
12092,GO:0002240,response to molecule of oomycetes origin,4,0.0,1.0,1.0,2
12093,GO:0002244,hematopoietic progenitor cell differentiation,4,0.0,1.0,1.0,3
12094,GO:0002262,myeloid cell homeostasis,4,0.0,1.0,1.0,7
12095,GO:0002264,endothelial cell activation involved in immune response,4,0.0,1.0,1.0,1
12096,GO:0002269,leukocyte activation involved in inflammatory response,4,0.0,1.0,1.0,1
12097,GO:0002270,plasmacytoid dendritic cell activation,4,0.0,1.0,1.0,2
12098,GO:0002274,myeloid leukocyte activation,4,0.0,1.0,1.0,6
12099,GO:0002326,B cell lineage commitment,4,0.0,1.0,1.0,1
12100,GO:0002360,T cell lineage commitment,4,0.0,1.0,1.0,3
12101,GO:0002366,leukocyte activation involved in immune response,4,0.0,1.0,1.0,5
12102,GO:0002385,mucosal immune response,4,0.0,1.0,1.0,2
12103,GO:0002388,immune response in Peyer's patch,4,0.0,1.0,1.0,1
12104,GO:0002395,immune response in nasopharyngeal-associated lymphoid tissue,4,0.0,1.0,1.0,1
12105,GO:0002418,immune response to tumor cell,4,0.0,1.0,1.0,3
12106,GO:0002428,antigen processing and presentation of peptide antigen via MHC class Ib,4,0.0,1.0,1.0,2
12107,GO:0002444,myeloid leukocyte mediated immunity,4,0.0,1.0,1.0,8
12108,GO:0002449,lymphocyte mediated immunity,4,0.0,1.0,1.0,3
12109,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,4,0.0,1.0,1.0,9
12110,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,4,0.0,1.0,1.0,2
12111,GO:0002478,antigen processing and presentation of exogenous peptide antigen,4,0.0,1.0,1.0,3
12112,GO:0002483,antigen processing and presentation of endogenous peptide antigen,4,0.0,1.0,1.0,3
12113,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,4,0.0,1.0,1.0,2
12114,GO:0002515,B cell anergy,4,0.0,1.0,1.0,2
12115,GO:0002521,leukocyte differentiation,4,0.0,1.0,1.0,2
12116,GO:0002577,regulation of antigen processing and presentation,4,0.0,1.0,1.0,11
12117,GO:0002643,regulation of tolerance induction,4,0.0,1.0,1.0,10
12118,GO:0002679,respiratory burst involved in defense response,4,0.0,1.0,1.0,2
12119,GO:0002683,negative regulation of immune system process,4,0.0,1.0,1.0,25
12120,GO:0002684,positive regulation of immune system process,4,0.0,1.0,1.0,15
12121,GO:0002697,regulation of immune effector process,4,0.0,1.0,1.0,20
12122,GO:0002751,antigen processing and presentation following receptor mediated endocytosis,4,0.0,1.0,1.0,1
12123,GO:0002831,regulation of response to biotic stimulus,4,0.0,1.0,1.0,16
12124,GO:0003015,heart process,4,0.0,1.0,1.0,2
12125,GO:0003018,vascular process in circulatory system,4,0.0,1.0,1.0,5
12126,GO:0003030,detection of hydrogen ion,4,0.0,1.0,1.0,1
12127,GO:0003031,detection of carbon dioxide,4,0.0,1.0,1.0,2
12128,GO:0003032,detection of oxygen,4,0.0,1.0,1.0,1
12129,GO:0003071,renal system process involved in regulation of systemic arterial blood pressure,4,0.0,1.0,1.0,4
12130,GO:0003073,regulation of systemic arterial blood pressure,4,0.0,1.0,1.0,5
12131,GO:0003171,atrioventricular valve development,4,0.0,1.0,1.0,2
12132,GO:0003181,atrioventricular valve morphogenesis,4,0.0,1.0,1.0,2
12133,GO:0003190,atrioventricular valve formation,4,0.0,1.0,1.0,2
12134,GO:0003208,cardiac ventricle morphogenesis,4,0.0,1.0,1.0,2
12135,GO:0003209,cardiac atrium morphogenesis,4,0.0,1.0,1.0,2
12136,GO:0003210,cardiac atrium formation,4,0.0,1.0,1.0,2
12137,GO:0003211,cardiac ventricle formation,4,0.0,1.0,1.0,2
12138,GO:0003241,growth involved in heart morphogenesis,4,0.0,1.0,1.0,6
12139,GO:0003254,regulation of membrane depolarization,4,0.0,1.0,1.0,6
12140,GO:0003281,ventricular septum development,4,0.0,1.0,1.0,1
12141,GO:0003283,atrial septum development,4,0.0,1.0,1.0,3
12142,GO:0003341,cilium movement,4,0.0,1.0,1.0,2
12143,GO:0003365,establishment of cell polarity involved in ameboidal cell migration,4,0.0,1.0,1.0,1
12144,GO:0003382,epithelial cell morphogenesis,4,0.0,1.0,1.0,3
12145,GO:0003394,cell adhesion involved in dendrite retrograde extension,4,0.0,1.0,1.0,1
12146,GO:0003401,axis elongation,4,0.0,1.0,1.0,3
12147,GO:0003415,chondrocyte hypertrophy,4,0.0,1.0,1.0,1
12148,GO:0003677,DNA binding,4,0.0,1.0,1.0,15
12149,GO:0003713,transcription coactivator activity,4,0.0,1.0,1.0,1
12150,GO:0003714,transcription corepressor activity,4,0.0,1.0,1.0,2
12151,GO:0003723,RNA binding,4,0.0,1.0,1.0,28
12152,GO:0003724,RNA helicase activity,4,0.0,1.0,1.0,2
12153,GO:0003755,peptidyl-prolyl cis-trans isomerase activity,4,0.0,1.0,1.0,1
12154,GO:0003779,actin binding,4,0.0,1.0,1.0,2
12155,GO:0003906,DNA-(apurinic or apyrimidinic site) endonuclease activity,4,0.0,1.0,1.0,2
12156,GO:0003909,DNA ligase activity,4,0.0,1.0,1.0,2
12157,GO:0003913,DNA photolyase activity,4,0.0,1.0,1.0,2
12158,GO:0003916,DNA topoisomerase activity,4,0.0,1.0,1.0,3
12159,GO:0003954,NADH dehydrogenase activity,4,0.0,1.0,1.0,1
12160,GO:0003961,O-acetylhomoserine aminocarboxypropyltransferase activity,4,0.0,1.0,1.0,1
12161,GO:0004016,adenylate cyclase activity,4,0.0,1.0,1.0,1
12162,GO:0004152,dihydroorotate dehydrogenase activity,4,0.0,1.0,1.0,4
12163,GO:0004175,endopeptidase activity,4,0.0,1.0,1.0,8
12164,GO:0004344,glucose dehydrogenase activity,4,0.0,1.0,1.0,3
12165,GO:0004457,lactate dehydrogenase activity,4,0.0,1.0,1.0,4
12166,GO:0004518,nuclease activity,4,0.0,1.0,1.0,5
12167,GO:0004553,"hydrolase activity, hydrolyzing O-glycosyl compounds",4,0.0,1.0,1.0,102
12168,GO:0004601,peroxidase activity,4,0.0,1.0,1.0,17
12169,GO:0004659,prenyltransferase activity,4,0.0,1.0,1.0,23
12170,GO:0004738,pyruvate dehydrogenase activity,4,0.0,1.0,1.0,2
12171,GO:0004875,complement receptor activity,4,0.0,1.0,1.0,8
12172,GO:0004879,nuclear receptor activity,4,0.0,1.0,1.0,4
12173,GO:0004896,cytokine receptor activity,4,0.0,1.0,1.0,38
12174,GO:0004930,G protein-coupled receptor activity,4,0.0,1.0,1.0,45
12175,GO:0004984,olfactory receptor activity,4,0.0,1.0,1.0,2
12176,GO:0005034,osmosensor activity,4,0.0,1.0,1.0,1
12177,GO:0005035,death receptor activity,4,0.0,1.0,1.0,2
12178,GO:0005042,netrin receptor activity,4,0.0,1.0,1.0,2
12179,GO:0005126,cytokine receptor binding,4,0.0,1.0,1.0,47
12180,GO:0005178,integrin binding,4,0.0,1.0,1.0,1
12181,GO:0005277,acetylcholine transmembrane transporter activity,4,0.0,1.0,1.0,1
12182,GO:0005337,nucleoside transmembrane transporter activity,4,0.0,1.0,1.0,8
12183,GO:0005338,nucleotide-sugar transmembrane transporter activity,4,0.0,1.0,1.0,2
12184,GO:0005345,purine nucleobase transmembrane transporter activity,4,0.0,1.0,1.0,4
12185,GO:0005350,pyrimidine nucleobase transmembrane transporter activity,4,0.0,1.0,1.0,3
12186,GO:0005368,taurine transmembrane transporter activity,4,0.0,1.0,1.0,2
12187,GO:0005372,water transmembrane transporter activity,4,0.0,1.0,1.0,1
12188,GO:0005499,vitamin D binding,4,0.0,1.0,1.0,1
12189,GO:0005501,retinoid binding,4,0.0,1.0,1.0,4
12190,GO:0005520,insulin-like growth factor binding,4,0.0,1.0,1.0,2
12191,GO:0005669,transcription factor TFIID complex,4,0.0,1.0,1.0,1
12192,GO:0005684,U2-type spliceosomal complex,4,0.0,1.0,1.0,7
12193,GO:0005689,U12-type spliceosomal complex,4,0.0,1.0,1.0,6
12194,GO:0005721,pericentric heterochromatin,4,0.0,1.0,1.0,2
12195,GO:0005742,mitochondrial outer membrane translocase complex,4,0.0,1.0,1.0,3
12196,GO:0005789,endoplasmic reticulum membrane,4,0.0,1.0,1.0,4
12197,GO:0005858,axonemal dynein complex,4,0.0,1.0,1.0,2
12198,GO:0005911,cell-cell junction,4,0.0,1.0,1.0,13
12199,GO:0005929,cilium,4,0.0,1.0,1.0,2
12200,GO:0005975,carbohydrate metabolic process,4,0.0,1.0,1.0,12
12201,GO:0006022,aminoglycan metabolic process,4,0.0,1.0,1.0,5
12202,GO:0006040,amino sugar metabolic process,4,0.0,1.0,1.0,10
12203,GO:0006117,acetaldehyde metabolic process,4,0.0,1.0,1.0,2
12204,GO:0006139,nucleobase-containing compound metabolic process,4,0.0,1.0,1.0,6
12205,GO:0006325,chromatin organization,4,0.0,1.0,1.0,9
12206,GO:0006396,RNA processing,4,0.0,1.0,1.0,15
12207,GO:0006520,amino acid metabolic process,4,0.0,1.0,1.0,12
12208,GO:0006576,biogenic amine metabolic process,4,0.0,1.0,1.0,8
12209,GO:0006577,amino-acid betaine metabolic process,4,0.0,1.0,1.0,8
12210,GO:0006730,one-carbon metabolic process,4,0.0,1.0,1.0,2
12211,GO:0006749,glutathione metabolic process,4,0.0,1.0,1.0,3
12212,GO:0006760,folic acid-containing compound metabolic process,4,0.0,1.0,1.0,6
12213,GO:0006766,vitamin metabolic process,4,0.0,1.0,1.0,4
12214,GO:0006778,porphyrin-containing compound metabolic process,4,0.0,1.0,1.0,6
12215,GO:0006801,superoxide metabolic process,4,0.0,1.0,1.0,2
12216,GO:0006811,monoatomic ion transport,4,0.0,1.0,1.0,3
12217,GO:0006836,neurotransmitter transport,4,0.0,1.0,1.0,3
12218,GO:0006839,mitochondrial transport,4,0.0,1.0,1.0,4
12219,GO:0006858,extracellular transport,4,0.0,1.0,1.0,2
12220,GO:0006865,amino acid transport,4,0.0,1.0,1.0,14
12221,GO:0006873,intracellular monoatomic ion homeostasis,4,0.0,1.0,1.0,2
12222,GO:0006914,autophagy,4,0.0,1.0,1.0,6
12223,GO:0006915,apoptotic process,4,0.0,1.0,1.0,19
12224,GO:0006929,substrate-dependent cell migration,4,0.0,1.0,1.0,2
12225,GO:0006936,muscle contraction,4,0.0,1.0,1.0,2
12226,GO:0006954,inflammatory response,4,0.0,1.0,1.0,6
12227,GO:0006971,hypotonic response,4,0.0,1.0,1.0,2
12228,GO:0006972,hyperosmotic response,4,0.0,1.0,1.0,2
12229,GO:0006974,DNA damage response,4,0.0,1.0,1.0,5
12230,GO:0006986,response to unfolded protein,4,0.0,1.0,1.0,2
12231,GO:0006996,organelle organization,4,0.0,1.0,1.0,30
12232,GO:0007028,cytoplasm organization,4,0.0,1.0,1.0,2
12233,GO:0007105,"cytokinesis, division site positioning",4,0.0,1.0,1.0,1
12234,GO:0007159,leukocyte cell-cell adhesion,4,0.0,1.0,1.0,3
12235,GO:0007160,cell-matrix adhesion,4,0.0,1.0,1.0,7
12236,GO:0007267,cell-cell signaling,4,0.0,1.0,1.0,32
12237,GO:0007281,germ cell development,4,0.0,1.0,1.0,3
12238,GO:0007282,cystoblast division,4,0.0,1.0,1.0,1
12239,GO:0007292,female gamete generation,4,0.0,1.0,1.0,1
12240,GO:0007309,oocyte axis specification,4,0.0,1.0,1.0,3
12241,GO:0007316,pole plasm RNA localization,4,0.0,1.0,1.0,2
12242,GO:0007365,periodic partitioning,4,0.0,1.0,1.0,2
12243,GO:0007369,gastrulation,4,0.0,1.0,1.0,2
12244,GO:0007380,"specification of segmental identity, head",4,0.0,1.0,1.0,5
12245,GO:0007414,axonal defasciculation,4,0.0,1.0,1.0,1
12246,GO:0007423,sensory organ development,4,0.0,1.0,1.0,11
12247,GO:0007439,ectodermal digestive tract development,4,0.0,1.0,1.0,2
12248,GO:0007444,imaginal disc development,4,0.0,1.0,1.0,8
12249,GO:0007445,determination of imaginal disc primordium,4,0.0,1.0,1.0,2
12250,GO:0007447,imaginal disc pattern formation,4,0.0,1.0,1.0,6
12251,GO:0007498,mesoderm development,4,0.0,1.0,1.0,5
12252,GO:0007500,mesodermal cell fate determination,4,0.0,1.0,1.0,4
12253,GO:0007501,mesodermal cell fate specification,4,0.0,1.0,1.0,4
12254,GO:0007503,fat body development,4,0.0,1.0,1.0,2
12255,GO:0007507,heart development,4,0.0,1.0,1.0,2
12256,GO:0007517,muscle organ development,4,0.0,1.0,1.0,5
12257,GO:0007518,myoblast fate determination,4,0.0,1.0,1.0,1
12258,GO:0007521,muscle cell fate determination,4,0.0,1.0,1.0,2
12259,GO:0007525,somatic muscle development,4,0.0,1.0,1.0,3
12260,GO:0007531,mating type determination,4,0.0,1.0,1.0,2
12261,GO:0007538,primary sex determination,4,0.0,1.0,1.0,2
12262,GO:0007545,processes downstream of sex determination signal,4,0.0,1.0,1.0,2
12263,GO:0007560,imaginal disc morphogenesis,4,0.0,1.0,1.0,9
12264,GO:0007593,chitin-based cuticle sclerotization,4,0.0,1.0,1.0,2
12265,GO:0007599,hemostasis,4,0.0,1.0,1.0,2
12266,GO:0007600,sensory perception,4,0.0,1.0,1.0,12
12267,GO:0007617,mating behavior,4,0.0,1.0,1.0,6
12268,GO:0008015,blood circulation,4,0.0,1.0,1.0,2
12269,GO:0008066,glutamate receptor activity,4,0.0,1.0,1.0,2
12270,GO:0008094,"ATP-dependent activity, acting on DNA",4,0.0,1.0,1.0,10
12271,GO:0008104,protein localization,4,0.0,1.0,1.0,32
12272,GO:0008146,sulfotransferase activity,4,0.0,1.0,1.0,38
12273,GO:0008168,methyltransferase activity,4,0.0,1.0,1.0,86
12274,GO:0008194,UDP-glycosyltransferase activity,4,0.0,1.0,1.0,21
12275,GO:0008230,ecdysone receptor holocomplex,4,0.0,1.0,1.0,2
12276,GO:0008234,cysteine-type peptidase activity,4,0.0,1.0,1.0,9
12277,GO:0008236,serine-type peptidase activity,4,0.0,1.0,1.0,2
12278,GO:0008237,metallopeptidase activity,4,0.0,1.0,1.0,4
12279,GO:0008238,exopeptidase activity,4,0.0,1.0,1.0,10
12280,GO:0008242,omega peptidase activity,4,0.0,1.0,1.0,5
12281,GO:0008287,protein serine/threonine phosphatase complex,4,0.0,1.0,1.0,9
12282,GO:0008291,acetylcholine metabolic process,4,0.0,1.0,1.0,2
12283,GO:0008298,intracellular mRNA localization,4,0.0,1.0,1.0,2
12284,GO:0008320,protein transmembrane transporter activity,4,0.0,1.0,1.0,3
12285,GO:0008324,monoatomic cation transmembrane transporter activity,4,0.0,1.0,1.0,8
12286,GO:0008344,adult locomotory behavior,4,0.0,1.0,1.0,3
12287,GO:0008345,larval locomotory behavior,4,0.0,1.0,1.0,3
12288,GO:0008347,glial cell migration,4,0.0,1.0,1.0,5
12289,GO:0008373,sialyltransferase activity,4,0.0,1.0,1.0,10
12290,GO:0008391,arachidonate monooxygenase activity,4,0.0,1.0,1.0,1
12291,GO:0008395,steroid hydroxylase activity,4,0.0,1.0,1.0,18
12292,GO:0008401,retinoic acid 4-hydroxylase activity,4,0.0,1.0,1.0,1
12293,GO:0008406,gonad development,4,0.0,1.0,1.0,2
12294,GO:0008407,chaeta morphogenesis,4,0.0,1.0,1.0,1
12295,GO:0008410,CoA-transferase activity,4,0.0,1.0,1.0,23
12296,GO:0008452,RNA ligase activity,4,0.0,1.0,1.0,2
12297,GO:0008483,transaminase activity,4,0.0,1.0,1.0,77
12298,GO:0008484,sulfuric ester hydrolase activity,4,0.0,1.0,1.0,18
12299,GO:0008504,monoamine transmembrane transporter activity,4,0.0,1.0,1.0,5
12300,GO:0008509,monoatomic anion transmembrane transporter activity,4,0.0,1.0,1.0,9
12301,GO:0008521,acetyl-CoA transmembrane transporter activity,4,0.0,1.0,1.0,1
12302,GO:0008525,phosphatidylcholine transporter activity,4,0.0,1.0,1.0,3
12303,GO:0008527,taste receptor activity,4,0.0,1.0,1.0,6
12304,GO:0008544,epidermis development,4,0.0,1.0,1.0,1
12305,GO:0008641,ubiquitin-like modifier activating enzyme activity,4,0.0,1.0,1.0,10
12306,GO:0008643,carbohydrate transport,4,0.0,1.0,1.0,4
12307,GO:0008812,choline dehydrogenase activity,4,0.0,1.0,1.0,1
12308,GO:0008907,integrase activity,4,0.0,1.0,1.0,2
12309,GO:0008920,lipopolysaccharide heptosyltransferase activity,4,0.0,1.0,1.0,3
12310,GO:0008940,nitrate reductase activity,4,0.0,1.0,1.0,4
12311,GO:0009057,macromolecule catabolic process,4,0.0,1.0,1.0,10
12312,GO:0009233,menaquinone metabolic process,4,0.0,1.0,1.0,2
12313,GO:0009237,siderophore metabolic process,4,0.0,1.0,1.0,10
12314,GO:0009267,cellular response to starvation,4,0.0,1.0,1.0,20
12315,GO:0009274,peptidoglycan-based cell wall,4,0.0,1.0,1.0,2
12316,GO:0009277,fungal-type cell wall,4,0.0,1.0,1.0,3
12317,GO:0009279,cell outer membrane,4,0.0,1.0,1.0,1
12318,GO:0009288,bacterial-type flagellum,4,0.0,1.0,1.0,1
12319,GO:0009309,amine biosynthetic process,4,0.0,1.0,1.0,1
12320,GO:0009310,amine catabolic process,4,0.0,1.0,1.0,2
12321,GO:0009325,nitrate reductase complex,4,0.0,1.0,1.0,1
12322,GO:0009329,acetate CoA-transferase complex,4,0.0,1.0,1.0,1
12323,GO:0009408,response to heat,4,0.0,1.0,1.0,3
12324,GO:0009409,response to cold,4,0.0,1.0,1.0,4
12325,GO:0009415,response to water,4,0.0,1.0,1.0,6
12326,GO:0009416,response to light stimulus,4,0.0,1.0,1.0,13
12327,GO:0009438,methylglyoxal metabolic process,4,0.0,1.0,1.0,4
12328,GO:0009454,aerotaxis,4,0.0,1.0,1.0,2
12329,GO:0009503,thylakoid light-harvesting complex,4,0.0,1.0,1.0,2
12330,GO:0009505,plant-type cell wall,4,0.0,1.0,1.0,2
12331,GO:0009522,photosystem I,4,0.0,1.0,1.0,2
12332,GO:0009523,photosystem II,4,0.0,1.0,1.0,2
12333,GO:0009590,detection of gravity,4,0.0,1.0,1.0,1
12334,GO:0009594,detection of nutrient,4,0.0,1.0,1.0,1
12335,GO:0009630,gravitropism,4,0.0,1.0,1.0,2
12336,GO:0009649,entrainment of circadian clock,4,0.0,1.0,1.0,1
12337,GO:0009651,response to salt stress,4,0.0,1.0,1.0,5
12338,GO:0009698,phenylpropanoid metabolic process,4,0.0,1.0,1.0,13
12339,GO:0009720,detection of hormone stimulus,4,0.0,1.0,1.0,7
12340,GO:0009723,response to ethylene,4,0.0,1.0,1.0,2
12341,GO:0009733,response to auxin,4,0.0,1.0,1.0,3
12342,GO:0009735,response to cytokinin,4,0.0,1.0,1.0,2
12343,GO:0009739,response to gibberellin,4,0.0,1.0,1.0,2
12344,GO:0009741,response to brassinosteroid,4,0.0,1.0,1.0,2
12345,GO:0009751,response to salicylic acid,4,0.0,1.0,1.0,2
12346,GO:0009765,"photosynthesis, light harvesting",4,0.0,1.0,1.0,2
12347,GO:0009810,stilbene metabolic process,4,0.0,1.0,1.0,2
12348,GO:0009813,flavonoid biosynthetic process,4,0.0,1.0,1.0,8
12349,GO:0009822,alkaloid catabolic process,4,0.0,1.0,1.0,6
12350,GO:0009826,unidimensional cell growth,4,0.0,1.0,1.0,7
12351,GO:0009835,fruit ripening,4,0.0,1.0,1.0,2
12352,GO:0009855,determination of bilateral symmetry,4,0.0,1.0,1.0,2
12353,GO:0009883,red or far-red light photoreceptor activity,4,0.0,1.0,1.0,2
12354,GO:0009884,cytokinin receptor activity,4,0.0,1.0,1.0,2
12355,GO:0009898,cytoplasmic side of plasma membrane,4,0.0,1.0,1.0,3
12356,GO:0009914,hormone transport,4,0.0,1.0,1.0,4
12357,GO:0009946,proximal/distal axis specification,4,0.0,1.0,1.0,1
12358,GO:0009948,anterior/posterior axis specification,4,0.0,1.0,1.0,3
12359,GO:0009950,dorsal/ventral axis specification,4,0.0,1.0,1.0,3
12360,GO:0009952,anterior/posterior pattern specification,4,0.0,1.0,1.0,14
12361,GO:0009953,dorsal/ventral pattern formation,4,0.0,1.0,1.0,7
12362,GO:0009954,proximal/distal pattern formation,4,0.0,1.0,1.0,4
12363,GO:0009956,radial pattern formation,4,0.0,1.0,1.0,2
12364,GO:0009957,epidermal cell fate specification,4,0.0,1.0,1.0,3
12365,GO:0009965,leaf morphogenesis,4,0.0,1.0,1.0,3
12366,GO:0009982,pseudouridine synthase activity,4,0.0,1.0,1.0,3
12367,GO:0009994,oocyte differentiation,4,0.0,1.0,1.0,1
12368,GO:0010001,glial cell differentiation,4,0.0,1.0,1.0,8
12369,GO:0010009,cytoplasmic side of endosome membrane,4,0.0,1.0,1.0,2
12370,GO:0010015,root morphogenesis,4,0.0,1.0,1.0,2
12371,GO:0010026,trichome differentiation,4,0.0,1.0,1.0,1
12372,GO:0010037,response to carbon dioxide,4,0.0,1.0,1.0,1
12373,GO:0010039,response to iron ion,4,0.0,1.0,1.0,3
12374,GO:0010042,response to manganese ion,4,0.0,1.0,1.0,1
12375,GO:0010043,response to zinc ion,4,0.0,1.0,1.0,2
12376,GO:0010044,response to aluminum ion,4,0.0,1.0,1.0,1
12377,GO:0010045,response to nickel cation,4,0.0,1.0,1.0,1
12378,GO:0010046,response to mycotoxin,4,0.0,1.0,1.0,1
12379,GO:0010051,xylem and phloem pattern formation,4,0.0,1.0,1.0,5
12380,GO:0010070,zygote asymmetric cell division,4,0.0,1.0,1.0,1
12381,GO:0010074,maintenance of meristem identity,4,0.0,1.0,1.0,5
12382,GO:0010087,phloem or xylem histogenesis,4,0.0,1.0,1.0,2
12383,GO:0010092,specification of animal organ identity,4,0.0,1.0,1.0,6
12384,GO:0010119,regulation of stomatal movement,4,0.0,1.0,1.0,2
12385,GO:0010135,ureide metabolic process,4,0.0,1.0,1.0,2
12386,GO:0010157,response to chlorate,4,0.0,1.0,1.0,1
12387,GO:0010160,formation of animal organ boundary,4,0.0,1.0,1.0,2
12388,GO:0010164,response to cesium ion,4,0.0,1.0,1.0,1
12389,GO:0010167,response to nitrate,4,0.0,1.0,1.0,1
12390,GO:0010178,IAA-amino acid conjugate hydrolase activity,4,0.0,1.0,1.0,3
12391,GO:0010192,mucilage biosynthetic process,4,0.0,1.0,1.0,4
12392,GO:0010200,response to chitin,4,0.0,1.0,1.0,1
12393,GO:0010209,vacuolar sorting signal binding,4,0.0,1.0,1.0,1
12394,GO:0010212,response to ionizing radiation,4,0.0,1.0,1.0,3
12395,GO:0010226,response to lithium ion,4,0.0,1.0,1.0,1
12396,GO:0010231,maintenance of seed dormancy,4,0.0,1.0,1.0,1
12397,GO:0010272,response to silver ion,4,0.0,1.0,1.0,1
12398,GO:0010288,response to lead ion,4,0.0,1.0,1.0,1
12399,GO:0010297,heteropolysaccharide binding,4,0.0,1.0,1.0,2
12400,GO:0010330,cellulose synthase complex,4,0.0,1.0,1.0,2
12401,GO:0010335,response to non-ionic osmotic stress,4,0.0,1.0,1.0,1
12402,GO:0010346,shoot axis formation,4,0.0,1.0,1.0,1
12403,GO:0010446,response to alkaline pH,4,0.0,1.0,1.0,1
12404,GO:0010447,response to acidic pH,4,0.0,1.0,1.0,1
12405,GO:0010453,regulation of cell fate commitment,4,0.0,1.0,1.0,8
12406,GO:0010477,response to sulfur dioxide,4,0.0,1.0,1.0,1
12407,GO:0010496,intercellular transport,4,0.0,1.0,1.0,3
12408,GO:0010570,regulation of filamentous growth,4,0.0,1.0,1.0,3
12409,GO:0010583,response to cyclopentenone,4,0.0,1.0,1.0,1
12410,GO:0010590,regulation of septum digestion after cytokinesis,4,0.0,1.0,1.0,2
12411,GO:0010623,programmed cell death involved in cell development,4,0.0,1.0,1.0,7
12412,GO:0010646,regulation of cell communication,4,0.0,1.0,1.0,17
12413,GO:0010852,cyclase inhibitor activity,4,0.0,1.0,1.0,2
12414,GO:0010853,cyclase activator activity,4,0.0,1.0,1.0,2
12415,GO:0010854,adenylate cyclase regulator activity,4,0.0,1.0,1.0,2
12416,GO:0010911,regulation of isomerase activity,4,0.0,1.0,1.0,3
12417,GO:0014010,Schwann cell proliferation,4,0.0,1.0,1.0,1
12418,GO:0014016,neuroblast differentiation,4,0.0,1.0,1.0,1
12419,GO:0014017,neuroblast fate commitment,4,0.0,1.0,1.0,1
12420,GO:0014069,postsynaptic density,4,0.0,1.0,1.0,1
12421,GO:0014071,response to cycloalkane,4,0.0,1.0,1.0,1
12422,GO:0014074,response to purine-containing compound,4,0.0,1.0,1.0,9
12423,GO:0014075,response to amine,4,0.0,1.0,1.0,6
12424,GO:0014076,response to fluoxetine,4,0.0,1.0,1.0,1
12425,GO:0014812,muscle cell migration,4,0.0,1.0,1.0,4
12426,GO:0014822,detection of wounding,4,0.0,1.0,1.0,1
12427,GO:0014855,striated muscle cell proliferation,4,0.0,1.0,1.0,2
12428,GO:0014864,detection of muscle activity,4,0.0,1.0,1.0,1
12429,GO:0014869,detection of muscle inactivity,4,0.0,1.0,1.0,1
12430,GO:0014873,response to muscle activity involved in regulation of muscle adaptation,4,0.0,1.0,1.0,1
12431,GO:0014876,response to injury involved in regulation of muscle adaptation,4,0.0,1.0,1.0,1
12432,GO:0014877,response to muscle inactivity involved in regulation of muscle adaptation,4,0.0,1.0,1.0,3
12433,GO:0014878,response to electrical stimulus involved in regulation of muscle adaptation,4,0.0,1.0,1.0,1
12434,GO:0014896,muscle hypertrophy,4,0.0,1.0,1.0,4
12435,GO:0014916,regulation of lung blood pressure,4,0.0,1.0,1.0,2
12436,GO:0015009,corrin metabolic process,4,0.0,1.0,1.0,2
12437,GO:0015011,nickel-tetrapyrrole coenzyme metabolic process,4,0.0,1.0,1.0,1
12438,GO:0015036,disulfide oxidoreductase activity,4,0.0,1.0,1.0,7
12439,GO:0015067,amidinotransferase activity,4,0.0,1.0,1.0,2
12440,GO:0015103,inorganic anion transmembrane transporter activity,4,0.0,1.0,1.0,23
12441,GO:0015106,bicarbonate transmembrane transporter activity,4,0.0,1.0,1.0,4
12442,GO:0015119,hexose phosphate transmembrane transporter activity,4,0.0,1.0,1.0,2
12443,GO:0015136,sialic acid transmembrane transporter activity,4,0.0,1.0,1.0,2
12444,GO:0015157,oligosaccharide transmembrane transporter activity,4,0.0,1.0,1.0,4
12445,GO:0015159,polysaccharide transmembrane transporter activity,4,0.0,1.0,1.0,3
12446,GO:0015164,glucuronoside transmembrane transporter activity,4,0.0,1.0,1.0,1
12447,GO:0015166,polyol transmembrane transporter activity,4,0.0,1.0,1.0,9
12448,GO:0015169,glycerol-3-phosphate transmembrane transporter activity,4,0.0,1.0,1.0,1
12449,GO:0015172,acidic amino acid transmembrane transporter activity,4,0.0,1.0,1.0,2
12450,GO:0015174,basic amino acid transmembrane transporter activity,4,0.0,1.0,1.0,6
12451,GO:0015175,neutral L-amino acid transmembrane transporter activity,4,0.0,1.0,1.0,17
12452,GO:0015200,methylammonium transmembrane transporter activity,4,0.0,1.0,1.0,1
12453,GO:0015204,urea transmembrane transporter activity,4,0.0,1.0,1.0,3
12454,GO:0015215,nucleotide transmembrane transporter activity,4,0.0,1.0,1.0,6
12455,GO:0015220,choline transmembrane transporter activity,4,0.0,1.0,1.0,2
12456,GO:0015228,coenzyme A transmembrane transporter activity,4,0.0,1.0,1.0,1
12457,GO:0015234,thiamine transmembrane transporter activity,4,0.0,1.0,1.0,3
12458,GO:0015267,channel activity,4,0.0,1.0,1.0,14
12459,GO:0015291,secondary active transmembrane transporter activity,4,0.0,1.0,1.0,22
12460,GO:0015399,primary active transmembrane transporter activity,4,0.0,1.0,1.0,5
12461,GO:0015489,putrescine transmembrane transporter activity,4,0.0,1.0,1.0,3
12462,GO:0015551,3-hydroxyphenyl propanoate transmembrane transporter activity,4,0.0,1.0,1.0,1
12463,GO:0015554,tartrate transmembrane transporter activity,4,0.0,1.0,1.0,1
12464,GO:0015572,N-acetylglucosamine transmembrane transporter activity,4,0.0,1.0,1.0,1
12465,GO:0015631,tubulin binding,4,0.0,1.0,1.0,4
12466,GO:0015647,peptidoglycan transmembrane transporter activity,4,0.0,1.0,1.0,2
12467,GO:0015651,quaternary ammonium group transmembrane transporter activity,4,0.0,1.0,1.0,9
12468,GO:0015665,alcohol transmembrane transporter activity,4,0.0,1.0,1.0,13
12469,GO:0015669,gas transport,4,0.0,1.0,1.0,2
12470,GO:0015695,organic cation transport,4,0.0,1.0,1.0,48
12471,GO:0015698,inorganic anion transport,4,0.0,1.0,1.0,16
12472,GO:0015700,arsenite transport,4,0.0,1.0,1.0,1
12473,GO:0015711,organic anion transport,4,0.0,1.0,1.0,40
12474,GO:0015748,organophosphate ester transport,4,0.0,1.0,1.0,15
12475,GO:0015849,organic acid transport,4,0.0,1.0,1.0,2
12476,GO:0015930,glutamate synthase activity,4,0.0,1.0,1.0,3
12477,GO:0015934,large ribosomal subunit,4,0.0,1.0,1.0,2
12478,GO:0015935,small ribosomal subunit,4,0.0,1.0,1.0,2
12479,GO:0015975,energy derivation by oxidation of reduced inorganic compounds,4,0.0,1.0,1.0,10
12480,GO:0015980,energy derivation by oxidation of organic compounds,4,0.0,1.0,1.0,3
12481,GO:0016002,sulfite reductase activity,4,0.0,1.0,1.0,1
12482,GO:0016048,detection of temperature stimulus,4,0.0,1.0,1.0,1
12483,GO:0016057,regulation of membrane potential in photoreceptor cell,4,0.0,1.0,1.0,1
12484,GO:0016168,chlorophyll binding,4,0.0,1.0,1.0,1
12485,GO:0016192,vesicle-mediated transport,4,0.0,1.0,1.0,19
12486,GO:0016198,axon choice point recognition,4,0.0,1.0,1.0,1
12487,GO:0016222,procollagen-proline 4-dioxygenase complex,4,0.0,1.0,1.0,3
12488,GO:0016248,channel inhibitor activity,4,0.0,1.0,1.0,1
12489,GO:0016301,kinase activity,4,0.0,1.0,1.0,117
12490,GO:0016405,CoA-ligase activity,4,0.0,1.0,1.0,31
12491,GO:0016421,CoA carboxylase activity,4,0.0,1.0,1.0,4
12492,GO:0016446,somatic hypermutation of immunoglobulin genes,4,0.0,1.0,1.0,1
12493,GO:0016465,chaperonin ATPase complex,4,0.0,1.0,1.0,1
12494,GO:0016502,nucleotide receptor activity,4,0.0,1.0,1.0,2
12495,GO:0016504,peptidase activator activity,4,0.0,1.0,1.0,3
12496,GO:0016610,nitrogenase complex,4,0.0,1.0,1.0,3
12497,GO:0016615,malate dehydrogenase activity,4,0.0,1.0,1.0,5
12498,GO:0016616,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",4,0.0,1.0,1.0,293
12499,GO:0016620,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",4,0.0,1.0,1.0,52
12500,GO:0016622,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, cytochrome as acceptor",4,0.0,1.0,1.0,3
12501,GO:0016623,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor",4,0.0,1.0,1.0,7
12502,GO:0016624,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor",4,0.0,1.0,1.0,4
12503,GO:0016625,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, iron-sulfur protein as acceptor",4,0.0,1.0,1.0,8
12504,GO:0016628,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor",4,0.0,1.0,1.0,92
12505,GO:0016632,"oxidoreductase activity, acting on the CH-CH group of donors, cytochrome as acceptor",4,0.0,1.0,1.0,2
12506,GO:0016634,"oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor",4,0.0,1.0,1.0,11
12507,GO:0016635,"oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor",4,0.0,1.0,1.0,4
12508,GO:0016636,"oxidoreductase activity, acting on the CH-CH group of donors, iron-sulfur protein as acceptor",4,0.0,1.0,1.0,8
12509,GO:0016639,"oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor",4,0.0,1.0,1.0,16
12510,GO:0016640,"oxidoreductase activity, acting on the CH-NH2 group of donors, cytochrome as acceptor",4,0.0,1.0,1.0,1
12511,GO:0016641,"oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor",4,0.0,1.0,1.0,5
12512,GO:0016642,"oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor",4,0.0,1.0,1.0,1
12513,GO:0016643,"oxidoreductase activity, acting on the CH-NH2 group of donors, iron-sulfur protein as acceptor",4,0.0,1.0,1.0,1
12514,GO:0016646,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor",4,0.0,1.0,1.0,39
12515,GO:0016647,"oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor",4,0.0,1.0,1.0,12
12516,GO:0016648,"oxidoreductase activity, acting on the CH-NH group of donors, disulfide as acceptor",4,0.0,1.0,1.0,1
12517,GO:0016649,"oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor",4,0.0,1.0,1.0,2
12518,GO:0016652,"oxidoreductase activity, acting on NAD(P)H as acceptor",4,0.0,1.0,1.0,1
12519,GO:0016653,"oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor",4,0.0,1.0,1.0,4
12520,GO:0016655,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor",4,0.0,1.0,1.0,8
12521,GO:0016662,"oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor",4,0.0,1.0,1.0,6
12522,GO:0016663,"oxidoreductase activity, acting on other nitrogenous compounds as donors, oxygen as acceptor",4,0.0,1.0,1.0,5
12523,GO:0016664,"oxidoreductase activity, acting on other nitrogenous compounds as donors, iron-sulfur protein as acceptor",4,0.0,1.0,1.0,2
12524,GO:0016668,"oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor",4,0.0,1.0,1.0,14
12525,GO:0016669,"oxidoreductase activity, acting on a sulfur group of donors, cytochrome as acceptor",4,0.0,1.0,1.0,3
12526,GO:0016670,"oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor",4,0.0,1.0,1.0,7
12527,GO:0016671,"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor",4,0.0,1.0,1.0,14
12528,GO:0016672,"oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor",4,0.0,1.0,1.0,4
12529,GO:0016673,"oxidoreductase activity, acting on a sulfur group of donors, iron-sulfur protein as acceptor",4,0.0,1.0,1.0,2
12530,GO:0016677,"oxidoreductase activity, acting on a heme group of donors, nitrogenous group as acceptor",4,0.0,1.0,1.0,1
12531,GO:0016680,"oxidoreductase activity, acting on diphenols and related substances as donors, NAD or NADP as acceptor",4,0.0,1.0,1.0,1
12532,GO:0016682,"oxidoreductase activity, acting on diphenols and related substances as donors, oxygen as acceptor",4,0.0,1.0,1.0,8
12533,GO:0016696,"oxidoreductase activity, acting on hydrogen as donor, NAD or NADP as acceptor",4,0.0,1.0,1.0,3
12534,GO:0016697,"oxidoreductase activity, acting on hydrogen as donor, cytochrome as acceptor",4,0.0,1.0,1.0,1
12535,GO:0016699,"oxidoreductase activity, acting on hydrogen as donor, iron-sulfur protein as acceptor",4,0.0,1.0,1.0,1
12536,GO:0016702,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",4,0.0,1.0,1.0,67
12537,GO:0016703,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)",4,0.0,1.0,1.0,18
12538,GO:0016706,2-oxoglutarate-dependent dioxygenase activity,4,0.0,1.0,1.0,51
12539,GO:0016708,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor",4,0.0,1.0,1.0,22
12540,GO:0016709,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen",4,0.0,1.0,1.0,161
12541,GO:0016712,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",4,0.0,1.0,1.0,59
12542,GO:0016713,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen",4,0.0,1.0,1.0,15
12543,GO:0016714,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen",4,0.0,1.0,1.0,5
12544,GO:0016715,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen",4,0.0,1.0,1.0,3
12545,GO:0016716,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen",4,0.0,1.0,1.0,6
12546,GO:0016717,"oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water",4,0.0,1.0,1.0,30
12547,GO:0016723,"oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor",4,0.0,1.0,1.0,7
12548,GO:0016724,"oxidoreductase activity, acting on metal ions, oxygen as acceptor",4,0.0,1.0,1.0,1
12549,GO:0016726,"oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor",4,0.0,1.0,1.0,6
12550,GO:0016727,"oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor",4,0.0,1.0,1.0,5
12551,GO:0016728,"oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor",4,0.0,1.0,1.0,4
12552,GO:0016731,"oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor",4,0.0,1.0,1.0,3
12553,GO:0016732,"oxidoreductase activity, acting on iron-sulfur proteins as donors, dinitrogen as acceptor",4,0.0,1.0,1.0,1
12554,GO:0016738,"oxidoreductase activity, acting on reduced flavodoxin as donor, dinitrogen as acceptor",4,0.0,1.0,1.0,1
12555,GO:0016742,"hydroxymethyl-, formyl- and related transferase activity",4,0.0,1.0,1.0,11
12556,GO:0016743,carboxyl- or carbamoyltransferase activity,4,0.0,1.0,1.0,8
12557,GO:0016747,"acyltransferase activity, transferring groups other than amino-acyl groups",4,0.0,1.0,1.0,106
12558,GO:0016755,aminoacyltransferase activity,4,0.0,1.0,1.0,16
12559,GO:0016758,hexosyltransferase activity,4,0.0,1.0,1.0,86
12560,GO:0016763,pentosyltransferase activity,4,0.0,1.0,1.0,37
12561,GO:0016773,"phosphotransferase activity, alcohol group as acceptor",4,0.0,1.0,1.0,119
12562,GO:0016774,"phosphotransferase activity, carboxyl group as acceptor",4,0.0,1.0,1.0,13
12563,GO:0016775,"phosphotransferase activity, nitrogenous group as acceptor",4,0.0,1.0,1.0,11
12564,GO:0016776,"phosphotransferase activity, phosphate group as acceptor",4,0.0,1.0,1.0,26
12565,GO:0016778,diphosphotransferase activity,4,0.0,1.0,1.0,6
12566,GO:0016779,nucleotidyltransferase activity,4,0.0,1.0,1.0,23
12567,GO:0016780,"phosphotransferase activity, for other substituted phosphate groups",4,0.0,1.0,1.0,38
12568,GO:0016781,"phosphotransferase activity, paired acceptors",4,0.0,1.0,1.0,5
12569,GO:0016783,sulfurtransferase activity,4,0.0,1.0,1.0,15
12570,GO:0016790,thiolester hydrolase activity,4,0.0,1.0,1.0,8
12571,GO:0016799,"hydrolase activity, hydrolyzing N-glycosyl compounds",4,0.0,1.0,1.0,26
12572,GO:0016802,trialkylsulfonium hydrolase activity,4,0.0,1.0,1.0,1
12573,GO:0016803,ether hydrolase activity,4,0.0,1.0,1.0,7
12574,GO:0016811,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides",4,0.0,1.0,1.0,113
12575,GO:0016812,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides",4,0.0,1.0,1.0,20
12576,GO:0016813,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines",4,0.0,1.0,1.0,29
12577,GO:0016814,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines",4,0.0,1.0,1.0,30
12578,GO:0016815,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles",4,0.0,1.0,1.0,2
12579,GO:0016818,"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides",4,0.0,1.0,1.0,10
12580,GO:0016819,"hydrolase activity, acting on acid anhydrides, in sulfonyl-containing anhydrides",4,0.0,1.0,1.0,2
12581,GO:0016823,"hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances",4,0.0,1.0,1.0,21
12582,GO:0016831,carboxy-lyase activity,4,0.0,1.0,1.0,94
12583,GO:0016832,aldehyde-lyase activity,4,0.0,1.0,1.0,43
12584,GO:0016833,oxo-acid-lyase activity,4,0.0,1.0,1.0,25
12585,GO:0016836,hydro-lyase activity,4,0.0,1.0,1.0,118
12586,GO:0016837,"carbon-oxygen lyase activity, acting on polysaccharides",4,0.0,1.0,1.0,28
12587,GO:0016838,"carbon-oxygen lyase activity, acting on phosphates",4,0.0,1.0,1.0,67
12588,GO:0016841,ammonia-lyase activity,4,0.0,1.0,1.0,21
12589,GO:0016842,amidine-lyase activity,4,0.0,1.0,1.0,9
12590,GO:0016843,amine-lyase activity,4,0.0,1.0,1.0,3
12591,GO:0016855,"racemase and epimerase activity, acting on amino acids and derivatives",4,0.0,1.0,1.0,6
12592,GO:0016856,"racemase and epimerase activity, acting on hydroxy acids and derivatives",4,0.0,1.0,1.0,7
12593,GO:0016857,"racemase and epimerase activity, acting on carbohydrates and derivatives",4,0.0,1.0,1.0,26
12594,GO:0016861,"intramolecular oxidoreductase activity, interconverting aldoses and ketoses",4,0.0,1.0,1.0,26
12595,GO:0016862,"intramolecular oxidoreductase activity, interconverting keto- and enol-groups",4,0.0,1.0,1.0,4
12596,GO:0016863,"intramolecular oxidoreductase activity, transposing C=C bonds",4,0.0,1.0,1.0,18
12597,GO:0016864,"intramolecular oxidoreductase activity, transposing S-S bonds",4,0.0,1.0,1.0,1
12598,GO:0016867,intramolecular acyltransferase activity,4,0.0,1.0,1.0,4
12599,GO:0016868,intramolecular phosphotransferase activity,4,0.0,1.0,1.0,10
12600,GO:0016869,intramolecular aminotransferase activity,4,0.0,1.0,1.0,6
12601,GO:0016878,acid-thiol ligase activity,4,0.0,1.0,1.0,35
12602,GO:0016880,acid-ammonia (or amide) ligase activity,4,0.0,1.0,1.0,15
12603,GO:0016881,acid-amino acid ligase activity,4,0.0,1.0,1.0,42
12604,GO:0016882,cyclo-ligase activity,4,0.0,1.0,1.0,4
12605,GO:0016884,"carbon-nitrogen ligase activity, with glutamine as amido-N-donor",4,0.0,1.0,1.0,11
12606,GO:0016898,"oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor",4,0.0,1.0,1.0,7
12607,GO:0016899,"oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor",4,0.0,1.0,1.0,29
12608,GO:0016901,"oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor",4,0.0,1.0,1.0,10
12609,GO:0016917,GABA receptor activity,4,0.0,1.0,1.0,2
12610,GO:0017000,antibiotic biosynthetic process,4,0.0,1.0,1.0,10
12611,GO:0017001,antibiotic catabolic process,4,0.0,1.0,1.0,5
12612,GO:0017022,myosin binding,4,0.0,1.0,1.0,7
12613,GO:0017085,response to insecticide,4,0.0,1.0,1.0,4
12614,GO:0017089,glycolipid transfer activity,4,0.0,1.0,1.0,1
12615,GO:0018131,oxazole or thiazole biosynthetic process,4,0.0,1.0,1.0,1
12616,GO:0018866,adamantanone metabolic process,4,0.0,1.0,1.0,1
12617,GO:0018879,biphenyl metabolic process,4,0.0,1.0,1.0,1
12618,GO:0018889,2-chloro-N-isopropylacetanilide metabolic process,4,0.0,1.0,1.0,1
12619,GO:0018893,dibenzofuran metabolic process,4,0.0,1.0,1.0,1
12620,GO:0018894,dibenzo-p-dioxin metabolic process,4,0.0,1.0,1.0,1
12621,GO:0018895,dibenzothiophene metabolic process,4,0.0,1.0,1.0,2
12622,GO:0018904,ether metabolic process,4,0.0,1.0,1.0,29
12623,GO:0018910,benzene metabolic process,4,0.0,1.0,1.0,2
12624,GO:0018916,nitrobenzene metabolic process,4,0.0,1.0,1.0,2
12625,GO:0018928,methyl ethyl ketone metabolic process,4,0.0,1.0,1.0,1
12626,GO:0018938,2-nitropropane metabolic process,4,0.0,1.0,1.0,1
12627,GO:0018943,organotin metabolic process,4,0.0,1.0,1.0,1
12628,GO:0018945,organosilicon metabolic process,4,0.0,1.0,1.0,5
12629,GO:0018948,xylene metabolic process,4,0.0,1.0,1.0,4
12630,GO:0018955,phenanthrene metabolic process,4,0.0,1.0,1.0,1
12631,GO:0018958,phenol-containing compound metabolic process,4,0.0,1.0,1.0,54
12632,GO:0018965,s-triazine compound metabolic process,4,0.0,1.0,1.0,4
12633,GO:0018966,styrene metabolic process,4,0.0,1.0,1.0,1
12634,GO:0018983,Z-phenylacetaldoxime metabolic process,4,0.0,1.0,1.0,2
12635,GO:0018992,germ-line sex determination,4,0.0,1.0,1.0,3
12636,GO:0018993,somatic sex determination,4,0.0,1.0,1.0,3
12637,GO:0019093,mitochondrial RNA localization,4,0.0,1.0,1.0,1
12638,GO:0019113,limonene monooxygenase activity,4,0.0,1.0,1.0,5
12639,GO:0019120,"hydrolase activity, acting on acid halide bonds, in C-halide compounds",4,0.0,1.0,1.0,11
12640,GO:0019196,galactosamine transmembrane transporter activity,4,0.0,1.0,1.0,2
12641,GO:0019209,kinase activator activity,4,0.0,1.0,1.0,2
12642,GO:0019210,kinase inhibitor activity,4,0.0,1.0,1.0,1
12643,GO:0019211,phosphatase activator activity,4,0.0,1.0,1.0,1
12644,GO:0019212,phosphatase inhibitor activity,4,0.0,1.0,1.0,2
12645,GO:0019239,deaminase activity,4,0.0,1.0,1.0,32
12646,GO:0019329,ammonia oxidation,4,0.0,1.0,1.0,3
12647,GO:0019417,sulfur oxidation,4,0.0,1.0,1.0,2
12648,GO:0019418,sulfide oxidation,4,0.0,1.0,1.0,3
12649,GO:0019507,pyridine metabolic process,4,0.0,1.0,1.0,2
12650,GO:0019627,urea metabolic process,4,0.0,1.0,1.0,3
12651,GO:0019695,choline metabolic process,4,0.0,1.0,1.0,3
12652,GO:0019750,chloroplast localization,4,0.0,1.0,1.0,1
12653,GO:0019755,one-carbon compound transport,4,0.0,1.0,1.0,4
12654,GO:0019763,immunoglobulin receptor activity,4,0.0,1.0,1.0,5
12655,GO:0019783,ubiquitin-like protein peptidase activity,4,0.0,1.0,1.0,6
12656,GO:0019866,organelle inner membrane,4,0.0,1.0,1.0,3
12657,GO:0019887,protein kinase regulator activity,4,0.0,1.0,1.0,8
12658,GO:0019888,protein phosphatase regulator activity,4,0.0,1.0,1.0,4
12659,GO:0019889,pteridine metabolic process,4,0.0,1.0,1.0,2
12660,GO:0019900,kinase binding,4,0.0,1.0,1.0,2
12661,GO:0019902,phosphatase binding,4,0.0,1.0,1.0,1
12662,GO:0019905,syntaxin binding,4,0.0,1.0,1.0,2
12663,GO:0019956,chemokine binding,4,0.0,1.0,1.0,3
12664,GO:0019961,interferon binding,4,0.0,1.0,1.0,3
12665,GO:0019966,interleukin-1 binding,4,0.0,1.0,1.0,1
12666,GO:0019972,interleukin-12 binding,4,0.0,1.0,1.0,2
12667,GO:0019975,interleukin-17 binding,4,0.0,1.0,1.0,2
12668,GO:0021515,cell differentiation in spinal cord,4,0.0,1.0,1.0,7
12669,GO:0021533,cell differentiation in hindbrain,4,0.0,1.0,1.0,9
12670,GO:0021534,cell proliferation in hindbrain,4,0.0,1.0,1.0,2
12671,GO:0021535,cell migration in hindbrain,4,0.0,1.0,1.0,7
12672,GO:0021545,cranial nerve development,4,0.0,1.0,1.0,13
12673,GO:0021682,nerve maturation,4,0.0,1.0,1.0,1
12674,GO:0021730,trigeminal sensory nucleus development,4,0.0,1.0,1.0,3
12675,GO:0021747,cochlear nucleus development,4,0.0,1.0,1.0,2
12676,GO:0021751,salivary nucleus development,4,0.0,1.0,1.0,2
12677,GO:0021780,glial cell fate specification,4,0.0,1.0,1.0,1
12678,GO:0021781,glial cell fate commitment,4,0.0,1.0,1.0,4
12679,GO:0021782,glial cell development,4,0.0,1.0,1.0,7
12680,GO:0021807,motogenic signaling initiating cell movement in cerebral cortex,4,0.0,1.0,1.0,1
12681,GO:0021846,cell proliferation in forebrain,4,0.0,1.0,1.0,2
12682,GO:0021848,neuroblast division in subpallium,4,0.0,1.0,1.0,1
12683,GO:0021855,hypothalamus cell migration,4,0.0,1.0,1.0,1
12684,GO:0021873,forebrain neuroblast division,4,0.0,1.0,1.0,2
12685,GO:0021885,forebrain cell migration,4,0.0,1.0,1.0,2
12686,GO:0021979,hypothalamus cell differentiation,4,0.0,1.0,1.0,1
12687,GO:0022008,neurogenesis,4,0.0,1.0,1.0,2
12688,GO:0022411,cellular component disassembly,4,0.0,1.0,1.0,14
12689,GO:0022603,regulation of anatomical structure morphogenesis,4,0.0,1.0,1.0,36
12690,GO:0022607,cellular component assembly,4,0.0,1.0,1.0,60
12691,GO:0022612,gland morphogenesis,4,0.0,1.0,1.0,7
12692,GO:0022613,ribonucleoprotein complex biogenesis,4,0.0,1.0,1.0,3
12693,GO:0022853,active monoatomic ion transmembrane transporter activity,4,0.0,1.0,1.0,30
12694,GO:0022885,bacteriocin transmembrane transporter activity,4,0.0,1.0,1.0,2
12695,GO:0022890,inorganic cation transmembrane transporter activity,4,0.0,1.0,1.0,6
12696,GO:0022900,electron transport chain,4,0.0,1.0,1.0,3
12697,GO:0023056,positive regulation of signaling,4,0.0,1.0,1.0,8
12698,GO:0023057,negative regulation of signaling,4,0.0,1.0,1.0,9
12699,GO:0030027,lamellipodium,4,0.0,1.0,1.0,1
12700,GO:0030030,cell projection organization,4,0.0,1.0,1.0,5
12701,GO:0030055,cell-substrate junction,4,0.0,1.0,1.0,3
12702,GO:0030058,aliphatic amine dehydrogenase activity,4,0.0,1.0,1.0,1
12703,GO:0030097,hemopoiesis,4,0.0,1.0,1.0,5
12704,GO:0030099,myeloid cell differentiation,4,0.0,1.0,1.0,5
12705,GO:0030118,clathrin coat,4,0.0,1.0,1.0,2
12706,GO:0030120,vesicle coat,4,0.0,1.0,1.0,3
12707,GO:0030131,clathrin adaptor complex,4,0.0,1.0,1.0,2
12708,GO:0030155,regulation of cell adhesion,4,0.0,1.0,1.0,9
12709,GO:0030159,signaling receptor complex adaptor activity,4,0.0,1.0,1.0,2
12710,GO:0030182,neuron differentiation,4,0.0,1.0,1.0,17
12711,GO:0030237,female sex determination,4,0.0,1.0,1.0,2
12712,GO:0030238,male sex determination,4,0.0,1.0,1.0,2
12713,GO:0030249,guanylate cyclase regulator activity,4,0.0,1.0,1.0,2
12714,GO:0030275,LRR domain binding,4,0.0,1.0,1.0,1
12715,GO:0030278,regulation of ossification,4,0.0,1.0,1.0,3
12716,GO:0030323,respiratory tube development,4,0.0,1.0,1.0,2
12717,GO:0030324,lung development,4,0.0,1.0,1.0,2
12718,GO:0030329,prenylcysteine metabolic process,4,0.0,1.0,1.0,2
12719,GO:0030414,peptidase inhibitor activity,4,0.0,1.0,1.0,2
12720,GO:0030416,methylamine metabolic process,4,0.0,1.0,1.0,1
12721,GO:0030519,snoRNP binding,4,0.0,1.0,1.0,2
12722,GO:0030548,acetylcholine receptor regulator activity,4,0.0,1.0,1.0,2
12723,GO:0030587,sorocarp development,4,0.0,1.0,1.0,1
12724,GO:0030614,"oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor",4,0.0,1.0,1.0,2
12725,GO:0030638,polyketide metabolic process,4,0.0,1.0,1.0,18
12726,GO:0030650,peptide antibiotic metabolic process,4,0.0,1.0,1.0,4
12727,GO:0030695,GTPase regulator activity,4,0.0,1.0,1.0,5
12728,GO:0030716,oocyte fate determination,4,0.0,1.0,1.0,1
12729,GO:0030718,germ-line stem cell population maintenance,4,0.0,1.0,1.0,2
12730,GO:0030855,epithelial cell differentiation,4,0.0,1.0,1.0,24
12731,GO:0030931,heterotetrameric ADPG pyrophosphorylase complex,4,0.0,1.0,1.0,1
12732,GO:0030935,sheet-forming collagen trimer,4,0.0,1.0,1.0,2
12733,GO:0030936,transmembrane collagen trimer,4,0.0,1.0,1.0,4
12734,GO:0030964,NADH dehydrogenase complex,4,0.0,1.0,1.0,2
12735,GO:0031001,response to brefeldin A,4,0.0,1.0,1.0,1
12736,GO:0031023,microtubule organizing center organization,4,0.0,1.0,1.0,7
12737,GO:0031026,glutamate synthase complex,4,0.0,1.0,1.0,2
12738,GO:0031100,animal organ regeneration,4,0.0,1.0,1.0,2
12739,GO:0031134,sister chromatid biorientation,4,0.0,1.0,1.0,1
12740,GO:0031137,regulation of conjugation with cellular fusion,4,0.0,1.0,1.0,4
12741,GO:0031156,regulation of sorocarp development,4,0.0,1.0,1.0,1
12742,GO:0031160,spore wall,4,0.0,1.0,1.0,4
12743,GO:0031179,peptide modification,4,0.0,1.0,1.0,1
12744,GO:0031214,biomineral tissue development,4,0.0,1.0,1.0,5
12745,GO:0031223,auditory behavior,4,0.0,1.0,1.0,1
12746,GO:0031232,extrinsic component of external side of plasma membrane,4,0.0,1.0,1.0,1
12747,GO:0031242,extrinsic component of external side of cell outer membrane,4,0.0,1.0,1.0,1
12748,GO:0031253,cell projection membrane,4,0.0,1.0,1.0,13
12749,GO:0031264,death-inducing signaling complex,4,0.0,1.0,1.0,2
12750,GO:0031279,regulation of cyclase activity,4,0.0,1.0,1.0,5
12751,GO:0031313,extrinsic component of endosome membrane,4,0.0,1.0,1.0,2
12752,GO:0031314,extrinsic component of mitochondrial inner membrane,4,0.0,1.0,1.0,1
12753,GO:0031320,hexitol dehydrogenase activity,4,0.0,1.0,1.0,4
12754,GO:0031341,regulation of cell killing,4,0.0,1.0,1.0,5
12755,GO:0031371,ubiquitin conjugating enzyme complex,4,0.0,1.0,1.0,3
12756,GO:0031427,response to methotrexate,4,0.0,1.0,1.0,1
12757,GO:0031494,regulation of mating type switching,4,0.0,1.0,1.0,2
12758,GO:0031501,mannosyltransferase complex,4,0.0,1.0,1.0,5
12759,GO:0031520,plasma membrane of cell tip,4,0.0,1.0,1.0,2
12760,GO:0031559,oxidosqualene cyclase activity,4,0.0,1.0,1.0,10
12761,GO:0031593,polyubiquitin modification-dependent protein binding,4,0.0,1.0,1.0,4
12762,GO:0031594,neuromuscular junction,4,0.0,1.0,1.0,4
12763,GO:0031649,heat generation,4,0.0,1.0,1.0,1
12764,GO:0031650,regulation of heat generation,4,0.0,1.0,1.0,3
12765,GO:0031654,regulation of heat dissipation,4,0.0,1.0,1.0,2
12766,GO:0031965,nuclear membrane,4,0.0,1.0,1.0,2
12767,GO:0031966,mitochondrial membrane,4,0.0,1.0,1.0,2
12768,GO:0031983,vesicle lumen,4,0.0,1.0,1.0,2
12769,GO:0031985,Golgi cisterna,4,0.0,1.0,1.0,3
12770,GO:0032025,response to cobalt ion,4,0.0,1.0,1.0,1
12771,GO:0032107,regulation of response to nutrient levels,4,0.0,1.0,1.0,15
12772,GO:0032183,SUMO binding,4,0.0,1.0,1.0,1
12773,GO:0032252,secretory granule localization,4,0.0,1.0,1.0,1
12774,GO:0032285,non-myelinated axon ensheathment,4,0.0,1.0,1.0,2
12775,GO:0032291,axon ensheathment in central nervous system,4,0.0,1.0,1.0,2
12776,GO:0032292,peripheral nervous system axon ensheathment,4,0.0,1.0,1.0,2
12777,GO:0032355,response to estradiol,4,0.0,1.0,1.0,1
12778,GO:0032393,MHC class I receptor activity,4,0.0,1.0,1.0,2
12779,GO:0032394,MHC class Ib receptor activity,4,0.0,1.0,1.0,2
12780,GO:0032418,lysosome localization,4,0.0,1.0,1.0,1
12781,GO:0032452,histone demethylase activity,4,0.0,1.0,1.0,2
12782,GO:0032476,polyprenyl diphosphate synthase complex,4,0.0,1.0,1.0,6
12783,GO:0032495,response to muramyl dipeptide,4,0.0,1.0,1.0,2
12784,GO:0032507,maintenance of protein location in cell,4,0.0,1.0,1.0,9
12785,GO:0032526,response to retinoic acid,4,0.0,1.0,1.0,1
12786,GO:0032535,regulation of cellular component size,4,0.0,1.0,1.0,10
12787,GO:0032580,Golgi cisterna membrane,4,0.0,1.0,1.0,3
12788,GO:0032780,negative regulation of ATP-dependent activity,4,0.0,1.0,1.0,5
12789,GO:0032781,positive regulation of ATP-dependent activity,4,0.0,1.0,1.0,5
12790,GO:0032838,plasma membrane bounded cell projection cytoplasm,4,0.0,1.0,1.0,2
12791,GO:0032878,regulation of establishment or maintenance of cell polarity,4,0.0,1.0,1.0,5
12792,GO:0032886,regulation of microtubule-based process,4,0.0,1.0,1.0,4
12793,GO:0032899,regulation of neurotrophin production,4,0.0,1.0,1.0,3
12794,GO:0032934,sterol binding,4,0.0,1.0,1.0,3
12795,GO:0032943,mononuclear cell proliferation,4,0.0,1.0,1.0,2
12796,GO:0032970,regulation of actin filament-based process,4,0.0,1.0,1.0,3
12797,GO:0032997,Fc receptor complex,4,0.0,1.0,1.0,4
12798,GO:0033014,tetrapyrrole biosynthetic process,4,0.0,1.0,1.0,7
12799,GO:0033015,tetrapyrrole catabolic process,4,0.0,1.0,1.0,3
12800,GO:0033076,isoquinoline alkaloid metabolic process,4,0.0,1.0,1.0,6
12801,GO:0033179,"proton-transporting V-type ATPase, V0 domain",4,0.0,1.0,1.0,2
12802,GO:0033180,"proton-transporting V-type ATPase, V1 domain",4,0.0,1.0,1.0,2
12803,GO:0033194,response to hydroperoxide,4,0.0,1.0,1.0,3
12804,GO:0033273,response to vitamin,4,0.0,1.0,1.0,13
12805,GO:0033301,cell cycle comprising mitosis without cytokinesis,4,0.0,1.0,1.0,2
12806,GO:0033333,fin development,4,0.0,1.0,1.0,3
12807,GO:0033334,fin morphogenesis,4,0.0,1.0,1.0,3
12808,GO:0033341,regulation of collagen binding,4,0.0,1.0,1.0,2
12809,GO:0033477,S-methylmethionine metabolic process,4,0.0,1.0,1.0,2
12810,GO:0033558,protein lysine deacetylase activity,4,0.0,1.0,1.0,2
12811,GO:0033598,mammary gland epithelial cell proliferation,4,0.0,1.0,1.0,2
12812,GO:0033612,receptor serine/threonine kinase binding,4,0.0,1.0,1.0,1
12813,GO:0033644,host cell membrane,4,0.0,1.0,1.0,15
12814,GO:0033646,host intracellular part,4,0.0,1.0,1.0,5
12815,GO:0033694,"oxidoreductase activity, acting on the CH-NH group of donors, iron-sulfur protein as acceptor",4,0.0,1.0,1.0,1
12816,GO:0033695,"oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor",4,0.0,1.0,1.0,3
12817,GO:0033765,"steroid dehydrogenase activity, acting on the CH-CH group of donors",4,0.0,1.0,1.0,3
12818,GO:0034014,response to triglyceride,4,0.0,1.0,1.0,1
12819,GO:0034021,response to silicon dioxide,4,0.0,1.0,1.0,1
12820,GO:0034088,maintenance of mitotic sister chromatid cohesion,4,0.0,1.0,1.0,3
12821,GO:0034090,maintenance of meiotic sister chromatid cohesion,4,0.0,1.0,1.0,1
12822,GO:0034097,response to cytokine,4,0.0,1.0,1.0,30
12823,GO:0034103,regulation of tissue remodeling,4,0.0,1.0,1.0,7
12824,GO:0034109,homotypic cell-cell adhesion,4,0.0,1.0,1.0,5
12825,GO:0034113,heterotypic cell-cell adhesion,4,0.0,1.0,1.0,6
12826,GO:0034190,apolipoprotein receptor binding,4,0.0,1.0,1.0,1
12827,GO:0034330,cell junction organization,4,0.0,1.0,1.0,7
12828,GO:0034397,telomere localization,4,0.0,1.0,1.0,4
12829,GO:0034465,response to carbon monoxide,4,0.0,1.0,1.0,1
12830,GO:0034616,response to laminar fluid shear stress,4,0.0,1.0,1.0,1
12831,GO:0034694,response to prostaglandin,4,0.0,1.0,1.0,5
12832,GO:0034698,response to gonadotropin,4,0.0,1.0,1.0,4
12833,GO:0034702,monoatomic ion channel complex,4,0.0,1.0,1.0,4
12834,GO:0034708,methyltransferase complex,4,0.0,1.0,1.0,9
12835,GO:0034776,response to histamine,4,0.0,1.0,1.0,2
12836,GO:0034976,response to endoplasmic reticulum stress,4,0.0,1.0,1.0,6
12837,GO:0034987,immunoglobulin receptor binding,4,0.0,1.0,1.0,1
12838,GO:0035014,phosphatidylinositol 3-kinase regulator activity,4,0.0,1.0,1.0,2
12839,GO:0035017,cuticle pattern formation,4,0.0,1.0,1.0,2
12840,GO:0035019,somatic stem cell population maintenance,4,0.0,1.0,1.0,2
12841,GO:0035028,leading edge cell fate determination,4,0.0,1.0,1.0,1
12842,GO:0035036,sperm-egg recognition,4,0.0,1.0,1.0,1
12843,GO:0035051,cardiocyte differentiation,4,0.0,1.0,1.0,11
12844,GO:0035088,establishment or maintenance of apical/basal cell polarity,4,0.0,1.0,1.0,3
12845,GO:0035091,phosphatidylinositol binding,4,0.0,1.0,1.0,3
12846,GO:0035108,limb morphogenesis,4,0.0,1.0,1.0,4
12847,GO:0035112,genitalia morphogenesis,4,0.0,1.0,1.0,6
12848,GO:0035113,embryonic appendage morphogenesis,4,0.0,1.0,1.0,4
12849,GO:0035114,imaginal disc-derived appendage morphogenesis,4,0.0,1.0,1.0,4
12850,GO:0035120,post-embryonic appendage morphogenesis,4,0.0,1.0,1.0,7
12851,GO:0035146,tube fusion,4,0.0,1.0,1.0,1
12852,GO:0035150,regulation of tube size,4,0.0,1.0,1.0,3
12853,GO:0035153,"epithelial cell type specification, open tracheal system",4,0.0,1.0,1.0,2
12854,GO:0035254,glutamate receptor binding,4,0.0,1.0,1.0,2
12855,GO:0035262,gonad morphogenesis,4,0.0,1.0,1.0,1
12856,GO:0035282,segmentation,4,0.0,1.0,1.0,7
12857,GO:0035292,"specification of segmental identity, trunk",4,0.0,1.0,1.0,2
12858,GO:0035325,Toll-like receptor binding,4,0.0,1.0,1.0,2
12859,GO:0035383,thioester metabolic process,4,0.0,1.0,1.0,2
12860,GO:0035426,extracellular matrix-cell signaling,4,0.0,1.0,1.0,2
12861,GO:0035441,cell migration involved in vasculogenesis,4,0.0,1.0,1.0,1
12862,GO:0035452,extrinsic component of plastid membrane,4,0.0,1.0,1.0,2
12863,GO:0035459,vesicle cargo loading,4,0.0,1.0,1.0,2
12864,GO:0035476,angioblast cell migration,4,0.0,1.0,1.0,2
12865,GO:0035482,gastric motility,4,0.0,1.0,1.0,1
12866,GO:0035490,regulation of leukotriene production involved in inflammatory response,4,0.0,1.0,1.0,2
12867,GO:0035514,DNA demethylase activity,4,0.0,1.0,1.0,3
12868,GO:0035561,regulation of chromatin binding,4,0.0,1.0,1.0,3
12869,GO:0035564,regulation of kidney size,4,0.0,1.0,1.0,2
12870,GO:0035634,response to stilbenoid,4,0.0,1.0,1.0,1
12871,GO:0035673,oligopeptide transmembrane transporter activity,4,0.0,1.0,1.0,5
12872,GO:0035701,hematopoietic stem cell migration,4,0.0,1.0,1.0,1
12873,GO:0035713,response to nitrogen dioxide,4,0.0,1.0,1.0,1
12874,GO:0035728,response to hepatocyte growth factor,4,0.0,1.0,1.0,1
12875,GO:0035787,cell migration involved in kidney development,4,0.0,1.0,1.0,3
12876,GO:0035803,egg coat formation,4,0.0,1.0,1.0,1
12877,GO:0035805,egg coat,4,0.0,1.0,1.0,2
12878,GO:0035807,induction of blood coagulation in another organism,4,0.0,1.0,1.0,1
12879,GO:0035809,regulation of urine volume,4,0.0,1.0,1.0,2
12880,GO:0035834,indole alkaloid metabolic process,4,0.0,1.0,1.0,3
12881,GO:0035838,growing cell tip,4,0.0,1.0,1.0,3
12882,GO:0035864,response to potassium ion,4,0.0,1.0,1.0,1
12883,GO:0035891,exit from host cell,4,0.0,1.0,1.0,2
12884,GO:0035899,suppression of blood coagulation in another organism,4,0.0,1.0,1.0,1
12885,GO:0035914,skeletal muscle cell differentiation,4,0.0,1.0,1.0,2
12886,GO:0035967,cellular response to topologically incorrect protein,4,0.0,1.0,1.0,2
12887,GO:0035976,transcription factor AP-1 complex,4,0.0,1.0,1.0,1
12888,GO:0035983,response to trichostatin A,4,0.0,1.0,1.0,1
12889,GO:0035994,response to muscle stretch,4,0.0,1.0,1.0,1
12890,GO:0036065,fucosylation,4,0.0,1.0,1.0,2
12891,GO:0036119,response to platelet-derived growth factor,4,0.0,1.0,1.0,1
12892,GO:0036125,fatty acid beta-oxidation multienzyme complex,4,0.0,1.0,1.0,1
12893,GO:0036176,response to neutral pH,4,0.0,1.0,1.0,2
12894,GO:0036177,filamentous growth of a population of unicellular organisms in response to pH,4,0.0,1.0,1.0,1
12895,GO:0036180,filamentous growth of a population of unicellular organisms in response to biotic stimulus,4,0.0,1.0,1.0,1
12896,GO:0036213,contractile ring contraction,4,0.0,1.0,1.0,1
12897,GO:0036273,response to statin,4,0.0,1.0,1.0,1
12898,GO:0036296,response to increased oxygen levels,4,0.0,1.0,1.0,2
12899,GO:0036314,response to sterol,4,0.0,1.0,1.0,4
12900,GO:0036420,extrinsic component of mycolate outer membrane,4,0.0,1.0,1.0,1
12901,GO:0036465,synaptic vesicle recycling,4,0.0,1.0,1.0,1
12902,GO:0036506,maintenance of unfolded protein,4,0.0,1.0,1.0,1
12903,GO:0038064,collagen receptor activity,4,0.0,1.0,1.0,1
12904,GO:0039017,pattern specification involved in pronephros development,4,0.0,1.0,1.0,4
12905,GO:0039713,viral factory,4,0.0,1.0,1.0,2
12906,GO:0040002,collagen and cuticulin-based cuticle development,4,0.0,1.0,1.0,1
12907,GO:0040003,chitin-based cuticle development,4,0.0,1.0,1.0,3
12908,GO:0040009,regulation of growth rate,4,0.0,1.0,1.0,2
12909,GO:0040013,negative regulation of locomotion,4,0.0,1.0,1.0,5
12910,GO:0040017,positive regulation of locomotion,4,0.0,1.0,1.0,5
12911,GO:0040028,regulation of vulval development,4,0.0,1.0,1.0,2
12912,GO:0040034,"regulation of development, heterochronic",4,0.0,1.0,1.0,7
12913,GO:0042044,fluid transport,4,0.0,1.0,1.0,2
12914,GO:0042048,olfactory behavior,4,0.0,1.0,1.0,1
12915,GO:0042060,wound healing,4,0.0,1.0,1.0,1
12916,GO:0042065,glial cell growth,4,0.0,1.0,1.0,1
12917,GO:0042078,germ-line stem cell division,4,0.0,1.0,1.0,2
12918,GO:0042127,regulation of cell population proliferation,4,0.0,1.0,1.0,31
12919,GO:0042170,plastid membrane,4,0.0,1.0,1.0,9
12920,GO:0042178,xenobiotic catabolic process,4,0.0,1.0,1.0,39
12921,GO:0042191,methylmercury metabolic process,4,0.0,1.0,1.0,2
12922,GO:0042197,halogenated hydrocarbon metabolic process,4,0.0,1.0,1.0,7
12923,GO:0042198,nylon metabolic process,4,0.0,1.0,1.0,1
12924,GO:0042219,modified amino acid catabolic process,4,0.0,1.0,1.0,17
12925,GO:0042246,tissue regeneration,4,0.0,1.0,1.0,6
12926,GO:0042268,regulation of cytolysis,4,0.0,1.0,1.0,2
12927,GO:0042287,MHC protein binding,4,0.0,1.0,1.0,3
12928,GO:0042332,gravitaxis,4,0.0,1.0,1.0,2
12929,GO:0042386,hemocyte differentiation,4,0.0,1.0,1.0,4
12930,GO:0042398,modified amino acid biosynthetic process,4,0.0,1.0,1.0,20
12931,GO:0042405,nuclear inclusion body,4,0.0,1.0,1.0,1
12932,GO:0042431,indole metabolic process,4,0.0,1.0,1.0,2
12933,GO:0042435,indole-containing compound biosynthetic process,4,0.0,1.0,1.0,11
12934,GO:0042436,indole-containing compound catabolic process,4,0.0,1.0,1.0,7
12935,GO:0042445,hormone metabolic process,4,0.0,1.0,1.0,18
12936,GO:0042472,inner ear morphogenesis,4,0.0,1.0,1.0,1
12937,GO:0042476,odontogenesis,4,0.0,1.0,1.0,2
12938,GO:0042546,cell wall biogenesis,4,0.0,1.0,1.0,4
12939,GO:0042552,myelination,4,0.0,1.0,1.0,3
12940,GO:0042559,pteridine-containing compound biosynthetic process,4,0.0,1.0,1.0,5
12941,GO:0042560,pteridine-containing compound catabolic process,4,0.0,1.0,1.0,5
12942,GO:0042578,phosphoric ester hydrolase activity,4,0.0,1.0,1.0,5
12943,GO:0042593,glucose homeostasis,4,0.0,1.0,1.0,1
12944,GO:0042596,fear response,4,0.0,1.0,1.0,1
12945,GO:0042611,MHC protein complex,4,0.0,1.0,1.0,3
12946,GO:0042618,poly-hydroxybutyrate metabolic process,4,0.0,1.0,1.0,1
12947,GO:0042634,regulation of hair cycle,4,0.0,1.0,1.0,3
12948,GO:0042651,thylakoid membrane,4,0.0,1.0,1.0,3
12949,GO:0042692,muscle cell differentiation,4,0.0,1.0,1.0,2
12950,GO:0042693,muscle cell fate commitment,4,0.0,1.0,1.0,2
12951,GO:0042694,muscle cell fate specification,4,0.0,1.0,1.0,1
12952,GO:0042709,succinate-CoA ligase complex,4,0.0,1.0,1.0,2
12953,GO:0042710,biofilm formation,4,0.0,1.0,1.0,4
12954,GO:0042717,plasma membrane-derived chromatophore membrane,4,0.0,1.0,1.0,1
12955,GO:0042727,flavin-containing compound biosynthetic process,4,0.0,1.0,1.0,4
12956,GO:0042728,flavin-containing compound catabolic process,4,0.0,1.0,1.0,3
12957,GO:0042743,hydrogen peroxide metabolic process,4,0.0,1.0,1.0,3
12958,GO:0042753,positive regulation of circadian rhythm,4,0.0,1.0,1.0,3
12959,GO:0042754,negative regulation of circadian rhythm,4,0.0,1.0,1.0,3
12960,GO:0042755,eating behavior,4,0.0,1.0,1.0,2
12961,GO:0042756,drinking behavior,4,0.0,1.0,1.0,1
12962,GO:0042805,actinin binding,4,0.0,1.0,1.0,1
12963,GO:0042908,xenobiotic transport,4,0.0,1.0,1.0,5
12964,GO:0042947,glucoside transmembrane transporter activity,4,0.0,1.0,1.0,3
12965,GO:0042952,beta-ketoadipate pathway,4,0.0,1.0,1.0,1
12966,GO:0043022,ribosome binding,4,0.0,1.0,1.0,3
12967,GO:0043043,peptide biosynthetic process,4,0.0,1.0,1.0,4
12968,GO:0043058,regulation of backward locomotion,4,0.0,1.0,1.0,2
12969,GO:0043059,regulation of forward locomotion,4,0.0,1.0,1.0,2
12970,GO:0043062,extracellular structure organization,4,0.0,1.0,1.0,2
12971,GO:0043067,regulation of programmed cell death,4,0.0,1.0,1.0,10
12972,GO:0043086,negative regulation of catalytic activity,4,0.0,1.0,1.0,9
12973,GO:0043112,receptor metabolic process,4,0.0,1.0,1.0,3
12974,GO:0043120,tumor necrosis factor binding,4,0.0,1.0,1.0,1
12975,GO:0043121,neurotrophin binding,4,0.0,1.0,1.0,2
12976,GO:0043130,ubiquitin binding,4,0.0,1.0,1.0,1
12977,GO:0043168,anion binding,4,0.0,1.0,1.0,68
12978,GO:0043181,vacuolar sequestering,4,0.0,1.0,1.0,1
12979,GO:0043208,glycosphingolipid binding,4,0.0,1.0,1.0,1
12980,GO:0043264,extracellular membraneless organelle,4,0.0,1.0,1.0,4
12981,GO:0043279,response to alkaloid,4,0.0,1.0,1.0,7
12982,GO:0043331,response to dsRNA,4,0.0,1.0,1.0,2
12983,GO:0043393,regulation of protein binding,4,0.0,1.0,1.0,10
12984,GO:0043412,macromolecule modification,4,0.0,1.0,1.0,8
12985,GO:0043446,alkane metabolic process,4,0.0,1.0,1.0,7
12986,GO:0043452,alkyne metabolic process,4,0.0,1.0,1.0,3
12987,GO:0043474,pigment metabolic process involved in pigmentation,4,0.0,1.0,1.0,3
12988,GO:0043480,pigment accumulation in tissues,4,0.0,1.0,1.0,1
12989,GO:0043482,cellular pigment accumulation,4,0.0,1.0,1.0,1
12990,GO:0043500,muscle adaptation,4,0.0,1.0,1.0,5
12991,GO:0043542,endothelial cell migration,4,0.0,1.0,1.0,3
12992,GO:0043562,cellular response to nitrogen levels,4,0.0,1.0,1.0,1
12993,GO:0043576,regulation of respiratory gaseous exchange,4,0.0,1.0,1.0,3
12994,GO:0043604,amide biosynthetic process,4,0.0,1.0,1.0,45
12995,GO:0043605,amide catabolic process,4,0.0,1.0,1.0,10
12996,GO:0043606,formamide metabolic process,4,0.0,1.0,1.0,3
12997,GO:0043627,response to estrogen,4,0.0,1.0,1.0,1
12998,GO:0043708,cell adhesion involved in biofilm formation,4,0.0,1.0,1.0,2
12999,GO:0043935,sexual sporulation resulting in formation of a cellular spore,4,0.0,1.0,1.0,4
13000,GO:0043936,asexual sporulation resulting in formation of a cellular spore,4,0.0,1.0,1.0,9
13001,GO:0043937,regulation of sporulation,4,0.0,1.0,1.0,5
13002,GO:0043954,cellular component maintenance,4,0.0,1.0,1.0,7
13003,GO:0044001,migration in host,4,0.0,1.0,1.0,3
13004,GO:0044002,acquisition of nutrients from host,4,0.0,1.0,1.0,1
13005,GO:0044003,symbiont-mediated perturbation of host process,4,0.0,1.0,1.0,36
13006,GO:0044036,cell wall macromolecule metabolic process,4,0.0,1.0,1.0,4
13007,GO:0044057,regulation of system process,4,0.0,1.0,1.0,10
13008,GO:0044087,regulation of cellular component biogenesis,4,0.0,1.0,1.0,23
13009,GO:0044091,membrane biogenesis,4,0.0,1.0,1.0,4
13010,GO:0044127,regulation of development of symbiont in host,4,0.0,1.0,1.0,2
13011,GO:0044147,negative regulation of formation of structure involved in a symbiotic process,4,0.0,1.0,1.0,3
13012,GO:0044149,positive regulation of formation of structure involved in a symbiotic process,4,0.0,1.0,1.0,3
13013,GO:0044156,host cell junction,4,0.0,1.0,1.0,1
13014,GO:0044157,host cell projection,4,0.0,1.0,1.0,2
13015,GO:0044248,cellular catabolic process,4,0.0,1.0,1.0,7
13016,GO:0044278,disruption of cell wall in another organism,4,0.0,1.0,1.0,1
13017,GO:0044282,small molecule catabolic process,4,0.0,1.0,1.0,13
13018,GO:0044319,"wound healing, spreading of cells",4,0.0,1.0,1.0,1
13019,GO:0044321,response to leptin,4,0.0,1.0,1.0,1
13020,GO:0044358,envenomation resulting in hemorrhagic damage in another organism,4,0.0,1.0,1.0,1
13021,GO:0044362,negative regulation of molecular function in another organism,4,0.0,1.0,1.0,2
13022,GO:0044388,small protein activating enzyme binding,4,0.0,1.0,1.0,1
13023,GO:0044389,ubiquitin-like protein ligase binding,4,0.0,1.0,1.0,1
13024,GO:0044390,ubiquitin-like protein conjugating enzyme binding,4,0.0,1.0,1.0,1
13025,GO:0044396,actin cortical patch organization,4,0.0,1.0,1.0,1
13026,GO:0044406,adhesion of symbiont to host,4,0.0,1.0,1.0,4
13027,GO:0044409,symbiont entry into host,4,0.0,1.0,1.0,4
13028,GO:0044417,translocation of molecules into host,4,0.0,1.0,1.0,3
13029,GO:0044468,envenomation resulting in modulation of blood coagulation in another organism,4,0.0,1.0,1.0,3
13030,GO:0044479,envenomation resulting in modulation of mast cell degranulation in another organism,4,0.0,1.0,1.0,1
13031,GO:0044483,envenomation resulting in impairment of hemostasis in another organism,4,0.0,1.0,1.0,4
13032,GO:0044491,positive regulation of molecular function in another organism,4,0.0,1.0,1.0,2
13033,GO:0044495,modulation of blood pressure in another organism,4,0.0,1.0,1.0,2
13034,GO:0044498,envenomation resulting in modulation of blood pressure in another organism,4,0.0,1.0,1.0,2
13035,GO:0044504,modulation of receptor activity in another organism,4,0.0,1.0,1.0,4
13036,GO:0044509,envenomation resulting in modulation of signal transduction in another organism,4,0.0,1.0,1.0,1
13037,GO:0044511,envenomation resulting in modulation of receptor activity in another organism,4,0.0,1.0,1.0,3
13038,GO:0044521,envenomation resulting in muscle damage in another organism,4,0.0,1.0,1.0,2
13039,GO:0044550,secondary metabolite biosynthetic process,4,0.0,1.0,1.0,39
13040,GO:0044560,envenomation resulting in modulation of ion channel activity in another organism,4,0.0,1.0,1.0,4
13041,GO:0044561,modulation of ion channel activity in another organism,4,0.0,1.0,1.0,4
13042,GO:0044719,regulation of imaginal disc-derived wing size,4,0.0,1.0,1.0,2
13043,GO:0044732,mitotic spindle pole body,4,0.0,1.0,1.0,2
13044,GO:0044742,envenomation resulting in modulation of sensory perception of pain in another organism,4,0.0,1.0,1.0,1
13045,GO:0044771,meiotic cell cycle phase transition,4,0.0,1.0,1.0,4
13046,GO:0044772,mitotic cell cycle phase transition,4,0.0,1.0,1.0,4
13047,GO:0044839,cell cycle G2/M phase transition,4,0.0,1.0,1.0,2
13048,GO:0044843,cell cycle G1/S phase transition,4,0.0,1.0,1.0,1
13049,GO:0045121,membrane raft,4,0.0,1.0,1.0,1
13050,GO:0045229,external encapsulating structure organization,4,0.0,1.0,1.0,9
13051,GO:0045240,alpha-ketoacid dehydrogenase complex,4,0.0,1.0,1.0,4
13052,GO:0045289,luciferin monooxygenase activity,4,0.0,1.0,1.0,6
13053,GO:0045296,cadherin binding,4,0.0,1.0,1.0,1
13054,GO:0045304,regulation of establishment of competence for transformation,4,0.0,1.0,1.0,2
13055,GO:0045309,protein phosphorylated amino acid binding,4,0.0,1.0,1.0,3
13056,GO:0045444,fat cell differentiation,4,0.0,1.0,1.0,2
13057,GO:0045445,myoblast differentiation,4,0.0,1.0,1.0,2
13058,GO:0045448,"mitotic cell cycle, embryonic",4,0.0,1.0,1.0,2
13059,GO:0045472,response to ether,4,0.0,1.0,1.0,13
13060,GO:0045682,regulation of epidermis development,4,0.0,1.0,1.0,3
13061,GO:0045703,ketoreductase activity,4,0.0,1.0,1.0,1
13062,GO:0045704,regulation of salivary gland boundary specification,4,0.0,1.0,1.0,4
13063,GO:0045776,negative regulation of blood pressure,4,0.0,1.0,1.0,2
13064,GO:0045777,positive regulation of blood pressure,4,0.0,1.0,1.0,3
13065,GO:0045837,negative regulation of membrane potential,4,0.0,1.0,1.0,1
13066,GO:0045838,positive regulation of membrane potential,4,0.0,1.0,1.0,1
13067,GO:0045926,negative regulation of growth,4,0.0,1.0,1.0,5
13068,GO:0045927,positive regulation of growth,4,0.0,1.0,1.0,5
13069,GO:0046148,pigment biosynthetic process,4,0.0,1.0,1.0,13
13070,GO:0046149,pigment catabolic process,4,0.0,1.0,1.0,6
13071,GO:0046184,aldehyde biosynthetic process,4,0.0,1.0,1.0,13
13072,GO:0046185,aldehyde catabolic process,4,0.0,1.0,1.0,9
13073,GO:0046209,nitric oxide metabolic process,4,0.0,1.0,1.0,2
13074,GO:0046275,flavonoid catabolic process,4,0.0,1.0,1.0,3
13075,GO:0046283,anthocyanin-containing compound metabolic process,4,0.0,1.0,1.0,2
13076,GO:0046285,flavonoid phytoalexin metabolic process,4,0.0,1.0,1.0,2
13077,GO:0046292,formaldehyde metabolic process,4,0.0,1.0,1.0,3
13078,GO:0046374,teichoic acid metabolic process,4,0.0,1.0,1.0,7
13079,GO:0046377,colanic acid metabolic process,4,0.0,1.0,1.0,1
13080,GO:0046412,phenylmercury acetate metabolic process,4,0.0,1.0,1.0,1
13081,GO:0046414,organomercury biosynthetic process,4,0.0,1.0,1.0,1
13082,GO:0046415,urate metabolic process,4,0.0,1.0,1.0,2
13083,GO:0046433,2-aminoethylphosphonate metabolic process,4,0.0,1.0,1.0,1
13084,GO:0046446,purine alkaloid metabolic process,4,0.0,1.0,1.0,1
13085,GO:0046448,tropane alkaloid metabolic process,4,0.0,1.0,1.0,4
13086,GO:0046458,hexadecanal metabolic process,4,0.0,1.0,1.0,1
13087,GO:0046500,S-adenosylmethionine metabolic process,4,0.0,1.0,1.0,3
13088,GO:0046543,development of secondary female sexual characteristics,4,0.0,1.0,1.0,1
13089,GO:0046649,lymphocyte activation,4,0.0,1.0,1.0,6
13090,GO:0046678,response to bacteriocin,4,0.0,1.0,1.0,1
13091,GO:0046686,response to cadmium ion,4,0.0,1.0,1.0,2
13092,GO:0046687,response to chromate,4,0.0,1.0,1.0,1
13093,GO:0046689,response to mercury ion,4,0.0,1.0,1.0,1
13094,GO:0046690,response to tellurium ion,4,0.0,1.0,1.0,1
13095,GO:0046719,regulation by virus of viral protein levels in host cell,4,0.0,1.0,1.0,2
13096,GO:0046782,regulation of viral transcription,4,0.0,1.0,1.0,2
13097,GO:0046857,"oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor",4,0.0,1.0,1.0,12
13098,GO:0046903,secretion,4,0.0,1.0,1.0,11
13099,GO:0046907,intracellular transport,4,0.0,1.0,1.0,24
13100,GO:0046912,"acyltransferase activity, acyl groups converted into alkyl on transfer",4,0.0,1.0,1.0,15
13101,GO:0046923,ER retention sequence binding,4,0.0,1.0,1.0,3
13102,GO:0046937,phytochelatin metabolic process,4,0.0,1.0,1.0,3
13103,GO:0046943,carboxylic acid transmembrane transporter activity,4,0.0,1.0,1.0,39
13104,GO:0046993,"oxidoreductase activity, acting on X-H and Y-H to form an X-Y bond, with oxygen as acceptor",4,0.0,1.0,1.0,9
13105,GO:0046994,"oxidoreductase activity, acting on hydrogen as donor, with a quinone or similar compound as acceptor",4,0.0,1.0,1.0,1
13106,GO:0046995,"oxidoreductase activity, acting on hydrogen as donor, with other known acceptors",4,0.0,1.0,1.0,3
13107,GO:0046997,"oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor",4,0.0,1.0,1.0,4
13108,GO:0047545,2-hydroxyglutarate dehydrogenase activity,4,0.0,1.0,1.0,2
13109,GO:0048003,antigen processing and presentation of lipid antigen via MHC class Ib,4,0.0,1.0,1.0,2
13110,GO:0048018,receptor ligand activity,4,0.0,1.0,1.0,11
13111,GO:0048019,receptor antagonist activity,4,0.0,1.0,1.0,4
13112,GO:0048028,galacturonan binding,4,0.0,1.0,1.0,1
13113,GO:0048030,disaccharide binding,4,0.0,1.0,1.0,4
13114,GO:0048031,trisaccharide binding,4,0.0,1.0,1.0,1
13115,GO:0048039,ubiquinone binding,4,0.0,1.0,1.0,1
13116,GO:0048070,regulation of developmental pigmentation,4,0.0,1.0,1.0,6
13117,GO:0048099,"anterior/posterior lineage restriction, imaginal disc",4,0.0,1.0,1.0,1
13118,GO:0048103,somatic stem cell division,4,0.0,1.0,1.0,3
13119,GO:0048135,female germ-line cyst formation,4,0.0,1.0,1.0,1
13120,GO:0048139,female germ-line cyst encapsulation,4,0.0,1.0,1.0,1
13121,GO:0048143,astrocyte activation,4,0.0,1.0,1.0,1
13122,GO:0048229,gametophyte development,4,0.0,1.0,1.0,2
13123,GO:0048232,male gamete generation,4,0.0,1.0,1.0,1
13124,GO:0048236,plant-type sporogenesis,4,0.0,1.0,1.0,2
13125,GO:0048278,vesicle docking,4,0.0,1.0,1.0,3
13126,GO:0048281,inflorescence morphogenesis,4,0.0,1.0,1.0,2
13127,GO:0048311,mitochondrion distribution,4,0.0,1.0,1.0,3
13128,GO:0048315,conidium formation,4,0.0,1.0,1.0,2
13129,GO:0048332,mesoderm morphogenesis,4,0.0,1.0,1.0,4
13130,GO:0048333,mesodermal cell differentiation,4,0.0,1.0,1.0,5
13131,GO:0048359,mucilage metabolic process involved in seed coat development,4,0.0,1.0,1.0,1
13132,GO:0048364,root development,4,0.0,1.0,1.0,4
13133,GO:0048367,shoot system development,4,0.0,1.0,1.0,2
13134,GO:0048437,floral organ development,4,0.0,1.0,1.0,4
13135,GO:0048449,floral organ formation,4,0.0,1.0,1.0,4
13136,GO:0048467,gynoecium development,4,0.0,1.0,1.0,1
13137,GO:0048469,cell maturation,4,0.0,1.0,1.0,11
13138,GO:0048483,autonomic nervous system development,4,0.0,1.0,1.0,1
13139,GO:0048494,chromatophore ribulose bisphosphate carboxylase complex,4,0.0,1.0,1.0,1
13140,GO:0048507,meristem development,4,0.0,1.0,1.0,3
13141,GO:0048509,regulation of meristem development,4,0.0,1.0,1.0,2
13142,GO:0048512,circadian behavior,4,0.0,1.0,1.0,5
13143,GO:0048514,blood vessel morphogenesis,4,0.0,1.0,1.0,5
13144,GO:0048524,positive regulation of viral process,4,0.0,1.0,1.0,6
13145,GO:0048525,negative regulation of viral process,4,0.0,1.0,1.0,7
13146,GO:0048533,sporocyte differentiation,4,0.0,1.0,1.0,2
13147,GO:0048534,hematopoietic or lymphoid organ development,4,0.0,1.0,1.0,8
13148,GO:0048546,digestive tract morphogenesis,4,0.0,1.0,1.0,1
13149,GO:0048560,establishment of anatomical structure orientation,4,0.0,1.0,1.0,2
13150,GO:0048562,embryonic organ morphogenesis,4,0.0,1.0,1.0,7
13151,GO:0048565,digestive tract development,4,0.0,1.0,1.0,3
13152,GO:0048568,embryonic organ development,4,0.0,1.0,1.0,10
13153,GO:0048625,myoblast fate commitment,4,0.0,1.0,1.0,3
13154,GO:0048626,myoblast fate specification,4,0.0,1.0,1.0,1
13155,GO:0048634,regulation of muscle organ development,4,0.0,1.0,1.0,5
13156,GO:0048638,regulation of developmental growth,4,0.0,1.0,1.0,25
13157,GO:0048644,muscle organ morphogenesis,4,0.0,1.0,1.0,1
13158,GO:0048659,smooth muscle cell proliferation,4,0.0,1.0,1.0,1
13159,GO:0048663,neuron fate commitment,4,0.0,1.0,1.0,10
13160,GO:0048664,neuron fate determination,4,0.0,1.0,1.0,3
13161,GO:0048665,neuron fate specification,4,0.0,1.0,1.0,6
13162,GO:0048666,neuron development,4,0.0,1.0,1.0,10
13163,GO:0048667,cell morphogenesis involved in neuron differentiation,4,0.0,1.0,1.0,4
13164,GO:0048668,collateral sprouting,4,0.0,1.0,1.0,3
13165,GO:0048678,response to axon injury,4,0.0,1.0,1.0,1
13166,GO:0048682,sprouting of injured axon,4,0.0,1.0,1.0,3
13167,GO:0048705,skeletal system morphogenesis,4,0.0,1.0,1.0,1
13168,GO:0048737,imaginal disc-derived appendage development,4,0.0,1.0,1.0,1
13169,GO:0048760,plant parenchymal cell differentiation,4,0.0,1.0,1.0,1
13170,GO:0048762,mesenchymal cell differentiation,4,0.0,1.0,1.0,8
13171,GO:0048799,animal organ maturation,4,0.0,1.0,1.0,4
13172,GO:0048806,genitalia development,4,0.0,1.0,1.0,3
13173,GO:0048809,analia morphogenesis,4,0.0,1.0,1.0,2
13174,GO:0048819,regulation of hair follicle maturation,4,0.0,1.0,1.0,5
13175,GO:0048827,phyllome development,4,0.0,1.0,1.0,6
13176,GO:0048831,regulation of shoot system development,4,0.0,1.0,1.0,1
13177,GO:0048832,specification of plant organ number,4,0.0,1.0,1.0,1
13178,GO:0048863,stem cell differentiation,4,0.0,1.0,1.0,9
13179,GO:0048864,stem cell development,4,0.0,1.0,1.0,1
13180,GO:0048865,stem cell fate commitment,4,0.0,1.0,1.0,1
13181,GO:0048866,stem cell fate specification,4,0.0,1.0,1.0,1
13182,GO:0048867,stem cell fate determination,4,0.0,1.0,1.0,2
13183,GO:0048880,sensory system development,4,0.0,1.0,1.0,3
13184,GO:0048882,lateral line development,4,0.0,1.0,1.0,2
13185,GO:0048883,neuromast primordium migration,4,0.0,1.0,1.0,2
13186,GO:0048888,neuromast mantle cell differentiation,4,0.0,1.0,1.0,2
13187,GO:0048889,neuromast support cell differentiation,4,0.0,1.0,1.0,2
13188,GO:0048938,lateral line nerve glial cell morphogenesis involved in differentiation,4,0.0,1.0,1.0,2
13189,GO:0050435,amyloid-beta metabolic process,4,0.0,1.0,1.0,2
13190,GO:0050485,"oxidoreductase activity, acting on X-H and Y-H to form an X-Y bond, with a disulfide as acceptor",4,0.0,1.0,1.0,4
13191,GO:0050486,intramolecular hydroxytransferase activity,4,0.0,1.0,1.0,5
13192,GO:0050497,alkylthioltransferase activity,4,0.0,1.0,1.0,3
13193,GO:0050498,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with 2-oxoglutarate as one donor, and the other dehydrogenated",4,0.0,1.0,1.0,3
13194,GO:0050499,"oxidoreductase activity, acting on phosphorus or arsenic in donors, with NAD(P)+ as acceptor",4,0.0,1.0,1.0,1
13195,GO:0050664,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor",4,0.0,1.0,1.0,2
13196,GO:0050761,depsipeptide metabolic process,4,0.0,1.0,1.0,4
13197,GO:0050776,regulation of immune response,4,0.0,1.0,1.0,22
13198,GO:0050795,regulation of behavior,4,0.0,1.0,1.0,14
13199,GO:0050811,GABA receptor binding,4,0.0,1.0,1.0,1
13200,GO:0050818,regulation of coagulation,4,0.0,1.0,1.0,3
13201,GO:0050822,peptide stabilization,4,0.0,1.0,1.0,1
13202,GO:0050865,regulation of cell activation,4,0.0,1.0,1.0,9
13203,GO:0050890,cognition,4,0.0,1.0,1.0,2
13204,GO:0050891,multicellular organismal-level water homeostasis,4,0.0,1.0,1.0,1
13205,GO:0050899,nitrile catabolic process,4,0.0,1.0,1.0,3
13206,GO:0050900,leukocyte migration,4,0.0,1.0,1.0,7
13207,GO:0050905,neuromuscular process,4,0.0,1.0,1.0,4
13208,GO:0050907,detection of chemical stimulus involved in sensory perception,4,0.0,1.0,1.0,4
13209,GO:0050918,positive chemotaxis,4,0.0,1.0,1.0,8
13210,GO:0050919,negative chemotaxis,4,0.0,1.0,1.0,8
13211,GO:0050931,pigment cell differentiation,4,0.0,1.0,1.0,7
13212,GO:0050981,detection of electrical stimulus,4,0.0,1.0,1.0,2
13213,GO:0050982,detection of mechanical stimulus,4,0.0,1.0,1.0,4
13214,GO:0051003,"ligase activity, forming nitrogen-metal bonds, forming coordination complexes",4,0.0,1.0,1.0,2
13215,GO:0051012,microtubule sliding,4,0.0,1.0,1.0,2
13216,GO:0051020,GTPase binding,4,0.0,1.0,1.0,1
13217,GO:0051032,nucleic acid transmembrane transporter activity,4,0.0,1.0,1.0,2
13218,GO:0051084,'de novo' post-translational protein folding,4,0.0,1.0,1.0,2
13219,GO:0051093,negative regulation of developmental process,4,0.0,1.0,1.0,102
13220,GO:0051095,regulation of helicase activity,4,0.0,1.0,1.0,4
13221,GO:0051099,positive regulation of binding,4,0.0,1.0,1.0,11
13222,GO:0051100,negative regulation of binding,4,0.0,1.0,1.0,10
13223,GO:0051101,regulation of DNA binding,4,0.0,1.0,1.0,8
13224,GO:0051119,sugar transmembrane transporter activity,4,0.0,1.0,1.0,1
13225,GO:0051128,regulation of cellular component organization,4,0.0,1.0,1.0,42
13226,GO:0051165,"2,5-dihydroxypyridine metabolic process",4,0.0,1.0,1.0,1
13227,GO:0051180,vitamin transport,4,0.0,1.0,1.0,9
13228,GO:0051191,prosthetic group biosynthetic process,4,0.0,1.0,1.0,1
13229,GO:0051216,cartilage development,4,0.0,1.0,1.0,4
13230,GO:0051220,cytoplasmic sequestering of protein,4,0.0,1.0,1.0,1
13231,GO:0051241,negative regulation of multicellular organismal process,4,0.0,1.0,1.0,130
13232,GO:0051282,regulation of sequestering of calcium ion,4,0.0,1.0,1.0,3
13233,GO:0051302,regulation of cell division,4,0.0,1.0,1.0,8
13234,GO:0051303,establishment of chromosome localization,4,0.0,1.0,1.0,5
13235,GO:0051305,chromosome movement towards spindle pole,4,0.0,1.0,1.0,2
13236,GO:0051307,meiotic chromosome separation,4,0.0,1.0,1.0,3
13237,GO:0051315,attachment of mitotic spindle microtubules to kinetochore,4,0.0,1.0,1.0,2
13238,GO:0051316,attachment of meiotic spindle microtubules to kinetochore,4,0.0,1.0,1.0,2
13239,GO:0051323,metaphase,4,0.0,1.0,1.0,2
13240,GO:0051328,meiotic interphase,4,0.0,1.0,1.0,1
13241,GO:0051338,regulation of transferase activity,4,0.0,1.0,1.0,22
13242,GO:0051339,regulation of lyase activity,4,0.0,1.0,1.0,8
13243,GO:0051340,regulation of ligase activity,4,0.0,1.0,1.0,6
13244,GO:0051341,regulation of oxidoreductase activity,4,0.0,1.0,1.0,16
13245,GO:0051400,BH domain binding,4,0.0,1.0,1.0,4
13246,GO:0051427,hormone receptor binding,4,0.0,1.0,1.0,2
13247,GO:0051536,iron-sulfur cluster binding,4,0.0,1.0,1.0,5
13248,GO:0051550,aurone metabolic process,4,0.0,1.0,1.0,1
13249,GO:0051552,flavone metabolic process,4,0.0,1.0,1.0,6
13250,GO:0051558,phlobaphene metabolic process,4,0.0,1.0,1.0,1
13251,GO:0051650,establishment of vesicle localization,4,0.0,1.0,1.0,11
13252,GO:0051654,establishment of mitochondrion localization,4,0.0,1.0,1.0,3
13253,GO:0051657,maintenance of organelle location,4,0.0,1.0,1.0,9
13254,GO:0051663,oocyte nucleus localization involved in oocyte dorsal/ventral axis specification,4,0.0,1.0,1.0,2
13255,GO:0051665,membrane raft localization,4,0.0,1.0,1.0,2
13256,GO:0051667,establishment of plastid localization,4,0.0,1.0,1.0,1
13257,GO:0051673,disruption of plasma membrane integrity in another organism,4,0.0,1.0,1.0,3
13258,GO:0051686,establishment of ER localization,4,0.0,1.0,1.0,1
13259,GO:0051726,regulation of cell cycle,4,0.0,1.0,1.0,7
13260,GO:0051788,response to misfolded protein,4,0.0,1.0,1.0,2
13261,GO:0051851,modulation by host of symbiont process,4,0.0,1.0,1.0,9
13262,GO:0051862,translocation of molecules into symbiont,4,0.0,1.0,1.0,1
13263,GO:0051875,pigment granule localization,4,0.0,1.0,1.0,2
13264,GO:0051881,regulation of mitochondrial membrane potential,4,0.0,1.0,1.0,4
13265,GO:0051899,membrane depolarization,4,0.0,1.0,1.0,3
13266,GO:0051923,sulfation,4,0.0,1.0,1.0,1
13267,GO:0052008,symbiont-mediated disruption of host cellular anatomical structure,4,0.0,1.0,1.0,13
13268,GO:0052128,positive energy taxis,4,0.0,1.0,1.0,2
13269,GO:0052129,negative energy taxis,4,0.0,1.0,1.0,2
13270,GO:0052372,modulation by symbiont of entry into host,4,0.0,1.0,1.0,6
13271,GO:0052545,callose localization,4,0.0,1.0,1.0,3
13272,GO:0052592,"oxidoreductase activity, acting on CH or CH2 groups, with an iron-sulfur protein as acceptor",4,0.0,1.0,1.0,4
13273,GO:0052701,modified histidine metabolic process,4,0.0,1.0,1.0,4
13274,GO:0052738,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, with a quinone or similar compound as acceptor",4,0.0,1.0,1.0,1
13275,GO:0052779,amino disaccharide metabolic process,4,0.0,1.0,1.0,3
13276,GO:0052802,nitroimidazole metabolic process,4,0.0,1.0,1.0,1
13277,GO:0052805,imidazole-containing compound catabolic process,4,0.0,1.0,1.0,3
13278,GO:0052838,thiazole metabolic process,4,0.0,1.0,1.0,1
13279,GO:0052877,"oxidoreductase activity, acting on the CH-NH2 group of donors, with a copper protein as acceptor",4,0.0,1.0,1.0,2
13280,GO:0052880,"oxidoreductase activity, acting on diphenols and related substances as donors, with copper protein as acceptor",4,0.0,1.0,1.0,1
13281,GO:0052882,"oxidoreductase activity, acting on phosphorus or arsenic in donors, with a copper protein as acceptor",4,0.0,1.0,1.0,1
13282,GO:0052890,"oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor",4,0.0,1.0,1.0,3
13283,GO:0055001,muscle cell development,4,0.0,1.0,1.0,2
13284,GO:0055006,cardiac cell development,4,0.0,1.0,1.0,8
13285,GO:0055059,asymmetric neuroblast division,4,0.0,1.0,1.0,1
13286,GO:0055062,phosphate ion homeostasis,4,0.0,1.0,1.0,1
13287,GO:0055063,sulfate ion homeostasis,4,0.0,1.0,1.0,1
13288,GO:0055080,monoatomic cation homeostasis,4,0.0,1.0,1.0,9
13289,GO:0055081,monoatomic anion homeostasis,4,0.0,1.0,1.0,2
13290,GO:0055085,transmembrane transport,4,0.0,1.0,1.0,45
13291,GO:0055094,response to lipoprotein particle,4,0.0,1.0,1.0,2
13292,GO:0055102,lipase inhibitor activity,4,0.0,1.0,1.0,1
13293,GO:0055105,ubiquitin-protein transferase inhibitor activity,4,0.0,1.0,1.0,1
13294,GO:0060005,vestibular reflex,4,0.0,1.0,1.0,2
13295,GO:0060046,regulation of acrosome reaction,4,0.0,1.0,1.0,2
13296,GO:0060055,angiogenesis involved in wound healing,4,0.0,1.0,1.0,1
13297,GO:0060076,excitatory synapse,4,0.0,1.0,1.0,3
13298,GO:0060077,inhibitory synapse,4,0.0,1.0,1.0,2
13299,GO:0060078,regulation of postsynaptic membrane potential,4,0.0,1.0,1.0,4
13300,GO:0060173,limb development,4,0.0,1.0,1.0,2
13301,GO:0060229,lipase activator activity,4,0.0,1.0,1.0,2
13302,GO:0060245,detection of cell density,4,0.0,1.0,1.0,2
13303,GO:0060278,regulation of ovulation,4,0.0,1.0,1.0,2
13304,GO:0060285,cilium-dependent cell motility,4,0.0,1.0,1.0,1
13305,GO:0060306,regulation of membrane repolarization,4,0.0,1.0,1.0,2
13306,GO:0060326,cell chemotaxis,4,0.0,1.0,1.0,14
13307,GO:0060341,regulation of cellular localization,4,0.0,1.0,1.0,10
13308,GO:0060349,bone morphogenesis,4,0.0,1.0,1.0,5
13309,GO:0060353,regulation of cell adhesion molecule production,4,0.0,1.0,1.0,2
13310,GO:0060359,response to ammonium ion,4,0.0,1.0,1.0,1
13311,GO:0060363,cranial suture morphogenesis,4,0.0,1.0,1.0,4
13312,GO:0060405,regulation of penile erection,4,0.0,1.0,1.0,2
13313,GO:0060412,ventricular septum morphogenesis,4,0.0,1.0,1.0,1
13314,GO:0060413,atrial septum morphogenesis,4,0.0,1.0,1.0,3
13315,GO:0060415,muscle tissue morphogenesis,4,0.0,1.0,1.0,3
13316,GO:0060425,lung morphogenesis,4,0.0,1.0,1.0,2
13317,GO:0060429,epithelium development,4,0.0,1.0,1.0,19
13318,GO:0060470,positive regulation of cytosolic calcium ion concentration involved in egg activation,4,0.0,1.0,1.0,1
13319,GO:0060479,lung cell differentiation,4,0.0,1.0,1.0,2
13320,GO:0060485,mesenchyme development,4,0.0,1.0,1.0,10
13321,GO:0060494,inductive mesenchymal-endodermal cell signaling,4,0.0,1.0,1.0,1
13322,GO:0060502,epithelial cell proliferation involved in lung morphogenesis,4,0.0,1.0,1.0,1
13323,GO:0060522,inductive mesenchymal to epithelial cell signaling,4,0.0,1.0,1.0,1
13324,GO:0060536,cartilage morphogenesis,4,0.0,1.0,1.0,3
13325,GO:0060537,muscle tissue development,4,0.0,1.0,1.0,2
13326,GO:0060541,respiratory system development,4,0.0,1.0,1.0,1
13327,GO:0060573,cell fate specification involved in pattern specification,4,0.0,1.0,1.0,6
13328,GO:0060581,cell fate commitment involved in pattern specification,4,0.0,1.0,1.0,4
13329,GO:0060582,cell fate determination involved in pattern specification,4,0.0,1.0,1.0,2
13330,GO:0060605,tube lumen cavitation,4,0.0,1.0,1.0,2
13331,GO:0060606,tube closure,4,0.0,1.0,1.0,4
13332,GO:0060607,cell-cell adhesion involved in sealing an epithelial fold,4,0.0,1.0,1.0,1
13333,GO:0060674,placenta blood vessel development,4,0.0,1.0,1.0,1
13334,GO:0060689,cell differentiation involved in salivary gland development,4,0.0,1.0,1.0,3
13335,GO:0060706,cell differentiation involved in embryonic placenta development,4,0.0,1.0,1.0,5
13336,GO:0060736,prostate gland growth,4,0.0,1.0,1.0,1
13337,GO:0060746,parental behavior,4,0.0,1.0,1.0,3
13338,GO:0060759,regulation of response to cytokine stimulus,4,0.0,1.0,1.0,5
13339,GO:0060767,epithelial cell proliferation involved in prostate gland development,4,0.0,1.0,1.0,1
13340,GO:0060795,cell fate commitment involved in formation of primary germ layer,4,0.0,1.0,1.0,3
13341,GO:0060840,artery development,4,0.0,1.0,1.0,1
13342,GO:0060847,endothelial cell fate specification,4,0.0,1.0,1.0,1
13343,GO:0060856,establishment of blood-brain barrier,4,0.0,1.0,1.0,2
13344,GO:0060860,regulation of floral organ abscission,4,0.0,1.0,1.0,3
13345,GO:0060872,semicircular canal development,4,0.0,1.0,1.0,3
13346,GO:0060897,neural plate regionalization,4,0.0,1.0,1.0,2
13347,GO:0060911,cardiac cell fate commitment,4,0.0,1.0,1.0,10
13348,GO:0060912,cardiac cell fate specification,4,0.0,1.0,1.0,2
13349,GO:0060913,cardiac cell fate determination,4,0.0,1.0,1.0,3
13350,GO:0060972,left/right pattern formation,4,0.0,1.0,1.0,1
13351,GO:0060973,cell migration involved in heart development,4,0.0,1.0,1.0,9
13352,GO:0060993,kidney morphogenesis,4,0.0,1.0,1.0,3
13353,GO:0060998,regulation of dendritic spine development,4,0.0,1.0,1.0,2
13354,GO:0061005,cell differentiation involved in kidney development,4,0.0,1.0,1.0,13
13355,GO:0061009,common bile duct development,4,0.0,1.0,1.0,3
13356,GO:0061024,membrane organization,4,0.0,1.0,1.0,30
13357,GO:0061049,cell growth involved in cardiac muscle cell development,4,0.0,1.0,1.0,1
13358,GO:0061068,urethra development,4,0.0,1.0,1.0,2
13359,GO:0061074,regulation of neural retina development,4,0.0,1.0,1.0,2
13360,GO:0061135,endopeptidase regulator activity,4,0.0,1.0,1.0,2
13361,GO:0061162,establishment of monopolar cell polarity,4,0.0,1.0,1.0,3
13362,GO:0061171,establishment of bipolar cell polarity,4,0.0,1.0,1.0,2
13363,GO:0061174,type I terminal bouton,4,0.0,1.0,1.0,2
13364,GO:0061183,regulation of dermatome development,4,0.0,1.0,1.0,2
13365,GO:0061190,regulation of sclerotome development,4,0.0,1.0,1.0,1
13366,GO:0061209,cell proliferation involved in mesonephros development,4,0.0,1.0,1.0,4
13367,GO:0061227,pattern specification involved in mesonephros development,4,0.0,1.0,1.0,5
13368,GO:0061318,renal filtration cell differentiation,4,0.0,1.0,1.0,2
13369,GO:0061334,cell rearrangement involved in Malpighian tubule morphogenesis,4,0.0,1.0,1.0,1
13370,GO:0061366,behavioral response to chemical pain,4,0.0,1.0,1.0,2
13371,GO:0061384,heart trabecula morphogenesis,4,0.0,1.0,1.0,1
13372,GO:0061448,connective tissue development,4,0.0,1.0,1.0,9
13373,GO:0061458,reproductive system development,4,0.0,1.0,1.0,1
13374,GO:0061517,macrophage proliferation,4,0.0,1.0,1.0,1
13375,GO:0061548,ganglion development,4,0.0,1.0,1.0,3
13376,GO:0061552,ganglion morphogenesis,4,0.0,1.0,1.0,2
13377,GO:0061553,ganglion maturation,4,0.0,1.0,1.0,1
13378,GO:0061560,cranial ganglion formation,4,0.0,1.0,1.0,1
13379,GO:0061562,cranial ganglion structural organization,4,0.0,1.0,1.0,1
13380,GO:0061640,cytoskeleton-dependent cytokinesis,4,0.0,1.0,1.0,2
13381,GO:0061695,"transferase complex, transferring phosphorus-containing groups",4,0.0,1.0,1.0,19
13382,GO:0061754,negative regulation of circulating fibrinogen levels,4,0.0,1.0,1.0,1
13383,GO:0061906,autophagosome localization,4,0.0,1.0,1.0,1
13384,GO:0061949,regulation of premature acrosome loss,4,0.0,1.0,1.0,1
13385,GO:0061963,regulation of entry into reproductive diapause,4,0.0,1.0,1.0,2
13386,GO:0061982,meiosis I cell cycle process,4,0.0,1.0,1.0,14
13387,GO:0061983,meiosis II cell cycle process,4,0.0,1.0,1.0,3
13388,GO:0062023,collagen-containing extracellular matrix,4,0.0,1.0,1.0,8
13389,GO:0062039,biofilm matrix,4,0.0,1.0,1.0,2
13390,GO:0062149,detection of stimulus involved in sensory perception of pain,4,0.0,1.0,1.0,4
13391,GO:0062179,vitamin D 23-hydroxylase activity,4,0.0,1.0,1.0,2
13392,GO:0062197,cellular response to chemical stress,4,0.0,1.0,1.0,9
13393,GO:0062223,regulation of somatic muscle development,4,0.0,1.0,1.0,4
13394,GO:0065010,extracellular membrane-bounded organelle,4,0.0,1.0,1.0,2
13395,GO:0070001,aspartic-type peptidase activity,4,0.0,1.0,1.0,1
13396,GO:0070002,glutamic-type peptidase activity,4,0.0,1.0,1.0,1
13397,GO:0070003,threonine-type peptidase activity,4,0.0,1.0,1.0,3
13398,GO:0070063,RNA polymerase binding,4,0.0,1.0,1.0,2
13399,GO:0070252,actin-mediated cell contraction,4,0.0,1.0,1.0,7
13400,GO:0070279,vitamin B6 binding,4,0.0,1.0,1.0,4
13401,GO:0070293,renal absorption,4,0.0,1.0,1.0,6
13402,GO:0070325,lipoprotein particle receptor binding,4,0.0,1.0,1.0,3
13403,GO:0070419,nonhomologous end joining complex,4,0.0,1.0,1.0,3
13404,GO:0070484,"dehydro-D-arabinono-1,4-lactone metabolic process",4,0.0,1.0,1.0,1
13405,GO:0070503,selenium-containing prosthetic group metabolic process,4,0.0,1.0,1.0,1
13406,GO:0070513,death domain binding,4,0.0,1.0,1.0,1
13407,GO:0070541,response to platinum ion,4,0.0,1.0,1.0,1
13408,GO:0070576,vitamin D 24-hydroxylase activity,4,0.0,1.0,1.0,2
13409,GO:0070603,SWI/SNF superfamily-type complex,4,0.0,1.0,1.0,13
13410,GO:0070633,transepithelial transport,4,0.0,1.0,1.0,3
13411,GO:0070643,vitamin D 25-hydroxylase activity,4,0.0,1.0,1.0,1
13412,GO:0070704,sterol desaturase activity,4,0.0,1.0,1.0,3
13413,GO:0070783,growth of unicellular organism as a thread of attached cells,4,0.0,1.0,1.0,2
13414,GO:0070799,regulation of conidiophore stalk development,4,0.0,1.0,1.0,2
13415,GO:0070813,hydrogen sulfide metabolic process,4,0.0,1.0,1.0,1
13416,GO:0070818,protoporphyrinogen oxidase activity,4,0.0,1.0,1.0,2
13417,GO:0070822,Sin3-type complex,4,0.0,1.0,1.0,2
13418,GO:0070849,response to epidermal growth factor,4,0.0,1.0,1.0,1
13419,GO:0070851,growth factor receptor binding,4,0.0,1.0,1.0,21
13420,GO:0070989,oxidative demethylation,4,0.0,1.0,1.0,1
13421,GO:0070990,snRNP binding,4,0.0,1.0,1.0,2
13422,GO:0071010,prespliceosome,4,0.0,1.0,1.0,2
13423,GO:0071011,precatalytic spliceosome,4,0.0,1.0,1.0,2
13424,GO:0071012,catalytic step 1 spliceosome,4,0.0,1.0,1.0,2
13425,GO:0071013,catalytic step 2 spliceosome,4,0.0,1.0,1.0,2
13426,GO:0071014,post-mRNA release spliceosomal complex,4,0.0,1.0,1.0,2
13427,GO:0071020,post-spliceosomal complex,4,0.0,1.0,1.0,2
13428,GO:0071107,response to parathyroid hormone,4,0.0,1.0,1.0,1
13429,GO:0071183,protocadherin-alpha-protocadherin-gamma complex,4,0.0,1.0,1.0,8
13430,GO:0071214,cellular response to abiotic stimulus,4,0.0,1.0,1.0,9
13431,GO:0071229,cellular response to acid chemical,4,0.0,1.0,1.0,2
13432,GO:0071236,cellular response to antibiotic,4,0.0,1.0,1.0,5
13433,GO:0071243,cellular response to arsenic-containing substance,4,0.0,1.0,1.0,3
13434,GO:0071248,cellular response to metal ion,4,0.0,1.0,1.0,19
13435,GO:0071363,cellular response to growth factor stimulus,4,0.0,1.0,1.0,9
13436,GO:0071407,cellular response to organic cyclic compound,4,0.0,1.0,1.0,91
13437,GO:0071444,cellular response to pheromone,4,0.0,1.0,1.0,2
13438,GO:0071453,cellular response to oxygen levels,4,0.0,1.0,1.0,2
13439,GO:0071498,cellular response to fluid shear stress,4,0.0,1.0,1.0,4
13440,GO:0071501,cellular response to sterol depletion,4,0.0,1.0,1.0,1
13441,GO:0071503,response to heparin,4,0.0,1.0,1.0,1
13442,GO:0071505,response to mycophenolic acid,4,0.0,1.0,1.0,1
13443,GO:0071559,response to transforming growth factor beta,4,0.0,1.0,1.0,1
13444,GO:0071667,DNA/RNA hybrid binding,4,0.0,1.0,1.0,1
13445,GO:0071694,maintenance of protein location in extracellular region,4,0.0,1.0,1.0,2
13446,GO:0071705,nitrogen compound transport,4,0.0,1.0,1.0,74
13447,GO:0071714,icosanoid transmembrane transporter activity,4,0.0,1.0,1.0,1
13448,GO:0071731,response to nitric oxide,4,0.0,1.0,1.0,1
13449,GO:0071746,"IgA immunoglobulin complex, circulating",4,0.0,1.0,1.0,2
13450,GO:0071754,"IgM immunoglobulin complex, circulating",4,0.0,1.0,1.0,2
13451,GO:0071772,response to BMP,4,0.0,1.0,1.0,1
13452,GO:0071774,response to fibroblast growth factor,4,0.0,1.0,1.0,1
13453,GO:0071782,endoplasmic reticulum tubular network,4,0.0,1.0,1.0,1
13454,GO:0071867,response to monoamine,4,0.0,1.0,1.0,4
13455,GO:0071917,triose-phosphate transmembrane transporter activity,4,0.0,1.0,1.0,1
13456,GO:0072029,long nephron development,4,0.0,1.0,1.0,1
13457,GO:0072030,short nephron development,4,0.0,1.0,1.0,1
13458,GO:0072031,proximal convoluted tubule segment 1 development,4,0.0,1.0,1.0,1
13459,GO:0072032,proximal convoluted tubule segment 2 development,4,0.0,1.0,1.0,1
13460,GO:0072044,collecting duct development,4,0.0,1.0,1.0,4
13461,GO:0072065,long descending thin limb bend development,4,0.0,1.0,1.0,1
13462,GO:0072066,prebend segment development,4,0.0,1.0,1.0,1
13463,GO:0072081,specification of nephron tubule identity,4,0.0,1.0,1.0,8
13464,GO:0072104,glomerular capillary formation,4,0.0,1.0,1.0,2
13465,GO:0072110,glomerular mesangial cell proliferation,4,0.0,1.0,1.0,3
13466,GO:0072116,pronephros formation,4,0.0,1.0,1.0,1
13467,GO:0072122,extraglomerular mesangial cell proliferation,4,0.0,1.0,1.0,2
13468,GO:0072128,renal capsule morphogenesis,4,0.0,1.0,1.0,2
13469,GO:0072130,renal capsule specification,4,0.0,1.0,1.0,2
13470,GO:0072132,mesenchyme morphogenesis,4,0.0,1.0,1.0,4
13471,GO:0072135,kidney mesenchymal cell proliferation,4,0.0,1.0,1.0,2
13472,GO:0072140,DCT cell development,4,0.0,1.0,1.0,1
13473,GO:0072141,renal interstitial fibroblast development,4,0.0,1.0,1.0,2
13474,GO:0072142,juxtaglomerulus cell development,4,0.0,1.0,1.0,2
13475,GO:0072143,mesangial cell development,4,0.0,1.0,1.0,1
13476,GO:0072146,DCT cell fate commitment,4,0.0,1.0,1.0,1
13477,GO:0072148,epithelial cell fate commitment,4,0.0,1.0,1.0,10
13478,GO:0072150,juxtaglomerulus cell fate commitment,4,0.0,1.0,1.0,2
13479,GO:0072151,mesangial cell fate commitment,4,0.0,1.0,1.0,1
13480,GO:0072153,renal interstitial fibroblast fate commitment,4,0.0,1.0,1.0,2
13481,GO:0072175,epithelial tube formation,4,0.0,1.0,1.0,8
13482,GO:0072203,cell proliferation involved in metanephros development,4,0.0,1.0,1.0,4
13483,GO:0072210,metanephric nephron development,4,0.0,1.0,1.0,2
13484,GO:0072268,pattern specification involved in metanephros development,4,0.0,1.0,1.0,4
13485,GO:0072338,lactam metabolic process,4,0.0,1.0,1.0,10
13486,GO:0072348,sulfur compound transport,4,0.0,1.0,1.0,17
13487,GO:0072396,response to cell cycle checkpoint signaling,4,0.0,1.0,1.0,5
13488,GO:0072490,toluene-containing compound metabolic process,4,0.0,1.0,1.0,7
13489,GO:0072522,purine-containing compound biosynthetic process,4,0.0,1.0,1.0,12
13490,GO:0072523,purine-containing compound catabolic process,4,0.0,1.0,1.0,14
13491,GO:0072525,pyridine-containing compound biosynthetic process,4,0.0,1.0,1.0,10
13492,GO:0072526,pyridine-containing compound catabolic process,4,0.0,1.0,1.0,9
13493,GO:0072528,pyrimidine-containing compound biosynthetic process,4,0.0,1.0,1.0,5
13494,GO:0072529,pyrimidine-containing compound catabolic process,4,0.0,1.0,1.0,4
13495,GO:0072564,blood microparticle formation,4,0.0,1.0,1.0,1
13496,GO:0072575,epithelial cell proliferation involved in liver morphogenesis,4,0.0,1.0,1.0,1
13497,GO:0072588,box H/ACA RNP complex,4,0.0,1.0,1.0,3
13498,GO:0072702,response to methyl methanesulfonate,4,0.0,1.0,1.0,1
13499,GO:0072706,response to sodium dodecyl sulfate,4,0.0,1.0,1.0,1
13500,GO:0072710,response to hydroxyurea,4,0.0,1.0,1.0,1
13501,GO:0072712,response to thiabendazole,4,0.0,1.0,1.0,1
13502,GO:0072714,response to selenite ion,4,0.0,1.0,1.0,1
13503,GO:0072716,response to actinomycin D,4,0.0,1.0,1.0,1
13504,GO:0072720,response to dithiothreitol,4,0.0,1.0,1.0,1
13505,GO:0072722,response to amitrole,4,0.0,1.0,1.0,1
13506,GO:0072724,response to 4-nitroquinoline N-oxide,4,0.0,1.0,1.0,1
13507,GO:0072730,response to papulacandin B,4,0.0,1.0,1.0,1
13508,GO:0072737,response to diamide,4,0.0,1.0,1.0,1
13509,GO:0075010,regulation of germ tube formation,4,0.0,1.0,1.0,2
13510,GO:0075030,modulation of formation of symbiont germ tube hook structure for appressorium development,4,0.0,1.0,1.0,2
13511,GO:0075184,regulation of infection cushion formation,4,0.0,1.0,1.0,2
13512,GO:0075193,regulation of haustorium mother cell formation,4,0.0,1.0,1.0,2
13513,GO:0075214,spore encystment,4,0.0,1.0,1.0,1
13514,GO:0075259,spore-bearing structure development,4,0.0,1.0,1.0,9
13515,GO:0075260,regulation of spore-bearing organ development,4,0.0,1.0,1.0,11
13516,GO:0075519,microtubule-dependent intracellular transport of viral material,4,0.0,1.0,1.0,2
13517,GO:0075520,actin-dependent intracellular transport of virus,4,0.0,1.0,1.0,1
13518,GO:0075606,transport of viral material towards nucleus,4,0.0,1.0,1.0,2
13519,GO:0075732,viral penetration into host nucleus,4,0.0,1.0,1.0,4
13520,GO:0080021,response to benzoic acid,4,0.0,1.0,1.0,1
13521,GO:0080028,nitrile biosynthetic process,4,0.0,1.0,1.0,3
13522,GO:0080029,cellular response to boron-containing substance levels,4,0.0,1.0,1.0,1
13523,GO:0080033,response to nitrite,4,0.0,1.0,1.0,1
13524,GO:0080094,response to trehalose-6-phosphate,4,0.0,1.0,1.0,1
13525,GO:0080144,intracellular amino acid homeostasis,4,0.0,1.0,1.0,8
13526,GO:0080154,regulation of fertilization,4,0.0,1.0,1.0,3
13527,GO:0080184,response to phenylpropanoid,4,0.0,1.0,1.0,3
13528,GO:0086009,membrane repolarization,4,0.0,1.0,1.0,2
13529,GO:0086064,cell communication by electrical coupling involved in cardiac conduction,4,0.0,1.0,1.0,5
13530,GO:0086066,atrial cardiac muscle cell to AV node cell communication,4,0.0,1.0,1.0,2
13531,GO:0086067,AV node cell to bundle of His cell communication,4,0.0,1.0,1.0,2
13532,GO:0086068,Purkinje myocyte to ventricular cardiac muscle cell communication,4,0.0,1.0,1.0,2
13533,GO:0086069,bundle of His cell to Purkinje myocyte communication,4,0.0,1.0,1.0,2
13534,GO:0086070,SA node cell to atrial cardiac muscle cell communication,4,0.0,1.0,1.0,2
13535,GO:0090075,relaxation of muscle,4,0.0,1.0,1.0,3
13536,GO:0090077,foam cell differentiation,4,0.0,1.0,1.0,2
13537,GO:0090079,"translation regulator activity, nucleic acid binding",4,0.0,1.0,1.0,3
13538,GO:0090136,epithelial cell-cell adhesion,4,0.0,1.0,1.0,4
13539,GO:0090143,nucleoid organization,4,0.0,1.0,1.0,1
13540,GO:0090162,establishment of epithelial cell polarity,4,0.0,1.0,1.0,2
13541,GO:0090171,chondrocyte morphogenesis,4,0.0,1.0,1.0,1
13542,GO:0090183,regulation of kidney development,4,0.0,1.0,1.0,6
13543,GO:0090235,regulation of metaphase plate congression,4,0.0,1.0,1.0,1
13544,GO:0090287,regulation of cellular response to growth factor stimulus,4,0.0,1.0,1.0,9
13545,GO:0090346,organofluorine metabolic process,4,0.0,1.0,1.0,1
13546,GO:0090400,stress-induced premature senescence,4,0.0,1.0,1.0,1
13547,GO:0090487,secondary metabolite catabolic process,4,0.0,1.0,1.0,30
13548,GO:0090558,plant epidermis development,4,0.0,1.0,1.0,1
13549,GO:0090571,RNA polymerase II transcription repressor complex,4,0.0,1.0,1.0,8
13550,GO:0090596,sensory organ morphogenesis,4,0.0,1.0,1.0,7
13551,GO:0090603,sieve element differentiation,4,0.0,1.0,1.0,1
13552,GO:0090627,plant epidermal cell differentiation,4,0.0,1.0,1.0,5
13553,GO:0090628,plant epidermal cell fate specification,4,0.0,1.0,1.0,2
13554,GO:0090659,walking behavior,4,0.0,1.0,1.0,2
13555,GO:0090672,telomerase RNA localization,4,0.0,1.0,1.0,1
13556,GO:0090678,cell dedifferentiation involved in phenotypic switching,4,0.0,1.0,1.0,1
13557,GO:0090679,cell differentiation involved in phenotypic switching,4,0.0,1.0,1.0,1
13558,GO:0090685,RNA localization to nucleus,4,0.0,1.0,1.0,1
13559,GO:0090691,formation of plant organ boundary,4,0.0,1.0,1.0,3
13560,GO:0090696,post-embryonic plant organ development,4,0.0,1.0,1.0,1
13561,GO:0090697,post-embryonic plant organ morphogenesis,4,0.0,1.0,1.0,2
13562,GO:0090701,specification of plant organ identity,4,0.0,1.0,1.0,1
13563,GO:0090716,adaptive immune memory response,4,0.0,1.0,1.0,1
13564,GO:0090718,adaptive immune effector response,4,0.0,1.0,1.0,1
13565,GO:0090720,primary adaptive immune response,4,0.0,1.0,1.0,1
13566,GO:0097001,ceramide binding,4,0.0,1.0,1.0,2
13567,GO:0097027,ubiquitin-protein transferase activator activity,4,0.0,1.0,1.0,1
13568,GO:0097060,synaptic membrane,4,0.0,1.0,1.0,8
13569,GO:0097066,response to thyroid hormone,4,0.0,1.0,1.0,2
13570,GO:0097096,facial suture morphogenesis,4,0.0,1.0,1.0,1
13571,GO:0097168,mesenchymal stem cell proliferation,4,0.0,1.0,1.0,1
13572,GO:0097180,serine protease inhibitor complex,4,0.0,1.0,1.0,11
13573,GO:0097184,response to azide,4,0.0,1.0,1.0,1
13574,GO:0097205,renal filtration,4,0.0,1.0,1.0,2
13575,GO:0097237,cellular response to toxic substance,4,0.0,1.0,1.0,1
13576,GO:0097240,chromosome attachment to the nuclear envelope,4,0.0,1.0,1.0,5
13577,GO:0097245,flavanol binding,4,0.0,1.0,1.0,1
13578,GO:0097254,renal tubular secretion,4,0.0,1.0,1.0,5
13579,GO:0097272,ammonium homeostasis,4,0.0,1.0,1.0,1
13580,GO:0097287,7-cyano-7-deazaguanine metabolic process,4,0.0,1.0,1.0,1
13581,GO:0097300,programmed necrotic cell death,4,0.0,1.0,1.0,2
13582,GO:0097305,response to alcohol,4,0.0,1.0,1.0,34
13583,GO:0097315,response to N-acetyl-D-glucosamine,4,0.0,1.0,1.0,1
13584,GO:0097381,photoreceptor disc membrane,4,0.0,1.0,1.0,2
13585,GO:0097386,glial cell projection,4,0.0,1.0,1.0,5
13586,GO:0097413,Lewy body,4,0.0,1.0,1.0,2
13587,GO:0097435,supramolecular fiber organization,4,0.0,1.0,1.0,14
13588,GO:0097468,programmed cell death in response to reactive oxygen species,4,0.0,1.0,1.0,2
13589,GO:0097470,ribbon synapse,4,0.0,1.0,1.0,2
13590,GO:0097479,synaptic vesicle localization,4,0.0,1.0,1.0,2
13591,GO:0097501,stress response to metal ion,4,0.0,1.0,1.0,4
13592,GO:0097502,mannosylation,4,0.0,1.0,1.0,1
13593,GO:0097525,spliceosomal snRNP complex,4,0.0,1.0,1.0,15
13594,GO:0097532,stress response to acid chemical,4,0.0,1.0,1.0,1
13595,GO:0097534,lymphoid lineage cell migration,4,0.0,1.0,1.0,1
13596,GO:0097577,sequestering of iron ion,4,0.0,1.0,1.0,2
13597,GO:0097588,archaeal or bacterial-type flagellum-dependent cell motility,4,0.0,1.0,1.0,2
13598,GO:0097644,calcitonin family binding,4,0.0,1.0,1.0,4
13599,GO:0097701,response to pulsatile fluid shear stress,4,0.0,1.0,1.0,1
13600,GO:0097702,response to oscillatory fluid shear stress,4,0.0,1.0,1.0,1
13601,GO:0098035,viral DNA genome packaging via site-specific sequence recognition,4,0.0,1.0,1.0,2
13602,GO:0098513,detection of humidity,4,0.0,1.0,1.0,3
13603,GO:0098533,ATPase dependent transmembrane transport complex,4,0.0,1.0,1.0,2
13604,GO:0098538,lumenal side of transport vesicle membrane,4,0.0,1.0,1.0,1
13605,GO:0098539,cytoplasmic side of transport vesicle membrane,4,0.0,1.0,1.0,1
13606,GO:0098553,lumenal side of endoplasmic reticulum membrane,4,0.0,1.0,1.0,2
13607,GO:0098554,cytoplasmic side of endoplasmic reticulum membrane,4,0.0,1.0,1.0,2
13608,GO:0098565,lumenal side of endosome membrane,4,0.0,1.0,1.0,2
13609,GO:0098581,detection of external biotic stimulus,4,0.0,1.0,1.0,4
13610,GO:0098610,adhesion between unicellular organisms,4,0.0,1.0,1.0,2
13611,GO:0098631,cell adhesion mediator activity,4,0.0,1.0,1.0,4
13612,GO:0098645,collagen network,4,0.0,1.0,1.0,1
13613,GO:0098648,collagen anchoring fibril,4,0.0,1.0,1.0,1
13614,GO:0098653,centromere clustering,4,0.0,1.0,1.0,2
13615,GO:0098657,import into cell,4,0.0,1.0,1.0,7
13616,GO:0098722,asymmetric stem cell division,4,0.0,1.0,1.0,2
13617,GO:0098724,symmetric stem cell division,4,0.0,1.0,1.0,2
13618,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,4,0.0,1.0,1.0,12
13619,GO:0098751,bone cell development,4,0.0,1.0,1.0,1
13620,GO:0098764,meiosis I cell cycle phase,4,0.0,1.0,1.0,10
13621,GO:0098765,meiosis II cell cycle phase,4,0.0,1.0,1.0,5
13622,GO:0098802,plasma membrane signaling receptor complex,4,0.0,1.0,1.0,40
13623,GO:0098809,nitrite reductase activity,4,0.0,1.0,1.0,5
13624,GO:0098813,nuclear chromosome segregation,4,0.0,1.0,1.0,2
13625,GO:0098859,actin filament bundle of actin-based cell projection,4,0.0,1.0,1.0,3
13626,GO:0098868,bone growth,4,0.0,1.0,1.0,2
13627,GO:0098879,structural constituent of postsynaptic specialization,4,0.0,1.0,1.0,1
13628,GO:0098900,regulation of action potential,4,0.0,1.0,1.0,9
13629,GO:0098922,extrinsic component of dense core granule membrane,4,0.0,1.0,1.0,1
13630,GO:0098953,receptor diffusion trapping,4,0.0,1.0,1.0,1
13631,GO:0098960,postsynaptic neurotransmitter receptor activity,4,0.0,1.0,1.0,4
13632,GO:0098978,glutamatergic synapse,4,0.0,1.0,1.0,1
13633,GO:0098981,cholinergic synapse,4,0.0,1.0,1.0,1
13634,GO:0098982,GABA-ergic synapse,4,0.0,1.0,1.0,1
13635,GO:0098984,neuron to neuron synapse,4,0.0,1.0,1.0,3
13636,GO:0099022,vesicle tethering,4,0.0,1.0,1.0,3
13637,GO:0099098,microtubule polymerization based movement,4,0.0,1.0,1.0,2
13638,GO:0099103,channel activator activity,4,0.0,1.0,1.0,1
13639,GO:0099106,ion channel regulator activity,4,0.0,1.0,1.0,6
13640,GO:0099111,microtubule-based transport,4,0.0,1.0,1.0,4
13641,GO:0099135,chimeric colonial development,4,0.0,1.0,1.0,1
13642,GO:0099172,presynapse organization,4,0.0,1.0,1.0,2
13643,GO:0099173,postsynapse organization,4,0.0,1.0,1.0,2
13644,GO:0099243,extrinsic component of synaptic membrane,4,0.0,1.0,1.0,2
13645,GO:0099512,supramolecular fiber,4,0.0,1.0,1.0,10
13646,GO:0099533,positive regulation of presynaptic cytosolic calcium concentration,4,0.0,1.0,1.0,1
13647,GO:0099589,serotonin receptor activity,4,0.0,1.0,1.0,2
13648,GO:0099738,cell cortex region,4,0.0,1.0,1.0,12
13649,GO:0106020,regulation of vesicle docking,4,0.0,1.0,1.0,4
13650,GO:0106068,SUMO ligase complex,4,0.0,1.0,1.0,3
13651,GO:0106094,nuclear membrane microtubule tethering complex,4,0.0,1.0,1.0,2
13652,GO:0110065,regulation of interphase mitotic telomere clustering,4,0.0,1.0,1.0,1
13653,GO:0110085,mitotic actomyosin contractile ring,4,0.0,1.0,1.0,1
13654,GO:0110086,meiotic actomyosin contractile ring,4,0.0,1.0,1.0,1
13655,GO:0110107,regulation of imaginal disc-derived wing vein specification,4,0.0,1.0,1.0,2
13656,GO:0120014,phospholipid transfer activity,4,0.0,1.0,1.0,7
13657,GO:0120015,sterol transfer activity,4,0.0,1.0,1.0,2
13658,GO:0120016,sphingolipid transfer activity,4,0.0,1.0,1.0,2
13659,GO:0120054,intestinal motility,4,0.0,1.0,1.0,2
13660,GO:0120126,response to copper ion starvation,4,0.0,1.0,1.0,1
13661,GO:0120127,response to zinc ion starvation,4,0.0,1.0,1.0,1
13662,GO:0120194,regulation of anther dehiscence,4,0.0,1.0,1.0,2
13663,GO:0120244,terminal acetylenic compound metabolic process,4,0.0,1.0,1.0,3
13664,GO:0120247,acetylenic compound biosynthetic process,4,0.0,1.0,1.0,2
13665,GO:0120248,acetylenic compound catabolic process,4,0.0,1.0,1.0,2
13666,GO:0120251,hydrocarbon biosynthetic process,4,0.0,1.0,1.0,7
13667,GO:0120253,hydrocarbon catabolic process,4,0.0,1.0,1.0,12
13668,GO:0120255,olefinic compound biosynthetic process,4,0.0,1.0,1.0,28
13669,GO:0120256,olefinic compound catabolic process,4,0.0,1.0,1.0,20
13670,GO:0140031,phosphorylation-dependent protein binding,4,0.0,1.0,1.0,1
13671,GO:0140033,acetylation-dependent protein binding,4,0.0,1.0,1.0,1
13672,GO:0140034,methylation-dependent protein binding,4,0.0,1.0,1.0,1
13673,GO:0140035,ubiquitin-like protein reader activity,4,0.0,1.0,1.0,3
13674,GO:0140039,cell-cell adhesion in response to extracellular stimulus,4,0.0,1.0,1.0,2
13675,GO:0140041,cellular detoxification of methylglyoxal,4,0.0,1.0,1.0,1
13676,GO:0140101,"catalytic activity, acting on a tRNA",4,0.0,1.0,1.0,45
13677,GO:0140102,"catalytic activity, acting on a rRNA",4,0.0,1.0,1.0,3
13678,GO:0140112,extracellular vesicle biogenesis,4,0.0,1.0,1.0,2
13679,GO:0140220,pathogen-containing vacuole,4,0.0,1.0,1.0,1
13680,GO:0140273,repair of mitotic kinetochore microtubule attachment defect,4,0.0,1.0,1.0,1
13681,GO:0140296,general transcription initiation factor binding,4,0.0,1.0,1.0,4
13682,GO:0140297,DNA-binding transcription factor binding,4,0.0,1.0,1.0,3
13683,GO:0140326,ATPase-coupled intramembrane lipid transporter activity,4,0.0,1.0,1.0,2
13684,GO:0140352,export from cell,4,0.0,1.0,1.0,5
13685,GO:0140475,spindle pole body anchor activity,4,0.0,1.0,1.0,1
13686,GO:0140566,histone reader activity,4,0.0,1.0,1.0,1
13687,GO:0140666,annealing activity,4,0.0,1.0,1.0,3
13688,GO:0140707,chromatin-nuclear membrane anchor activity,4,0.0,1.0,1.0,2
13689,GO:0140721,nuclease inhibitor activity,4,0.0,1.0,1.0,2
13690,GO:0140906,halogenase activity,4,0.0,1.0,1.0,2
13691,GO:0141041,disruption of extracellular matrix of another organism,4,0.0,1.0,1.0,2
13692,GO:0141067,intracellular nitrogen homeostasis,4,0.0,1.0,1.0,1
13693,GO:0141146,symbiont-mediated disruption of host tissue,4,0.0,1.0,1.0,1
13694,GO:0141165,glucosinolate transmembrane transporter activity,4,0.0,1.0,1.0,1
13695,GO:0141218,NAD-dependent protein lysine deacylase activity,4,0.0,1.0,1.0,2
13696,GO:0150065,regulation of deacetylase activity,4,0.0,1.0,1.0,3
13697,GO:0150086,multiple synapse bouton,4,0.0,1.0,1.0,2
13698,GO:0160002,ADP-D-ribose modification-dependent protein binding,4,0.0,1.0,1.0,2
13699,GO:0160173,histamine transmembrane transporter activity,4,0.0,1.0,1.0,1
13700,GO:0160183,autophagosome-membrane adaptor activity,4,0.0,1.0,1.0,2
13701,GO:0170009,endoplasmic reticulum-organelle membrane tether activity,4,0.0,1.0,1.0,3
13702,GO:0170049,box C/D RNP complex,4,0.0,1.0,1.0,4
13703,GO:0170053,nuclease activator activity,4,0.0,1.0,1.0,2
13704,GO:1900046,regulation of hemostasis,4,0.0,1.0,1.0,3
13705,GO:1900055,regulation of leaf senescence,4,0.0,1.0,1.0,2
13706,GO:1900067,regulation of cellular response to alkaline pH,4,0.0,1.0,1.0,1
13707,GO:1900117,regulation of execution phase of apoptosis,4,0.0,1.0,1.0,2
13708,GO:1900130,regulation of lipid binding,4,0.0,1.0,1.0,2
13709,GO:1900154,regulation of bone trabecula formation,4,0.0,1.0,1.0,2
13710,GO:1900190,regulation of single-species biofilm formation,4,0.0,1.0,1.0,4
13711,GO:1900206,regulation of pronephric nephron tubule development,4,0.0,1.0,1.0,1
13712,GO:1900221,regulation of amyloid-beta clearance,4,0.0,1.0,1.0,2
13713,GO:1900239,regulation of phenotypic switching,4,0.0,1.0,1.0,2
13714,GO:1900518,regulation of response to pullulan,4,0.0,1.0,1.0,2
13715,GO:1900521,regulation of response to amylopectin,4,0.0,1.0,1.0,2
13716,GO:1900549,"N',N'',N'''-triacetylfusarinine C metabolic process",4,0.0,1.0,1.0,2
13717,GO:1900561,dehydroaustinol metabolic process,4,0.0,1.0,1.0,2
13718,GO:1900585,arugosin metabolic process,4,0.0,1.0,1.0,2
13719,GO:1900594,(+)-kotanin metabolic process,4,0.0,1.0,1.0,2
13720,GO:1900597,demethylkotanin metabolic process,4,0.0,1.0,1.0,2
13721,GO:1900603,tensidol A metabolic process,4,0.0,1.0,1.0,2
13722,GO:1900620,acetate ester biosynthetic process,4,0.0,1.0,1.0,7
13723,GO:1900673,olefin metabolic process,4,0.0,1.0,1.0,6
13724,GO:1900785,naphtho-gamma-pyrone metabolic process,4,0.0,1.0,1.0,3
13725,GO:1900819,orlandin metabolic process,4,0.0,1.0,1.0,2
13726,GO:1901122,bacitracin A metabolic process,4,0.0,1.0,1.0,2
13727,GO:1901161,primary amino compound catabolic process,4,0.0,1.0,1.0,5
13728,GO:1901162,primary amino compound biosynthetic process,4,0.0,1.0,1.0,6
13729,GO:1901210,regulation of cardiac chamber formation,4,0.0,1.0,1.0,3
13730,GO:1901264,carbohydrate derivative transport,4,0.0,1.0,1.0,21
13731,GO:1901269,lipooligosaccharide metabolic process,4,0.0,1.0,1.0,5
13732,GO:1901322,response to chloramphenicol,4,0.0,1.0,1.0,1
13733,GO:1901323,response to erythromycin,4,0.0,1.0,1.0,1
13734,GO:1901325,response to antimycin A,4,0.0,1.0,1.0,1
13735,GO:1901327,response to tacrolimus,4,0.0,1.0,1.0,1
13736,GO:1901328,response to cytochalasin B,4,0.0,1.0,1.0,1
13737,GO:1901335,lactone catabolic process,4,0.0,1.0,1.0,7
13738,GO:1901336,lactone biosynthetic process,4,0.0,1.0,1.0,15
13739,GO:1901370,response to glutathione,4,0.0,1.0,1.0,1
13740,GO:1901374,acetate ester transport,4,0.0,1.0,1.0,1
13741,GO:1901377,organic heteropentacyclic compound catabolic process,4,0.0,1.0,1.0,6
13742,GO:1901378,organic heteropentacyclic compound biosynthetic process,4,0.0,1.0,1.0,7
13743,GO:1901419,regulation of response to alcohol,4,0.0,1.0,1.0,6
13744,GO:1901431,regulation of response to cycloalkane,4,0.0,1.0,1.0,2
13745,GO:1901441,poly(hydroxyalkanoate) biosynthetic process,4,0.0,1.0,1.0,4
13746,GO:1901442,regulation of response to furfural,4,0.0,1.0,1.0,2
13747,GO:1901451,regulation of response to benzene,4,0.0,1.0,1.0,2
13748,GO:1901454,regulation of response to toluene,4,0.0,1.0,1.0,2
13749,GO:1901457,regulation of response to acetate,4,0.0,1.0,1.0,3
13750,GO:1901460,regulation of response to formic acid,4,0.0,1.0,1.0,2
13751,GO:1901478,aminotriazole transmembrane transporter activity,4,0.0,1.0,1.0,1
13752,GO:1901501,response to xylene,4,0.0,1.0,1.0,1
13753,GO:1901593,response to GW 7647,4,0.0,1.0,1.0,1
13754,GO:1901594,response to capsazepine,4,0.0,1.0,1.0,1
13755,GO:1901597,response to carbendazim,4,0.0,1.0,1.0,1
13756,GO:1901616,organic hydroxy compound catabolic process,4,0.0,1.0,1.0,17
13757,GO:1901617,organic hydroxy compound biosynthetic process,4,0.0,1.0,1.0,33
13758,GO:1901654,response to ketone,4,0.0,1.0,1.0,35
13759,GO:1901657,glycosyl compound metabolic process,4,0.0,1.0,1.0,7
13760,GO:1901661,quinone metabolic process,4,0.0,1.0,1.0,4
13761,GO:1901685,glutathione derivative metabolic process,4,0.0,1.0,1.0,3
13762,GO:1901699,cellular response to nitrogen compound,4,0.0,1.0,1.0,88
13763,GO:1901775,mitomycin C metabolic process,4,0.0,1.0,1.0,2
13764,GO:1901861,regulation of muscle tissue development,4,0.0,1.0,1.0,4
13765,GO:1901876,regulation of calcium ion binding,4,0.0,1.0,1.0,2
13766,GO:1901922,regulation of sclerotium development,4,0.0,1.0,1.0,2
13767,GO:1902026,regulation of cartilage condensation,4,0.0,1.0,1.0,2
13768,GO:1902075,cellular response to salt,4,0.0,1.0,1.0,2
13769,GO:1902111,response to diethyl maleate,4,0.0,1.0,1.0,1
13770,GO:1902140,response to inositol,4,0.0,1.0,1.0,1
13771,GO:1902265,abscisic acid homeostasis,4,0.0,1.0,1.0,1
13772,GO:1902347,response to strigolactone,4,0.0,1.0,1.0,1
13773,GO:1902349,response to chloroquine,4,0.0,1.0,1.0,1
13774,GO:1902410,mitotic cytokinetic process,4,0.0,1.0,1.0,11
13775,GO:1902422,hydrogen biosynthetic process,4,0.0,1.0,1.0,3
13776,GO:1902438,response to vanadate(3-),4,0.0,1.0,1.0,1
13777,GO:1902493,acetyltransferase complex,4,0.0,1.0,1.0,2
13778,GO:1902500,vacuolar HOPS complex,4,0.0,1.0,1.0,1
13779,GO:1902509,methionine-importing complex,4,0.0,1.0,1.0,1
13780,GO:1902555,endoribonuclease complex,4,0.0,1.0,1.0,11
13781,GO:1902630,regulation of membrane hyperpolarization,4,0.0,1.0,1.0,2
13782,GO:1902683,regulation of receptor localization to synapse,4,0.0,1.0,1.0,6
13783,GO:1902755,sulfurated eukaryotic molybdenum cofactor(2-) metabolic process,4,0.0,1.0,1.0,1
13784,GO:1902762,regulation of embryonic skeletal joint development,4,0.0,1.0,1.0,2
13785,GO:1902779,cellular response to alkane,4,0.0,1.0,1.0,5
13786,GO:1902780,response to nonane,4,0.0,1.0,1.0,1
13787,GO:1902782,response to decane,4,0.0,1.0,1.0,1
13788,GO:1902784,response to undecane,4,0.0,1.0,1.0,1
13789,GO:1902786,response to dodecane,4,0.0,1.0,1.0,1
13790,GO:1902788,response to isooctane,4,0.0,1.0,1.0,1
13791,GO:1902790,undecan-2-one metabolic process,4,0.0,1.0,1.0,1
13792,GO:1902818,ethyl acetate metabolic process,4,0.0,1.0,1.0,1
13793,GO:1902863,regulation of embryonic camera-type eye development,4,0.0,1.0,1.0,2
13794,GO:1902866,regulation of retina development in camera-type eye,4,0.0,1.0,1.0,2
13795,GO:1902872,regulation of horizontal cell localization,4,0.0,1.0,1.0,2
13796,GO:1902875,regulation of embryonic pattern specification,4,0.0,1.0,1.0,2
13797,GO:1902920,poly(hydroxyvalerate) metabolic process,4,0.0,1.0,1.0,3
13798,GO:1902933,isopentenol metabolic process,4,0.0,1.0,1.0,1
13799,GO:1903113,copper ion transmembrane transporter complex,4,0.0,1.0,1.0,1
13800,GO:1903114,silver ion transmembrane transporter complex,4,0.0,1.0,1.0,1
13801,GO:1903132,regulation of tube lumen cavitation,4,0.0,1.0,1.0,1
13802,GO:1903165,response to polycyclic arene,4,0.0,1.0,1.0,2
13803,GO:1903189,glyoxal metabolic process,4,0.0,1.0,1.0,3
13804,GO:1903332,regulation of protein folding,4,0.0,1.0,1.0,5
13805,GO:1903338,regulation of cell wall organization or biogenesis,4,0.0,1.0,1.0,7
13806,GO:1903409,reactive oxygen species biosynthetic process,4,0.0,1.0,1.0,2
13807,GO:1903412,response to bile acid,4,0.0,1.0,1.0,1
13808,GO:1903416,response to glycoside,4,0.0,1.0,1.0,5
13809,GO:1903610,regulation of calcium-dependent ATPase activity,4,0.0,1.0,1.0,2
13810,GO:1903664,regulation of asexual reproduction,4,0.0,1.0,1.0,4
13811,GO:1903772,regulation of viral budding via host ESCRT complex,4,0.0,1.0,1.0,2
13812,GO:1903840,response to arsenite(3-),4,0.0,1.0,1.0,1
13813,GO:1903842,response to arsenite ion,4,0.0,1.0,1.0,1
13814,GO:1903900,regulation of viral life cycle,4,0.0,1.0,1.0,7
13815,GO:1903925,response to bisphenol A,4,0.0,1.0,1.0,1
13816,GO:1903935,response to sodium arsenite,4,0.0,1.0,1.0,1
13817,GO:1903937,response to acrylamide,4,0.0,1.0,1.0,1
13818,GO:1903958,nitric-oxide synthase complex,4,0.0,1.0,1.0,1
13819,GO:1903967,response to micafungin,4,0.0,1.0,1.0,1
13820,GO:1904101,response to acadesine,4,0.0,1.0,1.0,1
13821,GO:1904144,phosphatidylinositol phosphate phosphatase complex,4,0.0,1.0,1.0,1
13822,GO:1904187,regulation of transformation of host cell by virus,4,0.0,1.0,1.0,2
13823,GO:1904238,pericyte cell differentiation,4,0.0,1.0,1.0,1
13824,GO:1904301,regulation of maternal process involved in parturition,4,0.0,1.0,1.0,2
13825,GO:1904307,response to desipramine,4,0.0,1.0,1.0,1
13826,GO:1904359,regulation of spore germination,4,0.0,1.0,1.0,3
13827,GO:1904383,response to sodium phosphate,4,0.0,1.0,1.0,1
13828,GO:1904386,response to L-phenylalanine derivative,4,0.0,1.0,1.0,3
13829,GO:1904391,response to ciliary neurotrophic factor,4,0.0,1.0,1.0,1
13830,GO:1904404,response to formaldehyde,4,0.0,1.0,1.0,1
13831,GO:1904412,regulation of cardiac ventricle development,4,0.0,1.0,1.0,2
13832,GO:1904421,response to D-galactosamine,4,0.0,1.0,1.0,1
13833,GO:1904424,regulation of GTP binding,4,0.0,1.0,1.0,3
13834,GO:1904432,regulation of ferrous iron binding,4,0.0,1.0,1.0,2
13835,GO:1904481,response to tetrahydrofolate,4,0.0,1.0,1.0,1
13836,GO:1904511,cytoplasmic microtubule plus-end,4,0.0,1.0,1.0,1
13837,GO:1904536,regulation of mitotic telomere tethering at nuclear periphery,4,0.0,1.0,1.0,1
13838,GO:1904565,response to 1-oleoyl-sn-glycerol 3-phosphate,4,0.0,1.0,1.0,1
13839,GO:1904583,response to polyamine macromolecule,4,0.0,1.0,1.0,1
13840,GO:1904585,response to putrescine,4,0.0,1.0,1.0,1
13841,GO:1904587,response to glycoprotein,4,0.0,1.0,1.0,3
13842,GO:1904610,"response to 3,3',4,4',5-pentachlorobiphenyl",4,0.0,1.0,1.0,1
13843,GO:1904612,"response to 2,3,7,8-tetrachlorodibenzodioxine",4,0.0,1.0,1.0,1
13844,GO:1904614,response to biphenyl,4,0.0,1.0,1.0,1
13845,GO:1904629,response to diterpene,4,0.0,1.0,1.0,1
13846,GO:1904641,response to dinitrophenol,4,0.0,1.0,1.0,1
13847,GO:1904645,response to amyloid-beta,4,0.0,1.0,1.0,1
13848,GO:1904653,regulation of lung alveolus development,4,0.0,1.0,1.0,2
13849,GO:1904842,response to nitroglycerin,4,0.0,1.0,1.0,1
13850,GO:1904872,regulation of telomerase RNA localization to Cajal body,4,0.0,1.0,1.0,2
13851,GO:1904910,regulation of establishment of RNA localization to telomere,4,0.0,1.0,1.0,2
13852,GO:1904913,regulation of establishment of protein-containing complex localization to telomere,4,0.0,1.0,1.0,2
13853,GO:1904971,regulation of viral translation,4,0.0,1.0,1.0,2
13854,GO:1904975,response to bleomycin,4,0.0,1.0,1.0,1
13855,GO:1905144,response to acetylcholine,4,0.0,1.0,1.0,1
13856,GO:1905174,regulation of vascular associated smooth muscle cell dedifferentiation,4,0.0,1.0,1.0,2
13857,GO:1905177,tracheary element differentiation,4,0.0,1.0,1.0,1
13858,GO:1905214,regulation of RNA binding,4,0.0,1.0,1.0,4
13859,GO:1905217,response to astaxanthin,4,0.0,1.0,1.0,1
13860,GO:1905230,response to borneol,4,0.0,1.0,1.0,1
13861,GO:1905237,response to cyclosporin A,4,0.0,1.0,1.0,1
13862,GO:1905286,serine-type peptidase complex,4,0.0,1.0,1.0,1
13863,GO:1905307,response to miconazole,4,0.0,1.0,1.0,1
13864,GO:1905314,semi-lunar valve development,4,0.0,1.0,1.0,2
13865,GO:1905347,endodeoxyribonuclease complex,4,0.0,1.0,1.0,6
13866,GO:1905369,endopeptidase complex,4,0.0,1.0,1.0,5
13867,GO:1905387,response to beta-carotene,4,0.0,1.0,1.0,1
13868,GO:1905395,response to flavonoid,4,0.0,1.0,1.0,3
13869,GO:1905439,response to chondroitin 6'-sulfate,4,0.0,1.0,1.0,1
13870,GO:1905441,response to chondroitin 4'-sulfate,4,0.0,1.0,1.0,1
13871,GO:1905640,response to acetaldehyde,4,0.0,1.0,1.0,1
13872,GO:1905709,negative regulation of membrane permeability,4,0.0,1.0,1.0,2
13873,GO:1905710,positive regulation of membrane permeability,4,0.0,1.0,1.0,2
13874,GO:1905711,response to phosphatidylethanolamine,4,0.0,1.0,1.0,1
13875,GO:1905802,regulation of cellular response to manganese ion,4,0.0,1.0,1.0,2
13876,GO:1905834,response to pyrimidine ribonucleotide,4,0.0,1.0,1.0,1
13877,GO:1905836,response to triterpenoid,4,0.0,1.0,1.0,2
13878,GO:1905846,regulation of cellular response to oxidopamine,4,0.0,1.0,1.0,2
13879,GO:1905853,regulation of heparan sulfate binding,4,0.0,1.0,1.0,2
13880,GO:1905862,ferroxidase complex,4,0.0,1.0,1.0,2
13881,GO:1905890,regulation of cellular response to very-low-density lipoprotein particle stimulus,4,0.0,1.0,1.0,2
13882,GO:1905902,regulation of mesoderm formation,4,0.0,1.0,1.0,2
13883,GO:1905933,regulation of cell fate determination,4,0.0,1.0,1.0,4
13884,GO:1905939,regulation of gonad development,4,0.0,1.0,1.0,4
13885,GO:1905945,regulation of response to calcium ion,4,0.0,1.0,1.0,2
13886,GO:1990011,laminated body,4,0.0,1.0,1.0,1
13887,GO:1990089,response to nerve growth factor,4,0.0,1.0,1.0,1
13888,GO:1990099,pre-primosome complex,4,0.0,1.0,1.0,4
13889,GO:1990138,neuron projection extension,4,0.0,1.0,1.0,4
13890,GO:1990195,macrolide transmembrane transporter complex,4,0.0,1.0,1.0,1
13891,GO:1990228,sulfurtransferase complex,4,0.0,1.0,1.0,4
13892,GO:1990239,steroid hormone binding,4,0.0,1.0,1.0,6
13893,GO:1990608,mitotic spindle pole body localization,4,0.0,1.0,1.0,1
13894,GO:1990658,transnitrosylase complex,4,0.0,1.0,1.0,1
13895,GO:1990709,presynaptic active zone organization,4,0.0,1.0,1.0,3
13896,GO:1990735,gamma-tubulin complex localization to mitotic spindle pole body,4,0.0,1.0,1.0,2
13897,GO:1990784,response to dsDNA,4,0.0,1.0,1.0,1
13898,GO:1990790,response to glial cell derived neurotrophic factor,4,0.0,1.0,1.0,1
13899,GO:1990858,cellular response to lectin,4,0.0,1.0,1.0,1
13900,GO:1990907,beta-catenin-TCF complex,4,0.0,1.0,1.0,1
13901,GO:1990928,response to amino acid starvation,4,0.0,1.0,1.0,1
13902,GO:2000014,regulation of endosperm development,4,0.0,1.0,1.0,1
13903,GO:2000015,regulation of determination of dorsal identity,4,0.0,1.0,1.0,2
13904,GO:2000024,regulation of leaf development,4,0.0,1.0,1.0,3
13905,GO:2000028,"regulation of photoperiodism, flowering",4,0.0,1.0,1.0,2
13906,GO:2000030,regulation of response to red or far red light,4,0.0,1.0,1.0,3
13907,GO:2000036,regulation of stem cell population maintenance,4,0.0,1.0,1.0,3
13908,GO:2000145,regulation of cell motility,4,0.0,1.0,1.0,6
13909,GO:2000242,negative regulation of reproductive process,4,0.0,1.0,1.0,50
13910,GO:2000243,positive regulation of reproductive process,4,0.0,1.0,1.0,51
13911,GO:2000280,regulation of root development,4,0.0,1.0,1.0,1
13912,GO:2000290,regulation of myotome development,4,0.0,1.0,1.0,1
13913,GO:2000354,regulation of ovarian follicle development,4,0.0,1.0,1.0,2
13914,GO:2000359,regulation of binding of sperm to zona pellucida,4,0.0,1.0,1.0,1
13915,GO:2000380,regulation of mesoderm development,4,0.0,1.0,1.0,2
13916,GO:2000383,regulation of ectoderm development,4,0.0,1.0,1.0,2
13917,GO:2000603,regulation of secondary growth,4,0.0,1.0,1.0,2
13918,GO:2000654,regulation of cellular response to testosterone stimulus,4,0.0,1.0,1.0,1
13919,GO:2000683,regulation of cellular response to X-ray,4,0.0,1.0,1.0,2
13920,GO:2000742,regulation of anterior head development,4,0.0,1.0,1.0,2
13921,GO:2000807,regulation of synaptic vesicle clustering,4,0.0,1.0,1.0,2
13922,GO:2000896,amylopectin metabolic process,4,0.0,1.0,1.0,2
13923,GO:2000970,regulation of detection of glucose,4,0.0,1.0,1.0,2
13924,GO:2001013,epithelial cell proliferation involved in renal tubule morphogenesis,4,0.0,1.0,1.0,1
13925,GO:2001023,regulation of response to drug,4,0.0,1.0,1.0,4
13926,GO:2001062,xylan binding,4,0.0,1.0,1.0,1
13927,GO:2001228,regulation of response to gamma radiation,4,0.0,1.0,1.0,3
13928,GO:2001305,xanthone-containing compound metabolic process,4,0.0,1.0,1.0,2
25,GO:0034367,protein-containing complex remodeling,5,6727.26,528.78,3.8616410221148273e-44,4
26,GO:0071825,protein-lipid complex organization,5,6727.26,519.7,5.335767675635711e-44,4
6,GO:0004806,triacylglycerol lipase activity,5,5255.67,849.07,4.723806163884979e-105,1
1,GO:0016042,lipid catabolic process,5,4484.84,132.43,4.8797457683975785e-165,11
52,GO:0055095,lipoprotein particle mediated signaling,5,3669.41,3669.41,4.1313095243317145e-21,2
3,GO:0004620,phospholipase activity,5,3165.77,300.32,2.0409911464069115e-138,11
46,GO:0047714,galactolipase activity,5,2770.05,2770.05,2.3945668276909386e-23,0
123,GO:0010986,positive regulation of lipoprotein particle clearance,5,2242.42,1187.16,2.149273206173426e-09,4
131,GO:0010982,regulation of high-density lipoprotein particle clearance,5,2242.42,877.47,5.593986355607188e-09,2
212,GO:0035478,chylomicron binding,5,2242.42,2242.42,0.0004458815702065,0
44,GO:0050253,retinyl-palmitate esterase activity,5,2087.77,1142.36,9.9118717880177e-26,2
203,GO:1903509,liposaccharide metabolic process,5,1922.07,7.39,0.0001734087032884,2
204,GO:0006643,membrane lipid metabolic process,5,1922.07,7.36,0.0001771840455141,4
18,GO:0006638,neutral lipid metabolic process,5,1774.22,216.14,3.0166930956970254e-49,3
30,GO:0046486,glycerolipid metabolic process,5,1774.22,42.95,1.6153484273217373e-36,4
61,GO:1905954,positive regulation of lipid localization,5,1441.55,140.48,2.7800637590129613e-17,2
73,GO:0010885,regulation of cholesterol storage,5,1441.55,602.44,8.865136599248494e-16,2
60,GO:1904179,positive regulation of adipose tissue development,5,1223.14,1223.14,9.878427150311329e-18,0
302,GO:0009893,positive regulation of metabolic process,5,820.4,2.16,0.0595378498464624,40
357,GO:0060255,regulation of macromolecule metabolic process,5,820.4,1.3,0.2566537413840127,13
391,GO:0009889,regulation of biosynthetic process,5,820.4,0.99,0.5719617177560331,47
74,GO:0010889,regulation of sequestering of triglyceride,5,733.88,538.18,1.7870452871641888e-15,2
109,GO:0030659,cytoplasmic vesicle membrane,5,692.51,14.95,2.3458729817118947e-10,20
94,GO:0010743,regulation of macrophage derived foam cell differentiation,5,672.73,410.2,1.7334000959435617e-12,2
173,GO:0045597,positive regulation of cell differentiation,5,672.73,12.46,9.75570085266306e-06,37
142,GO:0098856,intestinal lipid absorption,5,576.62,448.48,4.471560673664388e-08,2
120,GO:0006644,phospholipid metabolic process,5,509.64,7.39,1.6452253310518931e-09,21
154,GO:0046434,organophosphate catabolic process,5,509.64,7.6,8.373157767518854e-07,16
88,GO:0015918,sterol transport,5,368.62,107.76,6.739342449344715e-13,5
337,GO:0080090,regulation of primary metabolic process,5,360.39,0.47,0.9578708558369932,12
45,GO:0042627,chylomicron,5,352.38,352.38,2.5503897591441764e-25,2
69,GO:0047372,monoacylglycerol lipase activity,5,351.42,351.42,1.5937528581391126e-16,0
50,GO:0070328,triglyceride homeostasis,5,307.18,307.18,1.6477710076022522e-22,1
36,GO:0042632,cholesterol homeostasis,5,260.75,260.75,3.5629893935519244e-32,0
49,GO:0034385,triglyceride-rich plasma lipoprotein particle,5,225.61,225.61,3.739670520313943e-23,2
102,GO:0071398,cellular response to fatty acid,5,211.55,211.55,5.0039056067380227e-11,10
186,GO:0030169,low-density lipoprotein particle binding,5,186.87,186.87,5.5413887184222794e-05,0
103,GO:0045598,regulation of fat cell differentiation,5,185.15,89.5,9.596350335467292e-11,3
196,GO:0032368,regulation of lipid transport,5,134.55,33.64,0.0001063559582588,14
266,GO:0051050,positive regulation of transport,5,134.55,5.35,0.0189459378396599,39
278,GO:0060191,regulation of lipase activity,5,105.11,29.64,0.0331894809662155,4
320,GO:0051345,positive regulation of hydrolase activity,5,105.11,8.39,0.1124691727626737,10
147,GO:0008610,lipid biosynthetic process,5,92.79,4.49,4.351791270401978e-07,15
305,GO:0090407,organophosphate biosynthetic process,5,92.79,0.3,0.9919526769544464,19
300,GO:0043385,mycotoxin metabolic process,5,90.91,18.08,0.0538178212530359,4
133,GO:0034364,high-density lipoprotein particle,5,81.44,81.44,5.9740563757063945e-09,2
311,GO:0009100,glycoprotein metabolic process,5,73.12,11.1,0.0861944177823044,7
101,GO:0034284,response to monosaccharide,5,72.56,58.64,4.665890172955075e-11,5
259,GO:0034338,short-chain carboxylesterase activity,5,72.34,65.31,0.0151967487187464,1
181,GO:0032103,positive regulation of response to external stimulus,5,65.82,14.86,2.428521511679447e-05,16
200,GO:0031347,regulation of defense response,5,65.82,10.11,0.0001474780742007,15
273,GO:1900077,negative regulation of cellular response to insulin stimulus,5,42.05,42.05,0.0235083106019757,1
185,GO:1902652,secondary alcohol metabolic process,5,31.69,20.46,4.84898203022354e-05,15
209,GO:0008202,steroid metabolic process,5,31.69,12.42,0.0003249328442727,18
205,GO:0031960,response to corticosteroid,5,31.53,27.57,0.0001905898442474,3
342,GO:0035770,ribonucleoprotein granule,5,26.49,3.73,0.2353397997884832,2
289,GO:0005902,microvillus,5,24.73,24.73,0.0396384723655855,2
243,GO:0046872,metal ion binding,5,21.71,1.56,0.004296738179805,6
281,GO:0097708,intracellular vesicle,5,21.07,3.27,0.0346099822434031,2
299,GO:0045995,regulation of embryonic development,5,18.23,18.23,0.0533954652519795,8
229,GO:0016053,organic acid biosynthetic process,5,17.18,2.35,0.0022701616461805,5
275,GO:0043436,oxoacid metabolic process,5,17.18,1.74,0.0159161840933903,12
308,GO:0001889,liver development,5,13.11,13.11,0.0734599710601582,1
152,GO:0009617,response to bacterium,5,10.96,10.96,7.804170763160178e-07,5
321,GO:0005788,endoplasmic reticulum lumen,5,7.37,7.37,0.1270168007774836,5
329,GO:0009792,embryo development ending in birth or egg hatching,5,5.51,5.51,0.1661610245235661,2
334,GO:0001666,response to hypoxia,5,4.4,4.4,0.2034517544590392,3
284,GO:0005794,Golgi apparatus,5,4.13,4.13,0.0366643089299213,1
9562,GO:0000030,mannosyltransferase activity,5,0.0,1.0,1.0,13
9563,GO:0000049,tRNA binding,5,0.0,1.0,1.0,2
9564,GO:0000099,sulfur amino acid transmembrane transporter activity,5,0.0,1.0,1.0,5
9565,GO:0000128,flocculation,5,0.0,1.0,1.0,2
9566,GO:0000136,mannan polymerase complex,5,0.0,1.0,1.0,2
9567,GO:0000152,nuclear ubiquitin ligase complex,5,0.0,1.0,1.0,8
9568,GO:0000153,cytoplasmic ubiquitin ligase complex,5,0.0,1.0,1.0,3
9569,GO:0000164,protein phosphatase type 1 complex,5,0.0,1.0,1.0,1
9570,GO:0000176,nuclear exosome (RNase complex),5,0.0,1.0,1.0,1
9571,GO:0000177,cytoplasmic exosome (RNase complex),5,0.0,1.0,1.0,2
9572,GO:0000217,DNA secondary structure binding,5,0.0,1.0,1.0,8
9573,GO:0000220,"vacuolar proton-transporting V-type ATPase, V0 domain",5,0.0,1.0,1.0,1
9574,GO:0000221,"vacuolar proton-transporting V-type ATPase, V1 domain",5,0.0,1.0,1.0,1
9575,GO:0000256,allantoin catabolic process,5,0.0,1.0,1.0,1
9576,GO:0000257,nitrilase activity,5,0.0,1.0,1.0,6
9577,GO:0000281,mitotic cytokinesis,5,0.0,1.0,1.0,1
9578,GO:0000304,response to singlet oxygen,5,0.0,1.0,1.0,1
9579,GO:0000305,response to oxygen radical,5,0.0,1.0,1.0,2
9580,GO:0000314,organellar small ribosomal subunit,5,0.0,1.0,1.0,2
9581,GO:0000315,organellar large ribosomal subunit,5,0.0,1.0,1.0,2
9582,GO:0000339,RNA cap binding,5,0.0,1.0,1.0,4
9583,GO:0000422,autophagy of mitochondrion,5,0.0,1.0,1.0,3
9584,GO:0000497,DNA template activity,5,0.0,1.0,1.0,1
9585,GO:0000502,proteasome complex,5,0.0,1.0,1.0,3
9586,GO:0000756,response to pheromone regulating conjugation with mutual genetic exchange,5,0.0,1.0,1.0,1
9587,GO:0000912,assembly of actomyosin apparatus involved in cytokinesis,5,0.0,1.0,1.0,2
9588,GO:0000916,actomyosin contractile ring contraction,5,0.0,1.0,1.0,1
9589,GO:0000919,cell plate assembly,5,0.0,1.0,1.0,1
9590,GO:0000966,RNA 5'-end processing,5,0.0,1.0,1.0,4
9591,GO:0001025,RNA polymerase III general transcription initiation factor binding,5,0.0,1.0,1.0,3
9592,GO:0001050,single-subunit type RNA polymerase binding,5,0.0,1.0,1.0,2
9593,GO:0001069,regulatory region RNA binding,5,0.0,1.0,1.0,1
9594,GO:0001091,RNA polymerase II general transcription initiation factor binding,5,0.0,1.0,1.0,6
9595,GO:0001115,protein-DNA-RNA complex organization,5,0.0,1.0,1.0,3
9596,GO:0001504,neurotransmitter uptake,5,0.0,1.0,1.0,2
9597,GO:0001558,regulation of cell growth,5,0.0,1.0,1.0,12
9598,GO:0001562,response to protozoan,5,0.0,1.0,1.0,3
9599,GO:0001614,purinergic nucleotide receptor activity,5,0.0,1.0,1.0,1
9600,GO:0001637,G protein-coupled chemoattractant receptor activity,5,0.0,1.0,1.0,1
9601,GO:0001654,eye development,5,0.0,1.0,1.0,3
9602,GO:0001656,metanephros development,5,0.0,1.0,1.0,1
9603,GO:0001678,intracellular glucose homeostasis,5,0.0,1.0,1.0,1
9604,GO:0001692,histamine metabolic process,5,0.0,1.0,1.0,2
9605,GO:0001703,gastrulation with mouth forming first,5,0.0,1.0,1.0,1
9606,GO:0001710,mesodermal cell fate commitment,5,0.0,1.0,1.0,4
9607,GO:0001727,lipid kinase activity,5,0.0,1.0,1.0,5
9608,GO:0001773,myeloid dendritic cell activation,5,0.0,1.0,1.0,2
9609,GO:0001793,IgM receptor activity,5,0.0,1.0,1.0,2
9610,GO:0001837,epithelial to mesenchymal transition,5,0.0,1.0,1.0,5
9611,GO:0001838,embryonic epithelial tube formation,5,0.0,1.0,1.0,5
9612,GO:0001881,receptor recycling,5,0.0,1.0,1.0,4
9613,GO:0001883,purine nucleoside binding,5,0.0,1.0,1.0,2
9614,GO:0001884,pyrimidine nucleoside binding,5,0.0,1.0,1.0,2
9615,GO:0001885,endothelial cell development,5,0.0,1.0,1.0,3
9616,GO:0001895,retina homeostasis,5,0.0,1.0,1.0,2
9617,GO:0001907,symbiont-mediated killing of host cell,5,0.0,1.0,1.0,4
9618,GO:0001941,postsynaptic membrane organization,5,0.0,1.0,1.0,1
9619,GO:0001975,response to amphetamine,5,0.0,1.0,1.0,1
9620,GO:0001977,renal system process involved in regulation of blood volume,5,0.0,1.0,1.0,4
9621,GO:0001978,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,5,0.0,1.0,1.0,2
9622,GO:0001979,regulation of systemic arterial blood pressure by chemoreceptor signaling,5,0.0,1.0,1.0,2
9623,GO:0001981,baroreceptor detection of arterial stretch,5,0.0,1.0,1.0,2
9624,GO:0002008,excitation of vasomotor center by chemoreceptor signaling,5,0.0,1.0,1.0,2
9625,GO:0002011,morphogenesis of an epithelial sheet,5,0.0,1.0,1.0,5
9626,GO:0002060,purine nucleobase binding,5,0.0,1.0,1.0,3
9627,GO:0002061,pyrimidine nucleobase binding,5,0.0,1.0,1.0,3
9628,GO:0002065,columnar/cuboidal epithelial cell differentiation,5,0.0,1.0,1.0,4
9629,GO:0002066,columnar/cuboidal epithelial cell development,5,0.0,1.0,1.0,2
9630,GO:0002070,epithelial cell maturation,5,0.0,1.0,1.0,3
9631,GO:0002094,polyprenyltransferase activity,5,0.0,1.0,1.0,4
9632,GO:0002119,nematode larval development,5,0.0,1.0,1.0,1
9633,GO:0002161,aminoacyl-tRNA editing activity,5,0.0,1.0,1.0,6
9634,GO:0002185,creatine kinase complex,5,0.0,1.0,1.0,2
9635,GO:0002190,cap-independent translational initiation,5,0.0,1.0,1.0,2
9636,GO:0002239,response to oomycetes,5,0.0,1.0,1.0,2
9637,GO:0002260,lymphocyte homeostasis,5,0.0,1.0,1.0,3
9638,GO:0002271,plasmacytoid dendritic cell activation involved in immune response,5,0.0,1.0,1.0,1
9639,GO:0002275,myeloid cell activation involved in immune response,5,0.0,1.0,1.0,5
9640,GO:0002285,lymphocyte activation involved in immune response,5,0.0,1.0,1.0,3
9641,GO:0002320,lymphoid progenitor cell differentiation,5,0.0,1.0,1.0,3
9642,GO:0002363,alpha-beta T cell lineage commitment,5,0.0,1.0,1.0,3
9643,GO:0002437,inflammatory response to antigenic stimulus,5,0.0,1.0,1.0,3
9644,GO:0002446,neutrophil mediated immunity,5,0.0,1.0,1.0,1
9645,GO:0002448,mast cell mediated immunity,5,0.0,1.0,1.0,1
9646,GO:0002456,T cell mediated immunity,5,0.0,1.0,1.0,5
9647,GO:0002461,tolerance induction dependent upon immune response,5,0.0,1.0,1.0,2
9648,GO:0002476,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,5,0.0,1.0,1.0,1
9649,GO:0002477,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,5,0.0,1.0,1.0,2
9650,GO:0002522,leukocyte migration involved in immune response,5,0.0,1.0,1.0,1
9651,GO:0002523,leukocyte migration involved in inflammatory response,5,0.0,1.0,1.0,1
9652,GO:0002526,acute inflammatory response,5,0.0,1.0,1.0,5
9653,GO:0002544,chronic inflammatory response,5,0.0,1.0,1.0,2
9654,GO:0002560,basophil mediated immunity,5,0.0,1.0,1.0,1
9655,GO:0002573,myeloid leukocyte differentiation,5,0.0,1.0,1.0,7
9656,GO:0002578,negative regulation of antigen processing and presentation,5,0.0,1.0,1.0,9
9657,GO:0002579,positive regulation of antigen processing and presentation,5,0.0,1.0,1.0,9
9658,GO:0002580,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,5,0.0,1.0,1.0,4
9659,GO:0002583,regulation of antigen processing and presentation of peptide antigen,5,0.0,1.0,1.0,6
9660,GO:0002592,regulation of antigen processing and presentation via MHC class Ib,5,0.0,1.0,1.0,4
9661,GO:0002604,regulation of dendritic cell antigen processing and presentation,5,0.0,1.0,1.0,4
9662,GO:0002613,regulation of monocyte antigen processing and presentation,5,0.0,1.0,1.0,2
9663,GO:0002616,regulation of macrophage antigen processing and presentation,5,0.0,1.0,1.0,2
9664,GO:0002619,regulation of non-professional antigen presenting cell antigen processing and presentation,5,0.0,1.0,1.0,2
9665,GO:0002644,negative regulation of tolerance induction,5,0.0,1.0,1.0,7
9666,GO:0002645,positive regulation of tolerance induction,5,0.0,1.0,1.0,8
9667,GO:0002646,regulation of central tolerance induction,5,0.0,1.0,1.0,3
9668,GO:0002649,regulation of tolerance induction to self antigen,5,0.0,1.0,1.0,2
9669,GO:0002661,regulation of B cell tolerance induction,5,0.0,1.0,1.0,5
9670,GO:0002664,regulation of T cell tolerance induction,5,0.0,1.0,1.0,4
9671,GO:0002694,regulation of leukocyte activation,5,0.0,1.0,1.0,8
9672,GO:0002698,negative regulation of immune effector process,5,0.0,1.0,1.0,17
9673,GO:0002699,positive regulation of immune effector process,5,0.0,1.0,1.0,19
9674,GO:0002703,regulation of leukocyte mediated immunity,5,0.0,1.0,1.0,6
9675,GO:0002764,immune response-regulating signaling pathway,5,0.0,1.0,1.0,3
9676,GO:0002777,antimicrobial peptide biosynthetic process,5,0.0,1.0,1.0,2
9677,GO:0002819,regulation of adaptive immune response,5,0.0,1.0,1.0,5
9678,GO:0002828,regulation of type 2 immune response,5,0.0,1.0,1.0,4
9679,GO:0002832,negative regulation of response to biotic stimulus,5,0.0,1.0,1.0,12
9680,GO:0002833,positive regulation of response to biotic stimulus,5,0.0,1.0,1.0,11
9681,GO:0002834,regulation of response to tumor cell,5,0.0,1.0,1.0,3
9682,GO:0002871,regulation of natural killer cell tolerance induction,5,0.0,1.0,1.0,2
9683,GO:0002911,regulation of lymphocyte anergy,5,0.0,1.0,1.0,4
9684,GO:0002920,regulation of humoral immune response,5,0.0,1.0,1.0,5
9685,GO:0003021,detection of increased carbon dioxide by chemoreceptor signaling,5,0.0,1.0,1.0,2
9686,GO:0003022,detection of pH by chemoreceptor signaling,5,0.0,1.0,1.0,2
9687,GO:0003044,regulation of systemic arterial blood pressure mediated by a chemical signal,5,0.0,1.0,1.0,5
9688,GO:0003045,regulation of systemic arterial blood pressure by physical factors,5,0.0,1.0,1.0,2
9689,GO:0003052,circadian regulation of systemic arterial blood pressure,5,0.0,1.0,1.0,1
9690,GO:0003072,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,5,0.0,1.0,1.0,2
9691,GO:0003084,positive regulation of systemic arterial blood pressure,5,0.0,1.0,1.0,7
9692,GO:0003085,negative regulation of systemic arterial blood pressure,5,0.0,1.0,1.0,5
9693,GO:0003128,heart field specification,5,0.0,1.0,1.0,2
9694,GO:0003131,mesodermal-endodermal cell signaling,5,0.0,1.0,1.0,1
9695,GO:0003133,endodermal-mesodermal cell signaling,5,0.0,1.0,1.0,1
9696,GO:0003158,endothelium development,5,0.0,1.0,1.0,2
9697,GO:0003159,morphogenesis of an endothelium,5,0.0,1.0,1.0,1
9698,GO:0003203,endocardial cushion morphogenesis,5,0.0,1.0,1.0,2
9699,GO:0003292,cardiac septum cell differentiation,5,0.0,1.0,1.0,1
9700,GO:0003298,physiological muscle hypertrophy,5,0.0,1.0,1.0,1
9701,GO:0003299,muscle hypertrophy in response to stress,5,0.0,1.0,1.0,1
9702,GO:0003318,cell migration to the midline involved in heart development,5,0.0,1.0,1.0,2
9703,GO:0003333,amino acid transmembrane transport,5,0.0,1.0,1.0,17
9704,GO:0003351,epithelial cilium movement involved in extracellular fluid movement,5,0.0,1.0,1.0,4
9705,GO:0003357,noradrenergic neuron differentiation,5,0.0,1.0,1.0,1
9706,GO:0003359,noradrenergic neuron fate commitment,5,0.0,1.0,1.0,1
9707,GO:0003366,cell-matrix adhesion involved in ameboidal cell migration,5,0.0,1.0,1.0,1
9708,GO:0003367,cell-cell adhesion involved in ameboidal cell migration,5,0.0,1.0,1.0,1
9709,GO:0003379,establishment of cell polarity involved in gastrulation cell migration,5,0.0,1.0,1.0,1
9710,GO:0003383,apical constriction,5,0.0,1.0,1.0,1
9711,GO:0003393,neuron migration involved in retrograde extension,5,0.0,1.0,1.0,1
9712,GO:0003413,chondrocyte differentiation involved in endochondral bone morphogenesis,5,0.0,1.0,1.0,1
9713,GO:0003414,chondrocyte morphogenesis involved in endochondral bone morphogenesis,5,0.0,1.0,1.0,1
9714,GO:0003420,regulation of growth plate cartilage chondrocyte proliferation,5,0.0,1.0,1.0,2
9715,GO:0003422,growth plate cartilage morphogenesis,5,0.0,1.0,1.0,1
9716,GO:0003430,growth plate cartilage chondrocyte growth,5,0.0,1.0,1.0,1
9717,GO:0003433,chondrocyte development involved in endochondral bone morphogenesis,5,0.0,1.0,1.0,1
9718,GO:0003678,DNA helicase activity,5,0.0,1.0,1.0,6
9719,GO:0003684,damaged DNA binding,5,0.0,1.0,1.0,4
9720,GO:0003690,double-stranded DNA binding,5,0.0,1.0,1.0,9
9721,GO:0003697,single-stranded DNA binding,5,0.0,1.0,1.0,4
9722,GO:0003725,double-stranded RNA binding,5,0.0,1.0,1.0,2
9723,GO:0003727,single-stranded RNA binding,5,0.0,1.0,1.0,5
9724,GO:0003729,mRNA binding,5,0.0,1.0,1.0,9
9725,GO:0003857,3-hydroxyacyl-CoA dehydrogenase activity,5,0.0,1.0,1.0,1
9726,GO:0003865,3-oxo-5-alpha-steroid 4-dehydrogenase activity,5,0.0,1.0,1.0,1
9727,GO:0003918,"DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity",5,0.0,1.0,1.0,1
9728,GO:0003955,NAD(P)H dehydrogenase (quinone) activity,5,0.0,1.0,1.0,1
9729,GO:0003995,acyl-CoA dehydrogenase activity,5,0.0,1.0,1.0,5
9730,GO:0003997,acyl-CoA oxidase activity,5,0.0,1.0,1.0,6
9731,GO:0004027,alcohol sulfotransferase activity,5,0.0,1.0,1.0,1
9732,GO:0004030,aldehyde dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,4
9733,GO:0004031,aldehyde oxidase activity,5,0.0,1.0,1.0,2
9734,GO:0004040,amidase activity,5,0.0,1.0,1.0,4
9735,GO:0004058,aromatic-L-amino-acid decarboxylase activity,5,0.0,1.0,1.0,3
9736,GO:0004074,biliverdin reductase [NAD(P)+] activity,5,0.0,1.0,1.0,2
9737,GO:0004084,branched-chain-amino-acid transaminase activity,5,0.0,1.0,1.0,3
9738,GO:0004104,cholinesterase activity,5,0.0,1.0,1.0,1
9739,GO:0004128,"cytochrome-b5 reductase activity, acting on NAD(P)H",5,0.0,1.0,1.0,2
9740,GO:0004177,aminopeptidase activity,5,0.0,1.0,1.0,5
9741,GO:0004180,carboxypeptidase activity,5,0.0,1.0,1.0,4
9742,GO:0004190,aspartic-type endopeptidase activity,5,0.0,1.0,1.0,2
9743,GO:0004197,cysteine-type endopeptidase activity,5,0.0,1.0,1.0,3
9744,GO:0004222,metalloendopeptidase activity,5,0.0,1.0,1.0,1
9745,GO:0004300,enoyl-CoA hydratase activity,5,0.0,1.0,1.0,2
9746,GO:0004301,epoxide hydrolase activity,5,0.0,1.0,1.0,5
9747,GO:0004353,glutamate dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,2
9748,GO:0004407,histone deacetylase activity,5,0.0,1.0,1.0,4
9749,GO:0004448,isocitrate dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,2
9750,GO:0004463,leukotriene-A4 hydrolase activity,5,0.0,1.0,1.0,1
9751,GO:0004470,malic enzyme activity,5,0.0,1.0,1.0,2
9752,GO:0004486,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,2
9753,GO:0004489,methylenetetrahydrofolate reductase (NAD(P)H) activity,5,0.0,1.0,1.0,2
9754,GO:0004509,steroid 21-monooxygenase activity,5,0.0,1.0,1.0,2
9755,GO:0004519,endonuclease activity,5,0.0,1.0,1.0,4
9756,GO:0004527,exonuclease activity,5,0.0,1.0,1.0,7
9757,GO:0004536,DNA nuclease activity,5,0.0,1.0,1.0,3
9758,GO:0004540,RNA nuclease activity,5,0.0,1.0,1.0,10
9759,GO:0004564,beta-fructofuranosidase activity,5,0.0,1.0,1.0,1
9760,GO:0004568,chitinase activity,5,0.0,1.0,1.0,2
9761,GO:0004576,oligosaccharyl transferase activity,5,0.0,1.0,1.0,1
9762,GO:0004611,phosphoenolpyruvate carboxykinase activity,5,0.0,1.0,1.0,4
9763,GO:0004614,phosphoglucomutase activity,5,0.0,1.0,1.0,1
9764,GO:0004619,phosphoglycerate mutase activity,5,0.0,1.0,1.0,2
9765,GO:0004645,"1,4-alpha-oligoglucan phosphorylase activity",5,0.0,1.0,1.0,8
9766,GO:0004668,protein-arginine deiminase activity,5,0.0,1.0,1.0,1
9767,GO:0004672,protein kinase activity,5,0.0,1.0,1.0,13
9768,GO:0004731,purine-nucleoside phosphorylase activity,5,0.0,1.0,1.0,1
9769,GO:0004753,saccharopine dehydrogenase activity,5,0.0,1.0,1.0,4
9770,GO:0004774,succinate-CoA ligase activity,5,0.0,1.0,1.0,2
9771,GO:0004793,threonine aldolase activity,5,0.0,1.0,1.0,1
9772,GO:0004812,aminoacyl-tRNA ligase activity,5,0.0,1.0,1.0,26
9773,GO:0004859,phospholipase inhibitor activity,5,0.0,1.0,1.0,3
9774,GO:0004860,protein kinase inhibitor activity,5,0.0,1.0,1.0,2
9775,GO:0004864,protein phosphatase inhibitor activity,5,0.0,1.0,1.0,1
9776,GO:0004866,endopeptidase inhibitor activity,5,0.0,1.0,1.0,4
9777,GO:0004883,nuclear glucocorticoid receptor activity,5,0.0,1.0,1.0,1
9778,GO:0004897,ciliary neurotrophic factor receptor activity,5,0.0,1.0,1.0,1
9779,GO:0004904,interferon receptor activity,5,0.0,1.0,1.0,3
9780,GO:0004908,interleukin-1 receptor activity,5,0.0,1.0,1.0,2
9781,GO:0004952,dopamine neurotransmitter receptor activity,5,0.0,1.0,1.0,2
9782,GO:0004953,icosanoid receptor activity,5,0.0,1.0,1.0,2
9783,GO:0004985,G protein-coupled opioid receptor activity,5,0.0,1.0,1.0,5
9784,GO:0005092,GDP-dissociation inhibitor activity,5,0.0,1.0,1.0,2
9785,GO:0005104,fibroblast growth factor receptor binding,5,0.0,1.0,1.0,3
9786,GO:0005125,cytokine activity,5,0.0,1.0,1.0,1
9787,GO:0005149,interleukin-1 receptor binding,5,0.0,1.0,1.0,2
9788,GO:0005152,interleukin-1 receptor antagonist activity,5,0.0,1.0,1.0,2
9789,GO:0005160,transforming growth factor beta receptor binding,5,0.0,1.0,1.0,3
9790,GO:0005165,neurotrophin receptor binding,5,0.0,1.0,1.0,4
9791,GO:0005172,vascular endothelial growth factor receptor binding,5,0.0,1.0,1.0,3
9792,GO:0005179,hormone activity,5,0.0,1.0,1.0,14
9793,GO:0005186,pheromone activity,5,0.0,1.0,1.0,2
9794,GO:0005216,monoatomic ion channel activity,5,0.0,1.0,1.0,7
9795,GO:0005246,calcium channel regulator activity,5,0.0,1.0,1.0,1
9796,GO:0005287,high-affinity basic amino acid transmembrane transporter activity,5,0.0,1.0,1.0,4
9797,GO:0005294,neutral L-amino acid secondary active transmembrane transporter activity,5,0.0,1.0,1.0,1
9798,GO:0005308,creatine transmembrane transporter activity,5,0.0,1.0,1.0,1
9799,GO:0005310,dicarboxylic acid transmembrane transporter activity,5,0.0,1.0,1.0,18
9800,GO:0005315,phosphate transmembrane transporter activity,5,0.0,1.0,1.0,7
9801,GO:0005365,myo-inositol transmembrane transporter activity,5,0.0,1.0,1.0,2
9802,GO:0005371,tricarboxylate secondary active transmembrane transporter activity,5,0.0,1.0,1.0,1
9803,GO:0005634,nucleus,5,0.0,1.0,1.0,11
9804,GO:0005694,chromosome,5,0.0,1.0,1.0,7
9805,GO:0005773,vacuole,5,0.0,1.0,1.0,6
9806,GO:0005774,vacuolar membrane,5,0.0,1.0,1.0,4
9807,GO:0005775,vacuolar lumen,5,0.0,1.0,1.0,8
9808,GO:0005783,endoplasmic reticulum,5,0.0,1.0,1.0,5
9809,GO:0005796,Golgi lumen,5,0.0,1.0,1.0,2
9810,GO:0005811,lipid droplet,5,0.0,1.0,1.0,2
9811,GO:0005818,aster,5,0.0,1.0,1.0,1
9812,GO:0005819,spindle,5,0.0,1.0,1.0,2
9813,GO:0005840,ribosome,5,0.0,1.0,1.0,2
9814,GO:0005856,cytoskeleton,5,0.0,1.0,1.0,9
9815,GO:0005912,adherens junction,5,0.0,1.0,1.0,2
9816,GO:0005942,phosphatidylinositol 3-kinase complex,5,0.0,1.0,1.0,3
9817,GO:0005976,polysaccharide metabolic process,5,0.0,1.0,1.0,15
9818,GO:0005996,monosaccharide metabolic process,5,0.0,1.0,1.0,10
9819,GO:0006002,fructose 6-phosphate metabolic process,5,0.0,1.0,1.0,2
9820,GO:0006023,aminoglycan biosynthetic process,5,0.0,1.0,1.0,3
9821,GO:0006026,aminoglycan catabolic process,5,0.0,1.0,1.0,3
9822,GO:0006050,mannosamine metabolic process,5,0.0,1.0,1.0,3
9823,GO:0006112,energy reserve metabolic process,5,0.0,1.0,1.0,1
9824,GO:0006113,fermentation,5,0.0,1.0,1.0,10
9825,GO:0006338,chromatin remodeling,5,0.0,1.0,1.0,7
9826,GO:0006412,translation,5,0.0,1.0,1.0,4
9827,GO:0006414,translational elongation,5,0.0,1.0,1.0,6
9828,GO:0006508,proteolysis,5,0.0,1.0,1.0,4
9829,GO:0006578,amino-acid betaine biosynthetic process,5,0.0,1.0,1.0,6
9830,GO:0006579,amino-acid betaine catabolic process,5,0.0,1.0,1.0,5
9831,GO:0006581,acetylcholine catabolic process,5,0.0,1.0,1.0,1
9832,GO:0006582,melanin metabolic process,5,0.0,1.0,1.0,3
9833,GO:0006586,indolalkylamine metabolic process,5,0.0,1.0,1.0,5
9834,GO:0006595,polyamine metabolic process,5,0.0,1.0,1.0,11
9835,GO:0006599,phosphagen metabolic process,5,0.0,1.0,1.0,4
9836,GO:0006662,glycerol ether metabolic process,5,0.0,1.0,1.0,3
9837,GO:0006720,isoprenoid metabolic process,5,0.0,1.0,1.0,7
9838,GO:0006743,ubiquinone metabolic process,5,0.0,1.0,1.0,3
9839,GO:0006767,water-soluble vitamin metabolic process,5,0.0,1.0,1.0,11
9840,GO:0006775,fat-soluble vitamin metabolic process,5,0.0,1.0,1.0,6
9841,GO:0006779,porphyrin-containing compound biosynthetic process,5,0.0,1.0,1.0,5
9842,GO:0006787,porphyrin-containing compound catabolic process,5,0.0,1.0,1.0,3
9843,GO:0006792,regulation of sulfur utilization,5,0.0,1.0,1.0,2
9844,GO:0006808,regulation of nitrogen utilization,5,0.0,1.0,1.0,4
9845,GO:0006812,monoatomic cation transport,5,0.0,1.0,1.0,2
9846,GO:0006817,phosphate ion transport,5,0.0,1.0,1.0,2
9847,GO:0006820,monoatomic anion transport,5,0.0,1.0,1.0,3
9848,GO:0006833,water transport,5,0.0,1.0,1.0,4
9849,GO:0006885,regulation of pH,5,0.0,1.0,1.0,3
9850,GO:0006897,endocytosis,5,0.0,1.0,1.0,9
9851,GO:0006904,vesicle docking involved in exocytosis,5,0.0,1.0,1.0,3
9852,GO:0006921,cellular component disassembly involved in execution phase of apoptosis,5,0.0,1.0,1.0,1
9853,GO:0006925,inflammatory cell apoptotic process,5,0.0,1.0,1.0,2
9854,GO:0006939,smooth muscle contraction,5,0.0,1.0,1.0,9
9855,GO:0006941,striated muscle contraction,5,0.0,1.0,1.0,3
9856,GO:0006982,response to lipid hydroperoxide,5,0.0,1.0,1.0,1
9857,GO:0006995,cellular response to nitrogen starvation,5,0.0,1.0,1.0,1
9858,GO:0006997,nucleus organization,5,0.0,1.0,1.0,13
9859,GO:0006998,nuclear envelope organization,5,0.0,1.0,1.0,1
9860,GO:0007005,mitochondrion organization,5,0.0,1.0,1.0,7
9861,GO:0007009,plasma membrane organization,5,0.0,1.0,1.0,10
9862,GO:0007010,cytoskeleton organization,5,0.0,1.0,1.0,9
9863,GO:0007015,actin filament organization,5,0.0,1.0,1.0,11
9864,GO:0007029,endoplasmic reticulum organization,5,0.0,1.0,1.0,7
9865,GO:0007030,Golgi organization,5,0.0,1.0,1.0,6
9866,GO:0007031,peroxisome organization,5,0.0,1.0,1.0,5
9867,GO:0007033,vacuole organization,5,0.0,1.0,1.0,7
9868,GO:0007034,vacuolar transport,5,0.0,1.0,1.0,7
9869,GO:0007097,nuclear migration,5,0.0,1.0,1.0,10
9870,GO:0007107,membrane addition at site of cytokinesis,5,0.0,1.0,1.0,1
9871,GO:0007116,regulation of cell budding,5,0.0,1.0,1.0,2
9872,GO:0007162,negative regulation of cell adhesion,5,0.0,1.0,1.0,6
9873,GO:0007166,cell surface receptor signaling pathway,5,0.0,1.0,1.0,31
9874,GO:0007186,G protein-coupled receptor signaling pathway,5,0.0,1.0,1.0,40
9875,GO:0007210,serotonin receptor signaling pathway,5,0.0,1.0,1.0,3
9876,GO:0007214,gamma-aminobutyric acid signaling pathway,5,0.0,1.0,1.0,1
9877,GO:0007310,oocyte dorsal/ventral axis specification,5,0.0,1.0,1.0,2
9878,GO:0007346,regulation of mitotic cell cycle,5,0.0,1.0,1.0,9
9879,GO:0007368,determination of left/right symmetry,5,0.0,1.0,1.0,8
9880,GO:0007386,compartment pattern specification,5,0.0,1.0,1.0,2
9881,GO:0007432,salivary gland boundary specification,5,0.0,1.0,1.0,2
9882,GO:0007435,salivary gland morphogenesis,5,0.0,1.0,1.0,3
9883,GO:0007448,"anterior/posterior pattern specification, imaginal disc",5,0.0,1.0,1.0,3
9884,GO:0007449,"proximal/distal pattern formation, imaginal disc",5,0.0,1.0,1.0,2
9885,GO:0007450,"dorsal/ventral pattern formation, imaginal disc",5,0.0,1.0,1.0,1
9886,GO:0007484,imaginal disc-derived genitalia development,5,0.0,1.0,1.0,2
9887,GO:0007520,myoblast fusion,5,0.0,1.0,1.0,1
9888,GO:0007522,visceral muscle development,5,0.0,1.0,1.0,2
9889,GO:0007542,"primary sex determination, germ-line",5,0.0,1.0,1.0,2
9890,GO:0007563,regulation of eclosion,5,0.0,1.0,1.0,2
9891,GO:0007564,regulation of chitin-based cuticle tanning,5,0.0,1.0,1.0,2
9892,GO:0007589,body fluid secretion,5,0.0,1.0,1.0,7
9893,GO:0007606,sensory perception of chemical stimulus,5,0.0,1.0,1.0,3
9894,GO:0007611,learning or memory,5,0.0,1.0,1.0,3
9895,GO:0007619,courtship behavior,5,0.0,1.0,1.0,2
9896,GO:0007630,jump response,5,0.0,1.0,1.0,1
9897,GO:0007632,visual behavior,5,0.0,1.0,1.0,3
9898,GO:0008017,microtubule binding,5,0.0,1.0,1.0,3
9899,GO:0008028,monocarboxylic acid transmembrane transporter activity,5,0.0,1.0,1.0,25
9900,GO:0008029,pentraxin receptor activity,5,0.0,1.0,1.0,1
9901,GO:0008069,"dorsal/ventral axis specification, ovarian follicular epithelium",5,0.0,1.0,1.0,2
9902,GO:0008078,mesodermal cell migration,5,0.0,1.0,1.0,1
9903,GO:0008081,phosphoric diester hydrolase activity,5,0.0,1.0,1.0,31
9904,GO:0008131,primary methylamine oxidase activity,5,0.0,1.0,1.0,3
9905,GO:0008135,"translation factor activity, RNA binding",5,0.0,1.0,1.0,3
9906,GO:0008169,C-methyltransferase activity,5,0.0,1.0,1.0,10
9907,GO:0008170,N-methyltransferase activity,5,0.0,1.0,1.0,32
9908,GO:0008171,O-methyltransferase activity,5,0.0,1.0,1.0,29
9909,GO:0008172,S-methyltransferase activity,5,0.0,1.0,1.0,12
9910,GO:0008173,RNA methyltransferase activity,5,0.0,1.0,1.0,7
9911,GO:0008200,ion channel inhibitor activity,5,0.0,1.0,1.0,4
9912,GO:0008227,G protein-coupled amine receptor activity,5,0.0,1.0,1.0,8
9913,GO:0008235,metalloexopeptidase activity,5,0.0,1.0,1.0,3
9914,GO:0008251,tRNA-specific adenosine deaminase activity,5,0.0,1.0,1.0,2
9915,GO:0008276,protein methyltransferase activity,5,0.0,1.0,1.0,13
9916,GO:0008284,positive regulation of cell population proliferation,5,0.0,1.0,1.0,28
9917,GO:0008285,negative regulation of cell population proliferation,5,0.0,1.0,1.0,27
9918,GO:0008301,"DNA binding, bending",5,0.0,1.0,1.0,2
9919,GO:0008303,caspase complex,5,0.0,1.0,1.0,2
9920,GO:0008305,integrin complex,5,0.0,1.0,1.0,24
9921,GO:0008318,protein prenyltransferase activity,5,0.0,1.0,1.0,2
9922,GO:0008361,regulation of cell size,5,0.0,1.0,1.0,5
9923,GO:0008374,O-acyltransferase activity,5,0.0,1.0,1.0,44
9924,GO:0008375,acetylglucosaminyltransferase activity,5,0.0,1.0,1.0,32
9925,GO:0008376,acetylgalactosaminyltransferase activity,5,0.0,1.0,1.0,11
9926,GO:0008378,galactosyltransferase activity,5,0.0,1.0,1.0,9
9927,GO:0008380,RNA splicing,5,0.0,1.0,1.0,3
9928,GO:0008387,steroid 7-alpha-hydroxylase activity,5,0.0,1.0,1.0,2
9929,GO:0008392,arachidonate epoxygenase activity,5,0.0,1.0,1.0,4
9930,GO:0008397,sterol 12-alpha-hydroxylase activity,5,0.0,1.0,1.0,2
9931,GO:0008417,fucosyltransferase activity,5,0.0,1.0,1.0,5
9932,GO:0008428,ribonuclease inhibitor activity,5,0.0,1.0,1.0,1
9933,GO:0008477,purine nucleosidase activity,5,0.0,1.0,1.0,5
9934,GO:0008493,tetracycline transmembrane transporter activity,5,0.0,1.0,1.0,1
9935,GO:0008517,folic acid transmembrane transporter activity,5,0.0,1.0,1.0,2
9936,GO:0008528,G protein-coupled peptide receptor activity,5,0.0,1.0,1.0,24
9937,GO:0008595,"anterior/posterior axis specification, embryo",5,0.0,1.0,1.0,2
9938,GO:0008603,cAMP-dependent protein kinase regulator activity,5,0.0,1.0,1.0,1
9939,GO:0008652,amino acid biosynthetic process,5,0.0,1.0,1.0,9
9940,GO:0008757,S-adenosylmethionine-dependent methyltransferase activity,5,0.0,1.0,1.0,128
9941,GO:0008793,aromatic-amino-acid transaminase activity,5,0.0,1.0,1.0,4
9942,GO:0008875,gluconate dehydrogenase activity,5,0.0,1.0,1.0,3
9943,GO:0008912,lactaldehyde reductase activity,5,0.0,1.0,1.0,2
9944,GO:0008933,lytic transglycosylase activity,5,0.0,1.0,1.0,1
9945,GO:0008937,ferredoxin-NAD(P) reductase activity,5,0.0,1.0,1.0,2
9946,GO:0008946,oligonucleotidase activity,5,0.0,1.0,1.0,2
9947,GO:0008982,protein-N(PI)-phosphohistidine-sugar phosphotransferase activity,5,0.0,1.0,1.0,19
9948,GO:0009008,DNA-methyltransferase activity,5,0.0,1.0,1.0,3
9949,GO:0009009,site-specific recombinase activity,5,0.0,1.0,1.0,3
9950,GO:0009013,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,2
9951,GO:0009038,undecaprenol kinase activity,5,0.0,1.0,1.0,2
9952,GO:0009063,amino acid catabolic process,5,0.0,1.0,1.0,7
9953,GO:0009110,vitamin biosynthetic process,5,0.0,1.0,1.0,2
9954,GO:0009111,vitamin catabolic process,5,0.0,1.0,1.0,2
9955,GO:0009270,response to humidity,5,0.0,1.0,1.0,2
9956,GO:0009272,fungal-type cell wall biogenesis,5,0.0,1.0,1.0,1
9957,GO:0009273,peptidoglycan-based cell wall biogenesis,5,0.0,1.0,1.0,2
9958,GO:0009311,oligosaccharide metabolic process,5,0.0,1.0,1.0,14
9959,GO:0009372,quorum sensing,5,0.0,1.0,1.0,1
9960,GO:0009396,folic acid-containing compound biosynthetic process,5,0.0,1.0,1.0,4
9961,GO:0009397,folic acid-containing compound catabolic process,5,0.0,1.0,1.0,2
9962,GO:0009403,toxin biosynthetic process,5,0.0,1.0,1.0,4
9963,GO:0009407,toxin catabolic process,5,0.0,1.0,1.0,5
9964,GO:0009411,response to UV,5,0.0,1.0,1.0,7
9965,GO:0009414,response to water deprivation,5,0.0,1.0,1.0,3
9966,GO:0009437,carnitine metabolic process,5,0.0,1.0,1.0,3
9967,GO:0009439,cyanate metabolic process,5,0.0,1.0,1.0,2
9968,GO:0009506,plasmodesma,5,0.0,1.0,1.0,2
9969,GO:0009518,PSI associated light-harvesting complex I,5,0.0,1.0,1.0,2
9970,GO:0009528,plastid inner membrane,5,0.0,1.0,1.0,4
9971,GO:0009536,plastid,5,0.0,1.0,1.0,10
9972,GO:0009579,thylakoid,5,0.0,1.0,1.0,3
9973,GO:0009583,detection of light stimulus,5,0.0,1.0,1.0,4
9974,GO:0009608,response to symbiont,5,0.0,1.0,1.0,5
9975,GO:0009615,response to virus,5,0.0,1.0,1.0,4
9976,GO:0009620,response to fungus,5,0.0,1.0,1.0,4
9977,GO:0009637,response to blue light,5,0.0,1.0,1.0,5
9978,GO:0009639,response to red or far red light,5,0.0,1.0,1.0,5
9979,GO:0009642,response to light intensity,5,0.0,1.0,1.0,8
9980,GO:0009648,photoperiodism,5,0.0,1.0,1.0,6
9981,GO:0009657,plastid organization,5,0.0,1.0,1.0,8
9982,GO:0009668,plastid membrane organization,5,0.0,1.0,1.0,3
9983,GO:0009690,cytokinin metabolic process,5,0.0,1.0,1.0,5
9984,GO:0009699,phenylpropanoid biosynthetic process,5,0.0,1.0,1.0,13
9985,GO:0009712,catechol-containing compound metabolic process,5,0.0,1.0,1.0,15
9986,GO:0009714,chalcone metabolic process,5,0.0,1.0,1.0,2
9987,GO:0009718,anthocyanin-containing compound biosynthetic process,5,0.0,1.0,1.0,1
9988,GO:0009730,detection of carbohydrate stimulus,5,0.0,1.0,1.0,2
9989,GO:0009737,response to abscisic acid,5,0.0,1.0,1.0,2
9990,GO:0009753,response to jasmonic acid,5,0.0,1.0,1.0,3
9991,GO:0009755,hormone-mediated signaling pathway,5,0.0,1.0,1.0,15
9992,GO:0009756,carbohydrate mediated signaling,5,0.0,1.0,1.0,1
9993,GO:0009767,photosynthetic electron transport chain,5,0.0,1.0,1.0,2
9994,GO:0009786,regulation of asymmetric cell division,5,0.0,1.0,1.0,3
9995,GO:0009793,embryo development ending in seed dormancy,5,0.0,1.0,1.0,2
9996,GO:0009801,cinnamic acid ester metabolic process,5,0.0,1.0,1.0,2
9997,GO:0009804,coumarin metabolic process,5,0.0,1.0,1.0,5
9998,GO:0009806,lignan metabolic process,5,0.0,1.0,1.0,9
9999,GO:0009808,lignin metabolic process,5,0.0,1.0,1.0,5
10000,GO:0009821,alkaloid biosynthetic process,5,0.0,1.0,1.0,10
10001,GO:0009832,plant-type cell wall biogenesis,5,0.0,1.0,1.0,2
10002,GO:0009850,auxin metabolic process,5,0.0,1.0,1.0,5
10003,GO:0009863,salicylic acid mediated signaling pathway,5,0.0,1.0,1.0,1
10004,GO:0009892,negative regulation of metabolic process,5,0.0,1.0,1.0,42
10005,GO:0009894,regulation of catabolic process,5,0.0,1.0,1.0,34
10006,GO:0009913,epidermal cell differentiation,5,0.0,1.0,1.0,4
10007,GO:0009932,cell tip growth,5,0.0,1.0,1.0,2
10008,GO:0009961,response to 1-aminocyclopropane-1-carboxylic acid,5,0.0,1.0,1.0,1
10009,GO:0009966,regulation of signal transduction,5,0.0,1.0,1.0,61
10010,GO:0010002,cardioblast differentiation,5,0.0,1.0,1.0,2
10011,GO:0010040,response to iron(II) ion,5,0.0,1.0,1.0,1
10012,GO:0010041,response to iron(III) ion,5,0.0,1.0,1.0,1
10013,GO:0010053,root epidermal cell differentiation,5,0.0,1.0,1.0,3
10014,GO:0010075,regulation of meristem growth,5,0.0,1.0,1.0,5
10015,GO:0010089,xylem development,5,0.0,1.0,1.0,2
10016,GO:0010093,specification of floral organ identity,5,0.0,1.0,1.0,4
10017,GO:0010101,post-embryonic root morphogenesis,5,0.0,1.0,1.0,1
10018,GO:0010109,regulation of photosynthesis,5,0.0,1.0,1.0,5
10019,GO:0010165,response to X-ray,5,0.0,1.0,1.0,1
10020,GO:0010193,response to ozone,5,0.0,1.0,1.0,1
10021,GO:0010219,regulation of vernalization response,5,0.0,1.0,1.0,2
10022,GO:0010232,vascular transport,5,0.0,1.0,1.0,3
10023,GO:0010238,response to proline,5,0.0,1.0,1.0,1
10024,GO:0010266,response to vitamin B1,5,0.0,1.0,1.0,1
10025,GO:0010279,indole-3-acetic acid amido synthetase activity,5,0.0,1.0,1.0,1
10026,GO:0010286,heat acclimation,5,0.0,1.0,1.0,1
10027,GO:0010324,membrane invagination,5,0.0,1.0,1.0,2
10028,GO:0010326,methionine-oxo-acid transaminase activity,5,0.0,1.0,1.0,1
10029,GO:0010332,response to gamma radiation,5,0.0,1.0,1.0,1
10030,GO:0010333,terpene synthase activity,5,0.0,1.0,1.0,11
10031,GO:0010354,homogentisate prenyltransferase activity,5,0.0,1.0,1.0,4
10032,GO:0010369,chromocenter,5,0.0,1.0,1.0,2
10033,GO:0010436,carotenoid dioxygenase activity,5,0.0,1.0,1.0,3
10034,GO:0010464,regulation of mesenchymal cell proliferation,5,0.0,1.0,1.0,6
10035,GO:0010467,gene expression,5,0.0,1.0,1.0,6
10036,GO:0010543,regulation of platelet activation,5,0.0,1.0,1.0,3
10037,GO:0010549,regulation of membrane disassembly,5,0.0,1.0,1.0,2
10038,GO:0010555,response to mannitol,5,0.0,1.0,1.0,1
10039,GO:0010564,regulation of cell cycle process,5,0.0,1.0,1.0,39
10040,GO:0010565,regulation of ketone metabolic process,5,0.0,1.0,1.0,21
10041,GO:0010631,epithelial cell migration,5,0.0,1.0,1.0,10
10042,GO:0010645,regulation of cell communication by chemical coupling,5,0.0,1.0,1.0,2
10043,GO:0010647,positive regulation of cell communication,5,0.0,1.0,1.0,10
10044,GO:0010648,negative regulation of cell communication,5,0.0,1.0,1.0,11
10045,GO:0010649,regulation of cell communication by electrical coupling,5,0.0,1.0,1.0,3
10046,GO:0010657,muscle cell apoptotic process,5,0.0,1.0,1.0,2
10047,GO:0010669,epithelial structure maintenance,5,0.0,1.0,1.0,2
10048,GO:0010712,regulation of collagen metabolic process,5,0.0,1.0,1.0,4
10049,GO:0010717,regulation of epithelial to mesenchymal transition,5,0.0,1.0,1.0,4
10050,GO:0010761,fibroblast migration,5,0.0,1.0,1.0,1
10051,GO:0010810,regulation of cell-substrate adhesion,5,0.0,1.0,1.0,6
10052,GO:0010835,regulation of protein ADP-ribosylation,5,0.0,1.0,1.0,2
10053,GO:0010858,calcium-dependent protein kinase regulator activity,5,0.0,1.0,1.0,1
10054,GO:0010877,lipid transport involved in lipid storage,5,0.0,1.0,1.0,1
10055,GO:0010901,regulation of very-low-density lipoprotein particle remodeling,5,0.0,1.0,1.0,2
10056,GO:0010912,positive regulation of isomerase activity,5,0.0,1.0,1.0,2
10057,GO:0010915,regulation of very-low-density lipoprotein particle clearance,5,0.0,1.0,1.0,2
10058,GO:0010927,cellular component assembly involved in morphogenesis,5,0.0,1.0,1.0,18
10059,GO:0010932,regulation of macrophage tolerance induction,5,0.0,1.0,1.0,1
10060,GO:0010960,magnesium ion homeostasis,5,0.0,1.0,1.0,1
10061,GO:0010966,regulation of phosphate transport,5,0.0,1.0,1.0,2
10062,GO:0010985,negative regulation of lipoprotein particle clearance,5,0.0,1.0,1.0,3
10063,GO:0010988,regulation of low-density lipoprotein particle clearance,5,0.0,1.0,1.0,2
10064,GO:0014002,astrocyte development,5,0.0,1.0,1.0,1
10065,GO:0014032,neural crest cell development,5,0.0,1.0,1.0,1
10066,GO:0014033,neural crest cell differentiation,5,0.0,1.0,1.0,3
10067,GO:0014072,response to isoquinoline alkaloid,5,0.0,1.0,1.0,4
10068,GO:0014073,response to tropane,5,0.0,1.0,1.0,1
10069,GO:0014706,striated muscle tissue development,5,0.0,1.0,1.0,3
10070,GO:0014708,regulation of somitomeric trunk muscle development,5,0.0,1.0,1.0,2
10071,GO:0014805,smooth muscle adaptation,5,0.0,1.0,1.0,3
10072,GO:0014833,skeletal muscle satellite stem cell asymmetric division,5,0.0,1.0,1.0,1
10073,GO:0014856,skeletal muscle cell proliferation,5,0.0,1.0,1.0,1
10074,GO:0014857,regulation of skeletal muscle cell proliferation,5,0.0,1.0,1.0,3
10075,GO:0014888,striated muscle adaptation,5,0.0,1.0,1.0,3
10076,GO:0014889,muscle atrophy,5,0.0,1.0,1.0,2
10077,GO:0014897,striated muscle hypertrophy,5,0.0,1.0,1.0,2
10078,GO:0014900,muscle hyperplasia,5,0.0,1.0,1.0,1
10079,GO:0014909,smooth muscle cell migration,5,0.0,1.0,1.0,2
10080,GO:0015020,glucuronosyltransferase activity,5,0.0,1.0,1.0,11
10081,GO:0015035,protein-disulfide reductase activity,5,0.0,1.0,1.0,3
10082,GO:0015038,glutathione disulfide oxidoreductase activity,5,0.0,1.0,1.0,2
10083,GO:0015045,rubredoxin-NAD(P)+ reductase activity,5,0.0,1.0,1.0,2
10084,GO:0015078,proton transmembrane transporter activity,5,0.0,1.0,1.0,26
10085,GO:0015098,molybdate ion transmembrane transporter activity,5,0.0,1.0,1.0,1
10086,GO:0015104,antimonite transmembrane transporter activity,5,0.0,1.0,1.0,2
10087,GO:0015105,arsenite transmembrane transporter activity,5,0.0,1.0,1.0,1
10088,GO:0015108,chloride transmembrane transporter activity,5,0.0,1.0,1.0,6
10089,GO:0015111,iodide transmembrane transporter activity,5,0.0,1.0,1.0,2
10090,GO:0015112,nitrate transmembrane transporter activity,5,0.0,1.0,1.0,3
10091,GO:0015113,nitrite transmembrane transporter activity,5,0.0,1.0,1.0,1
10092,GO:0015116,sulfate transmembrane transporter activity,5,0.0,1.0,1.0,3
10093,GO:0015117,thiosulfate transmembrane transporter activity,5,0.0,1.0,1.0,1
10094,GO:0015135,glucuronate transmembrane transporter activity,5,0.0,1.0,1.0,1
10095,GO:0015142,tricarboxylic acid transmembrane transporter activity,5,0.0,1.0,1.0,1
10096,GO:0015145,monosaccharide transmembrane transporter activity,5,0.0,1.0,1.0,7
10097,GO:0015151,alpha-glucoside transmembrane transporter activity,5,0.0,1.0,1.0,1
10098,GO:0015152,glucose-6-phosphate transmembrane transporter activity,5,0.0,1.0,1.0,1
10099,GO:0015154,disaccharide transmembrane transporter activity,5,0.0,1.0,1.0,6
10100,GO:0015158,raffinose transmembrane transporter activity,5,0.0,1.0,1.0,1
10101,GO:0015160,beta-glucan transmembrane transporter activity,5,0.0,1.0,1.0,1
10102,GO:0015165,pyrimidine nucleotide-sugar transmembrane transporter activity,5,0.0,1.0,1.0,8
10103,GO:0015168,glycerol transmembrane transporter activity,5,0.0,1.0,1.0,1
10104,GO:0015170,propanediol transmembrane transporter activity,5,0.0,1.0,1.0,1
10105,GO:0015173,aromatic amino acid transmembrane transporter activity,5,0.0,1.0,1.0,5
10106,GO:0015179,L-amino acid transmembrane transporter activity,5,0.0,1.0,1.0,28
10107,GO:0015199,amino-acid betaine transmembrane transporter activity,5,0.0,1.0,1.0,3
10108,GO:0015208,guanine transmembrane transporter activity,5,0.0,1.0,1.0,1
10109,GO:0015209,cytosine transmembrane transporter activity,5,0.0,1.0,1.0,1
10110,GO:0015210,uracil transmembrane transporter activity,5,0.0,1.0,1.0,1
10111,GO:0015211,purine nucleoside transmembrane transporter activity,5,0.0,1.0,1.0,2
10112,GO:0015214,pyrimidine nucleoside transmembrane transporter activity,5,0.0,1.0,1.0,2
10113,GO:0015216,purine nucleotide transmembrane transporter activity,5,0.0,1.0,1.0,4
10114,GO:0015226,carnitine transmembrane transporter activity,5,0.0,1.0,1.0,2
10115,GO:0015227,acyl carnitine transmembrane transporter activity,5,0.0,1.0,1.0,1
10116,GO:0015243,cycloheximide transmembrane transporter activity,5,0.0,1.0,1.0,1
10117,GO:0015244,fluconazole transmembrane transporter activity,5,0.0,1.0,1.0,1
10118,GO:0015292,uniporter activity,5,0.0,1.0,1.0,4
10119,GO:0015293,symporter activity,5,0.0,1.0,1.0,1
10120,GO:0015297,antiporter activity,5,0.0,1.0,1.0,41
10121,GO:0015451,decarboxylation-driven active transmembrane transporter activity,5,0.0,1.0,1.0,1
10122,GO:0015453,oxidoreduction-driven active transmembrane transporter activity,5,0.0,1.0,1.0,7
10123,GO:0015459,potassium channel regulator activity,5,0.0,1.0,1.0,2
10124,GO:0015464,acetylcholine receptor activity,5,0.0,1.0,1.0,1
10125,GO:0015556,C4-dicarboxylate transmembrane transporter activity,5,0.0,1.0,1.0,8
10126,GO:0015571,N-acetylgalactosamine transmembrane transporter activity,5,0.0,1.0,1.0,1
10127,GO:0015573,beta-glucoside transmembrane transporter activity,5,0.0,1.0,1.0,3
10128,GO:0015575,mannitol transmembrane transporter activity,5,0.0,1.0,1.0,1
10129,GO:0015576,sorbitol transmembrane transporter activity,5,0.0,1.0,1.0,1
10130,GO:0015577,galactitol transmembrane transporter activity,5,0.0,1.0,1.0,1
10131,GO:0015616,DNA translocase activity,5,0.0,1.0,1.0,2
10132,GO:0015645,fatty acid ligase activity,5,0.0,1.0,1.0,3
10133,GO:0015658,branched-chain amino acid transmembrane transporter activity,5,0.0,1.0,1.0,4
10134,GO:0015670,carbon dioxide transport,5,0.0,1.0,1.0,1
10135,GO:0015689,molybdate ion transport,5,0.0,1.0,1.0,1
10136,GO:0015697,quaternary ammonium group transport,5,0.0,1.0,1.0,5
10137,GO:0015712,hexose phosphate transport,5,0.0,1.0,1.0,1
10138,GO:0015717,triose phosphate transport,5,0.0,1.0,1.0,1
10139,GO:0015772,oligosaccharide transport,5,0.0,1.0,1.0,7
10140,GO:0015774,polysaccharide transport,5,0.0,1.0,1.0,4
10141,GO:0015791,polyol transmembrane transport,5,0.0,1.0,1.0,10
10142,GO:0015798,myo-inositol transport,5,0.0,1.0,1.0,1
10143,GO:0015800,acidic amino acid transport,5,0.0,1.0,1.0,5
10144,GO:0015802,basic amino acid transport,5,0.0,1.0,1.0,3
10145,GO:0015804,neutral amino acid transport,5,0.0,1.0,1.0,16
10146,GO:0015805,S-adenosyl-L-methionine transport,5,0.0,1.0,1.0,1
10147,GO:0015835,peptidoglycan transport,5,0.0,1.0,1.0,1
10148,GO:0015837,amine transport,5,0.0,1.0,1.0,5
10149,GO:0015844,monoamine transport,5,0.0,1.0,1.0,3
10150,GO:0015846,polyamine transport,5,0.0,1.0,1.0,4
10151,GO:0015851,nucleobase transport,5,0.0,1.0,1.0,2
10152,GO:0015870,acetylcholine transport,5,0.0,1.0,1.0,2
10153,GO:0015888,thiamine transport,5,0.0,1.0,1.0,1
10154,GO:0015914,phospholipid transport,5,0.0,1.0,1.0,7
10155,GO:0015923,mannosidase activity,5,0.0,1.0,1.0,3
10156,GO:0015925,galactosidase activity,5,0.0,1.0,1.0,7
10157,GO:0015926,glucosidase activity,5,0.0,1.0,1.0,6
10158,GO:0015927,trehalase activity,5,0.0,1.0,1.0,2
10159,GO:0015928,fucosidase activity,5,0.0,1.0,1.0,1
10160,GO:0015929,hexosaminidase activity,5,0.0,1.0,1.0,8
10161,GO:0015931,nucleobase-containing compound transport,5,0.0,1.0,1.0,8
10162,GO:0015947,methane metabolic process,5,0.0,1.0,1.0,2
10163,GO:0015994,chlorophyll metabolic process,5,0.0,1.0,1.0,6
10164,GO:0016004,phospholipase activator activity,5,0.0,1.0,1.0,4
10165,GO:0016007,mitochondrial derivative,5,0.0,1.0,1.0,3
10166,GO:0016050,vesicle organization,5,0.0,1.0,1.0,13
10167,GO:0016051,carbohydrate biosynthetic process,5,0.0,1.0,1.0,9
10168,GO:0016052,carbohydrate catabolic process,5,0.0,1.0,1.0,12
10169,GO:0016054,organic acid catabolic process,5,0.0,1.0,1.0,5
10170,GO:0016137,glycoside metabolic process,5,0.0,1.0,1.0,16
10171,GO:0016143,S-glycoside metabolic process,5,0.0,1.0,1.0,4
10172,GO:0016154,pyrimidine-nucleoside phosphorylase activity,5,0.0,1.0,1.0,3
10173,GO:0016160,amylase activity,5,0.0,1.0,1.0,2
10174,GO:0016174,NAD(P)H oxidase H2O2-forming activity,5,0.0,1.0,1.0,2
10175,GO:0016175,superoxide-generating NAD(P)H oxidase activity,5,0.0,1.0,1.0,2
10176,GO:0016197,endosomal transport,5,0.0,1.0,1.0,6
10177,GO:0016199,axon midline choice point recognition,5,0.0,1.0,1.0,1
10178,GO:0016202,regulation of striated muscle tissue development,5,0.0,1.0,1.0,4
10179,GO:0016211,ammonia ligase activity,5,0.0,1.0,1.0,2
10180,GO:0016215,acyl-CoA desaturase activity,5,0.0,1.0,1.0,6
10181,GO:0016236,macroautophagy,5,0.0,1.0,1.0,11
10182,GO:0016237,microautophagy,5,0.0,1.0,1.0,5
10183,GO:0016289,acyl-CoA hydrolase activity,5,0.0,1.0,1.0,10
10184,GO:0016310,phosphorylation,5,0.0,1.0,1.0,7
10185,GO:0016311,dephosphorylation,5,0.0,1.0,1.0,5
10186,GO:0016331,morphogenesis of embryonic epithelium,5,0.0,1.0,1.0,14
10187,GO:0016344,meiotic chromosome movement towards spindle pole,5,0.0,1.0,1.0,5
10188,GO:0016407,acetyltransferase activity,5,0.0,1.0,1.0,9
10189,GO:0016408,C-acyltransferase activity,5,0.0,1.0,1.0,7
10190,GO:0016409,palmitoyltransferase activity,5,0.0,1.0,1.0,3
10191,GO:0016410,N-acyltransferase activity,5,0.0,1.0,1.0,31
10192,GO:0016417,S-acyltransferase activity,5,0.0,1.0,1.0,4
10193,GO:0016420,malonyltransferase activity,5,0.0,1.0,1.0,3
10194,GO:0016462,pyrophosphatase activity,5,0.0,1.0,1.0,44
10195,GO:0016482,cytosolic transport,5,0.0,1.0,1.0,6
10196,GO:0016503,pheromone receptor activity,5,0.0,1.0,1.0,2
10197,GO:0016505,peptidase activator activity involved in apoptotic process,5,0.0,1.0,1.0,1
10198,GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,5,0.0,1.0,1.0,2
10199,GO:0016618,hydroxypyruvate reductase [NAD(P)H] activity,5,0.0,1.0,1.0,2
10200,GO:0016631,enoyl-[acyl-carrier-protein] reductase activity (NAD(P)H),5,0.0,1.0,1.0,2
10201,GO:0016748,succinyltransferase activity,5,0.0,1.0,1.0,3
10202,GO:0016752,sinapoyltransferase activity,5,0.0,1.0,1.0,1
10203,GO:0016791,phosphatase activity,5,0.0,1.0,1.0,62
10204,GO:0016793,triphosphoric monoester hydrolase activity,5,0.0,1.0,1.0,2
10205,GO:0016794,diphosphoric monoester hydrolase activity,5,0.0,1.0,1.0,3
10206,GO:0016795,phosphoric triester hydrolase activity,5,0.0,1.0,1.0,1
10207,GO:0016805,dipeptidase activity,5,0.0,1.0,1.0,2
10208,GO:0016918,retinal binding,5,0.0,1.0,1.0,2
10209,GO:0016972,thiol oxidase activity,5,0.0,1.0,1.0,1
10210,GO:0016997,alpha-sialidase activity,5,0.0,1.0,1.0,3
10211,GO:0016998,cell wall macromolecule catabolic process,5,0.0,1.0,1.0,3
10212,GO:0017024,myosin I binding,5,0.0,1.0,1.0,2
10213,GO:0017042,glycosylceramidase activity,5,0.0,1.0,1.0,2
10214,GO:0017069,snRNA binding,5,0.0,1.0,1.0,13
10215,GO:0017076,purine nucleotide binding,5,0.0,1.0,1.0,4
10216,GO:0017080,sodium channel regulator activity,5,0.0,1.0,1.0,1
10217,GO:0017081,chloride channel regulator activity,5,0.0,1.0,1.0,1
10218,GO:0017143,insecticide metabolic process,5,0.0,1.0,1.0,2
10219,GO:0017169,CDP-alcohol phosphatidyltransferase activity,5,0.0,1.0,1.0,5
10220,GO:0018366,chiral amino acid racemization,5,0.0,1.0,1.0,1
10221,GO:0018455,alcohol dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,3
10222,GO:0018671,4-hydroxybenzoate 3-monooxygenase [NAD(P)H] activity,5,0.0,1.0,1.0,2
10223,GO:0018822,nitrile hydratase activity,5,0.0,1.0,1.0,1
10224,GO:0018864,acetylene metabolic process,5,0.0,1.0,1.0,1
10225,GO:0018868,2-aminobenzenesulfonate metabolic process,5,0.0,1.0,1.0,2
10226,GO:0018883,caprolactam metabolic process,5,0.0,1.0,1.0,1
10227,GO:0018885,carbon tetrachloride metabolic process,5,0.0,1.0,1.0,2
10228,GO:0018899,"1,2-dichloroethane metabolic process",5,0.0,1.0,1.0,1
10229,GO:0018915,ethylbenzene catabolic process,5,0.0,1.0,1.0,1
10230,GO:0018939,n-octane metabolic process,5,0.0,1.0,1.0,1
10231,GO:0018940,orcinol metabolic process,5,0.0,1.0,1.0,2
10232,GO:0018946,aerobic organosilicon metabolic process,5,0.0,1.0,1.0,1
10233,GO:0018947,anaerobic organosilicon metabolic process,5,0.0,1.0,1.0,1
10234,GO:0018949,m-xylene metabolic process,5,0.0,1.0,1.0,1
10235,GO:0018950,o-xylene metabolic process,5,0.0,1.0,1.0,1
10236,GO:0018951,p-xylene metabolic process,5,0.0,1.0,1.0,1
10237,GO:0018952,parathion metabolic process,5,0.0,1.0,1.0,1
10238,GO:0018959,aerobic phenol-containing compound metabolic process,5,0.0,1.0,1.0,2
10239,GO:0018960,4-nitrophenol metabolic process,5,0.0,1.0,1.0,1
10240,GO:0018961,pentachlorophenol metabolic process,5,0.0,1.0,1.0,1
10241,GO:0018969,thiocyanate metabolic process,5,0.0,1.0,1.0,1
10242,GO:0018970,toluene metabolic process,5,0.0,1.0,1.0,4
10243,GO:0018972,toluene-4-sulfonate metabolic process,5,0.0,1.0,1.0,1
10244,GO:0018982,vanillin metabolic process,5,0.0,1.0,1.0,2
10245,GO:0019048,modulation by virus of host process,5,0.0,1.0,1.0,2
10246,GO:0019076,viral release from host cell,5,0.0,1.0,1.0,2
10247,GO:0019095,pole plasm mitochondrial rRNA localization,5,0.0,1.0,1.0,2
10248,GO:0019103,pyrimidine nucleotide binding,5,0.0,1.0,1.0,2
10249,GO:0019104,DNA N-glycosylase activity,5,0.0,1.0,1.0,5
10250,GO:0019107,myristoyltransferase activity,5,0.0,1.0,1.0,4
10251,GO:0019116,hydroxy-nicotine oxidase activity,5,0.0,1.0,1.0,2
10252,GO:0019152,acetoin dehydrogenase (NAD+) activity,5,0.0,1.0,1.0,2
10253,GO:0019184,nonribosomal peptide biosynthetic process,5,0.0,1.0,1.0,3
10254,GO:0019200,carbohydrate kinase activity,5,0.0,1.0,1.0,19
10255,GO:0019202,amino acid kinase activity,5,0.0,1.0,1.0,6
10256,GO:0019205,nucleobase-containing compound kinase activity,5,0.0,1.0,1.0,10
10257,GO:0019230,proprioception,5,0.0,1.0,1.0,3
10258,GO:0019233,sensory perception of pain,5,0.0,1.0,1.0,2
10259,GO:0019238,cyclohydrolase activity,5,0.0,1.0,1.0,5
10260,GO:0019255,glucose 1-phosphate metabolic process,5,0.0,1.0,1.0,1
10261,GO:0019296,coenzyme M metabolic process,5,0.0,1.0,1.0,1
10262,GO:0019326,nitrotoluene metabolic process,5,0.0,1.0,1.0,3
10263,GO:0019336,phenol-containing compound catabolic process,5,0.0,1.0,1.0,45
10264,GO:0019536,vibriobactin metabolic process,5,0.0,1.0,1.0,1
10265,GO:0019649,formaldehyde assimilation,5,0.0,1.0,1.0,2
10266,GO:0019682,glyceraldehyde-3-phosphate metabolic process,5,0.0,1.0,1.0,7
10267,GO:0019692,deoxyribose phosphate metabolic process,5,0.0,1.0,1.0,6
10268,GO:0019693,ribose phosphate metabolic process,5,0.0,1.0,1.0,4
10269,GO:0019694,alkanesulfonate metabolic process,5,0.0,1.0,1.0,6
10270,GO:0019724,B cell mediated immunity,5,0.0,1.0,1.0,3
10271,GO:0019740,nitrogen utilization,5,0.0,1.0,1.0,1
10272,GO:0019751,polyol metabolic process,5,0.0,1.0,1.0,17
10273,GO:0019766,IgA receptor activity,5,0.0,1.0,1.0,2
10274,GO:0019767,IgE receptor activity,5,0.0,1.0,1.0,2
10275,GO:0019770,IgG receptor activity,5,0.0,1.0,1.0,2
10276,GO:0019784,deNEDDylase activity,5,0.0,1.0,1.0,2
10277,GO:0019787,ubiquitin-like protein transferase activity,5,0.0,1.0,1.0,11
10278,GO:0019815,B cell receptor complex,5,0.0,1.0,1.0,5
10279,GO:0019841,retinol binding,5,0.0,1.0,1.0,1
10280,GO:0019843,rRNA binding,5,0.0,1.0,1.0,6
10281,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,5,0.0,1.0,1.0,2
10282,GO:0019901,protein kinase binding,5,0.0,1.0,1.0,12
10283,GO:0019903,protein phosphatase binding,5,0.0,1.0,1.0,4
10284,GO:0019957,C-C chemokine binding,5,0.0,1.0,1.0,6
10285,GO:0019958,C-X-C chemokine binding,5,0.0,1.0,1.0,1
10286,GO:0020027,hemoglobin metabolic process,5,0.0,1.0,1.0,2
10287,GO:0021605,cranial nerve maturation,5,0.0,1.0,1.0,12
10288,GO:0021778,oligodendrocyte cell fate specification,5,0.0,1.0,1.0,1
10289,GO:0021856,hypothalamic tangential migration using cell-axon interactions,5,0.0,1.0,1.0,1
10290,GO:0021859,pyramidal neuron differentiation,5,0.0,1.0,1.0,2
10291,GO:0021877,forebrain neuron fate commitment,5,0.0,1.0,1.0,2
10292,GO:0021923,cell proliferation in hindbrain ventricular zone,5,0.0,1.0,1.0,5
10293,GO:0021924,cell proliferation in external granule layer,5,0.0,1.0,1.0,2
10294,GO:0021932,hindbrain radial glia guided cell migration,5,0.0,1.0,1.0,2
10295,GO:0021934,hindbrain tangential cell migration,5,0.0,1.0,1.0,2
10296,GO:0021953,central nervous system neuron differentiation,5,0.0,1.0,1.0,18
10297,GO:0021954,central nervous system neuron development,5,0.0,1.0,1.0,4
10298,GO:0022012,subpallium cell proliferation in forebrain,5,0.0,1.0,1.0,5
10299,GO:0022029,telencephalon cell migration,5,0.0,1.0,1.0,5
10300,GO:0022407,regulation of cell-cell adhesion,5,0.0,1.0,1.0,16
10301,GO:0022410,circadian sleep/wake cycle process,5,0.0,1.0,1.0,4
10302,GO:0022416,chaeta development,5,0.0,1.0,1.0,1
10303,GO:0022604,regulation of cell morphogenesis,5,0.0,1.0,1.0,13
10304,GO:0022606,establishment of proximal/distal cell polarity,5,0.0,1.0,1.0,1
10305,GO:0022829,wide pore channel activity,5,0.0,1.0,1.0,3
10306,GO:0022836,gated channel activity,5,0.0,1.0,1.0,6
10307,GO:0022842,narrow pore channel activity,5,0.0,1.0,1.0,2
10308,GO:0022858,alanine transmembrane transporter activity,5,0.0,1.0,1.0,4
10309,GO:0022904,respiratory electron transport chain,5,0.0,1.0,1.0,5
10310,GO:0023029,MHC class Ib protein binding,5,0.0,1.0,1.0,2
10311,GO:0030002,intracellular monoatomic anion homeostasis,5,0.0,1.0,1.0,1
10312,GO:0030003,intracellular monoatomic cation homeostasis,5,0.0,1.0,1.0,11
10313,GO:0030031,cell projection assembly,5,0.0,1.0,1.0,4
10314,GO:0030091,protein repair,5,0.0,1.0,1.0,2
10315,GO:0030101,natural killer cell activation,5,0.0,1.0,1.0,3
10316,GO:0030125,clathrin vesicle coat,5,0.0,1.0,1.0,3
10317,GO:0030163,protein catabolic process,5,0.0,1.0,1.0,15
10318,GO:0030175,filopodium,5,0.0,1.0,1.0,2
10319,GO:0030186,melatonin metabolic process,5,0.0,1.0,1.0,2
10320,GO:0030198,extracellular matrix organization,5,0.0,1.0,1.0,9
10321,GO:0030203,glycosaminoglycan metabolic process,5,0.0,1.0,1.0,5
10322,GO:0030218,erythrocyte differentiation,5,0.0,1.0,1.0,4
10323,GO:0030242,autophagy of peroxisome,5,0.0,1.0,1.0,2
10324,GO:0030250,guanylate cyclase activator activity,5,0.0,1.0,1.0,1
10325,GO:0030258,lipid modification,5,0.0,1.0,1.0,6
10326,GO:0030279,negative regulation of ossification,5,0.0,1.0,1.0,1
10327,GO:0030282,bone mineralization,5,0.0,1.0,1.0,1
10328,GO:0030295,protein kinase activator activity,5,0.0,1.0,1.0,3
10329,GO:0030309,poly-N-acetyllactosamine metabolic process,5,0.0,1.0,1.0,2
10330,GO:0030318,melanocyte differentiation,5,0.0,1.0,1.0,2
10331,GO:0030326,embryonic limb morphogenesis,5,0.0,1.0,1.0,2
10332,GO:0030334,regulation of cell migration,5,0.0,1.0,1.0,27
10333,GO:0030368,interleukin-17 receptor activity,5,0.0,1.0,1.0,3
10334,GO:0030389,fructosamine metabolic process,5,0.0,1.0,1.0,4
10335,GO:0030397,membrane disassembly,5,0.0,1.0,1.0,5
10336,GO:0030424,axon,5,0.0,1.0,1.0,6
10337,GO:0030425,dendrite,5,0.0,1.0,1.0,8
10338,GO:0030515,snoRNA binding,5,0.0,1.0,1.0,3
10339,GO:0030540,female genitalia development,5,0.0,1.0,1.0,2
10340,GO:0030551,cyclic nucleotide binding,5,0.0,1.0,1.0,5
10341,GO:0030555,RNA modification guide activity,5,0.0,1.0,1.0,5
10342,GO:0030572,phosphatidyltransferase activity,5,0.0,1.0,1.0,3
10343,GO:0030582,reproductive fruiting body development,5,0.0,1.0,1.0,4
10344,GO:0030595,leukocyte chemotaxis,5,0.0,1.0,1.0,8
10345,GO:0030597,RNA glycosylase activity,5,0.0,1.0,1.0,1
10346,GO:0030639,polyketide biosynthetic process,5,0.0,1.0,1.0,25
10347,GO:0030640,polyketide catabolic process,5,0.0,1.0,1.0,14
10348,GO:0030651,peptide antibiotic biosynthetic process,5,0.0,1.0,1.0,2
10349,GO:0030653,beta-lactam antibiotic metabolic process,5,0.0,1.0,1.0,6
10350,GO:0030677,ribonuclease P complex,5,0.0,1.0,1.0,3
10351,GO:0030705,cytoskeleton-dependent intracellular transport,5,0.0,1.0,1.0,4
10352,GO:0030719,P granule organization,5,0.0,1.0,1.0,2
10353,GO:0030856,regulation of epithelial cell differentiation,5,0.0,1.0,1.0,15
10354,GO:0030859,polarized epithelial cell differentiation,5,0.0,1.0,1.0,1
10355,GO:0030880,RNA polymerase complex,5,0.0,1.0,1.0,2
10356,GO:0031000,response to caffeine,5,0.0,1.0,1.0,1
10357,GO:0031009,plastid ADPG pyrophosphorylase complex,5,0.0,1.0,1.0,2
10358,GO:0031010,ISWI-type complex,5,0.0,1.0,1.0,8
10359,GO:0031027,glutamate synthase complex (NADH),5,0.0,1.0,1.0,1
10360,GO:0031123,RNA 3'-end processing,5,0.0,1.0,1.0,9
10361,GO:0031138,negative regulation of conjugation with cellular fusion,5,0.0,1.0,1.0,2
10362,GO:0031139,positive regulation of conjugation with cellular fusion,5,0.0,1.0,1.0,5
10363,GO:0031147,"1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one metabolic process",5,0.0,1.0,1.0,1
10364,GO:0031155,regulation of reproductive fruiting body development,5,0.0,1.0,1.0,2
10365,GO:0031163,metallo-sulfur cluster assembly,5,0.0,1.0,1.0,1
10366,GO:0031168,ferrichrome metabolic process,5,0.0,1.0,1.0,2
10367,GO:0031248,protein acetyltransferase complex,5,0.0,1.0,1.0,3
10368,GO:0031280,negative regulation of cyclase activity,5,0.0,1.0,1.0,2
10369,GO:0031281,positive regulation of cyclase activity,5,0.0,1.0,1.0,2
10370,GO:0031285,regulation of sorocarp stalk cell differentiation,5,0.0,1.0,1.0,2
10371,GO:0031342,negative regulation of cell killing,5,0.0,1.0,1.0,3
10372,GO:0031343,positive regulation of cell killing,5,0.0,1.0,1.0,3
10373,GO:0031344,regulation of cell projection organization,5,0.0,1.0,1.0,5
10374,GO:0031406,carboxylic acid binding,5,0.0,1.0,1.0,33
10375,GO:0031425,chloroplast RNA processing,5,0.0,1.0,1.0,1
10376,GO:0031455,glycine betaine metabolic process,5,0.0,1.0,1.0,2
10377,GO:0031461,cullin-RING ubiquitin ligase complex,5,0.0,1.0,1.0,8
10378,GO:0031469,bacterial microcompartment,5,0.0,1.0,1.0,3
10379,GO:0031490,chromatin DNA binding,5,0.0,1.0,1.0,3
10380,GO:0031502,dolichyl-phosphate-mannose-protein mannosyltransferase complex,5,0.0,1.0,1.0,5
10381,GO:0031514,motile cilium,5,0.0,1.0,1.0,2
10382,GO:0031528,microvillus membrane,5,0.0,1.0,1.0,1
10383,GO:0031543,peptidyl-proline dioxygenase activity,5,0.0,1.0,1.0,3
10384,GO:0031579,membrane raft organization,5,0.0,1.0,1.0,3
10385,GO:0031590,wybutosine metabolic process,5,0.0,1.0,1.0,1
10386,GO:0031628,opioid receptor binding,5,0.0,1.0,1.0,4
10387,GO:0031644,regulation of nervous system process,5,0.0,1.0,1.0,8
10388,GO:0031651,negative regulation of heat generation,5,0.0,1.0,1.0,1
10389,GO:0031652,positive regulation of heat generation,5,0.0,1.0,1.0,1
10390,GO:0031685,adenosine receptor binding,5,0.0,1.0,1.0,4
10391,GO:0031690,adrenergic receptor binding,5,0.0,1.0,1.0,9
10392,GO:0031701,angiotensin receptor binding,5,0.0,1.0,1.0,2
10393,GO:0031711,bradykinin receptor binding,5,0.0,1.0,1.0,2
10394,GO:0031714,C5a anaphylatoxin chemotactic receptor binding,5,0.0,1.0,1.0,1
10395,GO:0031717,cannabinoid receptor binding,5,0.0,1.0,1.0,2
10396,GO:0031745,cysteinyl leukotriene receptor binding,5,0.0,1.0,1.0,2
10397,GO:0031753,endothelial differentiation G protein-coupled receptor binding,5,0.0,1.0,1.0,7
10398,GO:0031784,melatonin receptor binding,5,0.0,1.0,1.0,3
10399,GO:0031795,G protein-coupled GABA receptor binding,5,0.0,1.0,1.0,2
10400,GO:0031806,G protein-coupled histamine receptor binding,5,0.0,1.0,1.0,4
10401,GO:0031811,G protein-coupled nucleotide receptor binding,5,0.0,1.0,1.0,9
10402,GO:0031821,G protein-coupled serotonin receptor binding,5,0.0,1.0,1.0,12
10403,GO:0031856,parathyroid hormone receptor binding,5,0.0,1.0,1.0,1
10404,GO:0031862,prostanoid receptor binding,5,0.0,1.0,1.0,8
10405,GO:0031871,proteinase activated receptor binding,5,0.0,1.0,1.0,4
10406,GO:0031883,taste receptor binding,5,0.0,1.0,1.0,3
10407,GO:0031893,vasopressin receptor binding,5,0.0,1.0,1.0,3
10408,GO:0031904,endosome lumen,5,0.0,1.0,1.0,4
10409,GO:0031907,microbody lumen,5,0.0,1.0,1.0,1
10410,GO:0031919,vitamin B6 transport,5,0.0,1.0,1.0,4
10411,GO:0031968,organelle outer membrane,5,0.0,1.0,1.0,4
10412,GO:0031969,chloroplast membrane,5,0.0,1.0,1.0,2
10413,GO:0031970,organelle envelope lumen,5,0.0,1.0,1.0,3
10414,GO:0032027,myosin light chain binding,5,0.0,1.0,1.0,3
10415,GO:0032036,myosin heavy chain binding,5,0.0,1.0,1.0,5
10416,GO:0032065,maintenance of protein location in cell cortex,5,0.0,1.0,1.0,1
10417,GO:0032091,negative regulation of protein binding,5,0.0,1.0,1.0,8
10418,GO:0032092,positive regulation of protein binding,5,0.0,1.0,1.0,7
10419,GO:0032095,regulation of response to food,5,0.0,1.0,1.0,2
10420,GO:0032102,negative regulation of response to external stimulus,5,0.0,1.0,1.0,19
10421,GO:0032108,negative regulation of response to nutrient levels,5,0.0,1.0,1.0,9
10422,GO:0032109,positive regulation of response to nutrient levels,5,0.0,1.0,1.0,8
10423,GO:0032239,regulation of nucleobase-containing compound transport,5,0.0,1.0,1.0,8
10424,GO:0032253,dense core granule localization,5,0.0,1.0,1.0,2
10425,GO:0032254,establishment of secretory granule localization,5,0.0,1.0,1.0,1
10426,GO:0032279,asymmetric synapse,5,0.0,1.0,1.0,3
10427,GO:0032280,symmetric synapse,5,0.0,1.0,1.0,1
10428,GO:0032350,regulation of hormone metabolic process,5,0.0,1.0,1.0,11
10429,GO:0032354,response to follicle-stimulating hormone,5,0.0,1.0,1.0,1
10430,GO:0032365,intracellular lipid transport,5,0.0,1.0,1.0,5
10431,GO:0032386,regulation of intracellular transport,5,0.0,1.0,1.0,21
10432,GO:0032396,inhibitory MHC class I receptor activity,5,0.0,1.0,1.0,3
10433,GO:0032397,activating MHC class I receptor activity,5,0.0,1.0,1.0,1
10434,GO:0032400,melanosome localization,5,0.0,1.0,1.0,1
10435,GO:0032440,2-alkenal reductase [NAD(P)+] activity,5,0.0,1.0,1.0,1
10436,GO:0032490,detection of molecule of bacterial origin,5,0.0,1.0,1.0,4
10437,GO:0032493,response to bacterial lipoprotein,5,0.0,1.0,1.0,3
10438,GO:0032494,response to peptidoglycan,5,0.0,1.0,1.0,2
10439,GO:0032496,response to lipopolysaccharide,5,0.0,1.0,1.0,2
10440,GO:0032536,regulation of cell projection size,5,0.0,1.0,1.0,2
10441,GO:0032538,regulation of host-seeking behavior,5,0.0,1.0,1.0,2
10442,GO:0032546,deoxyribonucleoside binding,5,0.0,1.0,1.0,2
10443,GO:0032549,ribonucleoside binding,5,0.0,1.0,1.0,2
10444,GO:0032552,deoxyribonucleotide binding,5,0.0,1.0,1.0,2
10445,GO:0032553,ribonucleotide binding,5,0.0,1.0,1.0,4
10446,GO:0032570,response to progesterone,5,0.0,1.0,1.0,1
10447,GO:0032571,response to vitamin K,5,0.0,1.0,1.0,3
10448,GO:0032589,neuron projection membrane,5,0.0,1.0,1.0,4
10449,GO:0032768,regulation of monooxygenase activity,5,0.0,1.0,1.0,8
10450,GO:0032799,low-density lipoprotein receptor particle metabolic process,5,0.0,1.0,1.0,1
10451,GO:0032801,receptor catabolic process,5,0.0,1.0,1.0,3
10452,GO:0032813,tumor necrosis factor receptor superfamily binding,5,0.0,1.0,1.0,4
10453,GO:0032868,response to insulin,5,0.0,1.0,1.0,1
10454,GO:0032880,regulation of protein localization,5,0.0,1.0,1.0,24
10455,GO:0032890,regulation of organic acid transport,5,0.0,1.0,1.0,22
10456,GO:0032900,negative regulation of neurotrophin production,5,0.0,1.0,1.0,1
10457,GO:0032903,regulation of nerve growth factor production,5,0.0,1.0,1.0,1
10458,GO:0032940,secretion by cell,5,0.0,1.0,1.0,13
10459,GO:0032941,secretion by tissue,5,0.0,1.0,1.0,6
10460,GO:0032982,myosin filament,5,0.0,1.0,1.0,2
10461,GO:0032984,protein-containing complex disassembly,5,0.0,1.0,1.0,19
10462,GO:0032995,regulation of fungal-type cell wall biogenesis,5,0.0,1.0,1.0,2
10463,GO:0033017,sarcoplasmic reticulum membrane,5,0.0,1.0,1.0,2
10464,GO:0033020,cyclopentanol metabolic process,5,0.0,1.0,1.0,2
10465,GO:0033028,myeloid cell apoptotic process,5,0.0,1.0,1.0,4
10466,GO:0033038,bitter taste receptor activity,5,0.0,1.0,1.0,1
10467,GO:0033041,sweet taste receptor activity,5,0.0,1.0,1.0,1
10468,GO:0033043,regulation of organelle organization,5,0.0,1.0,1.0,22
10469,GO:0033067,macrolide metabolic process,5,0.0,1.0,1.0,4
10470,GO:0033069,ansamycin metabolic process,5,0.0,1.0,1.0,1
10471,GO:0033071,vancomycin metabolic process,5,0.0,1.0,1.0,1
10472,GO:0033097,amyloplast membrane,5,0.0,1.0,1.0,1
10473,GO:0033113,cyanelle membrane,5,0.0,1.0,1.0,2
10474,GO:0033189,response to vitamin A,5,0.0,1.0,1.0,1
10475,GO:0033195,response to alkyl hydroperoxide,5,0.0,1.0,1.0,2
10476,GO:0033197,response to vitamin E,5,0.0,1.0,1.0,1
10477,GO:0033198,response to ATP,5,0.0,1.0,1.0,1
10478,GO:0033206,meiotic cytokinesis,5,0.0,1.0,1.0,4
10479,GO:0033238,regulation of amine metabolic process,5,0.0,1.0,1.0,11
10480,GO:0033271,myo-inositol phosphate transport,5,0.0,1.0,1.0,1
10481,GO:0033274,response to vitamin B2,5,0.0,1.0,1.0,1
10482,GO:0033275,actin-myosin filament sliding,5,0.0,1.0,1.0,1
10483,GO:0033280,response to vitamin D,5,0.0,1.0,1.0,1
10484,GO:0033328,peroxisome membrane targeting sequence binding,5,0.0,1.0,1.0,2
10485,GO:0033338,medial fin development,5,0.0,1.0,1.0,3
10486,GO:0033365,protein localization to organelle,5,0.0,1.0,1.0,19
10487,GO:0033370,maintenance of protein location in mast cell secretory granule,5,0.0,1.0,1.0,1
10488,GO:0033377,maintenance of protein location in T cell secretory granule,5,0.0,1.0,1.0,1
10489,GO:0033510,luteolin metabolic process,5,0.0,1.0,1.0,1
10490,GO:0033524,sinapate ester metabolic process,5,0.0,1.0,1.0,1
10491,GO:0033552,response to vitamin B3,5,0.0,1.0,1.0,1
10492,GO:0033574,response to testosterone,5,0.0,1.0,1.0,1
10493,GO:0033590,response to cobalamin,5,0.0,1.0,1.0,1
10494,GO:0033594,response to hydroxyisoflavone,5,0.0,1.0,1.0,2
10495,GO:0033628,regulation of cell adhesion mediated by integrin,5,0.0,1.0,1.0,3
10496,GO:0033635,symbiont-mediated perturbation of host response to abiotic stimulus,5,0.0,1.0,1.0,1
10497,GO:0033647,host intracellular organelle,5,0.0,1.0,1.0,4
10498,GO:0033655,host cell cytoplasm part,5,0.0,1.0,1.0,24
10499,GO:0033677,DNA/RNA helicase activity,5,0.0,1.0,1.0,2
10500,GO:0033688,regulation of osteoblast proliferation,5,0.0,1.0,1.0,2
10501,GO:0033731,arogenate dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,1
10502,GO:0033744,L-methionine:thioredoxin-disulfide S-oxidoreductase activity,5,0.0,1.0,1.0,1
10503,GO:0033762,response to glucagon,5,0.0,1.0,1.0,1
10504,GO:0033764,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",5,0.0,1.0,1.0,23
10505,GO:0033860,regulation of NAD(P)H oxidase activity,5,0.0,1.0,1.0,2
10506,GO:0033986,response to methanol,5,0.0,1.0,1.0,1
10507,GO:0034059,response to anoxia,5,0.0,1.0,1.0,2
10508,GO:0034061,DNA polymerase activity,5,0.0,1.0,1.0,3
10509,GO:0034068,aminoglycoside nucleotidyltransferase activity,5,0.0,1.0,1.0,2
10510,GO:0034071,aminoglycoside phosphotransferase activity,5,0.0,1.0,1.0,5
10511,GO:0034104,negative regulation of tissue remodeling,5,0.0,1.0,1.0,5
10512,GO:0034105,positive regulation of tissue remodeling,5,0.0,1.0,1.0,5
10513,GO:0034106,regulation of erythrocyte clearance,5,0.0,1.0,1.0,2
10514,GO:0034196,acylglycerol transport,5,0.0,1.0,1.0,1
10515,GO:0034198,cellular response to amino acid starvation,5,0.0,1.0,1.0,1
10516,GO:0034201,response to oleic acid,5,0.0,1.0,1.0,1
10517,GO:0034219,carbohydrate transmembrane transport,5,0.0,1.0,1.0,18
10518,GO:0034220,monoatomic ion transmembrane transport,5,0.0,1.0,1.0,3
10519,GO:0034235,GPI anchor binding,5,0.0,1.0,1.0,1
10520,GO:0034248,regulation of amide metabolic process,5,0.0,1.0,1.0,24
10521,GO:0034285,response to disaccharide,5,0.0,1.0,1.0,5
10522,GO:0034300,sporangiospore formation,5,0.0,1.0,1.0,2
10523,GO:0034305,regulation of asexual sporulation,5,0.0,1.0,1.0,3
10524,GO:0034308,primary alcohol metabolic process,5,0.0,1.0,1.0,25
10525,GO:0034326,butanoyltransferase activity,5,0.0,1.0,1.0,1
10526,GO:0034327,hexanoyltransferase activity,5,0.0,1.0,1.0,1
10527,GO:0034328,decanoyltransferase activity,5,0.0,1.0,1.0,1
10528,GO:0034329,cell junction assembly,5,0.0,1.0,1.0,3
10529,GO:0034331,cell junction maintenance,5,0.0,1.0,1.0,2
10530,GO:0034340,response to type I interferon,5,0.0,1.0,1.0,1
10531,GO:0034341,response to type II interferon,5,0.0,1.0,1.0,1
10532,GO:0034342,response to type III interferon,5,0.0,1.0,1.0,1
10533,GO:0034349,glial cell apoptotic process,5,0.0,1.0,1.0,1
10534,GO:0034389,lipid droplet organization,5,0.0,1.0,1.0,3
10535,GO:0034398,telomere tethering at nuclear periphery,5,0.0,1.0,1.0,2
10536,GO:0034444,regulation of plasma lipoprotein oxidation,5,0.0,1.0,1.0,1
10537,GO:0034481,chondroitin sulfotransferase activity,5,0.0,1.0,1.0,3
10538,GO:0034483,heparan sulfate sulfotransferase activity,5,0.0,1.0,1.0,6
10539,GO:0034486,vacuolar transmembrane transport,5,0.0,1.0,1.0,19
10540,GO:0034505,tooth mineralization,5,0.0,1.0,1.0,3
10541,GO:0034516,response to vitamin B6,5,0.0,1.0,1.0,1
10542,GO:0034599,cellular response to oxidative stress,5,0.0,1.0,1.0,3
10543,GO:0034601,oxoglutarate dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,2
10544,GO:0034603,pyruvate dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,2
10545,GO:0034605,cellular response to heat,5,0.0,1.0,1.0,3
10546,GO:0034612,response to tumor necrosis factor,5,0.0,1.0,1.0,1
10547,GO:0034620,cellular response to unfolded protein,5,0.0,1.0,1.0,1
10548,GO:0034643,"establishment of mitochondrion localization, microtubule-mediated",5,0.0,1.0,1.0,2
10549,GO:0034654,nucleobase-containing compound biosynthetic process,5,0.0,1.0,1.0,4
10550,GO:0034655,nucleobase-containing compound catabolic process,5,0.0,1.0,1.0,3
10551,GO:0034695,response to prostaglandin E,5,0.0,1.0,1.0,1
10552,GO:0034696,response to prostaglandin F,5,0.0,1.0,1.0,1
10553,GO:0034697,response to prostaglandin I,5,0.0,1.0,1.0,1
10554,GO:0034699,response to luteinizing hormone,5,0.0,1.0,1.0,1
10555,GO:0034701,tripeptidase activity,5,0.0,1.0,1.0,1
10556,GO:0034703,cation channel complex,5,0.0,1.0,1.0,6
10557,GO:0034707,chloride channel complex,5,0.0,1.0,1.0,2
10558,GO:0034762,regulation of transmembrane transport,5,0.0,1.0,1.0,17
10559,GO:0034979,NAD-dependent protein lysine deacetylase activity,5,0.0,1.0,1.0,2
10560,GO:0034993,meiotic nuclear membrane microtubule tethering complex,5,0.0,1.0,1.0,1
10561,GO:0035026,leading edge cell differentiation,5,0.0,1.0,1.0,1
10562,GO:0035027,leading edge cell fate commitment,5,0.0,1.0,1.0,1
10563,GO:0035064,methylated histone binding,5,0.0,1.0,1.0,3
10564,GO:0035075,response to ecdysone,5,0.0,1.0,1.0,1
10565,GO:0035089,establishment of apical/basal cell polarity,5,0.0,1.0,1.0,1
10566,GO:0035090,maintenance of apical/basal cell polarity,5,0.0,1.0,1.0,1
10567,GO:0035097,histone methyltransferase complex,5,0.0,1.0,1.0,6
10568,GO:0035126,post-embryonic genitalia morphogenesis,5,0.0,1.0,1.0,1
10569,GO:0035127,post-embryonic limb morphogenesis,5,0.0,1.0,1.0,2
10570,GO:0035136,forelimb morphogenesis,5,0.0,1.0,1.0,2
10571,GO:0035137,hindlimb morphogenesis,5,0.0,1.0,1.0,2
10572,GO:0035138,pectoral fin morphogenesis,5,0.0,1.0,1.0,2
10573,GO:0035139,pelvic fin morphogenesis,5,0.0,1.0,1.0,2
10574,GO:0035141,medial fin morphogenesis,5,0.0,1.0,1.0,5
10575,GO:0035151,"regulation of tube size, open tracheal system",5,0.0,1.0,1.0,2
10576,GO:0035162,embryonic hemopoiesis,5,0.0,1.0,1.0,1
10577,GO:0035163,embryonic hemocyte differentiation,5,0.0,1.0,1.0,2
10578,GO:0035166,post-embryonic hemopoiesis,5,0.0,1.0,1.0,1
10579,GO:0035168,larval lymph gland hemocyte differentiation,5,0.0,1.0,1.0,3
10580,GO:0035206,regulation of hemocyte proliferation,5,0.0,1.0,1.0,2
10581,GO:0035220,wing disc development,5,0.0,1.0,1.0,1
10582,GO:0035221,genital disc pattern formation,5,0.0,1.0,1.0,1
10583,GO:0035222,wing disc pattern formation,5,0.0,1.0,1.0,3
10584,GO:0035223,leg disc pattern formation,5,0.0,1.0,1.0,2
10585,GO:0035227,regulation of glutamate-cysteine ligase activity,5,0.0,1.0,1.0,1
10586,GO:0035256,G protein-coupled glutamate receptor binding,5,0.0,1.0,1.0,8
10587,GO:0035285,appendage segmentation,5,0.0,1.0,1.0,1
10588,GO:0035296,regulation of tube diameter,5,0.0,1.0,1.0,3
10589,GO:0035298,regulation of Malpighian tubule size,5,0.0,1.0,1.0,1
10590,GO:0035384,thioester biosynthetic process,5,0.0,1.0,1.0,1
10591,GO:0035449,extrinsic component of plastid thylakoid membrane,5,0.0,1.0,1.0,2
10592,GO:0035453,extrinsic component of plastid inner membrane,5,0.0,1.0,1.0,1
10593,GO:0035455,response to interferon-alpha,5,0.0,1.0,1.0,1
10594,GO:0035456,response to interferon-beta,5,0.0,1.0,1.0,1
10595,GO:0035461,vitamin transmembrane transport,5,0.0,1.0,1.0,9
10596,GO:0035515,oxidative RNA demethylase activity,5,0.0,1.0,1.0,3
10597,GO:0035556,intracellular signal transduction,5,0.0,1.0,1.0,20
10598,GO:0035562,negative regulation of chromatin binding,5,0.0,1.0,1.0,1
10599,GO:0035563,positive regulation of chromatin binding,5,0.0,1.0,1.0,1
10600,GO:0035594,ganglioside binding,5,0.0,1.0,1.0,5
10601,GO:0035596,methylthiotransferase activity,5,0.0,1.0,1.0,5
10602,GO:0035613,RNA stem-loop binding,5,0.0,1.0,1.0,1
10603,GO:0035639,purine ribonucleoside triphosphate binding,5,0.0,1.0,1.0,4
10604,GO:0035652,clathrin-coated vesicle cargo loading,5,0.0,1.0,1.0,3
10605,GO:0035671,enone reductase activity,5,0.0,1.0,1.0,3
10606,GO:0035675,neuromast hair cell development,5,0.0,1.0,1.0,2
10607,GO:0035678,neuromast hair cell morphogenesis,5,0.0,1.0,1.0,2
10608,GO:0035766,cell chemotaxis to fibroblast growth factor,5,0.0,1.0,1.0,1
10609,GO:0035767,endothelial cell chemotaxis,5,0.0,1.0,1.0,1
10610,GO:0035788,cell migration involved in metanephros development,5,0.0,1.0,1.0,2
10611,GO:0035810,positive regulation of urine volume,5,0.0,1.0,1.0,1
10612,GO:0035811,negative regulation of urine volume,5,0.0,1.0,1.0,1
10613,GO:0035830,palmatine metabolic process,5,0.0,1.0,1.0,1
10614,GO:0035840,old growing cell tip,5,0.0,1.0,1.0,1
10615,GO:0035846,oviduct epithelium development,5,0.0,1.0,1.0,1
10616,GO:0035850,epithelial cell differentiation involved in kidney development,5,0.0,1.0,1.0,6
10617,GO:0035875,"maintenance of meiotic sister chromatid cohesion, centromeric",5,0.0,1.0,1.0,1
10618,GO:0035904,aorta development,5,0.0,1.0,1.0,2
10619,GO:0035916,modulation of calcium channel activity in another organism,5,0.0,1.0,1.0,1
10620,GO:0035962,response to interleukin-13,5,0.0,1.0,1.0,1
10621,GO:0036002,pre-mRNA binding,5,0.0,1.0,1.0,5
10622,GO:0036005,response to macrophage colony-stimulating factor,5,0.0,1.0,1.0,1
10623,GO:0036015,response to interleukin-3,5,0.0,1.0,1.0,1
10624,GO:0036017,response to erythropoietin,5,0.0,1.0,1.0,1
10625,GO:0036039,curcumin metabolic process,5,0.0,1.0,1.0,1
10626,GO:0036051,protein localization to trailing edge,5,0.0,1.0,1.0,1
10627,GO:0036056,filtration diaphragm,5,0.0,1.0,1.0,2
10628,GO:0036080,purine nucleotide-sugar transmembrane transporter activity,5,0.0,1.0,1.0,2
10629,GO:0036135,Schwann cell migration,5,0.0,1.0,1.0,1
10630,GO:0036168,filamentous growth of a population of unicellular organisms in response to heat,5,0.0,1.0,1.0,1
10631,GO:0036182,asperthecin metabolic process,5,0.0,1.0,1.0,2
10632,GO:0036211,protein modification process,5,0.0,1.0,1.0,45
10633,GO:0036215,response to stem cell factor,5,0.0,1.0,1.0,1
10634,GO:0036230,granulocyte activation,5,0.0,1.0,1.0,3
10635,GO:0036255,response to methylamine,5,0.0,1.0,1.0,1
10636,GO:0036267,invasive filamentous growth,5,0.0,1.0,1.0,5
10637,GO:0036294,cellular response to decreased oxygen levels,5,0.0,1.0,1.0,3
10638,GO:0036295,cellular response to increased oxygen levels,5,0.0,1.0,1.0,1
10639,GO:0036315,cellular response to sterol,5,0.0,1.0,1.0,4
10640,GO:0036361,"racemase activity, acting on amino acids and derivatives",5,0.0,1.0,1.0,1
10641,GO:0036440,citrate synthase activity,5,0.0,1.0,1.0,2
10642,GO:0036441,2-dehydropantolactone reductase activity,5,0.0,1.0,1.0,2
10643,GO:0036447,cellular response to sugar-phosphate stress,5,0.0,1.0,1.0,1
10644,GO:0038034,signal transduction in absence of ligand,5,0.0,1.0,1.0,2
10645,GO:0038183,bile acid signaling pathway,5,0.0,1.0,1.0,2
10646,GO:0039005,specification of pronephric tubule identity,5,0.0,1.0,1.0,2
10647,GO:0039014,cell differentiation involved in pronephros development,5,0.0,1.0,1.0,1
10648,GO:0039524,symbiont-mediated suppression of host mRNA processing,5,0.0,1.0,1.0,1
10649,GO:0039604,symbiont-mediated suppression of host translation,5,0.0,1.0,1.0,1
10650,GO:0039653,symbiont-mediated suppression of host transcription,5,0.0,1.0,1.0,1
10651,GO:0039657,symbiont-mediated suppression of host gene expression,5,0.0,1.0,1.0,1
10652,GO:0039674,exit of virus from host cell nucleus,5,0.0,1.0,1.0,3
10653,GO:0039715,nuclear viral factory,5,0.0,1.0,1.0,3
10654,GO:0040014,regulation of multicellular organism growth,5,0.0,1.0,1.0,2
10655,GO:0040021,hermaphrodite germ-line sex determination,5,0.0,1.0,1.0,2
10656,GO:0042000,translocation of peptides or proteins into host,5,0.0,1.0,1.0,1
10657,GO:0042001,hermaphrodite somatic sex determination,5,0.0,1.0,1.0,2
10658,GO:0042045,epithelial fluid transport,5,0.0,1.0,1.0,2
10659,GO:0042056,chemoattractant activity,5,0.0,1.0,1.0,1
10660,GO:0042068,regulation of pteridine metabolic process,5,0.0,1.0,1.0,4
10661,GO:0042074,cell migration involved in gastrulation,5,0.0,1.0,1.0,5
10662,GO:0042083,"5,10-methylenetetrahydrofolate-dependent methyltransferase activity",5,0.0,1.0,1.0,2
10663,GO:0042084,5-methyltetrahydrofolate-dependent methyltransferase activity,5,0.0,1.0,1.0,1
10664,GO:0042085,5-methyltetrahydropteroyltri-L-glutamate-dependent methyltransferase activity,5,0.0,1.0,1.0,1
10665,GO:0042086,"5-methyl-5,6,7,8-tetrahydromethanopterin-dependent methyltransferase activity",5,0.0,1.0,1.0,1
10666,GO:0042101,T cell receptor complex,5,0.0,1.0,1.0,2
10667,GO:0042110,T cell activation,5,0.0,1.0,1.0,6
10668,GO:0042113,B cell activation,5,0.0,1.0,1.0,3
10669,GO:0042116,macrophage activation,5,0.0,1.0,1.0,2
10670,GO:0042117,monocyte activation,5,0.0,1.0,1.0,1
10671,GO:0042149,cellular response to glucose starvation,5,0.0,1.0,1.0,1
10672,GO:0042157,lipoprotein metabolic process,5,0.0,1.0,1.0,3
10673,GO:0042168,heme metabolic process,5,0.0,1.0,1.0,8
10674,GO:0042173,regulation of sporulation resulting in formation of a cellular spore,5,0.0,1.0,1.0,4
10675,GO:0042181,ketone biosynthetic process,5,0.0,1.0,1.0,52
10676,GO:0042182,ketone catabolic process,5,0.0,1.0,1.0,38
10677,GO:0042184,xylene catabolic process,5,0.0,1.0,1.0,3
10678,GO:0042196,chlorinated hydrocarbon metabolic process,5,0.0,1.0,1.0,6
10679,GO:0042199,cyanuric acid metabolic process,5,0.0,1.0,1.0,2
10680,GO:0042201,N-cyclopropylmelamine metabolic process,5,0.0,1.0,1.0,1
10681,GO:0042204,s-triazine compound catabolic process,5,0.0,1.0,1.0,3
10682,GO:0042206,halogenated hydrocarbon catabolic process,5,0.0,1.0,1.0,3
10683,GO:0042212,cresol metabolic process,5,0.0,1.0,1.0,3
10684,GO:0042215,anaerobic phenol-containing compound metabolic process,5,0.0,1.0,1.0,2
10685,GO:0042216,phenanthrene catabolic process,5,0.0,1.0,1.0,2
10686,GO:0042220,response to cocaine,5,0.0,1.0,1.0,1
10687,GO:0042249,establishment of planar polarity of embryonic epithelium,5,0.0,1.0,1.0,1
10688,GO:0042285,xylosyltransferase activity,5,0.0,1.0,1.0,3
10689,GO:0042288,MHC class I protein binding,5,0.0,1.0,1.0,2
10690,GO:0042289,MHC class II protein binding,5,0.0,1.0,1.0,2
10691,GO:0042314,bacteriochlorophyll binding,5,0.0,1.0,1.0,1
10692,GO:0042331,phototaxis,5,0.0,1.0,1.0,2
10693,GO:0042337,cuticle development involved in chitin-based cuticle molting cycle,5,0.0,1.0,1.0,2
10694,GO:0042379,chemokine receptor binding,5,0.0,1.0,1.0,5
10695,GO:0042387,plasmatocyte differentiation,5,0.0,1.0,1.0,2
10696,GO:0042401,biogenic amine biosynthetic process,5,0.0,1.0,1.0,9
10697,GO:0042402,biogenic amine catabolic process,5,0.0,1.0,1.0,8
10698,GO:0042403,thyroid hormone metabolic process,5,0.0,1.0,1.0,2
10699,GO:0042428,serotonin metabolic process,5,0.0,1.0,1.0,2
10700,GO:0042439,ethanolamine-containing compound metabolic process,5,0.0,1.0,1.0,3
10701,GO:0042443,phenylethylamine metabolic process,5,0.0,1.0,1.0,3
10702,GO:0042446,hormone biosynthetic process,5,0.0,1.0,1.0,10
10703,GO:0042447,hormone catabolic process,5,0.0,1.0,1.0,13
10704,GO:0042461,photoreceptor cell development,5,0.0,1.0,1.0,2
10705,GO:0042475,odontogenesis of dentin-containing tooth,5,0.0,1.0,1.0,2
10706,GO:0042490,mechanoreceptor differentiation,5,0.0,1.0,1.0,3
10707,GO:0042538,hyperosmotic salinity response,5,0.0,1.0,1.0,1
10708,GO:0042539,hypotonic salinity response,5,0.0,1.0,1.0,1
10709,GO:0042542,response to hydrogen peroxide,5,0.0,1.0,1.0,1
10710,GO:0042551,neuron maturation,5,0.0,1.0,1.0,1
10711,GO:0042556,eukaryotic elongation factor-2 kinase regulator activity,5,0.0,1.0,1.0,1
10712,GO:0042575,DNA polymerase complex,5,0.0,1.0,1.0,7
10713,GO:0042579,microbody,5,0.0,1.0,1.0,3
10714,GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,5,0.0,1.0,1.0,2
10715,GO:0042626,ATPase-coupled transmembrane transporter activity,5,0.0,1.0,1.0,12
10716,GO:0042646,plastid nucleoid,5,0.0,1.0,1.0,2
10717,GO:0042659,regulation of cell fate specification,5,0.0,1.0,1.0,12
10718,GO:0042688,crystal cell differentiation,5,0.0,1.0,1.0,2
10719,GO:0042744,hydrogen peroxide catabolic process,5,0.0,1.0,1.0,1
10720,GO:0042749,regulation of circadian sleep/wake cycle,5,0.0,1.0,1.0,2
10721,GO:0042762,regulation of sulfur metabolic process,5,0.0,1.0,1.0,24
10722,GO:0042810,pheromone metabolic process,5,0.0,1.0,1.0,2
10723,GO:0042854,eugenol metabolic process,5,0.0,1.0,1.0,2
10724,GO:0042876,aldarate transmembrane transporter activity,5,0.0,1.0,1.0,2
10725,GO:0042879,aldonate transmembrane transporter activity,5,0.0,1.0,1.0,5
10726,GO:0042886,amide transport,5,0.0,1.0,1.0,27
10727,GO:0042912,colicin transmembrane transporter activity,5,0.0,1.0,1.0,1
10728,GO:0042937,tripeptide transmembrane transporter activity,5,0.0,1.0,1.0,1
10729,GO:0042943,D-amino acid transmembrane transporter activity,5,0.0,1.0,1.0,4
10730,GO:0042957,dextrin transmembrane transporter activity,5,0.0,1.0,1.0,1
10731,GO:0042981,regulation of apoptotic process,5,0.0,1.0,1.0,20
10732,GO:0042982,amyloid precursor protein metabolic process,5,0.0,1.0,1.0,2
10733,GO:0043023,ribosomal large subunit binding,5,0.0,1.0,1.0,1
10734,GO:0043038,amino acid activation,5,0.0,1.0,1.0,2
10735,GO:0043063,intercellular bridge organization,5,0.0,1.0,1.0,1
10736,GO:0043068,positive regulation of programmed cell death,5,0.0,1.0,1.0,10
10737,GO:0043069,negative regulation of programmed cell death,5,0.0,1.0,1.0,8
10738,GO:0043087,regulation of GTPase activity,5,0.0,1.0,1.0,3
10739,GO:0043101,purine-containing compound salvage,5,0.0,1.0,1.0,4
10740,GO:0043114,regulation of vascular permeability,5,0.0,1.0,1.0,5
10741,GO:0043157,response to cation stress,5,0.0,1.0,1.0,1
10742,GO:0043171,peptide catabolic process,5,0.0,1.0,1.0,2
10743,GO:0043175,RNA polymerase core enzyme binding,5,0.0,1.0,1.0,6
10744,GO:0043190,ATP-binding cassette (ABC) transporter complex,5,0.0,1.0,1.0,11
10745,GO:0043201,response to L-leucine,5,0.0,1.0,1.0,1
10746,GO:0043210,alkanesulfonate binding,5,0.0,1.0,1.0,1
10747,GO:0043244,regulation of protein-containing complex disassembly,5,0.0,1.0,1.0,9
10748,GO:0043249,erythrocyte maturation,5,0.0,1.0,1.0,2
10749,GO:0043254,regulation of protein-containing complex assembly,5,0.0,1.0,1.0,38
10750,GO:0043269,regulation of monoatomic ion transport,5,0.0,1.0,1.0,6
10751,GO:0043292,contractile muscle fiber,5,0.0,1.0,1.0,2
10752,GO:0043324,pigment metabolic process involved in developmental pigmentation,5,0.0,1.0,1.0,2
10753,GO:0043330,response to exogenous dsRNA,5,0.0,1.0,1.0,1
10754,GO:0043369,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",5,0.0,1.0,1.0,2
10755,GO:0043388,positive regulation of DNA binding,5,0.0,1.0,1.0,6
10756,GO:0043392,negative regulation of DNA binding,5,0.0,1.0,1.0,5
10757,GO:0043403,skeletal muscle tissue regeneration,5,0.0,1.0,1.0,1
10758,GO:0043413,macromolecule glycosylation,5,0.0,1.0,1.0,1
10759,GO:0043414,macromolecule methylation,5,0.0,1.0,1.0,2
10760,GO:0043416,regulation of skeletal muscle tissue regeneration,5,0.0,1.0,1.0,3
10761,GO:0043425,bHLH transcription factor binding,5,0.0,1.0,1.0,1
10762,GO:0043435,response to corticotropin-releasing hormone,5,0.0,1.0,1.0,1
10763,GO:0043447,alkane biosynthetic process,5,0.0,1.0,1.0,4
10764,GO:0043448,alkane catabolic process,5,0.0,1.0,1.0,1
10765,GO:0043449,alkene metabolic process,5,0.0,1.0,1.0,11
10766,GO:0043454,alkyne catabolic process,5,0.0,1.0,1.0,1
10767,GO:0043455,regulation of secondary metabolic process,5,0.0,1.0,1.0,9
10768,GO:0043467,regulation of generation of precursor metabolites and energy,5,0.0,1.0,1.0,8
10769,GO:0043475,pigment metabolic process involved in pigment accumulation,5,0.0,1.0,1.0,1
10770,GO:0043485,endosome to pigment granule transport,5,0.0,1.0,1.0,1
10771,GO:0043496,regulation of protein homodimerization activity,5,0.0,1.0,1.0,1
10772,GO:0043527,tRNA methyltransferase complex,5,0.0,1.0,1.0,3
10773,GO:0043534,blood vessel endothelial cell migration,5,0.0,1.0,1.0,3
10774,GO:0043545,molybdopterin cofactor metabolic process,5,0.0,1.0,1.0,4
10775,GO:0043565,sequence-specific DNA binding,5,0.0,1.0,1.0,6
10776,GO:0043574,peroxisomal transport,5,0.0,1.0,1.0,1
10777,GO:0043582,sporangium development,5,0.0,1.0,1.0,2
10778,GO:0043615,astrocyte cell migration,5,0.0,1.0,1.0,2
10779,GO:0043632,modification-dependent macromolecule catabolic process,5,0.0,1.0,1.0,3
10780,GO:0043703,photoreceptor cell fate determination,5,0.0,1.0,1.0,1
10781,GO:0043704,photoreceptor cell fate specification,5,0.0,1.0,1.0,2
10782,GO:0043709,cell adhesion involved in single-species biofilm formation,5,0.0,1.0,1.0,1
10783,GO:0043711,pilus organization,5,0.0,1.0,1.0,2
10784,GO:0043773,coenzyme F420-0 gamma-glutamyl ligase activity,5,0.0,1.0,1.0,2
10785,GO:0043860,cyanophycin synthetase activity,5,0.0,1.0,1.0,2
10786,GO:0043891,glyceraldehyde-3-phosphate dehydrogenase [NAD(P)+] (phosphorylating) activity,5,0.0,1.0,1.0,2
10787,GO:0043922,negative regulation by host of viral transcription,5,0.0,1.0,1.0,1
10788,GO:0043938,positive regulation of sporulation,5,0.0,1.0,1.0,3
10789,GO:0043939,negative regulation of sporulation,5,0.0,1.0,1.0,3
10790,GO:0044010,single-species biofilm formation,5,0.0,1.0,1.0,3
10791,GO:0044038,cell wall macromolecule biosynthetic process,5,0.0,1.0,1.0,4
10792,GO:0044058,regulation of digestive system process,5,0.0,1.0,1.0,11
10793,GO:0044060,regulation of endocrine process,5,0.0,1.0,1.0,7
10794,GO:0044065,regulation of respiratory system process,5,0.0,1.0,1.0,1
10795,GO:0044067,symbiont-mediated perturbation of host cell-cell junction,5,0.0,1.0,1.0,1
10796,GO:0044068,symbiont-mediated perturbation of host cellular process,5,0.0,1.0,1.0,24
10797,GO:0044089,positive regulation of cellular component biogenesis,5,0.0,1.0,1.0,19
10798,GO:0044094,host cell nuclear part,5,0.0,1.0,1.0,8
10799,GO:0044167,host cell endoplasmic reticulum membrane,5,0.0,1.0,1.0,2
10800,GO:0044175,host cell endosome membrane,5,0.0,1.0,1.0,1
10801,GO:0044191,host cell mitochondrial membrane,5,0.0,1.0,1.0,2
10802,GO:0044200,host cell nuclear membrane,5,0.0,1.0,1.0,2
10803,GO:0044273,sulfur compound catabolic process,5,0.0,1.0,1.0,35
10804,GO:0044291,cell-cell contact zone,5,0.0,1.0,1.0,2
10805,GO:0044309,neuron spine,5,0.0,1.0,1.0,3
10806,GO:0044363,modulation of potassium channel activity in another organism,5,0.0,1.0,1.0,1
10807,GO:0044365,envenomation resulting in modulation of platelet aggregation in another organism,5,0.0,1.0,1.0,2
10808,GO:0044384,host outer membrane,5,0.0,1.0,1.0,2
10809,GO:0044469,envenomation resulting in positive regulation of blood coagulation in another organism,5,0.0,1.0,1.0,1
10810,GO:0044472,envenomation resulting in modulation of calcium channel activity in another organism,5,0.0,1.0,1.0,1
10811,GO:0044484,envenomation resulting in fibrinolysis in another organism,5,0.0,1.0,1.0,1
10812,GO:0044488,modulation of voltage-gated sodium channel activity in another organism,5,0.0,1.0,1.0,2
10813,GO:0044492,envenomation resulting in modulation of voltage-gated sodium channel activity in another organism,5,0.0,1.0,1.0,2
10814,GO:0044500,envenomation resulting in negative regulation of blood pressure in another organism,5,0.0,1.0,1.0,1
10815,GO:0044503,modulation of G protein-coupled receptor activity in another organism,5,0.0,1.0,1.0,1
10816,GO:0044507,positive regulation of receptor activity in another organism,5,0.0,1.0,1.0,1
10817,GO:0044512,envenomation resulting in modulation of glucagon-like peptide receptor 1 activity in another organism,5,0.0,1.0,1.0,1
10818,GO:0044513,envenomation resulting in modulation of G protein-coupled receptor activity in another organism,5,0.0,1.0,1.0,1
10819,GO:0044519,envenomation resulting in modulation of vasoactive intestinal polypeptide receptor activity in another organism,5,0.0,1.0,1.0,1
10820,GO:0044536,envenomation resulting in depletion of circulating fibrinogen in another organism,5,0.0,1.0,1.0,1
10821,GO:0044557,relaxation of smooth muscle,5,0.0,1.0,1.0,3
10822,GO:0044559,envenomation resulting in modulation of voltage-gated potassium channel activity in another organism,5,0.0,1.0,1.0,1
10823,GO:0044650,adhesion of symbiont to host cell,5,0.0,1.0,1.0,9
10824,GO:0044733,envenomation resulting in modulation of acid-sensing ion channel activity in another organism,5,0.0,1.0,1.0,2
10825,GO:0044737,modulation of acid-sensing ion channel in another organism,5,0.0,1.0,1.0,2
10826,GO:0044752,response to human chorionic gonadotropin,5,0.0,1.0,1.0,1
10827,GO:0044781,bacterial-type flagellum organization,5,0.0,1.0,1.0,1
10828,GO:0044788,modulation by host of viral process,5,0.0,1.0,1.0,5
10829,GO:0044853,plasma membrane raft,5,0.0,1.0,1.0,2
10830,GO:0044872,lipoprotein localization,5,0.0,1.0,1.0,2
10831,GO:0045056,transcytosis,5,0.0,1.0,1.0,3
10832,GO:0045069,regulation of viral genome replication,5,0.0,1.0,1.0,3
10833,GO:0045105,intermediate filament polymerization or depolymerization,5,0.0,1.0,1.0,2
10834,GO:0045108,regulation of intermediate filament polymerization or depolymerization,5,0.0,1.0,1.0,2
10835,GO:0045112,integrin biosynthetic process,5,0.0,1.0,1.0,1
10836,GO:0045117,azole transmembrane transport,5,0.0,1.0,1.0,5
10837,GO:0045123,cellular extravasation,5,0.0,1.0,1.0,4
10838,GO:0045125,bioactive lipid receptor activity,5,0.0,1.0,1.0,2
10839,GO:0045132,meiotic chromosome segregation,5,0.0,1.0,1.0,5
10840,GO:0045159,myosin II binding,5,0.0,1.0,1.0,2
10841,GO:0045161,neuronal ion channel clustering,5,0.0,1.0,1.0,3
10842,GO:0045168,cell-cell signaling involved in cell fate commitment,5,0.0,1.0,1.0,2
10843,GO:0045179,apical cortex,5,0.0,1.0,1.0,1
10844,GO:0045184,establishment of protein localization,5,0.0,1.0,1.0,6
10845,GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,5,0.0,1.0,1.0,2
10846,GO:0045216,cell-cell junction organization,5,0.0,1.0,1.0,7
10847,GO:0045230,capsule organization,5,0.0,1.0,1.0,2
10848,GO:0045231,slime layer organization,5,0.0,1.0,1.0,1
10849,GO:0045253,pyruvate dehydrogenase (lipoamide) phosphatase complex,5,0.0,1.0,1.0,2
10850,GO:0045290,D-arabinose 1-dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,2
10851,GO:0045299,otolith mineralization,5,0.0,1.0,1.0,2
10852,GO:0045333,cellular respiration,5,0.0,1.0,1.0,2
10853,GO:0045446,endothelial cell differentiation,5,0.0,1.0,1.0,3
10854,GO:0045460,sterigmatocystin metabolic process,5,0.0,1.0,1.0,2
10855,GO:0045471,response to ethanol,5,0.0,1.0,1.0,1
10856,GO:0045478,fusome organization,5,0.0,1.0,1.0,2
10857,GO:0045570,regulation of imaginal disc growth,5,0.0,1.0,1.0,2
10858,GO:0045576,mast cell activation,5,0.0,1.0,1.0,1
10859,GO:0045596,negative regulation of cell differentiation,5,0.0,1.0,1.0,40
10860,GO:0045610,regulation of hemocyte differentiation,5,0.0,1.0,1.0,5
10861,GO:0045661,regulation of myoblast differentiation,5,0.0,1.0,1.0,3
10862,GO:0045664,regulation of neuron differentiation,5,0.0,1.0,1.0,13
10863,GO:0045667,regulation of osteoblast differentiation,5,0.0,1.0,1.0,2
10864,GO:0045683,negative regulation of epidermis development,5,0.0,1.0,1.0,1
10865,GO:0045684,positive regulation of epidermis development,5,0.0,1.0,1.0,1
10866,GO:0045685,regulation of glial cell differentiation,5,0.0,1.0,1.0,6
10867,GO:0045688,regulation of antipodal cell differentiation,5,0.0,1.0,1.0,2
10868,GO:0045691,regulation of embryo sac central cell differentiation,5,0.0,1.0,1.0,2
10869,GO:0045694,regulation of embryo sac egg cell differentiation,5,0.0,1.0,1.0,2
10870,GO:0045697,regulation of synergid differentiation,5,0.0,1.0,1.0,2
10871,GO:0045705,negative regulation of salivary gland boundary specification,5,0.0,1.0,1.0,2
10872,GO:0045706,positive regulation of salivary gland boundary specification,5,0.0,1.0,1.0,2
10873,GO:0045707,regulation of adult salivary gland boundary specification,5,0.0,1.0,1.0,2
10874,GO:0045708,regulation of larval salivary gland boundary specification,5,0.0,1.0,1.0,2
10875,GO:0045759,negative regulation of action potential,5,0.0,1.0,1.0,4
10876,GO:0045760,positive regulation of action potential,5,0.0,1.0,1.0,4
10877,GO:0045761,regulation of adenylate cyclase activity,5,0.0,1.0,1.0,2
10878,GO:0045778,positive regulation of ossification,5,0.0,1.0,1.0,1
10879,GO:0045785,positive regulation of cell adhesion,5,0.0,1.0,1.0,4
10880,GO:0045786,negative regulation of cell cycle,5,0.0,1.0,1.0,4
10881,GO:0045787,positive regulation of cell cycle,5,0.0,1.0,1.0,4
10882,GO:0045961,"negative regulation of development, heterochronic",5,0.0,1.0,1.0,1
10883,GO:0045962,"positive regulation of development, heterochronic",5,0.0,1.0,1.0,1
10884,GO:0046158,ocellus pigment metabolic process,5,0.0,1.0,1.0,3
10885,GO:0046164,alcohol catabolic process,5,0.0,1.0,1.0,20
10886,GO:0046165,alcohol biosynthetic process,5,0.0,1.0,1.0,13
10887,GO:0046189,phenol-containing compound biosynthetic process,5,0.0,1.0,1.0,50
10888,GO:0046206,trypanothione metabolic process,5,0.0,1.0,1.0,2
10889,GO:0046215,siderophore catabolic process,5,0.0,1.0,1.0,5
10890,GO:0046224,bacteriocin metabolic process,5,0.0,1.0,1.0,2
10891,GO:0046271,phenylpropanoid catabolic process,5,0.0,1.0,1.0,8
10892,GO:0046287,isoflavonoid metabolic process,5,0.0,1.0,1.0,3
10893,GO:0046348,amino sugar catabolic process,5,0.0,1.0,1.0,7
10894,GO:0046349,amino sugar biosynthetic process,5,0.0,1.0,1.0,7
10895,GO:0046445,benzyl isoquinoline alkaloid metabolic process,5,0.0,1.0,1.0,2
10896,GO:0046447,terpenoid indole alkaloid metabolic process,5,0.0,1.0,1.0,3
10897,GO:0046449,creatinine metabolic process,5,0.0,1.0,1.0,1
10898,GO:0046454,dimethylsilanediol metabolic process,5,0.0,1.0,1.0,2
10899,GO:0046455,organosilicon catabolic process,5,0.0,1.0,1.0,2
10900,GO:0046501,protoporphyrinogen IX metabolic process,5,0.0,1.0,1.0,1
10901,GO:0046505,sulfolipid metabolic process,5,0.0,1.0,1.0,1
10902,GO:0046518,octamethylcyclotetrasiloxane metabolic process,5,0.0,1.0,1.0,1
10903,GO:0046527,glucosyltransferase activity,5,0.0,1.0,1.0,22
10904,GO:0046530,photoreceptor cell differentiation,5,0.0,1.0,1.0,2
10905,GO:0046552,photoreceptor cell fate commitment,5,0.0,1.0,1.0,2
10906,GO:0046573,lactonohydrolase activity,5,0.0,1.0,1.0,2
10907,GO:0046583,monoatomic cation efflux transmembrane transporter activity,5,0.0,1.0,1.0,1
10908,GO:0046584,enniatin metabolic process,5,0.0,1.0,1.0,1
10909,GO:0046592,polyamine oxidase activity,5,0.0,1.0,1.0,5
10910,GO:0046596,regulation of viral entry into host cell,5,0.0,1.0,1.0,3
10911,GO:0046618,xenobiotic export from cell,5,0.0,1.0,1.0,1
10912,GO:0046620,regulation of organ growth,5,0.0,1.0,1.0,3
10913,GO:0046651,lymphocyte proliferation,5,0.0,1.0,1.0,3
10914,GO:0046653,tetrahydrofolate metabolic process,5,0.0,1.0,1.0,3
10915,GO:0046662,regulation of egg-laying behavior,5,0.0,1.0,1.0,2
10916,GO:0046666,retinal cell programmed cell death,5,0.0,1.0,1.0,1
10917,GO:0046668,regulation of retinal cell programmed cell death,5,0.0,1.0,1.0,3
10918,GO:0046679,response to streptomycin,5,0.0,1.0,1.0,1
10919,GO:0046713,borate transport,5,0.0,1.0,1.0,1
10920,GO:0046717,acid secretion,5,0.0,1.0,1.0,8
10921,GO:0046718,symbiont entry into host cell,5,0.0,1.0,1.0,1
10922,GO:0046739,transport of virus in multicellular host,5,0.0,1.0,1.0,2
10923,GO:0046836,glycolipid transport,5,0.0,1.0,1.0,2
10924,GO:0046850,regulation of bone remodeling,5,0.0,1.0,1.0,3
10925,GO:0046862,chromoplast membrane,5,0.0,1.0,1.0,2
10926,GO:0046864,isoprenoid transport,5,0.0,1.0,1.0,1
10927,GO:0046873,metal ion transmembrane transporter activity,5,0.0,1.0,1.0,7
10928,GO:0046898,response to cycloheximide,5,0.0,1.0,1.0,1
10929,GO:0046900,tetrahydrofolylpolyglutamate metabolic process,5,0.0,1.0,1.0,1
10930,GO:0046942,carboxylic acid transport,5,0.0,1.0,1.0,29
10931,GO:0046967,cytosol to endoplasmic reticulum transport,5,0.0,1.0,1.0,5
10932,GO:0047484,regulation of response to osmotic stress,5,0.0,1.0,1.0,2
10933,GO:0047606,(S)-hydroxynitrile lyase activity,5,0.0,1.0,1.0,2
10934,GO:0047623,adenosine-phosphate deaminase activity,5,0.0,1.0,1.0,3
10935,GO:0047635,alanine-oxo-acid transaminase activity,5,0.0,1.0,1.0,1
10936,GO:0047936,glucose 1-dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,2
10937,GO:0047979,hexose oxidase activity,5,0.0,1.0,1.0,1
10938,GO:0048073,regulation of eye pigmentation,5,0.0,1.0,1.0,3
10939,GO:0048079,regulation of cuticle pigmentation,5,0.0,1.0,1.0,3
10940,GO:0048086,negative regulation of developmental pigmentation,5,0.0,1.0,1.0,5
10941,GO:0048087,positive regulation of developmental pigmentation,5,0.0,1.0,1.0,5
10942,GO:0048088,regulation of male pigmentation,5,0.0,1.0,1.0,2
10943,GO:0048089,regulation of female pigmentation,5,0.0,1.0,1.0,2
10944,GO:0048104,establishment of body hair or bristle planar orientation,5,0.0,1.0,1.0,2
10945,GO:0048145,regulation of fibroblast proliferation,5,0.0,1.0,1.0,4
10946,GO:0048193,Golgi vesicle transport,5,0.0,1.0,1.0,7
10947,GO:0048227,plasma membrane to endosome transport,5,0.0,1.0,1.0,1
10948,GO:0048284,organelle fusion,5,0.0,1.0,1.0,6
10949,GO:0048285,organelle fission,5,0.0,1.0,1.0,6
10950,GO:0048308,organelle inheritance,5,0.0,1.0,1.0,6
10951,GO:0048366,leaf development,5,0.0,1.0,1.0,1
10952,GO:0048444,floral organ morphogenesis,5,0.0,1.0,1.0,6
10953,GO:0048489,synaptic vesicle transport,5,0.0,1.0,1.0,1
10954,GO:0048499,synaptic vesicle membrane organization,5,0.0,1.0,1.0,1
10955,GO:0048505,regulation of timing of cell differentiation,5,0.0,1.0,1.0,2
10956,GO:0048506,regulation of timing of meristematic phase transition,5,0.0,1.0,1.0,1
10957,GO:0048508,embryonic meristem development,5,0.0,1.0,1.0,1
10958,GO:0048520,positive regulation of behavior,5,0.0,1.0,1.0,11
10959,GO:0048521,negative regulation of behavior,5,0.0,1.0,1.0,11
10960,GO:0048528,post-embryonic root development,5,0.0,1.0,1.0,1
10961,GO:0048537,mucosa-associated lymphoid tissue development,5,0.0,1.0,1.0,1
10962,GO:0048566,embryonic digestive tract development,5,0.0,1.0,1.0,1
10963,GO:0048580,regulation of post-embryonic development,5,0.0,1.0,1.0,13
10964,GO:0048586,"regulation of long-day photoperiodism, flowering",5,0.0,1.0,1.0,2
10965,GO:0048587,"regulation of short-day photoperiodism, flowering",5,0.0,1.0,1.0,2
10966,GO:0048592,eye morphogenesis,5,0.0,1.0,1.0,5
10967,GO:0048628,myoblast maturation,5,0.0,1.0,1.0,1
10968,GO:0048631,regulation of skeletal muscle tissue growth,5,0.0,1.0,1.0,2
10969,GO:0048635,negative regulation of muscle organ development,5,0.0,1.0,1.0,2
10970,GO:0048636,positive regulation of muscle organ development,5,0.0,1.0,1.0,2
10971,GO:0048639,positive regulation of developmental growth,5,0.0,1.0,1.0,19
10972,GO:0048640,negative regulation of developmental growth,5,0.0,1.0,1.0,19
10973,GO:0048660,regulation of smooth muscle cell proliferation,5,0.0,1.0,1.0,3
10974,GO:0048675,axon extension,5,0.0,1.0,1.0,2
10975,GO:0048699,generation of neurons,5,0.0,1.0,1.0,1
10976,GO:0048704,embryonic skeletal system morphogenesis,5,0.0,1.0,1.0,2
10977,GO:0048706,embryonic skeletal system development,5,0.0,1.0,1.0,1
10978,GO:0048708,astrocyte differentiation,5,0.0,1.0,1.0,2
10979,GO:0048709,oligodendrocyte differentiation,5,0.0,1.0,1.0,2
10980,GO:0048730,epidermis morphogenesis,5,0.0,1.0,1.0,1
10981,GO:0048733,sebaceous gland development,5,0.0,1.0,1.0,1
10982,GO:0048745,smooth muscle tissue development,5,0.0,1.0,1.0,3
10983,GO:0048764,trichoblast maturation,5,0.0,1.0,1.0,1
10984,GO:0048793,pronephros development,5,0.0,1.0,1.0,1
10985,GO:0048807,female genitalia morphogenesis,5,0.0,1.0,1.0,1
10986,GO:0048808,male genitalia morphogenesis,5,0.0,1.0,1.0,2
10987,GO:0048833,specification of floral organ number,5,0.0,1.0,1.0,1
10988,GO:0048844,artery morphogenesis,5,0.0,1.0,1.0,6
10989,GO:0048845,venous blood vessel morphogenesis,5,0.0,1.0,1.0,4
10990,GO:0048858,cell projection morphogenesis,5,0.0,1.0,1.0,4
10991,GO:0048873,homeostasis of number of cells within a tissue,5,0.0,1.0,1.0,2
10992,GO:0048884,neuromast development,5,0.0,1.0,1.0,2
10993,GO:0048892,lateral line nerve development,5,0.0,1.0,1.0,2
10994,GO:0048895,lateral line nerve glial cell differentiation,5,0.0,1.0,1.0,2
10995,GO:0048896,lateral line nerve glial cell migration,5,0.0,1.0,1.0,2
10996,GO:0048897,myelination of lateral line nerve axons,5,0.0,1.0,1.0,2
10997,GO:0048925,lateral line system development,5,0.0,1.0,1.0,4
10998,GO:0048934,peripheral nervous system neuron differentiation,5,0.0,1.0,1.0,1
10999,GO:0048937,lateral line nerve glial cell development,5,0.0,1.0,1.0,2
11000,GO:0050263,ribosylpyrimidine nucleosidase activity,5,0.0,1.0,1.0,1
11001,GO:0050463,nitrate reductase [NAD(P)H] activity,5,0.0,1.0,1.0,2
11002,GO:0050492,glycerol-1-phosphate dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,2
11003,GO:0050660,flavin adenine dinucleotide binding,5,0.0,1.0,1.0,2
11004,GO:0050678,regulation of epithelial cell proliferation,5,0.0,1.0,1.0,16
11005,GO:0050694,galactose 3-O-sulfotransferase activity,5,0.0,1.0,1.0,1
11006,GO:0050734,hydroxycinnamoyltransferase activity,5,0.0,1.0,1.0,2
11007,GO:0050738,fructosyltransferase activity,5,0.0,1.0,1.0,4
11008,GO:0050762,depsipeptide catabolic process,5,0.0,1.0,1.0,1
11009,GO:0050763,depsipeptide biosynthetic process,5,0.0,1.0,1.0,2
11010,GO:0050777,negative regulation of immune response,5,0.0,1.0,1.0,18
11011,GO:0050778,positive regulation of immune response,5,0.0,1.0,1.0,20
11012,GO:0050780,dopamine receptor binding,5,0.0,1.0,1.0,5
11013,GO:0050783,cocaine metabolic process,5,0.0,1.0,1.0,2
11014,GO:0050807,regulation of synapse organization,5,0.0,1.0,1.0,11
11015,GO:0050808,synapse organization,5,0.0,1.0,1.0,8
11016,GO:0050815,phosphoserine residue binding,5,0.0,1.0,1.0,1
11017,GO:0050819,negative regulation of coagulation,5,0.0,1.0,1.0,1
11018,GO:0050820,positive regulation of coagulation,5,0.0,1.0,1.0,1
11019,GO:0050826,response to freezing,5,0.0,1.0,1.0,1
11020,GO:0050846,teichuronic acid metabolic process,5,0.0,1.0,1.0,1
11021,GO:0050866,negative regulation of cell activation,5,0.0,1.0,1.0,6
11022,GO:0050867,positive regulation of cell activation,5,0.0,1.0,1.0,6
11023,GO:0050872,white fat cell differentiation,5,0.0,1.0,1.0,1
11024,GO:0050881,musculoskeletal movement,5,0.0,1.0,1.0,2
11025,GO:0050893,sensory processing,5,0.0,1.0,1.0,4
11026,GO:0050904,diapedesis,5,0.0,1.0,1.0,1
11027,GO:0050912,detection of chemical stimulus involved in sensory perception of taste,5,0.0,1.0,1.0,5
11028,GO:0050920,regulation of chemotaxis,5,0.0,1.0,1.0,15
11029,GO:0050932,regulation of pigment cell differentiation,5,0.0,1.0,1.0,8
11030,GO:0050951,sensory perception of temperature stimulus,5,0.0,1.0,1.0,1
11031,GO:0050952,sensory perception of electrical stimulus,5,0.0,1.0,1.0,2
11032,GO:0050953,sensory perception of light stimulus,5,0.0,1.0,1.0,1
11033,GO:0050954,sensory perception of mechanical stimulus,5,0.0,1.0,1.0,4
11034,GO:0050958,magnetoreception,5,0.0,1.0,1.0,3
11035,GO:0050961,detection of temperature stimulus involved in sensory perception,5,0.0,1.0,1.0,2
11036,GO:0050963,detection of electrical stimulus involved in sensory perception,5,0.0,1.0,1.0,3
11037,GO:0050974,detection of mechanical stimulus involved in sensory perception,5,0.0,1.0,1.0,8
11038,GO:0051015,actin filament binding,5,0.0,1.0,1.0,1
11039,GO:0051033,RNA transmembrane transporter activity,5,0.0,1.0,1.0,1
11040,GO:0051046,regulation of secretion,5,0.0,1.0,1.0,14
11041,GO:0051051,negative regulation of transport,5,0.0,1.0,1.0,39
11042,GO:0051096,positive regulation of helicase activity,5,0.0,1.0,1.0,1
11043,GO:0051129,negative regulation of cellular component organization,5,0.0,1.0,1.0,38
11044,GO:0051130,positive regulation of cellular component organization,5,0.0,1.0,1.0,41
11045,GO:0051145,smooth muscle cell differentiation,5,0.0,1.0,1.0,5
11046,GO:0051146,striated muscle cell differentiation,5,0.0,1.0,1.0,2
11047,GO:0051147,regulation of muscle cell differentiation,5,0.0,1.0,1.0,4
11048,GO:0051156,glucose 6-phosphate metabolic process,5,0.0,1.0,1.0,3
11049,GO:0051166,"2,5-dihydroxypyridine catabolic process",5,0.0,1.0,1.0,1
11050,GO:0051167,xylulose 5-phosphate metabolic process,5,0.0,1.0,1.0,2
11051,GO:0051169,nuclear transport,5,0.0,1.0,1.0,1
11052,GO:0051174,regulation of phosphorus metabolic process,5,0.0,1.0,1.0,5
11053,GO:0051255,spindle midzone assembly,5,0.0,1.0,1.0,2
11054,GO:0051276,chromosome organization,5,0.0,1.0,1.0,18
11055,GO:0051283,negative regulation of sequestering of calcium ion,5,0.0,1.0,1.0,1
11056,GO:0051284,positive regulation of sequestering of calcium ion,5,0.0,1.0,1.0,1
11057,GO:0051285,cell cortex of cell tip,5,0.0,1.0,1.0,2
11058,GO:0051300,spindle pole body organization,5,0.0,1.0,1.0,3
11059,GO:0051310,metaphase chromosome alignment,5,0.0,1.0,1.0,2
11060,GO:0051342,regulation of cyclic-nucleotide phosphodiesterase activity,5,0.0,1.0,1.0,2
11061,GO:0051346,negative regulation of hydrolase activity,5,0.0,1.0,1.0,9
11062,GO:0051347,positive regulation of transferase activity,5,0.0,1.0,1.0,12
11063,GO:0051348,negative regulation of transferase activity,5,0.0,1.0,1.0,11
11064,GO:0051349,positive regulation of lyase activity,5,0.0,1.0,1.0,4
11065,GO:0051350,negative regulation of lyase activity,5,0.0,1.0,1.0,4
11066,GO:0051351,positive regulation of ligase activity,5,0.0,1.0,1.0,3
11067,GO:0051353,positive regulation of oxidoreductase activity,5,0.0,1.0,1.0,9
11068,GO:0051354,negative regulation of oxidoreductase activity,5,0.0,1.0,1.0,5
11069,GO:0051377,mannose-ethanolamine phosphotransferase activity,5,0.0,1.0,1.0,1
11070,GO:0051393,alpha-actinin binding,5,0.0,1.0,1.0,1
11071,GO:0051402,neuron apoptotic process,5,0.0,1.0,1.0,5
11072,GO:0051428,peptide hormone receptor binding,5,0.0,1.0,1.0,4
11073,GO:0051438,regulation of ubiquitin-protein transferase activity,5,0.0,1.0,1.0,3
11074,GO:0051445,regulation of meiotic cell cycle,5,0.0,1.0,1.0,6
11075,GO:0051451,myoblast migration,5,0.0,1.0,1.0,1
11076,GO:0051467,detection of steroid hormone stimulus,5,0.0,1.0,1.0,1
11077,GO:0051553,flavone biosynthetic process,5,0.0,1.0,1.0,5
11078,GO:0051554,flavonol metabolic process,5,0.0,1.0,1.0,1
11079,GO:0051556,leucoanthocyanidin metabolic process,5,0.0,1.0,1.0,1
11080,GO:0051588,regulation of neurotransmitter transport,5,0.0,1.0,1.0,5
11081,GO:0051591,response to cAMP,5,0.0,1.0,1.0,2
11082,GO:0051593,response to folic acid,5,0.0,1.0,1.0,3
11083,GO:0051595,response to methylglyoxal,5,0.0,1.0,1.0,1
11084,GO:0051599,response to hydrostatic pressure,5,0.0,1.0,1.0,1
11085,GO:0051604,protein maturation,5,0.0,1.0,1.0,13
11086,GO:0051608,histamine transport,5,0.0,1.0,1.0,2
11087,GO:0051621,regulation of norepinephrine uptake,5,0.0,1.0,1.0,2
11088,GO:0051626,regulation of epinephrine uptake,5,0.0,1.0,1.0,2
11089,GO:0051655,maintenance of vesicle location,5,0.0,1.0,1.0,2
11090,GO:0051658,maintenance of nucleus location,5,0.0,1.0,1.0,1
11091,GO:0051685,maintenance of ER location,5,0.0,1.0,1.0,1
11092,GO:0051709,regulation of killing of cells of another organism,5,0.0,1.0,1.0,5
11093,GO:0051715,cytolysis in another organism,5,0.0,1.0,1.0,2
11094,GO:0051723,protein methylesterase activity,5,0.0,1.0,1.0,3
11095,GO:0051781,positive regulation of cell division,5,0.0,1.0,1.0,5
11096,GO:0051782,negative regulation of cell division,5,0.0,1.0,1.0,5
11097,GO:0051794,regulation of timing of catagen,5,0.0,1.0,1.0,2
11098,GO:0051797,regulation of hair follicle development,5,0.0,1.0,1.0,2
11099,GO:0051880,G-quadruplex DNA binding,5,0.0,1.0,1.0,1
11100,GO:0051884,regulation of timing of anagen,5,0.0,1.0,1.0,2
11101,GO:0051887,regulation of timing of exogen,5,0.0,1.0,1.0,2
11102,GO:0051900,regulation of mitochondrial depolarization,5,0.0,1.0,1.0,2
11103,GO:0051903,S-(hydroxymethyl)glutathione dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,2
11104,GO:0051905,establishment of pigment granule localization,5,0.0,1.0,1.0,4
11105,GO:0051920,peroxiredoxin activity,5,0.0,1.0,1.0,2
11106,GO:0051952,regulation of amine transport,5,0.0,1.0,1.0,7
11107,GO:0051960,regulation of nervous system development,5,0.0,1.0,1.0,4
11108,GO:0051995,Se-methyltransferase activity,5,0.0,1.0,1.0,1
11109,GO:0052031,symbiont-mediated perturbation of host defense response,5,0.0,1.0,1.0,7
11110,GO:0052039,symbiont-mediated perturbation of host cytoskeleton,5,0.0,1.0,1.0,2
11111,GO:0052041,symbiont-mediated suppression of host programmed cell death,5,0.0,1.0,1.0,2
11112,GO:0052042,symbiont-mediated activation of host programmed cell death,5,0.0,1.0,1.0,3
11113,GO:0052091,modulation of nutrient release by host,5,0.0,1.0,1.0,1
11114,GO:0052173,response to defenses of other organism,5,0.0,1.0,1.0,1
11115,GO:0052314,phytoalexin metabolic process,5,0.0,1.0,1.0,5
11116,GO:0052422,modulation by host of symbiont catalytic activity,5,0.0,1.0,1.0,2
11117,GO:0052460,modulation of nutrient release by symbiont,5,0.0,1.0,1.0,1
11118,GO:0052542,defense response by callose deposition,5,0.0,1.0,1.0,1
11119,GO:0052553,symbiont-mediated perturbation of host immune response,5,0.0,1.0,1.0,7
11120,GO:0052562,symbiont-mediated suppression of host immune response,5,0.0,1.0,1.0,3
11121,GO:0052595,aliphatic amine oxidase activity,5,0.0,1.0,1.0,2
11122,GO:0052597,diamine oxidase activity,5,0.0,1.0,1.0,3
11123,GO:0052636,arabinosyltransferase activity,5,0.0,1.0,1.0,2
11124,GO:0052646,alditol phosphate metabolic process,5,0.0,1.0,1.0,3
11125,GO:0052673,prenol kinase activity,5,0.0,1.0,1.0,4
11126,GO:0052702,modified histidine catabolic process,5,0.0,1.0,1.0,1
11127,GO:0052703,modified histidine biosynthetic process,5,0.0,1.0,1.0,2
11128,GO:0052736,beta-glucanase activity,5,0.0,1.0,1.0,3
11129,GO:0052778,diacetylchitobiose metabolic process,5,0.0,1.0,1.0,1
11130,GO:0052780,chitobiose metabolic process,5,0.0,1.0,1.0,1
11131,GO:0052782,amino disaccharide catabolic process,5,0.0,1.0,1.0,2
11132,GO:0052801,bicyclic nitroimidazole metabolic process,5,0.0,1.0,1.0,1
11133,GO:0052804,nitroimidazole catabolic process,5,0.0,1.0,1.0,1
11134,GO:0052863,1-deoxy-D-xylulose 5-phosphate metabolic process,5,0.0,1.0,1.0,2
11135,GO:0055002,striated muscle cell development,5,0.0,1.0,1.0,2
11136,GO:0055008,cardiac muscle tissue morphogenesis,5,0.0,1.0,1.0,2
11137,GO:0055035,plastid thylakoid membrane,5,0.0,1.0,1.0,3
11138,GO:0055064,chloride ion homeostasis,5,0.0,1.0,1.0,1
11139,GO:0055070,copper ion homeostasis,5,0.0,1.0,1.0,1
11140,GO:0055071,manganese ion homeostasis,5,0.0,1.0,1.0,1
11141,GO:0055074,calcium ion homeostasis,5,0.0,1.0,1.0,1
11142,GO:0055075,potassium ion homeostasis,5,0.0,1.0,1.0,1
11143,GO:0055078,sodium ion homeostasis,5,0.0,1.0,1.0,1
11144,GO:0055086,nucleobase-containing small molecule metabolic process,5,0.0,1.0,1.0,6
11145,GO:0055093,response to hyperoxia,5,0.0,1.0,1.0,1
11146,GO:0060009,Sertoli cell development,5,0.0,1.0,1.0,1
11147,GO:0060018,astrocyte fate commitment,5,0.0,1.0,1.0,1
11148,GO:0060019,radial glial cell differentiation,5,0.0,1.0,1.0,2
11149,GO:0060026,convergent extension,5,0.0,1.0,1.0,3
11150,GO:0060079,excitatory postsynaptic potential,5,0.0,1.0,1.0,2
11151,GO:0060119,inner ear receptor cell development,5,0.0,1.0,1.0,2
11152,GO:0060120,inner ear receptor cell fate commitment,5,0.0,1.0,1.0,2
11153,GO:0060142,regulation of syncytium formation by plasma membrane fusion,5,0.0,1.0,1.0,4
11154,GO:0060170,ciliary membrane,5,0.0,1.0,1.0,4
11155,GO:0060179,male mating behavior,5,0.0,1.0,1.0,5
11156,GO:0060180,female mating behavior,5,0.0,1.0,1.0,2
11157,GO:0060205,cytoplasmic vesicle lumen,5,0.0,1.0,1.0,17
11158,GO:0060222,regulation of retinal cone cell fate commitment,5,0.0,1.0,1.0,2
11159,GO:0060231,mesenchymal to epithelial transition,5,0.0,1.0,1.0,3
11160,GO:0060251,regulation of glial cell proliferation,5,0.0,1.0,1.0,3
11161,GO:0060258,negative regulation of filamentous growth,5,0.0,1.0,1.0,1
11162,GO:0060259,regulation of feeding behavior,5,0.0,1.0,1.0,4
11163,GO:0060263,regulation of respiratory burst,5,0.0,1.0,1.0,3
11164,GO:0060284,regulation of cell development,5,0.0,1.0,1.0,25
11165,GO:0060294,cilium movement involved in cell motility,5,0.0,1.0,1.0,1
11166,GO:0060312,regulation of blood vessel remodeling,5,0.0,1.0,1.0,3
11167,GO:0060327,cytoplasmic actin-based contraction involved in cell motility,5,0.0,1.0,1.0,3
11168,GO:0060350,endochondral bone morphogenesis,5,0.0,1.0,1.0,1
11169,GO:0060351,cartilage development involved in endochondral bone morphogenesis,5,0.0,1.0,1.0,1
11170,GO:0060416,response to growth hormone,5,0.0,1.0,1.0,1
11171,GO:0060423,foregut regionalization,5,0.0,1.0,1.0,1
11172,GO:0060428,lung epithelium development,5,0.0,1.0,1.0,3
11173,GO:0060433,bronchus development,5,0.0,1.0,1.0,1
11174,GO:0060467,negative regulation of fertilization,5,0.0,1.0,1.0,1
11175,GO:0060484,lung-associated mesenchyme development,5,0.0,1.0,1.0,1
11176,GO:0060487,lung epithelial cell differentiation,5,0.0,1.0,1.0,4
11177,GO:0060495,cell-cell signaling involved in lung development,5,0.0,1.0,1.0,3
11178,GO:0060497,mesenchymal-endodermal cell signaling,5,0.0,1.0,1.0,1
11179,GO:0060538,skeletal muscle organ development,5,0.0,1.0,1.0,3
11180,GO:0060562,epithelial tube morphogenesis,5,0.0,1.0,1.0,8
11181,GO:0060571,morphogenesis of an epithelial fold,5,0.0,1.0,1.0,10
11182,GO:0060584,regulation of prostaglandin-endoperoxide synthase activity,5,0.0,1.0,1.0,1
11183,GO:0060600,dichotomous subdivision of an epithelial terminal unit,5,0.0,1.0,1.0,5
11184,GO:0060601,lateral sprouting from an epithelium,5,0.0,1.0,1.0,4
11185,GO:0060602,branch elongation of an epithelium,5,0.0,1.0,1.0,7
11186,GO:0060608,cell-cell adhesion involved in neural tube closure,5,0.0,1.0,1.0,1
11187,GO:0060612,adipose tissue development,5,0.0,1.0,1.0,2
11188,GO:0060627,regulation of vesicle-mediated transport,5,0.0,1.0,1.0,12
11189,GO:0060632,regulation of microtubule-based movement,5,0.0,1.0,1.0,7
11190,GO:0060638,mesenchymal-epithelial cell signaling,5,0.0,1.0,1.0,7
11191,GO:0060644,mammary gland epithelial cell differentiation,5,0.0,1.0,1.0,3
11192,GO:0060684,epithelial-mesenchymal cell signaling,5,0.0,1.0,1.0,3
11193,GO:0060688,regulation of morphogenesis of a branching structure,5,0.0,1.0,1.0,10
11194,GO:0060690,epithelial cell differentiation involved in salivary gland development,5,0.0,1.0,1.0,1
11195,GO:0060723,regulation of cell proliferation involved in embryonic placenta development,5,0.0,1.0,1.0,1
11196,GO:0060737,prostate gland morphogenetic growth,5,0.0,1.0,1.0,2
11197,GO:0060740,prostate gland epithelium morphogenesis,5,0.0,1.0,1.0,5
11198,GO:0060742,epithelial cell differentiation involved in prostate gland development,5,0.0,1.0,1.0,3
11199,GO:0060760,positive regulation of response to cytokine stimulus,5,0.0,1.0,1.0,3
11200,GO:0060761,negative regulation of response to cytokine stimulus,5,0.0,1.0,1.0,3
11201,GO:0060771,phyllotactic patterning,5,0.0,1.0,1.0,3
11202,GO:0060800,regulation of cell differentiation involved in embryonic placenta development,5,0.0,1.0,1.0,1
11203,GO:0060810,intracellular mRNA localization involved in pattern specification process,5,0.0,1.0,1.0,1
11204,GO:0060839,endothelial cell fate commitment,5,0.0,1.0,1.0,3
11205,GO:0060884,clearance of cells from fusion plate,5,0.0,1.0,1.0,2
11206,GO:0060918,auxin transport,5,0.0,1.0,1.0,4
11207,GO:0060923,cardiac muscle cell fate commitment,5,0.0,1.0,1.0,3
11208,GO:0060935,cardiac fibroblast cell differentiation,5,0.0,1.0,1.0,2
11209,GO:0060936,cardiac fibroblast cell development,5,0.0,1.0,1.0,2
11210,GO:0060937,cardiac fibroblast cell fate commitment,5,0.0,1.0,1.0,2
11211,GO:0060950,cardiac glial cell differentiation,5,0.0,1.0,1.0,1
11212,GO:0060952,cardiac glial cell development,5,0.0,1.0,1.0,1
11213,GO:0060953,cardiac glial cell fate commitment,5,0.0,1.0,1.0,1
11214,GO:0060974,cell migration involved in heart formation,5,0.0,1.0,1.0,2
11215,GO:0060977,coronary vasculature morphogenesis,5,0.0,1.0,1.0,2
11216,GO:0060995,cell-cell signaling involved in kidney development,5,0.0,1.0,1.0,3
11217,GO:0060999,positive regulation of dendritic spine development,5,0.0,1.0,1.0,1
11218,GO:0061000,negative regulation of dendritic spine development,5,0.0,1.0,1.0,1
11219,GO:0061025,membrane fusion,5,0.0,1.0,1.0,4
11220,GO:0061035,regulation of cartilage development,5,0.0,1.0,1.0,3
11221,GO:0061083,regulation of protein refolding,5,0.0,1.0,1.0,2
11222,GO:0061133,endopeptidase activator activity,5,0.0,1.0,1.0,1
11223,GO:0061138,morphogenesis of a branching epithelium,5,0.0,1.0,1.0,6
11224,GO:0061168,regulation of hair follicle placode formation,5,0.0,1.0,1.0,2
11225,GO:0061208,cell differentiation involved in mesonephros development,5,0.0,1.0,1.0,9
11226,GO:0061217,regulation of mesonephros development,5,0.0,1.0,1.0,5
11227,GO:0061269,mesonephric glomerular mesangial cell proliferation involved in mesonephros development,5,0.0,1.0,1.0,1
11228,GO:0061282,specification of mesonephric nephron tubule identity,5,0.0,1.0,1.0,3
11229,GO:0061319,nephrocyte differentiation,5,0.0,1.0,1.0,3
11230,GO:0061326,renal tubule development,5,0.0,1.0,1.0,2
11231,GO:0061437,renal system vasculature development,5,0.0,1.0,1.0,1
11232,GO:0061515,myeloid cell development,5,0.0,1.0,1.0,4
11233,GO:0061550,cranial ganglion development,5,0.0,1.0,1.0,3
11234,GO:0061558,cranial ganglion maturation,5,0.0,1.0,1.0,1
11235,GO:0061559,cranial ganglion morphogenesis,5,0.0,1.0,1.0,2
11236,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,5,0.0,1.0,1.0,6
11237,GO:0061642,chemoattraction of axon,5,0.0,1.0,1.0,3
11238,GO:0061643,chemorepulsion of axon,5,0.0,1.0,1.0,3
11239,GO:0061691,detoxification of hydrogen peroxide,5,0.0,1.0,1.0,1
11240,GO:0061731,ribonucleoside-diphosphate reductase activity,5,0.0,1.0,1.0,2
11241,GO:0061756,leukocyte adhesion to vascular endothelial cell,5,0.0,1.0,1.0,4
11242,GO:0061785,peptidoglycan endopeptidase activity,5,0.0,1.0,1.0,2
11243,GO:0061847,response to cholecystokinin,5,0.0,1.0,1.0,1
11244,GO:0061940,regulation of c-di-GMP signaling,5,0.0,1.0,1.0,2
11245,GO:0061973,membrane bone morphogenesis,5,0.0,1.0,1.0,2
11246,GO:0061975,articular cartilage development,5,0.0,1.0,1.0,2
11247,GO:0061980,regulatory RNA binding,5,0.0,1.0,1.0,3
11248,GO:0061984,catabolite repression,5,0.0,1.0,1.0,2
11249,GO:0061999,regulation of cardiac endothelial to mesenchymal transition,5,0.0,1.0,1.0,2
11250,GO:0062002,"regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity",5,0.0,1.0,1.0,1
11251,GO:0062012,regulation of small molecule metabolic process,5,0.0,1.0,1.0,64
11252,GO:0062080,inhibitory MHC class Ib receptor activity,5,0.0,1.0,1.0,2
11253,GO:0062098,regulation of programmed necrotic cell death,5,0.0,1.0,1.0,3
11254,GO:0062186,anandamide epoxidase activity,5,0.0,1.0,1.0,3
11255,GO:0062224,positive regulation of somatic muscle development,5,0.0,1.0,1.0,2
11256,GO:0062225,negative regulation of somatic muscle development,5,0.0,1.0,1.0,2
11257,GO:0062226,regulation of adult somatic muscle development,5,0.0,1.0,1.0,2
11258,GO:0062229,regulation of larval somatic muscle development,5,0.0,1.0,1.0,2
11259,GO:0065003,protein-containing complex assembly,5,0.0,1.0,1.0,98
11260,GO:0070004,cysteine-type exopeptidase activity,5,0.0,1.0,1.0,2
11261,GO:0070008,serine-type exopeptidase activity,5,0.0,1.0,1.0,3
11262,GO:0070160,tight junction,5,0.0,1.0,1.0,3
11263,GO:0070167,regulation of biomineral tissue development,5,0.0,1.0,1.0,5
11264,GO:0070269,pyroptotic inflammatory response,5,0.0,1.0,1.0,1
11265,GO:0070305,response to cGMP,5,0.0,1.0,1.0,1
11266,GO:0070336,flap-structured DNA binding,5,0.0,1.0,1.0,2
11267,GO:0070344,regulation of fat cell proliferation,5,0.0,1.0,1.0,4
11268,GO:0070391,response to lipoteichoic acid,5,0.0,1.0,1.0,2
11269,GO:0070393,teichoic acid catabolic process,5,0.0,1.0,1.0,1
11270,GO:0070394,lipoteichoic acid metabolic process,5,0.0,1.0,1.0,2
11271,GO:0070397,wall teichoic acid metabolic process,5,0.0,1.0,1.0,2
11272,GO:0070408,carbamoyl phosphate metabolic process,5,0.0,1.0,1.0,1
11273,GO:0070417,cellular response to cold,5,0.0,1.0,1.0,2
11274,GO:0070486,leukocyte aggregation,5,0.0,1.0,1.0,3
11275,GO:0070501,poly-gamma-glutamate biosynthetic process,5,0.0,1.0,1.0,1
11276,GO:0070529,L-tryptophan aminotransferase activity,5,0.0,1.0,1.0,2
11277,GO:0070543,response to linoleic acid,5,0.0,1.0,1.0,1
11278,GO:0070548,L-glutamine aminotransferase activity,5,0.0,1.0,1.0,4
11279,GO:0070555,response to interleukin-1,5,0.0,1.0,1.0,1
11280,GO:0070566,adenylyltransferase activity,5,0.0,1.0,1.0,21
11281,GO:0070567,cytidylyltransferase activity,5,0.0,1.0,1.0,16
11282,GO:0070568,guanylyltransferase activity,5,0.0,1.0,1.0,16
11283,GO:0070569,uridylyltransferase activity,5,0.0,1.0,1.0,7
11284,GO:0070586,cell-cell adhesion involved in gastrulation,5,0.0,1.0,1.0,1
11285,GO:0070590,spore wall biogenesis,5,0.0,1.0,1.0,1
11286,GO:0070663,regulation of leukocyte proliferation,5,0.0,1.0,1.0,6
11287,GO:0070669,response to interleukin-2,5,0.0,1.0,1.0,1
11288,GO:0070670,response to interleukin-4,5,0.0,1.0,1.0,1
11289,GO:0070671,response to interleukin-12,5,0.0,1.0,1.0,1
11290,GO:0070672,response to interleukin-15,5,0.0,1.0,1.0,1
11291,GO:0070673,response to interleukin-18,5,0.0,1.0,1.0,1
11292,GO:0070696,transmembrane receptor protein serine/threonine kinase binding,5,0.0,1.0,1.0,2
11293,GO:0070723,response to cholesterol,5,0.0,1.0,1.0,1
11294,GO:0070735,protein-glycine ligase activity,5,0.0,1.0,1.0,3
11295,GO:0070739,protein-glutamic acid ligase activity,5,0.0,1.0,1.0,4
11296,GO:0070741,response to interleukin-6,5,0.0,1.0,1.0,1
11297,GO:0070781,response to biotin,5,0.0,1.0,1.0,1
11298,GO:0070793,regulation of conidiophore development,5,0.0,1.0,1.0,3
11299,GO:0070815,peptidyl-lysine 5-dioxygenase activity,5,0.0,1.0,1.0,1
11300,GO:0070828,heterochromatin organization,5,0.0,1.0,1.0,1
11301,GO:0070841,inclusion body assembly,5,0.0,1.0,1.0,3
11302,GO:0070853,myosin VI binding,5,0.0,1.0,1.0,2
11303,GO:0070883,pre-miRNA binding,5,0.0,1.0,1.0,1
11304,GO:0070918,regulatory ncRNA processing,5,0.0,1.0,1.0,5
11305,GO:0070925,organelle assembly,5,0.0,1.0,1.0,18
11306,GO:0071104,response to interleukin-9,5,0.0,1.0,1.0,1
11307,GO:0071105,response to interleukin-11,5,0.0,1.0,1.0,1
11308,GO:0071219,cellular response to molecule of bacterial origin,5,0.0,1.0,1.0,4
11309,GO:0071230,cellular response to amino acid stimulus,5,0.0,1.0,1.0,18
11310,GO:0071272,morphine metabolic process,5,0.0,1.0,1.0,2
11311,GO:0071274,isoquinoline alkaloid catabolic process,5,0.0,1.0,1.0,2
11312,GO:0071281,cellular response to iron ion,5,0.0,1.0,1.0,2
11313,GO:0071287,cellular response to manganese ion,5,0.0,1.0,1.0,1
11314,GO:0071295,cellular response to vitamin,5,0.0,1.0,1.0,12
11315,GO:0071312,cellular response to alkaloid,5,0.0,1.0,1.0,6
11316,GO:0071322,cellular response to carbohydrate stimulus,5,0.0,1.0,1.0,5
11317,GO:0071336,regulation of hair follicle cell proliferation,5,0.0,1.0,1.0,2
11318,GO:0071345,cellular response to cytokine stimulus,5,0.0,1.0,1.0,28
11319,GO:0071359,cellular response to dsRNA,5,0.0,1.0,1.0,1
11320,GO:0071362,cellular response to ether,5,0.0,1.0,1.0,7
11321,GO:0071365,cellular response to auxin stimulus,5,0.0,1.0,1.0,1
11322,GO:0071371,cellular response to gonadotropin stimulus,5,0.0,1.0,1.0,3
11323,GO:0071375,cellular response to peptide hormone stimulus,5,0.0,1.0,1.0,14
11324,GO:0071379,cellular response to prostaglandin stimulus,5,0.0,1.0,1.0,4
11325,GO:0071383,cellular response to steroid hormone stimulus,5,0.0,1.0,1.0,2
11326,GO:0071404,cellular response to low-density lipoprotein particle stimulus,5,0.0,1.0,1.0,1
11327,GO:0071415,cellular response to purine-containing compound,5,0.0,1.0,1.0,3
11328,GO:0071418,cellular response to amine stimulus,5,0.0,1.0,1.0,4
11329,GO:0071462,cellular response to water stimulus,5,0.0,1.0,1.0,3
11330,GO:0071467,cellular response to pH,5,0.0,1.0,1.0,3
11331,GO:0071470,cellular response to osmotic stress,5,0.0,1.0,1.0,6
11332,GO:0071478,cellular response to radiation,5,0.0,1.0,1.0,2
11333,GO:0071499,cellular response to laminar fluid shear stress,5,0.0,1.0,1.0,1
11334,GO:0071500,cellular response to nitrosative stress,5,0.0,1.0,1.0,1
11335,GO:0071542,dopaminergic neuron differentiation,5,0.0,1.0,1.0,1
11336,GO:0071553,G protein-coupled pyrimidinergic nucleotide receptor activity,5,0.0,1.0,1.0,2
11337,GO:0071555,cell wall organization,5,0.0,1.0,1.0,8
11338,GO:0071617,lysophospholipid acyltransferase activity,5,0.0,1.0,1.0,2
11339,GO:0071674,mononuclear cell migration,5,0.0,1.0,1.0,6
11340,GO:0071680,response to indole-3-methanol,5,0.0,1.0,1.0,1
11341,GO:0071682,endocytic vesicle lumen,5,0.0,1.0,1.0,2
11342,GO:0071692,protein localization to extracellular region,5,0.0,1.0,1.0,1
11343,GO:0071709,membrane assembly,5,0.0,1.0,1.0,7
11344,GO:0071749,polymeric IgA immunoglobulin complex,5,0.0,1.0,1.0,2
11345,GO:0071763,nuclear membrane organization,5,0.0,1.0,1.0,7
11346,GO:0071798,response to prostaglandin D,5,0.0,1.0,1.0,1
11347,GO:0071823,protein-carbohydrate complex subunit organization,5,0.0,1.0,1.0,1
11348,GO:0071824,protein-DNA complex organization,5,0.0,1.0,1.0,4
11349,GO:0071826,protein-RNA complex organization,5,0.0,1.0,1.0,3
11350,GO:0071855,neuropeptide receptor binding,5,0.0,1.0,1.0,24
11351,GO:0071863,regulation of cell proliferation in bone marrow,5,0.0,1.0,1.0,2
11352,GO:0071868,cellular response to monoamine stimulus,5,0.0,1.0,1.0,2
11353,GO:0071869,response to catecholamine,5,0.0,1.0,1.0,4
11354,GO:0071887,leukocyte apoptotic process,5,0.0,1.0,1.0,5
11355,GO:0071916,dipeptide transmembrane transporter activity,5,0.0,1.0,1.0,3
11356,GO:0071973,bacterial-type flagellum-dependent cell motility,5,0.0,1.0,1.0,2
11357,GO:0071985,multivesicular body sorting pathway,5,0.0,1.0,1.0,1
11358,GO:0072004,kidney field specification,5,0.0,1.0,1.0,1
11359,GO:0072007,mesangial cell differentiation,5,0.0,1.0,1.0,3
11360,GO:0072038,mesenchymal stem cell maintenance involved in nephron morphogenesis,5,0.0,1.0,1.0,2
11361,GO:0072046,establishment of planar polarity involved in nephron morphogenesis,5,0.0,1.0,1.0,2
11362,GO:0072047,proximal/distal pattern formation involved in nephron development,5,0.0,1.0,1.0,3
11363,GO:0072052,juxtaglomerulus cell differentiation,5,0.0,1.0,1.0,2
11364,GO:0072069,DCT cell differentiation,5,0.0,1.0,1.0,1
11365,GO:0072071,kidney interstitial fibroblast differentiation,5,0.0,1.0,1.0,2
11366,GO:0072073,kidney epithelium development,5,0.0,1.0,1.0,5
11367,GO:0072074,kidney mesenchyme development,5,0.0,1.0,1.0,4
11368,GO:0072077,renal vesicle morphogenesis,5,0.0,1.0,1.0,2
11369,GO:0072082,specification of proximal tubule identity,5,0.0,1.0,1.0,3
11370,GO:0072084,specification of distal tubule identity,5,0.0,1.0,1.0,3
11371,GO:0072085,specification of connecting tubule identity,5,0.0,1.0,1.0,2
11372,GO:0072086,specification of loop of Henle identity,5,0.0,1.0,1.0,1
11373,GO:0072088,nephron epithelium morphogenesis,5,0.0,1.0,1.0,1
11374,GO:0072091,regulation of stem cell proliferation,5,0.0,1.0,1.0,4
11375,GO:0072095,regulation of branch elongation involved in ureteric bud branching,5,0.0,1.0,1.0,1
11376,GO:0072098,anterior/posterior pattern specification involved in kidney development,5,0.0,1.0,1.0,4
11377,GO:0072103,glomerulus vasculature morphogenesis,5,0.0,1.0,1.0,2
11378,GO:0072109,glomerular mesangium development,5,0.0,1.0,1.0,2
11379,GO:0072114,pronephros morphogenesis,5,0.0,1.0,1.0,1
11380,GO:0072120,pronephros maturation,5,0.0,1.0,1.0,1
11381,GO:0072123,intraglomerular mesangial cell proliferation,5,0.0,1.0,1.0,2
11382,GO:0072127,renal capsule development,5,0.0,1.0,1.0,2
11383,GO:0072131,kidney mesenchyme morphogenesis,5,0.0,1.0,1.0,3
11384,GO:0072144,glomerular mesangial cell development,5,0.0,1.0,1.0,2
11385,GO:0072152,glomerular mesangial cell fate commitment,5,0.0,1.0,1.0,2
11386,GO:0072167,specification of mesonephric tubule identity,5,0.0,1.0,1.0,2
11387,GO:0072174,metanephric tubule formation,5,0.0,1.0,1.0,1
11388,GO:0072179,nephric duct formation,5,0.0,1.0,1.0,1
11389,GO:0072202,cell differentiation involved in metanephros development,5,0.0,1.0,1.0,9
11390,GO:0072215,regulation of metanephros development,5,0.0,1.0,1.0,3
11391,GO:0072262,metanephric glomerular mesangial cell proliferation involved in metanephros development,5,0.0,1.0,1.0,1
11392,GO:0072293,specification of metanephric nephron tubule identity,5,0.0,1.0,1.0,4
11393,GO:0072310,glomerular epithelial cell development,5,0.0,1.0,1.0,4
11394,GO:0072314,glomerular epithelial cell fate commitment,5,0.0,1.0,1.0,4
11395,GO:0072337,modified amino acid transport,5,0.0,1.0,1.0,12
11396,GO:0072339,lactam biosynthetic process,5,0.0,1.0,1.0,6
11397,GO:0072340,lactam catabolic process,5,0.0,1.0,1.0,5
11398,GO:0072390,phenol metabolic process,5,0.0,1.0,1.0,2
11399,GO:0072402,response to DNA integrity checkpoint signaling,5,0.0,1.0,1.0,3
11400,GO:0072410,response to meiotic cell cycle checkpoint signaling,5,0.0,1.0,1.0,3
11401,GO:0072414,response to mitotic cell cycle checkpoint signaling,5,0.0,1.0,1.0,6
11402,GO:0072417,response to spindle checkpoint signaling,5,0.0,1.0,1.0,2
11403,GO:0072491,toluene-containing compound catabolic process,5,0.0,1.0,1.0,7
11404,GO:0072497,mesenchymal stem cell differentiation,5,0.0,1.0,1.0,2
11405,GO:0072530,purine-containing compound transmembrane transport,5,0.0,1.0,1.0,12
11406,GO:0072531,pyrimidine-containing compound transmembrane transport,5,0.0,1.0,1.0,4
11407,GO:0072532,tri-(feruloyl or hydroxyferuloyl) spermidine meta-hydroxylase activity,5,0.0,1.0,1.0,3
11408,GO:0072533,tri-(coumaroyl or caffeoyl) spermidine meta-hydroxylase activity,5,0.0,1.0,1.0,3
11409,GO:0072542,protein phosphatase activator activity,5,0.0,1.0,1.0,1
11410,GO:0072570,ADP-D-ribose binding,5,0.0,1.0,1.0,1
11411,GO:0072595,maintenance of protein localization in organelle,5,0.0,1.0,1.0,7
11412,GO:0072657,protein localization to membrane,5,0.0,1.0,1.0,20
11413,GO:0072658,maintenance of protein location in membrane,5,0.0,1.0,1.0,1
11414,GO:0072704,response to mercaptoethanol,5,0.0,1.0,1.0,1
11415,GO:0072708,response to sorbitol,5,0.0,1.0,1.0,1
11416,GO:0072733,response to staurosporine,5,0.0,1.0,1.0,1
11417,GO:0072741,protein localization to cell division site,5,0.0,1.0,1.0,8
11418,GO:0075001,adhesion of symbiont infection structure to host,5,0.0,1.0,1.0,5
11419,GO:0075017,regulation of appressorium formation,5,0.0,1.0,1.0,2
11420,GO:0075045,regulation of formation by symbiont of haustorium for nutrient acquisition from host,5,0.0,1.0,1.0,2
11421,GO:0075054,modulation of penetration peg formation,5,0.0,1.0,1.0,1
11422,GO:0075136,response to host,5,0.0,1.0,1.0,8
11423,GO:0075188,regulation of hyphopodium formation,5,0.0,1.0,1.0,2
11424,GO:0075198,modulation of symbiont haustorium neck formation for entry into host,5,0.0,1.0,1.0,1
11425,GO:0075202,regulation of penetration hypha formation,5,0.0,1.0,1.0,1
11426,GO:0075227,regulation of encysted zoospore germination,5,0.0,1.0,1.0,2
11427,GO:0075261,positive regulation of spore-bearing organ development,5,0.0,1.0,1.0,11
11428,GO:0075262,negative regulation of spore-bearing organ development,5,0.0,1.0,1.0,11
11429,GO:0075264,regulation of oogonium development,5,0.0,1.0,1.0,2
11430,GO:0075272,regulation of zygosporangium development,5,0.0,1.0,1.0,2
11431,GO:0075276,regulation of telium development,5,0.0,1.0,1.0,2
11432,GO:0075280,regulation of uredinium development,5,0.0,1.0,1.0,2
11433,GO:0075294,positive regulation by symbiont of entry into host,5,0.0,1.0,1.0,4
11434,GO:0075310,regulation of sporangium development,5,0.0,1.0,1.0,4
11435,GO:0075314,regulation of basidium development,5,0.0,1.0,1.0,2
11436,GO:0075318,regulation of ascus development,5,0.0,1.0,1.0,2
11437,GO:0080026,response to indolebutyric acid,5,0.0,1.0,1.0,1
11438,GO:0080052,response to histidine,5,0.0,1.0,1.0,1
11439,GO:0080053,response to phenylalanine,5,0.0,1.0,1.0,1
11440,GO:0080132,fatty acid 2-hydroxylase activity,5,0.0,1.0,1.0,3
11441,GO:0080135,regulation of cellular response to stress,5,0.0,1.0,1.0,26
11442,GO:0080155,regulation of double fertilization forming a zygote and endosperm,5,0.0,1.0,1.0,1
11443,GO:0080164,regulation of nitric oxide metabolic process,5,0.0,1.0,1.0,3
11444,GO:0086001,cardiac muscle cell action potential,5,0.0,1.0,1.0,5
11445,GO:0086010,membrane depolarization during action potential,5,0.0,1.0,1.0,1
11446,GO:0086011,membrane repolarization during action potential,5,0.0,1.0,1.0,1
11447,GO:0086019,cell-cell signaling involved in cardiac conduction,5,0.0,1.0,1.0,5
11448,GO:0086042,cardiac muscle cell-cardiac muscle cell adhesion,5,0.0,1.0,1.0,5
11449,GO:0090033,positive regulation of filamentous growth,5,0.0,1.0,1.0,1
11450,GO:0090069,regulation of ribosome biogenesis,5,0.0,1.0,1.0,2
11451,GO:0090083,regulation of inclusion body assembly,5,0.0,1.0,1.0,4
11452,GO:0090087,regulation of peptide transport,5,0.0,1.0,1.0,3
11453,GO:0090148,membrane fission,5,0.0,1.0,1.0,2
11454,GO:0090158,endoplasmic reticulum membrane organization,5,0.0,1.0,1.0,2
11455,GO:0090184,positive regulation of kidney development,5,0.0,1.0,1.0,5
11456,GO:0090185,negative regulation of kidney development,5,0.0,1.0,1.0,4
11457,GO:0090192,regulation of glomerulus development,5,0.0,1.0,1.0,4
11458,GO:0090220,chromosome localization to nuclear envelope involved in homologous chromosome segregation,5,0.0,1.0,1.0,1
11459,GO:0090257,regulation of muscle system process,5,0.0,1.0,1.0,4
11460,GO:0090264,regulation of immune complex clearance by monocytes and macrophages,5,0.0,1.0,1.0,1
11461,GO:0090288,negative regulation of cellular response to growth factor stimulus,5,0.0,1.0,1.0,8
11462,GO:0090304,nucleic acid metabolic process,5,0.0,1.0,1.0,4
11463,GO:0090318,regulation of chylomicron remodeling,5,0.0,1.0,1.0,1
11464,GO:0090320,regulation of chylomicron remnant clearance,5,0.0,1.0,1.0,1
11465,GO:0090325,regulation of locomotion involved in locomotory behavior,5,0.0,1.0,1.0,2
11466,GO:0090347,regulation of organohalogen metabolic process,5,0.0,1.0,1.0,2
11467,GO:0090382,phagosome maturation,5,0.0,1.0,1.0,1
11468,GO:0090384,phagosome-lysosome docking,5,0.0,1.0,1.0,1
11469,GO:0090497,mesenchymal cell migration,5,0.0,1.0,1.0,2
11470,GO:0090520,sphingolipid mediated signaling pathway,5,0.0,1.0,1.0,1
11471,GO:0090522,vesicle tethering involved in exocytosis,5,0.0,1.0,1.0,3
11472,GO:0090529,cell septum assembly,5,0.0,1.0,1.0,1
11473,GO:0090533,cation-transporting ATPase complex,5,0.0,1.0,1.0,5
11474,GO:0090545,CHD-type complex,5,0.0,1.0,1.0,1
11475,GO:0090563,protein-phosphocysteine-sugar phosphotransferase activity,5,0.0,1.0,1.0,12
11476,GO:0090567,reproductive shoot system development,5,0.0,1.0,1.0,2
11477,GO:0090601,enucleation,5,0.0,1.0,1.0,2
11478,GO:0090604,surface biofilm formation,5,0.0,1.0,1.0,1
11479,GO:0090605,submerged biofilm formation,5,0.0,1.0,1.0,1
11480,GO:0090649,response to oxygen-glucose deprivation,5,0.0,1.0,1.0,1
11481,GO:0090667,cell chemotaxis to vascular endothelial growth factor,5,0.0,1.0,1.0,1
11482,GO:0090670,RNA localization to Cajal body,5,0.0,1.0,1.0,3
11483,GO:0090673,endothelial cell-matrix adhesion,5,0.0,1.0,1.0,1
11484,GO:0090681,GPCR taste receptor activity,5,0.0,1.0,1.0,3
11485,GO:0090707,establishment of plant organ orientation,5,0.0,1.0,1.0,1
11486,GO:0097012,response to granulocyte macrophage colony-stimulating factor,5,0.0,1.0,1.0,1
11487,GO:0097017,renal protein absorption,5,0.0,1.0,1.0,1
11488,GO:0097035,regulation of membrane lipid distribution,5,0.0,1.0,1.0,3
11489,GO:0097067,cellular response to thyroid hormone stimulus,5,0.0,1.0,1.0,1
11490,GO:0097068,response to thyroxine,5,0.0,1.0,1.0,1
11491,GO:0097081,vascular associated smooth muscle cell fate commitment,5,0.0,1.0,1.0,1
11492,GO:0097084,vascular associated smooth muscle cell development,5,0.0,1.0,1.0,1
11493,GO:0097090,presynaptic membrane organization,5,0.0,1.0,1.0,1
11494,GO:0097101,blood vessel endothelial cell fate specification,5,0.0,1.0,1.0,2
11495,GO:0097152,mesenchymal cell apoptotic process,5,0.0,1.0,1.0,2
11496,GO:0097154,GABAergic neuron differentiation,5,0.0,1.0,1.0,5
11497,GO:0097176,epoxide metabolic process,5,0.0,1.0,1.0,9
11498,GO:0097177,mitochondrial ribosome binding,5,0.0,1.0,1.0,1
11499,GO:0097190,apoptotic signaling pathway,5,0.0,1.0,1.0,4
11500,GO:0097210,response to gonadotropin-releasing hormone,5,0.0,1.0,1.0,1
11501,GO:0097212,lysosomal membrane organization,5,0.0,1.0,1.0,2
11502,GO:0097306,cellular response to alcohol,5,0.0,1.0,1.0,27
11503,GO:0097307,response to farnesol,5,0.0,1.0,1.0,1
11504,GO:0097346,INO80-type complex,5,0.0,1.0,1.0,2
11505,GO:0097395,response to interleukin-32,5,0.0,1.0,1.0,1
11506,GO:0097396,response to interleukin-17,5,0.0,1.0,1.0,1
11507,GO:0097449,astrocyte projection,5,0.0,1.0,1.0,1
11508,GO:0097475,motor neuron migration,5,0.0,1.0,1.0,1
11509,GO:0097494,regulation of vesicle size,5,0.0,1.0,1.0,2
11510,GO:0097503,sialylation,5,0.0,1.0,1.0,1
11511,GO:0097526,spliceosomal tri-snRNP complex,5,0.0,1.0,1.0,2
11512,GO:0097529,myeloid leukocyte migration,5,0.0,1.0,1.0,7
11513,GO:0097535,lymphoid lineage cell migration into thymus,5,0.0,1.0,1.0,1
11514,GO:0097599,xylanase activity,5,0.0,1.0,1.0,6
11515,GO:0097615,modulation by host of symbiont type IV pilus-dependent motility,5,0.0,1.0,1.0,1
11516,GO:0097625,low-affinity basic amino acid transmembrane transporter activity,5,0.0,1.0,1.0,1
11517,GO:0097648,G protein-coupled receptor complex,5,0.0,1.0,1.0,2
11518,GO:0097699,vascular endothelial cell response to fluid shear stress,5,0.0,1.0,1.0,3
11519,GO:0097703,cellular response to pulsatile fluid shear stress,5,0.0,1.0,1.0,1
11520,GO:0097704,cellular response to oscillatory fluid shear stress,5,0.0,1.0,1.0,1
11521,GO:0097730,non-motile cilium,5,0.0,1.0,1.0,2
11522,GO:0097747,RNA polymerase activity,5,0.0,1.0,1.0,2
11523,GO:0097749,membrane tubulation,5,0.0,1.0,1.0,1
11524,GO:0097753,membrane bending,5,0.0,1.0,1.0,1
11525,GO:0098509,sensory perception of humidity,5,0.0,1.0,1.0,2
11526,GO:0098512,detection of humidity stimulus involved in sensory perception,5,0.0,1.0,1.0,2
11527,GO:0098516,detection of high humidity,5,0.0,1.0,1.0,1
11528,GO:0098517,detection of low humidity,5,0.0,1.0,1.0,1
11529,GO:0098520,excitatory neuromuscular junction,5,0.0,1.0,1.0,2
11530,GO:0098521,inhibitory neuromuscular junction,5,0.0,1.0,1.0,1
11531,GO:0098523,neuromuscular junction of myotube,5,0.0,1.0,1.0,2
11532,GO:0098527,neuromuscular junction of somatic muscle,5,0.0,1.0,1.0,1
11533,GO:0098542,defense response to other organism,5,0.0,1.0,1.0,11
11534,GO:0098543,detection of other organism,5,0.0,1.0,1.0,7
11535,GO:0098632,cell-cell adhesion mediator activity,5,0.0,1.0,1.0,2
11536,GO:0098634,cell-matrix adhesion mediator activity,5,0.0,1.0,1.0,3
11537,GO:0098660,inorganic ion transmembrane transport,5,0.0,1.0,1.0,4
11538,GO:0098700,neurotransmitter loading into synaptic vesicle,5,0.0,1.0,1.0,1
11539,GO:0098728,germline stem cell asymmetric division,5,0.0,1.0,1.0,2
11540,GO:0098729,germline stem cell symmetric division,5,0.0,1.0,1.0,2
11541,GO:0098732,macromolecule deacylation,5,0.0,1.0,1.0,3
11542,GO:0098739,import across plasma membrane,5,0.0,1.0,1.0,26
11543,GO:0098756,response to interleukin-21,5,0.0,1.0,1.0,1
11544,GO:0098758,response to interleukin-8,5,0.0,1.0,1.0,1
11545,GO:0098760,response to interleukin-7,5,0.0,1.0,1.0,1
11546,GO:0098773,skin epidermis development,5,0.0,1.0,1.0,2
11547,GO:0098801,regulation of renal system process,5,0.0,1.0,1.0,8
11548,GO:0098870,action potential propagation,5,0.0,1.0,1.0,2
11549,GO:0098876,vesicle-mediated transport to the plasma membrane,5,0.0,1.0,1.0,3
11550,GO:0098878,neurotransmitter receptor complex,5,0.0,1.0,1.0,2
11551,GO:0098888,extrinsic component of presynaptic membrane,5,0.0,1.0,1.0,2
11552,GO:0098890,extrinsic component of postsynaptic membrane,5,0.0,1.0,1.0,2
11553,GO:0098901,regulation of cardiac muscle cell action potential,5,0.0,1.0,1.0,7
11554,GO:0098902,regulation of membrane depolarization during action potential,5,0.0,1.0,1.0,1
11555,GO:0098903,regulation of membrane repolarization during action potential,5,0.0,1.0,1.0,1
11556,GO:0098926,postsynaptic signal transduction,5,0.0,1.0,1.0,2
11557,GO:0098928,presynaptic signal transduction,5,0.0,1.0,1.0,1
11558,GO:0098933,symbiont-mediated disruption of host cell envelope,5,0.0,1.0,1.0,3
11559,GO:0098966,perisynaptic extracellular matrix,5,0.0,1.0,1.0,1
11560,GO:0098988,G protein-coupled glutamate receptor activity,5,0.0,1.0,1.0,2
11561,GO:0098999,extrinsic component of postsynaptic endosome membrane,5,0.0,1.0,1.0,2
11562,GO:0099003,vesicle-mediated transport in synapse,5,0.0,1.0,1.0,7
11563,GO:0099017,maintenance of protein localization at cell tip,5,0.0,1.0,1.0,1
11564,GO:0099075,mitochondrion-derived vesicle mediated transport,5,0.0,1.0,1.0,2
11565,GO:0099084,postsynaptic specialization organization,5,0.0,1.0,1.0,2
11566,GO:0099091,"postsynaptic specialization, intracellular component",5,0.0,1.0,1.0,2
11567,GO:0099107,ion channel regulator activity involved in G protein-coupled receptor signaling pathway,5,0.0,1.0,1.0,1
11568,GO:0099136,chimeric non-reproductive fruiting body development,5,0.0,1.0,1.0,2
11569,GO:0099156,cell-cell signaling via exosome,5,0.0,1.0,1.0,1
11570,GO:0099177,regulation of trans-synaptic signaling,5,0.0,1.0,1.0,4
11571,GO:0099513,polymeric cytoskeletal fiber,5,0.0,1.0,1.0,4
11572,GO:0099528,G protein-coupled neurotransmitter receptor activity,5,0.0,1.0,1.0,5
11573,GO:0099529,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,5,0.0,1.0,1.0,2
11574,GO:0099530,G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential,5,0.0,1.0,1.0,1
11575,GO:0099536,synaptic signaling,5,0.0,1.0,1.0,3
11576,GO:0099583,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,5,0.0,1.0,1.0,1
11577,GO:0099612,protein localization to axon,5,0.0,1.0,1.0,2
11578,GO:0099622,cardiac muscle cell membrane repolarization,5,0.0,1.0,1.0,3
11579,GO:0099623,regulation of cardiac muscle cell membrane repolarization,5,0.0,1.0,1.0,3
11580,GO:0099628,neurotransmitter receptor diffusion trapping,5,0.0,1.0,1.0,1
11581,GO:0099634,postsynaptic specialization membrane,5,0.0,1.0,1.0,2
11582,GO:0101005,deubiquitinase activity,5,0.0,1.0,1.0,6
11583,GO:0101025,nuclear membrane biogenesis,5,0.0,1.0,1.0,1
11584,GO:0106001,intestinal hexose absorption,5,0.0,1.0,1.0,1
11585,GO:0106029,tRNA pseudouridine synthase activity,5,0.0,1.0,1.0,8
11586,GO:0106088,regulation of cell adhesion involved in sprouting angiogenesis,5,0.0,1.0,1.0,2
11587,GO:0106130,purine phosphoribosyltransferase activity,5,0.0,1.0,1.0,4
11588,GO:0106259,symbiont-mediated cell-to-cell migration in host,5,0.0,1.0,1.0,2
11589,GO:0106345,glyoxylate reductase activity,5,0.0,1.0,1.0,2
11590,GO:0106359,2-hydroxyacyl-CoA lyase activity,5,0.0,1.0,1.0,1
11591,GO:0106396,regulation of R7 cell fate commitment,5,0.0,1.0,1.0,2
11592,GO:0106413,RNA dihydrouridine synthase activity,5,0.0,1.0,1.0,2
11593,GO:0110037,regulation of nematode male tail tip morphogenesis,5,0.0,1.0,1.0,2
11594,GO:0110075,regulation of ferroptosis,5,0.0,1.0,1.0,2
11595,GO:0110096,cellular response to aldehyde,5,0.0,1.0,1.0,5
11596,GO:0110122,myotube cell migration,5,0.0,1.0,1.0,1
11597,GO:0110137,regulation of imaginal disc-derived leg joint morphogenesis,5,0.0,1.0,1.0,2
11598,GO:0120009,intermembrane lipid transfer,5,0.0,1.0,1.0,3
11599,GO:0120017,ceramide transfer activity,5,0.0,1.0,1.0,2
11600,GO:0120036,plasma membrane bounded cell projection organization,5,0.0,1.0,1.0,10
11601,GO:0120111,neuron projection cytoplasm,5,0.0,1.0,1.0,2
11602,GO:0120159,rRNA pseudouridine synthase activity,5,0.0,1.0,1.0,8
11603,GO:0120161,regulation of cold-induced thermogenesis,5,0.0,1.0,1.0,2
11604,GO:0120208,telodendria,5,0.0,1.0,1.0,2
11605,GO:0120227,acyl-CoA binding,5,0.0,1.0,1.0,3
11606,GO:0120237,terminal acetylenic compound biosynthetic process,5,0.0,1.0,1.0,2
11607,GO:0120241,2-iminobutanoate/2-iminopropanoate deaminase,5,0.0,1.0,1.0,2
11608,GO:0120250,fatty acid omega-hydroxylase activity,5,0.0,1.0,1.0,3
11609,GO:0120502,fatty acid omega-1 hydroxylase activity,5,0.0,1.0,1.0,2
11610,GO:0140036,ubiquitin-modified protein reader activity,5,0.0,1.0,1.0,1
11611,GO:0140083,ATP-dependent protein-DNA unloader activity,5,0.0,1.0,1.0,1
11612,GO:0140115,export across plasma membrane,5,0.0,1.0,1.0,15
11613,GO:0140294,NAD DNA ADP-ribosyltransferase activity,5,0.0,1.0,1.0,1
11614,GO:0140317,export across cell outer membrane,5,0.0,1.0,1.0,1
11615,GO:0140327,flippase activity,5,0.0,1.0,1.0,3
11616,GO:0140328,floppase activity,5,0.0,1.0,1.0,7
11617,GO:0140353,lipid export from cell,5,0.0,1.0,1.0,6
11618,GO:0140354,lipid import into cell,5,0.0,1.0,1.0,2
11619,GO:0140418,effector-mediated modulation of host process by symbiont,5,0.0,1.0,1.0,3
11620,GO:0140495,migracytosis,5,0.0,1.0,1.0,1
11621,GO:0140507,granzyme-mediated programmed cell death signaling pathway,5,0.0,1.0,1.0,1
11622,GO:0140650,radial glia-guided pyramidal neuron migration,5,0.0,1.0,1.0,1
11623,GO:0140656,endodeoxyribonuclease activator activity,5,0.0,1.0,1.0,1
11624,GO:0140658,ATP-dependent chromatin remodeler activity,5,0.0,1.0,1.0,2
11625,GO:0140699,cyclic GMP-AMP synthase activity,5,0.0,1.0,1.0,3
11626,GO:0140820,cytosol to Golgi apparatus transport,5,0.0,1.0,1.0,3
11627,GO:0140838,RNA polymerase II CTD heptapeptide repeat peptidyl-prolyl isomerase activity,5,0.0,1.0,1.0,2
11628,GO:0140905,haloperoxidase activity,5,0.0,1.0,1.0,3
11629,GO:0141052,histone H3 demethylase activity,5,0.0,1.0,1.0,6
11630,GO:0141058,histone H4 demethylase activity,5,0.0,1.0,1.0,2
11631,GO:0141088,symbiont-mediated activation of host autophagy,5,0.0,1.0,1.0,1
11632,GO:0141142,symbiont-mediated migration across host tissue barrier,5,0.0,1.0,1.0,1
11633,GO:0141171,symbiont-mediated perturbation of host membrane,5,0.0,1.0,1.0,4
11634,GO:0150070,regulation of arginase activity,5,0.0,1.0,1.0,1
11635,GO:0150073,regulation of protein-glutamine gamma-glutamyltransferase activity,5,0.0,1.0,1.0,1
11636,GO:0150076,neuroinflammatory response,5,0.0,1.0,1.0,1
11637,GO:0150098,glial cell-neuron signaling,5,0.0,1.0,1.0,1
11638,GO:0150115,cell-substrate junction organization,5,0.0,1.0,1.0,2
11639,GO:0150116,regulation of cell-substrate junction organization,5,0.0,1.0,1.0,4
11640,GO:0150146,cell junction disassembly,5,0.0,1.0,1.0,3
11641,GO:0150200,regulation of transport across blood-brain barrier,5,0.0,1.0,1.0,3
11642,GO:0160008,protein decrotonylase activity,5,0.0,1.0,1.0,1
11643,GO:0160011,NAD-dependent protein decrotonylase activity,5,0.0,1.0,1.0,1
11644,GO:0160041,neuropeptide activity,5,0.0,1.0,1.0,1
11645,GO:0170054,ribonuclease activator activity,5,0.0,1.0,1.0,2
11646,GO:0180030,inositol phosphate kinase activity,5,0.0,1.0,1.0,8
11647,GO:0180035,lncRNA processing,5,0.0,1.0,1.0,1
11648,GO:1900032,regulation of trichome patterning,5,0.0,1.0,1.0,1
11649,GO:1900047,negative regulation of hemostasis,5,0.0,1.0,1.0,1
11650,GO:1900048,positive regulation of hemostasis,5,0.0,1.0,1.0,1
11651,GO:1900078,positive regulation of cellular response to insulin stimulus,5,0.0,1.0,1.0,1
11652,GO:1900104,regulation of hyaluranon cable assembly,5,0.0,1.0,1.0,2
11653,GO:1900120,regulation of receptor binding,5,0.0,1.0,1.0,8
11654,GO:1900191,negative regulation of single-species biofilm formation,5,0.0,1.0,1.0,2
11655,GO:1900192,positive regulation of single-species biofilm formation,5,0.0,1.0,1.0,2
11656,GO:1900228,regulation of single-species biofilm formation in or on host organism,5,0.0,1.0,1.0,2
11657,GO:1900231,regulation of single-species biofilm formation on inanimate substrate,5,0.0,1.0,1.0,2
11658,GO:1900240,negative regulation of phenotypic switching,5,0.0,1.0,1.0,1
11659,GO:1900259,regulation of RNA-dependent RNA polymerase activity,5,0.0,1.0,1.0,1
11660,GO:1900285,regulation of cellotriose transport,5,0.0,1.0,1.0,2
11661,GO:1900291,regulation of galactotriose transport,5,0.0,1.0,1.0,2
11662,GO:1900294,regulation of heptasaccharide transport,5,0.0,1.0,1.0,3
11663,GO:1900297,regulation of hexasaccharide transport,5,0.0,1.0,1.0,3
11664,GO:1900303,regulation of laminaritriose transport,5,0.0,1.0,1.0,2
11665,GO:1900321,regulation of maltotetraose transport,5,0.0,1.0,1.0,2
11666,GO:1900324,regulation of maltotriulose transport,5,0.0,1.0,1.0,2
11667,GO:1900327,regulation of mannotriose transport,5,0.0,1.0,1.0,2
11668,GO:1900354,regulation of methanofuran metabolic process,5,0.0,1.0,1.0,3
11669,GO:1900357,regulation of nigerotriose transport,5,0.0,1.0,1.0,2
11670,GO:1900360,regulation of pentasaccharide transport,5,0.0,1.0,1.0,3
11671,GO:1900428,regulation of filamentous growth of a population of unicellular organisms,5,0.0,1.0,1.0,8
11672,GO:1900555,emericellamide metabolic process,5,0.0,1.0,1.0,3
11673,GO:1900570,diorcinol metabolic process,5,0.0,1.0,1.0,2
11674,GO:1900573,emodin metabolic process,5,0.0,1.0,1.0,2
11675,GO:1900609,F-9775A metabolic process,5,0.0,1.0,1.0,2
11676,GO:1900612,F-9775B metabolic process,5,0.0,1.0,1.0,2
11677,GO:1900618,regulation of shoot system morphogenesis,5,0.0,1.0,1.0,1
11678,GO:1900631,tridecane metabolic process,5,0.0,1.0,1.0,1
11679,GO:1900633,pentadecane metabolic process,5,0.0,1.0,1.0,1
11680,GO:1900635,heptadecane metabolic process,5,0.0,1.0,1.0,1
11681,GO:1900674,olefin biosynthetic process,5,0.0,1.0,1.0,5
11682,GO:1900761,averantin metabolic process,5,0.0,1.0,1.0,2
11683,GO:1900764,emericellin metabolic process,5,0.0,1.0,1.0,2
11684,GO:1900767,fonsecin metabolic process,5,0.0,1.0,1.0,2
11685,GO:1900788,pseurotin A metabolic process,5,0.0,1.0,1.0,2
11686,GO:1900791,shamixanthone metabolic process,5,0.0,1.0,1.0,2
11687,GO:1900878,"(Z)-nonadeca-1,14-diene metabolic process",5,0.0,1.0,1.0,1
11688,GO:1900890,regulation of pentadecane metabolic process,5,0.0,1.0,1.0,3
11689,GO:1900893,regulation of tridecane metabolic process,5,0.0,1.0,1.0,3
11690,GO:1900899,regulation of heptadecane metabolic process,5,0.0,1.0,1.0,3
11691,GO:1900905,regulation of hexadecanal metabolic process,5,0.0,1.0,1.0,3
11692,GO:1900908,regulation of olefin metabolic process,5,0.0,1.0,1.0,9
11693,GO:1900965,regulation of methanophenazine metabolic process,5,0.0,1.0,1.0,3
11694,GO:1901071,glucosamine-containing compound metabolic process,5,0.0,1.0,1.0,5
11695,GO:1901107,granaticin metabolic process,5,0.0,1.0,1.0,2
11696,GO:1901142,insulin metabolic process,5,0.0,1.0,1.0,2
11697,GO:1901211,negative regulation of cardiac chamber formation,5,0.0,1.0,1.0,1
11698,GO:1901236,4-(trimethylammonio)butanoate transmembrane transporter activity,5,0.0,1.0,1.0,1
11699,GO:1901252,regulation of intracellular transport of viral material,5,0.0,1.0,1.0,2
11700,GO:1901261,regulation of sorocarp spore cell differentiation,5,0.0,1.0,1.0,3
11701,GO:1901271,lipooligosaccharide biosynthetic process,5,0.0,1.0,1.0,3
11702,GO:1901298,regulation of hydrogen peroxide-mediated programmed cell death,5,0.0,1.0,1.0,3
11703,GO:1901324,response to trichodermin,5,0.0,1.0,1.0,1
11704,GO:1901326,response to tetracycline,5,0.0,1.0,1.0,1
11705,GO:1901337,thioester transport,5,0.0,1.0,1.0,1
11706,GO:1901342,regulation of vasculature development,5,0.0,1.0,1.0,5
11707,GO:1901344,response to leptomycin B,5,0.0,1.0,1.0,1
11708,GO:1901345,response to L-thialysine,5,0.0,1.0,1.0,1
11709,GO:1901349,glucosinolate transport,5,0.0,1.0,1.0,1
11710,GO:1901354,response to L-canavanine,5,0.0,1.0,1.0,1
11711,GO:1901355,response to rapamycin,5,0.0,1.0,1.0,1
11712,GO:1901364,funalenone metabolic process,5,0.0,1.0,1.0,2
11713,GO:1901367,response to L-cysteine,5,0.0,1.0,1.0,1
11714,GO:1901382,regulation of chorionic trophoblast cell proliferation,5,0.0,1.0,1.0,2
11715,GO:1901401,regulation of tetrapyrrole metabolic process,5,0.0,1.0,1.0,6
11716,GO:1901416,regulation of response to ethanol,5,0.0,1.0,1.0,2
11717,GO:1901420,negative regulation of response to alcohol,5,0.0,1.0,1.0,4
11718,GO:1901421,positive regulation of response to alcohol,5,0.0,1.0,1.0,4
11719,GO:1901437,regulation of toluene metabolic process,5,0.0,1.0,1.0,3
11720,GO:1901445,regulation of response to propan-1-ol,5,0.0,1.0,1.0,2
11721,GO:1901448,regulation of response to butan-1-ol,5,0.0,1.0,1.0,2
11722,GO:1901458,negative regulation of response to acetate,5,0.0,1.0,1.0,1
11723,GO:1901459,positive regulation of response to acetate,5,0.0,1.0,1.0,1
11724,GO:1901490,regulation of lymphangiogenesis,5,0.0,1.0,1.0,2
11725,GO:1901502,ether catabolic process,5,0.0,1.0,1.0,25
11726,GO:1901503,ether biosynthetic process,5,0.0,1.0,1.0,30
11727,GO:1901510,(-)-microperfuranone metabolic process,5,0.0,1.0,1.0,2
11728,GO:1901516,aspyridone A metabolic process,5,0.0,1.0,1.0,2
11729,GO:1901519,aspyridone B metabolic process,5,0.0,1.0,1.0,2
11730,GO:1901532,regulation of hematopoietic progenitor cell differentiation,5,0.0,1.0,1.0,5
11731,GO:1901545,response to raffinose,5,0.0,1.0,1.0,1
11732,GO:1901560,response to purvalanol A,5,0.0,1.0,1.0,1
11733,GO:1901563,response to camptothecin,5,0.0,1.0,1.0,1
11734,GO:1901568,fatty acid derivative metabolic process,5,0.0,1.0,1.0,15
11735,GO:1901571,fatty acid derivative transport,5,0.0,1.0,1.0,1
11736,GO:1901595,response to hesperadin,5,0.0,1.0,1.0,1
11737,GO:1901596,response to reversine,5,0.0,1.0,1.0,1
11738,GO:1901611,phosphatidylglycerol binding,5,0.0,1.0,1.0,1
11739,GO:1901626,regulation of postsynaptic membrane organization,5,0.0,1.0,1.0,2
11740,GO:1901632,regulation of synaptic vesicle membrane organization,5,0.0,1.0,1.0,3
11741,GO:1901655,cellular response to ketone,5,0.0,1.0,1.0,27
11742,GO:1901656,glycoside transport,5,0.0,1.0,1.0,7
11743,GO:1901658,glycosyl compound catabolic process,5,0.0,1.0,1.0,3
11744,GO:1901659,glycosyl compound biosynthetic process,5,0.0,1.0,1.0,4
11745,GO:1901668,regulation of superoxide dismutase activity,5,0.0,1.0,1.0,2
11746,GO:1901687,glutathione derivative biosynthetic process,5,0.0,1.0,1.0,1
11747,GO:1901722,regulation of cell proliferation involved in kidney development,5,0.0,1.0,1.0,5
11748,GO:1901732,quercetin metabolic process,5,0.0,1.0,1.0,2
11749,GO:1901761,oxytetracycline metabolic process,5,0.0,1.0,1.0,2
11750,GO:1901862,negative regulation of muscle tissue development,5,0.0,1.0,1.0,2
11751,GO:1901863,positive regulation of muscle tissue development,5,0.0,1.0,1.0,2
11752,GO:1901867,ecgonine methyl ester metabolic process,5,0.0,1.0,1.0,2
11753,GO:1901870,ecgonone methyl ester metabolic process,5,0.0,1.0,1.0,2
11754,GO:1901888,regulation of cell junction assembly,5,0.0,1.0,1.0,6
11755,GO:1901913,regulation of capsule organization,5,0.0,1.0,1.0,3
11756,GO:1901965,endoplasmic reticulum to chloroplast transport,5,0.0,1.0,1.0,1
11757,GO:1901981,phosphatidylinositol phosphate binding,5,0.0,1.0,1.0,5
11758,GO:1902011,poly(ribitol phosphate) teichoic acid metabolic process,5,0.0,1.0,1.0,1
11759,GO:1902013,poly(glycerol phosphate) teichoic acid metabolic process,5,0.0,1.0,1.0,1
11760,GO:1902015,poly(glucopyranosyl N-acetylgalactosamine 1-phosphate) teichoic acid metabolic process,5,0.0,1.0,1.0,1
11761,GO:1902019,regulation of cilium-dependent cell motility,5,0.0,1.0,1.0,3
11762,GO:1902021,regulation of bacterial-type flagellum-dependent cell motility,5,0.0,1.0,1.0,2
11763,GO:1902025,nitrate import,5,0.0,1.0,1.0,1
11764,GO:1902065,response to L-glutamate,5,0.0,1.0,1.0,1
11765,GO:1902145,regulation of response to cell cycle checkpoint signaling,5,0.0,1.0,1.0,3
11766,GO:1902168,response to catechin,5,0.0,1.0,1.0,1
11767,GO:1902170,cellular response to reactive nitrogen species,5,0.0,1.0,1.0,3
11768,GO:1902183,regulation of shoot apical meristem development,5,0.0,1.0,1.0,2
11769,GO:1902271,D3 vitamins binding,5,0.0,1.0,1.0,2
11770,GO:1902275,regulation of chromatin organization,5,0.0,1.0,1.0,4
11771,GO:1902284,neuron projection extension involved in neuron projection guidance,5,0.0,1.0,1.0,1
11772,GO:1902343,regulation of maltose transport,5,0.0,1.0,1.0,2
11773,GO:1902414,protein localization to cell junction,5,0.0,1.0,1.0,2
11774,GO:1902415,regulation of mRNA binding,5,0.0,1.0,1.0,5
11775,GO:1902435,regulation of male mating behavior,5,0.0,1.0,1.0,3
11776,GO:1902446,regulation of shade avoidance,5,0.0,1.0,1.0,2
11777,GO:1902455,negative regulation of stem cell population maintenance,5,0.0,1.0,1.0,1
11778,GO:1902456,regulation of stomatal opening,5,0.0,1.0,1.0,2
11779,GO:1902459,positive regulation of stem cell population maintenance,5,0.0,1.0,1.0,1
11780,GO:1902503,adenylyltransferase complex,5,0.0,1.0,1.0,3
11781,GO:1902547,regulation of cellular response to vascular endothelial growth factor stimulus,5,0.0,1.0,1.0,3
11782,GO:1902595,regulation of DNA replication origin binding,5,0.0,1.0,1.0,2
11783,GO:1902644,tertiary alcohol metabolic process,5,0.0,1.0,1.0,12
11784,GO:1902708,response to plumbagin,5,0.0,1.0,1.0,1
11785,GO:1902734,regulation of receptor-mediated virion attachment to host cell,5,0.0,1.0,1.0,2
11786,GO:1902742,apoptotic process involved in development,5,0.0,1.0,1.0,7
11787,GO:1902776,6-sulfoquinovose(1-) metabolic process,5,0.0,1.0,1.0,1
11788,GO:1902803,regulation of synaptic vesicle transport,5,0.0,1.0,1.0,3
11789,GO:1902867,negative regulation of retina development in camera-type eye,5,0.0,1.0,1.0,1
11790,GO:1902868,positive regulation of retina development in camera-type eye,5,0.0,1.0,1.0,1
11791,GO:1902882,regulation of response to oxidative stress,5,0.0,1.0,1.0,4
11792,GO:1902903,regulation of supramolecular fiber organization,5,0.0,1.0,1.0,10
11793,GO:1902908,regulation of melanosome transport,5,0.0,1.0,1.0,2
11794,GO:1902911,protein kinase complex,5,0.0,1.0,1.0,9
11795,GO:1902912,pyruvate kinase complex,5,0.0,1.0,1.0,1
11796,GO:1902918,poly(5-hydroxyvalerate) metabolic process,5,0.0,1.0,1.0,1
11797,GO:1902921,poly(hydroxyvalerate) biosynthetic process,5,0.0,1.0,1.0,2
11798,GO:1902922,poly(3-hydroxyvalerate) metabolic process,5,0.0,1.0,1.0,1
11799,GO:1903008,organelle disassembly,5,0.0,1.0,1.0,13
11800,GO:1903010,regulation of bone development,5,0.0,1.0,1.0,3
11801,GO:1903013,response to differentiation-inducing factor 1,5,0.0,1.0,1.0,1
11802,GO:1903015,regulation of exo-alpha-sialidase activity,5,0.0,1.0,1.0,2
11803,GO:1903027,regulation of opsonization,5,0.0,1.0,1.0,1
11804,GO:1903034,regulation of response to wounding,5,0.0,1.0,1.0,5
11805,GO:1903053,regulation of extracellular matrix organization,5,0.0,1.0,1.0,7
11806,GO:1903095,ribonuclease III complex,5,0.0,1.0,1.0,1
11807,GO:1903115,regulation of actin filament-based movement,5,0.0,1.0,1.0,6
11808,GO:1903131,mononuclear cell differentiation,5,0.0,1.0,1.0,4
11809,GO:1903166,cellular response to polycyclic arene,5,0.0,1.0,1.0,1
11810,GO:1903167,regulation of pyrroline-5-carboxylate reductase activity,5,0.0,1.0,1.0,1
11811,GO:1903186,regulation of vitellogenesis,5,0.0,1.0,1.0,2
11812,GO:1903198,regulation of L-dopa decarboxylase activity,5,0.0,1.0,1.0,1
11813,GO:1903224,regulation of endodermal cell differentiation,5,0.0,1.0,1.0,3
11814,GO:1903256,selenoneine metabolic process,5,0.0,1.0,1.0,1
11815,GO:1903314,regulation of nitrogen cycle metabolic process,5,0.0,1.0,1.0,4
11816,GO:1903329,regulation of iron-sulfur cluster assembly,5,0.0,1.0,1.0,5
11817,GO:1903333,negative regulation of protein folding,5,0.0,1.0,1.0,2
11818,GO:1903334,positive regulation of protein folding,5,0.0,1.0,1.0,2
11819,GO:1903339,negative regulation of cell wall organization or biogenesis,5,0.0,1.0,1.0,1
11820,GO:1903340,positive regulation of cell wall organization or biogenesis,5,0.0,1.0,1.0,1
11821,GO:1903365,regulation of fear response,5,0.0,1.0,1.0,3
11822,GO:1903368,regulation of foraging behavior,5,0.0,1.0,1.0,2
11823,GO:1903391,regulation of adherens junction organization,5,0.0,1.0,1.0,2
11824,GO:1903421,regulation of synaptic vesicle recycling,5,0.0,1.0,1.0,4
11825,GO:1903425,fluoride transmembrane transporter activity,5,0.0,1.0,1.0,1
11826,GO:1903442,response to lipoic acid,5,0.0,1.0,1.0,1
11827,GO:1903494,response to dehydroepiandrosterone,5,0.0,1.0,1.0,1
11828,GO:1903513,endoplasmic reticulum to cytosol transport,5,0.0,1.0,1.0,1
11829,GO:1903519,regulation of mammary gland involution,5,0.0,1.0,1.0,2
11830,GO:1903522,regulation of blood circulation,5,0.0,1.0,1.0,6
11831,GO:1903544,response to butyrate,5,0.0,1.0,1.0,1
11832,GO:1903561,extracellular vesicle,5,0.0,1.0,1.0,7
11833,GO:1903576,response to L-arginine,5,0.0,1.0,1.0,1
11834,GO:1903590,regulation of lysozyme activity,5,0.0,1.0,1.0,1
11835,GO:1903604,cytochrome metabolic process,5,0.0,1.0,1.0,2
11836,GO:1903618,regulation of transdifferentiation,5,0.0,1.0,1.0,2
11837,GO:1903642,regulation of recombination hotspot binding,5,0.0,1.0,1.0,1
11838,GO:1903644,regulation of chaperone-mediated protein folding,5,0.0,1.0,1.0,2
11839,GO:1903659,regulation of complement-dependent cytotoxicity,5,0.0,1.0,1.0,2
11840,GO:1903665,negative regulation of asexual reproduction,5,0.0,1.0,1.0,4
11841,GO:1903666,positive regulation of asexual reproduction,5,0.0,1.0,1.0,4
11842,GO:1903729,regulation of plasma membrane organization,5,0.0,1.0,1.0,6
11843,GO:1903814,regulation of collecting lymphatic vessel constriction,5,0.0,1.0,1.0,2
11844,GO:1903825,organic acid transmembrane transport,5,0.0,1.0,1.0,2
11845,GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,5,0.0,1.0,1.0,3
11846,GO:1903853,regulation of stress response to copper ion,5,0.0,1.0,1.0,2
11847,GO:1903888,regulation of plant epidermal cell differentiation,5,0.0,1.0,1.0,4
11848,GO:1903901,negative regulation of viral life cycle,5,0.0,1.0,1.0,3
11849,GO:1903902,positive regulation of viral life cycle,5,0.0,1.0,1.0,5
11850,GO:1903918,regulation of actin filament severing,5,0.0,1.0,1.0,2
11851,GO:1903932,regulation of DNA primase activity,5,0.0,1.0,1.0,1
11852,GO:1903969,regulation of response to macrophage colony-stimulating factor,5,0.0,1.0,1.0,3
11853,GO:1904002,regulation of sebum secreting cell proliferation,5,0.0,1.0,1.0,2
11854,GO:1904014,response to serotonin,5,0.0,1.0,1.0,1
11855,GO:1904019,epithelial cell apoptotic process,5,0.0,1.0,1.0,9
11856,GO:1904041,regulation of cystathionine beta-synthase activity,5,0.0,1.0,1.0,1
11857,GO:1904059,regulation of locomotor rhythm,5,0.0,1.0,1.0,2
11858,GO:1904073,regulation of trophectodermal cell proliferation,5,0.0,1.0,1.0,2
11859,GO:1904092,regulation of autophagic cell death,5,0.0,1.0,1.0,2
11860,GO:1904106,protein localization to microvillus,5,0.0,1.0,1.0,1
11861,GO:1904116,response to vasopressin,5,0.0,1.0,1.0,1
11862,GO:1904180,negative regulation of membrane depolarization,5,0.0,1.0,1.0,3
11863,GO:1904181,positive regulation of membrane depolarization,5,0.0,1.0,1.0,3
11864,GO:1904220,regulation of serine C-palmitoyltransferase activity,5,0.0,1.0,1.0,2
11865,GO:1904226,"regulation of glycogen synthase activity, transferring glucose-1-phosphate",5,0.0,1.0,1.0,1
11866,GO:1904229,regulation of succinate dehydrogenase activity,5,0.0,1.0,1.0,1
11867,GO:1904232,regulation of aconitate hydratase activity,5,0.0,1.0,1.0,2
11868,GO:1904245,regulation of polynucleotide adenylyltransferase activity,5,0.0,1.0,1.0,2
11869,GO:1904309,response to cordycepin,5,0.0,1.0,1.0,1
11870,GO:1904313,response to methamphetamine hydrochloride,5,0.0,1.0,1.0,1
11871,GO:1904316,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,5,0.0,1.0,1.0,1
11872,GO:1904321,response to forskolin,5,0.0,1.0,1.0,1
11873,GO:1904360,negative regulation of spore germination,5,0.0,1.0,1.0,1
11874,GO:1904361,positive regulation of spore germination,5,0.0,1.0,1.0,1
11875,GO:1904365,regulation of chemokinesis,5,0.0,1.0,1.0,2
11876,GO:1904368,regulation of sclerenchyma cell differentiation,5,0.0,1.0,1.0,1
11877,GO:1904373,response to kainic acid,5,0.0,1.0,1.0,1
11878,GO:1904387,cellular response to L-phenylalanine derivative,5,0.0,1.0,1.0,2
11879,GO:1904400,response to Thyroid stimulating hormone,5,0.0,1.0,1.0,1
11880,GO:1904402,response to nocodazole,5,0.0,1.0,1.0,1
11881,GO:1904413,negative regulation of cardiac ventricle development,5,0.0,1.0,1.0,1
11882,GO:1904426,positive regulation of GTP binding,5,0.0,1.0,1.0,1
11883,GO:1904473,response to L-dopa,5,0.0,1.0,1.0,1
11884,GO:1904475,regulation of small GTPase binding,5,0.0,1.0,1.0,2
11885,GO:1904526,regulation of microtubule binding,5,0.0,1.0,1.0,4
11886,GO:1904550,response to arachidonate,5,0.0,1.0,1.0,1
11887,GO:1904560,response to diphenidol,5,0.0,1.0,1.0,1
11888,GO:1904567,response to wortmannin,5,0.0,1.0,1.0,1
11889,GO:1904580,regulation of intracellular mRNA localization,5,0.0,1.0,1.0,4
11890,GO:1904588,cellular response to glycoprotein,5,0.0,1.0,1.0,2
11891,GO:1904616,regulation of actin binding,5,0.0,1.0,1.0,3
11892,GO:1904627,response to phorbol 13-acetate 12-myristate,5,0.0,1.0,1.0,1
11893,GO:1904631,response to glucoside,5,0.0,1.0,1.0,2
11894,GO:1904636,response to ionomycin,5,0.0,1.0,1.0,1
11895,GO:1904638,response to resveratrol,5,0.0,1.0,1.0,1
11896,GO:1904640,response to methionine,5,0.0,1.0,1.0,1
11897,GO:1904643,response to curcumin,5,0.0,1.0,1.0,1
11898,GO:1904647,response to rotenone,5,0.0,1.0,1.0,1
11899,GO:1904672,regulation of somatic stem cell population maintenance,5,0.0,1.0,1.0,3
11900,GO:1904681,response to 3-methylcholanthrene,5,0.0,1.0,1.0,1
11901,GO:1904726,regulation of replicative senescence,5,0.0,1.0,1.0,2
11902,GO:1904742,regulation of telomeric DNA binding,5,0.0,1.0,1.0,4
11903,GO:1904760,regulation of myofibroblast differentiation,5,0.0,1.0,1.0,2
11904,GO:1904793,regulation of euchromatin binding,5,0.0,1.0,1.0,2
11905,GO:1904844,response to L-glutamine,5,0.0,1.0,1.0,1
11906,GO:1904926,response to palmitoleic acid,5,0.0,1.0,1.0,1
11907,GO:1904936,interneuron migration,5,0.0,1.0,1.0,1
11908,GO:1904942,regulation of cardiac ventricle formation,5,0.0,1.0,1.0,2
11909,GO:1904987,regulation of endothelial cell activation,5,0.0,1.0,1.0,2
11910,GO:1905041,regulation of epithelium regeneration,5,0.0,1.0,1.0,2
11911,GO:1905073,regulation of tight junction disassembly,5,0.0,1.0,1.0,2
11912,GO:1905085,regulation of bioluminescence,5,0.0,1.0,1.0,2
11913,GO:1905092,response to diosgenin,5,0.0,1.0,1.0,1
11914,GO:1905117,regulation of ribonucleoside-diphosphate reductase activity,5,0.0,1.0,1.0,1
11915,GO:1905119,response to haloperidol,5,0.0,1.0,1.0,1
11916,GO:1905137,regulation of viral DNA genome packaging via site-specific sequence recognition,5,0.0,1.0,1.0,1
11917,GO:1905140,regulation of apical ectodermal ridge formation,5,0.0,1.0,1.0,2
11918,GO:1905153,regulation of membrane invagination,5,0.0,1.0,1.0,3
11919,GO:1905178,regulation of cardiac muscle tissue regeneration,5,0.0,1.0,1.0,2
11920,GO:1905203,regulation of connective tissue replacement,5,0.0,1.0,1.0,3
11921,GO:1905207,regulation of cardiocyte differentiation,5,0.0,1.0,1.0,7
11922,GO:1905215,negative regulation of RNA binding,5,0.0,1.0,1.0,1
11923,GO:1905216,positive regulation of RNA binding,5,0.0,1.0,1.0,1
11924,GO:1905225,response to thyrotropin-releasing hormone,5,0.0,1.0,1.0,1
11925,GO:1905235,response to quercetin,5,0.0,1.0,1.0,1
11926,GO:1905242,"response to 3,3',5-triiodo-L-thyronine",5,0.0,1.0,1.0,1
11927,GO:1905330,regulation of morphogenesis of an epithelium,5,0.0,1.0,1.0,17
11928,GO:1905370,serine-type endopeptidase complex,5,0.0,1.0,1.0,2
11929,GO:1905374,response to homocysteine,5,0.0,1.0,1.0,1
11930,GO:1905389,response to leukotriene B4,5,0.0,1.0,1.0,1
11931,GO:1905396,cellular response to flavonoid,5,0.0,1.0,1.0,2
11932,GO:1905416,regulation of amoeboid sperm motility,5,0.0,1.0,1.0,2
11933,GO:1905421,regulation of plant organ morphogenesis,5,0.0,1.0,1.0,4
11934,GO:1905428,regulation of plant organ formation,5,0.0,1.0,1.0,3
11935,GO:1905429,response to glycine,5,0.0,1.0,1.0,1
11936,GO:1905493,regulation of G-quadruplex DNA binding,5,0.0,1.0,1.0,2
11937,GO:1905496,regulation of triplex DNA binding,5,0.0,1.0,1.0,2
11938,GO:1905518,regulation of presynaptic active zone assembly,5,0.0,1.0,1.0,2
11939,GO:1905546,cellular response to phenylpropanoid,5,0.0,1.0,1.0,2
11940,GO:1905613,regulation of developmental vegetative growth,5,0.0,1.0,1.0,3
11941,GO:1905623,positive regulation of leaf development,5,0.0,1.0,1.0,1
11942,GO:1905651,regulation of artery morphogenesis,5,0.0,1.0,1.0,4
11943,GO:1905715,regulation of cornification,5,0.0,1.0,1.0,2
11944,GO:1905770,regulation of mesodermal cell differentiation,5,0.0,1.0,1.0,4
11945,GO:1905790,regulation of mechanosensory behavior,5,0.0,1.0,1.0,2
11946,GO:1905794,response to puromycin,5,0.0,1.0,1.0,1
11947,GO:1905837,cellular response to triterpenoid,5,0.0,1.0,1.0,1
11948,GO:1905843,regulation of cellular response to gamma radiation,5,0.0,1.0,1.0,2
11949,GO:1905858,regulation of heparan sulfate proteoglycan binding,5,0.0,1.0,1.0,2
11950,GO:1905899,regulation of smooth muscle tissue development,5,0.0,1.0,1.0,2
11951,GO:1905915,regulation of cell differentiation involved in phenotypic switching,5,0.0,1.0,1.0,3
11952,GO:1905918,regulation of CoA-transferase activity,5,0.0,1.0,1.0,2
11953,GO:1905935,positive regulation of cell fate determination,5,0.0,1.0,1.0,1
11954,GO:1905936,regulation of germ cell proliferation,5,0.0,1.0,1.0,3
11955,GO:1905940,negative regulation of gonad development,5,0.0,1.0,1.0,2
11956,GO:1905941,positive regulation of gonad development,5,0.0,1.0,1.0,2
11957,GO:1905953,negative regulation of lipid localization,5,0.0,1.0,1.0,2
11958,GO:1905957,regulation of cellular response to alcohol,5,0.0,1.0,1.0,4
11959,GO:1905960,response to differentiation-inducing factor 2,5,0.0,1.0,1.0,1
11960,GO:1905962,glutamatergic neuron differentiation,5,0.0,1.0,1.0,2
11961,GO:1990009,retinal cell apoptotic process,5,0.0,1.0,1.0,3
11962,GO:1990042,glycerol dehydrogenase [NAD(P)+] activity,5,0.0,1.0,1.0,2
11963,GO:1990066,energy quenching,5,0.0,1.0,1.0,2
11964,GO:1990090,cellular response to nerve growth factor stimulus,5,0.0,1.0,1.0,1
11965,GO:1990151,protein localization to cell tip,5,0.0,1.0,1.0,6
11966,GO:1990183,lymphatic vascular process in circulatory system,5,0.0,1.0,1.0,2
11967,GO:1990221,L-cysteine desulfurase complex,5,0.0,1.0,1.0,3
11968,GO:1990399,epithelium regeneration,5,0.0,1.0,1.0,1
11969,GO:1990404,NAD+-protein ADP-ribosyltransferase activity,5,0.0,1.0,1.0,10
11970,GO:1990542,mitochondrial transmembrane transport,5,0.0,1.0,1.0,31
11971,GO:1990637,response to prolactin,5,0.0,1.0,1.0,1
11972,GO:1990638,response to granulocyte colony-stimulating factor,5,0.0,1.0,1.0,1
11973,GO:1990776,response to angiotensin,5,0.0,1.0,1.0,1
11974,GO:1990778,protein localization to cell periphery,5,0.0,1.0,1.0,17
11975,GO:1990806,ligand-gated ion channel signaling pathway,5,0.0,1.0,1.0,2
11976,GO:1990823,response to leukemia inhibitory factor,5,0.0,1.0,1.0,1
11977,GO:1990839,response to endothelin,5,0.0,1.0,1.0,1
11978,GO:1990867,response to gastrin,5,0.0,1.0,1.0,1
11979,GO:1990868,response to chemokine,5,0.0,1.0,1.0,1
11980,GO:2000018,regulation of male gonad development,5,0.0,1.0,1.0,2
11981,GO:2000027,regulation of animal organ morphogenesis,5,0.0,1.0,1.0,20
11982,GO:2000035,regulation of stem cell division,5,0.0,1.0,1.0,2
11983,GO:2000070,regulation of response to water deprivation,5,0.0,1.0,1.0,2
11984,GO:2000099,regulation of establishment or maintenance of bipolar cell polarity,5,0.0,1.0,1.0,1
11985,GO:2000101,regulation of mammary stem cell proliferation,5,0.0,1.0,1.0,2
11986,GO:2000114,regulation of establishment of cell polarity,5,0.0,1.0,1.0,3
11987,GO:2000136,regulation of cell proliferation involved in heart morphogenesis,5,0.0,1.0,1.0,5
11988,GO:2000146,negative regulation of cell motility,5,0.0,1.0,1.0,4
11989,GO:2000147,positive regulation of cell motility,5,0.0,1.0,1.0,3
11990,GO:2000177,regulation of neural precursor cell proliferation,5,0.0,1.0,1.0,7
11991,GO:2000194,regulation of female gonad development,5,0.0,1.0,1.0,3
11992,GO:2000197,regulation of ribonucleoprotein complex localization,5,0.0,1.0,1.0,5
11993,GO:2000291,regulation of myoblast proliferation,5,0.0,1.0,1.0,3
11994,GO:2000332,regulation of blood microparticle formation,5,0.0,1.0,1.0,3
11995,GO:2000361,regulation of prostaglandin-E synthase activity,5,0.0,1.0,1.0,1
11996,GO:2000371,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,5,0.0,1.0,1.0,2
11997,GO:2000374,regulation of oxygen metabolic process,5,0.0,1.0,1.0,2
11998,GO:2000377,regulation of reactive oxygen species metabolic process,5,0.0,1.0,1.0,5
11999,GO:2000381,negative regulation of mesoderm development,5,0.0,1.0,1.0,1
12000,GO:2000382,positive regulation of mesoderm development,5,0.0,1.0,1.0,1
12001,GO:2000387,regulation of antral ovarian follicle growth,5,0.0,1.0,1.0,2
12002,GO:2000465,regulation of glycogen (starch) synthase activity,5,0.0,1.0,1.0,2
12003,GO:2000468,regulation of peroxidase activity,5,0.0,1.0,1.0,5
12004,GO:2000489,regulation of hepatic stellate cell activation,5,0.0,1.0,1.0,2
12005,GO:2000495,regulation of cell proliferation involved in compound eye morphogenesis,5,0.0,1.0,1.0,2
12006,GO:2000535,regulation of entry of bacterium into host cell,5,0.0,1.0,1.0,1
12007,GO:2000592,regulation of metanephric DCT cell differentiation,5,0.0,1.0,1.0,2
12008,GO:2000595,regulation of optic nerve formation,5,0.0,1.0,1.0,2
12009,GO:2000652,regulation of secondary cell wall biogenesis,5,0.0,1.0,1.0,2
12010,GO:2000656,regulation of apolipoprotein binding,5,0.0,1.0,1.0,2
12011,GO:2000677,regulation of transcription regulatory region DNA binding,5,0.0,1.0,1.0,5
12012,GO:2000705,regulation of dense core granule biogenesis,5,0.0,1.0,1.0,2
12013,GO:2000736,regulation of stem cell differentiation,5,0.0,1.0,1.0,6
12014,GO:2000772,regulation of cellular senescence,5,0.0,1.0,1.0,2
12015,GO:2000983,regulation of ATP citrate synthase activity,5,0.0,1.0,1.0,2
12016,GO:2001012,mesenchymal cell differentiation involved in renal system development,5,0.0,1.0,1.0,1
12017,GO:2001014,regulation of skeletal muscle cell differentiation,5,0.0,1.0,1.0,3
12018,GO:2001024,negative regulation of response to drug,5,0.0,1.0,1.0,2
12019,GO:2001025,positive regulation of response to drug,5,0.0,1.0,1.0,1
12020,GO:2001038,regulation of cellular response to drug,5,0.0,1.0,1.0,2
12021,GO:2001049,regulation of tendon cell differentiation,5,0.0,1.0,1.0,2
12022,GO:2001058,D-tagatose 6-phosphate metabolic process,5,0.0,1.0,1.0,1
12023,GO:2001060,D-glycero-D-manno-heptose 7-phosphate metabolic process,5,0.0,1.0,1.0,1
12024,GO:2001112,regulation of cellular response to hepatocyte growth factor stimulus,5,0.0,1.0,1.0,2
12025,GO:2001115,methanopterin-containing compound metabolic process,5,0.0,1.0,1.0,3
12026,GO:2001212,regulation of vasculogenesis,5,0.0,1.0,1.0,2
12027,GO:2001229,negative regulation of response to gamma radiation,5,0.0,1.0,1.0,1
12028,GO:2001230,positive regulation of response to gamma radiation,5,0.0,1.0,1.0,1
12029,GO:2001263,regulation of C-C chemokine binding,5,0.0,1.0,1.0,2
12030,GO:2001291,codeine metabolic process,5,0.0,1.0,1.0,1
21,GO:0034368,protein-lipid complex remodeling,6,6727.26,835.11,6.891710172507885e-48,1
24,GO:0071827,plasma lipoprotein particle organization,6,6727.26,555.46,1.538230921804584e-44,3
9,GO:0004465,lipoprotein lipase activity,6,5255.67,5255.67,1.1350560580515759e-91,0
143,GO:0044258,intestinal lipid catabolic process,6,4484.84,4484.84,6.547496813901584e-08,0
53,GO:0055096,low-density lipoprotein particle mediated signaling,6,3669.41,3669.41,4.1313095243317145e-21,0
4,GO:0052739,phosphatidylserine 1-acylhydrolase activity,6,3165.77,3165.77,2.1027324484168365e-134,0
2,GO:0008970,phospholipase A1 activity,6,2346.72,2346.72,1.8234648000716332e-144,0
111,GO:0010983,positive regulation of high-density lipoprotein particle clearance,6,2242.42,2242.42,2.657266872392018e-10,0
41,GO:0047376,"all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity",6,2087.77,2087.77,2.2463967838429235e-28,0
91,GO:0046466,membrane lipid catabolic process,6,1922.07,185.15,1.2136658440151365e-12,2
193,GO:0006664,glycolipid metabolic process,6,1922.07,8.42,8.525627491924759e-05,12
13,GO:0046461,neutral lipid catabolic process,6,1774.22,901.98,1.1867744119890836e-64,1
15,GO:0046503,glycerolipid catabolic process,6,1774.22,448.48,5.126238841254421e-57,2
17,GO:0006639,acylglycerol metabolic process,6,1774.22,227.72,8.476646485106445e-50,6
77,GO:0010884,positive regulation of lipid storage,6,1441.55,373.74,1.6916544659187867e-14,2
269,GO:0009891,positive regulation of biosynthetic process,6,820.4,2.82,0.0201276118984916,44
288,GO:0010604,positive regulation of macromolecule metabolic process,6,820.4,2.42,0.03833938906679,18
384,GO:0010556,regulation of macromolecule biosynthetic process,6,820.4,1.03,0.5318947720906465,15
54,GO:0030667,secretory granule membrane,6,692.51,128.47,1.914456222245563e-20,11
85,GO:0010744,positive regulation of macrophage derived foam cell differentiation,6,672.73,672.73,1.3510386430358077e-13,0
137,GO:0030299,intestinal cholesterol absorption,6,576.62,576.62,2.0646801412401925e-08,0
55,GO:0009395,phospholipid catabolic process,6,509.64,187.91,2.3966210455276935e-20,8
132,GO:0006650,glycerophospholipid metabolic process,6,509.64,16.12,5.8411081289354095e-09,11
84,GO:0030301,cholesterol transport,6,368.62,136.5,1.2855989706431677e-13,5
363,GO:0051246,regulation of protein metabolic process,6,360.39,1.43,0.3506171889293436,16
48,GO:0034361,very-low-density lipoprotein particle,6,225.61,225.61,3.739670520313943e-23,0
90,GO:0045600,positive regulation of fat cell differentiation,6,185.15,185.15,1.2136658440151365e-12,1
106,GO:0004622,lysophospholipase activity,6,177.97,177.97,1.1954452972270628e-10,0
176,GO:0032371,regulation of sterol transport,6,134.55,66.83,1.3932945935359878e-05,5
178,GO:0032370,positive regulation of lipid transport,6,134.55,61.34,1.797663810759921e-05,12
256,GO:0060193,positive regulation of lipase activity,6,105.11,69.35,0.0143177927345358,2
244,GO:0045017,glycerolipid biosynthetic process,6,92.79,7.56,0.0075567998355418,2
377,GO:0008654,phospholipid biosynthetic process,6,92.79,1.1,0.5436591152283972,20
250,GO:0046222,aflatoxin metabolic process,6,90.91,90.91,0.01094127687216,2
282,GO:0006029,proteoglycan metabolic process,6,73.12,28.27,0.0347698404270273,6
283,GO:0009101,glycoprotein biosynthetic process,6,73.12,27.68,0.0354873418151884,9
100,GO:0009746,response to hexose,6,72.56,61.08,3.519535681579426e-11,7
255,GO:0008126,acetylesterase activity,6,72.34,72.34,0.0137313916139088,2
159,GO:0050727,regulation of inflammatory response,6,65.82,24.79,2.0852248645216537e-06,9
165,GO:0031349,positive regulation of defense response,6,65.82,20.4,5.348271800827229e-06,11
164,GO:0004623,phospholipase A2 activity,6,36.12,36.12,5.308386992956206e-06,2
190,GO:0016125,sterol metabolic process,6,31.69,18.48,7.176118602637506e-05,6
199,GO:0051384,response to glucocorticoid,6,31.53,31.53,0.0001285655904927,6
340,GO:0036464,cytoplasmic ribonucleoprotein granule,6,26.49,3.9,0.2265081905373711,11
295,GO:0046460,neutral lipid biosynthetic process,6,24.03,21.36,0.0457611331206001,1
62,GO:0005509,calcium ion binding,6,21.71,21.71,4.24074508363184e-17,1
280,GO:0031410,cytoplasmic vesicle,6,21.07,3.28,0.0342331809563387,26
274,GO:0019752,carboxylic acid metabolic process,6,17.18,1.76,0.0139601698084287,48
6995,GO:0000009,"alpha-1,6-mannosyltransferase activity",6,0.0,1.0,1.0,2
6996,GO:0000026,"alpha-1,2-mannosyltransferase activity",6,0.0,1.0,1.0,4
6997,GO:0000033,"alpha-1,3-mannosyltransferase activity",6,0.0,1.0,1.0,2
6998,GO:0000062,fatty-acyl-CoA binding,6,0.0,1.0,1.0,1
6999,GO:0000064,L-ornithine transmembrane transporter activity,6,0.0,1.0,1.0,2
7000,GO:0000101,sulfur amino acid transport,6,0.0,1.0,1.0,3
7001,GO:0000123,histone acetyltransferase complex,6,0.0,1.0,1.0,3
7002,GO:0000160,phosphorelay signal transduction system,6,0.0,1.0,1.0,2
7003,GO:0000226,microtubule cytoskeleton organization,6,0.0,1.0,1.0,18
7004,GO:0000228,nuclear chromosome,6,0.0,1.0,1.0,2
7005,GO:0000270,peptidoglycan metabolic process,6,0.0,1.0,1.0,3
7006,GO:0000271,polysaccharide biosynthetic process,6,0.0,1.0,1.0,19
7007,GO:0000272,polysaccharide catabolic process,6,0.0,1.0,1.0,15
7008,GO:0000280,nuclear division,6,0.0,1.0,1.0,3
7009,GO:0000295,adenine nucleotide transmembrane transporter activity,6,0.0,1.0,1.0,8
7010,GO:0000296,spermine transport,6,0.0,1.0,1.0,1
7011,GO:0000303,response to superoxide,6,0.0,1.0,1.0,1
7012,GO:0000311,plastid large ribosomal subunit,6,0.0,1.0,1.0,1
7013,GO:0000312,plastid small ribosomal subunit,6,0.0,1.0,1.0,1
7014,GO:0000313,organellar ribosome,6,0.0,1.0,1.0,2
7015,GO:0000322,storage vacuole,6,0.0,1.0,1.0,3
7016,GO:0000323,lytic vacuole,6,0.0,1.0,1.0,5
7017,GO:0000325,plant-type vacuole,6,0.0,1.0,1.0,3
7018,GO:0000330,plant-type vacuole lumen,6,0.0,1.0,1.0,1
7019,GO:0000375,"RNA splicing, via transesterification reactions",6,0.0,1.0,1.0,2
7020,GO:0000394,"RNA splicing, via endonucleolytic cleavage and ligation",6,0.0,1.0,1.0,2
7021,GO:0000400,four-way junction DNA binding,6,0.0,1.0,1.0,2
7022,GO:0000406,double-strand/single-strand DNA junction binding,6,0.0,1.0,1.0,1
7023,GO:0000421,autophagosome membrane,6,0.0,1.0,1.0,1
7024,GO:0000423,mitophagy,6,0.0,1.0,1.0,2
7025,GO:0000428,DNA-directed RNA polymerase complex,6,0.0,1.0,1.0,4
7026,GO:0000700,mismatch base pair DNA N-glycosylase activity,6,0.0,1.0,1.0,2
7027,GO:0000702,oxidized base lesion DNA N-glycosylase activity,6,0.0,1.0,1.0,2
7028,GO:0000715,"nucleotide-excision repair, DNA damage recognition",6,0.0,1.0,1.0,1
7029,GO:0000741,karyogamy,6,0.0,1.0,1.0,4
7030,GO:0000770,peptide pheromone export,6,0.0,1.0,1.0,2
7031,GO:0000793,condensed chromosome,6,0.0,1.0,1.0,1
7032,GO:0000803,sex chromosome,6,0.0,1.0,1.0,7
7033,GO:0000819,sister chromatid segregation,6,0.0,1.0,1.0,2
7034,GO:0000828,inositol hexakisphosphate kinase activity,6,0.0,1.0,1.0,5
7035,GO:0000829,diphosphoinositol pentakisphosphate kinase activity,6,0.0,1.0,1.0,4
7036,GO:0000835,ER ubiquitin ligase complex,6,0.0,1.0,1.0,3
7037,GO:0000917,division septum assembly,6,0.0,1.0,1.0,1
7038,GO:0000955,amino acid catabolic process via Ehrlich pathway,6,0.0,1.0,1.0,2
7039,GO:0000972,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,6,0.0,1.0,1.0,1
7040,GO:0000993,RNA polymerase II complex binding,6,0.0,1.0,1.0,2
7041,GO:0001000,bacterial-type RNA polymerase core enzyme binding,6,0.0,1.0,1.0,1
7042,GO:0001117,protein-DNA-RNA complex disassembly,6,0.0,1.0,1.0,1
7043,GO:0001120,protein-DNA complex remodeling,6,0.0,1.0,1.0,1
7044,GO:0001409,guanine nucleotide transmembrane transporter activity,6,0.0,1.0,1.0,4
7045,GO:0001594,trace-amine receptor activity,6,0.0,1.0,1.0,1
7046,GO:0001595,angiotensin receptor activity,6,0.0,1.0,1.0,2
7047,GO:0001640,adenylate cyclase inhibiting G protein-coupled glutamate receptor activity,6,0.0,1.0,1.0,2
7048,GO:0001648,proteinase-activated receptor activity,6,0.0,1.0,1.0,1
7049,GO:0001696,gastric acid secretion,6,0.0,1.0,1.0,3
7050,GO:0001716,L-amino-acid oxidase activity,6,0.0,1.0,1.0,5
7051,GO:0001754,eye photoreceptor cell differentiation,6,0.0,1.0,1.0,2
7052,GO:0001755,neural crest cell migration,6,0.0,1.0,1.0,4
7053,GO:0001765,membrane raft assembly,6,0.0,1.0,1.0,1
7054,GO:0001774,microglial cell activation,6,0.0,1.0,1.0,1
7055,GO:0001782,B cell homeostasis,6,0.0,1.0,1.0,1
7056,GO:0001787,natural killer cell proliferation,6,0.0,1.0,1.0,1
7057,GO:0001816,cytokine production,6,0.0,1.0,1.0,55
7058,GO:0001821,histamine secretion,6,0.0,1.0,1.0,2
7059,GO:0001878,response to yeast,6,0.0,1.0,1.0,1
7060,GO:0001897,symbiont-mediated cytolysis of host cell,6,0.0,1.0,1.0,2
7061,GO:0001910,regulation of leukocyte mediated cytotoxicity,6,0.0,1.0,1.0,7
7062,GO:0001913,T cell mediated cytotoxicity,6,0.0,1.0,1.0,1
7063,GO:0001919,regulation of receptor recycling,6,0.0,1.0,1.0,2
7064,GO:0001928,regulation of exocyst assembly,6,0.0,1.0,1.0,2
7065,GO:0001936,regulation of endothelial cell proliferation,6,0.0,1.0,1.0,4
7066,GO:0001949,sebaceous gland cell differentiation,6,0.0,1.0,1.0,1
7067,GO:0001952,regulation of cell-matrix adhesion,6,0.0,1.0,1.0,5
7068,GO:0001959,regulation of cytokine-mediated signaling pathway,6,0.0,1.0,1.0,18
7069,GO:0001990,regulation of systemic arterial blood pressure by hormone,6,0.0,1.0,1.0,7
7070,GO:0001993,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,6,0.0,1.0,1.0,1
7071,GO:0002053,positive regulation of mesenchymal cell proliferation,6,0.0,1.0,1.0,3
7072,GO:0002067,glandular epithelial cell differentiation,6,0.0,1.0,1.0,7
7073,GO:0002068,glandular epithelial cell development,6,0.0,1.0,1.0,6
7074,GO:0002069,columnar/cuboidal epithelial cell maturation,6,0.0,1.0,1.0,2
7075,GO:0002148,hypochlorous acid metabolic process,6,0.0,1.0,1.0,2
7076,GO:0002182,cytoplasmic translational elongation,6,0.0,1.0,1.0,2
7077,GO:0002213,defense response to insect,6,0.0,1.0,1.0,1
7078,GO:0002215,defense response to nematode,6,0.0,1.0,1.0,1
7079,GO:0002241,response to parasitic plant,6,0.0,1.0,1.0,2
7080,GO:0002253,activation of immune response,6,0.0,1.0,1.0,3
7081,GO:0002277,myeloid dendritic cell activation involved in immune response,6,0.0,1.0,1.0,1
7082,GO:0002281,macrophage activation involved in immune response,6,0.0,1.0,1.0,1
7083,GO:0002286,T cell activation involved in immune response,6,0.0,1.0,1.0,5
7084,GO:0002312,B cell activation involved in immune response,6,0.0,1.0,1.0,3
7085,GO:0002323,natural killer cell activation involved in immune response,6,0.0,1.0,1.0,2
7086,GO:0002396,MHC protein complex assembly,6,0.0,1.0,1.0,3
7087,GO:0002414,immunoglobulin transcytosis in epithelial cells,6,0.0,1.0,1.0,2
7088,GO:0002424,T cell mediated immune response to tumor cell,6,0.0,1.0,1.0,2
7089,GO:0002438,acute inflammatory response to antigenic stimulus,6,0.0,1.0,1.0,1
7090,GO:0002440,production of molecular mediator of immune response,6,0.0,1.0,1.0,7
7091,GO:0002462,tolerance induction to nonself antigen,6,0.0,1.0,1.0,3
7092,GO:0002465,peripheral tolerance induction,6,0.0,1.0,1.0,5
7093,GO:0002484,antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway,6,0.0,1.0,1.0,2
7094,GO:0002488,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,6,0.0,1.0,1.0,2
7095,GO:0002501,peptide antigen assembly with MHC protein complex,6,0.0,1.0,1.0,3
7096,GO:0002581,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,6,0.0,1.0,1.0,2
7097,GO:0002582,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,6,0.0,1.0,1.0,2
7098,GO:0002584,negative regulation of antigen processing and presentation of peptide antigen,6,0.0,1.0,1.0,5
7099,GO:0002585,positive regulation of antigen processing and presentation of peptide antigen,6,0.0,1.0,1.0,5
7100,GO:0002586,regulation of antigen processing and presentation of peptide antigen via MHC class II,6,0.0,1.0,1.0,2
7101,GO:0002589,regulation of antigen processing and presentation of peptide antigen via MHC class I,6,0.0,1.0,1.0,3
7102,GO:0002593,negative regulation of antigen processing and presentation via MHC class Ib,6,0.0,1.0,1.0,2
7103,GO:0002594,positive regulation of antigen processing and presentation via MHC class Ib,6,0.0,1.0,1.0,2
7104,GO:0002595,regulation of antigen processing and presentation of peptide antigen via MHC class Ib,6,0.0,1.0,1.0,2
7105,GO:0002598,regulation of antigen processing and presentation of lipid antigen via MHC class Ib,6,0.0,1.0,1.0,2
7106,GO:0002601,regulation of antigen processing and presentation of polysaccharide antigen via MHC class II,6,0.0,1.0,1.0,2
7107,GO:0002605,negative regulation of dendritic cell antigen processing and presentation,6,0.0,1.0,1.0,2
7108,GO:0002606,positive regulation of dendritic cell antigen processing and presentation,6,0.0,1.0,1.0,2
7109,GO:0002607,regulation of myeloid dendritic cell antigen processing and presentation,6,0.0,1.0,1.0,2
7110,GO:0002610,regulation of plasmacytoid dendritic cell antigen processing and presentation,6,0.0,1.0,1.0,2
7111,GO:0002647,negative regulation of central tolerance induction,6,0.0,1.0,1.0,1
7112,GO:0002648,positive regulation of central tolerance induction,6,0.0,1.0,1.0,1
7113,GO:0002662,negative regulation of B cell tolerance induction,6,0.0,1.0,1.0,3
7114,GO:0002663,positive regulation of B cell tolerance induction,6,0.0,1.0,1.0,3
7115,GO:0002665,negative regulation of T cell tolerance induction,6,0.0,1.0,1.0,2
7116,GO:0002666,positive regulation of T cell tolerance induction,6,0.0,1.0,1.0,2
7117,GO:0002667,regulation of T cell anergy,6,0.0,1.0,1.0,2
7118,GO:0002670,regulation of B cell anergy,6,0.0,1.0,1.0,4
7119,GO:0002685,regulation of leukocyte migration,6,0.0,1.0,1.0,7
7120,GO:0002695,negative regulation of leukocyte activation,6,0.0,1.0,1.0,7
7121,GO:0002696,positive regulation of leukocyte activation,6,0.0,1.0,1.0,6
7122,GO:0002704,negative regulation of leukocyte mediated immunity,6,0.0,1.0,1.0,4
7123,GO:0002705,positive regulation of leukocyte mediated immunity,6,0.0,1.0,1.0,4
7124,GO:0002706,regulation of lymphocyte mediated immunity,6,0.0,1.0,1.0,5
7125,GO:0002759,regulation of antimicrobial humoral response,6,0.0,1.0,1.0,3
7126,GO:0002765,immune response-inhibiting signal transduction,6,0.0,1.0,1.0,2
7127,GO:0002768,immune response-regulating cell surface receptor signaling pathway,6,0.0,1.0,1.0,4
7128,GO:0002780,antibacterial peptide biosynthetic process,6,0.0,1.0,1.0,2
7129,GO:0002791,regulation of peptide secretion,6,0.0,1.0,1.0,4
7130,GO:0002820,negative regulation of adaptive immune response,6,0.0,1.0,1.0,3
7131,GO:0002821,positive regulation of adaptive immune response,6,0.0,1.0,1.0,3
7132,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,6,0.0,1.0,1.0,8
7133,GO:0002829,negative regulation of type 2 immune response,6,0.0,1.0,1.0,2
7134,GO:0002830,positive regulation of type 2 immune response,6,0.0,1.0,1.0,2
7135,GO:0002835,negative regulation of response to tumor cell,6,0.0,1.0,1.0,1
7136,GO:0002836,positive regulation of response to tumor cell,6,0.0,1.0,1.0,1
7137,GO:0002837,regulation of immune response to tumor cell,6,0.0,1.0,1.0,5
7138,GO:0002886,regulation of myeloid leukocyte mediated immunity,6,0.0,1.0,1.0,11
7139,GO:0002895,regulation of central B cell tolerance induction,6,0.0,1.0,1.0,4
7140,GO:0002912,negative regulation of lymphocyte anergy,6,0.0,1.0,1.0,2
7141,GO:0002913,positive regulation of lymphocyte anergy,6,0.0,1.0,1.0,2
7142,GO:0002921,negative regulation of humoral immune response,6,0.0,1.0,1.0,3
7143,GO:0002922,positive regulation of humoral immune response,6,0.0,1.0,1.0,3
7144,GO:0002934,desmosome organization,6,0.0,1.0,1.0,3
7145,GO:0003009,skeletal muscle contraction,6,0.0,1.0,1.0,2
7146,GO:0003070,regulation of systemic arterial blood pressure by neurotransmitter,6,0.0,1.0,1.0,1
7147,GO:0003093,regulation of glomerular filtration,6,0.0,1.0,1.0,2
7148,GO:0003095,pressure natriuresis,6,0.0,1.0,1.0,2
7149,GO:0003097,renal water transport,6,0.0,1.0,1.0,1
7150,GO:0003143,embryonic heart tube morphogenesis,6,0.0,1.0,1.0,2
7151,GO:0003144,embryonic heart tube formation,6,0.0,1.0,1.0,1
7152,GO:0003152,morphogenesis of an epithelial fold involved in embryonic heart tube formation,6,0.0,1.0,1.0,1
7153,GO:0003156,regulation of animal organ formation,6,0.0,1.0,1.0,4
7154,GO:0003250,regulation of cell proliferation involved in heart valve morphogenesis,6,0.0,1.0,1.0,2
7155,GO:0003260,cardioblast migration,6,0.0,1.0,1.0,2
7156,GO:0003264,regulation of cardioblast proliferation,6,0.0,1.0,1.0,4
7157,GO:0003300,cardiac muscle hypertrophy,6,0.0,1.0,1.0,2
7158,GO:0003337,mesenchymal to epithelial transition involved in metanephros morphogenesis,6,0.0,1.0,1.0,1
7159,GO:0003348,cardiac endothelial cell differentiation,6,0.0,1.0,1.0,3
7160,GO:0003352,regulation of cilium movement,6,0.0,1.0,1.0,5
7161,GO:0003384,apical constriction involved in gastrulation,6,0.0,1.0,1.0,1
7162,GO:0003395,neuron migration involved in dendrite retrograde extension,6,0.0,1.0,1.0,1
7163,GO:0003730,mRNA 3'-UTR binding,6,0.0,1.0,1.0,1
7164,GO:0003845,11-beta-hydroxysteroid dehydrogenase [NAD(P)+] activity,6,0.0,1.0,1.0,2
7165,GO:0003854,3-beta-hydroxy-delta5-steroid dehydrogenase (NAD+) activity,6,0.0,1.0,1.0,1
7166,GO:0003884,D-amino-acid oxidase activity,6,0.0,1.0,1.0,3
7167,GO:0003886,DNA (cytosine-5-)-methyltransferase activity,6,0.0,1.0,1.0,4
7168,GO:0003905,alkylbase DNA N-glycosylase activity,6,0.0,1.0,1.0,5
7169,GO:0003933,GTP cyclohydrolase activity,6,0.0,1.0,1.0,4
7170,GO:0003964,RNA-directed DNA polymerase activity,6,0.0,1.0,1.0,1
7171,GO:0003988,acetyl-CoA C-acyltransferase activity,6,0.0,1.0,1.0,2
7172,GO:0004022,alcohol dehydrogenase (NAD+) activity,6,0.0,1.0,1.0,12
7173,GO:0004029,aldehyde dehydrogenase (NAD+) activity,6,0.0,1.0,1.0,18
7174,GO:0004033,aldo-keto reductase (NADPH) activity,6,0.0,1.0,1.0,2
7175,GO:0004112,cyclic-nucleotide phosphodiesterase activity,6,0.0,1.0,1.0,3
7176,GO:0004181,metallocarboxypeptidase activity,6,0.0,1.0,1.0,4
7177,GO:0004185,serine-type carboxypeptidase activity,6,0.0,1.0,1.0,2
7178,GO:0004376,glycolipid mannosyltransferase activity,6,0.0,1.0,1.0,4
7179,GO:0004396,hexokinase activity,6,0.0,1.0,1.0,4
7180,GO:0004520,DNA endonuclease activity,6,0.0,1.0,1.0,10
7181,GO:0004521,RNA endonuclease activity,6,0.0,1.0,1.0,4
7182,GO:0004529,DNA exonuclease activity,6,0.0,1.0,1.0,1
7183,GO:0004532,RNA exonuclease activity,6,0.0,1.0,1.0,1
7184,GO:0004549,tRNA-specific ribonuclease activity,6,0.0,1.0,1.0,2
7185,GO:0004551,dinucleotide phosphatase activity,6,0.0,1.0,1.0,4
7186,GO:0004557,alpha-galactosidase activity,6,0.0,1.0,1.0,1
7187,GO:0004559,alpha-mannosidase activity,6,0.0,1.0,1.0,6
7188,GO:0004560,alpha-L-fucosidase activity,6,0.0,1.0,1.0,3
7189,GO:0004563,beta-N-acetylhexosaminidase activity,6,0.0,1.0,1.0,2
7190,GO:0004565,beta-galactosidase activity,6,0.0,1.0,1.0,1
7191,GO:0004567,beta-mannosidase activity,6,0.0,1.0,1.0,2
7192,GO:0004583,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,6,0.0,1.0,1.0,2
7193,GO:0004629,phospholipase C activity,6,0.0,1.0,1.0,5
7194,GO:0004630,phospholipase D activity,6,0.0,1.0,1.0,1
7195,GO:0004661,protein geranylgeranyltransferase activity,6,0.0,1.0,1.0,2
7196,GO:0004673,protein histidine kinase activity,6,0.0,1.0,1.0,4
7197,GO:0004674,protein serine/threonine kinase activity,6,0.0,1.0,1.0,40
7198,GO:0004712,protein serine/threonine/tyrosine kinase activity,6,0.0,1.0,1.0,1
7199,GO:0004713,protein tyrosine kinase activity,6,0.0,1.0,1.0,4
7200,GO:0004721,phosphoprotein phosphatase activity,6,0.0,1.0,1.0,17
7201,GO:0004748,"ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor",6,0.0,1.0,1.0,3
7202,GO:0004767,sphingomyelin phosphodiesterase activity,6,0.0,1.0,1.0,2
7203,GO:0004772,sterol O-acyltransferase activity,6,0.0,1.0,1.0,3
7204,GO:0004779,sulfate adenylyltransferase activity,6,0.0,1.0,1.0,2
7205,GO:0004810,CCA tRNA nucleotidyltransferase activity,6,0.0,1.0,1.0,1
7206,GO:0004842,ubiquitin-protein transferase activity,6,0.0,1.0,1.0,2
7207,GO:0004843,cysteine-type deubiquitinase activity,6,0.0,1.0,1.0,1
7208,GO:0004869,cysteine-type endopeptidase inhibitor activity,6,0.0,1.0,1.0,1
7209,GO:0004932,mating-type factor pheromone receptor activity,6,0.0,1.0,1.0,4
7210,GO:0004935,adrenergic receptor activity,6,0.0,1.0,1.0,2
7211,GO:0004950,chemokine receptor activity,6,0.0,1.0,1.0,3
7212,GO:0004954,prostanoid receptor activity,6,0.0,1.0,1.0,2
7213,GO:0004974,leukotriene receptor activity,6,0.0,1.0,1.0,2
7214,GO:0004977,melanocortin receptor activity,6,0.0,1.0,1.0,3
7215,GO:0004993,G protein-coupled serotonin receptor activity,6,0.0,1.0,1.0,2
7216,GO:0005123,death receptor binding,6,0.0,1.0,1.0,1
7217,GO:0005167,neurotrophin TRK receptor binding,6,0.0,1.0,1.0,3
7218,GO:0005184,neuropeptide hormone activity,6,0.0,1.0,1.0,5
7219,GO:0005243,gap junction channel activity,6,0.0,1.0,1.0,1
7220,GO:0005253,monoatomic anion channel activity,6,0.0,1.0,1.0,6
7221,GO:0005261,monoatomic cation channel activity,6,0.0,1.0,1.0,9
7222,GO:0005290,L-histidine transmembrane transporter activity,6,0.0,1.0,1.0,3
7223,GO:0005302,L-tyrosine transmembrane transporter activity,6,0.0,1.0,1.0,1
7224,GO:0005313,L-glutamate transmembrane transporter activity,6,0.0,1.0,1.0,4
7225,GO:0005346,purine ribonucleotide transmembrane transporter activity,6,0.0,1.0,1.0,10
7226,GO:0005363,maltose transmembrane transporter activity,6,0.0,1.0,1.0,4
7227,GO:0005452,solute:inorganic anion antiporter activity,6,0.0,1.0,1.0,7
7228,GO:0005776,autophagosome,6,0.0,1.0,1.0,1
7229,GO:0005777,peroxisome,6,0.0,1.0,1.0,9
7230,GO:0005782,peroxisomal matrix,6,0.0,1.0,1.0,2
7231,GO:0005874,microtubule,6,0.0,1.0,1.0,7
7232,GO:0005882,intermediate filament,6,0.0,1.0,1.0,5
7233,GO:0005884,actin filament,6,0.0,1.0,1.0,2
7234,GO:0005915,zonula adherens,6,0.0,1.0,1.0,1
7235,GO:0005918,septate junction,6,0.0,1.0,1.0,2
7236,GO:0005923,bicellular tight junction,6,0.0,1.0,1.0,1
7237,GO:0005984,disaccharide metabolic process,6,0.0,1.0,1.0,8
7238,GO:0006020,inositol metabolic process,6,0.0,1.0,1.0,2
7239,GO:0006024,glycosaminoglycan biosynthetic process,6,0.0,1.0,1.0,7
7240,GO:0006027,glycosaminoglycan catabolic process,6,0.0,1.0,1.0,7
7241,GO:0006030,chitin metabolic process,6,0.0,1.0,1.0,2
7242,GO:0006041,glucosamine metabolic process,6,0.0,1.0,1.0,3
7243,GO:0006044,N-acetylglucosamine metabolic process,6,0.0,1.0,1.0,2
7244,GO:0006051,N-acetylmannosamine metabolic process,6,0.0,1.0,1.0,2
7245,GO:0006056,mannoprotein metabolic process,6,0.0,1.0,1.0,2
7246,GO:0006067,ethanol metabolic process,6,0.0,1.0,1.0,7
7247,GO:0006072,glycerol-3-phosphate metabolic process,6,0.0,1.0,1.0,2
7248,GO:0006080,substituted mannan metabolic process,6,0.0,1.0,1.0,3
7249,GO:0006109,regulation of carbohydrate metabolic process,6,0.0,1.0,1.0,14
7250,GO:0006259,DNA metabolic process,6,0.0,1.0,1.0,36
7251,GO:0006415,translational termination,6,0.0,1.0,1.0,2
7252,GO:0006468,protein phosphorylation,6,0.0,1.0,1.0,11
7253,GO:0006470,protein dephosphorylation,6,0.0,1.0,1.0,6
7254,GO:0006477,protein sulfation,6,0.0,1.0,1.0,1
7255,GO:0006486,protein glycosylation,6,0.0,1.0,1.0,8
7256,GO:0006491,N-glycan processing,6,0.0,1.0,1.0,4
7257,GO:0006497,protein lipidation,6,0.0,1.0,1.0,8
7258,GO:0006516,glycoprotein catabolic process,6,0.0,1.0,1.0,5
7259,GO:0006517,protein deglycosylation,6,0.0,1.0,1.0,2
7260,GO:0006521,regulation of amino acid metabolic process,6,0.0,1.0,1.0,13
7261,GO:0006580,ethanolamine metabolic process,6,0.0,1.0,1.0,2
7262,GO:0006584,catecholamine metabolic process,6,0.0,1.0,1.0,5
7263,GO:0006596,polyamine biosynthetic process,6,0.0,1.0,1.0,6
7264,GO:0006598,polyamine catabolic process,6,0.0,1.0,1.0,7
7265,GO:0006602,creatinine catabolic process,6,0.0,1.0,1.0,1
7266,GO:0006603,phosphocreatine metabolic process,6,0.0,1.0,1.0,2
7267,GO:0006605,protein targeting,6,0.0,1.0,1.0,7
7268,GO:0006665,sphingolipid metabolic process,6,0.0,1.0,1.0,9
7269,GO:0006694,steroid biosynthetic process,6,0.0,1.0,1.0,13
7270,GO:0006706,steroid catabolic process,6,0.0,1.0,1.0,13
7271,GO:0006721,terpenoid metabolic process,6,0.0,1.0,1.0,14
7272,GO:0006753,nucleoside phosphate metabolic process,6,0.0,1.0,1.0,11
7273,GO:0006769,nicotinamide metabolic process,6,0.0,1.0,1.0,1
7274,GO:0006771,riboflavin metabolic process,6,0.0,1.0,1.0,2
7275,GO:0006782,protoporphyrinogen IX biosynthetic process,6,0.0,1.0,1.0,2
7276,GO:0006783,heme biosynthetic process,6,0.0,1.0,1.0,5
7277,GO:0006795,regulation of phosphorus utilization,6,0.0,1.0,1.0,2
7278,GO:0006797,polyphosphate metabolic process,6,0.0,1.0,1.0,2
7279,GO:0006821,chloride transport,6,0.0,1.0,1.0,2
7280,GO:0006835,dicarboxylic acid transport,6,0.0,1.0,1.0,16
7281,GO:0006837,serotonin transport,6,0.0,1.0,1.0,2
7282,GO:0006842,tricarboxylic acid transport,6,0.0,1.0,1.0,2
7283,GO:0006844,acyl carnitine transport,6,0.0,1.0,1.0,1
7284,GO:0006862,nucleotide transport,6,0.0,1.0,1.0,7
7285,GO:0006863,purine nucleobase transport,6,0.0,1.0,1.0,5
7286,GO:0006867,asparagine transport,6,0.0,1.0,1.0,1
7287,GO:0006868,glutamine transport,6,0.0,1.0,1.0,2
7288,GO:0006874,intracellular calcium ion homeostasis,6,0.0,1.0,1.0,5
7289,GO:0006878,intracellular copper ion homeostasis,6,0.0,1.0,1.0,1
7290,GO:0006879,intracellular iron ion homeostasis,6,0.0,1.0,1.0,1
7291,GO:0006884,cell volume homeostasis,6,0.0,1.0,1.0,3
7292,GO:0006887,exocytosis,6,0.0,1.0,1.0,5
7293,GO:0006890,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum",6,0.0,1.0,1.0,1
7294,GO:0006891,intra-Golgi vesicle-mediated transport,6,0.0,1.0,1.0,3
7295,GO:0006892,post-Golgi vesicle-mediated transport,6,0.0,1.0,1.0,3
7296,GO:0006898,receptor-mediated endocytosis,6,0.0,1.0,1.0,7
7297,GO:0006900,vesicle budding from membrane,6,0.0,1.0,1.0,5
7298,GO:0006901,vesicle coating,6,0.0,1.0,1.0,3
7299,GO:0006907,pinocytosis,6,0.0,1.0,1.0,2
7300,GO:0006909,phagocytosis,6,0.0,1.0,1.0,1
7301,GO:0006913,nucleocytoplasmic transport,6,0.0,1.0,1.0,2
7302,GO:0006937,regulation of muscle contraction,6,0.0,1.0,1.0,5
7303,GO:0006953,acute-phase response,6,0.0,1.0,1.0,1
7304,GO:0006984,ER-nucleus signaling pathway,6,0.0,1.0,1.0,4
7305,GO:0006999,nuclear pore organization,6,0.0,1.0,1.0,2
7306,GO:0007000,nucleolus organization,6,0.0,1.0,1.0,1
7307,GO:0007006,mitochondrial membrane organization,6,0.0,1.0,1.0,4
7308,GO:0007032,endosome organization,6,0.0,1.0,1.0,4
7309,GO:0007039,protein catabolic process in the vacuole,6,0.0,1.0,1.0,1
7310,GO:0007041,lysosomal transport,6,0.0,1.0,1.0,13
7311,GO:0007043,cell-cell junction assembly,6,0.0,1.0,1.0,7
7312,GO:0007044,cell-substrate junction assembly,6,0.0,1.0,1.0,2
7313,GO:0007060,male meiosis chromosome segregation,6,0.0,1.0,1.0,1
7314,GO:0007062,sister chromatid cohesion,6,0.0,1.0,1.0,3
7315,GO:0007167,enzyme-linked receptor protein signaling pathway,6,0.0,1.0,1.0,5
7316,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",6,0.0,1.0,1.0,1
7317,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,6,0.0,1.0,1.0,2
7318,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,6,0.0,1.0,1.0,9
7319,GO:0007211,octopamine or tyramine signaling pathway,6,0.0,1.0,1.0,2
7320,GO:0007212,G protein-coupled dopamine receptor signaling pathway,6,0.0,1.0,1.0,3
7321,GO:0007215,glutamate receptor signaling pathway,6,0.0,1.0,1.0,2
7322,GO:0007217,tachykinin receptor signaling pathway,6,0.0,1.0,1.0,1
7323,GO:0007218,neuropeptide signaling pathway,6,0.0,1.0,1.0,1
7324,GO:0007219,Notch signaling pathway,6,0.0,1.0,1.0,6
7325,GO:0007224,smoothened signaling pathway,6,0.0,1.0,1.0,6
7326,GO:0007231,osmosensory signaling pathway,6,0.0,1.0,1.0,2
7327,GO:0007297,follicle cell of egg chamber migration,6,0.0,1.0,1.0,3
7328,GO:0007317,regulation of pole plasm oskar mRNA localization,6,0.0,1.0,1.0,2
7329,GO:0007323,peptide pheromone maturation,6,0.0,1.0,1.0,2
7330,GO:0007416,synapse assembly,6,0.0,1.0,1.0,4
7331,GO:0007519,skeletal muscle tissue development,6,0.0,1.0,1.0,2
7332,GO:0007528,neuromuscular junction development,6,0.0,1.0,1.0,2
7333,GO:0007601,visual perception,6,0.0,1.0,1.0,1
7334,GO:0007602,phototransduction,6,0.0,1.0,1.0,5
7335,GO:0007612,learning,6,0.0,1.0,1.0,5
7336,GO:0007613,memory,6,0.0,1.0,1.0,4
7337,GO:0007634,optokinetic behavior,6,0.0,1.0,1.0,1
7338,GO:0008016,regulation of heart contraction,6,0.0,1.0,1.0,8
7339,GO:0008049,male courtship behavior,6,0.0,1.0,1.0,5
7340,GO:0008053,mitochondrial fusion,6,0.0,1.0,1.0,1
7341,GO:0008055,ocellus pigment biosynthetic process,6,0.0,1.0,1.0,1
7342,GO:0008079,translation termination factor activity,6,0.0,1.0,1.0,1
7343,GO:0008080,N-acetyltransferase activity,6,0.0,1.0,1.0,28
7344,GO:0008097,5S rRNA binding,6,0.0,1.0,1.0,1
7345,GO:0008154,actin polymerization or depolymerization,6,0.0,1.0,1.0,2
7346,GO:0008174,mRNA methyltransferase activity,6,0.0,1.0,1.0,7
7347,GO:0008175,tRNA methyltransferase activity,6,0.0,1.0,1.0,5
7348,GO:0008187,poly-pyrimidine tract binding,6,0.0,1.0,1.0,3
7349,GO:0008188,neuropeptide receptor activity,6,0.0,1.0,1.0,15
7350,GO:0008192,RNA guanylyltransferase activity,6,0.0,1.0,1.0,2
7351,GO:0008207,C21-steroid hormone metabolic process,6,0.0,1.0,1.0,4
7352,GO:0008209,androgen metabolic process,6,0.0,1.0,1.0,2
7353,GO:0008210,estrogen metabolic process,6,0.0,1.0,1.0,2
7354,GO:0008211,glucocorticoid metabolic process,6,0.0,1.0,1.0,3
7355,GO:0008212,mineralocorticoid metabolic process,6,0.0,1.0,1.0,3
7356,GO:0008213,protein alkylation,6,0.0,1.0,1.0,1
7357,GO:0008214,protein dealkylation,6,0.0,1.0,1.0,1
7358,GO:0008215,spermine metabolic process,6,0.0,1.0,1.0,4
7359,GO:0008216,spermidine metabolic process,6,0.0,1.0,1.0,4
7360,GO:0008252,nucleotidase activity,6,0.0,1.0,1.0,3
7361,GO:0008271,secondary active sulfate transmembrane transporter activity,6,0.0,1.0,1.0,5
7362,GO:0008277,regulation of G protein-coupled receptor signaling pathway,6,0.0,1.0,1.0,17
7363,GO:0008299,isoprenoid biosynthetic process,6,0.0,1.0,1.0,7
7364,GO:0008300,isoprenoid catabolic process,6,0.0,1.0,1.0,5
7365,GO:0008328,ionotropic glutamate receptor complex,6,0.0,1.0,1.0,3
7366,GO:0008359,regulation of bicoid mRNA localization,6,0.0,1.0,1.0,2
7367,GO:0008360,regulation of cell shape,6,0.0,1.0,1.0,4
7368,GO:0008381,mechanosensitive monoatomic ion channel activity,6,0.0,1.0,1.0,2
7369,GO:0008396,oxysterol 7-alpha-hydroxylase activity,6,0.0,1.0,1.0,2
7370,GO:0008408,3'-5' exonuclease activity,6,0.0,1.0,1.0,2
7371,GO:0008409,5'-3' exonuclease activity,6,0.0,1.0,1.0,2
7372,GO:0008422,beta-glucosidase activity,6,0.0,1.0,1.0,20
7373,GO:0008443,phosphofructokinase activity,6,0.0,1.0,1.0,4
7374,GO:0008481,sphingosine kinase activity,6,0.0,1.0,1.0,1
7375,GO:0008486,diphosphoinositol-polyphosphate diphosphatase activity,6,0.0,1.0,1.0,3
7376,GO:0008515,sucrose transmembrane transporter activity,6,0.0,1.0,1.0,2
7377,GO:0008589,regulation of smoothened signaling pathway,6,0.0,1.0,1.0,3
7378,GO:0008592,regulation of Toll signaling pathway,6,0.0,1.0,1.0,2
7379,GO:0008593,regulation of Notch signaling pathway,6,0.0,1.0,1.0,3
7380,GO:0008637,apoptotic mitochondrial changes,6,0.0,1.0,1.0,4
7381,GO:0008649,rRNA methyltransferase activity,6,0.0,1.0,1.0,5
7382,GO:0008653,lipopolysaccharide metabolic process,6,0.0,1.0,1.0,2
7383,GO:0008655,pyrimidine-containing compound salvage,6,0.0,1.0,1.0,4
7384,GO:0008796,bis(5'-nucleosyl)-tetraphosphatase activity,6,0.0,1.0,1.0,2
7385,GO:0009060,aerobic respiration,6,0.0,1.0,1.0,10
7386,GO:0009061,anaerobic respiration,6,0.0,1.0,1.0,3
7387,GO:0009112,nucleobase metabolic process,6,0.0,1.0,1.0,4
7388,GO:0009116,nucleoside metabolic process,6,0.0,1.0,1.0,7
7389,GO:0009235,cobalamin metabolic process,6,0.0,1.0,1.0,2
7390,GO:0009238,enterobactin metabolic process,6,0.0,1.0,1.0,2
7391,GO:0009269,response to desiccation,6,0.0,1.0,1.0,1
7392,GO:0009297,pilus assembly,6,0.0,1.0,1.0,3
7393,GO:0009312,oligosaccharide biosynthetic process,6,0.0,1.0,1.0,4
7394,GO:0009313,oligosaccharide catabolic process,6,0.0,1.0,1.0,8
7395,GO:0009445,putrescine metabolic process,6,0.0,1.0,1.0,3
7396,GO:0009508,plastid chromosome,6,0.0,1.0,1.0,1
7397,GO:0009516,leucoplast,6,0.0,1.0,1.0,2
7398,GO:0009527,plastid outer membrane,6,0.0,1.0,1.0,3
7399,GO:0009529,plastid intermembrane space,6,0.0,1.0,1.0,3
7400,GO:0009562,embryo sac nuclear migration,6,0.0,1.0,1.0,2
7401,GO:0009584,detection of visible light,6,0.0,1.0,1.0,1
7402,GO:0009589,detection of UV,6,0.0,1.0,1.0,1
7403,GO:0009602,detection of symbiont,6,0.0,1.0,1.0,3
7404,GO:0009609,response to symbiotic bacterium,6,0.0,1.0,1.0,1
7405,GO:0009610,response to symbiotic fungus,6,0.0,1.0,1.0,1
7406,GO:0009644,response to high light intensity,6,0.0,1.0,1.0,3
7407,GO:0009645,response to low light intensity stimulus,6,0.0,1.0,1.0,3
7408,GO:0009646,response to absence of light,6,0.0,1.0,1.0,2
7409,GO:0009658,chloroplast organization,6,0.0,1.0,1.0,4
7410,GO:0009659,leucoplast organization,6,0.0,1.0,1.0,1
7411,GO:0009664,plant-type cell wall organization,6,0.0,1.0,1.0,2
7412,GO:0009691,cytokinin biosynthetic process,6,0.0,1.0,1.0,3
7413,GO:0009692,ethylene metabolic process,6,0.0,1.0,1.0,2
7414,GO:0009705,plant-type vacuole membrane,6,0.0,1.0,1.0,1
7415,GO:0009710,tropane alkaloid biosynthetic process,6,0.0,1.0,1.0,5
7416,GO:0009713,catechol-containing compound biosynthetic process,6,0.0,1.0,1.0,13
7417,GO:0009717,isoflavonoid biosynthetic process,6,0.0,1.0,1.0,1
7418,GO:0009734,auxin-activated signaling pathway,6,0.0,1.0,1.0,1
7419,GO:0009738,abscisic acid-activated signaling pathway,6,0.0,1.0,1.0,1
7420,GO:0009744,response to sucrose,6,0.0,1.0,1.0,2
7421,GO:0009777,photosynthetic phosphorylation,6,0.0,1.0,1.0,2
7422,GO:0009787,regulation of abscisic acid-activated signaling pathway,6,0.0,1.0,1.0,2
7423,GO:0009794,"regulation of mitotic cell cycle, embryonic",6,0.0,1.0,1.0,4
7424,GO:0009802,cinnamic acid ester biosynthetic process,6,0.0,1.0,1.0,1
7425,GO:0009805,coumarin biosynthetic process,6,0.0,1.0,1.0,5
7426,GO:0009807,lignan biosynthetic process,6,0.0,1.0,1.0,7
7427,GO:0009809,lignin biosynthetic process,6,0.0,1.0,1.0,3
7428,GO:0009823,cytokinin catabolic process,6,0.0,1.0,1.0,2
7429,GO:0009834,plant-type secondary cell wall biogenesis,6,0.0,1.0,1.0,1
7430,GO:0009851,auxin biosynthetic process,6,0.0,1.0,1.0,2
7431,GO:0009852,auxin catabolic process,6,0.0,1.0,1.0,1
7432,GO:0009867,jasmonic acid mediated signaling pathway,6,0.0,1.0,1.0,2
7433,GO:0009890,negative regulation of biosynthetic process,6,0.0,1.0,1.0,43
7434,GO:0009895,negative regulation of catabolic process,6,0.0,1.0,1.0,39
7435,GO:0009896,positive regulation of catabolic process,6,0.0,1.0,1.0,44
7436,GO:0009909,regulation of flower development,6,0.0,1.0,1.0,2
7437,GO:0009926,auxin polar transport,6,0.0,1.0,1.0,2
7438,GO:0009937,regulation of gibberellic acid mediated signaling pathway,6,0.0,1.0,1.0,2
7439,GO:0009962,regulation of flavonoid biosynthetic process,6,0.0,1.0,1.0,4
7440,GO:0009967,positive regulation of signal transduction,6,0.0,1.0,1.0,54
7441,GO:0009968,negative regulation of signal transduction,6,0.0,1.0,1.0,65
7442,GO:0010008,endosome membrane,6,0.0,1.0,1.0,7
7443,GO:0010027,thylakoid membrane organization,6,0.0,1.0,1.0,1
7444,GO:0010058,regulation of atrichoblast fate specification,6,0.0,1.0,1.0,2
7445,GO:0010065,primary meristem tissue development,6,0.0,1.0,1.0,3
7446,GO:0010099,regulation of photomorphogenesis,6,0.0,1.0,1.0,2
7447,GO:0010112,regulation of systemic acquired resistance,6,0.0,1.0,1.0,3
7448,GO:0010114,response to red light,6,0.0,1.0,1.0,4
7449,GO:0010126,mycothiol metabolic process,6,0.0,1.0,1.0,1
7450,GO:0010145,fructan metabolic process,6,0.0,1.0,1.0,3
7451,GO:0010166,wax metabolic process,6,0.0,1.0,1.0,1
7452,GO:0010182,sugar mediated signaling pathway,6,0.0,1.0,1.0,2
7453,GO:0010185,regulation of cellular defense response,6,0.0,1.0,1.0,2
7454,GO:0010207,photosystem II assembly,6,0.0,1.0,1.0,1
7455,GO:0010208,pollen wall assembly,6,0.0,1.0,1.0,2
7456,GO:0010218,response to far red light,6,0.0,1.0,1.0,2
7457,GO:0010224,response to UV-B,6,0.0,1.0,1.0,1
7458,GO:0010225,response to UV-C,6,0.0,1.0,1.0,1
7459,GO:0010233,phloem transport,6,0.0,1.0,1.0,3
7460,GO:0010257,NADH dehydrogenase complex assembly,6,0.0,1.0,1.0,2
7461,GO:0010275,NAD(P)H dehydrogenase complex assembly,6,0.0,1.0,1.0,1
7462,GO:0010310,regulation of hydrogen peroxide metabolic process,6,0.0,1.0,1.0,4
7463,GO:0010334,sesquiterpene synthase activity,6,0.0,1.0,1.0,13
7464,GO:0010337,regulation of salicylic acid metabolic process,6,0.0,1.0,1.0,1
7465,GO:0010340,carboxyl-O-methyltransferase activity,6,0.0,1.0,1.0,2
7466,GO:0010353,response to trehalose,6,0.0,1.0,1.0,1
7467,GO:0010383,cell wall polysaccharide metabolic process,6,0.0,1.0,1.0,8
7468,GO:0010393,galacturonan metabolic process,6,0.0,1.0,1.0,4
7469,GO:0010454,negative regulation of cell fate commitment,6,0.0,1.0,1.0,9
7470,GO:0010455,positive regulation of cell fate commitment,6,0.0,1.0,1.0,5
7471,GO:0010461,light-activated monoatomic ion channel activity,6,0.0,1.0,1.0,1
7472,GO:0010469,regulation of signaling receptor activity,6,0.0,1.0,1.0,15
7473,GO:0010470,regulation of gastrulation,6,0.0,1.0,1.0,3
7474,GO:0010476,gibberellin mediated signaling pathway,6,0.0,1.0,1.0,1
7475,GO:0010506,regulation of autophagy,6,0.0,1.0,1.0,6
7476,GO:0010514,induction of conjugation with cellular fusion,6,0.0,1.0,1.0,1
7477,GO:0010517,regulation of phospholipase activity,6,0.0,1.0,1.0,4
7478,GO:0010562,positive regulation of phosphorus metabolic process,6,0.0,1.0,1.0,3
7479,GO:0010563,negative regulation of phosphorus metabolic process,6,0.0,1.0,1.0,3
7480,GO:0010566,regulation of ketone biosynthetic process,6,0.0,1.0,1.0,19
7481,GO:0010594,regulation of endothelial cell migration,6,0.0,1.0,1.0,4
7482,GO:0010605,negative regulation of macromolecule metabolic process,6,0.0,1.0,1.0,20
7483,GO:0010624,regulation of Schwann cell proliferation,6,0.0,1.0,1.0,3
7484,GO:0010632,regulation of epithelial cell migration,6,0.0,1.0,1.0,5
7485,GO:0010638,positive regulation of organelle organization,6,0.0,1.0,1.0,24
7486,GO:0010639,negative regulation of organelle organization,6,0.0,1.0,1.0,22
7487,GO:0010640,regulation of platelet-derived growth factor receptor signaling pathway,6,0.0,1.0,1.0,4
7488,GO:0010650,positive regulation of cell communication by electrical coupling,6,0.0,1.0,1.0,1
7489,GO:0010651,negative regulation of cell communication by electrical coupling,6,0.0,1.0,1.0,1
7490,GO:0010658,striated muscle cell apoptotic process,6,0.0,1.0,1.0,1
7491,GO:0010660,regulation of muscle cell apoptotic process,6,0.0,1.0,1.0,4
7492,GO:0010695,regulation of mitotic spindle pole body separation,6,0.0,1.0,1.0,2
7493,GO:0010710,regulation of collagen catabolic process,6,0.0,1.0,1.0,2
7494,GO:0010713,negative regulation of collagen metabolic process,6,0.0,1.0,1.0,2
7495,GO:0010714,positive regulation of collagen metabolic process,6,0.0,1.0,1.0,2
7496,GO:0010715,regulation of extracellular matrix disassembly,6,0.0,1.0,1.0,2
7497,GO:0010718,positive regulation of epithelial to mesenchymal transition,6,0.0,1.0,1.0,3
7498,GO:0010719,negative regulation of epithelial to mesenchymal transition,6,0.0,1.0,1.0,2
7499,GO:0010720,positive regulation of cell development,6,0.0,1.0,1.0,23
7500,GO:0010721,negative regulation of cell development,6,0.0,1.0,1.0,24
7501,GO:0010762,regulation of fibroblast migration,6,0.0,1.0,1.0,3
7502,GO:0010807,regulation of synaptic vesicle priming,6,0.0,1.0,1.0,2
7503,GO:0010811,positive regulation of cell-substrate adhesion,6,0.0,1.0,1.0,4
7504,GO:0010812,negative regulation of cell-substrate adhesion,6,0.0,1.0,1.0,4
7505,GO:0010813,neuropeptide catabolic process,6,0.0,1.0,1.0,1
7506,GO:0010821,regulation of mitochondrion organization,6,0.0,1.0,1.0,7
7507,GO:0010827,regulation of D-glucose transmembrane transport,6,0.0,1.0,1.0,3
7508,GO:0010837,regulation of keratinocyte proliferation,6,0.0,1.0,1.0,2
7509,GO:0010840,"regulation of circadian sleep/wake cycle, wakefulness",6,0.0,1.0,1.0,2
7510,GO:0010888,negative regulation of lipid storage,6,0.0,1.0,1.0,2
7511,GO:0010928,regulation of auxin mediated signaling pathway,6,0.0,1.0,1.0,3
7512,GO:0010946,regulation of meiotic joint molecule formation,6,0.0,1.0,1.0,1
7513,GO:0010948,negative regulation of cell cycle process,6,0.0,1.0,1.0,32
7514,GO:0010959,regulation of metal ion transport,6,0.0,1.0,1.0,6
7515,GO:0010967,regulation of polyamine biosynthetic process,6,0.0,1.0,1.0,1
7516,GO:0010970,transport along microtubule,6,0.0,1.0,1.0,4
7517,GO:0010979,regulation of vitamin D 24-hydroxylase activity,6,0.0,1.0,1.0,1
7518,GO:0010981,regulation of cell wall macromolecule metabolic process,6,0.0,1.0,1.0,6
7519,GO:0012502,induction of programmed cell death,6,0.0,1.0,1.0,1
7520,GO:0014038,regulation of Schwann cell differentiation,6,0.0,1.0,1.0,2
7521,GO:0014717,regulation of satellite cell activation involved in skeletal muscle regeneration,6,0.0,1.0,1.0,2
7522,GO:0014731,spectrin-associated cytoskeleton,6,0.0,1.0,1.0,1
7523,GO:0014743,regulation of muscle hypertrophy,6,0.0,1.0,1.0,6
7524,GO:0014820,tonic smooth muscle contraction,6,0.0,1.0,1.0,2
7525,GO:0014821,phasic smooth muscle contraction,6,0.0,1.0,1.0,5
7526,GO:0014831,gastro-intestinal system smooth muscle contraction,6,0.0,1.0,1.0,3
7527,GO:0014842,regulation of skeletal muscle satellite cell proliferation,6,0.0,1.0,1.0,3
7528,GO:0014848,urinary tract smooth muscle contraction,6,0.0,1.0,1.0,2
7529,GO:0014858,positive regulation of skeletal muscle cell proliferation,6,0.0,1.0,1.0,1
7530,GO:0014859,negative regulation of skeletal muscle cell proliferation,6,0.0,1.0,1.0,1
7531,GO:0014887,cardiac muscle adaptation,6,0.0,1.0,1.0,2
7532,GO:0014891,striated muscle atrophy,6,0.0,1.0,1.0,2
7533,GO:0014902,myotube differentiation,6,0.0,1.0,1.0,2
7534,GO:0014904,myotube cell development,6,0.0,1.0,1.0,2
7535,GO:0014910,regulation of smooth muscle cell migration,6,0.0,1.0,1.0,4
7536,GO:0015031,protein transport,6,0.0,1.0,1.0,20
7537,GO:0015079,potassium ion transmembrane transporter activity,6,0.0,1.0,1.0,10
7538,GO:0015081,sodium ion transmembrane transporter activity,6,0.0,1.0,1.0,12
7539,GO:0015085,calcium ion transmembrane transporter activity,6,0.0,1.0,1.0,3
7540,GO:0015095,magnesium ion transmembrane transporter activity,6,0.0,1.0,1.0,2
7541,GO:0015123,acetate transmembrane transporter activity,6,0.0,1.0,1.0,1
7542,GO:0015125,bile acid transmembrane transporter activity,6,0.0,1.0,1.0,3
7543,GO:0015129,lactate transmembrane transporter activity,6,0.0,1.0,1.0,1
7544,GO:0015133,uronic acid transmembrane transporter activity,6,0.0,1.0,1.0,1
7545,GO:0015137,citrate transmembrane transporter activity,6,0.0,1.0,1.0,1
7546,GO:0015138,fumarate transmembrane transporter activity,6,0.0,1.0,1.0,2
7547,GO:0015139,alpha-ketoglutarate transmembrane transporter activity,6,0.0,1.0,1.0,2
7548,GO:0015140,malate transmembrane transporter activity,6,0.0,1.0,1.0,3
7549,GO:0015141,succinate transmembrane transporter activity,6,0.0,1.0,1.0,4
7550,GO:0015146,pentose transmembrane transporter activity,6,0.0,1.0,1.0,3
7551,GO:0015149,hexose transmembrane transporter activity,6,0.0,1.0,1.0,10
7552,GO:0015155,lactose transmembrane transporter activity,6,0.0,1.0,1.0,2
7553,GO:0015156,melibiose transmembrane transporter activity,6,0.0,1.0,1.0,1
7554,GO:0015180,L-alanine transmembrane transporter activity,6,0.0,1.0,1.0,1
7555,GO:0015182,L-asparagine transmembrane transporter activity,6,0.0,1.0,1.0,2
7556,GO:0015183,L-aspartate transmembrane transporter activity,6,0.0,1.0,1.0,1
7557,GO:0015185,gamma-aminobutyric acid transmembrane transporter activity,6,0.0,1.0,1.0,4
7558,GO:0015186,L-glutamine transmembrane transporter activity,6,0.0,1.0,1.0,4
7559,GO:0015187,glycine transmembrane transporter activity,6,0.0,1.0,1.0,2
7560,GO:0015189,L-lysine transmembrane transporter activity,6,0.0,1.0,1.0,3
7561,GO:0015195,L-threonine transmembrane transporter activity,6,0.0,1.0,1.0,1
7562,GO:0015196,L-tryptophan transmembrane transporter activity,6,0.0,1.0,1.0,2
7563,GO:0015213,uridine transmembrane transporter activity,6,0.0,1.0,1.0,1
7564,GO:0015245,fatty acid transmembrane transporter activity,6,0.0,1.0,1.0,3
7565,GO:0015247,aminophospholipid flippase activity,6,0.0,1.0,1.0,1
7566,GO:0015288,porin activity,6,0.0,1.0,1.0,7
7567,GO:0015294,solute:monoatomic cation symporter activity,6,0.0,1.0,1.0,10
7568,GO:0015355,secondary active monocarboxylate transmembrane transporter activity,6,0.0,1.0,1.0,12
7569,GO:0015450,protein-transporting ATPase activity,6,0.0,1.0,1.0,4
7570,GO:0015499,formate transmembrane transporter activity,6,0.0,1.0,1.0,1
7571,GO:0015513,high-affinity secondary active nitrite transmembrane transporter activity,6,0.0,1.0,1.0,2
7572,GO:0015530,shikimate transmembrane transporter activity,6,0.0,1.0,1.0,1
7573,GO:0015553,xanthosine transmembrane transporter activity,6,0.0,1.0,1.0,1
7574,GO:0015574,trehalose transmembrane transporter activity,6,0.0,1.0,1.0,2
7575,GO:0015629,actin cytoskeleton,6,0.0,1.0,1.0,2
7576,GO:0015705,iodide transport,6,0.0,1.0,1.0,1
7577,GO:0015718,monocarboxylic acid transport,6,0.0,1.0,1.0,27
7578,GO:0015749,monosaccharide transmembrane transport,6,0.0,1.0,1.0,4
7579,GO:0015766,disaccharide transport,6,0.0,1.0,1.0,7
7580,GO:0015780,nucleotide-sugar transmembrane transport,6,0.0,1.0,1.0,2
7581,GO:0015801,aromatic amino acid transport,6,0.0,1.0,1.0,6
7582,GO:0015803,branched-chain amino acid transport,6,0.0,1.0,1.0,3
7583,GO:0015807,L-amino acid transport,6,0.0,1.0,1.0,11
7584,GO:0015812,gamma-aminobutyric acid transport,6,0.0,1.0,1.0,3
7585,GO:0015817,histidine transport,6,0.0,1.0,1.0,1
7586,GO:0015822,ornithine transport,6,0.0,1.0,1.0,2
7587,GO:0015823,phenylalanine transport,6,0.0,1.0,1.0,1
7588,GO:0015824,proline transport,6,0.0,1.0,1.0,1
7589,GO:0015826,threonine transport,6,0.0,1.0,1.0,1
7590,GO:0015833,peptide transport,6,0.0,1.0,1.0,5
7591,GO:0015838,amino-acid betaine transport,6,0.0,1.0,1.0,3
7592,GO:0015840,urea transport,6,0.0,1.0,1.0,1
7593,GO:0015843,methylammonium transport,6,0.0,1.0,1.0,1
7594,GO:0015848,spermidine transport,6,0.0,1.0,1.0,1
7595,GO:0015855,pyrimidine nucleobase transport,6,0.0,1.0,1.0,4
7596,GO:0015858,nucleoside transport,6,0.0,1.0,1.0,7
7597,GO:0015880,coenzyme A transport,6,0.0,1.0,1.0,1
7598,GO:0015916,fatty-acyl-CoA transport,6,0.0,1.0,1.0,1
7599,GO:0015917,aminophospholipid transport,6,0.0,1.0,1.0,1
7600,GO:0015919,peroxisomal membrane transport,6,0.0,1.0,1.0,3
7601,GO:0015945,methanol metabolic process,6,0.0,1.0,1.0,4
7602,GO:0015949,nucleobase-containing small molecule interconversion,6,0.0,1.0,1.0,4
7603,GO:0015995,chlorophyll biosynthetic process,6,0.0,1.0,1.0,4
7604,GO:0015996,chlorophyll catabolic process,6,0.0,1.0,1.0,2
7605,GO:0016045,detection of bacterium,6,0.0,1.0,1.0,1
7606,GO:0016046,detection of fungus,6,0.0,1.0,1.0,2
7607,GO:0016055,Wnt signaling pathway,6,0.0,1.0,1.0,5
7608,GO:0016064,immunoglobulin mediated immune response,6,0.0,1.0,1.0,6
7609,GO:0016070,RNA metabolic process,6,0.0,1.0,1.0,18
7610,GO:0016090,prenol metabolic process,6,0.0,1.0,1.0,2
7611,GO:0016093,polyprenol metabolic process,6,0.0,1.0,1.0,5
7612,GO:0016128,phytosteroid metabolic process,6,0.0,1.0,1.0,4
7613,GO:0016134,saponin metabolic process,6,0.0,1.0,1.0,3
7614,GO:0016138,glycoside biosynthetic process,6,0.0,1.0,1.0,13
7615,GO:0016139,glycoside catabolic process,6,0.0,1.0,1.0,7
7616,GO:0016144,S-glycoside biosynthetic process,6,0.0,1.0,1.0,2
7617,GO:0016145,S-glycoside catabolic process,6,0.0,1.0,1.0,2
7618,GO:0016226,iron-sulfur cluster assembly,6,0.0,1.0,1.0,7
7619,GO:0016262,protein N-acetylglucosaminyltransferase activity,6,0.0,1.0,1.0,1
7620,GO:0016273,arginine N-methyltransferase activity,6,0.0,1.0,1.0,1
7621,GO:0016278,lysine N-methyltransferase activity,6,0.0,1.0,1.0,1
7622,GO:0016321,female meiosis chromosome segregation,6,0.0,1.0,1.0,1
7623,GO:0016406,carnitine O-acyltransferase activity,6,0.0,1.0,1.0,3
7624,GO:0016411,acylglycerol O-acyltransferase activity,6,0.0,1.0,1.0,5
7625,GO:0016412,serine O-acyltransferase activity,6,0.0,1.0,1.0,1
7626,GO:0016413,O-acetyltransferase activity,6,0.0,1.0,1.0,27
7627,GO:0016416,O-palmitoyltransferase activity,6,0.0,1.0,1.0,3
7628,GO:0016418,S-acetyltransferase activity,6,0.0,1.0,1.0,5
7629,GO:0016419,S-malonyltransferase activity,6,0.0,1.0,1.0,1
7630,GO:0016453,C-acetyltransferase activity,6,0.0,1.0,1.0,3
7631,GO:0016454,C-palmitoyltransferase activity,6,0.0,1.0,1.0,1
7632,GO:0016485,protein processing,6,0.0,1.0,1.0,12
7633,GO:0016581,NuRD complex,6,0.0,1.0,1.0,1
7634,GO:0016587,Isw1 complex,6,0.0,1.0,1.0,2
7635,GO:0016749,N-succinyltransferase activity,6,0.0,1.0,1.0,3
7636,GO:0016750,O-succinyltransferase activity,6,0.0,1.0,1.0,2
7637,GO:0016751,S-succinyltransferase activity,6,0.0,1.0,1.0,1
7638,GO:0016753,O-sinapoyltransferase activity,6,0.0,1.0,1.0,3
7639,GO:0016759,cellulose synthase activity,6,0.0,1.0,1.0,2
7640,GO:0016796,"exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",6,0.0,1.0,1.0,2
7641,GO:0016893,"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",6,0.0,1.0,1.0,2
7642,GO:0016894,"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters",6,0.0,1.0,1.0,2
7643,GO:0016922,nuclear receptor binding,6,0.0,1.0,1.0,8
7644,GO:0016937,short-chain fatty acyl-CoA dehydrogenase activity,6,0.0,1.0,1.0,2
7645,GO:0017004,cytochrome complex assembly,6,0.0,1.0,1.0,6
7646,GO:0017006,protein-tetrapyrrole linkage,6,0.0,1.0,1.0,2
7647,GO:0017014,protein nitrosylation,6,0.0,1.0,1.0,1
7648,GO:0017070,U6 snRNA binding,6,0.0,1.0,1.0,1
7649,GO:0017110,nucleoside diphosphate phosphatase activity,6,0.0,1.0,1.0,10
7650,GO:0017111,ribonucleoside triphosphate phosphatase activity,6,0.0,1.0,1.0,5
7651,GO:0017116,single-stranded DNA helicase activity,6,0.0,1.0,1.0,1
7652,GO:0017136,"histone deacetylase activity, NAD-dependent",6,0.0,1.0,1.0,6
7653,GO:0017150,tRNA dihydrouridine synthase activity,6,0.0,1.0,1.0,6
7654,GO:0018030,peptidyl-lysine N6-myristoyltransferase activity,6,0.0,1.0,1.0,2
7655,GO:0018031,peptidyl-lysine N6-palmitoyltransferase activity,6,0.0,1.0,1.0,2
7656,GO:0018126,protein hydroxylation,6,0.0,1.0,1.0,4
7657,GO:0018143,nucleic acid-protein covalent cross-linking,6,0.0,1.0,1.0,1
7658,GO:0018149,peptide cross-linking,6,0.0,1.0,1.0,2
7659,GO:0018158,protein oxidation,6,0.0,1.0,1.0,2
7660,GO:0018175,protein nucleotidylation,6,0.0,1.0,1.0,3
7661,GO:0018193,peptidyl-amino acid modification,6,0.0,1.0,1.0,21
7662,GO:0018214,protein carboxylation,6,0.0,1.0,1.0,1
7663,GO:0018215,protein phosphopantetheinylation,6,0.0,1.0,1.0,1
7664,GO:0018246,protein-coenzyme A linkage,6,0.0,1.0,1.0,1
7665,GO:0018249,protein dehydration,6,0.0,1.0,1.0,1
7666,GO:0018277,protein deamination,6,0.0,1.0,1.0,1
7667,GO:0018282,metal incorporation into metallo-sulfur cluster,6,0.0,1.0,1.0,4
7668,GO:0018342,protein prenylation,6,0.0,1.0,1.0,2
7669,GO:0018352,protein-pyridoxal-5-phosphate linkage,6,0.0,1.0,1.0,1
7670,GO:0018411,protein glucuronidation,6,0.0,1.0,1.0,1
7671,GO:0018488,aryl-aldehyde oxidase activity,6,0.0,1.0,1.0,2
7672,GO:0018812,3-hydroxyacyl-CoA dehydratase activity,6,0.0,1.0,1.0,1
7673,GO:0018873,atrazine metabolic process,6,0.0,1.0,1.0,1
7674,GO:0018891,cyclohexanol metabolic process,6,0.0,1.0,1.0,1
7675,GO:0018925,m-cresol metabolic process,6,0.0,1.0,1.0,1
7676,GO:0018964,propylene metabolic process,6,0.0,1.0,1.0,1
7677,GO:0018971,anaerobic toluene metabolic process,6,0.0,1.0,1.0,1
7678,GO:0018973,trinitrotoluene metabolic process,6,0.0,1.0,1.0,2
7679,GO:0018977,"1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process",6,0.0,1.0,1.0,2
7680,GO:0018979,trichloroethylene metabolic process,6,0.0,1.0,1.0,1
7681,GO:0018985,pronuclear envelope synthesis,6,0.0,1.0,1.0,1
7682,GO:0019001,guanyl nucleotide binding,6,0.0,1.0,1.0,2
7683,GO:0019005,SCF ubiquitin ligase complex,6,0.0,1.0,1.0,18
7684,GO:0019054,modulation by virus of host cellular process,6,0.0,1.0,1.0,7
7685,GO:0019057,symbiont-mediated perturbation of host translation,6,0.0,1.0,1.0,1
7686,GO:0019062,virion attachment to host cell,6,0.0,1.0,1.0,5
7687,GO:0019064,fusion of virus membrane with host plasma membrane,6,0.0,1.0,1.0,1
7688,GO:0019115,benzaldehyde dehydrogenase [NAD(P)+] activity,6,0.0,1.0,1.0,2
7689,GO:0019118,phenanthrene-epoxide hydrolase activity,6,0.0,1.0,1.0,1
7690,GO:0019144,ADP-sugar diphosphatase activity,6,0.0,1.0,1.0,2
7691,GO:0019187,"beta-1,4-mannosyltransferase activity",6,0.0,1.0,1.0,3
7692,GO:0019191,cellobiose transmembrane transporter activity,6,0.0,1.0,1.0,1
7693,GO:0019199,transmembrane receptor protein kinase activity,6,0.0,1.0,1.0,3
7694,GO:0019203,carbohydrate phosphatase activity,6,0.0,1.0,1.0,1
7695,GO:0019206,nucleoside kinase activity,6,0.0,1.0,1.0,6
7696,GO:0019216,regulation of lipid metabolic process,6,0.0,1.0,1.0,11
7697,GO:0019219,regulation of nucleobase-containing compound metabolic process,6,0.0,1.0,1.0,18
7698,GO:0019220,regulation of phosphate metabolic process,6,0.0,1.0,1.0,17
7699,GO:0019221,cytokine-mediated signaling pathway,6,0.0,1.0,1.0,41
7700,GO:0019257,4-nitrotoluene metabolic process,6,0.0,1.0,1.0,1
7701,GO:0019290,siderophore biosynthetic process,6,0.0,1.0,1.0,7
7702,GO:0019318,hexose metabolic process,6,0.0,1.0,1.0,10
7703,GO:0019321,pentose metabolic process,6,0.0,1.0,1.0,7
7704,GO:0019350,teichoic acid biosynthetic process,6,0.0,1.0,1.0,6
7705,GO:0019400,alditol metabolic process,6,0.0,1.0,1.0,6
7706,GO:0019497,hexachlorocyclohexane metabolic process,6,0.0,1.0,1.0,2
7707,GO:0019530,taurine metabolic process,6,0.0,1.0,1.0,3
7708,GO:0019531,oxalate transmembrane transporter activity,6,0.0,1.0,1.0,1
7709,GO:0019600,toluene oxidation,6,0.0,1.0,1.0,5
7710,GO:0019614,catechol-containing compound catabolic process,6,0.0,1.0,1.0,13
7711,GO:0019634,organic phosphonate metabolic process,6,0.0,1.0,1.0,2
7712,GO:0019660,glycolytic fermentation,6,0.0,1.0,1.0,7
7713,GO:0019662,non-glycolytic fermentation,6,0.0,1.0,1.0,6
7714,GO:0019665,anaerobic amino acid catabolic process,6,0.0,1.0,1.0,5
7715,GO:0019666,nitrogenous compound fermentation,6,0.0,1.0,1.0,6
7716,GO:0019685,"photosynthesis, dark reaction",6,0.0,1.0,1.0,3
7717,GO:0019707,protein-cysteine S-acyltransferase activity,6,0.0,1.0,1.0,5
7718,GO:0019720,Mo-molybdopterin cofactor metabolic process,6,0.0,1.0,1.0,4
7719,GO:0019760,glucosinolate metabolic process,6,0.0,1.0,1.0,3
7720,GO:0019775,FAT10 transferase activity,6,0.0,1.0,1.0,2
7721,GO:0019777,Atg12 transferase activity,6,0.0,1.0,1.0,2
7722,GO:0019788,NEDD8 transferase activity,6,0.0,1.0,1.0,2
7723,GO:0019789,SUMO transferase activity,6,0.0,1.0,1.0,2
7724,GO:0019798,procollagen-proline dioxygenase activity,6,0.0,1.0,1.0,2
7725,GO:0019829,ATPase-coupled monoatomic cation transmembrane transporter activity,6,0.0,1.0,1.0,20
7726,GO:0019870,potassium channel inhibitor activity,6,0.0,1.0,1.0,3
7727,GO:0021522,spinal cord motor neuron differentiation,6,0.0,1.0,1.0,3
7728,GO:0021792,chemoattraction of branchiomotor axon,6,0.0,1.0,1.0,2
7729,GO:0021793,chemorepulsion of branchiomotor axon,6,0.0,1.0,1.0,2
7730,GO:0021795,cerebral cortex cell migration,6,0.0,1.0,1.0,2
7731,GO:0021826,substrate-independent telencephalic tangential migration,6,0.0,1.0,1.0,2
7732,GO:0021879,forebrain neuron differentiation,6,0.0,1.0,1.0,2
7733,GO:0021884,forebrain neuron development,6,0.0,1.0,1.0,2
7734,GO:0021895,cerebral cortex neuron differentiation,6,0.0,1.0,1.0,5
7735,GO:0021898,commitment of multipotent stem cells to neuronal lineage in forebrain,6,0.0,1.0,1.0,3
7736,GO:0021921,regulation of cell proliferation in dorsal spinal cord,6,0.0,1.0,1.0,2
7737,GO:0021936,regulation of cerebellar granule cell precursor proliferation,6,0.0,1.0,1.0,2
7738,GO:0021980,subpallium cell migration,6,0.0,1.0,1.0,1
7739,GO:0022028,tangential migration from the subventricular zone to the olfactory bulb,6,0.0,1.0,1.0,2
7740,GO:0022030,telencephalon glial cell migration,6,0.0,1.0,1.0,5
7741,GO:0022408,negative regulation of cell-cell adhesion,6,0.0,1.0,1.0,12
7742,GO:0022409,positive regulation of cell-cell adhesion,6,0.0,1.0,1.0,11
7743,GO:0022617,extracellular matrix disassembly,6,0.0,1.0,1.0,2
7744,GO:0022618,protein-RNA complex assembly,6,0.0,1.0,1.0,24
7745,GO:0022810,membrane potential driven uniporter activity,6,0.0,1.0,1.0,5
7746,GO:0022832,voltage-gated channel activity,6,0.0,1.0,1.0,1
7747,GO:0022834,ligand-gated channel activity,6,0.0,1.0,1.0,5
7748,GO:0022840,leak channel activity,6,0.0,1.0,1.0,1
7749,GO:0022898,regulation of transmembrane transporter activity,6,0.0,1.0,1.0,5
7750,GO:0023058,adaptation of signaling pathway,6,0.0,1.0,1.0,3
7751,GO:0023061,signal release,6,0.0,1.0,1.0,10
7752,GO:0030001,metal ion transport,6,0.0,1.0,1.0,8
7753,GO:0030016,myofibril,6,0.0,1.0,1.0,2
7754,GO:0030036,actin cytoskeleton organization,6,0.0,1.0,1.0,9
7755,GO:0030098,lymphocyte differentiation,6,0.0,1.0,1.0,3
7756,GO:0030100,regulation of endocytosis,6,0.0,1.0,1.0,9
7757,GO:0030111,regulation of Wnt signaling pathway,6,0.0,1.0,1.0,5
7758,GO:0030216,keratinocyte differentiation,6,0.0,1.0,1.0,2
7759,GO:0030225,macrophage differentiation,6,0.0,1.0,1.0,1
7760,GO:0030261,chromosome condensation,6,0.0,1.0,1.0,4
7761,GO:0030277,maintenance of gastrointestinal epithelium,6,0.0,1.0,1.0,1
7762,GO:0030283,testosterone dehydrogenase [NAD(P)+] activity,6,0.0,1.0,1.0,1
7763,GO:0030291,protein serine/threonine kinase inhibitor activity,6,0.0,1.0,1.0,4
7764,GO:0030292,protein tyrosine kinase inhibitor activity,6,0.0,1.0,1.0,2
7765,GO:0030296,protein tyrosine kinase activator activity,6,0.0,1.0,1.0,2
7766,GO:0030307,positive regulation of cell growth,6,0.0,1.0,1.0,10
7767,GO:0030308,negative regulation of cell growth,6,0.0,1.0,1.0,11
7768,GO:0030316,osteoclast differentiation,6,0.0,1.0,1.0,1
7769,GO:0030335,positive regulation of cell migration,6,0.0,1.0,1.0,21
7770,GO:0030336,negative regulation of cell migration,6,0.0,1.0,1.0,23
7771,GO:0030391,fructosamine biosynthetic process,6,0.0,1.0,1.0,1
7772,GO:0030392,fructosamine catabolic process,6,0.0,1.0,1.0,1
7773,GO:0030422,siRNA processing,6,0.0,1.0,1.0,2
7774,GO:0030449,regulation of complement activation,6,0.0,1.0,1.0,6
7775,GO:0030474,spindle pole body duplication,6,0.0,1.0,1.0,1
7776,GO:0030493,bacteriochlorophyll metabolic process,6,0.0,1.0,1.0,2
7777,GO:0030500,regulation of bone mineralization,6,0.0,1.0,1.0,3
7778,GO:0030522,intracellular receptor signaling pathway,6,0.0,1.0,1.0,4
7779,GO:0030533,triplet codon-amino acid adaptor activity,6,0.0,1.0,1.0,64
7780,GO:0030554,adenyl nucleotide binding,6,0.0,1.0,1.0,4
7781,GO:0030556,rRNA modification guide activity,6,0.0,1.0,1.0,2
7782,GO:0030557,tRNA modification guide activity,6,0.0,1.0,1.0,2
7783,GO:0030558,RNA pseudouridylation guide activity,6,0.0,1.0,1.0,3
7784,GO:0030561,RNA 2'-O-ribose methylation guide activity,6,0.0,1.0,1.0,3
7785,GO:0030566,snRNA modification guide activity,6,0.0,1.0,1.0,2
7786,GO:0030575,nuclear body organization,6,0.0,1.0,1.0,5
7787,GO:0030584,sporocarp development,6,0.0,1.0,1.0,2
7788,GO:0030641,regulation of cellular pH,6,0.0,1.0,1.0,1
7789,GO:0030647,aminoglycoside antibiotic metabolic process,6,0.0,1.0,1.0,9
7790,GO:0030652,peptide antibiotic catabolic process,6,0.0,1.0,1.0,1
7791,GO:0030654,beta-lactam antibiotic biosynthetic process,6,0.0,1.0,1.0,4
7792,GO:0030655,beta-lactam antibiotic catabolic process,6,0.0,1.0,1.0,4
7793,GO:0030656,regulation of vitamin metabolic process,6,0.0,1.0,1.0,10
7794,GO:0030658,transport vesicle membrane,6,0.0,1.0,1.0,8
7795,GO:0030660,Golgi-associated vesicle membrane,6,0.0,1.0,1.0,2
7796,GO:0030662,coated vesicle membrane,6,0.0,1.0,1.0,3
7797,GO:0030666,endocytic vesicle membrane,6,0.0,1.0,1.0,3
7798,GO:0030681,multimeric ribonuclease P complex,6,0.0,1.0,1.0,2
7799,GO:0030710,regulation of border follicle cell delamination,6,0.0,1.0,1.0,2
7800,GO:0030725,germline ring canal formation,6,0.0,1.0,1.0,2
7801,GO:0030851,granulocyte differentiation,6,0.0,1.0,1.0,3
7802,GO:0030857,negative regulation of epithelial cell differentiation,6,0.0,1.0,1.0,13
7803,GO:0030858,positive regulation of epithelial cell differentiation,6,0.0,1.0,1.0,12
7804,GO:0030860,regulation of polarized epithelial cell differentiation,6,0.0,1.0,1.0,2
7805,GO:0030863,cortical cytoskeleton,6,0.0,1.0,1.0,3
7806,GO:0030865,cortical cytoskeleton organization,6,0.0,1.0,1.0,3
7807,GO:0030885,regulation of myeloid dendritic cell activation,6,0.0,1.0,1.0,2
7808,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,6,0.0,1.0,1.0,2
7809,GO:0030952,establishment or maintenance of cytoskeleton polarity,6,0.0,1.0,1.0,4
7810,GO:0030968,endoplasmic reticulum unfolded protein response,6,0.0,1.0,1.0,3
7811,GO:0030983,mismatched DNA binding,6,0.0,1.0,1.0,9
7812,GO:0030997,regulation of centriole-centriole cohesion,6,0.0,1.0,1.0,2
7813,GO:0031055,chromatin remodeling at centromere,6,0.0,1.0,1.0,1
7814,GO:0031098,stress-activated protein kinase signaling cascade,6,0.0,1.0,1.0,1
7815,GO:0031127,"alpha-(1,2)-fucosyltransferase activity",6,0.0,1.0,1.0,1
7816,GO:0031170,ferricrocin metabolic process,6,0.0,1.0,1.0,1
7817,GO:0031175,neuron projection development,6,0.0,1.0,1.0,8
7818,GO:0031221,arabinan metabolic process,6,0.0,1.0,1.0,2
7819,GO:0031268,pseudopodium organization,6,0.0,1.0,1.0,2
7820,GO:0031333,negative regulation of protein-containing complex assembly,6,0.0,1.0,1.0,32
7821,GO:0031334,positive regulation of protein-containing complex assembly,6,0.0,1.0,1.0,32
7822,GO:0031335,regulation of sulfur amino acid metabolic process,6,0.0,1.0,1.0,5
7823,GO:0031338,regulation of vesicle fusion,6,0.0,1.0,1.0,6
7824,GO:0031345,negative regulation of cell projection organization,6,0.0,1.0,1.0,10
7825,GO:0031346,positive regulation of cell projection organization,6,0.0,1.0,1.0,10
7826,GO:0031348,negative regulation of defense response,6,0.0,1.0,1.0,12
7827,GO:0031365,N-terminal protein amino acid modification,6,0.0,1.0,1.0,8
7828,GO:0031379,RNA-directed RNA polymerase complex,6,0.0,1.0,1.0,3
7829,GO:0031414,N-terminal protein acetyltransferase complex,6,0.0,1.0,1.0,3
7830,GO:0031420,alkali metal ion binding,6,0.0,1.0,1.0,3
7831,GO:0031456,glycine betaine biosynthetic process,6,0.0,1.0,1.0,2
7832,GO:0031468,nuclear membrane reassembly,6,0.0,1.0,1.0,2
7833,GO:0031505,fungal-type cell wall organization,6,0.0,1.0,1.0,2
7834,GO:0031529,ruffle organization,6,0.0,1.0,1.0,1
7835,GO:0031537,regulation of anthocyanin metabolic process,6,0.0,1.0,1.0,4
7836,GO:0031544,peptidyl-proline 3-dioxygenase activity,6,0.0,1.0,1.0,1
7837,GO:0031545,peptidyl-proline 4-dioxygenase activity,6,0.0,1.0,1.0,2
7838,GO:0031548,regulation of brain-derived neurotrophic factor receptor signaling pathway,6,0.0,1.0,1.0,2
7839,GO:0031580,membrane raft distribution,6,0.0,1.0,1.0,2
7840,GO:0031597,cytosolic proteasome complex,6,0.0,1.0,1.0,1
7841,GO:0031641,regulation of myelination,6,0.0,1.0,1.0,2
7842,GO:0031645,negative regulation of nervous system process,6,0.0,1.0,1.0,7
7843,GO:0031646,positive regulation of nervous system process,6,0.0,1.0,1.0,7
7844,GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway,6,0.0,1.0,1.0,2
7845,GO:0031705,bombesin receptor binding,6,0.0,1.0,1.0,5
7846,GO:0031739,cholecystokinin receptor binding,6,0.0,1.0,1.0,2
7847,GO:0031763,galanin receptor binding,6,0.0,1.0,1.0,3
7848,GO:0031776,melanin-concentrating hormone receptor binding,6,0.0,1.0,1.0,2
7849,GO:0031779,melanocortin receptor binding,6,0.0,1.0,1.0,5
7850,GO:0031834,neurokinin receptor binding,6,0.0,1.0,1.0,3
7851,GO:0031841,neuropeptide Y receptor binding,6,0.0,1.0,1.0,4
7852,GO:0031846,neurotensin receptor binding,6,0.0,1.0,1.0,1
7853,GO:0031877,somatostatin receptor binding,6,0.0,1.0,1.0,5
7854,GO:0031890,vasoactive intestinal polypeptide receptor binding,6,0.0,1.0,1.0,2
7855,GO:0031903,microbody membrane,6,0.0,1.0,1.0,1
7856,GO:0031906,late endosome lumen,6,0.0,1.0,1.0,1
7857,GO:0031920,pyridoxal transport,6,0.0,1.0,1.0,1
7858,GO:0031922,pyridoxamine transport,6,0.0,1.0,1.0,1
7859,GO:0031923,pyridoxine transport,6,0.0,1.0,1.0,1
7860,GO:0031929,TOR signaling,6,0.0,1.0,1.0,2
7861,GO:0031976,plastid thylakoid,6,0.0,1.0,1.0,3
7862,GO:0032005,signal transduction involved in positive regulation of conjugation with cellular fusion,6,0.0,1.0,1.0,1
7863,GO:0032028,myosin head/neck binding,6,0.0,1.0,1.0,3
7864,GO:0032029,myosin tail binding,6,0.0,1.0,1.0,3
7865,GO:0032037,myosin I heavy chain binding,6,0.0,1.0,1.0,2
7866,GO:0032038,myosin II heavy chain binding,6,0.0,1.0,1.0,2
7867,GO:0032069,regulation of nuclease activity,6,0.0,1.0,1.0,5
7868,GO:0032096,negative regulation of response to food,6,0.0,1.0,1.0,2
7869,GO:0032097,positive regulation of response to food,6,0.0,1.0,1.0,2
7870,GO:0032131,alkylated DNA binding,6,0.0,1.0,1.0,1
7871,GO:0032156,septin cytoskeleton,6,0.0,1.0,1.0,6
7872,GO:0032185,septin cytoskeleton organization,6,0.0,1.0,1.0,2
7873,GO:0032200,telomere organization,6,0.0,1.0,1.0,2
7874,GO:0032240,negative regulation of nucleobase-containing compound transport,6,0.0,1.0,1.0,5
7875,GO:0032241,positive regulation of nucleobase-containing compound transport,6,0.0,1.0,1.0,5
7876,GO:0032242,regulation of nucleoside transport,6,0.0,1.0,1.0,4
7877,GO:0032255,maintenance of secretory granule location,6,0.0,1.0,1.0,1
7878,GO:0032271,regulation of protein polymerization,6,0.0,1.0,1.0,6
7879,GO:0032288,myelin assembly,6,0.0,1.0,1.0,2
7880,GO:0032296,double-stranded RNA-specific ribonuclease activity,6,0.0,1.0,1.0,1
7881,GO:0032324,molybdopterin cofactor biosynthetic process,6,0.0,1.0,1.0,2
7882,GO:0032325,molybdopterin cofactor catabolic process,6,0.0,1.0,1.0,2
7883,GO:0032328,alanine transport,6,0.0,1.0,1.0,2
7884,GO:0032329,serine transport,6,0.0,1.0,1.0,4
7885,GO:0032330,regulation of chondrocyte differentiation,6,0.0,1.0,1.0,4
7886,GO:0032351,negative regulation of hormone metabolic process,6,0.0,1.0,1.0,9
7887,GO:0032352,positive regulation of hormone metabolic process,6,0.0,1.0,1.0,10
7888,GO:0032356,oxidized DNA binding,6,0.0,1.0,1.0,2
7889,GO:0032366,intracellular sterol transport,6,0.0,1.0,1.0,1
7890,GO:0032369,negative regulation of lipid transport,6,0.0,1.0,1.0,12
7891,GO:0032377,regulation of intracellular lipid transport,6,0.0,1.0,1.0,3
7892,GO:0032387,negative regulation of intracellular transport,6,0.0,1.0,1.0,16
7893,GO:0032388,positive regulation of intracellular transport,6,0.0,1.0,1.0,17
7894,GO:0032401,establishment of melanosome localization,6,0.0,1.0,1.0,1
7895,GO:0032410,negative regulation of transporter activity,6,0.0,1.0,1.0,4
7896,GO:0032411,positive regulation of transporter activity,6,0.0,1.0,1.0,4
7897,GO:0032453,histone H3K4 demethylase activity,6,0.0,1.0,1.0,2
7898,GO:0032454,histone H3K9 demethylase activity,6,0.0,1.0,1.0,3
7899,GO:0032456,endocytic recycling,6,0.0,1.0,1.0,3
7900,GO:0032459,regulation of protein oligomerization,6,0.0,1.0,1.0,4
7901,GO:0032465,regulation of cytokinesis,6,0.0,1.0,1.0,4
7902,GO:0032499,detection of peptidoglycan,6,0.0,1.0,1.0,1
7903,GO:0032509,endosome transport via multivesicular body sorting pathway,6,0.0,1.0,1.0,2
7904,GO:0032528,microvillus organization,6,0.0,1.0,1.0,2
7905,GO:0032550,purine ribonucleoside binding,6,0.0,1.0,1.0,1
7906,GO:0032554,purine deoxyribonucleotide binding,6,0.0,1.0,1.0,2
7907,GO:0032555,purine ribonucleotide binding,6,0.0,1.0,1.0,5
7908,GO:0032557,pyrimidine ribonucleotide binding,6,0.0,1.0,1.0,2
7909,GO:0032572,response to menaquinone,6,0.0,1.0,1.0,1
7910,GO:0032573,response to phylloquinone,6,0.0,1.0,1.0,1
7911,GO:0032576,O-linoleoyltransferase activity,6,0.0,1.0,1.0,1
7912,GO:0032769,negative regulation of monooxygenase activity,6,0.0,1.0,1.0,2
7913,GO:0032770,positive regulation of monooxygenase activity,6,0.0,1.0,1.0,5
7914,GO:0032771,regulation of tyrosinase activity,6,0.0,1.0,1.0,1
7915,GO:0032790,ribosome disassembly,6,0.0,1.0,1.0,1
7916,GO:0032796,uropod organization,6,0.0,1.0,1.0,2
7917,GO:0032836,glomerular basement membrane development,6,0.0,1.0,1.0,2
7918,GO:0032839,dendrite cytoplasm,6,0.0,1.0,1.0,1
7919,GO:0032887,regulation of spindle elongation,6,0.0,1.0,1.0,2
7920,GO:0032891,negative regulation of organic acid transport,6,0.0,1.0,1.0,19
7921,GO:0032892,positive regulation of organic acid transport,6,0.0,1.0,1.0,19
7922,GO:0032917,polyamine acetylation,6,0.0,1.0,1.0,3
7923,GO:0032944,regulation of mononuclear cell proliferation,6,0.0,1.0,1.0,3
7924,GO:0032954,regulation of cytokinetic process,6,0.0,1.0,1.0,5
7925,GO:0032965,regulation of collagen biosynthetic process,6,0.0,1.0,1.0,2
7926,GO:0032973,amino acid export across plasma membrane,6,0.0,1.0,1.0,2
7927,GO:0032974,amino acid transmembrane export from vacuole,6,0.0,1.0,1.0,8
7928,GO:0032975,amino acid transmembrane import into vacuole,6,0.0,1.0,1.0,5
7929,GO:0032986,protein-DNA complex disassembly,6,0.0,1.0,1.0,2
7930,GO:0032987,protein-lipid complex disassembly,6,0.0,1.0,1.0,1
7931,GO:0032988,protein-RNA complex disassembly,6,0.0,1.0,1.0,2
7932,GO:0033003,regulation of mast cell activation,6,0.0,1.0,1.0,3
7933,GO:0033018,sarcoplasmic reticulum lumen,6,0.0,1.0,1.0,2
7934,GO:0033032,regulation of myeloid cell apoptotic process,6,0.0,1.0,1.0,6
7935,GO:0033044,regulation of chromosome organization,6,0.0,1.0,1.0,13
7936,GO:0033068,macrolide biosynthetic process,6,0.0,1.0,1.0,4
7937,GO:0033075,isoquinoline alkaloid biosynthetic process,6,0.0,1.0,1.0,4
7938,GO:0033108,mitochondrial respiratory chain complex assembly,6,0.0,1.0,1.0,4
7939,GO:0033176,proton-transporting V-type ATPase complex,6,0.0,1.0,1.0,2
7940,GO:0033207,"beta-1,4-N-acetylgalactosaminyltransferase activity",6,0.0,1.0,1.0,1
7941,GO:0033229,cysteine transmembrane transporter activity,6,0.0,1.0,1.0,1
7942,GO:0033239,negative regulation of amine metabolic process,6,0.0,1.0,1.0,10
7943,GO:0033240,positive regulation of amine metabolic process,6,0.0,1.0,1.0,9
7944,GO:0033241,regulation of amine catabolic process,6,0.0,1.0,1.0,4
7945,GO:0033244,regulation of penicillin metabolic process,6,0.0,1.0,1.0,4
7946,GO:0033283,ATPase-coupled organic acid transmembrane transporter activity,6,0.0,1.0,1.0,2
7947,GO:0033293,monocarboxylic acid binding,6,0.0,1.0,1.0,14
7948,GO:0033302,quercetin O-glucoside metabolic process,6,0.0,1.0,1.0,1
7949,GO:0033304,chlorophyll a metabolic process,6,0.0,1.0,1.0,2
7950,GO:0033347,tetrose metabolic process,6,0.0,1.0,1.0,2
7951,GO:0033363,secretory granule organization,6,0.0,1.0,1.0,7
7952,GO:0033366,protein localization to secretory granule,6,0.0,1.0,1.0,2
7953,GO:0033379,maintenance of protease location in T cell secretory granule,6,0.0,1.0,1.0,1
7954,GO:0033397,zeatin metabolic process,6,0.0,1.0,1.0,3
7955,GO:0033492,esculetin metabolic process,6,0.0,1.0,1.0,1
7956,GO:0033530,raffinose metabolic process,6,0.0,1.0,1.0,2
7957,GO:0033531,stachyose metabolic process,6,0.0,1.0,1.0,1
7958,GO:0033533,verbascose metabolic process,6,0.0,1.0,1.0,1
7959,GO:0033535,ajugose metabolic process,6,0.0,1.0,1.0,1
7960,GO:0033591,response to L-ascorbic acid,6,0.0,1.0,1.0,1
7961,GO:0033595,response to genistein,6,0.0,1.0,1.0,1
7962,GO:0033599,regulation of mammary gland epithelial cell proliferation,6,0.0,1.0,1.0,3
7963,GO:0033619,membrane protein proteolysis,6,0.0,1.0,1.0,3
7964,GO:0033623,regulation of integrin activation,6,0.0,1.0,1.0,2
7965,GO:0033629,negative regulation of cell adhesion mediated by integrin,6,0.0,1.0,1.0,1
7966,GO:0033630,positive regulation of cell adhesion mediated by integrin,6,0.0,1.0,1.0,1
7967,GO:0033632,regulation of cell-cell adhesion mediated by integrin,6,0.0,1.0,1.0,2
7968,GO:0033648,host intracellular membrane-bounded organelle,6,0.0,1.0,1.0,11
7969,GO:0033721,aldehyde dehydrogenase (NADP+) activity,6,0.0,1.0,1.0,4
7970,GO:0033840,"alpha-1,4-glucan glucosyltransferase (NDP-glucose donor) activity",6,0.0,1.0,1.0,2
7971,GO:0033931,endogalactosaminidase activity,6,0.0,1.0,1.0,1
7972,GO:0034040,ATPase-coupled lipid transmembrane transporter activity,6,0.0,1.0,1.0,3
7973,GO:0034062,5'-3' RNA polymerase activity,6,0.0,1.0,1.0,2
7974,GO:0034067,protein localization to Golgi apparatus,6,0.0,1.0,1.0,3
7975,GO:0034110,regulation of homotypic cell-cell adhesion,6,0.0,1.0,1.0,4
7976,GO:0034114,regulation of heterotypic cell-cell adhesion,6,0.0,1.0,1.0,3
7977,GO:0034204,lipid translocation,6,0.0,1.0,1.0,3
7978,GO:0034239,regulation of macrophage fusion,6,0.0,1.0,1.0,2
7979,GO:0034242,negative regulation of syncytium formation by plasma membrane fusion,6,0.0,1.0,1.0,2
7980,GO:0034249,negative regulation of amide metabolic process,6,0.0,1.0,1.0,18
7981,GO:0034250,positive regulation of amide metabolic process,6,0.0,1.0,1.0,19
7982,GO:0034251,regulation of amide catabolic process,6,0.0,1.0,1.0,3
7983,GO:0034255,regulation of urea metabolic process,6,0.0,1.0,1.0,1
7984,GO:0034264,isopentenyl adenine metabolic process,6,0.0,1.0,1.0,2
7985,GO:0034286,response to maltose,6,0.0,1.0,1.0,2
7986,GO:0034287,detection of monosaccharide stimulus,6,0.0,1.0,1.0,1
7987,GO:0034288,detection of disaccharide stimulus,6,0.0,1.0,1.0,2
7988,GO:0034306,regulation of sexual sporulation,6,0.0,1.0,1.0,1
7989,GO:0034309,primary alcohol biosynthetic process,6,0.0,1.0,1.0,18
7990,GO:0034310,primary alcohol catabolic process,6,0.0,1.0,1.0,11
7991,GO:0034311,diol metabolic process,6,0.0,1.0,1.0,10
7992,GO:0034318,alcohol O-acyltransferase activity,6,0.0,1.0,1.0,1
7993,GO:0034332,adherens junction organization,6,0.0,1.0,1.0,3
7994,GO:0034350,regulation of glial cell apoptotic process,6,0.0,1.0,1.0,3
7995,GO:0034390,smooth muscle cell apoptotic process,6,0.0,1.0,1.0,1
7996,GO:0034404,nucleobase-containing small molecule biosynthetic process,6,0.0,1.0,1.0,1
7997,GO:0034440,lipid oxidation,6,0.0,1.0,1.0,4
7998,GO:0034487,vacuolar amino acid transmembrane transport,6,0.0,1.0,1.0,3
7999,GO:0034502,protein localization to chromosome,6,0.0,1.0,1.0,7
8000,GO:0034504,protein localization to nucleus,6,0.0,1.0,1.0,7
8001,GO:0034552,respiratory chain complex II assembly,6,0.0,1.0,1.0,1
8002,GO:0034587,piRNA processing,6,0.0,1.0,1.0,2
8003,GO:0034614,cellular response to reactive oxygen species,6,0.0,1.0,1.0,4
8004,GO:0034639,L-amino acid efflux transmembrane transporter activity,6,0.0,1.0,1.0,2
8005,GO:0034656,nucleobase-containing small molecule catabolic process,6,0.0,1.0,1.0,2
8006,GO:0034704,calcium channel complex,6,0.0,1.0,1.0,2
8007,GO:0034705,potassium channel complex,6,0.0,1.0,1.0,4
8008,GO:0034706,sodium channel complex,6,0.0,1.0,1.0,2
8009,GO:0034728,nucleosome organization,6,0.0,1.0,1.0,2
8010,GO:0034763,negative regulation of transmembrane transport,6,0.0,1.0,1.0,23
8011,GO:0034764,positive regulation of transmembrane transport,6,0.0,1.0,1.0,24
8012,GO:0034765,regulation of monoatomic ion transmembrane transport,6,0.0,1.0,1.0,4
8013,GO:0034774,secretory granule lumen,6,0.0,1.0,1.0,7
8014,GO:0035032,"phosphatidylinositol 3-kinase complex, class III",6,0.0,1.0,1.0,2
8015,GO:0035079,polytene chromosome puffing,6,0.0,1.0,1.0,2
8016,GO:0035122,embryonic medial fin morphogenesis,6,0.0,1.0,1.0,3
8017,GO:0035132,post-embryonic medial fin morphogenesis,6,0.0,1.0,1.0,3
8018,GO:0035142,dorsal fin morphogenesis,6,0.0,1.0,1.0,2
8019,GO:0035143,caudal fin morphogenesis,6,0.0,1.0,1.0,2
8020,GO:0035144,anal fin morphogenesis,6,0.0,1.0,1.0,2
8021,GO:0035173,histone kinase activity,6,0.0,1.0,1.0,5
8022,GO:0035190,syncytial nuclear migration,6,0.0,1.0,1.0,2
8023,GO:0035196,miRNA processing,6,0.0,1.0,1.0,2
8024,GO:0035198,miRNA binding,6,0.0,1.0,1.0,1
8025,GO:0035250,UDP-galactosyltransferase activity,6,0.0,1.0,1.0,29
8026,GO:0035251,UDP-glucosyltransferase activity,6,0.0,1.0,1.0,76
8027,GO:0035252,UDP-xylosyltransferase activity,6,0.0,1.0,1.0,9
8028,GO:0035315,hair cell differentiation,6,0.0,1.0,1.0,3
8029,GO:0035316,non-sensory hair organization,6,0.0,1.0,1.0,1
8030,GO:0035345,regulation of hypoxanthine transport,6,0.0,1.0,1.0,2
8031,GO:0035365,regulation of thymine transport,6,0.0,1.0,1.0,2
8032,GO:0035385,Roundabout signaling pathway,6,0.0,1.0,1.0,2
8033,GO:0035386,regulation of Roundabout signaling pathway,6,0.0,1.0,1.0,2
8034,GO:0035418,protein localization to synapse,6,0.0,1.0,1.0,3
8035,GO:0035430,regulation of gluconate transmembrane transport,6,0.0,1.0,1.0,2
8036,GO:0035437,maintenance of protein localization in endoplasmic reticulum,6,0.0,1.0,1.0,2
8037,GO:0035450,extrinsic component of lumenal side of plastid thylakoid membrane,6,0.0,1.0,1.0,1
8038,GO:0035495,regulation of SNARE complex disassembly,6,0.0,1.0,1.0,2
8039,GO:0035542,regulation of SNARE complex assembly,6,0.0,1.0,1.0,2
8040,GO:0035545,determination of left/right asymmetry in nervous system,6,0.0,1.0,1.0,1
8041,GO:0035590,purinergic nucleotide receptor signaling pathway,6,0.0,1.0,1.0,2
8042,GO:0035592,establishment of protein localization to extracellular region,6,0.0,1.0,1.0,2
8043,GO:0035601,protein deacylation,6,0.0,1.0,1.0,7
8044,GO:0035627,ceramide transport,6,0.0,1.0,1.0,4
8045,GO:0035832,berbamunine metabolic process,6,0.0,1.0,1.0,1
8046,GO:0035835,indole alkaloid biosynthetic process,6,0.0,1.0,1.0,8
8047,GO:0035836,ergot alkaloid metabolic process,6,0.0,1.0,1.0,3
8048,GO:0035886,vascular associated smooth muscle cell differentiation,6,0.0,1.0,1.0,3
8049,GO:0035909,aorta morphogenesis,6,0.0,1.0,1.0,2
8050,GO:0035917,negative regulation of calcium channel activity in another organism,6,0.0,1.0,1.0,1
8051,GO:0036009,protein-glutamine N-methyltransferase activity,6,0.0,1.0,1.0,1
8052,GO:0036010,protein localization to endosome,6,0.0,1.0,1.0,2
8053,GO:0036260,RNA capping,6,0.0,1.0,1.0,4
8054,GO:0036318,peptide pheromone receptor activity,6,0.0,1.0,1.0,4
8055,GO:0036336,dendritic cell migration,6,0.0,1.0,1.0,1
8056,GO:0036525,protein deglycation,6,0.0,1.0,1.0,5
8057,GO:0038003,G protein-coupled opioid receptor signaling pathway,6,0.0,1.0,1.0,1
8058,GO:0038037,G protein-coupled receptor dimeric complex,6,0.0,1.0,1.0,4
8059,GO:0038065,collagen-activated signaling pathway,6,0.0,1.0,1.0,1
8060,GO:0038166,angiotensin-activated signaling pathway,6,0.0,1.0,1.0,2
8061,GO:0038169,somatostatin receptor signaling pathway,6,0.0,1.0,1.0,1
8062,GO:0038171,cannabinoid signaling pathway,6,0.0,1.0,1.0,1
8063,GO:0038179,neurotrophin signaling pathway,6,0.0,1.0,1.0,2
8064,GO:0038188,cholecystokinin signaling pathway,6,0.0,1.0,1.0,1
8065,GO:0038189,neuropilin signaling pathway,6,0.0,1.0,1.0,1
8066,GO:0039504,symbiont-mediated suppression of host adaptive immune response,6,0.0,1.0,1.0,3
8067,GO:0039637,catabolism by virus of host DNA,6,0.0,1.0,1.0,1
8068,GO:0039656,symbiont-mediated perturbation of host gene expression,6,0.0,1.0,1.0,1
8069,GO:0039661,host organelle outer membrane,6,0.0,1.0,1.0,2
8070,GO:0039714,cytoplasmic viral factory,6,0.0,1.0,1.0,5
8071,GO:0040019,positive regulation of embryonic development,6,0.0,1.0,1.0,2
8072,GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,6,0.0,1.0,1.0,4
8073,GO:0042040,metal incorporation into metallo-molybdopterin complex,6,0.0,1.0,1.0,2
8074,GO:0042046,W-molybdopterin cofactor metabolic process,6,0.0,1.0,1.0,2
8075,GO:0042054,histone methyltransferase activity,6,0.0,1.0,1.0,4
8076,GO:0042069,regulation of catecholamine metabolic process,6,0.0,1.0,1.0,3
8077,GO:0042098,T cell proliferation,6,0.0,1.0,1.0,7
8078,GO:0042100,B cell proliferation,6,0.0,1.0,1.0,3
8079,GO:0042119,neutrophil activation,6,0.0,1.0,1.0,1
8080,GO:0042126,nitrate metabolic process,6,0.0,1.0,1.0,2
8081,GO:0042147,"retrograde transport, endosome to Golgi",6,0.0,1.0,1.0,3
8082,GO:0042159,lipoprotein catabolic process,6,0.0,1.0,1.0,2
8083,GO:0042160,lipoprotein modification,6,0.0,1.0,1.0,1
8084,GO:0042162,telomeric DNA binding,6,0.0,1.0,1.0,4
8085,GO:0042167,heme catabolic process,6,0.0,1.0,1.0,5
8086,GO:0042171,lysophosphatidic acid acyltransferase activity,6,0.0,1.0,1.0,2
8087,GO:0042174,negative regulation of sporulation resulting in formation of a cellular spore,6,0.0,1.0,1.0,2
8088,GO:0042203,toluene catabolic process,6,0.0,1.0,1.0,1
8089,GO:0042205,chlorinated hydrocarbon catabolic process,6,0.0,1.0,1.0,3
8090,GO:0042214,terpene metabolic process,6,0.0,1.0,1.0,10
8091,GO:0042294,URM1 transferase activity,6,0.0,1.0,1.0,2
8092,GO:0042296,ISG15 transferase activity,6,0.0,1.0,1.0,2
8093,GO:0042324,orexin receptor binding,6,0.0,1.0,1.0,2
8094,GO:0042341,cyanogenic glycoside metabolic process,6,0.0,1.0,1.0,2
8095,GO:0042359,vitamin D metabolic process,6,0.0,1.0,1.0,6
8096,GO:0042360,vitamin E metabolic process,6,0.0,1.0,1.0,1
8097,GO:0042362,fat-soluble vitamin biosynthetic process,6,0.0,1.0,1.0,4
8098,GO:0042363,fat-soluble vitamin catabolic process,6,0.0,1.0,1.0,3
8099,GO:0042364,water-soluble vitamin biosynthetic process,6,0.0,1.0,1.0,8
8100,GO:0042365,water-soluble vitamin catabolic process,6,0.0,1.0,1.0,8
8101,GO:0042373,vitamin K metabolic process,6,0.0,1.0,1.0,3
8102,GO:0042396,phosphagen biosynthetic process,6,0.0,1.0,1.0,2
8103,GO:0042397,phosphagen catabolic process,6,0.0,1.0,1.0,2
8104,GO:0042425,choline biosynthetic process,6,0.0,1.0,1.0,3
8105,GO:0042427,serotonin biosynthetic process,6,0.0,1.0,1.0,1
8106,GO:0042438,melanin biosynthetic process,6,0.0,1.0,1.0,2
8107,GO:0042441,eye pigment metabolic process,6,0.0,1.0,1.0,4
8108,GO:0042444,phenylethylamine biosynthetic process,6,0.0,1.0,1.0,1
8109,GO:0042462,eye photoreceptor cell development,6,0.0,1.0,1.0,4
8110,GO:0042481,regulation of odontogenesis,6,0.0,1.0,1.0,3
8111,GO:0042494,detection of bacterial lipoprotein,6,0.0,1.0,1.0,1
8112,GO:0042545,cell wall modification,6,0.0,1.0,1.0,3
8113,GO:0042548,"regulation of photosynthesis, light reaction",6,0.0,1.0,1.0,4
8114,GO:0042577,lipid phosphatase activity,6,0.0,1.0,1.0,3
8115,GO:0042625,ATPase-coupled ion transmembrane transporter activity,6,0.0,1.0,1.0,3
8116,GO:0042631,cellular response to water deprivation,6,0.0,1.0,1.0,1
8117,GO:0042661,regulation of mesodermal cell fate specification,6,0.0,1.0,1.0,6
8118,GO:0042663,regulation of endodermal cell fate specification,6,0.0,1.0,1.0,1
8119,GO:0042665,regulation of ectodermal cell fate specification,6,0.0,1.0,1.0,1
8120,GO:0042673,regulation of retinal cone cell fate specification,6,0.0,1.0,1.0,1
8121,GO:0042682,regulation of compound eye cone cell fate specification,6,0.0,1.0,1.0,1
8122,GO:0042689,regulation of crystal cell differentiation,6,0.0,1.0,1.0,2
8123,GO:0042700,luteinizing hormone signaling pathway,6,0.0,1.0,1.0,1
8124,GO:0042706,eye photoreceptor cell fate commitment,6,0.0,1.0,1.0,2
8125,GO:0042723,thiamine-containing compound metabolic process,6,0.0,1.0,1.0,4
8126,GO:0042742,defense response to bacterium,6,0.0,1.0,1.0,6
8127,GO:0042770,signal transduction in response to DNA damage,6,0.0,1.0,1.0,3
8128,GO:0042773,ATP synthesis coupled electron transport,6,0.0,1.0,1.0,2
8129,GO:0042816,vitamin B6 metabolic process,6,0.0,1.0,1.0,6
8130,GO:0042884,microcin transport,6,0.0,1.0,1.0,1
8131,GO:0042918,alkanesulfonate transmembrane transport,6,0.0,1.0,1.0,1
8132,GO:0042922,neuromedin U receptor binding,6,0.0,1.0,1.0,2
8133,GO:0042940,D-amino acid transport,6,0.0,1.0,1.0,4
8134,GO:0042946,glucoside transport,6,0.0,1.0,1.0,3
8135,GO:0042955,dextrin transport,6,0.0,1.0,1.0,1
8136,GO:0042987,amyloid precursor protein catabolic process,6,0.0,1.0,1.0,1
8137,GO:0043009,chordate embryonic development,6,0.0,1.0,1.0,1
8138,GO:0043010,camera-type eye development,6,0.0,1.0,1.0,2
8139,GO:0043012,regulation of fusion of sperm to egg plasma membrane,6,0.0,1.0,1.0,1
8140,GO:0043029,T cell homeostasis,6,0.0,1.0,1.0,1
8141,GO:0043030,regulation of macrophage activation,6,0.0,1.0,1.0,3
8142,GO:0043041,amino acid activation for nonribosomal peptide biosynthetic process,6,0.0,1.0,1.0,2
8143,GO:0043065,positive regulation of apoptotic process,6,0.0,1.0,1.0,18
8144,GO:0043066,negative regulation of apoptotic process,6,0.0,1.0,1.0,17
8145,GO:0043073,germ cell nucleus,6,0.0,1.0,1.0,2
8146,GO:0043076,megasporocyte nucleus,6,0.0,1.0,1.0,3
8147,GO:0043113,receptor clustering,6,0.0,1.0,1.0,5
8148,GO:0043116,negative regulation of vascular permeability,6,0.0,1.0,1.0,1
8149,GO:0043117,positive regulation of vascular permeability,6,0.0,1.0,1.0,1
8150,GO:0043138,3'-5' DNA helicase activity,6,0.0,1.0,1.0,1
8151,GO:0043197,dendritic spine,6,0.0,1.0,1.0,1
8152,GO:0043202,lysosomal lumen,6,0.0,1.0,1.0,2
8153,GO:0043213,bacteriocin transport,6,0.0,1.0,1.0,1
8154,GO:0043217,myelin maintenance,6,0.0,1.0,1.0,2
8155,GO:0043225,ATPase-coupled inorganic anion transmembrane transporter activity,6,0.0,1.0,1.0,8
8156,GO:0043242,negative regulation of protein-containing complex disassembly,6,0.0,1.0,1.0,6
8157,GO:0043243,positive regulation of protein-containing complex disassembly,6,0.0,1.0,1.0,5
8158,GO:0043248,proteasome assembly,6,0.0,1.0,1.0,2
8159,GO:0043270,positive regulation of monoatomic ion transport,6,0.0,1.0,1.0,7
8160,GO:0043271,negative regulation of monoatomic ion transport,6,0.0,1.0,1.0,8
8161,GO:0043278,response to morphine,6,0.0,1.0,1.0,1
8162,GO:0043288,apocarotenoid metabolic process,6,0.0,1.0,1.0,3
8163,GO:0043307,eosinophil activation,6,0.0,1.0,1.0,1
8164,GO:0043373,"CD4-positive, alpha-beta T cell lineage commitment",6,0.0,1.0,1.0,2
8165,GO:0043386,mycotoxin biosynthetic process,6,0.0,1.0,1.0,19
8166,GO:0043387,mycotoxin catabolic process,6,0.0,1.0,1.0,2
8167,GO:0043401,steroid hormone receptor signaling pathway,6,0.0,1.0,1.0,3
8168,GO:0043415,positive regulation of skeletal muscle tissue regeneration,6,0.0,1.0,1.0,1
8169,GO:0043450,alkene biosynthetic process,6,0.0,1.0,1.0,8
8170,GO:0043451,alkene catabolic process,6,0.0,1.0,1.0,2
8171,GO:0043457,regulation of cellular respiration,6,0.0,1.0,1.0,11
8172,GO:0043465,regulation of fermentation,6,0.0,1.0,1.0,4
8173,GO:0043477,pigment biosynthetic process involved in pigment accumulation,6,0.0,1.0,1.0,2
8174,GO:0043478,pigment accumulation in response to UV light,6,0.0,1.0,1.0,1
8175,GO:0043501,skeletal muscle adaptation,6,0.0,1.0,1.0,2
8176,GO:0043502,regulation of muscle adaptation,6,0.0,1.0,1.0,8
8177,GO:0043523,regulation of neuron apoptotic process,6,0.0,1.0,1.0,7
8178,GO:0043539,protein serine/threonine kinase activator activity,6,0.0,1.0,1.0,2
8179,GO:0043543,protein acylation,6,0.0,1.0,1.0,13
8180,GO:0043547,positive regulation of GTPase activity,6,0.0,1.0,1.0,1
8181,GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,6,0.0,1.0,1.0,2
8182,GO:0043572,plastid fission,6,0.0,1.0,1.0,2
8183,GO:0043578,nuclear matrix organization,6,0.0,1.0,1.0,1
8184,GO:0043628,regulatory ncRNA 3'-end processing,6,0.0,1.0,1.0,3
8185,GO:0043641,novobiocin metabolic process,6,0.0,1.0,1.0,1
8186,GO:0043643,tetracycline metabolic process,6,0.0,1.0,1.0,1
8187,GO:0043645,cephalosporin metabolic process,6,0.0,1.0,1.0,2
8188,GO:0043647,inositol phosphate metabolic process,6,0.0,1.0,1.0,5
8189,GO:0043686,co-translational protein modification,6,0.0,1.0,1.0,1
8190,GO:0043687,post-translational protein modification,6,0.0,1.0,1.0,6
8191,GO:0043865,methionine transmembrane transporter activity,6,0.0,1.0,1.0,2
8192,GO:0043943,regulation of asexual sporulation resulting in formation of a cellular spore,6,0.0,1.0,1.0,6
8193,GO:0044042,glucan metabolic process,6,0.0,1.0,1.0,12
8194,GO:0044062,regulation of excretion,6,0.0,1.0,1.0,4
8195,GO:0044070,regulation of monoatomic anion transport,6,0.0,1.0,1.0,5
8196,GO:0044071,symbiont-mediated perturbation of host cell cycle progression,6,0.0,1.0,1.0,2
8197,GO:0044075,symbiont-mediated perturbation of host vacuole organization,6,0.0,1.0,1.0,1
8198,GO:0044079,symbiont-mediated perturbation of host neurotransmitter secretion,6,0.0,1.0,1.0,1
8199,GO:0044088,regulation of vacuole organization,6,0.0,1.0,1.0,4
8200,GO:0044097,secretion by the type IV secretion system,6,0.0,1.0,1.0,2
8201,GO:0044160,host thylakoid membrane,6,0.0,1.0,1.0,1
8202,GO:0044162,host cell cytoplasmic vesicle membrane,6,0.0,1.0,1.0,3
8203,GO:0044163,host cytoskeleton,6,0.0,1.0,1.0,1
8204,GO:0044269,glycerol ether catabolic process,6,0.0,1.0,1.0,1
8205,GO:0044277,cell wall disassembly,6,0.0,1.0,1.0,2
8206,GO:0044360,modulation of voltage-gated potassium channel activity in another organism,6,0.0,1.0,1.0,1
8207,GO:0044380,protein localization to cytoskeleton,6,0.0,1.0,1.0,5
8208,GO:0044473,envenomation resulting in negative regulation of calcium channel activity in another organism,6,0.0,1.0,1.0,1
8209,GO:0044524,protein sulfhydration,6,0.0,1.0,1.0,1
8210,GO:0044532,modulation of apoptotic process in another organism,6,0.0,1.0,1.0,1
8211,GO:0044562,envenomation resulting in negative regulation of voltage-gated potassium channel activity in another organism,6,0.0,1.0,1.0,2
8212,GO:0044601,protein denucleotidylation,6,0.0,1.0,1.0,1
8213,GO:0044665,MLL1/2 complex,6,0.0,1.0,1.0,1
8214,GO:0044758,symbiont-mediated perturbation of host synaptic transmission,6,0.0,1.0,1.0,2
8215,GO:0044782,cilium organization,6,0.0,1.0,1.0,3
8216,GO:0044793,negative regulation by host of viral process,6,0.0,1.0,1.0,3
8217,GO:0044794,positive regulation by host of viral process,6,0.0,1.0,1.0,1
8218,GO:0044804,nucleophagy,6,0.0,1.0,1.0,1
8219,GO:0044827,modulation by host of viral genome replication,6,0.0,1.0,1.0,3
8220,GO:0044856,plasma membrane raft localization,6,0.0,1.0,1.0,1
8221,GO:0044857,plasma membrane raft organization,6,0.0,1.0,1.0,1
8222,GO:0044868,modulation by host of viral molecular function,6,0.0,1.0,1.0,2
8223,GO:0044870,modulation by host of viral glycoprotein metabolic process,6,0.0,1.0,1.0,1
8224,GO:0044873,lipoprotein localization to membrane,6,0.0,1.0,1.0,1
8225,GO:0045010,actin nucleation,6,0.0,1.0,1.0,2
8226,GO:0045026,plasma membrane fusion,6,0.0,1.0,1.0,4
8227,GO:0045028,G protein-coupled purinergic nucleotide receptor activity,6,0.0,1.0,1.0,3
8228,GO:0045070,positive regulation of viral genome replication,6,0.0,1.0,1.0,1
8229,GO:0045071,negative regulation of viral genome replication,6,0.0,1.0,1.0,1
8230,GO:0045088,regulation of innate immune response,6,0.0,1.0,1.0,14
8231,GO:0045104,intermediate filament cytoskeleton organization,6,0.0,1.0,1.0,3
8232,GO:0045111,intermediate filament cytoskeleton,6,0.0,1.0,1.0,3
8233,GO:0045119,azole:proton antiporter activity,6,0.0,1.0,1.0,3
8234,GO:0045120,pronucleus,6,0.0,1.0,1.0,2
8235,GO:0045124,regulation of bone resorption,6,0.0,1.0,1.0,2
8236,GO:0045149,acetoin metabolic process,6,0.0,1.0,1.0,2
8237,GO:0045187,"regulation of circadian sleep/wake cycle, sleep",6,0.0,1.0,1.0,4
8238,GO:0045198,establishment of epithelial cell apical/basal polarity,6,0.0,1.0,1.0,2
8239,GO:0045217,cell-cell junction maintenance,6,0.0,1.0,1.0,3
8240,GO:0045236,CXCR chemokine receptor binding,6,0.0,1.0,1.0,5
8241,GO:0045324,late endosome to vacuole transport,6,0.0,1.0,1.0,2
8242,GO:0045428,regulation of nitric oxide biosynthetic process,6,0.0,1.0,1.0,2
8243,GO:0045455,ecdysteroid metabolic process,6,0.0,1.0,1.0,3
8244,GO:0045575,basophil activation,6,0.0,1.0,1.0,1
8245,GO:0045592,regulation of cumulus cell differentiation,6,0.0,1.0,1.0,2
8246,GO:0045599,negative regulation of fat cell differentiation,6,0.0,1.0,1.0,1
8247,GO:0045601,regulation of endothelial cell differentiation,6,0.0,1.0,1.0,4
8248,GO:0045604,regulation of epidermal cell differentiation,6,0.0,1.0,1.0,4
8249,GO:0045611,negative regulation of hemocyte differentiation,6,0.0,1.0,1.0,3
8250,GO:0045612,positive regulation of hemocyte differentiation,6,0.0,1.0,1.0,3
8251,GO:0045613,regulation of plasmatocyte differentiation,6,0.0,1.0,1.0,2
8252,GO:0045631,regulation of mechanoreceptor differentiation,6,0.0,1.0,1.0,3
8253,GO:0045634,regulation of melanocyte differentiation,6,0.0,1.0,1.0,4
8254,GO:0045662,negative regulation of myoblast differentiation,6,0.0,1.0,1.0,1
8255,GO:0045663,positive regulation of myoblast differentiation,6,0.0,1.0,1.0,1
8256,GO:0045665,negative regulation of neuron differentiation,6,0.0,1.0,1.0,9
8257,GO:0045666,positive regulation of neuron differentiation,6,0.0,1.0,1.0,8
8258,GO:0045734,regulation of acetate catabolic process,6,0.0,1.0,1.0,3
8259,GO:0045762,positive regulation of adenylate cyclase activity,6,0.0,1.0,1.0,1
8260,GO:0045765,regulation of angiogenesis,6,0.0,1.0,1.0,5
8261,GO:0045769,negative regulation of asymmetric cell division,6,0.0,1.0,1.0,2
8262,GO:0045770,positive regulation of asymmetric cell division,6,0.0,1.0,1.0,1
8263,GO:0045800,negative regulation of chitin-based cuticle tanning,6,0.0,1.0,1.0,1
8264,GO:0045801,positive regulation of chitin-based cuticle tanning,6,0.0,1.0,1.0,1
8265,GO:0045843,negative regulation of striated muscle tissue development,6,0.0,1.0,1.0,2
8266,GO:0045844,positive regulation of striated muscle tissue development,6,0.0,1.0,1.0,2
8267,GO:0045847,negative regulation of nitrogen utilization,6,0.0,1.0,1.0,1
8268,GO:0045848,positive regulation of nitrogen utilization,6,0.0,1.0,1.0,1
8269,GO:0045863,negative regulation of pteridine metabolic process,6,0.0,1.0,1.0,2
8270,GO:0045864,positive regulation of pteridine metabolic process,6,0.0,1.0,1.0,2
8271,GO:0045881,positive regulation of sporulation resulting in formation of a cellular spore,6,0.0,1.0,1.0,2
8272,GO:0045924,regulation of female receptivity,6,0.0,1.0,1.0,3
8273,GO:0045930,negative regulation of mitotic cell cycle,6,0.0,1.0,1.0,7
8274,GO:0045931,positive regulation of mitotic cell cycle,6,0.0,1.0,1.0,6
8275,GO:0045992,negative regulation of embryonic development,6,0.0,1.0,1.0,2
8276,GO:0046156,siroheme metabolic process,6,0.0,1.0,1.0,2
8277,GO:0046159,ocellus pigment catabolic process,6,0.0,1.0,1.0,1
8278,GO:0046160,heme a metabolic process,6,0.0,1.0,1.0,2
8279,GO:0046162,heme C metabolic process,6,0.0,1.0,1.0,2
8280,GO:0046173,polyol biosynthetic process,6,0.0,1.0,1.0,20
8281,GO:0046174,polyol catabolic process,6,0.0,1.0,1.0,13
8282,GO:0046199,cresol catabolic process,6,0.0,1.0,1.0,2
8283,GO:0046204,nor-spermidine metabolic process,6,0.0,1.0,1.0,2
8284,GO:0046217,indole phytoalexin metabolic process,6,0.0,1.0,1.0,3
8285,GO:0046219,indolalkylamine biosynthetic process,6,0.0,1.0,1.0,1
8286,GO:0046226,coumarin catabolic process,6,0.0,1.0,1.0,1
8287,GO:0046252,toluene biosynthetic process,6,0.0,1.0,1.0,1
8288,GO:0046263,nitrotoluene catabolic process,6,0.0,1.0,1.0,2
8289,GO:0046273,lignan catabolic process,6,0.0,1.0,1.0,6
8290,GO:0046274,lignin catabolic process,6,0.0,1.0,1.0,4
8291,GO:0046288,isoflavonoid catabolic process,6,0.0,1.0,1.0,1
8292,GO:0046289,isoflavonoid phytoalexin metabolic process,6,0.0,1.0,1.0,2
8293,GO:0046305,alkanesulfonate biosynthetic process,6,0.0,1.0,1.0,1
8294,GO:0046306,alkanesulfonate catabolic process,6,0.0,1.0,1.0,1
8295,GO:0046333,octopamine metabolic process,6,0.0,1.0,1.0,2
8296,GO:0046346,mannosamine catabolic process,6,0.0,1.0,1.0,1
8297,GO:0046347,mannosamine biosynthetic process,6,0.0,1.0,1.0,1
8298,GO:0046350,galactosaminoglycan metabolic process,6,0.0,1.0,1.0,2
8299,GO:0046364,monosaccharide biosynthetic process,6,0.0,1.0,1.0,8
8300,GO:0046365,monosaccharide catabolic process,6,0.0,1.0,1.0,6
8301,GO:0046375,K antigen metabolic process,6,0.0,1.0,1.0,1
8302,GO:0046378,enterobacterial common antigen metabolic process,6,0.0,1.0,1.0,1
8303,GO:0046384,2-deoxyribose 1-phosphate metabolic process,6,0.0,1.0,1.0,2
8304,GO:0046385,deoxyribose phosphate biosynthetic process,6,0.0,1.0,1.0,3
8305,GO:0046386,deoxyribose phosphate catabolic process,6,0.0,1.0,1.0,3
8306,GO:0046387,"deoxyribose 1,5-bisphosphate metabolic process",6,0.0,1.0,1.0,1
8307,GO:0046389,deoxyribose 5-phosphate metabolic process,6,0.0,1.0,1.0,1
8308,GO:0046390,ribose phosphate biosynthetic process,6,0.0,1.0,1.0,3
8309,GO:0046391,5-phosphoribose 1-diphosphate metabolic process,6,0.0,1.0,1.0,1
8310,GO:0046401,lipopolysaccharide core region metabolic process,6,0.0,1.0,1.0,1
8311,GO:0046402,O antigen metabolic process,6,0.0,1.0,1.0,1
8312,GO:0046465,dolichyl diphosphate metabolic process,6,0.0,1.0,1.0,1
8313,GO:0046467,membrane lipid biosynthetic process,6,0.0,1.0,1.0,2
8314,GO:0046485,ether lipid metabolic process,6,0.0,1.0,1.0,2
8315,GO:0046490,isopentenyl diphosphate metabolic process,6,0.0,1.0,1.0,1
8316,GO:0046492,heme B metabolic process,6,0.0,1.0,1.0,2
8317,GO:0046504,glycerol ether biosynthetic process,6,0.0,1.0,1.0,1
8318,GO:0046517,octamethylcyclotetrasiloxane catabolic process,6,0.0,1.0,1.0,1
8319,GO:0046532,regulation of photoreceptor cell differentiation,6,0.0,1.0,1.0,5
8320,GO:0046568,3-methylbutanal reductase [NAD(P)H] activity,6,0.0,1.0,1.0,2
8321,GO:0046586,regulation of calcium-dependent cell-cell adhesion,6,0.0,1.0,1.0,2
8322,GO:0046597,negative regulation of viral entry into host cell,6,0.0,1.0,1.0,1
8323,GO:0046598,positive regulation of viral entry into host cell,6,0.0,1.0,1.0,1
8324,GO:0046602,regulation of mitotic centrosome separation,6,0.0,1.0,1.0,2
8325,GO:0046605,regulation of centrosome cycle,6,0.0,1.0,1.0,3
8326,GO:0046621,negative regulation of organ growth,6,0.0,1.0,1.0,2
8327,GO:0046622,positive regulation of organ growth,6,0.0,1.0,1.0,1
8328,GO:0046623,sphingolipid floppase activity,6,0.0,1.0,1.0,1
8329,GO:0046626,regulation of insulin receptor signaling pathway,6,0.0,1.0,1.0,2
8330,GO:0046629,gamma-delta T cell activation,6,0.0,1.0,1.0,3
8331,GO:0046631,alpha-beta T cell activation,6,0.0,1.0,1.0,7
8332,GO:0046654,tetrahydrofolate biosynthetic process,6,0.0,1.0,1.0,1
8333,GO:0046669,regulation of compound eye retinal cell programmed cell death,6,0.0,1.0,1.0,2
8334,GO:0046670,positive regulation of retinal cell programmed cell death,6,0.0,1.0,1.0,1
8335,GO:0046671,negative regulation of retinal cell programmed cell death,6,0.0,1.0,1.0,1
8336,GO:0046701,insecticide catabolic process,6,0.0,1.0,1.0,1
8337,GO:0046753,non-lytic viral release,6,0.0,1.0,1.0,3
8338,GO:0046822,regulation of nucleocytoplasmic transport,6,0.0,1.0,1.0,7
8339,GO:0046839,phospholipid dephosphorylation,6,0.0,1.0,1.0,1
8340,GO:0046851,negative regulation of bone remodeling,6,0.0,1.0,1.0,1
8341,GO:0046865,terpenoid transport,6,0.0,1.0,1.0,6
8342,GO:0046877,regulation of saliva secretion,6,0.0,1.0,1.0,2
8343,GO:0046885,regulation of hormone biosynthetic process,6,0.0,1.0,1.0,7
8344,GO:0046914,transition metal ion binding,6,0.0,1.0,1.0,10
8345,GO:0046915,transition metal ion transmembrane transporter activity,6,0.0,1.0,1.0,11
8346,GO:0046920,alpha-(1->3)-fucosyltransferase activity,6,0.0,1.0,1.0,2
8347,GO:0046921,alpha-(1->6)-fucosyltransferase activity,6,0.0,1.0,1.0,2
8348,GO:0046931,pore complex assembly,6,0.0,1.0,1.0,1
8349,GO:0047023,androsterone dehydrogenase activity,6,0.0,1.0,1.0,2
8350,GO:0047134,protein-disulfide reductase (NAD(P)H) activity,6,0.0,1.0,1.0,1
8351,GO:0047267,undecaprenyl-phosphate mannosyltransferase activity,6,0.0,1.0,1.0,2
8352,GO:0047429,nucleoside triphosphate diphosphatase activity,6,0.0,1.0,1.0,16
8353,GO:0047617,fatty acyl-CoA hydrolase activity,6,0.0,1.0,1.0,4
8354,GO:0047661,amino-acid racemase activity,6,0.0,1.0,1.0,13
8355,GO:0048020,CCR chemokine receptor binding,6,0.0,1.0,1.0,11
8356,GO:0048033,heme O metabolic process,6,0.0,1.0,1.0,2
8357,GO:0048048,embryonic eye morphogenesis,6,0.0,1.0,1.0,1
8358,GO:0048050,post-embryonic eye morphogenesis,6,0.0,1.0,1.0,1
8359,GO:0048074,negative regulation of eye pigmentation,6,0.0,1.0,1.0,1
8360,GO:0048075,positive regulation of eye pigmentation,6,0.0,1.0,1.0,1
8361,GO:0048076,regulation of compound eye pigmentation,6,0.0,1.0,1.0,2
8362,GO:0048080,negative regulation of cuticle pigmentation,6,0.0,1.0,1.0,1
8363,GO:0048081,positive regulation of cuticle pigmentation,6,0.0,1.0,1.0,1
8364,GO:0048082,regulation of adult chitin-containing cuticle pigmentation,6,0.0,1.0,1.0,2
8365,GO:0048146,positive regulation of fibroblast proliferation,6,0.0,1.0,1.0,2
8366,GO:0048147,negative regulation of fibroblast proliferation,6,0.0,1.0,1.0,2
8367,GO:0048268,clathrin coat assembly,6,0.0,1.0,1.0,2
8368,GO:0048334,regulation of mesodermal cell fate determination,6,0.0,1.0,1.0,6
8369,GO:0048450,floral organ structural organization,6,0.0,1.0,1.0,4
8370,GO:0048496,maintenance of animal organ identity,6,0.0,1.0,1.0,1
8371,GO:0048531,"beta-1,3-galactosyltransferase activity",6,0.0,1.0,1.0,3
8372,GO:0048559,establishment of floral organ orientation,6,0.0,1.0,1.0,1
8373,GO:0048571,long-day photoperiodism,6,0.0,1.0,1.0,1
8374,GO:0048572,short-day photoperiodism,6,0.0,1.0,1.0,1
8375,GO:0048573,"photoperiodism, flowering",6,0.0,1.0,1.0,2
8376,GO:0048581,negative regulation of post-embryonic development,6,0.0,1.0,1.0,10
8377,GO:0048582,positive regulation of post-embryonic development,6,0.0,1.0,1.0,9
8378,GO:0048641,regulation of skeletal muscle tissue development,6,0.0,1.0,1.0,4
8379,GO:0048661,positive regulation of smooth muscle cell proliferation,6,0.0,1.0,1.0,1
8380,GO:0048662,negative regulation of smooth muscle cell proliferation,6,0.0,1.0,1.0,1
8381,GO:0048710,regulation of astrocyte differentiation,6,0.0,1.0,1.0,3
8382,GO:0048713,regulation of oligodendrocyte differentiation,6,0.0,1.0,1.0,2
8383,GO:0048738,cardiac muscle tissue development,6,0.0,1.0,1.0,4
8384,GO:0048753,pigment granule organization,6,0.0,1.0,1.0,3
8385,GO:0048754,branching morphogenesis of an epithelial tube,6,0.0,1.0,1.0,6
8386,GO:0048775,regulation of leucophore differentiation,6,0.0,1.0,1.0,2
8387,GO:0048778,regulation of erythrophore differentiation,6,0.0,1.0,1.0,2
8388,GO:0048781,regulation of cyanophore differentiation,6,0.0,1.0,1.0,2
8389,GO:0048805,imaginal disc-derived genitalia morphogenesis,6,0.0,1.0,1.0,2
8390,GO:0048821,erythrocyte development,6,0.0,1.0,1.0,2
8391,GO:0048834,specification of petal number,6,0.0,1.0,1.0,2
8392,GO:0048890,lateral line ganglion development,6,0.0,1.0,1.0,2
8393,GO:0048891,lateral line ganglion neuron differentiation,6,0.0,1.0,1.0,2
8394,GO:0050145,nucleoside monophosphate kinase activity,6,0.0,1.0,1.0,5
8395,GO:0050542,icosanoid binding,6,0.0,1.0,1.0,4
8396,GO:0050657,nucleic acid transport,6,0.0,1.0,1.0,2
8397,GO:0050675,regulation of urothelial cell proliferation,6,0.0,1.0,1.0,2
8398,GO:0050679,positive regulation of epithelial cell proliferation,6,0.0,1.0,1.0,15
8399,GO:0050680,negative regulation of epithelial cell proliferation,6,0.0,1.0,1.0,14
8400,GO:0050688,regulation of defense response to virus,6,0.0,1.0,1.0,2
8401,GO:0050735,N-malonyltransferase activity,6,0.0,1.0,1.0,3
8402,GO:0050736,O-malonyltransferase activity,6,0.0,1.0,1.0,2
8403,GO:0050737,O-hydroxycinnamoyltransferase activity,6,0.0,1.0,1.0,7
8404,GO:0050767,regulation of neurogenesis,6,0.0,1.0,1.0,3
8405,GO:0050804,modulation of chemical synaptic transmission,6,0.0,1.0,1.0,23
8406,GO:0050813,epothilone metabolic process,6,0.0,1.0,1.0,1
8407,GO:0050832,defense response to fungus,6,0.0,1.0,1.0,2
8408,GO:0050833,pyruvate transmembrane transporter activity,6,0.0,1.0,1.0,1
8409,GO:0050854,regulation of antigen receptor-mediated signaling pathway,6,0.0,1.0,1.0,4
8410,GO:0050909,sensory perception of taste,6,0.0,1.0,1.0,5
8411,GO:0050921,positive regulation of chemotaxis,6,0.0,1.0,1.0,12
8412,GO:0050922,negative regulation of chemotaxis,6,0.0,1.0,1.0,15
8413,GO:0050923,regulation of negative chemotaxis,6,0.0,1.0,1.0,3
8414,GO:0050926,regulation of positive chemotaxis,6,0.0,1.0,1.0,3
8415,GO:0050937,regulation of iridophore differentiation,6,0.0,1.0,1.0,2
8416,GO:0050938,regulation of xanthophore differentiation,6,0.0,1.0,1.0,2
8417,GO:0050941,negative regulation of pigment cell differentiation,6,0.0,1.0,1.0,6
8418,GO:0050942,positive regulation of pigment cell differentiation,6,0.0,1.0,1.0,6
8419,GO:0050955,thermoception,6,0.0,1.0,1.0,2
8420,GO:0050960,detection of temperature stimulus involved in thermoception,6,0.0,1.0,1.0,2
8421,GO:0050962,detection of light stimulus involved in sensory perception,6,0.0,1.0,1.0,2
8422,GO:0050993,dimethylallyl diphosphate metabolic process,6,0.0,1.0,1.0,1
8423,GO:0050999,regulation of nitric-oxide synthase activity,6,0.0,1.0,1.0,2
8424,GO:0051004,regulation of lipoprotein lipase activity,6,0.0,1.0,1.0,2
8425,GO:0051019,mitogen-activated protein kinase binding,6,0.0,1.0,1.0,1
8426,GO:0051040,regulation of calcium-independent cell-cell adhesion,6,0.0,1.0,1.0,2
8427,GO:0051047,positive regulation of secretion,6,0.0,1.0,1.0,12
8428,GO:0051048,negative regulation of secretion,6,0.0,1.0,1.0,12
8429,GO:0051081,nuclear membrane disassembly,6,0.0,1.0,1.0,3
8430,GO:0051148,negative regulation of muscle cell differentiation,6,0.0,1.0,1.0,2
8431,GO:0051149,positive regulation of muscle cell differentiation,6,0.0,1.0,1.0,2
8432,GO:0051150,regulation of smooth muscle cell differentiation,6,0.0,1.0,1.0,5
8433,GO:0051153,regulation of striated muscle cell differentiation,6,0.0,1.0,1.0,4
8434,GO:0051175,negative regulation of sulfur metabolic process,6,0.0,1.0,1.0,17
8435,GO:0051176,positive regulation of sulfur metabolic process,6,0.0,1.0,1.0,19
8436,GO:0051249,regulation of lymphocyte activation,6,0.0,1.0,1.0,8
8437,GO:0051258,protein polymerization,6,0.0,1.0,1.0,4
8438,GO:0051259,protein complex oligomerization,6,0.0,1.0,1.0,5
8439,GO:0051261,protein depolymerization,6,0.0,1.0,1.0,6
8440,GO:0051311,meiotic metaphase chromosome alignment,6,0.0,1.0,1.0,2
8441,GO:0051383,kinetochore organization,6,0.0,1.0,1.0,2
8442,GO:0051385,response to mineralocorticoid,6,0.0,1.0,1.0,4
8443,GO:0051386,regulation of neurotrophin TRK receptor signaling pathway,6,0.0,1.0,1.0,2
8444,GO:0051429,corticotropin-releasing hormone receptor binding,6,0.0,1.0,1.0,2
8445,GO:0051446,positive regulation of meiotic cell cycle,6,0.0,1.0,1.0,6
8446,GO:0051447,negative regulation of meiotic cell cycle,6,0.0,1.0,1.0,5
8447,GO:0051457,maintenance of protein location in nucleus,6,0.0,1.0,1.0,2
8448,GO:0051493,regulation of cytoskeleton organization,6,0.0,1.0,1.0,6
8449,GO:0051499,D-aminoacyl-tRNA deacylase activity,6,0.0,1.0,1.0,2
8450,GO:0051510,regulation of unidimensional cell growth,6,0.0,1.0,1.0,5
8451,GO:0051541,elastin metabolic process,6,0.0,1.0,1.0,2
8452,GO:0051580,regulation of neurotransmitter uptake,6,0.0,1.0,1.0,6
8453,GO:0051589,negative regulation of neurotransmitter transport,6,0.0,1.0,1.0,2
8454,GO:0051590,positive regulation of neurotransmitter transport,6,0.0,1.0,1.0,2
8455,GO:0051596,methylglyoxal catabolic process,6,0.0,1.0,1.0,1
8456,GO:0051603,proteolysis involved in protein catabolic process,6,0.0,1.0,1.0,8
8457,GO:0051622,negative regulation of norepinephrine uptake,6,0.0,1.0,1.0,1
8458,GO:0051627,negative regulation of epinephrine uptake,6,0.0,1.0,1.0,1
8459,GO:0051631,regulation of acetylcholine uptake,6,0.0,1.0,1.0,2
8460,GO:0051679,6-alpha-maltosylglucose metabolic process,6,0.0,1.0,1.0,2
8461,GO:0051711,negative regulation of killing of cells of another organism,6,0.0,1.0,1.0,1
8462,GO:0051712,positive regulation of killing of cells of another organism,6,0.0,1.0,1.0,1
8463,GO:0051725,protein de-ADP-ribosylation,6,0.0,1.0,1.0,2
8464,GO:0051731,polynucleotide 5'-hydroxyl-kinase activity,6,0.0,1.0,1.0,2
8465,GO:0051748,UTP-monosaccharide-1-phosphate uridylyltransferase activity,6,0.0,1.0,1.0,4
8466,GO:0051751,"alpha-1,4-mannosyltransferase activity",6,0.0,1.0,1.0,1
8467,GO:0051765,inositol tetrakisphosphate kinase activity,6,0.0,1.0,1.0,6
8468,GO:0051766,inositol trisphosphate kinase activity,6,0.0,1.0,1.0,5
8469,GO:0051783,regulation of nuclear division,6,0.0,1.0,1.0,4
8470,GO:0051798,positive regulation of hair follicle development,6,0.0,1.0,1.0,1
8471,GO:0051799,negative regulation of hair follicle development,6,0.0,1.0,1.0,2
8472,GO:0051823,regulation of synapse structural plasticity,6,0.0,1.0,1.0,2
8473,GO:0051864,histone H3K36 demethylase activity,6,0.0,1.0,1.0,2
8474,GO:0051890,regulation of cardioblast differentiation,6,0.0,1.0,1.0,4
8475,GO:0051904,pigment granule transport,6,0.0,1.0,1.0,1
8476,GO:0051931,regulation of sensory perception,6,0.0,1.0,1.0,4
8477,GO:0051937,catecholamine transport,6,0.0,1.0,1.0,5
8478,GO:0051953,negative regulation of amine transport,6,0.0,1.0,1.0,5
8479,GO:0051954,positive regulation of amine transport,6,0.0,1.0,1.0,5
8480,GO:0051955,regulation of amino acid transport,6,0.0,1.0,1.0,10
8481,GO:0051961,negative regulation of nervous system development,6,0.0,1.0,1.0,3
8482,GO:0051962,positive regulation of nervous system development,6,0.0,1.0,1.0,2
8483,GO:0051963,regulation of synapse assembly,6,0.0,1.0,1.0,7
8484,GO:0051969,regulation of transmission of nerve impulse,6,0.0,1.0,1.0,4
8485,GO:0051977,lysophospholipid transport,6,0.0,1.0,1.0,1
8486,GO:0051983,regulation of chromosome segregation,6,0.0,1.0,1.0,5
8487,GO:0051988,regulation of attachment of spindle microtubules to kinetochore,6,0.0,1.0,1.0,4
8488,GO:0052009,symbiont-mediated disruption of host cell wall,6,0.0,1.0,1.0,2
8489,GO:0052027,symbiont-mediated perturbation of host signal transduction pathway,6,0.0,1.0,1.0,8
8490,GO:0052032,symbiont-mediated perturbation of host inflammatory response,6,0.0,1.0,1.0,1
8491,GO:0052040,symbiont-mediated perturbation of host programmed cell death,6,0.0,1.0,1.0,2
8492,GO:0052084,modulation by symbiont of host ethylene-mediated defense response,6,0.0,1.0,1.0,1
8493,GO:0052156,symbiont-mediated perturbation of host T-cell mediated immune response,6,0.0,1.0,1.0,1
8494,GO:0052158,modulation by symbiont of host resistance gene-dependent defense response,6,0.0,1.0,1.0,2
8495,GO:0052159,symbiont-mediated perturbation of host induced systemic resistance,6,0.0,1.0,1.0,1
8496,GO:0052167,symbiont-mediated perturbation of host innate immune response,6,0.0,1.0,1.0,3
8497,GO:0052200,response to host defenses,6,0.0,1.0,1.0,3
8498,GO:0052315,phytoalexin biosynthetic process,6,0.0,1.0,1.0,4
8499,GO:0052316,phytoalexin catabolic process,6,0.0,1.0,1.0,3
8500,GO:0052318,regulation of phytoalexin metabolic process,6,0.0,1.0,1.0,3
8501,GO:0052403,negative regulation by host of symbiont catalytic activity,6,0.0,1.0,1.0,1
8502,GO:0052643,chlorophyllide metabolic process,6,0.0,1.0,1.0,1
8503,GO:0052647,pentitol phosphate metabolic process,6,0.0,1.0,1.0,1
8504,GO:0052670,geraniol kinase activity,6,0.0,1.0,1.0,1
8505,GO:0052671,geranylgeraniol kinase activity,6,0.0,1.0,1.0,2
8506,GO:0052742,phosphatidylinositol kinase activity,6,0.0,1.0,1.0,9
8507,GO:0052745,inositol phosphate phosphatase activity,6,0.0,1.0,1.0,6
8508,GO:0052777,diacetylchitobiose catabolic process,6,0.0,1.0,1.0,1
8509,GO:0052800,bicyclic nitroimidazole catabolic process,6,0.0,1.0,1.0,1
8510,GO:0052866,phosphatidylinositol phosphate phosphatase activity,6,0.0,1.0,1.0,5
8511,GO:0055007,cardiac muscle cell differentiation,6,0.0,1.0,1.0,4
8512,GO:0055010,ventricular cardiac muscle tissue morphogenesis,6,0.0,1.0,1.0,4
8513,GO:0055013,cardiac muscle cell development,6,0.0,1.0,1.0,3
8514,GO:0055024,regulation of cardiac muscle tissue development,6,0.0,1.0,1.0,2
8515,GO:0055122,response to very low light intensity stimulus,6,0.0,1.0,1.0,2
8516,GO:0060027,convergent extension involved in gastrulation,6,0.0,1.0,1.0,4
8517,GO:0060028,convergent extension involved in axis elongation,6,0.0,1.0,1.0,1
8518,GO:0060029,convergent extension involved in organogenesis,6,0.0,1.0,1.0,5
8519,GO:0060040,retinal bipolar neuron differentiation,6,0.0,1.0,1.0,2
8520,GO:0060113,inner ear receptor cell differentiation,6,0.0,1.0,1.0,3
8521,GO:0060143,positive regulation of syncytium formation by plasma membrane fusion,6,0.0,1.0,1.0,2
8522,GO:0060164,regulation of timing of neuron differentiation,6,0.0,1.0,1.0,1
8523,GO:0060176,regulation of aggregation involved in sorocarp development,6,0.0,1.0,1.0,3
8524,GO:0060192,negative regulation of lipase activity,6,0.0,1.0,1.0,2
8525,GO:0060238,regulation of signal transduction involved in conjugation with cellular fusion,6,0.0,1.0,1.0,3
8526,GO:0060256,regulation of flocculation,6,0.0,1.0,1.0,2
8527,GO:0060267,positive regulation of respiratory burst,6,0.0,1.0,1.0,1
8528,GO:0060268,negative regulation of respiratory burst,6,0.0,1.0,1.0,1
8529,GO:0060272,embryonic skeletal joint morphogenesis,6,0.0,1.0,1.0,1
8530,GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,6,0.0,1.0,1.0,1
8531,GO:0060313,negative regulation of blood vessel remodeling,6,0.0,1.0,1.0,1
8532,GO:0060317,cardiac epithelial to mesenchymal transition,6,0.0,1.0,1.0,4
8533,GO:0060368,regulation of Fc receptor mediated stimulatory signaling pathway,6,0.0,1.0,1.0,2
8534,GO:0060372,regulation of atrial cardiac muscle cell membrane repolarization,6,0.0,1.0,1.0,1
8535,GO:0060380,regulation of single-stranded telomeric DNA binding,6,0.0,1.0,1.0,1
8536,GO:0060398,regulation of growth hormone receptor signaling pathway,6,0.0,1.0,1.0,2
8537,GO:0060408,regulation of acetylcholine metabolic process,6,0.0,1.0,1.0,3
8538,GO:0060420,regulation of heart growth,6,0.0,1.0,1.0,3
8539,GO:0060442,branching involved in prostate gland morphogenesis,6,0.0,1.0,1.0,1
8540,GO:0060445,branching involved in salivary gland morphogenesis,6,0.0,1.0,1.0,1
8541,GO:0060448,dichotomous subdivision of terminal units involved in lung branching,6,0.0,1.0,1.0,2
8542,GO:0060453,regulation of gastric acid secretion,6,0.0,1.0,1.0,3
8543,GO:0060456,positive regulation of digestive system process,6,0.0,1.0,1.0,9
8544,GO:0060457,negative regulation of digestive system process,6,0.0,1.0,1.0,8
8545,GO:0060491,regulation of cell projection assembly,6,0.0,1.0,1.0,3
8546,GO:0060496,mesenchymal-epithelial cell signaling involved in lung development,6,0.0,1.0,1.0,1
8547,GO:0060544,regulation of necroptotic process,6,0.0,1.0,1.0,2
8548,GO:0060558,regulation of calcidiol 1-monooxygenase activity,6,0.0,1.0,1.0,2
8549,GO:0060561,apoptotic process involved in morphogenesis,6,0.0,1.0,1.0,8
8550,GO:0060563,neuroepithelial cell differentiation,6,0.0,1.0,1.0,3
8551,GO:0060572,morphogenesis of an epithelial bud,6,0.0,1.0,1.0,4
8552,GO:0060575,intestinal epithelial cell differentiation,6,0.0,1.0,1.0,2
8553,GO:0060628,regulation of ER to Golgi vesicle-mediated transport,6,0.0,1.0,1.0,1
8554,GO:0060643,epithelial cell differentiation involved in mammary gland bud morphogenesis,6,0.0,1.0,1.0,2
8555,GO:0060693,regulation of branching involved in salivary gland morphogenesis,6,0.0,1.0,1.0,3
8556,GO:0060730,regulation of intestinal epithelial structure maintenance,6,0.0,1.0,1.0,1
8557,GO:0060739,mesenchymal-epithelial cell signaling involved in prostate gland development,6,0.0,1.0,1.0,1
8558,GO:0060751,branch elongation involved in mammary gland duct branching,6,0.0,1.0,1.0,1
8559,GO:0060762,regulation of branching involved in mammary gland duct morphogenesis,6,0.0,1.0,1.0,1
8560,GO:0060768,regulation of epithelial cell proliferation involved in prostate gland development,6,0.0,1.0,1.0,2
8561,GO:0060811,intracellular mRNA localization involved in anterior/posterior axis specification,6,0.0,1.0,1.0,5
8562,GO:0060837,blood vessel endothelial cell differentiation,6,0.0,1.0,1.0,3
8563,GO:0060846,blood vessel endothelial cell fate commitment,6,0.0,1.0,1.0,2
8564,GO:0060887,limb epidermis development,6,0.0,1.0,1.0,1
8565,GO:0060927,cardiac pacemaker cell fate commitment,6,0.0,1.0,1.0,2
8566,GO:0060948,cardiac vascular smooth muscle cell development,6,0.0,1.0,1.0,1
8567,GO:0060949,cardiac vascular smooth muscle cell fate commitment,6,0.0,1.0,1.0,1
8568,GO:0060957,endocardial cell fate commitment,6,0.0,1.0,1.0,1
8569,GO:0061028,establishment of endothelial barrier,6,0.0,1.0,1.0,2
8570,GO:0061036,positive regulation of cartilage development,6,0.0,1.0,1.0,1
8571,GO:0061037,negative regulation of cartilage development,6,0.0,1.0,1.0,1
8572,GO:0061041,regulation of wound healing,6,0.0,1.0,1.0,5
8573,GO:0061046,regulation of branching involved in lung morphogenesis,6,0.0,1.0,1.0,3
8574,GO:0061062,regulation of nematode larval development,6,0.0,1.0,1.0,4
8575,GO:0061094,regulation of turning behavior involved in mating,6,0.0,1.0,1.0,2
8576,GO:0061105,regulation of stomach neuroendocrine cell differentiation,6,0.0,1.0,1.0,1
8577,GO:0061114,branching involved in pancreas morphogenesis,6,0.0,1.0,1.0,1
8578,GO:0061140,lung secretory cell differentiation,6,0.0,1.0,1.0,3
8579,GO:0061154,endothelial tube morphogenesis,6,0.0,1.0,1.0,3
8580,GO:0061172,regulation of establishment of bipolar cell polarity,6,0.0,1.0,1.0,3
8581,GO:0061213,positive regulation of mesonephros development,6,0.0,1.0,1.0,1
8582,GO:0061218,negative regulation of mesonephros development,6,0.0,1.0,1.0,1
8583,GO:0061251,mesonephric glomerular epithelial cell development,6,0.0,1.0,1.0,3
8584,GO:0061252,mesonephric glomerular epithelial cell fate commitment,6,0.0,1.0,1.0,1
8585,GO:0061260,mesonephric mesangial cell differentiation,6,0.0,1.0,1.0,1
8586,GO:0061261,mesenchymal to epithelial transition involved in mesonephros morphogenesis,6,0.0,1.0,1.0,1
8587,GO:0061308,cardiac neural crest cell development involved in heart development,6,0.0,1.0,1.0,1
8588,GO:0061311,cell surface receptor signaling pathway involved in heart development,6,0.0,1.0,1.0,5
8589,GO:0061333,renal tubule morphogenesis,6,0.0,1.0,1.0,2
8590,GO:0061387,regulation of extent of cell growth,6,0.0,1.0,1.0,3
8591,GO:0061440,kidney vasculature development,6,0.0,1.0,1.0,1
8592,GO:0061459,L-arginine transmembrane transporter activity,6,0.0,1.0,1.0,3
8593,GO:0061469,regulation of type B pancreatic cell proliferation,6,0.0,1.0,1.0,2
8594,GO:0061512,protein localization to cilium,6,0.0,1.0,1.0,5
8595,GO:0061531,primary amine secretion,6,0.0,1.0,1.0,2
8596,GO:0061539,octopamine secretion,6,0.0,1.0,1.0,1
8597,GO:0061572,actin filament bundle organization,6,0.0,1.0,1.0,3
8598,GO:0061582,intestinal epithelial cell migration,6,0.0,1.0,1.0,1
8599,GO:0061650,ubiquitin-like protein conjugating enzyme activity,6,0.0,1.0,1.0,10
8600,GO:0061659,ubiquitin-like protein ligase activity,6,0.0,1.0,1.0,10
8601,GO:0061853,regulation of neuroblast migration,6,0.0,1.0,1.0,2
8602,GO:0061873,regulation of hepatic stellate cell contraction,6,0.0,1.0,1.0,2
8603,GO:0061920,protein propionyltransferase activity,6,0.0,1.0,1.0,1
8604,GO:0061924,regulation of formation of radial glial scaffolds,6,0.0,1.0,1.0,2
8605,GO:0061966,establishment of left/right asymmetry,6,0.0,1.0,1.0,1
8606,GO:0061976,temporomandibular joint articular cartilage development,6,0.0,1.0,1.0,1
8607,GO:0061977,hip joint articular cartilage development,6,0.0,1.0,1.0,1
8608,GO:0061985,carbon catabolite repression,6,0.0,1.0,1.0,1
8609,GO:0062013,positive regulation of small molecule metabolic process,6,0.0,1.0,1.0,70
8610,GO:0062014,negative regulation of small molecule metabolic process,6,0.0,1.0,1.0,73
8611,GO:0062037,D-loop DNA binding,6,0.0,1.0,1.0,1
8612,GO:0062042,regulation of cardiac epithelial to mesenchymal transition,6,0.0,1.0,1.0,4
8613,GO:0062089,regulation of taurine biosynthetic process,6,0.0,1.0,1.0,1
8614,GO:0062099,negative regulation of programmed necrotic cell death,6,0.0,1.0,1.0,1
8615,GO:0062100,positive regulation of programmed necrotic cell death,6,0.0,1.0,1.0,1
8616,GO:0062105,RNA 2'-O-methyltransferase activity,6,0.0,1.0,1.0,6
8617,GO:0062109,regulation of DNA recombinase disassembly,6,0.0,1.0,1.0,1
8618,GO:0062126,fatty acid primary amide metabolic process,6,0.0,1.0,1.0,2
8619,GO:0062161,regulation of pyocyanine biosynthetic process,6,0.0,1.0,1.0,1
8620,GO:0062169,regulation of plus-end directed microtubule sliding,6,0.0,1.0,1.0,1
8621,GO:0062173,brexanolone metabolic process,6,0.0,1.0,1.0,2
8622,GO:0065004,protein-DNA complex assembly,6,0.0,1.0,1.0,11
8623,GO:0065005,protein-lipid complex assembly,6,0.0,1.0,1.0,3
8624,GO:0070071,proton-transporting two-sector ATPase complex assembly,6,0.0,1.0,1.0,2
8625,GO:0070112,organellar chromatophore membrane,6,0.0,1.0,1.0,3
8626,GO:0070137,ubiquitin-like protein-specific endopeptidase activity,6,0.0,1.0,1.0,1
8627,GO:0070141,response to UV-A,6,0.0,1.0,1.0,1
8628,GO:0070168,negative regulation of biomineral tissue development,6,0.0,1.0,1.0,3
8629,GO:0070169,positive regulation of biomineral tissue development,6,0.0,1.0,1.0,3
8630,GO:0070170,regulation of tooth mineralization,6,0.0,1.0,1.0,3
8631,GO:0070180,large ribosomal subunit rRNA binding,6,0.0,1.0,1.0,1
8632,GO:0070192,chromosome organization involved in meiotic cell cycle,6,0.0,1.0,1.0,12
8633,GO:0070193,synaptonemal complex organization,6,0.0,1.0,1.0,2
8634,GO:0070201,regulation of establishment of protein localization,6,0.0,1.0,1.0,6
8635,GO:0070227,lymphocyte apoptotic process,6,0.0,1.0,1.0,3
8636,GO:0070255,regulation of mucus secretion,6,0.0,1.0,1.0,2
8637,GO:0070259,tyrosyl-DNA phosphodiesterase activity,6,0.0,1.0,1.0,2
8638,GO:0070278,extracellular matrix constituent secretion,6,0.0,1.0,1.0,2
8639,GO:0070286,axonemal dynein complex assembly,6,0.0,1.0,1.0,2
8640,GO:0070316,regulation of G0 to G1 transition,6,0.0,1.0,1.0,2
8641,GO:0070339,response to bacterial lipopeptide,6,0.0,1.0,1.0,4
8642,GO:0070345,negative regulation of fat cell proliferation,6,0.0,1.0,1.0,2
8643,GO:0070346,positive regulation of fat cell proliferation,6,0.0,1.0,1.0,2
8644,GO:0070347,regulation of brown fat cell proliferation,6,0.0,1.0,1.0,2
8645,GO:0070350,regulation of white fat cell proliferation,6,0.0,1.0,1.0,2
8646,GO:0070366,regulation of hepatocyte differentiation,6,0.0,1.0,1.0,2
8647,GO:0070445,regulation of oligodendrocyte progenitor proliferation,6,0.0,1.0,1.0,2
8648,GO:0070483,detection of hypoxia,6,0.0,1.0,1.0,1
8649,GO:0070585,protein localization to mitochondrion,6,0.0,1.0,1.0,1
8650,GO:0070587,regulation of cell-cell adhesion involved in gastrulation,6,0.0,1.0,1.0,1
8651,GO:0070654,sensory epithelium regeneration,6,0.0,1.0,1.0,1
8652,GO:0070656,mechanoreceptor differentiation involved in mechanosensory epithelium regeneration,6,0.0,1.0,1.0,2
8653,GO:0070664,negative regulation of leukocyte proliferation,6,0.0,1.0,1.0,4
8654,GO:0070665,positive regulation of leukocyte proliferation,6,0.0,1.0,1.0,4
8655,GO:0070666,regulation of mast cell proliferation,6,0.0,1.0,1.0,2
8656,GO:0070697,activin receptor binding,6,0.0,1.0,1.0,2
8657,GO:0070717,poly-purine tract binding,6,0.0,1.0,1.0,2
8658,GO:0070726,cell wall assembly,6,0.0,1.0,1.0,3
8659,GO:0070784,regulation of growth of unicellular organism as a thread of attached cells,6,0.0,1.0,1.0,6
8660,GO:0070794,negative regulation of conidiophore development,6,0.0,1.0,1.0,1
8661,GO:0070795,positive regulation of conidiophore development,6,0.0,1.0,1.0,1
8662,GO:0070802,regulation of metula development,6,0.0,1.0,1.0,2
8663,GO:0070805,regulation of phialide development,6,0.0,1.0,1.0,2
8664,GO:0070808,regulation of Hulle cell development,6,0.0,1.0,1.0,2
8665,GO:0070854,myosin VI heavy chain binding,6,0.0,1.0,1.0,1
8666,GO:0070871,cell wall organization involved in conjugation with cellular fusion,6,0.0,1.0,1.0,1
8667,GO:0070910,cell wall macromolecule catabolic process involved in cell wall disassembly,6,0.0,1.0,1.0,1
8668,GO:0070942,neutrophil mediated cytotoxicity,6,0.0,1.0,1.0,1
8669,GO:0070972,protein localization to endoplasmic reticulum,6,0.0,1.0,1.0,3
8670,GO:0071103,DNA conformation change,6,0.0,1.0,1.0,2
8671,GO:0071205,protein localization to juxtaparanode region of axon,6,0.0,1.0,1.0,1
8672,GO:0071220,cellular response to bacterial lipoprotein,6,0.0,1.0,1.0,1
8673,GO:0071307,cellular response to vitamin K,6,0.0,1.0,1.0,3
8674,GO:0071317,cellular response to isoquinoline alkaloid,6,0.0,1.0,1.0,3
8675,GO:0071318,cellular response to ATP,6,0.0,1.0,1.0,1
8676,GO:0071324,cellular response to disaccharide stimulus,6,0.0,1.0,1.0,4
8677,GO:0071326,cellular response to monosaccharide stimulus,6,0.0,1.0,1.0,3
8678,GO:0071384,cellular response to corticosteroid stimulus,6,0.0,1.0,1.0,2
8679,GO:0071413,cellular response to hydroxyisoflavone,6,0.0,1.0,1.0,1
8680,GO:0071447,cellular response to hydroperoxide,6,0.0,1.0,1.0,2
8681,GO:0071468,cellular response to acidic pH,6,0.0,1.0,1.0,1
8682,GO:0071472,cellular response to salt stress,6,0.0,1.0,1.0,3
8683,GO:0071474,cellular hyperosmotic response,6,0.0,1.0,1.0,1
8684,GO:0071476,cellular hypotonic response,6,0.0,1.0,1.0,1
8685,GO:0071479,cellular response to ionizing radiation,6,0.0,1.0,1.0,2
8686,GO:0071482,cellular response to light stimulus,6,0.0,1.0,1.0,5
8687,GO:0071526,semaphorin-plexin signaling pathway,6,0.0,1.0,1.0,4
8688,GO:0071550,death-inducing signaling complex assembly,6,0.0,1.0,1.0,1
8689,GO:0071568,UFM1 transferase activity,6,0.0,1.0,1.0,2
8690,GO:0071593,lymphocyte aggregation,6,0.0,1.0,1.0,1
8691,GO:0071711,basement membrane organization,6,0.0,1.0,1.0,2
8692,GO:0071715,icosanoid transport,6,0.0,1.0,1.0,6
8693,GO:0071750,dimeric IgA immunoglobulin complex,6,0.0,1.0,1.0,1
8694,GO:0071751,secretory IgA immunoglobulin complex,6,0.0,1.0,1.0,1
8695,GO:0071783,endoplasmic reticulum cisternal network organization,6,0.0,1.0,1.0,2
8696,GO:0071786,endoplasmic reticulum tubular network organization,6,0.0,1.0,1.0,3
8697,GO:0071865,regulation of apoptotic process in bone marrow cell,6,0.0,1.0,1.0,2
8698,GO:0071870,cellular response to catecholamine stimulus,6,0.0,1.0,1.0,3
8699,GO:0071873,response to norepinephrine,6,0.0,1.0,1.0,1
8700,GO:0071875,adrenergic receptor signaling pathway,6,0.0,1.0,1.0,4
8701,GO:0071907,determination of digestive tract left/right asymmetry,6,0.0,1.0,1.0,2
8702,GO:0071934,thiamine transmembrane transport,6,0.0,1.0,1.0,2
8703,GO:0071993,phytochelatin transport,6,0.0,1.0,1.0,1
8704,GO:0072002,Malpighian tubule development,6,0.0,1.0,1.0,2
8705,GO:0072008,glomerular mesangial cell differentiation,6,0.0,1.0,1.0,2
8706,GO:0072009,nephron epithelium development,6,0.0,1.0,1.0,9
8707,GO:0072015,podocyte development,6,0.0,1.0,1.0,2
8708,GO:0072016,glomerular parietal epithelial cell development,6,0.0,1.0,1.0,2
8709,GO:0072036,mesenchymal to epithelial transition involved in renal vesicle formation,6,0.0,1.0,1.0,2
8710,GO:0072037,mesenchymal stem cell differentiation involved in nephron morphogenesis,6,0.0,1.0,1.0,2
8711,GO:0072075,metanephric mesenchyme development,6,0.0,1.0,1.0,1
8712,GO:0072079,nephron tubule formation,6,0.0,1.0,1.0,3
8713,GO:0072099,anterior/posterior pattern specification involved in ureteric bud development,6,0.0,1.0,1.0,1
8714,GO:0072124,regulation of glomerular mesangial cell proliferation,6,0.0,1.0,1.0,4
8715,GO:0072133,metanephric mesenchyme morphogenesis,6,0.0,1.0,1.0,1
8716,GO:0072147,glomerular parietal epithelial cell fate commitment,6,0.0,1.0,1.0,2
8717,GO:0072149,podocyte cell fate commitment,6,0.0,1.0,1.0,2
8718,GO:0072155,epithelial cell migration involved in nephron tubule morphogenesis,6,0.0,1.0,1.0,4
8719,GO:0072160,nephron tubule epithelial cell differentiation,6,0.0,1.0,1.0,3
8720,GO:0072161,mesenchymal cell differentiation involved in kidney development,6,0.0,1.0,1.0,2
8721,GO:0072163,mesonephric epithelium development,6,0.0,1.0,1.0,2
8722,GO:0072173,metanephric tubule morphogenesis,6,0.0,1.0,1.0,1
8723,GO:0072176,nephric duct development,6,0.0,1.0,1.0,2
8724,GO:0072178,nephric duct morphogenesis,6,0.0,1.0,1.0,2
8725,GO:0072194,kidney smooth muscle tissue development,6,0.0,1.0,1.0,2
8726,GO:0072196,proximal/distal pattern formation involved in pronephric nephron development,6,0.0,1.0,1.0,2
8727,GO:0072199,regulation of mesenchymal cell proliferation involved in ureter development,6,0.0,1.0,1.0,2
8728,GO:0072201,negative regulation of mesenchymal cell proliferation,6,0.0,1.0,1.0,2
8729,GO:0072207,metanephric epithelium development,6,0.0,1.0,1.0,2
8730,GO:0072209,metanephric mesangial cell differentiation,6,0.0,1.0,1.0,1
8731,GO:0072216,positive regulation of metanephros development,6,0.0,1.0,1.0,2
8732,GO:0072217,negative regulation of metanephros development,6,0.0,1.0,1.0,2
8733,GO:0072298,regulation of metanephric glomerulus development,6,0.0,1.0,1.0,2
8734,GO:0072311,glomerular epithelial cell differentiation,6,0.0,1.0,1.0,4
8735,GO:0072313,metanephric glomerular epithelial cell development,6,0.0,1.0,1.0,2
8736,GO:0072315,metanephric glomerular epithelial cell fate commitment,6,0.0,1.0,1.0,2
8737,GO:0072331,signal transduction by p53 class mediator,6,0.0,1.0,1.0,2
8738,GO:0072376,protein activation cascade,6,0.0,1.0,1.0,6
8739,GO:0072423,response to DNA damage checkpoint signaling,6,0.0,1.0,1.0,3
8740,GO:0072438,response to DNA replication checkpoint signaling,6,0.0,1.0,1.0,2
8741,GO:0072470,response to cell size control checkpoint signaling,6,0.0,1.0,1.0,2
8742,GO:0072476,response to mitotic spindle checkpoint signaling,6,0.0,1.0,1.0,2
8743,GO:0072485,response to spindle assembly checkpoint signaling,6,0.0,1.0,1.0,2
8744,GO:0072496,Pup transferase activity,6,0.0,1.0,1.0,2
8745,GO:0072584,caveolin-mediated endocytosis,6,0.0,1.0,1.0,1
8746,GO:0072594,establishment of protein localization to organelle,6,0.0,1.0,1.0,14
8747,GO:0072598,protein localization to chloroplast,6,0.0,1.0,1.0,2
8748,GO:0072659,protein localization to plasma membrane,6,0.0,1.0,1.0,2
8749,GO:0072662,protein localization to peroxisome,6,0.0,1.0,1.0,2
8750,GO:0072665,protein localization to vacuole,6,0.0,1.0,1.0,3
8751,GO:0072676,lymphocyte migration,6,0.0,1.0,1.0,3
8752,GO:0072697,protein localization to cell cortex,6,0.0,1.0,1.0,9
8753,GO:0072735,response to tert-butyl hydroperoxide,6,0.0,1.0,1.0,1
8754,GO:0075215,modulation of spore encystment on host,6,0.0,1.0,1.0,3
8755,GO:0075223,regulation of sporangium germination,6,0.0,1.0,1.0,2
8756,GO:0075268,regulation of aecium development,6,0.0,1.0,1.0,2
8757,GO:0075306,regulation of conidium formation,6,0.0,1.0,1.0,2
8758,GO:0075311,positive regulation of sporangium development,6,0.0,1.0,1.0,2
8759,GO:0075312,negative regulation of sporangium development,6,0.0,1.0,1.0,2
8760,GO:0075322,regulation of oomycete sporangium development,6,0.0,1.0,1.0,2
8761,GO:0075329,regulation of arbuscule formation for nutrient acquisition from host,6,0.0,1.0,1.0,2
8762,GO:0075509,endocytosis involved in viral entry into host cell,6,0.0,1.0,1.0,2
8763,GO:0080008,Cul4-RING E3 ubiquitin ligase complex,6,0.0,1.0,1.0,3
8764,GO:0080036,regulation of cytokinin-activated signaling pathway,6,0.0,1.0,1.0,2
8765,GO:0080050,regulation of seed development,6,0.0,1.0,1.0,1
8766,GO:0080171,lytic vacuole organization,6,0.0,1.0,1.0,1
8767,GO:0085029,extracellular matrix assembly,6,0.0,1.0,1.0,4
8768,GO:0086002,cardiac muscle cell action potential involved in contraction,6,0.0,1.0,1.0,2
8769,GO:0086012,membrane depolarization during cardiac muscle cell action potential,6,0.0,1.0,1.0,6
8770,GO:0086013,membrane repolarization during cardiac muscle cell action potential,6,0.0,1.0,1.0,6
8771,GO:0086080,protein binding involved in heterotypic cell-cell adhesion,6,0.0,1.0,1.0,5
8772,GO:0086100,endothelin receptor signaling pathway,6,0.0,1.0,1.0,2
8773,GO:0086103,G protein-coupled receptor signaling pathway involved in heart process,6,0.0,1.0,1.0,4
8774,GO:0089718,amino acid import across plasma membrane,6,0.0,1.0,1.0,22
8775,GO:0089721,phosphoenolpyruvate transmembrane transporter activity,6,0.0,1.0,1.0,1
8776,GO:0090034,regulation of chaperone-mediated protein complex assembly,6,0.0,1.0,1.0,1
8777,GO:0090056,regulation of chlorophyll metabolic process,6,0.0,1.0,1.0,2
8778,GO:0090068,positive regulation of cell cycle process,6,0.0,1.0,1.0,37
8779,GO:0090071,negative regulation of ribosome biogenesis,6,0.0,1.0,1.0,2
8780,GO:0090084,negative regulation of inclusion body assembly,6,0.0,1.0,1.0,2
8781,GO:0090088,regulation of oligopeptide transport,6,0.0,1.0,1.0,3
8782,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,6,0.0,1.0,1.0,6
8783,GO:0090095,regulation of metanephric cap mesenchymal cell proliferation,6,0.0,1.0,1.0,1
8784,GO:0090107,regulation of high-density lipoprotein particle assembly,6,0.0,1.0,1.0,1
8785,GO:0090109,regulation of cell-substrate junction assembly,6,0.0,1.0,1.0,1
8786,GO:0090128,regulation of synapse maturation,6,0.0,1.0,1.0,2
8787,GO:0090150,establishment of protein localization to membrane,6,0.0,1.0,1.0,12
8788,GO:0090161,Golgi ribbon formation,6,0.0,1.0,1.0,1
8789,GO:0090174,organelle membrane fusion,6,0.0,1.0,1.0,5
8790,GO:0090175,regulation of establishment of planar polarity,6,0.0,1.0,1.0,1
8791,GO:0090186,regulation of pancreatic juice secretion,6,0.0,1.0,1.0,2
8792,GO:0090189,regulation of branching involved in ureteric bud morphogenesis,6,0.0,1.0,1.0,2
8793,GO:0090193,positive regulation of glomerulus development,6,0.0,1.0,1.0,2
8794,GO:0090194,negative regulation of glomerulus development,6,0.0,1.0,1.0,2
8795,GO:0090210,regulation of establishment of blood-brain barrier,6,0.0,1.0,1.0,2
8796,GO:0090227,regulation of red or far-red light signaling pathway,6,0.0,1.0,1.0,2
8797,GO:0090261,positive regulation of inclusion body assembly,6,0.0,1.0,1.0,2
8798,GO:0090289,regulation of osteoclast proliferation,6,0.0,1.0,1.0,2
8799,GO:0090299,regulation of neural crest formation,6,0.0,1.0,1.0,3
8800,GO:0090322,regulation of superoxide metabolic process,6,0.0,1.0,1.0,2
8801,GO:0090335,regulation of brown fat cell differentiation,6,0.0,1.0,1.0,2
8802,GO:0090348,regulation of organofluorine metabolic process,6,0.0,1.0,1.0,1
8803,GO:0090349,negative regulation of organohalogen metabolic process,6,0.0,1.0,1.0,1
8804,GO:0090354,regulation of auxin metabolic process,6,0.0,1.0,1.0,3
8805,GO:0090364,regulation of proteasome assembly,6,0.0,1.0,1.0,1
8806,GO:0090371,regulation of glycerol transport,6,0.0,1.0,1.0,2
8807,GO:0090504,epiboly,6,0.0,1.0,1.0,2
8808,GO:0090507,phenylethylamine metabolic process involved in synaptic transmission,6,0.0,1.0,1.0,1
8809,GO:0090599,alpha-glucosidase activity,6,0.0,1.0,1.0,11
8810,GO:0090609,single-species submerged biofilm formation,6,0.0,1.0,1.0,1
8811,GO:0090700,maintenance of plant organ identity,6,0.0,1.0,1.0,1
8812,GO:0090735,DNA repair complex assembly,6,0.0,1.0,1.0,2
8813,GO:0090741,pigment granule membrane,6,0.0,1.0,1.0,1
8814,GO:0095500,acetylcholine receptor signaling pathway,6,0.0,1.0,1.0,1
8815,GO:0097013,phagocytic vesicle lumen,6,0.0,1.0,1.0,2
8816,GO:0097028,dendritic cell differentiation,6,0.0,1.0,1.0,3
8817,GO:0097106,postsynaptic density organization,6,0.0,1.0,1.0,2
8818,GO:0097157,pre-mRNA intronic binding,6,0.0,1.0,1.0,1
8819,GO:0097191,extrinsic apoptotic signaling pathway,6,0.0,1.0,1.0,4
8820,GO:0097193,intrinsic apoptotic signaling pathway,6,0.0,1.0,1.0,7
8821,GO:0097213,regulation of lysosomal membrane permeability,6,0.0,1.0,1.0,2
8822,GO:0097250,mitochondrial respirasome assembly,6,0.0,1.0,1.0,5
8823,GO:0097264,self proteolysis,6,0.0,1.0,1.0,2
8824,GO:0097343,ripoptosome assembly,6,0.0,1.0,1.0,2
8825,GO:0097363,protein O-acetylglucosaminyltransferase activity,6,0.0,1.0,1.0,1
8826,GO:0097428,protein maturation by iron-sulfur cluster transfer,6,0.0,1.0,1.0,2
8827,GO:0097440,apical dendrite,6,0.0,1.0,1.0,2
8828,GO:0097441,basal dendrite,6,0.0,1.0,1.0,2
8829,GO:0097450,astrocyte end-foot,6,0.0,1.0,1.0,1
8830,GO:0097457,hippocampal mossy fiber,6,0.0,1.0,1.0,1
8831,GO:0097472,cyclin-dependent protein kinase activity,6,0.0,1.0,1.0,1
8832,GO:0097476,spinal cord motor neuron migration,6,0.0,1.0,1.0,1
8833,GO:0097506,deaminated base DNA N-glycosylase activity,6,0.0,1.0,1.0,4
8834,GO:0097530,granulocyte migration,6,0.0,1.0,1.0,3
8835,GO:0097531,mast cell migration,6,0.0,1.0,1.0,1
8836,GO:0097576,vacuole fusion,6,0.0,1.0,1.0,2
8837,GO:0097581,lamellipodium organization,6,0.0,1.0,1.0,2
8838,GO:0097603,temperature-gated ion channel activity,6,0.0,1.0,1.0,1
8839,GO:0097642,calcitonin family receptor activity,6,0.0,1.0,1.0,4
8840,GO:0097646,calcitonin family receptor signaling pathway,6,0.0,1.0,1.0,3
8841,GO:0097651,"phosphatidylinositol 3-kinase complex, class I",6,0.0,1.0,1.0,2
8842,GO:0097696,cell surface receptor signaling pathway via STAT,6,0.0,1.0,1.0,1
8843,GO:0097729,9+2 motile cilium,6,0.0,1.0,1.0,11
8844,GO:0097731,9+0 non-motile cilium,6,0.0,1.0,1.0,1
8845,GO:0097732,9+2 non-motile cilium,6,0.0,1.0,1.0,1
8846,GO:0097746,blood vessel diameter maintenance,6,0.0,1.0,1.0,4
8847,GO:0098524,neuromuscular junction of somatic muscle myotube,6,0.0,1.0,1.0,2
8848,GO:0098566,transport vesicle lumen,6,0.0,1.0,1.0,2
8849,GO:0098586,cellular response to virus,6,0.0,1.0,1.0,2
8850,GO:0098598,learned vocalization behavior or vocal learning,6,0.0,1.0,1.0,2
8851,GO:0098655,monoatomic cation transmembrane transport,6,0.0,1.0,1.0,15
8852,GO:0098656,monoatomic anion transmembrane transport,6,0.0,1.0,1.0,3
8853,GO:0098661,inorganic anion transmembrane transport,6,0.0,1.0,1.0,12
8854,GO:0098662,inorganic cation transmembrane transport,6,0.0,1.0,1.0,17
8855,GO:0098664,G protein-coupled serotonin receptor signaling pathway,6,0.0,1.0,1.0,2
8856,GO:0098693,regulation of synaptic vesicle cycle,6,0.0,1.0,1.0,1
8857,GO:0098698,postsynaptic specialization assembly,6,0.0,1.0,1.0,1
8858,GO:0098704,carbohydrate import across plasma membrane,6,0.0,1.0,1.0,4
8859,GO:0098734,macromolecule depalmitoylation,6,0.0,1.0,1.0,1
8860,GO:0098784,biofilm matrix organization,6,0.0,1.0,1.0,2
8861,GO:0098810,neurotransmitter reuptake,6,0.0,1.0,1.0,3
8862,GO:0098828,modulation of inhibitory postsynaptic potential,6,0.0,1.0,1.0,1
8863,GO:0098847,sequence-specific single stranded DNA binding,6,0.0,1.0,1.0,1
8864,GO:0098852,lytic vacuole membrane,6,0.0,1.0,1.0,2
8865,GO:0098865,symbiont-mediated perturbation of host tight cell-cell junction,6,0.0,1.0,1.0,1
8866,GO:0098883,synapse pruning,6,0.0,1.0,1.0,2
8867,GO:0098892,extrinsic component of postsynaptic specialization membrane,6,0.0,1.0,1.0,1
8868,GO:0098904,regulation of AV node cell action potential,6,0.0,1.0,1.0,3
8869,GO:0098927,vesicle-mediated transport between endosomal compartments,6,0.0,1.0,1.0,2
8870,GO:0098985,"asymmetric, glutamatergic, excitatory synapse",6,0.0,1.0,1.0,2
8871,GO:0099024,plasma membrane invagination,6,0.0,1.0,1.0,3
8872,GO:0099050,vesicle scission,6,0.0,1.0,1.0,1
8873,GO:0099099,G-protein gated monoatomic ion channel activity,6,0.0,1.0,1.0,1
8874,GO:0099104,potassium channel activator activity,6,0.0,1.0,1.0,1
8875,GO:0099105,"ion channel modulating, G protein-coupled receptor signaling pathway",6,0.0,1.0,1.0,1
8876,GO:0099134,chimeric sorocarp development,6,0.0,1.0,1.0,1
8877,GO:0099137,"altruistic, chimeric, non-reproductive fruiting body development",6,0.0,1.0,1.0,1
8878,GO:0099163,synaptic signaling by nitric oxide,6,0.0,1.0,1.0,1
8879,GO:0099174,regulation of presynapse organization,6,0.0,1.0,1.0,2
8880,GO:0099175,regulation of postsynapse organization,6,0.0,1.0,1.0,4
8881,GO:0099187,presynaptic cytoskeleton organization,6,0.0,1.0,1.0,1
8882,GO:0099188,postsynaptic cytoskeleton organization,6,0.0,1.0,1.0,3
8883,GO:0099515,actin filament-based transport,6,0.0,1.0,1.0,3
8884,GO:0099518,vesicle cytoskeletal trafficking,6,0.0,1.0,1.0,4
8885,GO:0099532,synaptic vesicle endosomal processing,6,0.0,1.0,1.0,1
8886,GO:0099537,trans-synaptic signaling,6,0.0,1.0,1.0,9
8887,GO:0099538,synaptic signaling via neuropeptide,6,0.0,1.0,1.0,1
8888,GO:0099558,maintenance of synapse structure,6,0.0,1.0,1.0,3
8889,GO:0099563,modification of synaptic structure,6,0.0,1.0,1.0,2
8890,GO:0099569,presynaptic cytoskeleton,6,0.0,1.0,1.0,3
8891,GO:0099571,postsynaptic cytoskeleton,6,0.0,1.0,1.0,5
8892,GO:0099587,inorganic ion import across plasma membrane,6,0.0,1.0,1.0,2
8893,GO:0099614,protein localization to spore cell wall,6,0.0,1.0,1.0,1
8894,GO:0099624,atrial cardiac muscle cell membrane repolarization,6,0.0,1.0,1.0,1
8895,GO:0099625,ventricular cardiac muscle cell membrane repolarization,6,0.0,1.0,1.0,1
8896,GO:0101024,mitotic nuclear membrane organization,6,0.0,1.0,1.0,3
8897,GO:0106023,regulation of pupariation,6,0.0,1.0,1.0,2
8898,GO:0106027,neuron projection organization,6,0.0,1.0,1.0,4
8899,GO:0106047,polyamine deacetylation,6,0.0,1.0,1.0,1
8900,GO:0106049,regulation of cellular response to osmotic stress,6,0.0,1.0,1.0,2
8901,GO:0106075,peptide N-succinyltransferase activity,6,0.0,1.0,1.0,2
8902,GO:0106091,glial cell projection elongation,6,0.0,1.0,1.0,1
8903,GO:0106107,regulation of (R)-mevalonic acid biosynthetic process,6,0.0,1.0,1.0,2
8904,GO:0106228,peptide glutaryltransferase activity,6,0.0,1.0,1.0,1
8905,GO:0106260,DNA-DNA tethering activity,6,0.0,1.0,1.0,1
8906,GO:0106303,mannogen metabolic process,6,0.0,1.0,1.0,2
8907,GO:0106310,protein serine kinase activity,6,0.0,1.0,1.0,1
8908,GO:0106346,snRNA methyltransferase activity,6,0.0,1.0,1.0,3
8909,GO:0110011,regulation of basement membrane organization,6,0.0,1.0,1.0,1
8910,GO:0110017,cap-independent translational initiation of linear mRNA,6,0.0,1.0,1.0,1
8911,GO:0110018,cap-independent translational initiation of circular RNA,6,0.0,1.0,1.0,1
8912,GO:0110022,regulation of cardiac muscle myoblast proliferation,6,0.0,1.0,1.0,2
8913,GO:0110041,regulation of nematode pharynx morphogenesis,6,0.0,1.0,1.0,2
8914,GO:0110044,"regulation of cell cycle switching, mitotic to meiotic cell cycle",6,0.0,1.0,1.0,2
8915,GO:0110079,regulation of placenta blood vessel development,6,0.0,1.0,1.0,2
8916,GO:0110110,positive regulation of animal organ morphogenesis,6,0.0,1.0,1.0,8
8917,GO:0110111,negative regulation of animal organ morphogenesis,6,0.0,1.0,1.0,3
8918,GO:0110112,regulation of lipid transporter activity,6,0.0,1.0,1.0,4
8919,GO:0110123,regulation of myotube cell migration,6,0.0,1.0,1.0,2
8920,GO:0120006,regulation of glutamatergic neuron differentiation,6,0.0,1.0,1.0,2
8921,GO:0120031,plasma membrane bounded cell projection assembly,6,0.0,1.0,1.0,14
8922,GO:0120035,regulation of plasma membrane bounded cell projection organization,6,0.0,1.0,1.0,6
8923,GO:0120039,plasma membrane bounded cell projection morphogenesis,6,0.0,1.0,1.0,3
8924,GO:0120040,regulation of macrophage proliferation,6,0.0,1.0,1.0,2
8925,GO:0120057,regulation of small intestinal transit,6,0.0,1.0,1.0,2
8926,GO:0120074,regulation of endocardial cushion cell differentiation,6,0.0,1.0,1.0,2
8927,GO:0120165,perithecium development,6,0.0,1.0,1.0,1
8928,GO:0120175,regulation of torso signaling pathway,6,0.0,1.0,1.0,2
8929,GO:0120180,cell-substrate junction disassembly,6,0.0,1.0,1.0,1
8930,GO:0120182,regulation of focal adhesion disassembly,6,0.0,1.0,1.0,2
8931,GO:0120188,regulation of bile acid secretion,6,0.0,1.0,1.0,2
8932,GO:0120193,tight junction organization,6,0.0,1.0,1.0,2
8933,GO:0120261,regulation of heterochromatin organization,6,0.0,1.0,1.0,2
8934,GO:0120264,regulation of chromosome attachment to the nuclear envelope,6,0.0,1.0,1.0,2
8935,GO:0120276,regulation of cerebral blood circulation,6,0.0,1.0,1.0,2
8936,GO:0120294,peptide serotonyltransferase activity,6,0.0,1.0,1.0,1
8937,GO:0120296,peptide dopaminyltransferase activity,6,0.0,1.0,1.0,1
8938,GO:0120300,peptide lactyltransferase (CoA-dependent) activity,6,0.0,1.0,1.0,1
8939,GO:0120302,background adaptation,6,0.0,1.0,1.0,2
8940,GO:0120322,lipid modification by small protein conjugation,6,0.0,1.0,1.0,1
8941,GO:0120515,fatty acid-CoA ligase activity,6,0.0,1.0,1.0,4
8942,GO:0120517,inositol pentakisphosphate kinase activity,6,0.0,1.0,1.0,2
8943,GO:0140053,mitochondrial gene expression,6,0.0,1.0,1.0,1
8944,GO:0140064,peptide crotonyltransferase activity,6,0.0,1.0,1.0,1
8945,GO:0140065,peptide butyryltransferase activity,6,0.0,1.0,1.0,1
8946,GO:0140122,regulation of Lewy body formation,6,0.0,1.0,1.0,2
8947,GO:0140202,polyamine import across plasma membrane,6,0.0,1.0,1.0,1
8948,GO:0140238,presynaptic endocytosis,6,0.0,1.0,1.0,1
8949,GO:0140239,postsynaptic endocytosis,6,0.0,1.0,1.0,1
8950,GO:0140241,translation at synapse,6,0.0,1.0,1.0,2
8951,GO:0140246,protein catabolic process at synapse,6,0.0,1.0,1.0,3
8952,GO:0140250,regulation protein catabolic process at synapse,6,0.0,1.0,1.0,3
8953,GO:0140255,regulation of cellular response to phosphate starvation,6,0.0,1.0,1.0,2
8954,GO:0140267,symbiont entry into host cell via permeabilization of host membrane,6,0.0,1.0,1.0,2
8955,GO:0140333,glycerophospholipid flippase activity,6,0.0,1.0,1.0,6
8956,GO:0140358,P-type transmembrane transporter activity,6,0.0,1.0,1.0,1
8957,GO:0140359,ABC-type transporter activity,6,0.0,1.0,1.0,41
8958,GO:0140546,defense response to symbiont,6,0.0,1.0,1.0,9
8959,GO:0140632,canonical inflammasome complex assembly,6,0.0,1.0,1.0,4
8960,GO:0140674,ATP-dependent histone chaperone activity,6,0.0,1.0,1.0,2
8961,GO:0140694,membraneless organelle assembly,6,0.0,1.0,1.0,15
8962,GO:0140702,cyclic GMP-AMP binding,6,0.0,1.0,1.0,2
8963,GO:0140751,histone octamer slider activity,6,0.0,1.0,1.0,1
8964,GO:0140794,histone arginine deiminase activity,6,0.0,1.0,1.0,4
8965,GO:0140805,NAD+-protein-serine ADP-ribosyltransferase activity,6,0.0,1.0,1.0,2
8966,GO:0140807,NAD+-protein-glutamate ADP-ribosyltransferase activity,6,0.0,1.0,1.0,3
8967,GO:0140824,thioredoxin-dependent peroxiredoxin activity,6,0.0,1.0,1.0,1
8968,GO:0140828,metal cation:monoatomic cation antiporter activity,6,0.0,1.0,1.0,5
8969,GO:0140829,bicarbonate:monoatomic anion antiporter activity,6,0.0,1.0,1.0,1
8970,GO:0140848,amino acid:monoatomic cation antiporter activity,6,0.0,1.0,1.0,9
8971,GO:0140920,regulation of thermomorphogenesis,6,0.0,1.0,1.0,2
8972,GO:0140934,histone deubiquitinase activity,6,0.0,1.0,1.0,2
8973,GO:0140971,regulation of AIM2 inflammasome complex assembly,6,0.0,1.0,1.0,2
8974,GO:0141027,symbiont-mediated perturbation of host actin cytoskeleton,6,0.0,1.0,1.0,5
8975,GO:0141050,histone H3K deacetylase activity,6,0.0,1.0,1.0,8
8976,GO:0141051,histone H4K deacetylase activity,6,0.0,1.0,1.0,5
8977,GO:0141124,intracellular signaling cassette,6,0.0,1.0,1.0,13
8978,GO:0141187,nucleic acid biosynthetic process,6,0.0,1.0,1.0,2
8979,GO:0141188,nucleic acid catabolic process,6,0.0,1.0,1.0,2
8980,GO:0141201,pyroptotic cell death,6,0.0,1.0,1.0,1
8981,GO:0141221,"histone deacetylase activity, hydrolytic mechanism",6,0.0,1.0,1.0,3
8982,GO:0150002,distal dendrite,6,0.0,1.0,1.0,2
8983,GO:0150011,regulation of neuron projection arborization,6,0.0,1.0,1.0,2
8984,GO:0150031,regulation of protein localization to lysosome,6,0.0,1.0,1.0,2
8985,GO:0150089,multiple spine synapse organization,6,0.0,1.0,1.0,2
8986,GO:0150104,transport across blood-brain barrier,6,0.0,1.0,1.0,3
8987,GO:0150105,protein localization to cell-cell junction,6,0.0,1.0,1.0,4
8988,GO:0150106,regulation of protein localization to cell-cell junction,6,0.0,1.0,1.0,3
8989,GO:0150117,positive regulation of cell-substrate junction organization,6,0.0,1.0,1.0,2
8990,GO:0150118,negative regulation of cell-substrate junction organization,6,0.0,1.0,1.0,2
8991,GO:0150147,cell-cell junction disassembly,6,0.0,1.0,1.0,3
8992,GO:0150195,transport across blood-cerebrospinal fluid barrier,6,0.0,1.0,1.0,1
8993,GO:0150201,positive regulation of transport across blood-brain barrier,6,0.0,1.0,1.0,1
8994,GO:0150202,negative regulation of transport across blood-brain barrier,6,0.0,1.0,1.0,1
8995,GO:0160009,histone decrotonylase activity,6,0.0,1.0,1.0,1
8996,GO:0170036,import into the mitochondrion,6,0.0,1.0,1.0,12
8997,GO:0170037,export from the mitochondrion,6,0.0,1.0,1.0,4
8998,GO:0180012,"co-transcriptional RNA 3'-end processing, cleavage and polyadenylation pathway",6,0.0,1.0,1.0,2
8999,GO:1900024,regulation of substrate adhesion-dependent cell spreading,6,0.0,1.0,1.0,2
9000,GO:1900034,regulation of cellular response to heat,6,0.0,1.0,1.0,3
9001,GO:1900037,regulation of cellular response to hypoxia,6,0.0,1.0,1.0,2
9002,GO:1900058,regulation of sulfate assimilation,6,0.0,1.0,1.0,1
9003,GO:1900063,regulation of peroxisome organization,6,0.0,1.0,1.0,1
9004,GO:1900115,extracellular regulation of signal transduction,6,0.0,1.0,1.0,1
9005,GO:1900121,negative regulation of receptor binding,6,0.0,1.0,1.0,4
9006,GO:1900122,positive regulation of receptor binding,6,0.0,1.0,1.0,4
9007,GO:1900123,regulation of nodal receptor complex assembly,6,0.0,1.0,1.0,1
9008,GO:1900140,regulation of seedling development,6,0.0,1.0,1.0,1
9009,GO:1900150,regulation of defense response to fungus,6,0.0,1.0,1.0,3
9010,GO:1900169,regulation of glucocorticoid mediated signaling pathway,6,0.0,1.0,1.0,2
9011,GO:1900180,regulation of protein localization to nucleus,6,0.0,1.0,1.0,5
9012,GO:1900187,regulation of cell adhesion involved in single-species biofilm formation,6,0.0,1.0,1.0,2
9013,GO:1900200,mesenchymal cell apoptotic process involved in metanephros development,6,0.0,1.0,1.0,1
9014,GO:1900225,regulation of NLRP3 inflammasome complex assembly,6,0.0,1.0,1.0,2
9015,GO:1900265,regulation of substance P receptor binding,6,0.0,1.0,1.0,2
9016,GO:1900288,regulation of coenzyme F420-dependent bicyclic nitroimidazole catabolic process,6,0.0,1.0,1.0,2
9017,GO:1900295,negative regulation of heptasaccharide transport,6,0.0,1.0,1.0,1
9018,GO:1900296,positive regulation of heptasaccharide transport,6,0.0,1.0,1.0,1
9019,GO:1900298,negative regulation of hexasaccharide transport,6,0.0,1.0,1.0,1
9020,GO:1900299,positive regulation of hexasaccharide transport,6,0.0,1.0,1.0,1
9021,GO:1900306,regulation of maltoheptaose transport,6,0.0,1.0,1.0,2
9022,GO:1900312,regulation of maltohexaose transport,6,0.0,1.0,1.0,2
9023,GO:1900315,regulation of maltopentaose transport,6,0.0,1.0,1.0,2
9024,GO:1900351,regulation of methanofuran biosynthetic process,6,0.0,1.0,1.0,2
9025,GO:1900355,negative regulation of methanofuran metabolic process,6,0.0,1.0,1.0,1
9026,GO:1900356,positive regulation of methanofuran metabolic process,6,0.0,1.0,1.0,1
9027,GO:1900361,negative regulation of pentasaccharide transport,6,0.0,1.0,1.0,1
9028,GO:1900362,positive regulation of pentasaccharide transport,6,0.0,1.0,1.0,1
9029,GO:1900376,regulation of secondary metabolite biosynthetic process,6,0.0,1.0,1.0,36
9030,GO:1900407,regulation of cellular response to oxidative stress,6,0.0,1.0,1.0,3
9031,GO:1900419,regulation of alcohol catabolic process,6,0.0,1.0,1.0,3
9032,GO:1900424,regulation of defense response to bacterium,6,0.0,1.0,1.0,2
9033,GO:1900429,negative regulation of filamentous growth of a population of unicellular organisms,6,0.0,1.0,1.0,5
9034,GO:1900430,positive regulation of filamentous growth of a population of unicellular organisms,6,0.0,1.0,1.0,6
9035,GO:1900431,regulation of filamentous growth of a population of unicellular organisms in response to heat,6,0.0,1.0,1.0,2
9036,GO:1900434,regulation of filamentous growth of a population of unicellular organisms in response to starvation,6,0.0,1.0,1.0,1
9037,GO:1900437,regulation of filamentous growth of a population of unicellular organisms in response to chemical stimulus,6,0.0,1.0,1.0,2
9038,GO:1900443,regulation of filamentous growth of a population of unicellular organisms in response to biotic stimulus,6,0.0,1.0,1.0,2
9039,GO:1900449,regulation of glutamate receptor signaling pathway,6,0.0,1.0,1.0,3
9040,GO:1900457,regulation of brassinosteroid mediated signaling pathway,6,0.0,1.0,1.0,2
9041,GO:1900487,regulation of [2Fe-2S] cluster assembly,6,0.0,1.0,1.0,2
9042,GO:1900491,regulation of [4Fe-4S] cluster assembly,6,0.0,1.0,1.0,2
9043,GO:1900506,regulation of iron-sulfur-molybdenum cofactor assembly,6,0.0,1.0,1.0,2
9044,GO:1900512,regulation of starch utilization system complex assembly,6,0.0,1.0,1.0,2
9045,GO:1900556,emericellamide catabolic process,6,0.0,1.0,1.0,1
9046,GO:1900557,emericellamide biosynthetic process,6,0.0,1.0,1.0,1
9047,GO:1900588,violaceol I metabolic process,6,0.0,1.0,1.0,2
9048,GO:1900591,violaceol II metabolic process,6,0.0,1.0,1.0,2
9049,GO:1900615,emericellamide A metabolic process,6,0.0,1.0,1.0,2
9050,GO:1900640,regulation of austinol biosynthetic process,6,0.0,1.0,1.0,2
9051,GO:1900681,octadecene metabolic process,6,0.0,1.0,1.0,1
9052,GO:1900741,regulation of filamentous growth of a population of unicellular organisms in response to pH,6,0.0,1.0,1.0,3
9053,GO:1900746,regulation of vascular endothelial growth factor signaling pathway,6,0.0,1.0,1.0,2
9054,GO:1900786,naphtho-gamma-pyrone catabolic process,6,0.0,1.0,1.0,1
9055,GO:1900787,naphtho-gamma-pyrone biosynthetic process,6,0.0,1.0,1.0,1
9056,GO:1900797,cordyol C metabolic process,6,0.0,1.0,1.0,2
9057,GO:1900825,regulation of membrane depolarization during cardiac muscle cell action potential,6,0.0,1.0,1.0,3
9058,GO:1900849,regulation of pseurotin A biosynthetic process,6,0.0,1.0,1.0,2
9059,GO:1900872,pentadec-1-ene metabolic process,6,0.0,1.0,1.0,1
9060,GO:1900874,heptadec-1-ene metabolic process,6,0.0,1.0,1.0,1
9061,GO:1900876,nonadec-1-ene metabolic process,6,0.0,1.0,1.0,1
9062,GO:1900880,18-methylnonadec-1-ene metabolic process,6,0.0,1.0,1.0,1
9063,GO:1900882,17-methylnonadec-1-ene metabolic process,6,0.0,1.0,1.0,1
9064,GO:1900891,negative regulation of pentadecane metabolic process,6,0.0,1.0,1.0,1
9065,GO:1900892,positive regulation of pentadecane metabolic process,6,0.0,1.0,1.0,1
9066,GO:1900894,negative regulation of tridecane metabolic process,6,0.0,1.0,1.0,1
9067,GO:1900895,positive regulation of tridecane metabolic process,6,0.0,1.0,1.0,1
9068,GO:1900900,negative regulation of heptadecane metabolic process,6,0.0,1.0,1.0,1
9069,GO:1900901,positive regulation of heptadecane metabolic process,6,0.0,1.0,1.0,1
9070,GO:1900902,regulation of hexadecanal biosynthetic process,6,0.0,1.0,1.0,2
9071,GO:1900906,negative regulation of hexadecanal metabolic process,6,0.0,1.0,1.0,1
9072,GO:1900907,positive regulation of hexadecanal metabolic process,6,0.0,1.0,1.0,1
9073,GO:1900909,negative regulation of olefin metabolic process,6,0.0,1.0,1.0,7
9074,GO:1900910,positive regulation of olefin metabolic process,6,0.0,1.0,1.0,7
9075,GO:1900911,regulation of olefin biosynthetic process,6,0.0,1.0,1.0,9
9076,GO:1900917,regulation of octadecene metabolic process,6,0.0,1.0,1.0,3
9077,GO:1900932,regulation of nonadec-1-ene metabolic process,6,0.0,1.0,1.0,3
9078,GO:1900938,"regulation of (Z)-nonadeca-1,14-diene metabolic process",6,0.0,1.0,1.0,3
9079,GO:1900953,regulation of 18-methylnonadec-1-ene metabolic process,6,0.0,1.0,1.0,3
9080,GO:1900959,regulation of 17-methylnonadec-1-ene metabolic process,6,0.0,1.0,1.0,3
9081,GO:1900962,regulation of methanophenazine biosynthetic process,6,0.0,1.0,1.0,2
9082,GO:1900966,negative regulation of methanophenazine metabolic process,6,0.0,1.0,1.0,1
9083,GO:1900967,positive regulation of methanophenazine metabolic process,6,0.0,1.0,1.0,1
9084,GO:1900977,regulation of tatiopterin metabolic process,6,0.0,1.0,1.0,3
9085,GO:1900980,regulation of phenazine biosynthetic process,6,0.0,1.0,1.0,2
9086,GO:1900983,vindoline metabolic process,6,0.0,1.0,1.0,1
9087,GO:1901000,regulation of response to salt stress,6,0.0,1.0,1.0,3
9088,GO:1901004,ubiquinone-6 metabolic process,6,0.0,1.0,1.0,2
9089,GO:1901031,regulation of response to reactive oxygen species,6,0.0,1.0,1.0,3
9090,GO:1901039,regulation of peptide antigen transport,6,0.0,1.0,1.0,2
9091,GO:1901055,trimethylenediamine metabolic process,6,0.0,1.0,1.0,2
9092,GO:1901058,p-hydroxyphenyl lignin metabolic process,6,0.0,1.0,1.0,2
9093,GO:1901061,guaiacyl lignin metabolic process,6,0.0,1.0,1.0,2
9094,GO:1901064,syringal lignin metabolic process,6,0.0,1.0,1.0,2
9095,GO:1901072,glucosamine-containing compound catabolic process,6,0.0,1.0,1.0,3
9096,GO:1901073,glucosamine-containing compound biosynthetic process,6,0.0,1.0,1.0,3
9097,GO:1901077,regulation of relaxation of muscle,6,0.0,1.0,1.0,5
9098,GO:1901104,tetracenomycin C metabolic process,6,0.0,1.0,1.0,2
9099,GO:1901113,erythromycin metabolic process,6,0.0,1.0,1.0,2
9100,GO:1901116,cephamycin C metabolic process,6,0.0,1.0,1.0,2
9101,GO:1901119,tobramycin metabolic process,6,0.0,1.0,1.0,2
9102,GO:1901159,xylulose 5-phosphate biosynthetic process,6,0.0,1.0,1.0,7
9103,GO:1901163,regulation of trophoblast cell migration,6,0.0,1.0,1.0,2
9104,GO:1901167,3-chlorocatechol metabolic process,6,0.0,1.0,1.0,2
9105,GO:1901184,regulation of ERBB signaling pathway,6,0.0,1.0,1.0,4
9106,GO:1901187,regulation of ephrin receptor signaling pathway,6,0.0,1.0,1.0,2
9107,GO:1901190,regulation of formation of translation initiation ternary complex,6,0.0,1.0,1.0,2
9108,GO:1901201,regulation of extracellular matrix assembly,6,0.0,1.0,1.0,3
9109,GO:1901207,regulation of heart looping,6,0.0,1.0,1.0,2
9110,GO:1901232,regulation of convergent extension involved in axis elongation,6,0.0,1.0,1.0,3
9111,GO:1901235,(R)-carnitine transmembrane transporter activity,6,0.0,1.0,1.0,1
9112,GO:1901239,malonate(1-) transmembrane transporter activity,6,0.0,1.0,1.0,1
9113,GO:1901246,regulation of lung ciliated cell differentiation,6,0.0,1.0,1.0,2
9114,GO:1901249,regulation of lung goblet cell differentiation,6,0.0,1.0,1.0,2
9115,GO:1901278,D-ribose 5-phosphate metabolic process,6,0.0,1.0,1.0,2
9116,GO:1901299,negative regulation of hydrogen peroxide-mediated programmed cell death,6,0.0,1.0,1.0,1
9117,GO:1901300,positive regulation of hydrogen peroxide-mediated programmed cell death,6,0.0,1.0,1.0,1
9118,GO:1901301,regulation of cargo loading into COPII-coated vesicle,6,0.0,1.0,1.0,1
9119,GO:1901329,regulation of odontoblast differentiation,6,0.0,1.0,1.0,2
9120,GO:1901343,negative regulation of vasculature development,6,0.0,1.0,1.0,2
9121,GO:1901371,regulation of leaf morphogenesis,6,0.0,1.0,1.0,1
9122,GO:1901402,negative regulation of tetrapyrrole metabolic process,6,0.0,1.0,1.0,3
9123,GO:1901403,positive regulation of tetrapyrrole metabolic process,6,0.0,1.0,1.0,3
9124,GO:1901404,regulation of tetrapyrrole catabolic process,6,0.0,1.0,1.0,3
9125,GO:1901434,regulation of toluene catabolic process,6,0.0,1.0,1.0,2
9126,GO:1901438,negative regulation of toluene metabolic process,6,0.0,1.0,1.0,1
9127,GO:1901439,positive regulation of toluene metabolic process,6,0.0,1.0,1.0,1
9128,GO:1901463,regulation of tetrapyrrole biosynthetic process,6,0.0,1.0,1.0,6
9129,GO:1901466,regulation of ferulate catabolic process,6,0.0,1.0,1.0,2
9130,GO:1901506,regulation of acylglycerol transport,6,0.0,1.0,1.0,3
9131,GO:1901509,regulation of endothelial tube morphogenesis,6,0.0,1.0,1.0,2
9132,GO:1901533,negative regulation of hematopoietic progenitor cell differentiation,6,0.0,1.0,1.0,3
9133,GO:1901534,positive regulation of hematopoietic progenitor cell differentiation,6,0.0,1.0,1.0,3
9134,GO:1901569,fatty acid derivative catabolic process,6,0.0,1.0,1.0,5
9135,GO:1901570,fatty acid derivative biosynthetic process,6,0.0,1.0,1.0,13
9136,GO:1901577,regulation of alkane biosynthetic process,6,0.0,1.0,1.0,13
9137,GO:1901598,(-)-pinoresinol metabolic process,6,0.0,1.0,1.0,2
9138,GO:1901628,positive regulation of postsynaptic membrane organization,6,0.0,1.0,1.0,1
9139,GO:1901629,regulation of presynaptic membrane organization,6,0.0,1.0,1.0,2
9140,GO:1901633,negative regulation of synaptic vesicle membrane organization,6,0.0,1.0,1.0,1
9141,GO:1901634,positive regulation of synaptic vesicle membrane organization,6,0.0,1.0,1.0,1
9142,GO:1901645,regulation of synoviocyte proliferation,6,0.0,1.0,1.0,2
9143,GO:1901662,quinone catabolic process,6,0.0,1.0,1.0,1
9144,GO:1901663,quinone biosynthetic process,6,0.0,1.0,1.0,3
9145,GO:1901664,regulation of NAD+ ADP-ribosyltransferase activity,6,0.0,1.0,1.0,1
9146,GO:1901686,glutathione derivative catabolic process,6,0.0,1.0,1.0,1
9147,GO:1901692,regulation of compound eye retinal cell apoptotic process,6,0.0,1.0,1.0,2
9148,GO:1901723,negative regulation of cell proliferation involved in kidney development,6,0.0,1.0,1.0,2
9149,GO:1901724,positive regulation of cell proliferation involved in kidney development,6,0.0,1.0,1.0,3
9150,GO:1901739,regulation of myoblast fusion,6,0.0,1.0,1.0,2
9151,GO:1901742,2-deoxystreptamine metabolic process,6,0.0,1.0,1.0,2
9152,GO:1901756,butirosin metabolic process,6,0.0,1.0,1.0,2
9153,GO:1901767,carbapenem metabolic process,6,0.0,1.0,1.0,2
9154,GO:1901772,lincomycin metabolic process,6,0.0,1.0,1.0,2
9155,GO:1901784,p-cresol metabolic process,6,0.0,1.0,1.0,2
9156,GO:1901801,"1,5-anhydro-D-fructose metabolic process",6,0.0,1.0,1.0,2
9157,GO:1901804,beta-glucoside metabolic process,6,0.0,1.0,1.0,7
9158,GO:1901839,regulation of RNA polymerase I regulatory region sequence-specific DNA binding,6,0.0,1.0,1.0,1
9159,GO:1901844,regulation of cell communication by electrical coupling involved in cardiac conduction,6,0.0,1.0,1.0,2
9160,GO:1901879,regulation of protein depolymerization,6,0.0,1.0,1.0,7
9161,GO:1901882,4-hydroxycoumarin metabolic process,6,0.0,1.0,1.0,2
9162,GO:1901889,negative regulation of cell junction assembly,6,0.0,1.0,1.0,4
9163,GO:1901890,positive regulation of cell junction assembly,6,0.0,1.0,1.0,4
9164,GO:1901900,regulation of protein localization to cell division site,6,0.0,1.0,1.0,4
9165,GO:1901915,positive regulation of capsule organization,6,0.0,1.0,1.0,1
9166,GO:1901950,dense core granule transport,6,0.0,1.0,1.0,1
9167,GO:1901960,isobutanol metabolic process,6,0.0,1.0,1.0,3
9168,GO:1901962,S-adenosyl-L-methionine transmembrane transport,6,0.0,1.0,1.0,1
9169,GO:1901963,regulation of cell proliferation involved in outflow tract morphogenesis,6,0.0,1.0,1.0,1
9170,GO:1901966,regulation of cellular response to iron ion starvation,6,0.0,1.0,1.0,1
9171,GO:1901987,regulation of cell cycle phase transition,6,0.0,1.0,1.0,8
9172,GO:1902020,negative regulation of cilium-dependent cell motility,6,0.0,1.0,1.0,1
9173,GO:1902033,regulation of hematopoietic stem cell proliferation,6,0.0,1.0,1.0,2
9174,GO:1902036,regulation of hematopoietic stem cell differentiation,6,0.0,1.0,1.0,2
9175,GO:1902044,regulation of Fas signaling pathway,6,0.0,1.0,1.0,2
9176,GO:1902047,polyamine transmembrane transport,6,0.0,1.0,1.0,2
9177,GO:1902048,neosartoricin metabolic process,6,0.0,1.0,1.0,2
9178,GO:1902058,regulation of sporocarp development involved in sexual reproduction,6,0.0,1.0,1.0,3
9179,GO:1902068,regulation of sphingolipid mediated signaling pathway,6,0.0,1.0,1.0,2
9180,GO:1902090,regulation of fumagillin biosynthetic process,6,0.0,1.0,1.0,2
9181,GO:1902115,regulation of organelle assembly,6,0.0,1.0,1.0,17
9182,GO:1902124,(+)-pinoresinol metabolic process,6,0.0,1.0,1.0,2
9183,GO:1902127,(-)-lariciresinol metabolic process,6,0.0,1.0,1.0,2
9184,GO:1902130,(+)-lariciresinol metabolic process,6,0.0,1.0,1.0,2
9185,GO:1902146,positive regulation of response to cell cycle checkpoint signaling,6,0.0,1.0,1.0,2
9186,GO:1902147,regulation of response to cytokinesis checkpoint signaling,6,0.0,1.0,1.0,1
9187,GO:1902151,regulation of response to DNA integrity checkpoint signaling,6,0.0,1.0,1.0,2
9188,GO:1902202,regulation of hepatocyte growth factor receptor signaling pathway,6,0.0,1.0,1.0,2
9189,GO:1902224,ketone body metabolic process,6,0.0,1.0,1.0,3
9190,GO:1902267,regulation of polyamine transmembrane transport,6,0.0,1.0,1.0,2
9191,GO:1902272,regulation of (R)-carnitine transmembrane transport,6,0.0,1.0,1.0,2
9192,GO:1902288,regulation of defense response to oomycetes,6,0.0,1.0,1.0,2
9193,GO:1902363,regulation of protein localization to spindle pole body,6,0.0,1.0,1.0,4
9194,GO:1902407,assembly of actomyosin apparatus involved in mitotic cytokinesis,6,0.0,1.0,1.0,2
9195,GO:1902416,positive regulation of mRNA binding,6,0.0,1.0,1.0,3
9196,GO:1902436,negative regulation of male mating behavior,6,0.0,1.0,1.0,1
9197,GO:1902437,positive regulation of male mating behavior,6,0.0,1.0,1.0,1
9198,GO:1902442,regulation of ripoptosome assembly involved in necroptotic process,6,0.0,1.0,1.0,1
9199,GO:1902460,regulation of mesenchymal stem cell proliferation,6,0.0,1.0,1.0,3
9200,GO:1902473,regulation of protein localization to synapse,6,0.0,1.0,1.0,4
9201,GO:1902486,protein localization to growing cell tip,6,0.0,1.0,1.0,2
9202,GO:1902513,regulation of organelle transport along microtubule,6,0.0,1.0,1.0,3
9203,GO:1902531,regulation of intracellular signal transduction,6,0.0,1.0,1.0,31
9204,GO:1902548,negative regulation of cellular response to vascular endothelial growth factor stimulus,6,0.0,1.0,1.0,2
9205,GO:1902551,regulation of catalase activity,6,0.0,1.0,1.0,1
9206,GO:1902554,serine/threonine protein kinase complex,6,0.0,1.0,1.0,17
9207,GO:1902563,regulation of neutrophil activation,6,0.0,1.0,1.0,2
9208,GO:1902566,regulation of eosinophil activation,6,0.0,1.0,1.0,2
9209,GO:1902575,"protein localization to cell division site involved in cytokinesis, actomyosin contractile ring assembly",6,0.0,1.0,1.0,1
9210,GO:1902619,regulation of microtubule minus-end binding,6,0.0,1.0,1.0,1
9211,GO:1902627,regulation of assembly of large subunit precursor of preribosome,6,0.0,1.0,1.0,1
9212,GO:1902645,tertiary alcohol biosynthetic process,6,0.0,1.0,1.0,12
9213,GO:1902653,secondary alcohol biosynthetic process,6,0.0,1.0,1.0,16
9214,GO:1902654,aromatic primary alcohol metabolic process,6,0.0,1.0,1.0,1
9215,GO:1902659,regulation of glucose mediated signaling pathway,6,0.0,1.0,1.0,3
9216,GO:1902692,regulation of neuroblast proliferation,6,0.0,1.0,1.0,2
9217,GO:1902746,regulation of lens fiber cell differentiation,6,0.0,1.0,1.0,2
9218,GO:1902752,regulation of renal amino acid absorption,6,0.0,1.0,1.0,2
9219,GO:1902777,6-sulfoquinovose(1-) catabolic process,6,0.0,1.0,1.0,3
9220,GO:1902804,negative regulation of synaptic vesicle transport,6,0.0,1.0,1.0,1
9221,GO:1902805,positive regulation of synaptic vesicle transport,6,0.0,1.0,1.0,1
9222,GO:1902816,regulation of protein localization to microtubule,6,0.0,1.0,1.0,1
9223,GO:1902820,1-undecene metabolic process,6,0.0,1.0,1.0,1
9224,GO:1902829,regulation of spinal cord association neuron differentiation,6,0.0,1.0,1.0,2
9225,GO:1902841,regulation of netrin-activated signaling pathway,6,0.0,1.0,1.0,2
9226,GO:1902847,regulation of neuronal signal transduction,6,0.0,1.0,1.0,2
9227,GO:1902869,regulation of amacrine cell differentiation,6,0.0,1.0,1.0,2
9228,GO:1902883,negative regulation of response to oxidative stress,6,0.0,1.0,1.0,2
9229,GO:1902884,positive regulation of response to oxidative stress,6,0.0,1.0,1.0,2
9230,GO:1902890,regulation of root hair elongation,6,0.0,1.0,1.0,2
9231,GO:1902898,fatty acid methyl ester metabolic process,6,0.0,1.0,1.0,1
9232,GO:1902904,negative regulation of supramolecular fiber organization,6,0.0,1.0,1.0,11
9233,GO:1902905,positive regulation of supramolecular fiber organization,6,0.0,1.0,1.0,11
9234,GO:1902930,regulation of alcohol biosynthetic process,6,0.0,1.0,1.0,16
9235,GO:1902936,phosphatidylinositol bisphosphate binding,6,0.0,1.0,1.0,2
9236,GO:1902954,regulation of early endosome to recycling endosome transport,6,0.0,1.0,1.0,1
9237,GO:1902996,regulation of neurofibrillary tangle assembly,6,0.0,1.0,1.0,2
9238,GO:1903000,regulation of lipid transport across blood-brain barrier,6,0.0,1.0,1.0,2
9239,GO:1903023,regulation of ascospore-type prospore membrane formation,6,0.0,1.0,1.0,1
9240,GO:1903025,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,6,0.0,1.0,1.0,2
9241,GO:1903031,regulation of microtubule plus-end binding,6,0.0,1.0,1.0,2
9242,GO:1903035,negative regulation of response to wounding,6,0.0,1.0,1.0,3
9243,GO:1903036,positive regulation of response to wounding,6,0.0,1.0,1.0,3
9244,GO:1903037,regulation of leukocyte cell-cell adhesion,6,0.0,1.0,1.0,7
9245,GO:1903044,protein localization to membrane raft,6,0.0,1.0,1.0,3
9246,GO:1903054,negative regulation of extracellular matrix organization,6,0.0,1.0,1.0,4
9247,GO:1903055,positive regulation of extracellular matrix organization,6,0.0,1.0,1.0,4
9248,GO:1903056,regulation of melanosome organization,6,0.0,1.0,1.0,2
9249,GO:1903066,regulation of protein localization to cell tip,6,0.0,1.0,1.0,4
9250,GO:1903072,regulation of death-inducing signaling complex assembly,6,0.0,1.0,1.0,1
9251,GO:1903116,positive regulation of actin filament-based movement,6,0.0,1.0,1.0,5
9252,GO:1903173,fatty alcohol metabolic process,6,0.0,1.0,1.0,6
9253,GO:1903176,regulation of tyrosine 3-monooxygenase activity,6,0.0,1.0,1.0,1
9254,GO:1903225,negative regulation of endodermal cell differentiation,6,0.0,1.0,1.0,1
9255,GO:1903282,regulation of glutathione peroxidase activity,6,0.0,1.0,1.0,1
9256,GO:1903315,negative regulation of nitrogen cycle metabolic process,6,0.0,1.0,1.0,1
9257,GO:1903316,positive regulation of nitrogen cycle metabolic process,6,0.0,1.0,1.0,1
9258,GO:1903330,negative regulation of iron-sulfur cluster assembly,6,0.0,1.0,1.0,3
9259,GO:1903331,positive regulation of iron-sulfur cluster assembly,6,0.0,1.0,1.0,3
9260,GO:1903335,regulation of vacuolar transport,6,0.0,1.0,1.0,6
9261,GO:1903350,response to dopamine,6,0.0,1.0,1.0,1
9262,GO:1903353,regulation of nucleus organization,6,0.0,1.0,1.0,2
9263,GO:1903354,regulation of distal tip cell migration,6,0.0,1.0,1.0,2
9264,GO:1903358,regulation of Golgi organization,6,0.0,1.0,1.0,2
9265,GO:1903366,negative regulation of fear response,6,0.0,1.0,1.0,1
9266,GO:1903367,positive regulation of fear response,6,0.0,1.0,1.0,1
9267,GO:1903371,regulation of endoplasmic reticulum tubular network organization,6,0.0,1.0,1.0,2
9268,GO:1903385,regulation of homophilic cell adhesion,6,0.0,1.0,1.0,2
9269,GO:1903422,negative regulation of synaptic vesicle recycling,6,0.0,1.0,1.0,1
9270,GO:1903423,positive regulation of synaptic vesicle recycling,6,0.0,1.0,1.0,1
9271,GO:1903426,regulation of reactive oxygen species biosynthetic process,6,0.0,1.0,1.0,3
9272,GO:1903429,regulation of cell maturation,6,0.0,1.0,1.0,6
9273,GO:1903439,calcitonin family receptor complex,6,0.0,1.0,1.0,3
9274,GO:1903450,regulation of G1 to G0 transition,6,0.0,1.0,1.0,2
9275,GO:1903487,regulation of lactation,6,0.0,1.0,1.0,2
9276,GO:1903510,mucopolysaccharide metabolic process,6,0.0,1.0,1.0,5
9277,GO:1903523,negative regulation of blood circulation,6,0.0,1.0,1.0,3
9278,GO:1903524,positive regulation of blood circulation,6,0.0,1.0,1.0,3
9279,GO:1903525,regulation of membrane tubulation,6,0.0,1.0,1.0,2
9280,GO:1903530,regulation of secretion by cell,6,0.0,1.0,1.0,12
9281,GO:1903538,regulation of meiotic cell cycle process involved in oocyte maturation,6,0.0,1.0,1.0,2
9282,GO:1903564,regulation of protein localization to cilium,6,0.0,1.0,1.0,3
9283,GO:1903596,regulation of gap junction assembly,6,0.0,1.0,1.0,2
9284,GO:1903601,thermospermine metabolic process,6,0.0,1.0,1.0,2
9285,GO:1903605,cytochrome biosynthetic process,6,0.0,1.0,1.0,1
9286,GO:1903606,cytochrome c metabolic process,6,0.0,1.0,1.0,1
9287,GO:1903681,regulation of epithelial cell-cell adhesion involved in epithelium migration,6,0.0,1.0,1.0,2
9288,GO:1903706,regulation of hemopoiesis,6,0.0,1.0,1.0,6
9289,GO:1903722,regulation of centriole elongation,6,0.0,1.0,1.0,2
9290,GO:1903786,regulation of glutathione biosynthetic process,6,0.0,1.0,1.0,2
9291,GO:1903795,regulation of inorganic anion transmembrane transport,6,0.0,1.0,1.0,6
9292,GO:1903828,negative regulation of protein localization,6,0.0,1.0,1.0,22
9293,GO:1903829,positive regulation of protein localization,6,0.0,1.0,1.0,21
9294,GO:1903832,regulation of cellular response to amino acid starvation,6,0.0,1.0,1.0,2
9295,GO:1903837,regulation of mRNA 3'-UTR binding,6,0.0,1.0,1.0,2
9296,GO:1903846,positive regulation of cellular response to transforming growth factor beta stimulus,6,0.0,1.0,1.0,1
9297,GO:1903847,regulation of aorta morphogenesis,6,0.0,1.0,1.0,2
9298,GO:1903859,regulation of dendrite extension,6,0.0,1.0,1.0,2
9299,GO:1903872,regulation of DNA recombinase mediator complex assembly,6,0.0,1.0,1.0,1
9300,GO:1903889,negative regulation of plant epidermal cell differentiation,6,0.0,1.0,1.0,2
9301,GO:1903890,positive regulation of plant epidermal cell differentiation,6,0.0,1.0,1.0,2
9302,GO:1903903,regulation of establishment of T cell polarity,6,0.0,1.0,1.0,2
9303,GO:1903906,regulation of plasma membrane raft polarization,6,0.0,1.0,1.0,2
9304,GO:1903913,regulation of fusion of virus membrane with host plasma membrane,6,0.0,1.0,1.0,2
9305,GO:1903970,negative regulation of response to macrophage colony-stimulating factor,6,0.0,1.0,1.0,1
9306,GO:1903971,positive regulation of response to macrophage colony-stimulating factor,6,0.0,1.0,1.0,1
9307,GO:1903972,regulation of cellular response to macrophage colony-stimulating factor stimulus,6,0.0,1.0,1.0,3
9308,GO:1903975,regulation of glial cell migration,6,0.0,1.0,1.0,5
9309,GO:1903998,regulation of eating behavior,6,0.0,1.0,1.0,3
9310,GO:1904018,positive regulation of vasculature development,6,0.0,1.0,1.0,1
9311,GO:1904026,regulation of collagen fibril organization,6,0.0,1.0,1.0,2
9312,GO:1904035,regulation of epithelial cell apoptotic process,6,0.0,1.0,1.0,8
9313,GO:1904054,regulation of cholangiocyte proliferation,6,0.0,1.0,1.0,2
9314,GO:1904069,ascaroside metabolic process,6,0.0,1.0,1.0,1
9315,GO:1904086,regulation of epiboly involved in gastrulation with mouth forming second,6,0.0,1.0,1.0,2
9316,GO:1904103,regulation of convergent extension involved in gastrulation,6,0.0,1.0,1.0,6
9317,GO:1904118,regulation of otic vesicle morphogenesis,6,0.0,1.0,1.0,2
9318,GO:1904195,regulation of granulosa cell proliferation,6,0.0,1.0,1.0,2
9319,GO:1904235,"regulation of substrate-dependent cell migration, cell attachment to substrate",6,0.0,1.0,1.0,2
9320,GO:1904239,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,6,0.0,1.0,1.0,2
9321,GO:1904298,regulation of transcytosis,6,0.0,1.0,1.0,2
9322,GO:1904328,regulation of myofibroblast contraction,6,0.0,1.0,1.0,2
9323,GO:1904335,regulation of ductus arteriosus closure,6,0.0,1.0,1.0,2
9324,GO:1904338,regulation of dopaminergic neuron differentiation,6,0.0,1.0,1.0,3
9325,GO:1904344,regulation of gastric mucosal blood circulation,6,0.0,1.0,1.0,2
9326,GO:1904375,regulation of protein localization to cell periphery,6,0.0,1.0,1.0,8
9327,GO:1904396,regulation of neuromuscular junction development,6,0.0,1.0,1.0,3
9328,GO:1904406,negative regulation of nitric oxide metabolic process,6,0.0,1.0,1.0,1
9329,GO:1904407,positive regulation of nitric oxide metabolic process,6,0.0,1.0,1.0,1
9330,GO:1904409,regulation of secretory granule organization,6,0.0,1.0,1.0,2
9331,GO:1904435,regulation of transferrin receptor binding,6,0.0,1.0,1.0,2
9332,GO:1904441,regulation of thyroid gland epithelial cell proliferation,6,0.0,1.0,1.0,2
9333,GO:1904444,regulation of establishment of Sertoli cell barrier,6,0.0,1.0,1.0,2
9334,GO:1904478,regulation of intestinal absorption,6,0.0,1.0,1.0,4
9335,GO:1904520,regulation of myofibroblast cell apoptotic process,6,0.0,1.0,1.0,2
9336,GO:1904527,negative regulation of microtubule binding,6,0.0,1.0,1.0,1
9337,GO:1904528,positive regulation of microtubule binding,6,0.0,1.0,1.0,2
9338,GO:1904529,regulation of actin filament binding,6,0.0,1.0,1.0,2
9339,GO:1904552,regulation of chemotaxis to arachidonate,6,0.0,1.0,1.0,2
9340,GO:1904558,response to dextromethorphan,6,0.0,1.0,1.0,1
9341,GO:1904572,negative regulation of mRNA binding,6,0.0,1.0,1.0,3
9342,GO:1904573,regulation of selenocysteine insertion sequence binding,6,0.0,1.0,1.0,2
9343,GO:1904581,negative regulation of intracellular mRNA localization,6,0.0,1.0,1.0,2
9344,GO:1904582,positive regulation of intracellular mRNA localization,6,0.0,1.0,1.0,2
9345,GO:1904596,regulation of connective tissue replacement involved in inflammatory response wound healing,6,0.0,1.0,1.0,2
9346,GO:1904617,negative regulation of actin binding,6,0.0,1.0,1.0,1
9347,GO:1904618,positive regulation of actin binding,6,0.0,1.0,1.0,1
9348,GO:1904649,regulation of fat cell apoptotic process,6,0.0,1.0,1.0,2
9349,GO:1904666,regulation of ubiquitin protein ligase activity,6,0.0,1.0,1.0,2
9350,GO:1904673,negative regulation of somatic stem cell population maintenance,6,0.0,1.0,1.0,1
9351,GO:1904674,positive regulation of somatic stem cell population maintenance,6,0.0,1.0,1.0,1
9352,GO:1904675,regulation of somatic stem cell division,6,0.0,1.0,1.0,2
9353,GO:1904697,regulation of acinar cell proliferation,6,0.0,1.0,1.0,2
9354,GO:1904705,regulation of vascular associated smooth muscle cell proliferation,6,0.0,1.0,1.0,2
9355,GO:1904711,regulation of Wnt-Frizzled-LRP5/6 complex assembly,6,0.0,1.0,1.0,2
9356,GO:1904732,regulation of electron transfer activity,6,0.0,1.0,1.0,3
9357,GO:1904743,negative regulation of telomeric DNA binding,6,0.0,1.0,1.0,1
9358,GO:1904744,positive regulation of telomeric DNA binding,6,0.0,1.0,1.0,2
9359,GO:1904748,regulation of apoptotic process involved in development,6,0.0,1.0,1.0,8
9360,GO:1904779,regulation of protein localization to centrosome,6,0.0,1.0,1.0,2
9361,GO:1904785,regulation of asymmetric protein localization involved in cell fate determination,6,0.0,1.0,1.0,2
9362,GO:1904790,regulation of shelterin complex assembly,6,0.0,1.0,1.0,2
9363,GO:1904796,regulation of core promoter binding,6,0.0,1.0,1.0,2
9364,GO:1904809,regulation of dense core granule transport,6,0.0,1.0,1.0,4
9365,GO:1904814,"regulation of protein localization to chromosome, telomeric region",6,0.0,1.0,1.0,3
9366,GO:1904826,regulation of hydrogen sulfide biosynthetic process,6,0.0,1.0,1.0,2
9367,GO:1904838,regulation of male germ-line stem cell asymmetric division,6,0.0,1.0,1.0,2
9368,GO:1904847,regulation of cell chemotaxis to fibroblast growth factor,6,0.0,1.0,1.0,3
9369,GO:1904857,regulation of endothelial cell chemotaxis to vascular endothelial growth factor,6,0.0,1.0,1.0,2
9370,GO:1904863,regulation of beta-catenin-TCF complex assembly,6,0.0,1.0,1.0,2
9371,GO:1904882,regulation of telomerase catalytic core complex assembly,6,0.0,1.0,1.0,2
9372,GO:1904892,regulation of receptor signaling pathway via STAT,6,0.0,1.0,1.0,3
9373,GO:1904895,ESCRT complex assembly,6,0.0,1.0,1.0,1
9374,GO:1904896,ESCRT complex disassembly,6,0.0,1.0,1.0,1
9375,GO:1904897,regulation of hepatic stellate cell proliferation,6,0.0,1.0,1.0,2
9376,GO:1904933,regulation of cell proliferation in midbrain,6,0.0,1.0,1.0,2
9377,GO:1904978,regulation of endosome organization,6,0.0,1.0,1.0,3
9378,GO:1904984,regulation of quinolinate biosynthetic process,6,0.0,1.0,1.0,2
9379,GO:1905031,regulation of membrane repolarization during cardiac muscle cell action potential,6,0.0,1.0,1.0,5
9380,GO:1905037,autophagosome organization,6,0.0,1.0,1.0,3
9381,GO:1905039,carboxylic acid transmembrane transport,6,0.0,1.0,1.0,47
9382,GO:1905079,regulation of cerebellar neuron development,6,0.0,1.0,1.0,2
9383,GO:1905094,regulation of apolipoprotein A-I-mediated signaling pathway,6,0.0,1.0,1.0,2
9384,GO:1905097,regulation of guanyl-nucleotide exchange factor activity,6,0.0,1.0,1.0,3
9385,GO:1905100,regulation of apoptosome assembly,6,0.0,1.0,1.0,2
9386,GO:1905109,regulation of pulmonary blood vessel remodeling,6,0.0,1.0,1.0,2
9387,GO:1905154,negative regulation of membrane invagination,6,0.0,1.0,1.0,1
9388,GO:1905155,positive regulation of membrane invagination,6,0.0,1.0,1.0,1
9389,GO:1905156,negative regulation of photosynthesis,6,0.0,1.0,1.0,2
9390,GO:1905162,regulation of phagosome maturation,6,0.0,1.0,1.0,2
9391,GO:1905169,regulation of protein localization to phagocytic vesicle,6,0.0,1.0,1.0,2
9392,GO:1905192,regulation of chloroplast fission,6,0.0,1.0,1.0,2
9393,GO:1905204,negative regulation of connective tissue replacement,6,0.0,1.0,1.0,1
9394,GO:1905205,positive regulation of connective tissue replacement,6,0.0,1.0,1.0,1
9395,GO:1905208,negative regulation of cardiocyte differentiation,6,0.0,1.0,1.0,5
9396,GO:1905209,positive regulation of cardiocyte differentiation,6,0.0,1.0,1.0,4
9397,GO:1905210,regulation of fibroblast chemotaxis,6,0.0,1.0,1.0,2
9398,GO:1905233,response to codeine,6,0.0,1.0,1.0,1
9399,GO:1905244,regulation of modification of synaptic structure,6,0.0,1.0,1.0,2
9400,GO:1905268,negative regulation of chromatin organization,6,0.0,1.0,1.0,4
9401,GO:1905276,regulation of epithelial tube formation,6,0.0,1.0,1.0,3
9402,GO:1905279,"regulation of retrograde transport, endosome to Golgi",6,0.0,1.0,1.0,2
9403,GO:1905292,regulation of neural crest cell differentiation,6,0.0,1.0,1.0,3
9404,GO:1905298,regulation of intestinal epithelial cell development,6,0.0,1.0,1.0,2
9405,GO:1905310,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,6,0.0,1.0,1.0,2
9406,GO:1905320,regulation of mesenchymal stem cell migration,6,0.0,1.0,1.0,2
9407,GO:1905331,negative regulation of morphogenesis of an epithelium,6,0.0,1.0,1.0,11
9408,GO:1905332,positive regulation of morphogenesis of an epithelium,6,0.0,1.0,1.0,14
9409,GO:1905333,regulation of gastric motility,6,0.0,1.0,1.0,1
9410,GO:1905340,regulation of protein localization to kinetochore,6,0.0,1.0,1.0,2
9411,GO:1905345,protein localization to cleavage furrow,6,0.0,1.0,1.0,1
9412,GO:1905432,regulation of retrograde trans-synaptic signaling by neuropeptide,6,0.0,1.0,1.0,2
9413,GO:1905443,regulation of clathrin coat assembly,6,0.0,1.0,1.0,2
9414,GO:1905446,regulation of mitochondrial ATP synthesis coupled electron transport,6,0.0,1.0,1.0,2
9415,GO:1905453,regulation of myeloid progenitor cell differentiation,6,0.0,1.0,1.0,2
9416,GO:1905456,regulation of lymphoid progenitor cell differentiation,6,0.0,1.0,1.0,4
9417,GO:1905475,regulation of protein localization to membrane,6,0.0,1.0,1.0,12
9418,GO:1905517,macrophage migration,6,0.0,1.0,1.0,2
9419,GO:1905529,regulation of uracil import across plasma membrane,6,0.0,1.0,1.0,2
9420,GO:1905535,regulation of eukaryotic translation initiation factor 4F complex assembly,6,0.0,1.0,1.0,2
9421,GO:1905550,regulation of protein localization to endoplasmic reticulum,6,0.0,1.0,1.0,2
9422,GO:1905557,regulation of mitotic nuclear envelope disassembly,6,0.0,1.0,1.0,2
9423,GO:1905595,regulation of low-density lipoprotein particle receptor binding,6,0.0,1.0,1.0,2
9424,GO:1905603,regulation of blood-brain barrier permeability,6,0.0,1.0,1.0,2
9425,GO:1905610,regulation of mRNA cap binding,6,0.0,1.0,1.0,2
9426,GO:1905627,regulation of serotonin biosynthetic process,6,0.0,1.0,1.0,2
9427,GO:1905630,response to glyceraldehyde,6,0.0,1.0,1.0,1
9428,GO:1905634,regulation of protein localization to chromatin,6,0.0,1.0,1.0,2
9429,GO:1905644,regulation of FACT complex assembly,6,0.0,1.0,1.0,2
9430,GO:1905648,regulation of shell calcification,6,0.0,1.0,1.0,2
9431,GO:1905653,positive regulation of artery morphogenesis,6,0.0,1.0,1.0,2
9432,GO:1905666,regulation of protein localization to endosome,6,0.0,1.0,1.0,3
9433,GO:1905674,regulation of adaptive immune memory response,6,0.0,1.0,1.0,2
9434,GO:1905677,regulation of adaptive immune effector response,6,0.0,1.0,1.0,2
9435,GO:1905684,regulation of plasma membrane repair,6,0.0,1.0,1.0,2
9436,GO:1905699,regulation of xenobiotic detoxification by transmembrane export across the plasma membrane,6,0.0,1.0,1.0,2
9437,GO:1905722,regulation of trypanothione biosynthetic process,6,0.0,1.0,1.0,2
9438,GO:1905767,regulation of double-stranded telomeric DNA binding,6,0.0,1.0,1.0,2
9439,GO:1905771,negative regulation of mesodermal cell differentiation,6,0.0,1.0,1.0,1
9440,GO:1905772,positive regulation of mesodermal cell differentiation,6,0.0,1.0,1.0,1
9441,GO:1905796,regulation of intraciliary anterograde transport,6,0.0,1.0,1.0,2
9442,GO:1905799,regulation of intraciliary retrograde transport,6,0.0,1.0,1.0,2
9443,GO:1905806,regulation of synapse pruning,6,0.0,1.0,1.0,3
9444,GO:1905809,negative regulation of synapse organization,6,0.0,1.0,1.0,6
9445,GO:1905841,response to oxidopamine,6,0.0,1.0,1.0,1
9446,GO:1905864,regulation of Atg1/ULK1 kinase complex assembly,6,0.0,1.0,1.0,2
9447,GO:1905871,regulation of protein localization to cell leading edge,6,0.0,1.0,1.0,2
9448,GO:1905879,regulation of oogenesis,6,0.0,1.0,1.0,3
9449,GO:1905897,regulation of response to endoplasmic reticulum stress,6,0.0,1.0,1.0,6
9450,GO:1905916,negative regulation of cell differentiation involved in phenotypic switching,6,0.0,1.0,1.0,1
9451,GO:1905917,positive regulation of cell differentiation involved in phenotypic switching,6,0.0,1.0,1.0,1
9452,GO:1905937,negative regulation of germ cell proliferation,6,0.0,1.0,1.0,1
9453,GO:1905938,positive regulation of germ cell proliferation,6,0.0,1.0,1.0,1
9454,GO:1905958,negative regulation of cellular response to alcohol,6,0.0,1.0,1.0,2
9455,GO:1990186,regulation of lymphatic vessel size,6,0.0,1.0,1.0,1
9456,GO:1990215,symbiont-mediated perturbation of host vesicle-mediated transport,6,0.0,1.0,1.0,1
9457,GO:1990635,proximal dendrite,6,0.0,1.0,1.0,2
9458,GO:1990742,microvesicle,6,0.0,1.0,1.0,1
9459,GO:1990782,protein tyrosine kinase binding,6,0.0,1.0,1.0,1
9460,GO:1990814,DNA/DNA annealing activity,6,0.0,1.0,1.0,1
9461,GO:1990822,basic amino acid transmembrane transport,6,0.0,1.0,1.0,4
9462,GO:1990837,sequence-specific double-stranded DNA binding,6,0.0,1.0,1.0,11
9463,GO:2000004,regulation of metanephric S-shaped body morphogenesis,6,0.0,1.0,1.0,1
9464,GO:2000006,regulation of metanephric comma-shaped body morphogenesis,6,0.0,1.0,1.0,1
9465,GO:2000008,regulation of protein localization to cell surface,6,0.0,1.0,1.0,2
9466,GO:2000031,regulation of salicylic acid mediated signaling pathway,6,0.0,1.0,1.0,2
9467,GO:2000038,regulation of stomatal complex development,6,0.0,1.0,1.0,2
9468,GO:2000043,regulation of cardiac cell fate specification,6,0.0,1.0,1.0,2
9469,GO:2000047,regulation of cell-cell adhesion mediated by cadherin,6,0.0,1.0,1.0,2
9470,GO:2000067,regulation of root morphogenesis,6,0.0,1.0,1.0,1
9471,GO:2000068,regulation of defense response to insect,6,0.0,1.0,1.0,2
9472,GO:2000069,regulation of post-embryonic root development,6,0.0,1.0,1.0,1
9473,GO:2000074,regulation of type B pancreatic cell development,6,0.0,1.0,1.0,2
9474,GO:2000087,regulation of mesonephric glomerulus development,6,0.0,1.0,1.0,2
9475,GO:2000106,regulation of leukocyte apoptotic process,6,0.0,1.0,1.0,7
9476,GO:2000118,regulation of sodium-dependent phosphate transport,6,0.0,1.0,1.0,2
9477,GO:2000137,negative regulation of cell proliferation involved in heart morphogenesis,6,0.0,1.0,1.0,2
9478,GO:2000138,positive regulation of cell proliferation involved in heart morphogenesis,6,0.0,1.0,1.0,3
9479,GO:2000155,positive regulation of cilium-dependent cell motility,6,0.0,1.0,1.0,1
9480,GO:2000172,regulation of branching morphogenesis of a nerve,6,0.0,1.0,1.0,2
9481,GO:2000178,negative regulation of neural precursor cell proliferation,6,0.0,1.0,1.0,5
9482,GO:2000179,positive regulation of neural precursor cell proliferation,6,0.0,1.0,1.0,5
9483,GO:2000191,regulation of fatty acid transport,6,0.0,1.0,1.0,4
9484,GO:2000195,negative regulation of female gonad development,6,0.0,1.0,1.0,1
9485,GO:2000196,positive regulation of female gonad development,6,0.0,1.0,1.0,1
9486,GO:2000198,negative regulation of ribonucleoprotein complex localization,6,0.0,1.0,1.0,2
9487,GO:2000199,positive regulation of ribonucleoprotein complex localization,6,0.0,1.0,1.0,2
9488,GO:2000209,regulation of anoikis,6,0.0,1.0,1.0,2
9489,GO:2000226,regulation of pancreatic A cell differentiation,6,0.0,1.0,1.0,2
9490,GO:2000229,regulation of pancreatic stellate cell proliferation,6,0.0,1.0,1.0,2
9491,GO:2000252,negative regulation of feeding behavior,6,0.0,1.0,1.0,1
9492,GO:2000253,positive regulation of feeding behavior,6,0.0,1.0,1.0,1
9493,GO:2000254,regulation of male germ cell proliferation,6,0.0,1.0,1.0,2
9494,GO:2000269,regulation of fibroblast apoptotic process,6,0.0,1.0,1.0,2
9495,GO:2000288,positive regulation of myoblast proliferation,6,0.0,1.0,1.0,1
9496,GO:2000333,negative regulation of blood microparticle formation,6,0.0,1.0,1.0,1
9497,GO:2000334,positive regulation of blood microparticle formation,6,0.0,1.0,1.0,1
9498,GO:2000335,regulation of endothelial microparticle formation,6,0.0,1.0,1.0,2
9499,GO:2000345,regulation of hepatocyte proliferation,6,0.0,1.0,1.0,2
9500,GO:2000348,regulation of CD40 signaling pathway,6,0.0,1.0,1.0,2
9501,GO:2000351,regulation of endothelial cell apoptotic process,6,0.0,1.0,1.0,2
9502,GO:2000378,negative regulation of reactive oxygen species metabolic process,6,0.0,1.0,1.0,4
9503,GO:2000379,positive regulation of reactive oxygen species metabolic process,6,0.0,1.0,1.0,4
9504,GO:2000470,positive regulation of peroxidase activity,6,0.0,1.0,1.0,2
9505,GO:2000471,regulation of hematopoietic stem cell migration,6,0.0,1.0,1.0,2
9506,GO:2000477,regulation of metanephric podocyte development,6,0.0,1.0,1.0,1
9507,GO:2000504,positive regulation of blood vessel remodeling,6,0.0,1.0,1.0,1
9508,GO:2000532,regulation of renal albumin absorption,6,0.0,1.0,1.0,2
9509,GO:2000589,regulation of metanephric mesenchymal cell migration,6,0.0,1.0,1.0,3
9510,GO:2000606,regulation of cell proliferation involved in mesonephros development,6,0.0,1.0,1.0,3
9511,GO:2000609,regulation of thyroid hormone generation,6,0.0,1.0,1.0,2
9512,GO:2000641,regulation of early endosome to late endosome transport,6,0.0,1.0,1.0,2
9513,GO:2000644,regulation of receptor catabolic process,6,0.0,1.0,1.0,3
9514,GO:2000647,negative regulation of stem cell proliferation,6,0.0,1.0,1.0,2
9515,GO:2000648,positive regulation of stem cell proliferation,6,0.0,1.0,1.0,2
9516,GO:2000678,negative regulation of transcription regulatory region DNA binding,6,0.0,1.0,1.0,3
9517,GO:2000679,positive regulation of transcription regulatory region DNA binding,6,0.0,1.0,1.0,2
9518,GO:2000689,actomyosin contractile ring assembly actin filament organization,6,0.0,1.0,1.0,3
9519,GO:2000696,regulation of epithelial cell differentiation involved in kidney development,6,0.0,1.0,1.0,5
9520,GO:2000733,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,6,0.0,1.0,1.0,2
9521,GO:2000737,negative regulation of stem cell differentiation,6,0.0,1.0,1.0,4
9522,GO:2000738,positive regulation of stem cell differentiation,6,0.0,1.0,1.0,4
9523,GO:2000739,regulation of mesenchymal stem cell differentiation,6,0.0,1.0,1.0,3
9524,GO:2000762,regulation of phenylpropanoid metabolic process,6,0.0,1.0,1.0,4
9525,GO:2000790,regulation of mesenchymal cell proliferation involved in lung development,6,0.0,1.0,1.0,2
9526,GO:2000794,regulation of epithelial cell proliferation involved in lung morphogenesis,6,0.0,1.0,1.0,2
9527,GO:2000810,regulation of bicellular tight junction assembly,6,0.0,1.0,1.0,2
9528,GO:2000818,negative regulation of myoblast proliferation,6,0.0,1.0,1.0,1
9529,GO:2000822,regulation of behavioral fear response,6,0.0,1.0,1.0,2
9530,GO:2000826,regulation of heart morphogenesis,6,0.0,1.0,1.0,3
9531,GO:2000893,cellotriose metabolic process,6,0.0,1.0,1.0,1
9532,GO:2000902,cellooligosaccharide metabolic process,6,0.0,1.0,1.0,1
9533,GO:2000942,regulation of amylopectin metabolic process,6,0.0,1.0,1.0,3
9534,GO:2000977,regulation of forebrain neuron differentiation,6,0.0,1.0,1.0,2
9535,GO:2001015,negative regulation of skeletal muscle cell differentiation,6,0.0,1.0,1.0,2
9536,GO:2001016,positive regulation of skeletal muscle cell differentiation,6,0.0,1.0,1.0,2
9537,GO:2001017,regulation of retrograde axon cargo transport,6,0.0,1.0,1.0,3
9538,GO:2001044,regulation of integrin-mediated signaling pathway,6,0.0,1.0,1.0,2
9539,GO:2001053,regulation of mesenchymal cell apoptotic process,6,0.0,1.0,1.0,4
9540,GO:2001074,regulation of metanephric ureteric bud development,6,0.0,1.0,1.0,2
9541,GO:2001088,trisaccharide transport,6,0.0,1.0,1.0,10
9542,GO:2001098,tetrasaccharide transport,6,0.0,1.0,1.0,1
9543,GO:2001100,pentasaccharide transport,6,0.0,1.0,1.0,1
9544,GO:2001102,hexasaccharide transport,6,0.0,1.0,1.0,1
9545,GO:2001104,heptasaccharide transport,6,0.0,1.0,1.0,1
9546,GO:2001109,regulation of lens epithelial cell proliferation,6,0.0,1.0,1.0,2
9547,GO:2001116,methanopterin-containing compound biosynthetic process,6,0.0,1.0,1.0,2
9548,GO:2001117,tetrahydromethanopterin metabolic process,6,0.0,1.0,1.0,3
9549,GO:2001122,maltoheptaose metabolic process,6,0.0,1.0,1.0,1
9550,GO:2001135,regulation of endocytic recycling,6,0.0,1.0,1.0,3
9551,GO:2001138,regulation of phospholipid transport,6,0.0,1.0,1.0,4
9552,GO:2001151,regulation of renal water transport,6,0.0,1.0,1.0,2
9553,GO:2001176,regulation of mediator complex assembly,6,0.0,1.0,1.0,2
9554,GO:2001222,regulation of neuron migration,6,0.0,1.0,1.0,3
9555,GO:2001233,regulation of apoptotic signaling pathway,6,0.0,1.0,1.0,4
9556,GO:2001260,regulation of semaphorin-plexin signaling pathway,6,0.0,1.0,1.0,2
9557,GO:2001281,regulation of muscle cell chemotaxis toward tendon cell,6,0.0,1.0,1.0,1
9558,GO:2001300,lipoxin metabolic process,6,0.0,1.0,1.0,3
9559,GO:2001307,xanthone-containing compound biosynthetic process,6,0.0,1.0,1.0,1
9560,GO:2001308,gliotoxin metabolic process,6,0.0,1.0,1.0,2
9561,GO:2001316,kojic acid metabolic process,6,0.0,1.0,1.0,1
20,GO:0034369,plasma lipoprotein particle remodeling,7,6727.26,852.75,4.618362238122552e-48,4
72,GO:0019374,galactolipid metabolic process,7,1922.07,684.13,4.0063672589795296e-16,3
78,GO:0019377,glycolipid catabolic process,7,1922.07,363.64,2.0009678161333584e-14,3
12,GO:0046464,acylglycerol catabolic process,7,1774.22,1090.91,8.670346100809381e-67,3
16,GO:0006641,triglyceride metabolic process,7,1774.22,277.89,6.6126083786084145e-52,4
59,GO:0010886,positive regulation of cholesterol storage,7,1441.55,1441.55,3.3621383319355096e-18,0
261,GO:0010557,positive regulation of macromolecule biosynthetic process,7,820.4,2.94,0.0167186640339457,14
383,GO:0010468,regulation of gene expression,7,820.4,1.04,0.5196434923279817,22
70,GO:0010890,positive regulation of sequestering of triglyceride,7,733.88,733.88,2.5788875960548984e-16,0
58,GO:0042589,zymogen granule membrane,7,692.51,692.51,1.1864230835470244e-18,0
93,GO:0046475,glycerophospholipid catabolic process,7,509.64,179.39,1.4690672717426865e-12,7
104,GO:0046470,phosphatidylcholine metabolic process,7,509.64,88.52,1.0250362555351202e-10,5
114,GO:0043691,reverse cholesterol transport,7,368.62,368.62,4.895807555421154e-10,0
145,GO:0050746,regulation of lipoprotein metabolic process,7,360.39,360.39,8.724829572829568e-08,4
197,GO:0006658,phosphatidylserine metabolic process,7,354.07,128.14,0.0001179956492112,3
127,GO:0002080,acrosomal membrane,7,233.99,233.99,3.09491619045684e-09,0
158,GO:0032373,positive regulation of sterol transport,7,134.55,131.05,1.8590849074343584e-06,3
174,GO:0032374,regulation of cholesterol transport,7,134.55,69.83,1.222153938661632e-05,6
160,GO:0046473,phosphatidic acid metabolic process,7,125.35,125.35,2.124516999499097e-06,1
248,GO:0061365,positive regulation of triglyceride lipase activity,7,105.11,105.11,0.0094696651958259,1
301,GO:0046474,glycerophospholipid biosynthetic process,7,92.79,5.36,0.0540339112216134,9
271,GO:0030166,proteoglycan biosynthetic process,7,73.12,43.97,0.0224913367042877,3
99,GO:0009749,response to glucose,7,72.56,72.56,1.0638552826032076e-11,2
135,GO:0050729,positive regulation of inflammatory response,7,65.82,65.82,1.7207056936724066e-08,9
172,GO:0008203,cholesterol metabolic process,7,31.69,31.69,8.857306542446288e-06,3
286,GO:0043186,P granule,7,26.49,26.49,0.0370639908835999,2
294,GO:0046463,acylglycerol biosynthetic process,7,24.03,21.36,0.0457611331206001,3
225,GO:0005768,endosome,7,21.07,7.43,0.0021565002665783,8
144,GO:0032787,monocarboxylic acid metabolic process,7,17.18,4.8,6.834308358867055e-08,69
224,GO:0046394,carboxylic acid biosynthetic process,7,17.18,2.37,0.0020777303739453,39
312,GO:0046337,phosphatidylethanolamine metabolic process,7,10.87,10.87,0.0879606733628704,4
4758,GO:0000014,single-stranded DNA endodeoxyribonuclease activity,7,0.0,1.0,1.0,2
4759,GO:0000023,maltose metabolic process,7,0.0,1.0,1.0,2
4760,GO:0000027,ribosomal large subunit assembly,7,0.0,1.0,1.0,2
4761,GO:0000028,ribosomal small subunit assembly,7,0.0,1.0,1.0,2
4762,GO:0000041,transition metal ion transport,7,0.0,1.0,1.0,10
4763,GO:0000096,sulfur amino acid metabolic process,7,0.0,1.0,1.0,6
4764,GO:0000165,MAPK cascade,7,0.0,1.0,1.0,6
4765,GO:0000182,rDNA binding,7,0.0,1.0,1.0,2
4766,GO:0000245,spliceosomal complex assembly,7,0.0,1.0,1.0,1
4767,GO:0000307,cyclin-dependent protein kinase holoenzyme complex,7,0.0,1.0,1.0,22
4768,GO:0000376,"RNA splicing, via transesterification reactions with guanosine as nucleophile",7,0.0,1.0,1.0,1
4769,GO:0000377,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",7,0.0,1.0,1.0,3
4770,GO:0000378,RNA exon ligation,7,0.0,1.0,1.0,1
4771,GO:0000387,spliceosomal snRNP assembly,7,0.0,1.0,1.0,1
4772,GO:0000427,plastid-encoded plastid RNA polymerase complex,7,0.0,1.0,1.0,2
4773,GO:0000491,small nucleolar ribonucleoprotein complex assembly,7,0.0,1.0,1.0,2
4774,GO:0000703,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,7,0.0,1.0,1.0,2
4775,GO:0000723,telomere maintenance,7,0.0,1.0,1.0,8
4776,GO:0000729,DNA double-strand break processing,7,0.0,1.0,1.0,3
4777,GO:0000730,DNA recombinase assembly,7,0.0,1.0,1.0,1
4778,GO:0000732,DNA strand displacement,7,0.0,1.0,1.0,1
4779,GO:0000735,removal of nonhomologous ends,7,0.0,1.0,1.0,1
4780,GO:0000740,nuclear membrane fusion,7,0.0,1.0,1.0,2
4781,GO:0000754,adaptation of signaling pathway by response to pheromone involved in conjugation with cellular fusion,7,0.0,1.0,1.0,1
4782,GO:0000805,X chromosome,7,0.0,1.0,1.0,1
4783,GO:0000820,regulation of glutamine family amino acid metabolic process,7,0.0,1.0,1.0,5
4784,GO:0000821,regulation of arginine metabolic process,7,0.0,1.0,1.0,3
4785,GO:0000836,Hrd1p ubiquitin ligase complex,7,0.0,1.0,1.0,2
4786,GO:0000909,sporocarp development involved in sexual reproduction,7,0.0,1.0,1.0,1
4787,GO:0000947,amino acid catabolic process to alcohol via Ehrlich pathway,7,0.0,1.0,1.0,3
4788,GO:0000959,mitochondrial RNA metabolic process,7,0.0,1.0,1.0,9
4789,GO:0000963,mitochondrial RNA processing,7,0.0,1.0,1.0,5
4790,GO:0000976,transcription cis-regulatory region binding,7,0.0,1.0,1.0,10
4791,GO:0001112,DNA-templated transcription open complex formation,7,0.0,1.0,1.0,1
4792,GO:0001325,formation of extrachromosomal circular DNA,7,0.0,1.0,1.0,1
4793,GO:0001578,microtubule bundle formation,7,0.0,1.0,1.0,3
4794,GO:0001674,female germ cell nucleus,7,0.0,1.0,1.0,1
4795,GO:0001681,sialate O-acetylesterase activity,7,0.0,1.0,1.0,2
4796,GO:0001751,compound eye photoreceptor cell differentiation,7,0.0,1.0,1.0,5
4797,GO:0001752,compound eye photoreceptor fate commitment,7,0.0,1.0,1.0,5
4798,GO:0001759,organ induction,7,0.0,1.0,1.0,4
4799,GO:0001766,membrane raft polarization,7,0.0,1.0,1.0,1
4800,GO:0001779,natural killer cell differentiation,7,0.0,1.0,1.0,1
4801,GO:0001783,B cell apoptotic process,7,0.0,1.0,1.0,3
4802,GO:0001820,serotonin secretion,7,0.0,1.0,1.0,2
4803,GO:0001868,"regulation of complement activation, lectin pathway",7,0.0,1.0,1.0,2
4804,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,7,0.0,1.0,1.0,5
4805,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,7,0.0,1.0,1.0,5
4806,GO:0001937,negative regulation of endothelial cell proliferation,7,0.0,1.0,1.0,2
4807,GO:0001938,positive regulation of endothelial cell proliferation,7,0.0,1.0,1.0,2
4808,GO:0001953,negative regulation of cell-matrix adhesion,7,0.0,1.0,1.0,3
4809,GO:0001954,positive regulation of cell-matrix adhesion,7,0.0,1.0,1.0,3
4810,GO:0001960,negative regulation of cytokine-mediated signaling pathway,7,0.0,1.0,1.0,16
4811,GO:0001961,positive regulation of cytokine-mediated signaling pathway,7,0.0,1.0,1.0,16
4812,GO:0001969,regulation of activation of membrane attack complex,7,0.0,1.0,1.0,2
4813,GO:0002026,regulation of the force of heart contraction,7,0.0,1.0,1.0,4
4814,GO:0002027,regulation of heart rate,7,0.0,1.0,1.0,6
4815,GO:0002028,regulation of sodium ion transport,7,0.0,1.0,1.0,3
4816,GO:0002071,glandular epithelial cell maturation,7,0.0,1.0,1.0,1
4817,GO:0002085,inhibition of neuroepithelial cell differentiation,7,0.0,1.0,1.0,2
4818,GO:0002155,regulation of thyroid hormone receptor signaling pathway,7,0.0,1.0,1.0,2
4819,GO:0002254,kinin cascade,7,0.0,1.0,1.0,2
4820,GO:0002273,plasmacytoid dendritic cell differentiation,7,0.0,1.0,1.0,1
4821,GO:0002287,alpha-beta T cell activation involved in immune response,7,0.0,1.0,1.0,3
4822,GO:0002290,gamma-delta T cell activation involved in immune response,7,0.0,1.0,1.0,2
4823,GO:0002295,T-helper cell lineage commitment,7,0.0,1.0,1.0,3
4824,GO:0002309,T cell proliferation involved in immune response,7,0.0,1.0,1.0,2
4825,GO:0002367,cytokine production involved in immune response,7,0.0,1.0,1.0,5
4826,GO:0002377,immunoglobulin production,7,0.0,1.0,1.0,1
4827,GO:0002407,dendritic cell chemotaxis,7,0.0,1.0,1.0,2
4828,GO:0002413,tolerance induction to tumor cell,7,0.0,1.0,1.0,1
4829,GO:0002427,mucosal tolerance induction,7,0.0,1.0,1.0,2
4830,GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,7,0.0,1.0,1.0,1
4831,GO:0002451,peripheral B cell tolerance induction,7,0.0,1.0,1.0,1
4832,GO:0002458,peripheral T cell tolerance induction,7,0.0,1.0,1.0,2
4833,GO:0002496,proteolysis associated with antigen processing and presentation,7,0.0,1.0,1.0,5
4834,GO:0002524,hypersensitivity,7,0.0,1.0,1.0,4
4835,GO:0002590,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,7,0.0,1.0,1.0,1
4836,GO:0002591,positive regulation of antigen processing and presentation of peptide antigen via MHC class I,7,0.0,1.0,1.0,1
4837,GO:0002634,regulation of germinal center formation,7,0.0,1.0,1.0,2
4838,GO:0002652,regulation of tolerance induction dependent upon immune response,7,0.0,1.0,1.0,4
4839,GO:0002671,negative regulation of B cell anergy,7,0.0,1.0,1.0,2
4840,GO:0002672,positive regulation of B cell anergy,7,0.0,1.0,1.0,2
4841,GO:0002673,regulation of acute inflammatory response,7,0.0,1.0,1.0,11
4842,GO:0002676,regulation of chronic inflammatory response,7,0.0,1.0,1.0,5
4843,GO:0002686,negative regulation of leukocyte migration,7,0.0,1.0,1.0,5
4844,GO:0002687,positive regulation of leukocyte migration,7,0.0,1.0,1.0,5
4845,GO:0002688,regulation of leukocyte chemotaxis,7,0.0,1.0,1.0,8
4846,GO:0002691,regulation of cellular extravasation,7,0.0,1.0,1.0,7
4847,GO:0002707,negative regulation of lymphocyte mediated immunity,7,0.0,1.0,1.0,3
4848,GO:0002708,positive regulation of lymphocyte mediated immunity,7,0.0,1.0,1.0,3
4849,GO:0002709,regulation of T cell mediated immunity,7,0.0,1.0,1.0,8
4850,GO:0002712,regulation of B cell mediated immunity,7,0.0,1.0,1.0,7
4851,GO:0002715,regulation of natural killer cell mediated immunity,7,0.0,1.0,1.0,5
4852,GO:0002757,immune response-activating signaling pathway,7,0.0,1.0,1.0,2
4853,GO:0002760,positive regulation of antimicrobial humoral response,7,0.0,1.0,1.0,1
4854,GO:0002767,immune response-inhibiting cell surface receptor signaling pathway,7,0.0,1.0,1.0,6
4855,GO:0002775,antimicrobial peptide production,7,0.0,1.0,1.0,2
4856,GO:0002790,peptide secretion,7,0.0,1.0,1.0,5
4857,GO:0002792,negative regulation of peptide secretion,7,0.0,1.0,1.0,2
4858,GO:0002793,positive regulation of peptide secretion,7,0.0,1.0,1.0,2
4859,GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7,0.0,1.0,1.0,6
4860,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7,0.0,1.0,1.0,7
4861,GO:0002825,regulation of T-helper 1 type immune response,7,0.0,1.0,1.0,4
4862,GO:0002838,negative regulation of immune response to tumor cell,7,0.0,1.0,1.0,3
4863,GO:0002839,positive regulation of immune response to tumor cell,7,0.0,1.0,1.0,3
4864,GO:0002861,regulation of inflammatory response to antigenic stimulus,7,0.0,1.0,1.0,4
4865,GO:0002887,negative regulation of myeloid leukocyte mediated immunity,7,0.0,1.0,1.0,9
4866,GO:0002888,positive regulation of myeloid leukocyte mediated immunity,7,0.0,1.0,1.0,8
4867,GO:0002896,negative regulation of central B cell tolerance induction,7,0.0,1.0,1.0,2
4868,GO:0002897,positive regulation of central B cell tolerance induction,7,0.0,1.0,1.0,2
4869,GO:0003010,voluntary skeletal muscle contraction,7,0.0,1.0,1.0,3
4870,GO:0003011,involuntary skeletal muscle contraction,7,0.0,1.0,1.0,1
4871,GO:0003020,detection of reduced oxygen by chemoreceptor signaling,7,0.0,1.0,1.0,2
4872,GO:0003081,regulation of systemic arterial blood pressure by renin-angiotensin,7,0.0,1.0,1.0,4
4873,GO:0003220,left ventricular cardiac muscle tissue morphogenesis,7,0.0,1.0,1.0,2
4874,GO:0003221,right ventricular cardiac muscle tissue morphogenesis,7,0.0,1.0,1.0,2
4875,GO:0003222,ventricular trabecula myocardium morphogenesis,7,0.0,1.0,1.0,2
4876,GO:0003223,ventricular compact myocardium morphogenesis,7,0.0,1.0,1.0,2
4877,GO:0003228,atrial cardiac muscle tissue development,7,0.0,1.0,1.0,1
4878,GO:0003229,ventricular cardiac muscle tissue development,7,0.0,1.0,1.0,3
4879,GO:0003266,regulation of secondary heart field cardioblast proliferation,7,0.0,1.0,1.0,1
4880,GO:0003278,apoptotic process involved in heart morphogenesis,7,0.0,1.0,1.0,4
4881,GO:0003306,Wnt signaling pathway involved in heart development,7,0.0,1.0,1.0,2
4882,GO:0003307,regulation of Wnt signaling pathway involved in heart development,7,0.0,1.0,1.0,1
4883,GO:0003330,regulation of extracellular matrix constituent secretion,7,0.0,1.0,1.0,2
4884,GO:0003339,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,7,0.0,1.0,1.0,2
4885,GO:0003353,positive regulation of cilium movement,7,0.0,1.0,1.0,1
4886,GO:0003354,negative regulation of cilium movement,7,0.0,1.0,1.0,1
4887,GO:0003356,regulation of cilium beat frequency,7,0.0,1.0,1.0,1
4888,GO:0003371,establishment or maintenance of cytoskeleton polarity involved in ameboidal cell migration,7,0.0,1.0,1.0,1
4889,GO:0003389,retrograde extension,7,0.0,1.0,1.0,1
4890,GO:0003426,cytoskeleton polarization involved in growth plate cartilage chondrocyte division,7,0.0,1.0,1.0,1
4891,GO:0003696,satellite DNA binding,7,0.0,1.0,1.0,1
4892,GO:0003747,translation release factor activity,7,0.0,1.0,1.0,2
4893,GO:0003843,"1,3-beta-D-glucan synthase activity",7,0.0,1.0,1.0,2
4894,GO:0003899,DNA-directed 5'-3' RNA polymerase activity,7,0.0,1.0,1.0,7
4895,GO:0003924,GTPase activity,7,0.0,1.0,1.0,2
4896,GO:0004114,"3',5'-cyclic-nucleotide phosphodiesterase activity",7,0.0,1.0,1.0,4
4897,GO:0004127,(d)CMP kinase activity,7,0.0,1.0,1.0,2
4898,GO:0004446,inositol-hexakisphosphate phosphatase activity,7,0.0,1.0,1.0,1
4899,GO:0004467,long-chain fatty acid-CoA ligase activity,7,0.0,1.0,1.0,4
4900,GO:0004675,transmembrane receptor protein serine/threonine kinase activity,7,0.0,1.0,1.0,3
4901,GO:0004683,calcium/calmodulin-dependent protein kinase activity,7,0.0,1.0,1.0,3
4902,GO:0004690,cyclic nucleotide-dependent protein kinase activity,7,0.0,1.0,1.0,2
4903,GO:0004697,diacylglycerol-dependent serine/threonine kinase activity,7,0.0,1.0,1.0,2
4904,GO:0004703,G protein-coupled receptor kinase activity,7,0.0,1.0,1.0,1
4905,GO:0004707,MAP kinase activity,7,0.0,1.0,1.0,1
4906,GO:0004708,MAP kinase kinase activity,7,0.0,1.0,1.0,1
4907,GO:0004709,MAP kinase kinase kinase activity,7,0.0,1.0,1.0,1
4908,GO:0004714,transmembrane receptor protein tyrosine kinase activity,7,0.0,1.0,1.0,14
4909,GO:0004722,protein serine/threonine phosphatase activity,7,0.0,1.0,1.0,5
4910,GO:0004725,protein tyrosine phosphatase activity,7,0.0,1.0,1.0,4
4911,GO:0004844,uracil DNA N-glycosylase activity,7,0.0,1.0,1.0,2
4912,GO:0004936,alpha-adrenergic receptor activity,7,0.0,1.0,1.0,2
4913,GO:0004939,beta-adrenergic receptor activity,7,0.0,1.0,1.0,3
4914,GO:0004955,prostaglandin receptor activity,7,0.0,1.0,1.0,5
4915,GO:0004960,thromboxane receptor activity,7,0.0,1.0,1.0,1
4916,GO:0004983,neuropeptide Y receptor activity,7,0.0,1.0,1.0,2
4917,GO:0004995,tachykinin receptor activity,7,0.0,1.0,1.0,3
4918,GO:0005153,interleukin-8 receptor binding,7,0.0,1.0,1.0,2
4919,GO:0005225,volume-sensitive anion channel activity,7,0.0,1.0,1.0,1
4920,GO:0005244,voltage-gated monoatomic ion channel activity,7,0.0,1.0,1.0,5
4921,GO:0005254,chloride channel activity,7,0.0,1.0,1.0,11
4922,GO:0005262,calcium channel activity,7,0.0,1.0,1.0,4
4923,GO:0005267,potassium channel activity,7,0.0,1.0,1.0,9
4924,GO:0005272,sodium channel activity,7,0.0,1.0,1.0,2
4925,GO:0005324,long-chain fatty acid transmembrane transporter activity,7,0.0,1.0,1.0,3
4926,GO:0005347,ATP transmembrane transporter activity,7,0.0,1.0,1.0,2
4927,GO:0005353,fructose transmembrane transporter activity,7,0.0,1.0,1.0,5
4928,GO:0005354,galactose transmembrane transporter activity,7,0.0,1.0,1.0,4
4929,GO:0005375,copper ion transmembrane transporter activity,7,0.0,1.0,1.0,4
4930,GO:0005381,iron ion transmembrane transporter activity,7,0.0,1.0,1.0,2
4931,GO:0005384,manganese ion transmembrane transporter activity,7,0.0,1.0,1.0,4
4932,GO:0005385,zinc ion transmembrane transporter activity,7,0.0,1.0,1.0,7
4933,GO:0005402,carbohydrate:monoatomic cation symporter activity,7,0.0,1.0,1.0,9
4934,GO:0005416,amino acid:monoatomic cation symporter activity,7,0.0,1.0,1.0,3
4935,GO:0005504,fatty acid binding,7,0.0,1.0,1.0,4
4936,GO:0005506,iron ion binding,7,0.0,1.0,1.0,2
4937,GO:0005507,copper ion binding,7,0.0,1.0,1.0,2
4938,GO:0005764,lysosome,7,0.0,1.0,1.0,6
4939,GO:0005765,lysosomal membrane,7,0.0,1.0,1.0,5
4940,GO:0005778,peroxisomal membrane,7,0.0,1.0,1.0,2
4941,GO:0005798,Golgi-associated vesicle,7,0.0,1.0,1.0,2
4942,GO:0005876,spindle microtubule,7,0.0,1.0,1.0,4
4943,GO:0005881,cytoplasmic microtubule,7,0.0,1.0,1.0,3
4944,GO:0005891,voltage-gated calcium channel complex,7,0.0,1.0,1.0,4
4945,GO:0005940,septin ring,7,0.0,1.0,1.0,7
4946,GO:0005977,glycogen metabolic process,7,0.0,1.0,1.0,2
4947,GO:0005982,starch metabolic process,7,0.0,1.0,1.0,2
4948,GO:0005985,sucrose metabolic process,7,0.0,1.0,1.0,2
4949,GO:0005988,lactose metabolic process,7,0.0,1.0,1.0,2
4950,GO:0005991,trehalose metabolic process,7,0.0,1.0,1.0,3
4951,GO:0005994,melibiose metabolic process,7,0.0,1.0,1.0,2
4952,GO:0005997,xylulose metabolic process,7,0.0,1.0,1.0,2
4953,GO:0006000,fructose metabolic process,7,0.0,1.0,1.0,2
4954,GO:0006004,fucose metabolic process,7,0.0,1.0,1.0,3
4955,GO:0006006,glucose metabolic process,7,0.0,1.0,1.0,9
4956,GO:0006012,galactose metabolic process,7,0.0,1.0,1.0,4
4957,GO:0006013,mannose metabolic process,7,0.0,1.0,1.0,3
4958,GO:0006014,D-ribose metabolic process,7,0.0,1.0,1.0,2
4959,GO:0006054,N-acetylneuraminate metabolic process,7,0.0,1.0,1.0,2
4960,GO:0006057,mannoprotein biosynthetic process,7,0.0,1.0,1.0,1
4961,GO:0006059,hexitol metabolic process,7,0.0,1.0,1.0,5
4962,GO:0006070,octanol metabolic process,7,0.0,1.0,1.0,2
4963,GO:0006071,glycerol metabolic process,7,0.0,1.0,1.0,3
4964,GO:0006140,regulation of nucleotide metabolic process,7,0.0,1.0,1.0,5
4965,GO:0006141,regulation of purine nucleobase metabolic process,7,0.0,1.0,1.0,3
4966,GO:0006142,regulation of pyrimidine nucleobase metabolic process,7,0.0,1.0,1.0,2
4967,GO:0006144,purine nucleobase metabolic process,7,0.0,1.0,1.0,6
4968,GO:0006206,pyrimidine nucleobase metabolic process,7,0.0,1.0,1.0,5
4969,GO:0006213,pyrimidine nucleoside metabolic process,7,0.0,1.0,1.0,6
4970,GO:0006260,DNA replication,7,0.0,1.0,1.0,1
4971,GO:0006266,DNA ligation,7,0.0,1.0,1.0,3
4972,GO:0006270,DNA replication initiation,7,0.0,1.0,1.0,1
4973,GO:0006274,DNA replication termination,7,0.0,1.0,1.0,2
4974,GO:0006281,DNA repair,7,0.0,1.0,1.0,17
4975,GO:0006285,"base-excision repair, AP site formation",7,0.0,1.0,1.0,3
4976,GO:0006304,DNA modification,7,0.0,1.0,1.0,7
4977,GO:0006308,DNA catabolic process,7,0.0,1.0,1.0,2
4978,GO:0006310,DNA recombination,7,0.0,1.0,1.0,11
4979,GO:0006376,mRNA splice site recognition,7,0.0,1.0,1.0,2
4980,GO:0006399,tRNA metabolic process,7,0.0,1.0,1.0,7
4981,GO:0006401,RNA catabolic process,7,0.0,1.0,1.0,15
4982,GO:0006465,signal peptide processing,7,0.0,1.0,1.0,1
4983,GO:0006473,protein acetylation,7,0.0,1.0,1.0,7
4984,GO:0006476,protein deacetylation,7,0.0,1.0,1.0,3
4985,GO:0006479,protein methylation,7,0.0,1.0,1.0,7
4986,GO:0006482,protein demethylation,7,0.0,1.0,1.0,1
4987,GO:0006487,protein N-linked glycosylation,7,0.0,1.0,1.0,1
4988,GO:0006493,protein O-linked glycosylation,7,0.0,1.0,1.0,8
4989,GO:0006498,N-terminal protein lipidation,7,0.0,1.0,1.0,2
4990,GO:0006509,membrane protein ectodomain proteolysis,7,0.0,1.0,1.0,1
4991,GO:0006515,protein quality control for misfolded or incompletely synthesized proteins,7,0.0,1.0,1.0,3
4992,GO:0006612,protein targeting to membrane,7,0.0,1.0,1.0,3
4993,GO:0006637,acyl-CoA metabolic process,7,0.0,1.0,1.0,8
4994,GO:0006668,sphinganine-1-phosphate metabolic process,7,0.0,1.0,1.0,2
4995,GO:0006672,ceramide metabolic process,7,0.0,1.0,1.0,5
4996,GO:0006673,inositol phosphoceramide metabolic process,7,0.0,1.0,1.0,2
4997,GO:0006684,sphingomyelin metabolic process,7,0.0,1.0,1.0,2
4998,GO:0006687,glycosphingolipid metabolic process,7,0.0,1.0,1.0,8
4999,GO:0006690,icosanoid metabolic process,7,0.0,1.0,1.0,5
5000,GO:0006712,mineralocorticoid catabolic process,7,0.0,1.0,1.0,1
5001,GO:0006714,sesquiterpenoid metabolic process,7,0.0,1.0,1.0,8
5002,GO:0006722,triterpenoid metabolic process,7,0.0,1.0,1.0,6
5003,GO:0006726,eye pigment biosynthetic process,7,0.0,1.0,1.0,2
5004,GO:0006744,ubiquinone biosynthetic process,7,0.0,1.0,1.0,5
5005,GO:0006772,thiamine metabolic process,7,0.0,1.0,1.0,2
5006,GO:0006777,Mo-molybdopterin cofactor biosynthetic process,7,0.0,1.0,1.0,2
5007,GO:0006813,potassium ion transport,7,0.0,1.0,1.0,1
5008,GO:0006814,sodium ion transport,7,0.0,1.0,1.0,2
5009,GO:0006816,calcium ion transport,7,0.0,1.0,1.0,7
5010,GO:0006846,acetate transport,7,0.0,1.0,1.0,1
5011,GO:0006848,pyruvate transport,7,0.0,1.0,1.0,1
5012,GO:0006857,oligopeptide transport,7,0.0,1.0,1.0,3
5013,GO:0006864,pyrimidine nucleotide transport,7,0.0,1.0,1.0,1
5014,GO:0006886,intracellular protein transport,7,0.0,1.0,1.0,20
5015,GO:0006893,Golgi to plasma membrane transport,7,0.0,1.0,1.0,1
5016,GO:0006896,Golgi to vacuole transport,7,0.0,1.0,1.0,1
5017,GO:0006906,vesicle fusion,7,0.0,1.0,1.0,18
5018,GO:0006911,"phagocytosis, engulfment",7,0.0,1.0,1.0,1
5019,GO:0006940,regulation of smooth muscle contraction,7,0.0,1.0,1.0,7
5020,GO:0006942,regulation of striated muscle contraction,7,0.0,1.0,1.0,4
5021,GO:0006956,complement activation,7,0.0,1.0,1.0,4
5022,GO:0006983,ER overload response,7,0.0,1.0,1.0,2
5023,GO:0007007,inner mitochondrial membrane organization,7,0.0,1.0,1.0,4
5024,GO:0007008,outer mitochondrial membrane organization,7,0.0,1.0,1.0,2
5025,GO:0007020,microtubule nucleation,7,0.0,1.0,1.0,3
5026,GO:0007040,lysosome organization,7,0.0,1.0,1.0,1
5027,GO:0007051,spindle organization,7,0.0,1.0,1.0,5
5028,GO:0007063,regulation of sister chromatid cohesion,7,0.0,1.0,1.0,4
5029,GO:0007064,mitotic sister chromatid cohesion,7,0.0,1.0,1.0,3
5030,GO:0007076,mitotic chromosome condensation,7,0.0,1.0,1.0,2
5031,GO:0007077,mitotic nuclear membrane disassembly,7,0.0,1.0,1.0,1
5032,GO:0007088,regulation of mitotic nuclear division,7,0.0,1.0,1.0,3
5033,GO:0007169,cell surface receptor protein tyrosine kinase signaling pathway,7,0.0,1.0,1.0,18
5034,GO:0007178,cell surface receptor protein serine/threonine kinase signaling pathway,7,0.0,1.0,1.0,2
5035,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,7,0.0,1.0,1.0,7
5036,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,7,0.0,1.0,1.0,6
5037,GO:0007213,G protein-coupled acetylcholine receptor signaling pathway,7,0.0,1.0,1.0,4
5038,GO:0007216,G protein-coupled glutamate receptor signaling pathway,7,0.0,1.0,1.0,2
5039,GO:0007263,nitric oxide mediated signal transduction,7,0.0,1.0,1.0,1
5040,GO:0007264,small GTPase-mediated signal transduction,7,0.0,1.0,1.0,9
5041,GO:0007347,regulation of preblastoderm mitotic cell cycle,7,0.0,1.0,1.0,2
5042,GO:0007348,regulation of syncytial blastoderm mitotic cell cycle,7,0.0,1.0,1.0,2
5043,GO:0007621,negative regulation of female receptivity,7,0.0,1.0,1.0,1
5044,GO:0008076,voltage-gated potassium channel complex,7,0.0,1.0,1.0,13
5045,GO:0008088,axo-dendritic transport,7,0.0,1.0,1.0,4
5046,GO:0008106,alcohol dehydrogenase (NADP+) activity,7,0.0,1.0,1.0,5
5047,GO:0008138,protein tyrosine/serine/threonine phosphatase activity,7,0.0,1.0,1.0,2
5048,GO:0008204,ergosterol metabolic process,7,0.0,1.0,1.0,1
5049,GO:0008205,ecdysone metabolic process,7,0.0,1.0,1.0,2
5050,GO:0008208,C21-steroid hormone catabolic process,7,0.0,1.0,1.0,2
5051,GO:0008253,5'-nucleotidase activity,7,0.0,1.0,1.0,5
5052,GO:0008263,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,7,0.0,1.0,1.0,2
5053,GO:0008306,associative learning,7,0.0,1.0,1.0,4
5054,GO:0008333,endosome to lysosome transport,7,0.0,1.0,1.0,3
5055,GO:0008348,negative regulation of antimicrobial humoral response,7,0.0,1.0,1.0,1
5056,GO:0008349,MAP kinase kinase kinase kinase activity,7,0.0,1.0,1.0,1
5057,GO:0008353,RNA polymerase II CTD heptapeptide repeat kinase activity,7,0.0,1.0,1.0,5
5058,GO:0008516,hexose uniporter activity,7,0.0,1.0,1.0,3
5059,GO:0008534,oxidized purine nucleobase lesion DNA N-glycosylase activity,7,0.0,1.0,1.0,1
5060,GO:0008535,respiratory chain complex IV assembly,7,0.0,1.0,1.0,2
5061,GO:0008559,ABC-type xenobiotic transporter activity,7,0.0,1.0,1.0,1
5062,GO:0008582,regulation of synaptic assembly at neuromuscular junction,7,0.0,1.0,1.0,2
5063,GO:0008611,ether lipid biosynthetic process,7,0.0,1.0,1.0,1
5064,GO:0008614,pyridoxine metabolic process,7,0.0,1.0,1.0,1
5065,GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,7,0.0,1.0,1.0,1
5066,GO:0008627,intrinsic apoptotic signaling pathway in response to osmotic stress,7,0.0,1.0,1.0,1
5067,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,7,0.0,1.0,1.0,1
5068,GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,7,0.0,1.0,1.0,2
5069,GO:0008645,hexose transmembrane transport,7,0.0,1.0,1.0,8
5070,GO:0009041,UMP/dUMP kinase activity,7,0.0,1.0,1.0,2
5071,GO:0009072,aromatic amino acid metabolic process,7,0.0,1.0,1.0,12
5072,GO:0009081,branched-chain amino acid metabolic process,7,0.0,1.0,1.0,6
5073,GO:0009117,nucleotide metabolic process,7,0.0,1.0,1.0,13
5074,GO:0009118,regulation of nucleoside metabolic process,7,0.0,1.0,1.0,2
5075,GO:0009119,ribonucleoside metabolic process,7,0.0,1.0,1.0,5
5076,GO:0009120,deoxyribonucleoside metabolic process,7,0.0,1.0,1.0,4
5077,GO:0009123,nucleoside monophosphate metabolic process,7,0.0,1.0,1.0,7
5078,GO:0009132,nucleoside diphosphate metabolic process,7,0.0,1.0,1.0,6
5079,GO:0009141,nucleoside triphosphate metabolic process,7,0.0,1.0,1.0,6
5080,GO:0009163,nucleoside biosynthetic process,7,0.0,1.0,1.0,6
5081,GO:0009164,nucleoside catabolic process,7,0.0,1.0,1.0,5
5082,GO:0009225,nucleotide-sugar metabolic process,7,0.0,1.0,1.0,22
5083,GO:0009236,cobalamin biosynthetic process,7,0.0,1.0,1.0,2
5084,GO:0009240,isopentenyl diphosphate biosynthetic process,7,0.0,1.0,1.0,2
5085,GO:0009247,glycolipid biosynthetic process,7,0.0,1.0,1.0,11
5086,GO:0009250,glucan biosynthetic process,7,0.0,1.0,1.0,7
5087,GO:0009251,glucan catabolic process,7,0.0,1.0,1.0,8
5088,GO:0009252,peptidoglycan biosynthetic process,7,0.0,1.0,1.0,1
5089,GO:0009306,protein secretion,7,0.0,1.0,1.0,19
5090,GO:0009401,phosphoenolpyruvate-dependent sugar phosphotransferase system,7,0.0,1.0,1.0,1
5091,GO:0009446,putrescine biosynthetic process,7,0.0,1.0,1.0,2
5092,GO:0009451,RNA modification,7,0.0,1.0,1.0,13
5093,GO:0009452,7-methylguanosine RNA capping,7,0.0,1.0,1.0,1
5094,GO:0009534,chloroplast thylakoid,7,0.0,1.0,1.0,2
5095,GO:0009547,plastid ribosome,7,0.0,1.0,1.0,1
5096,GO:0009693,ethylene biosynthetic process,7,0.0,1.0,1.0,1
5097,GO:0009700,indole phytoalexin biosynthetic process,7,0.0,1.0,1.0,1
5098,GO:0009708,benzyl isoquinoline alkaloid biosynthetic process,7,0.0,1.0,1.0,2
5099,GO:0009709,terpenoid indole alkaloid biosynthetic process,7,0.0,1.0,1.0,4
5100,GO:0009732,detection of hexose stimulus,7,0.0,1.0,1.0,1
5101,GO:0009740,gibberellic acid mediated signaling pathway,7,0.0,1.0,1.0,2
5102,GO:0009750,response to fructose,7,0.0,1.0,1.0,1
5103,GO:0009757,hexose mediated signaling,7,0.0,1.0,1.0,3
5104,GO:0009760,C4 photosynthesis,7,0.0,1.0,1.0,3
5105,GO:0009784,transmembrane receptor histidine kinase activity,7,0.0,1.0,1.0,1
5106,GO:0009827,plant-type cell wall modification,7,0.0,1.0,1.0,5
5107,GO:0009873,ethylene-activated signaling pathway,7,0.0,1.0,1.0,2
5108,GO:0009902,chloroplast relocation,7,0.0,1.0,1.0,2
5109,GO:0009931,calcium-dependent protein serine/threonine kinase activity,7,0.0,1.0,1.0,1
5110,GO:0009963,positive regulation of flavonoid biosynthetic process,7,0.0,1.0,1.0,2
5111,GO:0009964,negative regulation of flavonoid biosynthetic process,7,0.0,1.0,1.0,2
5112,GO:0009996,negative regulation of cell fate specification,7,0.0,1.0,1.0,12
5113,GO:0010029,regulation of seed germination,7,0.0,1.0,1.0,2
5114,GO:0010061,regulation of trichoblast fate specification,7,0.0,1.0,1.0,2
5115,GO:0010113,negative regulation of systemic acquired resistance,7,0.0,1.0,1.0,1
5116,GO:0010146,fructan biosynthetic process,7,0.0,1.0,1.0,1
5117,GO:0010147,fructan catabolic process,7,0.0,1.0,1.0,1
5118,GO:0010271,regulation of chlorophyll catabolic process,7,0.0,1.0,1.0,2
5119,GO:0010325,raffinose family oligosaccharide biosynthetic process,7,0.0,1.0,1.0,4
5120,GO:0010351,lithium ion transport,7,0.0,1.0,1.0,1
5121,GO:0010363,regulation of plant-type hypersensitive response,7,0.0,1.0,1.0,2
5122,GO:0010364,regulation of ethylene biosynthetic process,7,0.0,1.0,1.0,2
5123,GO:0010380,regulation of chlorophyll biosynthetic process,7,0.0,1.0,1.0,2
5124,GO:0010384,cell wall proteoglycan metabolic process,7,0.0,1.0,1.0,1
5125,GO:0010391,glucomannan metabolic process,7,0.0,1.0,1.0,1
5126,GO:0010392,galactoglucomannan metabolic process,7,0.0,1.0,1.0,1
5127,GO:0010394,homogalacturonan metabolic process,7,0.0,1.0,1.0,3
5128,GO:0010396,rhamnogalacturonan II metabolic process,7,0.0,1.0,1.0,3
5129,GO:0010410,hemicellulose metabolic process,7,0.0,1.0,1.0,3
5130,GO:0010412,mannan metabolic process,7,0.0,1.0,1.0,4
5131,GO:0010498,proteasomal protein catabolic process,7,0.0,1.0,1.0,4
5132,GO:0010507,negative regulation of autophagy,7,0.0,1.0,1.0,3
5133,GO:0010508,positive regulation of autophagy,7,0.0,1.0,1.0,5
5134,GO:0010518,positive regulation of phospholipase activity,7,0.0,1.0,1.0,2
5135,GO:0010519,negative regulation of phospholipase activity,7,0.0,1.0,1.0,1
5136,GO:0010558,negative regulation of macromolecule biosynthetic process,7,0.0,1.0,1.0,14
5137,GO:0010586,miRNA metabolic process,7,0.0,1.0,1.0,2
5138,GO:0010595,positive regulation of endothelial cell migration,7,0.0,1.0,1.0,2
5139,GO:0010596,negative regulation of endothelial cell migration,7,0.0,1.0,1.0,2
5140,GO:0010600,regulation of auxin biosynthetic process,7,0.0,1.0,1.0,2
5141,GO:0010603,regulation of cytoplasmic mRNA processing body assembly,7,0.0,1.0,1.0,2
5142,GO:0010611,regulation of cardiac muscle hypertrophy,7,0.0,1.0,1.0,3
5143,GO:0010612,regulation of cardiac muscle adaptation,7,0.0,1.0,1.0,3
5144,GO:0010630,"regulation of transcription, start site selection",7,0.0,1.0,1.0,1
5145,GO:0010633,negative regulation of epithelial cell migration,7,0.0,1.0,1.0,2
5146,GO:0010634,positive regulation of epithelial cell migration,7,0.0,1.0,1.0,2
5147,GO:0010635,regulation of mitochondrial fusion,7,0.0,1.0,1.0,2
5148,GO:0010641,positive regulation of platelet-derived growth factor receptor signaling pathway,7,0.0,1.0,1.0,2
5149,GO:0010642,negative regulation of platelet-derived growth factor receptor signaling pathway,7,0.0,1.0,1.0,2
5150,GO:0010656,negative regulation of muscle cell apoptotic process,7,0.0,1.0,1.0,2
5151,GO:0010661,positive regulation of muscle cell apoptotic process,7,0.0,1.0,1.0,2
5152,GO:0010662,regulation of striated muscle cell apoptotic process,7,0.0,1.0,1.0,3
5153,GO:0010726,positive regulation of hydrogen peroxide metabolic process,7,0.0,1.0,1.0,2
5154,GO:0010727,negative regulation of hydrogen peroxide metabolic process,7,0.0,1.0,1.0,2
5155,GO:0010728,regulation of hydrogen peroxide biosynthetic process,7,0.0,1.0,1.0,2
5156,GO:0010738,regulation of protein kinase A signaling,7,0.0,1.0,1.0,1
5157,GO:0010749,regulation of nitric oxide mediated signal transduction,7,0.0,1.0,1.0,3
5158,GO:0010752,regulation of cGMP-mediated signaling,7,0.0,1.0,1.0,3
5159,GO:0010763,positive regulation of fibroblast migration,7,0.0,1.0,1.0,1
5160,GO:0010764,negative regulation of fibroblast migration,7,0.0,1.0,1.0,1
5161,GO:0010770,positive regulation of cell morphogenesis,7,0.0,1.0,1.0,4
5162,GO:0010771,negative regulation of cell morphogenesis,7,0.0,1.0,1.0,2
5163,GO:0010795,regulation of ubiquinone biosynthetic process,7,0.0,1.0,1.0,2
5164,GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,7,0.0,1.0,1.0,2
5165,GO:0010824,regulation of centrosome duplication,7,0.0,1.0,1.0,3
5166,GO:0010828,positive regulation of D-glucose transmembrane transport,7,0.0,1.0,1.0,1
5167,GO:0010829,negative regulation of D-glucose transmembrane transport,7,0.0,1.0,1.0,1
5168,GO:0010830,regulation of myotube differentiation,7,0.0,1.0,1.0,4
5169,GO:0010906,regulation of glucose metabolic process,7,0.0,1.0,1.0,6
5170,GO:0010913,regulation of sterigmatocystin biosynthetic process,7,0.0,1.0,1.0,2
5171,GO:0010969,regulation of pheromone-dependent signal transduction involved in conjugation with cellular fusion,7,0.0,1.0,1.0,2
5172,GO:0010975,regulation of neuron projection development,7,0.0,1.0,1.0,7
5173,GO:0014013,regulation of gliogenesis,7,0.0,1.0,1.0,2
5174,GO:0014041,regulation of neuron maturation,7,0.0,1.0,1.0,3
5175,GO:0014047,glutamate secretion,7,0.0,1.0,1.0,1
5176,GO:0014048,regulation of glutamate secretion,7,0.0,1.0,1.0,3
5177,GO:0014051,gamma-aminobutyric acid secretion,7,0.0,1.0,1.0,1
5178,GO:0014052,regulation of gamma-aminobutyric acid secretion,7,0.0,1.0,1.0,2
5179,GO:0014062,regulation of serotonin secretion,7,0.0,1.0,1.0,2
5180,GO:0014711,regulation of branchiomeric skeletal muscle development,7,0.0,1.0,1.0,2
5181,GO:0014725,regulation of extraocular skeletal muscle development,7,0.0,1.0,1.0,2
5182,GO:0014733,regulation of skeletal muscle adaptation,7,0.0,1.0,1.0,3
5183,GO:0014735,regulation of muscle atrophy,7,0.0,1.0,1.0,2
5184,GO:0014738,regulation of muscle hyperplasia,7,0.0,1.0,1.0,3
5185,GO:0014741,negative regulation of muscle hypertrophy,7,0.0,1.0,1.0,3
5186,GO:0014742,positive regulation of muscle hypertrophy,7,0.0,1.0,1.0,3
5187,GO:0014744,positive regulation of muscle adaptation,7,0.0,1.0,1.0,5
5188,GO:0014745,negative regulation of muscle adaptation,7,0.0,1.0,1.0,5
5189,GO:0014832,urinary bladder smooth muscle contraction,7,0.0,1.0,1.0,1
5190,GO:0014849,ureter smooth muscle contraction,7,0.0,1.0,1.0,1
5191,GO:0014911,positive regulation of smooth muscle cell migration,7,0.0,1.0,1.0,2
5192,GO:0014912,negative regulation of smooth muscle cell migration,7,0.0,1.0,1.0,2
5193,GO:0015080,silver ion transmembrane transporter activity,7,0.0,1.0,1.0,1
5194,GO:0015086,cadmium ion transmembrane transporter activity,7,0.0,1.0,1.0,2
5195,GO:0015087,cobalt ion transmembrane transporter activity,7,0.0,1.0,1.0,1
5196,GO:0015099,nickel cation transmembrane transporter activity,7,0.0,1.0,1.0,2
5197,GO:0015148,D-xylose transmembrane transporter activity,7,0.0,1.0,1.0,2
5198,GO:0015150,fucose transmembrane transporter activity,7,0.0,1.0,1.0,1
5199,GO:0015153,rhamnose transmembrane transporter activity,7,0.0,1.0,1.0,1
5200,GO:0015191,L-methionine transmembrane transporter activity,7,0.0,1.0,1.0,1
5201,GO:0015217,ADP transmembrane transporter activity,7,0.0,1.0,1.0,2
5202,GO:0015252,proton channel activity,7,0.0,1.0,1.0,2
5203,GO:0015276,ligand-gated monoatomic ion channel activity,7,0.0,1.0,1.0,9
5204,GO:0015295,solute:proton symporter activity,7,0.0,1.0,1.0,30
5205,GO:0015296,monoatomic anion:monoatomic cation symporter activity,7,0.0,1.0,1.0,2
5206,GO:0015315,organophosphate:phosphate antiporter activity,7,0.0,1.0,1.0,7
5207,GO:0015368,calcium:monoatomic cation antiporter activity,7,0.0,1.0,1.0,5
5208,GO:0015370,solute:sodium symporter activity,7,0.0,1.0,1.0,21
5209,GO:0015391,nucleobase:monoatomic cation symporter activity,7,0.0,1.0,1.0,3
5210,GO:0015417,ABC-type polyamine transporter activity,7,0.0,1.0,1.0,1
5211,GO:0015418,ABC-type quaternary ammonium compound transporting activity,7,0.0,1.0,1.0,1
5212,GO:0015424,ABC-type amino acid transporter activity,7,0.0,1.0,1.0,4
5213,GO:0015440,ABC-type peptide transporter activity,7,0.0,1.0,1.0,1
5214,GO:0015578,mannose transmembrane transporter activity,7,0.0,1.0,1.0,3
5215,GO:0015591,D-ribose transmembrane transporter activity,7,0.0,1.0,1.0,1
5216,GO:0015636,short-chain fatty acid transmembrane transporter activity,7,0.0,1.0,1.0,1
5217,GO:0015662,P-type ion transporter activity,7,0.0,1.0,1.0,12
5218,GO:0015666,restriction endodeoxyribonuclease activity,7,0.0,1.0,1.0,4
5219,GO:0015693,magnesium ion transport,7,0.0,1.0,1.0,1
5220,GO:0015706,nitrate transmembrane transport,7,0.0,1.0,1.0,1
5221,GO:0015714,phosphoenolpyruvate transport,7,0.0,1.0,1.0,1
5222,GO:0015721,bile acid and bile salt transport,7,0.0,1.0,1.0,1
5223,GO:0015724,formate transport,7,0.0,1.0,1.0,1
5224,GO:0015727,lactate transport,7,0.0,1.0,1.0,1
5225,GO:0015735,uronic acid transmembrane transport,7,0.0,1.0,1.0,1
5226,GO:0015740,C4-dicarboxylate transport,7,0.0,1.0,1.0,7
5227,GO:0015742,alpha-ketoglutarate transport,7,0.0,1.0,1.0,1
5228,GO:0015746,citrate transport,7,0.0,1.0,1.0,2
5229,GO:0015750,pentose transmembrane transport,7,0.0,1.0,1.0,3
5230,GO:0015759,beta-glucoside transport,7,0.0,1.0,1.0,2
5231,GO:0015768,maltose transport,7,0.0,1.0,1.0,1
5232,GO:0015770,sucrose transport,7,0.0,1.0,1.0,3
5233,GO:0015771,trehalose transport,7,0.0,1.0,1.0,1
5234,GO:0015808,L-alanine transport,7,0.0,1.0,1.0,1
5235,GO:0015811,L-cystine transport,7,0.0,1.0,1.0,1
5236,GO:0015816,glycine transport,7,0.0,1.0,1.0,3
5237,GO:0015818,isoleucine transport,7,0.0,1.0,1.0,1
5238,GO:0015820,L-leucine transport,7,0.0,1.0,1.0,1
5239,GO:0015821,methionine transport,7,0.0,1.0,1.0,2
5240,GO:0015825,L-serine transport,7,0.0,1.0,1.0,2
5241,GO:0015827,tryptophan transport,7,0.0,1.0,1.0,1
5242,GO:0015828,tyrosine transport,7,0.0,1.0,1.0,2
5243,GO:0015829,valine transport,7,0.0,1.0,1.0,1
5244,GO:0015853,adenine transport,7,0.0,1.0,1.0,1
5245,GO:0015854,guanine transport,7,0.0,1.0,1.0,1
5246,GO:0015857,uracil transport,7,0.0,1.0,1.0,1
5247,GO:0015864,pyrimidine nucleoside transport,7,0.0,1.0,1.0,2
5248,GO:0015865,purine nucleotide transport,7,0.0,1.0,1.0,3
5249,GO:0015872,dopamine transport,7,0.0,1.0,1.0,2
5250,GO:0015874,norepinephrine transport,7,0.0,1.0,1.0,2
5251,GO:0015876,acetyl-CoA transport,7,0.0,1.0,1.0,1
5252,GO:0015878,biotin transport,7,0.0,1.0,1.0,1
5253,GO:0015879,carnitine transport,7,0.0,1.0,1.0,2
5254,GO:0015883,FAD transport,7,0.0,1.0,1.0,1
5255,GO:0015884,folic acid transport,7,0.0,1.0,1.0,1
5256,GO:0015887,pantothenate transmembrane transport,7,0.0,1.0,1.0,1
5257,GO:0015890,nicotinamide mononucleotide transport,7,0.0,1.0,1.0,1
5258,GO:0015908,fatty acid transport,7,0.0,1.0,1.0,6
5259,GO:0015924,mannosyl-oligosaccharide mannosidase activity,7,0.0,1.0,1.0,4
5260,GO:0015936,coenzyme A metabolic process,7,0.0,1.0,1.0,2
5261,GO:0015948,methanogenesis,7,0.0,1.0,1.0,11
5262,GO:0016056,G protein-coupled opsin signaling pathway,7,0.0,1.0,1.0,2
5263,GO:0016071,mRNA metabolic process,7,0.0,1.0,1.0,7
5264,GO:0016072,rRNA metabolic process,7,0.0,1.0,1.0,3
5265,GO:0016073,snRNA metabolic process,7,0.0,1.0,1.0,3
5266,GO:0016074,sno(s)RNA metabolic process,7,0.0,1.0,1.0,5
5267,GO:0016094,polyprenol biosynthetic process,7,0.0,1.0,1.0,3
5268,GO:0016095,polyprenol catabolic process,7,0.0,1.0,1.0,2
5269,GO:0016098,monoterpenoid metabolic process,7,0.0,1.0,1.0,6
5270,GO:0016101,diterpenoid metabolic process,7,0.0,1.0,1.0,9
5271,GO:0016108,tetraterpenoid metabolic process,7,0.0,1.0,1.0,3
5272,GO:0016111,polyterpenoid metabolic process,7,0.0,1.0,1.0,2
5273,GO:0016114,terpenoid biosynthetic process,7,0.0,1.0,1.0,16
5274,GO:0016115,terpenoid catabolic process,7,0.0,1.0,1.0,8
5275,GO:0016119,carotene metabolic process,7,0.0,1.0,1.0,9
5276,GO:0016126,sterol biosynthetic process,7,0.0,1.0,1.0,4
5277,GO:0016127,sterol catabolic process,7,0.0,1.0,1.0,2
5278,GO:0016129,phytosteroid biosynthetic process,7,0.0,1.0,1.0,2
5279,GO:0016130,phytosteroid catabolic process,7,0.0,1.0,1.0,1
5280,GO:0016131,brassinosteroid metabolic process,7,0.0,1.0,1.0,2
5281,GO:0016135,saponin biosynthetic process,7,0.0,1.0,1.0,1
5282,GO:0016136,saponin catabolic process,7,0.0,1.0,1.0,1
5283,GO:0016189,synaptic vesicle to endosome fusion,7,0.0,1.0,1.0,1
5284,GO:0016241,regulation of macroautophagy,7,0.0,1.0,1.0,8
5285,GO:0016243,regulation of autophagosome size,7,0.0,1.0,1.0,2
5286,GO:0016274,protein-arginine N-methyltransferase activity,7,0.0,1.0,1.0,11
5287,GO:0016279,protein-lysine N-methyltransferase activity,7,0.0,1.0,1.0,11
5288,GO:0016300,tRNA (uridine) methyltransferase activity,7,0.0,1.0,1.0,8
5289,GO:0016312,inositol bisphosphate phosphatase activity,7,0.0,1.0,1.0,3
5290,GO:0016358,dendrite development,7,0.0,1.0,1.0,4
5291,GO:0016423,tRNA (guanine) methyltransferase activity,7,0.0,1.0,1.0,11
5292,GO:0016426,tRNA (adenine) methyltransferase activity,7,0.0,1.0,1.0,7
5293,GO:0016427,tRNA (cytidine) methyltransferase activity,7,0.0,1.0,1.0,6
5294,GO:0016433,rRNA (adenine) methyltransferase activity,7,0.0,1.0,1.0,5
5295,GO:0016434,rRNA (cytosine) methyltransferase activity,7,0.0,1.0,1.0,3
5296,GO:0016435,rRNA (guanine) methyltransferase activity,7,0.0,1.0,1.0,4
5297,GO:0016436,rRNA (uridine) methyltransferase activity,7,0.0,1.0,1.0,3
5298,GO:0016471,vacuolar proton-transporting V-type ATPase complex,7,0.0,1.0,1.0,1
5299,GO:0016476,regulation of embryonic cell shape,7,0.0,1.0,1.0,1
5300,GO:0016493,C-C chemokine receptor activity,7,0.0,1.0,1.0,4
5301,GO:0016494,C-X-C chemokine receptor activity,7,0.0,1.0,1.0,2
5302,GO:0016888,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters",7,0.0,1.0,1.0,9
5303,GO:0016889,"DNA endonuclease activity, producing 3'-phosphomonoesters",7,0.0,1.0,1.0,3
5304,GO:0016890,"site-specific endodeoxyribonuclease activity, specific for altered base",7,0.0,1.0,1.0,1
5305,GO:0016891,"RNA endonuclease activity, producing 5'-phosphomonoesters",7,0.0,1.0,1.0,14
5306,GO:0016892,"RNA endonuclease activity, producing 3'-phosphomonoesters",7,0.0,1.0,1.0,6
5307,GO:0016895,"DNA exonuclease activity, producing 5'-phosphomonoesters",7,0.0,1.0,1.0,6
5308,GO:0016896,"RNA exonuclease activity, producing 5'-phosphomonoesters",7,0.0,1.0,1.0,4
5309,GO:0017003,protein-heme linkage,7,0.0,1.0,1.0,3
5310,GO:0017007,protein-bilin linkage,7,0.0,1.0,1.0,5
5311,GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,7,0.0,1.0,1.0,2
5312,GO:0017038,protein import,7,0.0,1.0,1.0,1
5313,GO:0017062,respiratory chain complex III assembly,7,0.0,1.0,1.0,1
5314,GO:0017157,regulation of exocytosis,7,0.0,1.0,1.0,6
5315,GO:0018085,peptidyl-L-amino acid racemization,7,0.0,1.0,1.0,1
5316,GO:0018103,protein C-linked glycosylation,7,0.0,1.0,1.0,1
5317,GO:0018117,protein adenylylation,7,0.0,1.0,1.0,1
5318,GO:0018144,RNA-protein covalent cross-linking,7,0.0,1.0,1.0,1
5319,GO:0018177,protein uridylylation,7,0.0,1.0,1.0,1
5320,GO:0018190,protein octanoylation,7,0.0,1.0,1.0,1
5321,GO:0018194,peptidyl-alanine modification,7,0.0,1.0,1.0,2
5322,GO:0018195,peptidyl-arginine modification,7,0.0,1.0,1.0,4
5323,GO:0018197,peptidyl-aspartic acid modification,7,0.0,1.0,1.0,4
5324,GO:0018198,peptidyl-cysteine modification,7,0.0,1.0,1.0,14
5325,GO:0018199,peptidyl-glutamine modification,7,0.0,1.0,1.0,3
5326,GO:0018200,peptidyl-glutamic acid modification,7,0.0,1.0,1.0,6
5327,GO:0018201,peptidyl-glycine modification,7,0.0,1.0,1.0,4
5328,GO:0018202,peptidyl-histidine modification,7,0.0,1.0,1.0,6
5329,GO:0018205,peptidyl-lysine modification,7,0.0,1.0,1.0,17
5330,GO:0018206,peptidyl-methionine modification,7,0.0,1.0,1.0,1
5331,GO:0018207,peptidyl-phenylalanine modification,7,0.0,1.0,1.0,1
5332,GO:0018208,peptidyl-proline modification,7,0.0,1.0,1.0,4
5333,GO:0018209,peptidyl-serine modification,7,0.0,1.0,1.0,9
5334,GO:0018210,peptidyl-threonine modification,7,0.0,1.0,1.0,3
5335,GO:0018211,peptidyl-tryptophan modification,7,0.0,1.0,1.0,1
5336,GO:0018212,peptidyl-tyrosine modification,7,0.0,1.0,1.0,4
5337,GO:0018256,protein formylation,7,0.0,1.0,1.0,1
5338,GO:0018262,isopeptide cross-linking,7,0.0,1.0,1.0,1
5339,GO:0018280,protein S-linked glycosylation,7,0.0,1.0,1.0,1
5340,GO:0018289,molybdenum incorporation into metallo-sulfur cluster,7,0.0,1.0,1.0,1
5341,GO:0018321,protein glucuronylation,7,0.0,1.0,1.0,1
5342,GO:0018345,protein palmitoylation,7,0.0,1.0,1.0,2
5343,GO:0018377,protein myristoylation,7,0.0,1.0,1.0,1
5344,GO:0018410,C-terminal protein amino acid modification,7,0.0,1.0,1.0,3
5345,GO:0018414,nickel incorporation into metallo-sulfur cluster,7,0.0,1.0,1.0,1
5346,GO:0018427,copper incorporation into metallo-sulfur cluster,7,0.0,1.0,1.0,1
5347,GO:0018872,arsonoacetate metabolic process,7,0.0,1.0,1.0,1
5348,GO:0018877,"beta-1,2,3,4,5,6-hexachlorocyclohexane metabolic process",7,0.0,1.0,1.0,1
5349,GO:0018963,phthalate metabolic process,7,0.0,1.0,1.0,1
5350,GO:0018974,"2,4,6-trinitrotoluene metabolic process",7,0.0,1.0,1.0,2
5351,GO:0019049,virus-mediated perturbation of host defense response,7,0.0,1.0,1.0,4
5352,GO:0019065,receptor-mediated endocytosis of virus by host cell,7,0.0,1.0,1.0,2
5353,GO:0019094,pole plasm mRNA localization,7,0.0,1.0,1.0,1
5354,GO:0019136,deoxynucleoside kinase activity,7,0.0,1.0,1.0,4
5355,GO:0019194,sorbose transmembrane transporter activity,7,0.0,1.0,1.0,1
5356,GO:0019198,transmembrane receptor protein phosphatase activity,7,0.0,1.0,1.0,1
5357,GO:0019217,regulation of fatty acid metabolic process,7,0.0,1.0,1.0,9
5358,GO:0019218,regulation of steroid metabolic process,7,0.0,1.0,1.0,8
5359,GO:0019229,regulation of vasoconstriction,7,0.0,1.0,1.0,5
5360,GO:0019299,rhamnose metabolic process,7,0.0,1.0,1.0,2
5361,GO:0019311,sorbose metabolic process,7,0.0,1.0,1.0,3
5362,GO:0019314,D-allose metabolic process,7,0.0,1.0,1.0,2
5363,GO:0019319,hexose biosynthetic process,7,0.0,1.0,1.0,8
5364,GO:0019320,hexose catabolic process,7,0.0,1.0,1.0,8
5365,GO:0019322,pentose biosynthetic process,7,0.0,1.0,1.0,4
5366,GO:0019323,pentose catabolic process,7,0.0,1.0,1.0,4
5367,GO:0019348,dolichol metabolic process,7,0.0,1.0,1.0,1
5368,GO:0019381,atrazine catabolic process,7,0.0,1.0,1.0,3
5369,GO:0019401,alditol biosynthetic process,7,0.0,1.0,1.0,4
5370,GO:0019405,alditol catabolic process,7,0.0,1.0,1.0,3
5371,GO:0019434,sophorosyloxydocosanoate metabolic process,7,0.0,1.0,1.0,2
5372,GO:0019519,pentitol metabolic process,7,0.0,1.0,1.0,5
5373,GO:0019532,oxalate transport,7,0.0,1.0,1.0,1
5374,GO:0019539,hydroxymate-containing siderophore biosynthetic process,7,0.0,1.0,1.0,1
5375,GO:0019540,catechol-containing siderophore biosynthetic process,7,0.0,1.0,1.0,1
5376,GO:0019566,arabinose metabolic process,7,0.0,1.0,1.0,4
5377,GO:0019646,aerobic electron transport chain,7,0.0,1.0,1.0,4
5378,GO:0019706,protein-cysteine S-palmitoyltransferase activity,7,0.0,1.0,1.0,1
5379,GO:0019722,calcium-mediated signaling,7,0.0,1.0,1.0,4
5380,GO:0019730,antimicrobial humoral response,7,0.0,1.0,1.0,3
5381,GO:0019747,regulation of isoprenoid metabolic process,7,0.0,1.0,1.0,13
5382,GO:0019756,cyanogenic glycoside biosynthetic process,7,0.0,1.0,1.0,2
5383,GO:0019761,glucosinolate biosynthetic process,7,0.0,1.0,1.0,4
5384,GO:0019762,glucosinolate catabolic process,7,0.0,1.0,1.0,1
5385,GO:0019852,L-ascorbic acid metabolic process,7,0.0,1.0,1.0,3
5386,GO:0019934,cGMP-mediated signaling,7,0.0,1.0,1.0,1
5387,GO:0019941,modification-dependent protein catabolic process,7,0.0,1.0,1.0,3
5388,GO:0021799,cerebral cortex radially oriented cell migration,7,0.0,1.0,1.0,2
5389,GO:0021800,cerebral cortex tangential migration,7,0.0,1.0,1.0,1
5390,GO:0021815,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,7,0.0,1.0,1.0,1
5391,GO:0021843,substrate-independent telencephalic tangential interneuron migration,7,0.0,1.0,1.0,2
5392,GO:0021910,smoothened signaling pathway involved in ventral spinal cord patterning,7,0.0,1.0,1.0,2
5393,GO:0022001,negative regulation of anterior neural cell fate commitment of the neural plate,7,0.0,1.0,1.0,1
5394,GO:0022400,regulation of opsin-mediated signaling pathway,7,0.0,1.0,1.0,1
5395,GO:0022401,negative adaptation of signaling pathway,7,0.0,1.0,1.0,3
5396,GO:0022616,DNA strand elongation,7,0.0,1.0,1.0,2
5397,GO:0022821,solute:potassium antiporter activity,7,0.0,1.0,1.0,2
5398,GO:0022835,transmitter-gated channel activity,7,0.0,1.0,1.0,1
5399,GO:0022839,monoatomic ion-gated channel activity,7,0.0,1.0,1.0,3
5400,GO:0023021,termination of signal transduction,7,0.0,1.0,1.0,3
5401,GO:0030032,lamellipodium assembly,7,0.0,1.0,1.0,1
5402,GO:0030042,actin filament depolymerization,7,0.0,1.0,1.0,1
5403,GO:0030047,actin modification,7,0.0,1.0,1.0,1
5404,GO:0030050,vesicle transport along actin filament,7,0.0,1.0,1.0,1
5405,GO:0030133,transport vesicle,7,0.0,1.0,1.0,8
5406,GO:0030135,coated vesicle,7,0.0,1.0,1.0,3
5407,GO:0030139,endocytic vesicle,7,0.0,1.0,1.0,4
5408,GO:0030148,sphingolipid biosynthetic process,7,0.0,1.0,1.0,7
5409,GO:0030149,sphingolipid catabolic process,7,0.0,1.0,1.0,6
5410,GO:0030162,regulation of proteolysis,7,0.0,1.0,1.0,6
5411,GO:0030167,proteoglycan catabolic process,7,0.0,1.0,1.0,1
5412,GO:0030177,positive regulation of Wnt signaling pathway,7,0.0,1.0,1.0,2
5413,GO:0030178,negative regulation of Wnt signaling pathway,7,0.0,1.0,1.0,3
5414,GO:0030183,B cell differentiation,7,0.0,1.0,1.0,2
5415,GO:0030193,regulation of blood coagulation,7,0.0,1.0,1.0,6
5416,GO:0030201,heparan sulfate proteoglycan metabolic process,7,0.0,1.0,1.0,1
5417,GO:0030202,heparin metabolic process,7,0.0,1.0,1.0,2
5418,GO:0030204,chondroitin sulfate metabolic process,7,0.0,1.0,1.0,2
5419,GO:0030212,hyaluronan metabolic process,7,0.0,1.0,1.0,2
5420,GO:0030217,T cell differentiation,7,0.0,1.0,1.0,8
5421,GO:0030330,"DNA damage response, signal transduction by p53 class mediator",7,0.0,1.0,1.0,2
5422,GO:0030393,fructoselysine metabolic process,7,0.0,1.0,1.0,2
5423,GO:0030432,peristalsis,7,0.0,1.0,1.0,1
5424,GO:0030451,"regulation of complement activation, alternative pathway",7,0.0,1.0,1.0,2
5425,GO:0030491,heteroduplex formation,7,0.0,1.0,1.0,1
5426,GO:0030494,bacteriochlorophyll biosynthetic process,7,0.0,1.0,1.0,2
5427,GO:0030501,positive regulation of bone mineralization,7,0.0,1.0,1.0,1
5428,GO:0030502,negative regulation of bone mineralization,7,0.0,1.0,1.0,1
5429,GO:0030510,regulation of BMP signaling pathway,7,0.0,1.0,1.0,2
5430,GO:0030516,regulation of axon extension,7,0.0,1.0,1.0,4
5431,GO:0030581,symbiont intracellular protein transport in host,7,0.0,1.0,1.0,1
5432,GO:0030648,aminoglycoside antibiotic biosynthetic process,7,0.0,1.0,1.0,7
5433,GO:0030649,aminoglycoside antibiotic catabolic process,7,0.0,1.0,1.0,6
5434,GO:0030663,COPI-coated vesicle membrane,7,0.0,1.0,1.0,2
5435,GO:0030665,clathrin-coated vesicle membrane,7,0.0,1.0,1.0,6
5436,GO:0030670,phagocytic vesicle membrane,7,0.0,1.0,1.0,3
5437,GO:0030682,symbiont-mediated perturbation of host defenses,7,0.0,1.0,1.0,2
5438,GO:0030704,vitelline membrane formation,7,0.0,1.0,1.0,1
5439,GO:0030839,regulation of intermediate filament polymerization,7,0.0,1.0,1.0,2
5440,GO:0030842,regulation of intermediate filament depolymerization,7,0.0,1.0,1.0,2
5441,GO:0030864,cortical actin cytoskeleton,7,0.0,1.0,1.0,1
5442,GO:0030866,cortical actin cytoskeleton organization,7,0.0,1.0,1.0,4
5443,GO:0030908,protein splicing,7,0.0,1.0,1.0,2
5444,GO:0030951,establishment or maintenance of microtubule cytoskeleton polarity,7,0.0,1.0,1.0,1
5445,GO:0030971,receptor tyrosine kinase binding,7,0.0,1.0,1.0,1
5446,GO:0030974,thiamine pyrophosphate transmembrane transport,7,0.0,1.0,1.0,1
5447,GO:0030978,alpha-glucan metabolic process,7,0.0,1.0,1.0,5
5448,GO:0031032,actomyosin structure organization,7,0.0,1.0,1.0,7
5449,GO:0031033,myosin filament organization,7,0.0,1.0,1.0,3
5450,GO:0031054,pre-miRNA processing,7,0.0,1.0,1.0,1
5451,GO:0031102,neuron projection regeneration,7,0.0,1.0,1.0,2
5452,GO:0031106,septin ring organization,7,0.0,1.0,1.0,3
5453,GO:0031109,microtubule polymerization or depolymerization,7,0.0,1.0,1.0,2
5454,GO:0031121,equatorial microtubule organization,7,0.0,1.0,1.0,1
5455,GO:0031122,cytoplasmic microtubule organization,7,0.0,1.0,1.0,3
5456,GO:0031140,induction of conjugation upon nutrient starvation,7,0.0,1.0,1.0,2
5457,GO:0031157,regulation of aggregate size involved in sorocarp development,7,0.0,1.0,1.0,2
5458,GO:0031269,pseudopodium assembly,7,0.0,1.0,1.0,2
5459,GO:0031270,pseudopodium retraction,7,0.0,1.0,1.0,1
5460,GO:0031293,membrane protein intracellular domain proteolysis,7,0.0,1.0,1.0,1
5461,GO:0031336,negative regulation of sulfur amino acid metabolic process,7,0.0,1.0,1.0,3
5462,GO:0031337,positive regulation of sulfur amino acid metabolic process,7,0.0,1.0,1.0,3
5463,GO:0031339,negative regulation of vesicle fusion,7,0.0,1.0,1.0,5
5464,GO:0031340,positive regulation of vesicle fusion,7,0.0,1.0,1.0,6
5465,GO:0031363,N-terminal protein amino acid deamination,7,0.0,1.0,1.0,2
5466,GO:0031399,regulation of protein modification process,7,0.0,1.0,1.0,16
5467,GO:0031407,oxylipin metabolic process,7,0.0,1.0,1.0,1
5468,GO:0031506,cell wall glycoprotein biosynthetic process,7,0.0,1.0,1.0,1
5469,GO:0031538,negative regulation of anthocyanin metabolic process,7,0.0,1.0,1.0,2
5470,GO:0031539,positive regulation of anthocyanin metabolic process,7,0.0,1.0,1.0,2
5471,GO:0031540,regulation of anthocyanin biosynthetic process,7,0.0,1.0,1.0,2
5472,GO:0031623,receptor internalization,7,0.0,1.0,1.0,6
5473,GO:0031630,regulation of synaptic vesicle fusion to presynaptic active zone membrane,7,0.0,1.0,1.0,3
5474,GO:0031634,replication fork barrier binding,7,0.0,1.0,1.0,2
5475,GO:0031638,zymogen activation,7,0.0,1.0,1.0,4
5476,GO:0031665,negative regulation of lipopolysaccharide-mediated signaling pathway,7,0.0,1.0,1.0,1
5477,GO:0031901,early endosome membrane,7,0.0,1.0,1.0,1
5478,GO:0031902,late endosome membrane,7,0.0,1.0,1.0,1
5479,GO:0031955,short-chain fatty acid-CoA ligase activity,7,0.0,1.0,1.0,2
5480,GO:0031956,medium-chain fatty acid-CoA ligase activity,7,0.0,1.0,1.0,1
5481,GO:0031991,regulation of actomyosin contractile ring contraction,7,0.0,1.0,1.0,1
5482,GO:0032006,regulation of TOR signaling,7,0.0,1.0,1.0,4
5483,GO:0032042,mitochondrial DNA metabolic process,7,0.0,1.0,1.0,5
5484,GO:0032052,bile acid binding,7,0.0,1.0,1.0,2
5485,GO:0032053,ciliary basal body organization,7,0.0,1.0,1.0,1
5486,GO:0032099,negative regulation of appetite,7,0.0,1.0,1.0,1
5487,GO:0032127,dense core granule membrane,7,0.0,1.0,1.0,1
5488,GO:0032135,DNA insertion or deletion binding,7,0.0,1.0,1.0,3
5489,GO:0032149,response to rhamnose,7,0.0,1.0,1.0,1
5490,GO:0032159,septin cap,7,0.0,1.0,1.0,2
5491,GO:0032160,septin filament array,7,0.0,1.0,1.0,2
5492,GO:0032173,septin collar,7,0.0,1.0,1.0,2
5493,GO:0032176,split septin rings,7,0.0,1.0,1.0,1
5494,GO:0032202,telomere assembly,7,0.0,1.0,1.0,1
5495,GO:0032222,"regulation of synaptic transmission, cholinergic",7,0.0,1.0,1.0,3
5496,GO:0032225,"regulation of synaptic transmission, dopaminergic",7,0.0,1.0,1.0,2
5497,GO:0032228,"regulation of synaptic transmission, GABAergic",7,0.0,1.0,1.0,2
5498,GO:0032243,negative regulation of nucleoside transport,7,0.0,1.0,1.0,1
5499,GO:0032244,positive regulation of nucleoside transport,7,0.0,1.0,1.0,1
5500,GO:0032245,regulation of purine nucleoside transport,7,0.0,1.0,1.0,4
5501,GO:0032272,negative regulation of protein polymerization,7,0.0,1.0,1.0,4
5502,GO:0032273,positive regulation of protein polymerization,7,0.0,1.0,1.0,4
5503,GO:0032303,regulation of icosanoid secretion,7,0.0,1.0,1.0,4
5504,GO:0032309,icosanoid secretion,7,0.0,1.0,1.0,2
5505,GO:0032322,ubiquinone catabolic process,7,0.0,1.0,1.0,1
5506,GO:0032331,negative regulation of chondrocyte differentiation,7,0.0,1.0,1.0,1
5507,GO:0032332,positive regulation of chondrocyte differentiation,7,0.0,1.0,1.0,1
5508,GO:0032341,aldosterone metabolic process,7,0.0,1.0,1.0,2
5509,GO:0032353,negative regulation of hormone biosynthetic process,7,0.0,1.0,1.0,7
5510,GO:0032357,oxidized purine DNA binding,7,0.0,1.0,1.0,1
5511,GO:0032367,intracellular cholesterol transport,7,0.0,1.0,1.0,1
5512,GO:0032372,negative regulation of sterol transport,7,0.0,1.0,1.0,3
5513,GO:0032378,negative regulation of intracellular lipid transport,7,0.0,1.0,1.0,1
5514,GO:0032379,positive regulation of intracellular lipid transport,7,0.0,1.0,1.0,1
5515,GO:0032380,regulation of intracellular sterol transport,7,0.0,1.0,1.0,3
5516,GO:0032392,DNA geometric change,7,0.0,1.0,1.0,3
5517,GO:0032412,regulation of monoatomic ion transmembrane transporter activity,7,0.0,1.0,1.0,14
5518,GO:0032429,regulation of phospholipase A2 activity,7,0.0,1.0,1.0,2
5519,GO:0032438,melanosome organization,7,0.0,1.0,1.0,1
5520,GO:0032460,negative regulation of protein oligomerization,7,0.0,1.0,1.0,2
5521,GO:0032461,positive regulation of protein oligomerization,7,0.0,1.0,1.0,2
5522,GO:0032462,regulation of protein homooligomerization,7,0.0,1.0,1.0,3
5523,GO:0032466,negative regulation of cytokinesis,7,0.0,1.0,1.0,5
5524,GO:0032467,positive regulation of cytokinesis,7,0.0,1.0,1.0,4
5525,GO:0032469,endoplasmic reticulum calcium ion homeostasis,7,0.0,1.0,1.0,3
5526,GO:0032511,late endosome to vacuole transport via multivesicular body sorting pathway,7,0.0,1.0,1.0,1
5527,GO:0032530,regulation of microvillus organization,7,0.0,1.0,1.0,3
5528,GO:0032558,adenyl deoxyribonucleotide binding,7,0.0,1.0,1.0,3
5529,GO:0032559,adenyl ribonucleotide binding,7,0.0,1.0,1.0,8
5530,GO:0032560,guanyl deoxyribonucleotide binding,7,0.0,1.0,1.0,3
5531,GO:0032561,guanyl ribonucleotide binding,7,0.0,1.0,1.0,8
5532,GO:0032602,chemokine production,7,0.0,1.0,1.0,22
5533,GO:0032606,type I interferon production,7,0.0,1.0,1.0,7
5534,GO:0032612,interleukin-1 production,7,0.0,1.0,1.0,2
5535,GO:0032620,interleukin-17 production,7,0.0,1.0,1.0,2
5536,GO:0032774,RNA biosynthetic process,7,0.0,1.0,1.0,10
5537,GO:0032806,carboxy-terminal domain protein kinase complex,7,0.0,1.0,1.0,3
5538,GO:0032814,regulation of natural killer cell activation,7,0.0,1.0,1.0,4
5539,GO:0032881,regulation of polysaccharide metabolic process,7,0.0,1.0,1.0,16
5540,GO:0032888,regulation of mitotic spindle elongation,7,0.0,1.0,1.0,3
5541,GO:0032889,"regulation of vacuole fusion, non-autophagic",7,0.0,1.0,1.0,2
5542,GO:0032925,regulation of activin receptor signaling pathway,7,0.0,1.0,1.0,3
5543,GO:0032928,regulation of superoxide anion generation,7,0.0,1.0,1.0,2
5544,GO:0032945,negative regulation of mononuclear cell proliferation,7,0.0,1.0,1.0,1
5545,GO:0032946,positive regulation of mononuclear cell proliferation,7,0.0,1.0,1.0,1
5546,GO:0032956,regulation of actin cytoskeleton organization,7,0.0,1.0,1.0,6
5547,GO:0032957,inositol trisphosphate metabolic process,7,0.0,1.0,1.0,1
5548,GO:0032958,inositol phosphate biosynthetic process,7,0.0,1.0,1.0,2
5549,GO:0032971,regulation of muscle filament sliding,7,0.0,1.0,1.0,4
5550,GO:0033004,negative regulation of mast cell activation,7,0.0,1.0,1.0,1
5551,GO:0033005,positive regulation of mast cell activation,7,0.0,1.0,1.0,2
5552,GO:0033006,regulation of mast cell activation involved in immune response,7,0.0,1.0,1.0,2
5553,GO:0033025,regulation of mast cell apoptotic process,7,0.0,1.0,1.0,2
5554,GO:0033029,regulation of neutrophil apoptotic process,7,0.0,1.0,1.0,2
5555,GO:0033033,negative regulation of myeloid cell apoptotic process,7,0.0,1.0,1.0,4
5556,GO:0033034,positive regulation of myeloid cell apoptotic process,7,0.0,1.0,1.0,4
5557,GO:0033045,regulation of sister chromatid segregation,7,0.0,1.0,1.0,4
5558,GO:0033079,immature T cell proliferation,7,0.0,1.0,1.0,1
5559,GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,7,0.0,1.0,1.0,6
5560,GO:0033164,"glycolipid 1,6-alpha-mannosyltransferase activity",7,0.0,1.0,1.0,1
5561,GO:0033210,leptin-mediated signaling pathway,7,0.0,1.0,1.0,1
5562,GO:0033242,negative regulation of amine catabolic process,7,0.0,1.0,1.0,2
5563,GO:0033243,positive regulation of amine catabolic process,7,0.0,1.0,1.0,1
5564,GO:0033245,negative regulation of penicillin metabolic process,7,0.0,1.0,1.0,2
5565,GO:0033246,positive regulation of penicillin metabolic process,7,0.0,1.0,1.0,2
5566,GO:0033247,regulation of penicillin catabolic process,7,0.0,1.0,1.0,2
5567,GO:0033258,plastid DNA metabolic process,7,0.0,1.0,1.0,1
5568,GO:0033284,ATPase-coupled carboxylic acid transmembrane transporter activity,7,0.0,1.0,1.0,5
5569,GO:0033305,chlorophyll a biosynthetic process,7,0.0,1.0,1.0,2
5570,GO:0033321,homomethionine metabolic process,7,0.0,1.0,1.0,2
5571,GO:0033329,kaempferol O-glucoside metabolic process,7,0.0,1.0,1.0,1
5572,GO:0033331,ent-kaurene metabolic process,7,0.0,1.0,1.0,2
5573,GO:0033348,tetrose biosynthetic process,7,0.0,1.0,1.0,1
5574,GO:0033349,apiose metabolic process,7,0.0,1.0,1.0,1
5575,GO:0033367,protein localization to mast cell secretory granule,7,0.0,1.0,1.0,1
5576,GO:0033374,protein localization to T cell secretory granule,7,0.0,1.0,1.0,1
5577,GO:0033383,geranyl diphosphate metabolic process,7,0.0,1.0,1.0,1
5578,GO:0033385,geranylgeranyl diphosphate metabolic process,7,0.0,1.0,1.0,2
5579,GO:0033398,zeatin biosynthetic process,7,0.0,1.0,1.0,2
5580,GO:0033399,cis-zeatin metabolic process,7,0.0,1.0,1.0,1
5581,GO:0033400,trans-zeatin metabolic process,7,0.0,1.0,1.0,1
5582,GO:0033517,myo-inositol hexakisphosphate metabolic process,7,0.0,1.0,1.0,1
5583,GO:0033519,phytyl diphosphate metabolic process,7,0.0,1.0,1.0,1
5584,GO:0033549,MAP kinase phosphatase activity,7,0.0,1.0,1.0,3
5585,GO:0033567,"DNA replication, Okazaki fragment processing",7,0.0,1.0,1.0,1
5586,GO:0033625,positive regulation of integrin activation,7,0.0,1.0,1.0,1
5587,GO:0033651,host cell plastid,7,0.0,1.0,1.0,1
5588,GO:0033865,nucleoside bisphosphate metabolic process,7,0.0,1.0,1.0,4
5589,GO:0034050,symbiont-induced defense-related programmed cell death,7,0.0,1.0,1.0,1
5590,GO:0034053,symbiont-mediated perturbation of host defense-related programmed cell death,7,0.0,1.0,1.0,2
5591,GO:0034069,aminoglycoside N-acetyltransferase activity,7,0.0,1.0,1.0,4
5592,GO:0034111,negative regulation of homotypic cell-cell adhesion,7,0.0,1.0,1.0,2
5593,GO:0034112,positive regulation of homotypic cell-cell adhesion,7,0.0,1.0,1.0,2
5594,GO:0034115,negative regulation of heterotypic cell-cell adhesion,7,0.0,1.0,1.0,1
5595,GO:0034116,positive regulation of heterotypic cell-cell adhesion,7,0.0,1.0,1.0,1
5596,GO:0034118,regulation of erythrocyte aggregation,7,0.0,1.0,1.0,2
5597,GO:0034212,peptide N-acetyltransferase activity,7,0.0,1.0,1.0,2
5598,GO:0034252,negative regulation of amide catabolic process,7,0.0,1.0,1.0,1
5599,GO:0034253,positive regulation of amide catabolic process,7,0.0,1.0,1.0,1
5600,GO:0034254,regulation of urea catabolic process,7,0.0,1.0,1.0,2
5601,GO:0034312,diol biosynthetic process,7,0.0,1.0,1.0,9
5602,GO:0034313,diol catabolic process,7,0.0,1.0,1.0,6
5603,GO:0034333,adherens junction assembly,7,0.0,1.0,1.0,2
5604,GO:0034334,adherens junction maintenance,7,0.0,1.0,1.0,1
5605,GO:0034343,type III interferon production,7,0.0,1.0,1.0,3
5606,GO:0034351,negative regulation of glial cell apoptotic process,7,0.0,1.0,1.0,1
5607,GO:0034352,positive regulation of glial cell apoptotic process,7,0.0,1.0,1.0,1
5608,GO:0034377,plasma lipoprotein particle assembly,7,0.0,1.0,1.0,3
5609,GO:0034391,regulation of smooth muscle cell apoptotic process,7,0.0,1.0,1.0,3
5610,GO:0034453,microtubule anchoring,7,0.0,1.0,1.0,2
5611,GO:0034484,raffinose catabolic process,7,0.0,1.0,1.0,1
5612,GO:0034489,neutral amino acid transmembrane export from vacuole,7,0.0,1.0,1.0,1
5613,GO:0034490,basic amino acid transmembrane import into vacuole,7,0.0,1.0,1.0,3
5614,GO:0034491,neutral amino acid transmembrane import into vacuole,7,0.0,1.0,1.0,2
5615,GO:0034585,21U-RNA metabolic process,7,0.0,1.0,1.0,1
5616,GO:0034593,phosphatidylinositol bisphosphate phosphatase activity,7,0.0,1.0,1.0,3
5617,GO:0034594,phosphatidylinositol trisphosphate phosphatase activity,7,0.0,1.0,1.0,3
5618,GO:0034595,phosphatidylinositol phosphate 5-phosphatase activity,7,0.0,1.0,1.0,4
5619,GO:0034596,phosphatidylinositol phosphate 4-phosphatase activity,7,0.0,1.0,1.0,3
5620,GO:0034644,cellular response to UV,7,0.0,1.0,1.0,5
5621,GO:0034650,cortisol metabolic process,7,0.0,1.0,1.0,1
5622,GO:0034659,isopropylmalate transport,7,0.0,1.0,1.0,1
5623,GO:0034756,regulation of iron ion transport,7,0.0,1.0,1.0,3
5624,GO:0034766,negative regulation of monoatomic ion transmembrane transport,7,0.0,1.0,1.0,3
5625,GO:0034767,positive regulation of monoatomic ion transmembrane transport,7,0.0,1.0,1.0,3
5626,GO:0034769,basement membrane disassembly,7,0.0,1.0,1.0,1
5627,GO:0034982,mitochondrial protein processing,7,0.0,1.0,1.0,1
5628,GO:0035007,regulation of melanization defense response,7,0.0,1.0,1.0,3
5629,GO:0035081,induction of programmed cell death by hormones,7,0.0,1.0,1.0,1
5630,GO:0035203,regulation of lamellocyte differentiation,7,0.0,1.0,1.0,2
5631,GO:0035235,ionotropic glutamate receptor signaling pathway,7,0.0,1.0,1.0,3
5632,GO:0035259,nuclear glucocorticoid receptor binding,7,0.0,1.0,1.0,1
5633,GO:0035268,protein mannosylation,7,0.0,1.0,1.0,3
5634,GO:0035303,regulation of dephosphorylation,7,0.0,1.0,1.0,4
5635,GO:0035330,regulation of hippo signaling,7,0.0,1.0,1.0,2
5636,GO:0035335,peptidyl-tyrosine dephosphorylation,7,0.0,1.0,1.0,1
5637,GO:0035349,coenzyme A transmembrane transport,7,0.0,1.0,1.0,1
5638,GO:0035358,regulation of peroxisome proliferator activated receptor signaling pathway,7,0.0,1.0,1.0,2
5639,GO:0035381,ATP-gated ion channel activity,7,0.0,1.0,1.0,3
5640,GO:0035387,negative regulation of Roundabout signaling pathway,7,0.0,1.0,1.0,1
5641,GO:0035435,phosphate ion transmembrane transport,7,0.0,1.0,1.0,3
5642,GO:0035445,borate transmembrane transport,7,0.0,1.0,1.0,1
5643,GO:0035498,carnosine metabolic process,7,0.0,1.0,1.0,1
5644,GO:0035524,proline transmembrane transport,7,0.0,1.0,1.0,2
5645,GO:0035567,non-canonical Wnt signaling pathway,7,0.0,1.0,1.0,5
5646,GO:0035588,G protein-coupled purinergic receptor signaling pathway,7,0.0,1.0,1.0,1
5647,GO:0035674,tricarboxylic acid transmembrane transport,7,0.0,1.0,1.0,1
5648,GO:0035710,"CD4-positive, alpha-beta T cell activation",7,0.0,1.0,1.0,4
5649,GO:0035813,regulation of renal sodium excretion,7,0.0,1.0,1.0,2
5650,GO:0035883,enteroendocrine cell differentiation,7,0.0,1.0,1.0,6
5651,GO:0035918,negative regulation of voltage-gated calcium channel activity in another organism,7,0.0,1.0,1.0,2
5652,GO:0035977,protein deglycosylation involved in glycoprotein catabolic process,7,0.0,1.0,1.0,1
5653,GO:0036037,"CD8-positive, alpha-beta T cell activation",7,0.0,1.0,1.0,2
5654,GO:0036046,protein demalonylation,7,0.0,1.0,1.0,1
5655,GO:0036048,protein desuccinylation,7,0.0,1.0,1.0,1
5656,GO:0036058,filtration diaphragm assembly,7,0.0,1.0,1.0,2
5657,GO:0036067,light-dependent chlorophyll biosynthetic process,7,0.0,1.0,1.0,1
5658,GO:0036068,light-independent chlorophyll biosynthetic process,7,0.0,1.0,1.0,1
5659,GO:0036089,cleavage furrow formation,7,0.0,1.0,1.0,1
5660,GO:0036090,cleavage furrow ingression,7,0.0,1.0,1.0,1
5661,GO:0036107,4-amino-4-deoxy-alpha-L-arabinopyranosyl undecaprenyl phosphate metabolic process,7,0.0,1.0,1.0,1
5662,GO:0036155,acylglycerol acyl-chain remodeling,7,0.0,1.0,1.0,2
5663,GO:0036196,zymosterol metabolic process,7,0.0,1.0,1.0,1
5664,GO:0036257,multivesicular body organization,7,0.0,1.0,1.0,1
5665,GO:0036388,pre-replicative complex assembly,7,0.0,1.0,1.0,1
5666,GO:0036484,trunk neural crest cell migration,7,0.0,1.0,1.0,2
5667,GO:0036507,protein demannosylation,7,0.0,1.0,1.0,1
5668,GO:0038093,Fc receptor signaling pathway,7,0.0,1.0,1.0,2
5669,GO:0039519,modulation by virus of host autophagy,7,0.0,1.0,1.0,2
5670,GO:0039588,symbiont-mediated suppression of host antigen processing and presentation,7,0.0,1.0,1.0,2
5671,GO:0039636,suppression by virus of host cell wall biogenesis,7,0.0,1.0,1.0,1
5672,GO:0040020,regulation of meiotic nuclear division,7,0.0,1.0,1.0,3
5673,GO:0040037,negative regulation of fibroblast growth factor receptor signaling pathway,7,0.0,1.0,1.0,2
5674,GO:0042051,compound eye photoreceptor development,7,0.0,1.0,1.0,5
5675,GO:0042053,regulation of dopamine metabolic process,7,0.0,1.0,1.0,3
5676,GO:0042058,regulation of epidermal growth factor receptor signaling pathway,7,0.0,1.0,1.0,3
5677,GO:0042073,intraciliary transport,7,0.0,1.0,1.0,3
5678,GO:0042076,protein phosphate-linked glycosylation,7,0.0,1.0,1.0,1
5679,GO:0042120,alginic acid metabolic process,7,0.0,1.0,1.0,3
5680,GO:0042138,meiotic DNA double-strand break formation,7,0.0,1.0,1.0,2
5681,GO:0042148,DNA strand invasion,7,0.0,1.0,1.0,1
5682,GO:0042161,lipoprotein oxidation,7,0.0,1.0,1.0,1
5683,GO:0042176,regulation of protein catabolic process,7,0.0,1.0,1.0,11
5684,GO:0042244,spore wall assembly,7,0.0,1.0,1.0,3
5685,GO:0042255,ribosome assembly,7,0.0,1.0,1.0,2
5686,GO:0042278,purine nucleoside metabolic process,7,0.0,1.0,1.0,5
5687,GO:0042310,vasoconstriction,7,0.0,1.0,1.0,7
5688,GO:0042311,vasodilation,7,0.0,1.0,1.0,8
5689,GO:0042320,"regulation of circadian sleep/wake cycle, REM sleep",7,0.0,1.0,1.0,2
5690,GO:0042321,"negative regulation of circadian sleep/wake cycle, sleep",7,0.0,1.0,1.0,2
5691,GO:0042325,regulation of phosphorylation,7,0.0,1.0,1.0,4
5692,GO:0042339,keratan sulfate metabolic process,7,0.0,1.0,1.0,2
5693,GO:0042343,indole glucosinolate metabolic process,7,0.0,1.0,1.0,2
5694,GO:0042357,thiamine diphosphate metabolic process,7,0.0,1.0,1.0,3
5695,GO:0042368,vitamin D biosynthetic process,7,0.0,1.0,1.0,2
5696,GO:0042369,vitamin D catabolic process,7,0.0,1.0,1.0,1
5697,GO:0042371,vitamin K biosynthetic process,7,0.0,1.0,1.0,1
5698,GO:0042374,phylloquinone metabolic process,7,0.0,1.0,1.0,2
5699,GO:0042377,vitamin K catabolic process,7,0.0,1.0,1.0,1
5700,GO:0042414,epinephrine metabolic process,7,0.0,1.0,1.0,2
5701,GO:0042415,norepinephrine metabolic process,7,0.0,1.0,1.0,2
5702,GO:0042417,dopamine metabolic process,7,0.0,1.0,1.0,2
5703,GO:0042423,catecholamine biosynthetic process,7,0.0,1.0,1.0,3
5704,GO:0042424,catecholamine catabolic process,7,0.0,1.0,1.0,3
5705,GO:0042448,progesterone metabolic process,7,0.0,1.0,1.0,2
5706,GO:0042478,regulation of eye photoreceptor cell development,7,0.0,1.0,1.0,3
5707,GO:0042482,positive regulation of odontogenesis,7,0.0,1.0,1.0,1
5708,GO:0042483,negative regulation of odontogenesis,7,0.0,1.0,1.0,1
5709,GO:0042487,regulation of odontogenesis of dentin-containing tooth,7,0.0,1.0,1.0,2
5710,GO:0042547,cell wall modification involved in multidimensional cell growth,7,0.0,1.0,1.0,1
5711,GO:0042660,positive regulation of cell fate specification,7,0.0,1.0,1.0,4
5712,GO:0042686,regulation of cardioblast cell fate specification,7,0.0,1.0,1.0,1
5713,GO:0042724,thiamine-containing compound biosynthetic process,7,0.0,1.0,1.0,2
5714,GO:0042725,thiamine-containing compound catabolic process,7,0.0,1.0,1.0,2
5715,GO:0042732,D-xylose metabolic process,7,0.0,1.0,1.0,2
5716,GO:0042772,"DNA damage response, signal transduction resulting in transcription",7,0.0,1.0,1.0,1
5717,GO:0042817,pyridoxal metabolic process,7,0.0,1.0,1.0,1
5718,GO:0042818,pyridoxamine metabolic process,7,0.0,1.0,1.0,1
5719,GO:0042819,vitamin B6 biosynthetic process,7,0.0,1.0,1.0,3
5720,GO:0042820,vitamin B6 catabolic process,7,0.0,1.0,1.0,1
5721,GO:0042822,pyridoxal phosphate metabolic process,7,0.0,1.0,1.0,2
5722,GO:0042844,glycol metabolic process,7,0.0,1.0,1.0,4
5723,GO:0042857,chrysobactin metabolic process,7,0.0,1.0,1.0,2
5724,GO:0042860,achromobactin metabolic process,7,0.0,1.0,1.0,2
5725,GO:0042863,pyochelin metabolic process,7,0.0,1.0,1.0,2
5726,GO:0042868,antisense RNA metabolic process,7,0.0,1.0,1.0,2
5727,GO:0042869,aldarate transmembrane transport,7,0.0,1.0,1.0,3
5728,GO:0042873,aldonate transmembrane transport,7,0.0,1.0,1.0,5
5729,GO:0042883,cysteine transport,7,0.0,1.0,1.0,1
5730,GO:0042900,arabinose transmembrane transporter activity,7,0.0,1.0,1.0,2
5731,GO:0042914,colicin transport,7,0.0,1.0,1.0,1
5732,GO:0042941,D-alanine transmembrane transport,7,0.0,1.0,1.0,1
5733,GO:0042959,ABC-type alkanesulfonate transporter transporter activity,7,0.0,1.0,1.0,1
5734,GO:0042974,nuclear retinoic acid receptor binding,7,0.0,1.0,1.0,1
5735,GO:0043011,myeloid dendritic cell differentiation,7,0.0,1.0,1.0,2
5736,GO:0043031,negative regulation of macrophage activation,7,0.0,1.0,1.0,1
5737,GO:0043032,positive regulation of macrophage activation,7,0.0,1.0,1.0,1
5738,GO:0043047,single-stranded telomeric DNA binding,7,0.0,1.0,1.0,2
5739,GO:0043051,regulation of nematode pharyngeal pumping,7,0.0,1.0,1.0,2
5740,GO:0043122,regulation of canonical NF-kappaB signal transduction,7,0.0,1.0,1.0,2
5741,GO:0043155,"negative regulation of photosynthesis, light reaction",7,0.0,1.0,1.0,1
5742,GO:0043211,ABC-type carbohydrate transporter activity,7,0.0,1.0,1.0,5
5743,GO:0043255,regulation of carbohydrate biosynthetic process,7,0.0,1.0,1.0,8
5744,GO:0043266,regulation of potassium ion transport,7,0.0,1.0,1.0,3
5745,GO:0043277,apoptotic cell clearance,7,0.0,1.0,1.0,1
5746,GO:0043289,apocarotenoid biosynthetic process,7,0.0,1.0,1.0,2
5747,GO:0043290,apocarotenoid catabolic process,7,0.0,1.0,1.0,1
5748,GO:0043408,regulation of MAPK cascade,7,0.0,1.0,1.0,8
5749,GO:0043461,proton-transporting ATP synthase complex assembly,7,0.0,1.0,1.0,3
5750,GO:0043470,regulation of carbohydrate catabolic process,7,0.0,1.0,1.0,22
5751,GO:0043479,pigment accumulation in tissues in response to UV light,7,0.0,1.0,1.0,1
5752,GO:0043524,negative regulation of neuron apoptotic process,7,0.0,1.0,1.0,5
5753,GO:0043525,positive regulation of neuron apoptotic process,7,0.0,1.0,1.0,4
5754,GO:0043535,regulation of blood vessel endothelial cell migration,7,0.0,1.0,1.0,3
5755,GO:0043570,maintenance of DNA repeat elements,7,0.0,1.0,1.0,3
5756,GO:0043611,isoprene metabolic process,7,0.0,1.0,1.0,2
5757,GO:0043646,cephalosporin biosynthetic process,7,0.0,1.0,1.0,1
5758,GO:0043648,dicarboxylic acid metabolic process,7,0.0,1.0,1.0,24
5759,GO:0043658,host symbiosome,7,0.0,1.0,1.0,1
5760,GO:0043661,peribacteroid membrane,7,0.0,1.0,1.0,1
5761,GO:0043692,monoterpene metabolic process,7,0.0,1.0,1.0,5
5762,GO:0043733,DNA-3-methylbase glycosylase activity,7,0.0,1.0,1.0,2
5763,GO:0043893,acetate:monoatomic cation symporter activity,7,0.0,1.0,1.0,1
5764,GO:0043921,modulation by host of viral transcription,7,0.0,1.0,1.0,1
5765,GO:0043940,regulation of sexual sporulation resulting in formation of a cellular spore,7,0.0,1.0,1.0,6
5766,GO:0043944,negative regulation of asexual sporulation resulting in formation of a cellular spore,7,0.0,1.0,1.0,4
5767,GO:0043945,positive regulation of asexual sporulation resulting in formation of a cellular spore,7,0.0,1.0,1.0,4
5768,GO:0043949,regulation of cAMP-mediated signaling,7,0.0,1.0,1.0,2
5769,GO:0044090,positive regulation of vacuole organization,7,0.0,1.0,1.0,3
5770,GO:0044161,host cell cytoplasmic vesicle,7,0.0,1.0,1.0,1
5771,GO:0044165,host cell endoplasmic reticulum,7,0.0,1.0,1.0,2
5772,GO:0044174,host cell endosome,7,0.0,1.0,1.0,1
5773,GO:0044347,cell wall polysaccharide catabolic process,7,0.0,1.0,1.0,5
5774,GO:0044349,DNA excision,7,0.0,1.0,1.0,1
5775,GO:0044351,macropinocytosis,7,0.0,1.0,1.0,1
5776,GO:0044374,"sequence-specific DNA binding, bending",7,0.0,1.0,1.0,2
5777,GO:0044474,envenomation resulting in negative regulation of voltage-gated calcium channel activity in another organism,7,0.0,1.0,1.0,2
5778,GO:0044597,daunorubicin metabolic process,7,0.0,1.0,1.0,2
5779,GO:0044616,modulation of relaxation of muscle in another organism,7,0.0,1.0,1.0,1
5780,GO:0044659,viral release from host cell by cytolysis,7,0.0,1.0,1.0,4
5781,GO:0044769,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism",7,0.0,1.0,1.0,2
5782,GO:0044854,plasma membrane raft assembly,7,0.0,1.0,1.0,1
5783,GO:0044855,plasma membrane raft distribution,7,0.0,1.0,1.0,1
5784,GO:0044860,protein localization to plasma membrane raft,7,0.0,1.0,1.0,2
5785,GO:0044863,modulation by virus of host cell division,7,0.0,1.0,1.0,2
5786,GO:0044867,modulation by host of viral catalytic activity,7,0.0,1.0,1.0,1
5787,GO:0045005,DNA-templated DNA replication maintenance of fidelity,7,0.0,1.0,1.0,4
5788,GO:0045055,regulated exocytosis,7,0.0,1.0,1.0,5
5789,GO:0045087,innate immune response,7,0.0,1.0,1.0,14
5790,GO:0045089,positive regulation of innate immune response,7,0.0,1.0,1.0,13
5791,GO:0045109,intermediate filament organization,7,0.0,1.0,1.0,1
5792,GO:0045113,regulation of integrin biosynthetic process,7,0.0,1.0,1.0,3
5793,GO:0045141,meiotic telomere clustering,7,0.0,1.0,1.0,1
5794,GO:0045147,regulation of initiation of acetate catabolic process by acetate,7,0.0,1.0,1.0,2
5795,GO:0045188,"regulation of circadian sleep/wake cycle, non-REM sleep",7,0.0,1.0,1.0,2
5796,GO:0045332,phospholipid translocation,7,0.0,1.0,1.0,3
5797,GO:0045338,farnesyl diphosphate metabolic process,7,0.0,1.0,1.0,2
5798,GO:0045343,regulation of MHC class I biosynthetic process,7,0.0,1.0,1.0,2
5799,GO:0045346,regulation of MHC class II biosynthetic process,7,0.0,1.0,1.0,2
5800,GO:0045456,ecdysteroid biosynthetic process,7,0.0,1.0,1.0,1
5801,GO:0045477,regulation of nurse cell apoptotic process,7,0.0,1.0,1.0,2
5802,GO:0045488,pectin metabolic process,7,0.0,1.0,1.0,4
5803,GO:0045602,negative regulation of endothelial cell differentiation,7,0.0,1.0,1.0,2
5804,GO:0045603,positive regulation of endothelial cell differentiation,7,0.0,1.0,1.0,1
5805,GO:0045605,negative regulation of epidermal cell differentiation,7,0.0,1.0,1.0,2
5806,GO:0045606,positive regulation of epidermal cell differentiation,7,0.0,1.0,1.0,2
5807,GO:0045616,regulation of keratinocyte differentiation,7,0.0,1.0,1.0,2
5808,GO:0045632,negative regulation of mechanoreceptor differentiation,7,0.0,1.0,1.0,1
5809,GO:0045633,positive regulation of mechanoreceptor differentiation,7,0.0,1.0,1.0,1
5810,GO:0045635,negative regulation of melanocyte differentiation,7,0.0,1.0,1.0,2
5811,GO:0045636,positive regulation of melanocyte differentiation,7,0.0,1.0,1.0,2
5812,GO:0045637,regulation of myeloid cell differentiation,7,0.0,1.0,1.0,6
5813,GO:0045700,regulation of spermatid nuclear differentiation,7,0.0,1.0,1.0,2
5814,GO:0045743,positive regulation of fibroblast growth factor receptor signaling pathway,7,0.0,1.0,1.0,2
5815,GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,7,0.0,1.0,1.0,13
5816,GO:0045745,positive regulation of G protein-coupled receptor signaling pathway,7,0.0,1.0,1.0,11
5817,GO:0045746,negative regulation of Notch signaling pathway,7,0.0,1.0,1.0,1
5818,GO:0045754,positive regulation of acetate catabolic process,7,0.0,1.0,1.0,2
5819,GO:0045763,negative regulation of amino acid metabolic process,7,0.0,1.0,1.0,12
5820,GO:0045764,positive regulation of amino acid metabolic process,7,0.0,1.0,1.0,10
5821,GO:0045766,positive regulation of angiogenesis,7,0.0,1.0,1.0,3
5822,GO:0045806,negative regulation of endocytosis,7,0.0,1.0,1.0,6
5823,GO:0045807,positive regulation of endocytosis,7,0.0,1.0,1.0,6
5824,GO:0045822,negative regulation of heart contraction,7,0.0,1.0,1.0,4
5825,GO:0045823,positive regulation of heart contraction,7,0.0,1.0,1.0,3
5826,GO:0045824,negative regulation of innate immune response,7,0.0,1.0,1.0,11
5827,GO:0045833,negative regulation of lipid metabolic process,7,0.0,1.0,1.0,9
5828,GO:0045834,positive regulation of lipid metabolic process,7,0.0,1.0,1.0,8
5829,GO:0045879,negative regulation of smoothened signaling pathway,7,0.0,1.0,1.0,3
5830,GO:0045880,positive regulation of smoothened signaling pathway,7,0.0,1.0,1.0,1
5831,GO:0045912,negative regulation of carbohydrate metabolic process,7,0.0,1.0,1.0,33
5832,GO:0045913,positive regulation of carbohydrate metabolic process,7,0.0,1.0,1.0,26
5833,GO:0045914,negative regulation of catecholamine metabolic process,7,0.0,1.0,1.0,1
5834,GO:0045915,positive regulation of catecholamine metabolic process,7,0.0,1.0,1.0,1
5835,GO:0045916,negative regulation of complement activation,7,0.0,1.0,1.0,4
5836,GO:0045917,positive regulation of complement activation,7,0.0,1.0,1.0,4
5837,GO:0045925,positive regulation of female receptivity,7,0.0,1.0,1.0,1
5838,GO:0045932,negative regulation of muscle contraction,7,0.0,1.0,1.0,3
5839,GO:0045933,positive regulation of muscle contraction,7,0.0,1.0,1.0,2
5840,GO:0045934,negative regulation of nucleobase-containing compound metabolic process,7,0.0,1.0,1.0,15
5841,GO:0045935,positive regulation of nucleobase-containing compound metabolic process,7,0.0,1.0,1.0,14
5842,GO:0045936,negative regulation of phosphate metabolic process,7,0.0,1.0,1.0,14
5843,GO:0045937,positive regulation of phosphate metabolic process,7,0.0,1.0,1.0,12
5844,GO:0045938,"positive regulation of circadian sleep/wake cycle, sleep",7,0.0,1.0,1.0,2
5845,GO:0045976,"negative regulation of mitotic cell cycle, embryonic",7,0.0,1.0,1.0,2
5846,GO:0045977,"positive regulation of mitotic cell cycle, embryonic",7,0.0,1.0,1.0,2
5847,GO:0046008,"regulation of female receptivity, post-mating",7,0.0,1.0,1.0,2
5848,GO:0046030,inositol trisphosphate phosphatase activity,7,0.0,1.0,1.0,5
5849,GO:0046112,nucleobase biosynthetic process,7,0.0,1.0,1.0,2
5850,GO:0046113,nucleobase catabolic process,7,0.0,1.0,1.0,2
5851,GO:0046136,positive regulation of vitamin metabolic process,7,0.0,1.0,1.0,5
5852,GO:0046137,negative regulation of vitamin metabolic process,7,0.0,1.0,1.0,6
5853,GO:0046146,tetrahydrobiopterin metabolic process,7,0.0,1.0,1.0,2
5854,GO:0046151,eye pigment catabolic process,7,0.0,1.0,1.0,2
5855,GO:0046152,ommochrome metabolic process,7,0.0,1.0,1.0,2
5856,GO:0046154,rhodopsin metabolic process,7,0.0,1.0,1.0,1
5857,GO:0046246,terpene biosynthetic process,7,0.0,1.0,1.0,9
5858,GO:0046247,terpene catabolic process,7,0.0,1.0,1.0,6
5859,GO:0046260,trinitrotoluene catabolic process,7,0.0,1.0,1.0,1
5860,GO:0046324,regulation of D-glucose import,7,0.0,1.0,1.0,2
5861,GO:0046339,diacylglycerol metabolic process,7,0.0,1.0,1.0,3
5862,GO:0046341,CDP-diacylglycerol metabolic process,7,0.0,1.0,1.0,2
5863,GO:0046343,streptomycin metabolic process,7,0.0,1.0,1.0,1
5864,GO:0046344,ecdysteroid catabolic process,7,0.0,1.0,1.0,1
5865,GO:0046351,disaccharide biosynthetic process,7,0.0,1.0,1.0,5
5866,GO:0046352,disaccharide catabolic process,7,0.0,1.0,1.0,6
5867,GO:0046376,GDP-alpha-D-mannosylchitobiosyldiphosphodolichol metabolic process,7,0.0,1.0,1.0,1
5868,GO:0046395,carboxylic acid catabolic process,7,0.0,1.0,1.0,30
5869,GO:0046400,keto-3-deoxy-D-manno-octulosonic acid metabolic process,7,0.0,1.0,1.0,1
5870,GO:0046425,regulation of receptor signaling pathway via JAK-STAT,7,0.0,1.0,1.0,2
5871,GO:0046462,monoacylglycerol metabolic process,7,0.0,1.0,1.0,2
5872,GO:0046469,platelet activating factor metabolic process,7,0.0,1.0,1.0,2
5873,GO:0046471,phosphatidylglycerol metabolic process,7,0.0,1.0,1.0,4
5874,GO:0046488,phosphatidylinositol metabolic process,7,0.0,1.0,1.0,8
5875,GO:0046493,lipid A metabolic process,7,0.0,1.0,1.0,1
5876,GO:0046494,rhizobactin 1021 metabolic process,7,0.0,1.0,1.0,1
5877,GO:0046502,uroporphyrinogen III metabolic process,7,0.0,1.0,1.0,1
5878,GO:0046519,sphingoid metabolic process,7,0.0,1.0,1.0,6
5879,GO:0046533,negative regulation of photoreceptor cell differentiation,7,0.0,1.0,1.0,2
5880,GO:0046534,positive regulation of photoreceptor cell differentiation,7,0.0,1.0,1.0,3
5881,GO:0046627,negative regulation of insulin receptor signaling pathway,7,0.0,1.0,1.0,1
5882,GO:0046628,positive regulation of insulin receptor signaling pathway,7,0.0,1.0,1.0,1
5883,GO:0046630,gamma-delta T cell proliferation,7,0.0,1.0,1.0,1
5884,GO:0046633,alpha-beta T cell proliferation,7,0.0,1.0,1.0,4
5885,GO:0046672,positive regulation of compound eye retinal cell programmed cell death,7,0.0,1.0,1.0,1
5886,GO:0046777,protein autophosphorylation,7,0.0,1.0,1.0,5
5887,GO:0046813,receptor-mediated virion attachment to host cell,7,0.0,1.0,1.0,2
5888,GO:0046823,negative regulation of nucleocytoplasmic transport,7,0.0,1.0,1.0,5
5889,GO:0046824,positive regulation of nucleocytoplasmic transport,7,0.0,1.0,1.0,5
5890,GO:0046828,regulation of RNA import into nucleus,7,0.0,1.0,1.0,2
5891,GO:0046831,regulation of RNA export from nucleus,7,0.0,1.0,1.0,4
5892,GO:0046841,trisporic acid metabolic process,7,0.0,1.0,1.0,1
5893,GO:0046847,filopodium assembly,7,0.0,1.0,1.0,1
5894,GO:0046866,tetraterpenoid transport,7,0.0,1.0,1.0,1
5895,GO:0046879,hormone secretion,7,0.0,1.0,1.0,7
5896,GO:0046883,regulation of hormone secretion,7,0.0,1.0,1.0,14
5897,GO:0046886,positive regulation of hormone biosynthetic process,7,0.0,1.0,1.0,5
5898,GO:0046890,regulation of lipid biosynthetic process,7,0.0,1.0,1.0,19
5899,GO:0046902,regulation of mitochondrial membrane permeability,7,0.0,1.0,1.0,5
5900,GO:0046928,regulation of neurotransmitter secretion,7,0.0,1.0,1.0,8
5901,GO:0046951,ketone body biosynthetic process,7,0.0,1.0,1.0,1
5902,GO:0046952,ketone body catabolic process,7,0.0,1.0,1.0,1
5903,GO:0046958,nonassociative learning,7,0.0,1.0,1.0,3
5904,GO:0046984,regulation of hemoglobin biosynthetic process,7,0.0,1.0,1.0,2
5905,GO:0047812,D-amino-acid N-acetyltransferase activity,7,0.0,1.0,1.0,1
5906,GO:0048021,regulation of melanin biosynthetic process,7,0.0,1.0,1.0,2
5907,GO:0048065,"male courtship behavior, veined wing extension",7,0.0,1.0,1.0,1
5908,GO:0048167,regulation of synaptic plasticity,7,0.0,1.0,1.0,12
5909,GO:0048200,Golgi transport vesicle coating,7,0.0,1.0,1.0,2
5910,GO:0048214,regulation of Golgi vesicle fusion to target membrane,7,0.0,1.0,1.0,2
5911,GO:0048241,epinephrine transport,7,0.0,1.0,1.0,1
5912,GO:0048247,lymphocyte chemotaxis,7,0.0,1.0,1.0,4
5913,GO:0048256,flap endonuclease activity,7,0.0,1.0,1.0,2
5914,GO:0048259,regulation of receptor-mediated endocytosis,7,0.0,1.0,1.0,5
5915,GO:0048324,regulation of axial mesodermal cell fate determination,7,0.0,1.0,1.0,2
5916,GO:0048328,regulation of axial mesodermal cell fate specification,7,0.0,1.0,1.0,2
5917,GO:0048336,positive regulation of mesodermal cell fate determination,7,0.0,1.0,1.0,4
5918,GO:0048345,regulation of paraxial mesodermal cell fate determination,7,0.0,1.0,1.0,2
5919,GO:0048349,regulation of paraxial mesodermal cell fate specification,7,0.0,1.0,1.0,2
5920,GO:0048374,regulation of lateral mesodermal cell fate determination,7,0.0,1.0,1.0,2
5921,GO:0048378,regulation of lateral mesodermal cell fate specification,7,0.0,1.0,1.0,2
5922,GO:0048385,regulation of retinoic acid receptor signaling pathway,7,0.0,1.0,1.0,2
5923,GO:0048395,regulation of intermediate mesodermal cell fate determination,7,0.0,1.0,1.0,2
5924,GO:0048399,regulation of intermediate mesodermal cell fate specification,7,0.0,1.0,1.0,2
5925,GO:0048488,synaptic vesicle endocytosis,7,0.0,1.0,1.0,2
5926,GO:0048548,regulation of pinocytosis,7,0.0,1.0,1.0,3
5927,GO:0048642,negative regulation of skeletal muscle tissue development,7,0.0,1.0,1.0,2
5928,GO:0048643,positive regulation of skeletal muscle tissue development,7,0.0,1.0,1.0,4
5929,GO:0048686,regulation of sprouting of injured axon,7,0.0,1.0,1.0,5
5930,GO:0048770,pigment granule,7,0.0,1.0,1.0,5
5931,GO:0048788,cytoskeleton of presynaptic active zone,7,0.0,1.0,1.0,1
5932,GO:0048812,neuron projection morphogenesis,7,0.0,1.0,1.0,5
5933,GO:0048817,negative regulation of hair follicle maturation,7,0.0,1.0,1.0,3
5934,GO:0048818,positive regulation of hair follicle maturation,7,0.0,1.0,1.0,3
5935,GO:0048861,leukemia inhibitory factor signaling pathway,7,0.0,1.0,1.0,1
5936,GO:0048885,neuromast deposition,7,0.0,1.0,1.0,2
5937,GO:0048886,neuromast hair cell differentiation,7,0.0,1.0,1.0,3
5938,GO:0050308,sugar-phosphatase activity,7,0.0,1.0,1.0,9
5939,GO:0050432,catecholamine secretion,7,0.0,1.0,1.0,4
5940,GO:0050433,regulation of catecholamine secretion,7,0.0,1.0,1.0,5
5941,GO:0050654,chondroitin sulfate proteoglycan metabolic process,7,0.0,1.0,1.0,1
5942,GO:0050655,dermatan sulfate proteoglycan metabolic process,7,0.0,1.0,1.0,1
5943,GO:0050658,RNA transport,7,0.0,1.0,1.0,9
5944,GO:0050661,NADP binding,7,0.0,1.0,1.0,2
5945,GO:0050666,regulation of homocysteine metabolic process,7,0.0,1.0,1.0,2
5946,GO:0050670,regulation of lymphocyte proliferation,7,0.0,1.0,1.0,5
5947,GO:0050687,negative regulation of defense response to virus,7,0.0,1.0,1.0,1
5948,GO:0050691,regulation of defense response to virus by host,7,0.0,1.0,1.0,2
5949,GO:0050728,negative regulation of inflammatory response,7,0.0,1.0,1.0,9
5950,GO:0050764,regulation of phagocytosis,7,0.0,1.0,1.0,4
5951,GO:0050768,negative regulation of neurogenesis,7,0.0,1.0,1.0,6
5952,GO:0050769,positive regulation of neurogenesis,7,0.0,1.0,1.0,6
5953,GO:0050805,negative regulation of synaptic transmission,7,0.0,1.0,1.0,8
5954,GO:0050806,positive regulation of synaptic transmission,7,0.0,1.0,1.0,11
5955,GO:0050831,male-specific defense response to bacterium,7,0.0,1.0,1.0,1
5956,GO:0050848,regulation of calcium-mediated signaling,7,0.0,1.0,1.0,4
5957,GO:0050855,regulation of B cell receptor signaling pathway,7,0.0,1.0,1.0,2
5958,GO:0050856,regulation of T cell receptor signaling pathway,7,0.0,1.0,1.0,2
5959,GO:0050857,positive regulation of antigen receptor-mediated signaling pathway,7,0.0,1.0,1.0,2
5960,GO:0050858,negative regulation of antigen receptor-mediated signaling pathway,7,0.0,1.0,1.0,2
5961,GO:0050863,regulation of T cell activation,7,0.0,1.0,1.0,9
5962,GO:0050864,regulation of B cell activation,7,0.0,1.0,1.0,5
5963,GO:0050924,positive regulation of negative chemotaxis,7,0.0,1.0,1.0,1
5964,GO:0050927,positive regulation of positive chemotaxis,7,0.0,1.0,1.0,2
5965,GO:0050928,negative regulation of positive chemotaxis,7,0.0,1.0,1.0,2
5966,GO:0050939,regulation of early stripe melanocyte differentiation,7,0.0,1.0,1.0,2
5967,GO:0050940,regulation of late stripe melanocyte differentiation,7,0.0,1.0,1.0,2
5968,GO:0050994,regulation of lipid catabolic process,7,0.0,1.0,1.0,12
5969,GO:0051017,actin filament bundle assembly,7,0.0,1.0,1.0,4
5970,GO:0051027,DNA transport,7,0.0,1.0,1.0,1
5971,GO:0051052,regulation of DNA metabolic process,7,0.0,1.0,1.0,17
5972,GO:0051056,regulation of small GTPase mediated signal transduction,7,0.0,1.0,1.0,11
5973,GO:0051069,galactomannan metabolic process,7,0.0,1.0,1.0,2
5974,GO:0051078,meiotic nuclear membrane disassembly,7,0.0,1.0,1.0,2
5975,GO:0051132,NK T cell activation,7,0.0,1.0,1.0,2
5976,GO:0051139,metal cation:proton antiporter activity,7,0.0,1.0,1.0,6
5977,GO:0051151,negative regulation of smooth muscle cell differentiation,7,0.0,1.0,1.0,3
5978,GO:0051152,positive regulation of smooth muscle cell differentiation,7,0.0,1.0,1.0,3
5979,GO:0051154,negative regulation of striated muscle cell differentiation,7,0.0,1.0,1.0,5
5980,GO:0051155,positive regulation of striated muscle cell differentiation,7,0.0,1.0,1.0,5
5981,GO:0051168,nuclear export,7,0.0,1.0,1.0,4
5982,GO:0051170,import into nucleus,7,0.0,1.0,1.0,3
5983,GO:0051177,meiotic sister chromatid cohesion,7,0.0,1.0,1.0,5
5984,GO:0051205,protein insertion into membrane,7,0.0,1.0,1.0,5
5985,GO:0051223,regulation of protein transport,7,0.0,1.0,1.0,10
5986,GO:0051247,positive regulation of protein metabolic process,7,0.0,1.0,1.0,13
5987,GO:0051248,negative regulation of protein metabolic process,7,0.0,1.0,1.0,13
5988,GO:0051250,negative regulation of lymphocyte activation,7,0.0,1.0,1.0,6
5989,GO:0051251,positive regulation of lymphocyte activation,7,0.0,1.0,1.0,6
5990,GO:0051252,regulation of RNA metabolic process,7,0.0,1.0,1.0,13
5991,GO:0051260,protein homooligomerization,7,0.0,1.0,1.0,2
5992,GO:0051262,protein tetramerization,7,0.0,1.0,1.0,2
5993,GO:0051273,beta-glucan metabolic process,7,0.0,1.0,1.0,6
5994,GO:0051287,NAD binding,7,0.0,1.0,1.0,2
5995,GO:0051291,protein heterooligomerization,7,0.0,1.0,1.0,2
5996,GO:0051292,nuclear pore complex assembly,7,0.0,1.0,1.0,1
5997,GO:0051293,establishment of spindle localization,7,0.0,1.0,1.0,3
5998,GO:0051333,meiotic nuclear membrane reassembly,7,0.0,1.0,1.0,2
5999,GO:0051412,response to corticosterone,7,0.0,1.0,1.0,1
6000,GO:0051413,response to cortisone,7,0.0,1.0,1.0,1
6001,GO:0051414,response to cortisol,7,0.0,1.0,1.0,1
6002,GO:0051453,regulation of intracellular pH,7,0.0,1.0,1.0,4
6003,GO:0051472,glucosylglycerol metabolic process,7,0.0,1.0,1.0,1
6004,GO:0051478,mannosylglycerate metabolic process,7,0.0,1.0,1.0,1
6005,GO:0051480,regulation of cytosolic calcium ion concentration,7,0.0,1.0,1.0,3
6006,GO:0051494,negative regulation of cytoskeleton organization,7,0.0,1.0,1.0,16
6007,GO:0051495,positive regulation of cytoskeleton organization,7,0.0,1.0,1.0,17
6008,GO:0051513,regulation of monopolar cell growth,7,0.0,1.0,1.0,2
6009,GO:0051516,regulation of bipolar cell growth,7,0.0,1.0,1.0,2
6010,GO:0051547,regulation of keratinocyte migration,7,0.0,1.0,1.0,2
6011,GO:0051560,mitochondrial calcium ion homeostasis,7,0.0,1.0,1.0,2
6012,GO:0051581,negative regulation of neurotransmitter uptake,7,0.0,1.0,1.0,5
6013,GO:0051582,positive regulation of neurotransmitter uptake,7,0.0,1.0,1.0,4
6014,GO:0051607,defense response to virus,7,0.0,1.0,1.0,3
6015,GO:0051611,regulation of serotonin uptake,7,0.0,1.0,1.0,2
6016,GO:0051616,regulation of histamine uptake,7,0.0,1.0,1.0,2
6017,GO:0051632,negative regulation of acetylcholine uptake,7,0.0,1.0,1.0,1
6018,GO:0051676,pullulan metabolic process,7,0.0,1.0,1.0,2
6019,GO:0051728,"cell cycle switching, mitotic to meiotic cell cycle",7,0.0,1.0,1.0,1
6020,GO:0051734,ATP-dependent polynucleotide 5'-hydroxyl-kinase activity,7,0.0,1.0,1.0,2
6021,GO:0051735,GTP-dependent polynucleotide 5'-hydroxyl-kinase activity,7,0.0,1.0,1.0,2
6022,GO:0051761,sesquiterpene metabolic process,7,0.0,1.0,1.0,7
6023,GO:0051784,negative regulation of nuclear division,7,0.0,1.0,1.0,2
6024,GO:0051785,positive regulation of nuclear division,7,0.0,1.0,1.0,2
6025,GO:0051873,killing by host of symbiont cells,7,0.0,1.0,1.0,2
6026,GO:0051891,positive regulation of cardioblast differentiation,7,0.0,1.0,1.0,1
6027,GO:0051892,negative regulation of cardioblast differentiation,7,0.0,1.0,1.0,2
6028,GO:0051893,regulation of focal adhesion assembly,7,0.0,1.0,1.0,2
6029,GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,7,0.0,1.0,1.0,2
6030,GO:0051924,regulation of calcium ion transport,7,0.0,1.0,1.0,6
6031,GO:0051930,regulation of sensory perception of pain,7,0.0,1.0,1.0,3
6032,GO:0051933,amino acid neurotransmitter reuptake,7,0.0,1.0,1.0,2
6033,GO:0051938,L-glutamate import,7,0.0,1.0,1.0,3
6034,GO:0051940,regulation of catecholamine uptake involved in synaptic transmission,7,0.0,1.0,1.0,3
6035,GO:0051941,regulation of amino acid uptake involved in synaptic transmission,7,0.0,1.0,1.0,4
6036,GO:0051956,negative regulation of amino acid transport,7,0.0,1.0,1.0,16
6037,GO:0051957,positive regulation of amino acid transport,7,0.0,1.0,1.0,16
6038,GO:0051964,negative regulation of synapse assembly,7,0.0,1.0,1.0,4
6039,GO:0051965,positive regulation of synapse assembly,7,0.0,1.0,1.0,3
6040,GO:0051966,"regulation of synaptic transmission, glutamatergic",7,0.0,1.0,1.0,3
6041,GO:0051970,negative regulation of transmission of nerve impulse,7,0.0,1.0,1.0,1
6042,GO:0051971,positive regulation of transmission of nerve impulse,7,0.0,1.0,1.0,1
6043,GO:0051984,positive regulation of chromosome segregation,7,0.0,1.0,1.0,2
6044,GO:0051985,negative regulation of chromosome segregation,7,0.0,1.0,1.0,3
6045,GO:0051998,protein carboxyl O-methyltransferase activity,7,0.0,1.0,1.0,3
6046,GO:0052028,symbiont-mediated activation of host signal transduction pathway,7,0.0,1.0,1.0,7
6047,GO:0052029,symbiont-mediated suppression of host signal transduction pathway,7,0.0,1.0,1.0,13
6048,GO:0052080,symbiont-mediated perturbation of host MAPK cascade,7,0.0,1.0,1.0,2
6049,GO:0052081,symbiont-mediated perturbation of host salicylic acid-mediated signal transduction pathway,7,0.0,1.0,1.0,1
6050,GO:0052089,modulation by symbiont of host salicylic acid-mediated defense response,7,0.0,1.0,1.0,1
6051,GO:0052150,symbiont-mediated perturbation of host apoptosis,7,0.0,1.0,1.0,1
6052,GO:0052164,symbiont defense to host-produced reactive oxygen species,7,0.0,1.0,1.0,2
6053,GO:0052317,camalexin metabolic process,7,0.0,1.0,1.0,1
6054,GO:0052319,regulation of phytoalexin biosynthetic process,7,0.0,1.0,1.0,3
6055,GO:0052320,positive regulation of phytoalexin metabolic process,7,0.0,1.0,1.0,1
6056,GO:0052321,negative regulation of phytoalexin metabolic process,7,0.0,1.0,1.0,1
6057,GO:0052386,cell wall thickening,7,0.0,1.0,1.0,2
6058,GO:0052572,response to host immune response,7,0.0,1.0,1.0,1
6059,GO:0052648,ribitol phosphate metabolic process,7,0.0,1.0,1.0,2
6060,GO:0052712,inositol phosphosphingolipid phospholipase activity,7,0.0,1.0,1.0,1
6061,GO:0052743,inositol tetrakisphosphate phosphatase activity,7,0.0,1.0,1.0,7
6062,GO:0052744,phosphatidylinositol monophosphate phosphatase activity,7,0.0,1.0,1.0,3
6063,GO:0052827,inositol pentakisphosphate phosphatase activity,7,0.0,1.0,1.0,3
6064,GO:0052834,inositol monophosphate phosphatase activity,7,0.0,1.0,1.0,3
6065,GO:0052840,inositol diphosphate tetrakisphosphate diphosphatase activity,7,0.0,1.0,1.0,1
6066,GO:0052841,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,7,0.0,1.0,1.0,3
6067,GO:0052842,inositol diphosphate pentakisphosphate diphosphatase activity,7,0.0,1.0,1.0,3
6068,GO:0055021,regulation of cardiac muscle tissue growth,7,0.0,1.0,1.0,4
6069,GO:0055029,nuclear DNA-directed RNA polymerase complex,7,0.0,1.0,1.0,7
6070,GO:0055056,D-glucose transmembrane transporter activity,7,0.0,1.0,1.0,7
6071,GO:0060024,rhythmic synaptic transmission,7,0.0,1.0,1.0,2
6072,GO:0060070,canonical Wnt signaling pathway,7,0.0,1.0,1.0,4
6073,GO:0060092,"regulation of synaptic transmission, glycinergic",7,0.0,1.0,1.0,3
6074,GO:0060122,inner ear receptor cell stereocilium organization,7,0.0,1.0,1.0,3
6075,GO:0060159,regulation of dopamine receptor signaling pathway,7,0.0,1.0,1.0,3
6076,GO:0060167,regulation of adenosine receptor signaling pathway,7,0.0,1.0,1.0,2
6077,GO:0060219,camera-type eye photoreceptor cell differentiation,7,0.0,1.0,1.0,2
6078,GO:0060220,camera-type eye photoreceptor cell fate commitment,7,0.0,1.0,1.0,2
6079,GO:0060224,regulation of retinal rod cell fate commitment,7,0.0,1.0,1.0,1
6080,GO:0060232,delamination,7,0.0,1.0,1.0,8
6081,GO:0060239,positive regulation of signal transduction involved in conjugation with cellular fusion,7,0.0,1.0,1.0,1
6082,GO:0060240,negative regulation of signal transduction involved in conjugation with cellular fusion,7,0.0,1.0,1.0,1
6083,GO:0060264,regulation of respiratory burst involved in inflammatory response,7,0.0,1.0,1.0,2
6084,GO:0060271,cilium assembly,7,0.0,1.0,1.0,3
6085,GO:0060281,regulation of oocyte development,7,0.0,1.0,1.0,2
6086,GO:0060295,regulation of cilium movement involved in cell motility,7,0.0,1.0,1.0,2
6087,GO:0060300,regulation of cytokine activity,7,0.0,1.0,1.0,3
6088,GO:0060330,regulation of response to type II interferon,7,0.0,1.0,1.0,3
6089,GO:0060338,regulation of type I interferon-mediated signaling pathway,7,0.0,1.0,1.0,2
6090,GO:0060369,positive regulation of Fc receptor mediated stimulatory signaling pathway,7,0.0,1.0,1.0,1
6091,GO:0060390,regulation of SMAD protein signal transduction,7,0.0,1.0,1.0,2
6092,GO:0060409,positive regulation of acetylcholine metabolic process,7,0.0,1.0,1.0,1
6093,GO:0060410,negative regulation of acetylcholine metabolic process,7,0.0,1.0,1.0,1
6094,GO:0060421,positive regulation of heart growth,7,0.0,1.0,1.0,1
6095,GO:0060441,epithelial tube branching involved in lung morphogenesis,7,0.0,1.0,1.0,1
6096,GO:0060444,branching involved in mammary gland duct morphogenesis,7,0.0,1.0,1.0,3
6097,GO:0060446,branching involved in open tracheal system development,7,0.0,1.0,1.0,3
6098,GO:0060454,positive regulation of gastric acid secretion,7,0.0,1.0,1.0,1
6099,GO:0060455,negative regulation of gastric acid secretion,7,0.0,1.0,1.0,1
6100,GO:0060501,positive regulation of epithelial cell proliferation involved in lung morphogenesis,7,0.0,1.0,1.0,1
6101,GO:0060551,"regulation of fructose 1,6-bisphosphate metabolic process",7,0.0,1.0,1.0,1
6102,GO:0060609,apoptotic process involved in tube lumen cavitation,7,0.0,1.0,1.0,1
6103,GO:0060623,regulation of chromosome condensation,7,0.0,1.0,1.0,3
6104,GO:0060629,regulation of homologous chromosome segregation,7,0.0,1.0,1.0,1
6105,GO:0060685,regulation of prostatic bud formation,7,0.0,1.0,1.0,2
6106,GO:0060694,regulation of cholesterol transporter activity,7,0.0,1.0,1.0,1
6107,GO:0060828,regulation of canonical Wnt signaling pathway,7,0.0,1.0,1.0,2
6108,GO:0060920,cardiac pacemaker cell differentiation,7,0.0,1.0,1.0,2
6109,GO:0060926,cardiac pacemaker cell development,7,0.0,1.0,1.0,2
6110,GO:0060932,His-Purkinje system cell differentiation,7,0.0,1.0,1.0,2
6111,GO:0060947,cardiac vascular smooth muscle cell differentiation,7,0.0,1.0,1.0,1
6112,GO:0060975,cardioblast migration to the midline involved in heart field formation,7,0.0,1.0,1.0,2
6113,GO:0060988,lipid tube assembly,7,0.0,1.0,1.0,2
6114,GO:0061043,regulation of vascular wound healing,7,0.0,1.0,1.0,2
6115,GO:0061045,negative regulation of wound healing,7,0.0,1.0,1.0,5
6116,GO:0061047,positive regulation of branching involved in lung morphogenesis,7,0.0,1.0,1.0,1
6117,GO:0061048,negative regulation of branching involved in lung morphogenesis,7,0.0,1.0,1.0,1
6118,GO:0061063,positive regulation of nematode larval development,7,0.0,1.0,1.0,2
6119,GO:0061064,negative regulation of nematode larval development,7,0.0,1.0,1.0,3
6120,GO:0061065,regulation of dauer larval development,7,0.0,1.0,1.0,3
6121,GO:0061091,regulation of phospholipid translocation,7,0.0,1.0,1.0,4
6122,GO:0061101,neuroendocrine cell differentiation,7,0.0,1.0,1.0,6
6123,GO:0061109,dense core granule organization,7,0.0,1.0,1.0,1
6124,GO:0061117,negative regulation of heart growth,7,0.0,1.0,1.0,1
6125,GO:0061118,regulation of positive chemotaxis to cAMP,7,0.0,1.0,1.0,3
6126,GO:0061173,positive regulation of establishment of bipolar cell polarity,7,0.0,1.0,1.0,1
6127,GO:0061181,regulation of chondrocyte development,7,0.0,1.0,1.0,3
6128,GO:0061204,paramyosin filament assembly or disassembly,7,0.0,1.0,1.0,1
6129,GO:0061241,mesonephric nephron epithelium development,7,0.0,1.0,1.0,3
6130,GO:0061250,mesonephric glomerular epithelial cell differentiation,7,0.0,1.0,1.0,2
6131,GO:0061278,epithelial cell migration involved in mesonephric nephron tubule morphogenesis,7,0.0,1.0,1.0,2
6132,GO:0061314,Notch signaling involved in heart development,7,0.0,1.0,1.0,1
6133,GO:0061337,cardiac conduction,7,0.0,1.0,1.0,2
6134,GO:0061389,regulation of direction of cell growth,7,0.0,1.0,1.0,4
6135,GO:0061462,protein localization to lysosome,7,0.0,1.0,1.0,2
6136,GO:0061523,cilium disassembly,7,0.0,1.0,1.0,1
6137,GO:0061526,acetylcholine secretion,7,0.0,1.0,1.0,1
6138,GO:0061545,tyramine secretion,7,0.0,1.0,1.0,1
6139,GO:0061564,axon development,7,0.0,1.0,1.0,2
6140,GO:0061580,colon epithelial cell migration,7,0.0,1.0,1.0,1
6141,GO:0061630,ubiquitin protein ligase activity,7,0.0,1.0,1.0,2
6142,GO:0061665,SUMO ligase activity,7,0.0,1.0,1.0,1
6143,GO:0061792,secretory granule maturation,7,0.0,1.0,1.0,1
6144,GO:0061864,basement membrane constituent secretion,7,0.0,1.0,1.0,1
6145,GO:0061869,regulation of hepatic stellate cell migration,7,0.0,1.0,1.0,2
6146,GO:0061880,regulation of anterograde axonal transport of mitochondrion,7,0.0,1.0,1.0,2
6147,GO:0061888,regulation of astrocyte activation,7,0.0,1.0,1.0,2
6148,GO:0061922,histone propionyltransferase activity,7,0.0,1.0,1.0,1
6149,GO:0061930,regulation of erythrocyte enucleation,7,0.0,1.0,1.0,2
6150,GO:0061951,establishment of protein localization to plasma membrane,7,0.0,1.0,1.0,3
6151,GO:0061988,karyosome formation,7,0.0,1.0,1.0,2
6152,GO:0062028,regulation of stress granule assembly,7,0.0,1.0,1.0,2
6153,GO:0062043,positive regulation of cardiac epithelial to mesenchymal transition,7,0.0,1.0,1.0,2
6154,GO:0062044,negative regulation of cardiac epithelial to mesenchymal transition,7,0.0,1.0,1.0,2
6155,GO:0062107,regulation of protein localization to non-growing cell tip,7,0.0,1.0,1.0,1
6156,GO:0062164,regulation of pseudohyphal septin ring assembly,7,0.0,1.0,1.0,2
6157,GO:0062207,regulation of pattern recognition receptor signaling pathway,7,0.0,1.0,1.0,11
6158,GO:0062237,protein localization to postsynapse,7,0.0,1.0,1.0,2
6159,GO:0062242,double membrane vesicle viral factory membrane,7,0.0,1.0,1.0,2
6160,GO:0070037,rRNA (pseudouridine) methyltransferase activity,7,0.0,1.0,1.0,1
6161,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,7,0.0,1.0,1.0,1
6162,GO:0070070,proton-transporting V-type ATPase complex assembly,7,0.0,1.0,1.0,1
6163,GO:0070098,chemokine-mediated signaling pathway,7,0.0,1.0,1.0,10
6164,GO:0070099,regulation of chemokine-mediated signaling pathway,7,0.0,1.0,1.0,3
6165,GO:0070103,regulation of interleukin-6-mediated signaling pathway,7,0.0,1.0,1.0,2
6166,GO:0070107,regulation of interleukin-27-mediated signaling pathway,7,0.0,1.0,1.0,2
6167,GO:0070142,synaptic vesicle budding,7,0.0,1.0,1.0,2
6168,GO:0070171,negative regulation of tooth mineralization,7,0.0,1.0,1.0,1
6169,GO:0070172,positive regulation of tooth mineralization,7,0.0,1.0,1.0,1
6170,GO:0070173,regulation of enamel mineralization,7,0.0,1.0,1.0,2
6171,GO:0070198,"protein localization to chromosome, telomeric region",7,0.0,1.0,1.0,2
6172,GO:0070199,establishment of protein localization to chromosome,7,0.0,1.0,1.0,3
6173,GO:0070202,regulation of establishment of protein localization to chromosome,7,0.0,1.0,1.0,1
6174,GO:0070206,protein trimerization,7,0.0,1.0,1.0,2
6175,GO:0070228,regulation of lymphocyte apoptotic process,7,0.0,1.0,1.0,5
6176,GO:0070231,T cell apoptotic process,7,0.0,1.0,1.0,6
6177,GO:0070297,regulation of phosphorelay signal transduction system,7,0.0,1.0,1.0,3
6178,GO:0070302,regulation of stress-activated protein kinase signaling cascade,7,0.0,1.0,1.0,3
6179,GO:0070340,detection of bacterial lipopeptide,7,0.0,1.0,1.0,2
6180,GO:0070400,teichoic acid D-alanylation,7,0.0,1.0,1.0,1
6181,GO:0070453,regulation of heme biosynthetic process,7,0.0,1.0,1.0,2
6182,GO:0070461,SAGA-type complex,7,0.0,1.0,1.0,5
6183,GO:0070489,T cell aggregation,7,0.0,1.0,1.0,1
6184,GO:0070494,regulation of thrombin-activated receptor signaling pathway,7,0.0,1.0,1.0,2
6185,GO:0070507,regulation of microtubule cytoskeleton organization,7,0.0,1.0,1.0,5
6186,GO:0070524,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,7,0.0,1.0,1.0,1
6187,GO:0070562,regulation of vitamin D receptor signaling pathway,7,0.0,1.0,1.0,2
6188,GO:0070592,cell wall polysaccharide biosynthetic process,7,0.0,1.0,1.0,8
6189,GO:0070601,centromeric sister chromatid cohesion,7,0.0,1.0,1.0,2
6190,GO:0070616,regulation of thiamine diphosphate biosynthetic process,7,0.0,1.0,1.0,1
6191,GO:0070623,regulation of thiamine biosynthetic process,7,0.0,1.0,1.0,2
6192,GO:0070637,pyridine nucleoside metabolic process,7,0.0,1.0,1.0,4
6193,GO:0070640,vitamin D3 metabolic process,7,0.0,1.0,1.0,3
6194,GO:0070647,protein modification by small protein conjugation or removal,7,0.0,1.0,1.0,2
6195,GO:0070650,actin filament bundle distribution,7,0.0,1.0,1.0,2
6196,GO:0070655,mechanosensory epithelium regeneration,7,0.0,1.0,1.0,2
6197,GO:0070729,cyclic nucleotide transport,7,0.0,1.0,1.0,3
6198,GO:0070758,regulation of interleukin-35-mediated signaling pathway,7,0.0,1.0,1.0,2
6199,GO:0070775,H3 histone acetyltransferase complex,7,0.0,1.0,1.0,4
6200,GO:0070785,negative regulation of growth of unicellular organism as a thread of attached cells,7,0.0,1.0,1.0,2
6201,GO:0070786,positive regulation of growth of unicellular organism as a thread of attached cells,7,0.0,1.0,1.0,2
6202,GO:0070796,regulation of cleistothecium development,7,0.0,1.0,1.0,2
6203,GO:0070831,basement membrane assembly,7,0.0,1.0,1.0,1
6204,GO:0070881,regulation of proline transport,7,0.0,1.0,1.0,1
6205,GO:0070897,transcription preinitiation complex assembly,7,0.0,1.0,1.0,3
6206,GO:0070948,regulation of neutrophil mediated cytotoxicity,7,0.0,1.0,1.0,3
6207,GO:0071043,CUT metabolic process,7,0.0,1.0,1.0,1
6208,GO:0071139,resolution of DNA recombination intermediates,7,0.0,1.0,1.0,1
6209,GO:0071163,DNA replication preinitiation complex assembly,7,0.0,1.0,1.0,4
6210,GO:0071168,protein localization to chromatin,7,0.0,1.0,1.0,4
6211,GO:0071221,cellular response to bacterial lipopeptide,7,0.0,1.0,1.0,2
6212,GO:0071270,1-butanol metabolic process,7,0.0,1.0,1.0,1
6213,GO:0071331,cellular response to hexose stimulus,7,0.0,1.0,1.0,5
6214,GO:0071385,cellular response to glucocorticoid stimulus,7,0.0,1.0,1.0,4
6215,GO:0071389,cellular response to mineralocorticoid stimulus,7,0.0,1.0,1.0,3
6216,GO:0071448,cellular response to alkyl hydroperoxide,7,0.0,1.0,1.0,1
6217,GO:0071450,cellular response to oxygen radical,7,0.0,1.0,1.0,1
6218,GO:0071459,"protein localization to chromosome, centromeric region",7,0.0,1.0,1.0,3
6219,GO:0071483,cellular response to blue light,7,0.0,1.0,1.0,1
6220,GO:0071484,cellular response to light intensity,7,0.0,1.0,1.0,4
6221,GO:0071489,cellular response to red or far red light,7,0.0,1.0,1.0,3
6222,GO:0071543,diphosphoinositol polyphosphate metabolic process,7,0.0,1.0,1.0,1
6223,GO:0071545,inositol phosphate catabolic process,7,0.0,1.0,1.0,1
6224,GO:0071548,response to dexamethasone,7,0.0,1.0,1.0,1
6225,GO:0071574,protein localization to medial cortex,7,0.0,1.0,1.0,1
6226,GO:0071579,regulation of zinc ion transport,7,0.0,1.0,1.0,2
6227,GO:0071604,transforming growth factor beta production,7,0.0,1.0,1.0,3
6228,GO:0071621,granulocyte chemotaxis,7,0.0,1.0,1.0,3
6229,GO:0071671,regulation of smooth muscle cell chemotaxis,7,0.0,1.0,1.0,2
6230,GO:0071675,regulation of mononuclear cell migration,7,0.0,1.0,1.0,7
6231,GO:0071706,tumor necrosis factor superfamily cytokine production,7,0.0,1.0,1.0,4
6232,GO:0071716,leukotriene transport,7,0.0,1.0,1.0,1
6233,GO:0071718,sodium-independent icosanoid transport,7,0.0,1.0,1.0,3
6234,GO:0071724,response to diacyl bacterial lipopeptide,7,0.0,1.0,1.0,2
6235,GO:0071725,response to triacyl bacterial lipopeptide,7,0.0,1.0,1.0,2
6236,GO:0071792,bacillithiol metabolic process,7,0.0,1.0,1.0,1
6237,GO:0071801,regulation of podosome assembly,7,0.0,1.0,1.0,2
6238,GO:0071806,protein transmembrane transport,7,0.0,1.0,1.0,11
6239,GO:0071829,plasma lipoprotein particle disassembly,7,0.0,1.0,1.0,1
6240,GO:0071853,fungal-type cell wall disassembly,7,0.0,1.0,1.0,1
6241,GO:0071897,DNA biosynthetic process,7,0.0,1.0,1.0,5
6242,GO:0071913,citrate secondary active transmembrane transporter activity,7,0.0,1.0,1.0,2
6243,GO:0071918,urea transmembrane transport,7,0.0,1.0,1.0,1
6244,GO:0071926,endocannabinoid signaling pathway,7,0.0,1.0,1.0,1
6245,GO:0071927,octopamine signaling pathway,7,0.0,1.0,1.0,2
6246,GO:0071938,vitamin A transport,7,0.0,1.0,1.0,1
6247,GO:0071940,fungal-type cell wall assembly,7,0.0,1.0,1.0,1
6248,GO:0071963,establishment or maintenance of cell polarity regulating cell shape,7,0.0,1.0,1.0,3
6249,GO:0071966,fungal-type cell wall polysaccharide metabolic process,7,0.0,1.0,1.0,3
6250,GO:0071994,phytochelatin transmembrane transport,7,0.0,1.0,1.0,1
6251,GO:0072010,glomerular epithelium development,7,0.0,1.0,1.0,3
6252,GO:0072012,glomerulus vasculature development,7,0.0,1.0,1.0,2
6253,GO:0072024,macula densa development,7,0.0,1.0,1.0,2
6254,GO:0072034,renal vesicle induction,7,0.0,1.0,1.0,2
6255,GO:0072045,convergent extension involved in nephron morphogenesis,7,0.0,1.0,1.0,2
6256,GO:0072063,short descending thin limb development,7,0.0,1.0,1.0,1
6257,GO:0072064,long descending thin limb development,7,0.0,1.0,1.0,1
6258,GO:0072067,early distal convoluted tubule development,7,0.0,1.0,1.0,1
6259,GO:0072068,late distal convoluted tubule development,7,0.0,1.0,1.0,1
6260,GO:0072078,nephron tubule morphogenesis,7,0.0,1.0,1.0,5
6261,GO:0072080,nephron tubule development,7,0.0,1.0,1.0,12
6262,GO:0072106,regulation of ureteric bud formation,7,0.0,1.0,1.0,1
6263,GO:0072112,podocyte differentiation,7,0.0,1.0,1.0,2
6264,GO:0072125,negative regulation of glomerular mesangial cell proliferation,7,0.0,1.0,1.0,2
6265,GO:0072126,positive regulation of glomerular mesangial cell proliferation,7,0.0,1.0,1.0,2
6266,GO:0072139,glomerular parietal epithelial cell differentiation,7,0.0,1.0,1.0,2
6267,GO:0072157,epithelial cell migration involved in distal tubule morphogenesis,7,0.0,1.0,1.0,2
6268,GO:0072159,epithelial cell migration involved in proximal tubule morphogenesis,7,0.0,1.0,1.0,2
6269,GO:0072164,mesonephric tubule development,7,0.0,1.0,1.0,5
6270,GO:0072170,metanephric tubule development,7,0.0,1.0,1.0,1
6271,GO:0072172,mesonephric tubule formation,7,0.0,1.0,1.0,3
6272,GO:0072182,regulation of nephron tubule epithelial cell differentiation,7,0.0,1.0,1.0,4
6273,GO:0072243,metanephric nephron epithelium development,7,0.0,1.0,1.0,7
6274,GO:0072290,epithelial cell migration involved in metanephric nephron tubule morphogenesis,7,0.0,1.0,1.0,2
6275,GO:0072301,regulation of metanephric glomerular mesangial cell proliferation,7,0.0,1.0,1.0,2
6276,GO:0072312,metanephric glomerular epithelial cell differentiation,7,0.0,1.0,1.0,2
6277,GO:0072319,vesicle uncoating,7,0.0,1.0,1.0,3
6278,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,7,0.0,1.0,1.0,2
6279,GO:0072344,rescue of stalled ribosome,7,0.0,1.0,1.0,1
6280,GO:0072350,tricarboxylic acid metabolic process,7,0.0,1.0,1.0,11
6281,GO:0072384,organelle transport along microtubule,7,0.0,1.0,1.0,7
6282,GO:0072426,response to G2 DNA damage checkpoint signaling,7,0.0,1.0,1.0,1
6283,GO:0072479,response to mitotic cell cycle spindle assembly checkpoint signaling,7,0.0,1.0,1.0,2
6284,GO:0072488,ammonium transmembrane transport,7,0.0,1.0,1.0,1
6285,GO:0072554,blood vessel lumenization,7,0.0,1.0,1.0,1
6286,GO:0072578,neurotransmitter-gated ion channel clustering,7,0.0,1.0,1.0,4
6287,GO:0072583,clathrin-dependent endocytosis,7,0.0,1.0,1.0,4
6288,GO:0072596,establishment of protein localization to chloroplast,7,0.0,1.0,1.0,3
6289,GO:0072599,establishment of protein localization to endoplasmic reticulum,7,0.0,1.0,1.0,2
6290,GO:0072655,establishment of protein localization to mitochondrion,7,0.0,1.0,1.0,4
6291,GO:0072663,establishment of protein localization to peroxisome,7,0.0,1.0,1.0,3
6292,GO:0072666,establishment of protein localization to vacuole,7,0.0,1.0,1.0,3
6293,GO:0072677,eosinophil migration,7,0.0,1.0,1.0,2
6294,GO:0072678,T cell migration,7,0.0,1.0,1.0,5
6295,GO:0072698,protein localization to microtubule cytoskeleton,7,0.0,1.0,1.0,5
6296,GO:0075109,symbiont-mediated perturbation of host receptor-mediated signal transduction,7,0.0,1.0,1.0,4
6297,GO:0075216,positive regulation of spore encystment on host,7,0.0,1.0,1.0,1
6298,GO:0075217,negative regulation of spore encystment on host,7,0.0,1.0,1.0,1
6299,GO:0075219,modulation of zoospore encystment on host,7,0.0,1.0,1.0,2
6300,GO:0075248,regulation of aeciospore formation,7,0.0,1.0,1.0,2
6301,GO:0075252,regulation of uredospore formation,7,0.0,1.0,1.0,2
6302,GO:0075256,regulation of teliospore formation,7,0.0,1.0,1.0,2
6303,GO:0075286,regulation of sporangiospore formation,7,0.0,1.0,1.0,4
6304,GO:0080091,regulation of raffinose metabolic process,7,0.0,1.0,1.0,1
6305,GO:0085032,symbiont-mediated perturbation of host NF-kappaB cascade,7,0.0,1.0,1.0,2
6306,GO:0086097,phospholipase C-activating angiotensin-activated signaling pathway,7,0.0,1.0,1.0,1
6307,GO:0086098,angiotensin-activated signaling pathway involved in heart process,7,0.0,1.0,1.0,1
6308,GO:0090016,regulation of leaflet formation,7,0.0,1.0,1.0,1
6309,GO:0090036,regulation of protein kinase C signaling,7,0.0,1.0,1.0,2
6310,GO:0090062,regulation of trehalose metabolic process,7,0.0,1.0,1.0,1
6311,GO:0090089,regulation of dipeptide transport,7,0.0,1.0,1.0,3
6312,GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,7,0.0,1.0,1.0,5
6313,GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,7,0.0,1.0,1.0,5
6314,GO:0090129,positive regulation of synapse maturation,7,0.0,1.0,1.0,1
6315,GO:0090140,regulation of mitochondrial fission,7,0.0,1.0,1.0,2
6316,GO:0090164,asymmetric Golgi ribbon formation,7,0.0,1.0,1.0,1
6317,GO:0090173,regulation of synaptonemal complex assembly,7,0.0,1.0,1.0,1
6318,GO:0090176,microtubule cytoskeleton organization involved in establishment of planar polarity,7,0.0,1.0,1.0,1
6319,GO:0090199,regulation of release of cytochrome c from mitochondria,7,0.0,1.0,1.0,2
6320,GO:0090207,regulation of triglyceride metabolic process,7,0.0,1.0,1.0,4
6321,GO:0090230,regulation of centromere complex assembly,7,0.0,1.0,1.0,1
6322,GO:0090300,positive regulation of neural crest formation,7,0.0,1.0,1.0,1
6323,GO:0090301,negative regulation of neural crest formation,7,0.0,1.0,1.0,1
6324,GO:0090303,positive regulation of wound healing,7,0.0,1.0,1.0,3
6325,GO:0090330,regulation of platelet aggregation,7,0.0,1.0,1.0,3
6326,GO:0090355,positive regulation of auxin metabolic process,7,0.0,1.0,1.0,1
6327,GO:0090356,negative regulation of auxin metabolic process,7,0.0,1.0,1.0,1
6328,GO:0090357,regulation of tryptophan metabolic process,7,0.0,1.0,1.0,3
6329,GO:0090368,regulation of ornithine metabolic process,7,0.0,1.0,1.0,2
6330,GO:0090381,regulation of heart induction,7,0.0,1.0,1.0,2
6331,GO:0090425,acinar cell differentiation,7,0.0,1.0,1.0,2
6332,GO:0090435,protein localization to nuclear envelope,7,0.0,1.0,1.0,2
6333,GO:0090444,"regulation of nematode larval development, heterochronic",7,0.0,1.0,1.0,2
6334,GO:0090454,glutamate transmembrane import into vacuole,7,0.0,1.0,1.0,1
6335,GO:0090472,dibasic protein processing,7,0.0,1.0,1.0,3
6336,GO:0090480,purine nucleotide-sugar transmembrane transport,7,0.0,1.0,1.0,2
6337,GO:0090481,pyrimidine nucleotide-sugar transmembrane transport,7,0.0,1.0,1.0,8
6338,GO:0090486,small RNA 2'-O-methyltransferase activity,7,0.0,1.0,1.0,1
6339,GO:0090493,catecholamine uptake,7,0.0,1.0,1.0,3
6340,GO:0090500,endocardial cushion to mesenchymal transition,7,0.0,1.0,1.0,3
6341,GO:0097021,lymphocyte migration into lymphoid organs,7,0.0,1.0,1.0,1
6342,GO:0097061,dendritic spine organization,7,0.0,1.0,1.0,2
6343,GO:0097092,polyacyltrehalose metabolic process,7,0.0,1.0,1.0,1
6344,GO:0097172,N-acetylmuramic acid metabolic process,7,0.0,1.0,1.0,1
6345,GO:0097232,lamellar body membrane,7,0.0,1.0,1.0,2
6346,GO:0097485,neuron projection guidance,7,0.0,1.0,1.0,3
6347,GO:0097498,endothelial tube lumen extension,7,0.0,1.0,1.0,1
6348,GO:0097499,protein localization to non-motile cilium,7,0.0,1.0,1.0,3
6349,GO:0097578,sequestering of copper ion,7,0.0,1.0,1.0,2
6350,GO:0097647,amylin receptor signaling pathway,7,0.0,1.0,1.0,3
6351,GO:0098528,skeletal muscle fiber differentiation,7,0.0,1.0,1.0,1
6352,GO:0098534,centriole assembly,7,0.0,1.0,1.0,2
6353,GO:0098597,observational learning,7,0.0,1.0,1.0,1
6354,GO:0098658,inorganic anion import across plasma membrane,7,0.0,1.0,1.0,2
6355,GO:0098659,inorganic cation import across plasma membrane,7,0.0,1.0,1.0,9
6356,GO:0098718,serine import across plasma membrane,7,0.0,1.0,1.0,1
6357,GO:0098815,modulation of excitatory postsynaptic potential,7,0.0,1.0,1.0,5
6358,GO:0098836,cytoskeleton of dendritic spine,7,0.0,1.0,1.0,1
6359,GO:0098871,postsynaptic actin cytoskeleton,7,0.0,1.0,1.0,1
6360,GO:0098880,maintenance of postsynaptic specialization structure,7,0.0,1.0,1.0,1
6361,GO:0098895,postsynaptic endosome membrane,7,0.0,1.0,1.0,2
6362,GO:0098898,dense core granule lumen,7,0.0,1.0,1.0,1
6363,GO:0098908,regulation of neuronal action potential,7,0.0,1.0,1.0,2
6364,GO:0098916,anterograde trans-synaptic signaling,7,0.0,1.0,1.0,3
6365,GO:0098917,retrograde trans-synaptic signaling,7,0.0,1.0,1.0,4
6366,GO:0099010,modification of postsynaptic structure,7,0.0,1.0,1.0,2
6367,GO:0099039,sphingolipid translocation,7,0.0,1.0,1.0,1
6368,GO:0099046,clearance of foreign intracellular nucleic acids,7,0.0,1.0,1.0,3
6369,GO:0099051,vesicle scission involved in endocytosis,7,0.0,1.0,1.0,1
6370,GO:0099118,microtubule-based protein transport,7,0.0,1.0,1.0,2
6371,GO:0099122,RNA polymerase II C-terminal domain binding,7,0.0,1.0,1.0,1
6372,GO:0099150,regulation of postsynaptic specialization assembly,7,0.0,1.0,1.0,1
6373,GO:0099159,regulation of modification of postsynaptic structure,7,0.0,1.0,1.0,1
6374,GO:0099170,postsynaptic modulation of chemical synaptic transmission,7,0.0,1.0,1.0,2
6375,GO:0099171,presynaptic modulation of chemical synaptic transmission,7,0.0,1.0,1.0,4
6376,GO:0099191,trans-synaptic signaling by BDNF,7,0.0,1.0,1.0,1
6377,GO:0099501,exocytic vesicle membrane,7,0.0,1.0,1.0,1
6378,GO:0099503,secretory vesicle,7,0.0,1.0,1.0,2
6379,GO:0099510,calcium ion binding involved in regulation of cytosolic calcium ion concentration,7,0.0,1.0,1.0,2
6380,GO:0099514,synaptic vesicle cytoskeletal transport,7,0.0,1.0,1.0,2
6381,GO:0099519,dense core granule cytoskeletal transport,7,0.0,1.0,1.0,2
6382,GO:0099540,trans-synaptic signaling by neuropeptide,7,0.0,1.0,1.0,2
6383,GO:0099541,trans-synaptic signaling by lipid,7,0.0,1.0,1.0,3
6384,GO:0099543,trans-synaptic signaling by soluble gas,7,0.0,1.0,1.0,4
6385,GO:0099545,trans-synaptic signaling by trans-synaptic complex,7,0.0,1.0,1.0,3
6386,GO:0099550,"trans-synaptic signaling, modulating synaptic transmission",7,0.0,1.0,1.0,5
6387,GO:0099601,regulation of neurotransmitter receptor activity,7,0.0,1.0,1.0,4
6388,GO:0099637,neurotransmitter receptor transport,7,0.0,1.0,1.0,6
6389,GO:0099643,signal release from synapse,7,0.0,1.0,1.0,2
6390,GO:0102673,fatty aldehyde dehydrogenase (NAD+) activity,7,0.0,1.0,1.0,2
6391,GO:0106014,regulation of inflammatory response to wounding,7,0.0,1.0,1.0,2
6392,GO:0106030,neuron projection fasciculation,7,0.0,1.0,1.0,1
6393,GO:0106064,regulation of cobalamin metabolic process,7,0.0,1.0,1.0,2
6394,GO:0106070,regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,7,0.0,1.0,1.0,3
6395,GO:0106214,regulation of vesicle fusion with Golgi apparatus,7,0.0,1.0,1.0,2
6396,GO:0106278,regulation of UDP-N-acetylglucosamine biosynthetic process,7,0.0,1.0,1.0,2
6397,GO:0106426,regulation of kainate selective glutamate receptor signaling pathway,7,0.0,1.0,1.0,2
6398,GO:0110009,formin-nucleated actin cable organization,7,0.0,1.0,1.0,1
6399,GO:0110057,regulation of blood vessel endothelial cell differentiation,7,0.0,1.0,1.0,3
6400,GO:0110061,regulation of angiotensin-activated signaling pathway,7,0.0,1.0,1.0,2
6401,GO:0110073,regulation of apical constriction involved in ventral furrow formation,7,0.0,1.0,1.0,1
6402,GO:0110082,regulation of protein localization to cell division site involved in mitotic actomyosin contractile ring assembly,7,0.0,1.0,1.0,2
6403,GO:0110089,regulation of hippocampal neuron apoptotic process,7,0.0,1.0,1.0,2
6404,GO:0110113,positive regulation of lipid transporter activity,7,0.0,1.0,1.0,1
6405,GO:0110114,negative regulation of lipid transporter activity,7,0.0,1.0,1.0,1
6406,GO:0110116,regulation of compound eye photoreceptor cell differentiation,7,0.0,1.0,1.0,4
6407,GO:0110126,phloem loading,7,0.0,1.0,1.0,3
6408,GO:0110127,phloem unloading,7,0.0,1.0,1.0,1
6409,GO:0110154,RNA decapping,7,0.0,1.0,1.0,2
6410,GO:0120032,regulation of plasma membrane bounded cell projection assembly,7,0.0,1.0,1.0,11
6411,GO:0120060,regulation of gastric emptying,7,0.0,1.0,1.0,2
6412,GO:0120063,stomach smooth muscle contraction,7,0.0,1.0,1.0,2
6413,GO:0120178,steroid hormone biosynthetic process,7,0.0,1.0,1.0,6
6414,GO:0120192,tight junction assembly,7,0.0,1.0,1.0,3
6415,GO:0120313,regulation of oocyte karyosome formation,7,0.0,1.0,1.0,2
6416,GO:0140013,meiotic nuclear division,7,0.0,1.0,1.0,4
6417,GO:0140014,mitotic nuclear division,7,0.0,1.0,1.0,1
6418,GO:0140049,regulation of endocardial cushion to mesenchymal transition,7,0.0,1.0,1.0,3
6419,GO:0140135,mechanosensitive monoatomic cation channel activity,7,0.0,1.0,1.0,3
6420,GO:0140212,regulation of long-chain fatty acid import into cell,7,0.0,1.0,1.0,3
6421,GO:0140236,translation at presynapse,7,0.0,1.0,1.0,1
6422,GO:0140394,ABC-type azole transporter activity,7,0.0,1.0,1.0,1
6423,GO:0140410,monoatomic cation:bicarbonate symporter activity,7,0.0,1.0,1.0,2
6424,GO:0140415,effector-mediated modulation of host defenses by symbiont,7,0.0,1.0,1.0,2
6425,GO:0140433,regulation of protein localization to meiotic spindle pole body,7,0.0,1.0,1.0,2
6426,GO:0140448,signaling receptor ligand precursor processing,7,0.0,1.0,1.0,3
6427,GO:0140467,integrated stress response signaling,7,0.0,1.0,1.0,4
6428,GO:0140568,extraction of mislocalized protein from membrane,7,0.0,1.0,1.0,2
6429,GO:0140587,chromatin loop anchoring activity,7,0.0,1.0,1.0,2
6430,GO:0140789,histone phosphatase activity,7,0.0,1.0,1.0,2
6431,GO:0140841,RNA polymerase II C-terminal domain O-GlcNAc transferase activity,7,0.0,1.0,1.0,2
6432,GO:0140888,interferon-mediated signaling pathway,7,0.0,1.0,1.0,3
6433,GO:0140900,chloride:bicarbonate antiporter activity,7,0.0,1.0,1.0,1
6434,GO:0140936,histone H2B deubiquitinase activity,7,0.0,1.0,1.0,1
6435,GO:0140938,histone H3 methyltransferase activity,7,0.0,1.0,1.0,11
6436,GO:0140939,histone H4 methyltransferase activity,7,0.0,1.0,1.0,3
6437,GO:0140940,histone H2A methyltransferase activity,7,0.0,1.0,1.0,2
6438,GO:0140995,histone H2A kinase activity,7,0.0,1.0,1.0,3
6439,GO:0140996,histone H3 kinase activity,7,0.0,1.0,1.0,8
6440,GO:0140997,histone H4 kinase activity,7,0.0,1.0,1.0,1
6441,GO:0140998,histone H2B kinase activity,7,0.0,1.0,1.0,2
6442,GO:0141003,histone H2AX kinase activity,7,0.0,1.0,1.0,2
6443,GO:0141057,histone H3 arginine deiminase activity,7,0.0,1.0,1.0,4
6444,GO:0141126,short-chain fatty acyl-CoA hydrolase activity,7,0.0,1.0,1.0,1
6445,GO:0141147,intracellularly calcium-gated channel activity,7,0.0,1.0,1.0,1
6446,GO:0141154,symbiont-mediated suppression of host-directed shutoff of host translation,7,0.0,1.0,1.0,1
6447,GO:0141161,regulation of cAMP/PKA signal transduction,7,0.0,1.0,1.0,2
6448,GO:0141166,chromosomal 5-methylcytosine DNA demethylation pathway,7,0.0,1.0,1.0,3
6449,GO:0141193,nuclear receptor-mediated signaling pathway,7,0.0,1.0,1.0,6
6450,GO:0150003,regulation of spontaneous synaptic transmission,7,0.0,1.0,1.0,1
6451,GO:0150077,regulation of neuroinflammatory response,7,0.0,1.0,1.0,3
6452,GO:0150107,positive regulation of protein localization to cell-cell junction,7,0.0,1.0,1.0,1
6453,GO:0150119,negative regulation of protein localization to cell-cell junction,7,0.0,1.0,1.0,1
6454,GO:0160012,NAD-dependent histone decrotonylase activity,7,0.0,1.0,1.0,1
6455,GO:0160017,regulation of platelet rolling,7,0.0,1.0,1.0,2
6456,GO:0170039,proteinogenic amino acid metabolic process,7,0.0,1.0,1.0,9
6457,GO:0170041,non-proteinogenic amino acid metabolic process,7,0.0,1.0,1.0,27
6458,GO:1900000,regulation of anthocyanin catabolic process,7,0.0,1.0,1.0,2
6459,GO:1900010,regulation of corticotropin-releasing hormone receptor activity,7,0.0,1.0,1.0,1
6460,GO:1900038,negative regulation of cellular response to hypoxia,7,0.0,1.0,1.0,2
6461,GO:1900065,regulation of ethanol catabolic process,7,0.0,1.0,1.0,1
6462,GO:1900069,regulation of cellular hyperosmotic salinity response,7,0.0,1.0,1.0,1
6463,GO:1900071,regulation of sulfite transmembrane transport,7,0.0,1.0,1.0,1
6464,GO:1900073,regulation of neuromuscular synaptic transmission,7,0.0,1.0,1.0,2
6465,GO:1900088,regulation of inositol biosynthetic process,7,0.0,1.0,1.0,2
6466,GO:1900101,regulation of endoplasmic reticulum unfolded protein response,7,0.0,1.0,1.0,5
6467,GO:1900116,extracellular negative regulation of signal transduction,7,0.0,1.0,1.0,1
6468,GO:1900118,negative regulation of execution phase of apoptosis,7,0.0,1.0,1.0,1
6469,GO:1900141,regulation of oligodendrocyte apoptotic process,7,0.0,1.0,1.0,2
6470,GO:1900147,regulation of Schwann cell migration,7,0.0,1.0,1.0,3
6471,GO:1900157,regulation of bone mineralization involved in bone maturation,7,0.0,1.0,1.0,2
6472,GO:1900177,regulation of aflatoxin biosynthetic process,7,0.0,1.0,1.0,2
6473,GO:1900181,negative regulation of protein localization to nucleus,7,0.0,1.0,1.0,3
6474,GO:1900182,positive regulation of protein localization to nucleus,7,0.0,1.0,1.0,3
6475,GO:1900183,regulation of xanthone-containing compound biosynthetic process,7,0.0,1.0,1.0,3
6476,GO:1900193,regulation of oocyte maturation,7,0.0,1.0,1.0,2
6477,GO:1900196,regulation of penicillin biosynthetic process,7,0.0,1.0,1.0,2
6478,GO:1900211,regulation of mesenchymal cell apoptotic process involved in metanephros development,7,0.0,1.0,1.0,3
6479,GO:1900214,regulation of apoptotic process involved in metanephric collecting duct development,7,0.0,1.0,1.0,2
6480,GO:1900217,regulation of apoptotic process involved in metanephric nephron tubule development,7,0.0,1.0,1.0,2
6481,GO:1900234,regulation of Kit signaling pathway,7,0.0,1.0,1.0,2
6482,GO:1900242,regulation of synaptic vesicle endocytosis,7,0.0,1.0,1.0,2
6483,GO:1900309,regulation of maltoheptaose metabolic process,7,0.0,1.0,1.0,2
6484,GO:1900318,regulation of methane biosynthetic process from dimethylamine,7,0.0,1.0,1.0,2
6485,GO:1900330,regulation of methane biosynthetic process from trimethylamine,7,0.0,1.0,1.0,2
6486,GO:1900336,regulation of methane biosynthetic process from carbon monoxide,7,0.0,1.0,1.0,2
6487,GO:1900339,regulation of methane biosynthetic process from formic acid,7,0.0,1.0,1.0,2
6488,GO:1900342,regulation of methane biosynthetic process from dimethyl sulfide,7,0.0,1.0,1.0,2
6489,GO:1900345,regulation of methane biosynthetic process from methanethiol,7,0.0,1.0,1.0,2
6490,GO:1900348,regulation of methane biosynthetic process from methylamine,7,0.0,1.0,1.0,2
6491,GO:1900377,negative regulation of secondary metabolite biosynthetic process,7,0.0,1.0,1.0,33
6492,GO:1900378,positive regulation of secondary metabolite biosynthetic process,7,0.0,1.0,1.0,34
6493,GO:1900379,regulation of asperthecin biosynthetic process,7,0.0,1.0,1.0,2
6494,GO:1900384,regulation of flavonol biosynthetic process,7,0.0,1.0,1.0,2
6495,GO:1900394,regulation of kojic acid biosynthetic process,7,0.0,1.0,1.0,2
6496,GO:1900408,negative regulation of cellular response to oxidative stress,7,0.0,1.0,1.0,1
6497,GO:1900421,positive regulation of alcohol catabolic process,7,0.0,1.0,1.0,2
6498,GO:1900425,negative regulation of defense response to bacterium,7,0.0,1.0,1.0,2
6499,GO:1900426,positive regulation of defense response to bacterium,7,0.0,1.0,1.0,3
6500,GO:1900440,regulation of filamentous growth of a population of unicellular organisms in response to neutral pH,7,0.0,1.0,1.0,2
6501,GO:1900450,negative regulation of glutamate receptor signaling pathway,7,0.0,1.0,1.0,1
6502,GO:1900503,regulation of cellulosome assembly,7,0.0,1.0,1.0,2
6503,GO:1900539,fumonisin metabolic process,7,0.0,1.0,1.0,2
6504,GO:1900552,asperfuranone metabolic process,7,0.0,1.0,1.0,2
6505,GO:1900567,chanoclavine-I aldehyde metabolic process,7,0.0,1.0,1.0,1
6506,GO:1900576,gerfelin metabolic process,7,0.0,1.0,1.0,2
6507,GO:1900600,endocrocin metabolic process,7,0.0,1.0,1.0,2
6508,GO:1900606,tensidol B metabolic process,7,0.0,1.0,1.0,2
6509,GO:1900623,regulation of monocyte aggregation,7,0.0,1.0,1.0,2
6510,GO:1900626,regulation of arugosin biosynthetic process,7,0.0,1.0,1.0,2
6511,GO:1900649,regulation of dehydroaustinol biosynthetic process,7,0.0,1.0,1.0,2
6512,GO:1900652,regulation of demethylkotanin biosynthetic process,7,0.0,1.0,1.0,2
6513,GO:1900655,regulation of diorcinol biosynthetic process,7,0.0,1.0,1.0,2
6514,GO:1900664,regulation of emodin biosynthetic process,7,0.0,1.0,1.0,2
6515,GO:1900667,regulation of endocrocin biosynthetic process,7,0.0,1.0,1.0,2
6516,GO:1900683,regulation of fumonisin biosynthetic process,7,0.0,1.0,1.0,2
6517,GO:1900686,regulation of gerfelin biosynthetic process,7,0.0,1.0,1.0,2
6518,GO:1900689,regulation of gliotoxin biosynthetic process,7,0.0,1.0,1.0,2
6519,GO:1900692,regulation of (+)-kotanin biosynthetic process,7,0.0,1.0,1.0,2
6520,GO:1900695,"regulation of N',N'',N'''-triacetylfusarinine C biosynthetic process",7,0.0,1.0,1.0,2
6521,GO:1900698,regulation of o-orsellinic acid biosynthetic process,7,0.0,1.0,1.0,2
6522,GO:1900701,regulation of orcinol biosynthetic process,7,0.0,1.0,1.0,2
6523,GO:1900704,regulation of siderophore biosynthetic process,7,0.0,1.0,1.0,3
6524,GO:1900707,regulation of tensidol A biosynthetic process,7,0.0,1.0,1.0,2
6525,GO:1900710,regulation of tensidol B biosynthetic process,7,0.0,1.0,1.0,2
6526,GO:1900713,regulation of violaceol I biosynthetic process,7,0.0,1.0,1.0,2
6527,GO:1900716,regulation of violaceol II biosynthetic process,7,0.0,1.0,1.0,2
6528,GO:1900725,osmoregulated periplasmic glucan metabolic process,7,0.0,1.0,1.0,2
6529,GO:1900732,regulation of polyketide biosynthetic process,7,0.0,1.0,1.0,6
6530,GO:1900736,regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,7,0.0,1.0,1.0,2
6531,GO:1900742,negative regulation of filamentous growth of a population of unicellular organisms in response to pH,7,0.0,1.0,1.0,1
6532,GO:1900743,positive regulation of filamentous growth of a population of unicellular organisms in response to pH,7,0.0,1.0,1.0,1
6533,GO:1900752,malonic acid transport,7,0.0,1.0,1.0,1
6534,GO:1900800,cspyrone B1 metabolic process,7,0.0,1.0,1.0,2
6535,GO:1900810,helvolic acid metabolic process,7,0.0,1.0,1.0,2
6536,GO:1900813,monodictyphenone metabolic process,7,0.0,1.0,1.0,2
6537,GO:1900822,regulation of ergot alkaloid biosynthetic process,7,0.0,1.0,1.0,4
6538,GO:1900826,negative regulation of membrane depolarization during cardiac muscle cell action potential,7,0.0,1.0,1.0,1
6539,GO:1900827,positive regulation of membrane depolarization during cardiac muscle cell action potential,7,0.0,1.0,1.0,1
6540,GO:1900843,regulation of monodictyphenone biosynthetic process,7,0.0,1.0,1.0,2
6541,GO:1900846,regulation of naphtho-gamma-pyrone biosynthetic process,7,0.0,1.0,1.0,2
6542,GO:1900861,regulation of cordyol C biosynthetic process,7,0.0,1.0,1.0,2
6543,GO:1900866,glycolate transport,7,0.0,1.0,1.0,1
6544,GO:1900869,tatiopterin metabolic process,7,0.0,1.0,1.0,1
6545,GO:1900884,regulation of tridecane biosynthetic process,7,0.0,1.0,1.0,2
6546,GO:1900887,regulation of pentadecane biosynthetic process,7,0.0,1.0,1.0,2
6547,GO:1900896,regulation of heptadecane biosynthetic process,7,0.0,1.0,1.0,2
6548,GO:1900912,negative regulation of olefin biosynthetic process,7,0.0,1.0,1.0,7
6549,GO:1900913,positive regulation of olefin biosynthetic process,7,0.0,1.0,1.0,7
6550,GO:1900914,regulation of octadecene biosynthetic process,7,0.0,1.0,1.0,2
6551,GO:1900918,negative regulation of octadecene metabolic process,7,0.0,1.0,1.0,1
6552,GO:1900919,positive regulation of octadecene metabolic process,7,0.0,1.0,1.0,1
6553,GO:1900933,negative regulation of nonadec-1-ene metabolic process,7,0.0,1.0,1.0,1
6554,GO:1900934,positive regulation of nonadec-1-ene metabolic process,7,0.0,1.0,1.0,1
6555,GO:1900935,regulation of nonadec-1-ene biosynthetic process,7,0.0,1.0,1.0,2
6556,GO:1900939,"negative regulation of (Z)-nonadeca-1,14-diene metabolic process",7,0.0,1.0,1.0,1
6557,GO:1900940,"positive regulation of (Z)-nonadeca-1,14-diene metabolic process",7,0.0,1.0,1.0,1
6558,GO:1900941,"regulation of (Z)-nonadeca-1,14-diene biosynthetic process",7,0.0,1.0,1.0,2
6559,GO:1900950,regulation of 18-methylnonadec-1-ene biosynthetic process,7,0.0,1.0,1.0,2
6560,GO:1900954,negative regulation of 18-methylnonadec-1-ene metabolic process,7,0.0,1.0,1.0,1
6561,GO:1900955,positive regulation of 18-methylnonadec-1-ene metabolic process,7,0.0,1.0,1.0,1
6562,GO:1900956,regulation of 17-methylnonadec-1-ene biosynthetic process,7,0.0,1.0,1.0,2
6563,GO:1900960,negative regulation of 17-methylnonadec-1-ene metabolic process,7,0.0,1.0,1.0,1
6564,GO:1900961,positive regulation of 17-methylnonadec-1-ene metabolic process,7,0.0,1.0,1.0,1
6565,GO:1900968,regulation of sarcinapterin metabolic process,7,0.0,1.0,1.0,3
6566,GO:1900974,regulation of tatiopterin biosynthetic process,7,0.0,1.0,1.0,2
6567,GO:1900978,negative regulation of tatiopterin metabolic process,7,0.0,1.0,1.0,1
6568,GO:1900979,positive regulation of tatiopterin metabolic process,7,0.0,1.0,1.0,1
6569,GO:1901001,negative regulation of response to salt stress,7,0.0,1.0,1.0,1
6570,GO:1901003,negative regulation of fermentation,7,0.0,1.0,1.0,3
6571,GO:1901032,negative regulation of response to reactive oxygen species,7,0.0,1.0,1.0,1
6572,GO:1901038,cyanidin 3-O-glucoside metabolic process,7,0.0,1.0,1.0,1
6573,GO:1901078,negative regulation of relaxation of muscle,7,0.0,1.0,1.0,2
6574,GO:1901079,positive regulation of relaxation of muscle,7,0.0,1.0,1.0,2
6575,GO:1901080,regulation of relaxation of smooth muscle,7,0.0,1.0,1.0,4
6576,GO:1901090,regulation of protein tetramerization,7,0.0,1.0,1.0,3
6577,GO:1901099,negative regulation of signal transduction in absence of ligand,7,0.0,1.0,1.0,1
6578,GO:1901128,gentamycin metabolic process,7,0.0,1.0,1.0,2
6579,GO:1901131,kanamycin metabolic process,7,0.0,1.0,1.0,2
6580,GO:1901141,regulation of lignin biosynthetic process,7,0.0,1.0,1.0,1
6581,GO:1901145,mesenchymal cell apoptotic process involved in nephron morphogenesis,7,0.0,1.0,1.0,2
6582,GO:1901150,vistamycin metabolic process,7,0.0,1.0,1.0,2
6583,GO:1901153,paromomycin metabolic process,7,0.0,1.0,1.0,2
6584,GO:1901156,neomycin metabolic process,7,0.0,1.0,1.0,2
6585,GO:1901166,neural crest cell migration involved in autonomic nervous system development,7,0.0,1.0,1.0,1
6586,GO:1901185,negative regulation of ERBB signaling pathway,7,0.0,1.0,1.0,3
6587,GO:1901186,positive regulation of ERBB signaling pathway,7,0.0,1.0,1.0,2
6588,GO:1901202,negative regulation of extracellular matrix assembly,7,0.0,1.0,1.0,1
6589,GO:1901203,positive regulation of extracellular matrix assembly,7,0.0,1.0,1.0,1
6590,GO:1901219,regulation of cardiac chamber morphogenesis,7,0.0,1.0,1.0,2
6591,GO:1901222,regulation of non-canonical NF-kappaB signal transduction,7,0.0,1.0,1.0,2
6592,GO:1901233,negative regulation of convergent extension involved in axis elongation,7,0.0,1.0,1.0,1
6593,GO:1901234,positive regulation of convergent extension involved in axis elongation,7,0.0,1.0,1.0,1
6594,GO:1901266,cephalosporin C metabolic process,7,0.0,1.0,1.0,2
6595,GO:1901292,nucleoside phosphate catabolic process,7,0.0,1.0,1.0,13
6596,GO:1901293,nucleoside phosphate biosynthetic process,7,0.0,1.0,1.0,9
6597,GO:1901304,regulation of spermidine biosynthetic process,7,0.0,1.0,1.0,2
6598,GO:1901405,negative regulation of tetrapyrrole catabolic process,7,0.0,1.0,1.0,1
6599,GO:1901406,positive regulation of tetrapyrrole catabolic process,7,0.0,1.0,1.0,1
6600,GO:1901413,regulation of tetrapyrrole biosynthetic process from glycine and succinyl-CoA,7,0.0,1.0,1.0,2
6601,GO:1901464,negative regulation of tetrapyrrole biosynthetic process,7,0.0,1.0,1.0,4
6602,GO:1901465,positive regulation of tetrapyrrole biosynthetic process,7,0.0,1.0,1.0,4
6603,GO:1901469,regulation of syringal lignin catabolic process,7,0.0,1.0,1.0,2
6604,GO:1901494,regulation of cysteine metabolic process,7,0.0,1.0,1.0,2
6605,GO:1901507,negative regulation of acylglycerol transport,7,0.0,1.0,1.0,1
6606,GO:1901508,positive regulation of acylglycerol transport,7,0.0,1.0,1.0,1
6607,GO:1901523,icosanoid catabolic process,7,0.0,1.0,1.0,5
6608,GO:1901539,"ent-pimara-8(14),15-diene metabolic process",7,0.0,1.0,1.0,2
6609,GO:1901550,regulation of endothelial cell development,7,0.0,1.0,1.0,3
6610,GO:1901578,negative regulation of alkane biosynthetic process,7,0.0,1.0,1.0,11
6611,GO:1901579,positive regulation of alkane biosynthetic process,7,0.0,1.0,1.0,11
6612,GO:1901605,alpha-amino acid metabolic process,7,0.0,1.0,1.0,19
6613,GO:1901608,regulation of vesicle transport along microtubule,7,0.0,1.0,1.0,5
6614,GO:1901620,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,7,0.0,1.0,1.0,2
6615,GO:1901627,negative regulation of postsynaptic membrane organization,7,0.0,1.0,1.0,1
6616,GO:1901642,nucleoside transmembrane transport,7,0.0,1.0,1.0,3
6617,GO:1901679,nucleotide transmembrane transport,7,0.0,1.0,1.0,10
6618,GO:1901715,regulation of gamma-aminobutyric acid catabolic process,7,0.0,1.0,1.0,2
6619,GO:1901728,monensin A metabolic process,7,0.0,1.0,1.0,2
6620,GO:1901759,beta-L-Ara4N-lipid A metabolic process,7,0.0,1.0,1.0,1
6621,GO:1901796,regulation of signal transduction by p53 class mediator,7,0.0,1.0,1.0,4
6622,GO:1901805,beta-glucoside catabolic process,7,0.0,1.0,1.0,2
6623,GO:1901806,beta-glucoside biosynthetic process,7,0.0,1.0,1.0,9
6624,GO:1901856,negative regulation of cellular respiration,7,0.0,1.0,1.0,9
6625,GO:1901857,positive regulation of cellular respiration,7,0.0,1.0,1.0,10
6626,GO:1901880,negative regulation of protein depolymerization,7,0.0,1.0,1.0,4
6627,GO:1901881,positive regulation of protein depolymerization,7,0.0,1.0,1.0,4
6628,GO:1901891,regulation of cell septum assembly,7,0.0,1.0,1.0,3
6629,GO:1901897,regulation of relaxation of cardiac muscle,7,0.0,1.0,1.0,2
6630,GO:1901944,miltiradiene metabolic process,7,0.0,1.0,1.0,2
6631,GO:1901957,regulation of cutin biosynthetic process,7,0.0,1.0,1.0,2
6632,GO:1901976,regulation of cell cycle checkpoint,7,0.0,1.0,1.0,4
6633,GO:1901988,negative regulation of cell cycle phase transition,7,0.0,1.0,1.0,6
6634,GO:1901989,positive regulation of cell cycle phase transition,7,0.0,1.0,1.0,6
6635,GO:1901990,regulation of mitotic cell cycle phase transition,7,0.0,1.0,1.0,6
6636,GO:1901993,regulation of meiotic cell cycle phase transition,7,0.0,1.0,1.0,5
6637,GO:1902022,L-lysine transport,7,0.0,1.0,1.0,2
6638,GO:1902024,L-histidine transport,7,0.0,1.0,1.0,2
6639,GO:1902059,negative regulation of sporocarp development involved in sexual reproduction,7,0.0,1.0,1.0,1
6640,GO:1902060,positive regulation of sporocarp development involved in sexual reproduction,7,0.0,1.0,1.0,1
6641,GO:1902071,regulation of hypoxia-inducible factor-1alpha signaling pathway,7,0.0,1.0,1.0,2
6642,GO:1902105,regulation of leukocyte differentiation,7,0.0,1.0,1.0,5
6643,GO:1902116,negative regulation of organelle assembly,7,0.0,1.0,1.0,16
6644,GO:1902117,positive regulation of organelle assembly,7,0.0,1.0,1.0,15
6645,GO:1902119,regulation of meiotic spindle elongation,7,0.0,1.0,1.0,1
6646,GO:1902133,(+)-secoisolariciresinol metabolic process,7,0.0,1.0,1.0,2
6647,GO:1902136,(-)-secoisolariciresinol metabolic process,7,0.0,1.0,1.0,2
6648,GO:1902152,positive regulation of response to DNA integrity checkpoint signaling,7,0.0,1.0,1.0,1
6649,GO:1902153,regulation of response to DNA damage checkpoint signaling,7,0.0,1.0,1.0,3
6650,GO:1902172,regulation of keratinocyte apoptotic process,7,0.0,1.0,1.0,2
6651,GO:1902179,verruculogen metabolic process,7,0.0,1.0,1.0,1
6652,GO:1902205,regulation of interleukin-2-mediated signaling pathway,7,0.0,1.0,1.0,2
6653,GO:1902208,regulation of bacterial-type flagellum assembly,7,0.0,1.0,1.0,2
6654,GO:1902211,regulation of prolactin signaling pathway,7,0.0,1.0,1.0,2
6655,GO:1902214,regulation of interleukin-4-mediated signaling pathway,7,0.0,1.0,1.0,2
6656,GO:1902226,regulation of macrophage colony-stimulating factor signaling pathway,7,0.0,1.0,1.0,2
6657,GO:1902250,regulation of erythrocyte apoptotic process,7,0.0,1.0,1.0,2
6658,GO:1902285,semaphorin-plexin signaling pathway involved in neuron projection guidance,7,0.0,1.0,1.0,2
6659,GO:1902337,regulation of apoptotic process involved in morphogenesis,7,0.0,1.0,1.0,4
6660,GO:1902358,sulfate transmembrane transport,7,0.0,1.0,1.0,2
6661,GO:1902364,negative regulation of protein localization to spindle pole body,7,0.0,1.0,1.0,2
6662,GO:1902365,positive regulation of protein localization to spindle pole body,7,0.0,1.0,1.0,1
6663,GO:1902366,regulation of Notch signaling pathway involved in somitogenesis,7,0.0,1.0,1.0,1
6664,GO:1902412,regulation of mitotic cytokinesis,7,0.0,1.0,1.0,3
6665,GO:1902427,regulation of water channel activity,7,0.0,1.0,1.0,1
6666,GO:1902474,positive regulation of protein localization to synapse,7,0.0,1.0,1.0,1
6667,GO:1902475,L-alpha-amino acid transmembrane transport,7,0.0,1.0,1.0,27
6668,GO:1902490,regulation of sperm capacitation,7,0.0,1.0,1.0,2
6669,GO:1902532,negative regulation of intracellular signal transduction,7,0.0,1.0,1.0,29
6670,GO:1902533,positive regulation of intracellular signal transduction,7,0.0,1.0,1.0,41
6671,GO:1902542,regulation of protein localization to mitotic spindle pole body,7,0.0,1.0,1.0,1
6672,GO:1902562,H4 histone acetyltransferase complex,7,0.0,1.0,1.0,4
6673,GO:1902600,proton transmembrane transport,7,0.0,1.0,1.0,4
6674,GO:1902612,regulation of anti-Mullerian hormone signaling pathway,7,0.0,1.0,1.0,2
6675,GO:1902622,regulation of neutrophil migration,7,0.0,1.0,1.0,4
6676,GO:1902639,propan-2-ol metabolic process,7,0.0,1.0,1.0,1
6677,GO:1902660,negative regulation of glucose mediated signaling pathway,7,0.0,1.0,1.0,1
6678,GO:1902723,negative regulation of skeletal muscle satellite cell proliferation,7,0.0,1.0,1.0,1
6679,GO:1902724,positive regulation of skeletal muscle satellite cell proliferation,7,0.0,1.0,1.0,1
6680,GO:1902738,regulation of chondrocyte differentiation involved in endochondral bone morphogenesis,7,0.0,1.0,1.0,1
6681,GO:1902743,regulation of lamellipodium organization,7,0.0,1.0,1.0,4
6682,GO:1902749,regulation of cell cycle G2/M phase transition,7,0.0,1.0,1.0,4
6683,GO:1902757,bis(molybdopterin guanine dinucleotide)molybdenum metabolic process,7,0.0,1.0,1.0,1
6684,GO:1902767,isoprenoid biosynthetic process via mevalonate,7,0.0,1.0,1.0,1
6685,GO:1902774,late endosome to lysosome transport,7,0.0,1.0,1.0,1
6686,GO:1902806,regulation of cell cycle G1/S phase transition,7,0.0,1.0,1.0,3
6687,GO:1902822,regulation of late endosome to lysosome transport,7,0.0,1.0,1.0,2
6688,GO:1902838,regulation of nuclear migration along microtubule,7,0.0,1.0,1.0,3
6689,GO:1902850,microtubule cytoskeleton organization involved in mitosis,7,0.0,1.0,1.0,4
6690,GO:1902913,positive regulation of neuroepithelial cell differentiation,7,0.0,1.0,1.0,1
6691,GO:1902926,inulin metabolic process,7,0.0,1.0,1.0,2
6692,GO:1902931,negative regulation of alcohol biosynthetic process,7,0.0,1.0,1.0,13
6693,GO:1902932,positive regulation of alcohol biosynthetic process,7,0.0,1.0,1.0,15
6694,GO:1902946,protein localization to early endosome,7,0.0,1.0,1.0,1
6695,GO:1902950,regulation of dendritic spine maintenance,7,0.0,1.0,1.0,2
6696,GO:1902965,regulation of protein localization to early endosome,7,0.0,1.0,1.0,1
6697,GO:1902991,regulation of amyloid precursor protein catabolic process,7,0.0,1.0,1.0,5
6698,GO:1902994,regulation of phospholipid efflux,7,0.0,1.0,1.0,2
6699,GO:1903018,regulation of glycoprotein metabolic process,7,0.0,1.0,1.0,4
6700,GO:1903038,negative regulation of leukocyte cell-cell adhesion,7,0.0,1.0,1.0,5
6701,GO:1903039,positive regulation of leukocyte cell-cell adhesion,7,0.0,1.0,1.0,5
6702,GO:1903067,negative regulation of protein localization to cell tip,7,0.0,1.0,1.0,1
6703,GO:1903076,regulation of protein localization to plasma membrane,7,0.0,1.0,1.0,5
6704,GO:1903083,protein localization to condensed chromosome,7,0.0,1.0,1.0,2
6705,GO:1903085,regulation of sinapate ester biosynthetic process,7,0.0,1.0,1.0,1
6706,GO:1903090,pyridoxal transmembrane transport,7,0.0,1.0,1.0,1
6707,GO:1903092,pyridoxine transmembrane transport,7,0.0,1.0,1.0,1
6708,GO:1903119,protein localization to actin cytoskeleton,7,0.0,1.0,1.0,3
6709,GO:1903146,regulation of autophagy of mitochondrion,7,0.0,1.0,1.0,3
6710,GO:1903174,fatty alcohol catabolic process,7,0.0,1.0,1.0,1
6711,GO:1903175,fatty alcohol biosynthetic process,7,0.0,1.0,1.0,4
6712,GO:1903192,sesquarterpene metabolic process,7,0.0,1.0,1.0,1
6713,GO:1903336,negative regulation of vacuolar transport,7,0.0,1.0,1.0,3
6714,GO:1903337,positive regulation of vacuolar transport,7,0.0,1.0,1.0,3
6715,GO:1903388,regulation of synaptic vesicle uncoating,7,0.0,1.0,1.0,2
6716,GO:1903402,regulation of renal phosphate excretion,7,0.0,1.0,1.0,2
6717,GO:1903420,protein localization to endoplasmic reticulum tubular network,7,0.0,1.0,1.0,1
6718,GO:1903424,fluoride transmembrane transport,7,0.0,1.0,1.0,1
6719,GO:1903427,negative regulation of reactive oxygen species biosynthetic process,7,0.0,1.0,1.0,1
6720,GO:1903428,positive regulation of reactive oxygen species biosynthetic process,7,0.0,1.0,1.0,1
6721,GO:1903430,negative regulation of cell maturation,7,0.0,1.0,1.0,5
6722,GO:1903431,positive regulation of cell maturation,7,0.0,1.0,1.0,5
6723,GO:1903440,amylin receptor complex,7,0.0,1.0,1.0,3
6724,GO:1903441,protein localization to ciliary membrane,7,0.0,1.0,1.0,1
6725,GO:1903479,mitotic actomyosin contractile ring assembly actin filament organization,7,0.0,1.0,1.0,1
6726,GO:1903489,positive regulation of lactation,7,0.0,1.0,1.0,1
6727,GO:1903496,response to 11-deoxycorticosterone,7,0.0,1.0,1.0,1
6728,GO:1903531,negative regulation of secretion by cell,7,0.0,1.0,1.0,10
6729,GO:1903532,positive regulation of secretion by cell,7,0.0,1.0,1.0,10
6730,GO:1903533,regulation of protein targeting,7,0.0,1.0,1.0,4
6731,GO:1903551,regulation of extracellular exosome assembly,7,0.0,1.0,1.0,2
6732,GO:1903565,negative regulation of protein localization to cilium,7,0.0,1.0,1.0,1
6733,GO:1903566,positive regulation of protein localization to cilium,7,0.0,1.0,1.0,1
6734,GO:1903567,regulation of protein localization to ciliary membrane,7,0.0,1.0,1.0,2
6735,GO:1903573,negative regulation of response to endoplasmic reticulum stress,7,0.0,1.0,1.0,3
6736,GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,7,0.0,1.0,1.0,2
6737,GO:1903639,regulation of gastrin-induced gastric acid secretion,7,0.0,1.0,1.0,2
6738,GO:1903656,regulation of type IV pilus biogenesis,7,0.0,1.0,1.0,2
6739,GO:1903670,regulation of sprouting angiogenesis,7,0.0,1.0,1.0,2
6740,GO:1903684,regulation of border follicle cell migration,7,0.0,1.0,1.0,2
6741,GO:1903689,"regulation of wound healing, spreading of epidermal cells",7,0.0,1.0,1.0,2
6742,GO:1903707,negative regulation of hemopoiesis,7,0.0,1.0,1.0,2
6743,GO:1903708,positive regulation of hemopoiesis,7,0.0,1.0,1.0,1
6744,GO:1903711,spermidine transmembrane transport,7,0.0,1.0,1.0,1
6745,GO:1903713,asparagine transmembrane transport,7,0.0,1.0,1.0,2
6746,GO:1903715,regulation of aerobic respiration,7,0.0,1.0,1.0,2
6747,GO:1903725,regulation of phospholipid metabolic process,7,0.0,1.0,1.0,9
6748,GO:1903747,regulation of establishment of protein localization to mitochondrion,7,0.0,1.0,1.0,3
6749,GO:1903763,gap junction channel activity involved in cell communication by electrical coupling,7,0.0,1.0,1.0,1
6750,GO:1903778,protein localization to vacuolar membrane,7,0.0,1.0,1.0,1
6751,GO:1903779,regulation of cardiac conduction,7,0.0,1.0,1.0,3
6752,GO:1903789,regulation of amino acid transmembrane transport,7,0.0,1.0,1.0,2
6753,GO:1903792,negative regulation of monoatomic anion transport,7,0.0,1.0,1.0,3
6754,GO:1903793,positive regulation of monoatomic anion transport,7,0.0,1.0,1.0,2
6755,GO:1903796,negative regulation of inorganic anion transmembrane transport,7,0.0,1.0,1.0,2
6756,GO:1903797,positive regulation of inorganic anion transmembrane transport,7,0.0,1.0,1.0,4
6757,GO:1903850,regulation of cristae formation,7,0.0,1.0,1.0,2
6758,GO:1903881,regulation of interleukin-17-mediated signaling pathway,7,0.0,1.0,1.0,2
6759,GO:1903909,regulation of receptor clustering,7,0.0,1.0,1.0,4
6760,GO:1903930,regulation of pyrimidine-containing compound salvage,7,0.0,1.0,1.0,1
6761,GO:1903943,regulation of hepatocyte apoptotic process,7,0.0,1.0,1.0,2
6762,GO:1903959,regulation of monoatomic anion transmembrane transport,7,0.0,1.0,1.0,5
6763,GO:1903976,negative regulation of glial cell migration,7,0.0,1.0,1.0,4
6764,GO:1903977,positive regulation of glial cell migration,7,0.0,1.0,1.0,3
6765,GO:1903999,negative regulation of eating behavior,7,0.0,1.0,1.0,1
6766,GO:1904000,positive regulation of eating behavior,7,0.0,1.0,1.0,1
6767,GO:1904032,regulation of t-SNARE clustering,7,0.0,1.0,1.0,2
6768,GO:1904036,negative regulation of epithelial cell apoptotic process,7,0.0,1.0,1.0,6
6769,GO:1904037,positive regulation of epithelial cell apoptotic process,7,0.0,1.0,1.0,6
6770,GO:1904044,response to aldosterone,7,0.0,1.0,1.0,1
6771,GO:1904062,regulation of monoatomic cation transmembrane transport,7,0.0,1.0,1.0,10
6772,GO:1904082,pyrimidine nucleobase transmembrane transport,7,0.0,1.0,1.0,1
6773,GO:1904104,negative regulation of convergent extension involved in gastrulation,7,0.0,1.0,1.0,4
6774,GO:1904105,positive regulation of convergent extension involved in gastrulation,7,0.0,1.0,1.0,4
6775,GO:1904127,regulation of convergent extension involved in somitogenesis,7,0.0,1.0,1.0,2
6776,GO:1904130,regulation of convergent extension involved in neural plate elongation,7,0.0,1.0,1.0,2
6777,GO:1904133,regulation of convergent extension involved in rhombomere morphogenesis,7,0.0,1.0,1.0,2
6778,GO:1904136,regulation of convergent extension involved in notochord morphogenesis,7,0.0,1.0,1.0,2
6779,GO:1904149,regulation of microglial cell mediated cytotoxicity,7,0.0,1.0,1.0,2
6780,GO:1904192,regulation of cholangiocyte apoptotic process,7,0.0,1.0,1.0,2
6781,GO:1904201,regulation of iodide transport,7,0.0,1.0,1.0,3
6782,GO:1904248,regulation of age-related resistance,7,0.0,1.0,1.0,2
6783,GO:1904259,regulation of basement membrane assembly involved in embryonic body morphogenesis,7,0.0,1.0,1.0,2
6784,GO:1904282,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,7,0.0,1.0,1.0,2
6785,GO:1904339,negative regulation of dopaminergic neuron differentiation,7,0.0,1.0,1.0,1
6786,GO:1904340,positive regulation of dopaminergic neuron differentiation,7,0.0,1.0,1.0,1
6787,GO:1904376,negative regulation of protein localization to cell periphery,7,0.0,1.0,1.0,4
6788,GO:1904377,positive regulation of protein localization to cell periphery,7,0.0,1.0,1.0,4
6789,GO:1904397,negative regulation of neuromuscular junction development,7,0.0,1.0,1.0,1
6790,GO:1904398,positive regulation of neuromuscular junction development,7,0.0,1.0,1.0,1
6791,GO:1904448,regulation of aspartate secretion,7,0.0,1.0,1.0,2
6792,GO:1904461,ergosteryl 3-beta-D-glucoside metabolic process,7,0.0,1.0,1.0,2
6793,GO:1904479,negative regulation of intestinal absorption,7,0.0,1.0,1.0,1
6794,GO:1904480,positive regulation of intestinal absorption,7,0.0,1.0,1.0,1
6795,GO:1904491,protein localization to ciliary transition zone,7,0.0,1.0,1.0,1
6796,GO:1904508,regulation of protein localization to basolateral plasma membrane,7,0.0,1.0,1.0,2
6797,GO:1904542,regulation of free ubiquitin chain polymerization,7,0.0,1.0,1.0,2
6798,GO:1904603,regulation of advanced glycation end-product receptor activity,7,0.0,1.0,1.0,1
6799,GO:1904633,regulation of podocyte apoptotic process,7,0.0,1.0,1.0,2
6800,GO:1904656,regulation of sensory perception of sweet taste,7,0.0,1.0,1.0,2
6801,GO:1904660,regulation of sensory perception of bitter taste,7,0.0,1.0,1.0,2
6802,GO:1904702,regulation of protein localization to adherens junction,7,0.0,1.0,1.0,2
6803,GO:1904708,regulation of granulosa cell apoptotic process,7,0.0,1.0,1.0,2
6804,GO:1904729,regulation of intestinal lipid absorption,7,0.0,1.0,1.0,3
6805,GO:1904734,positive regulation of electron transfer activity,7,0.0,1.0,1.0,1
6806,GO:1904746,negative regulation of apoptotic process involved in development,7,0.0,1.0,1.0,6
6807,GO:1904747,positive regulation of apoptotic process involved in development,7,0.0,1.0,1.0,6
6808,GO:1904749,regulation of protein localization to nucleolus,7,0.0,1.0,1.0,2
6809,GO:1904752,regulation of vascular associated smooth muscle cell migration,7,0.0,1.0,1.0,2
6810,GO:1904755,regulation of gut granule assembly,7,0.0,1.0,1.0,2
6811,GO:1904776,regulation of protein localization to cell cortex,7,0.0,1.0,1.0,5
6812,GO:1904810,negative regulation of dense core granule transport,7,0.0,1.0,1.0,2
6813,GO:1904811,positive regulation of dense core granule transport,7,0.0,1.0,1.0,2
6814,GO:1904815,"negative regulation of protein localization to chromosome, telomeric region",7,0.0,1.0,1.0,1
6815,GO:1904816,"positive regulation of protein localization to chromosome, telomeric region",7,0.0,1.0,1.0,1
6816,GO:1904823,purine nucleobase transmembrane transport,7,0.0,1.0,1.0,2
6817,GO:1904848,negative regulation of cell chemotaxis to fibroblast growth factor,7,0.0,1.0,1.0,1
6818,GO:1904849,positive regulation of cell chemotaxis to fibroblast growth factor,7,0.0,1.0,1.0,1
6819,GO:1904869,regulation of protein localization to Cajal body,7,0.0,1.0,1.0,2
6820,GO:1904889,regulation of excitatory synapse assembly,7,0.0,1.0,1.0,3
6821,GO:1904893,negative regulation of receptor signaling pathway via STAT,7,0.0,1.0,1.0,1
6822,GO:1904894,positive regulation of receptor signaling pathway via STAT,7,0.0,1.0,1.0,1
6823,GO:1904904,regulation of endothelial cell-matrix adhesion via fibronectin,7,0.0,1.0,1.0,2
6824,GO:1904950,negative regulation of establishment of protein localization,7,0.0,1.0,1.0,4
6825,GO:1904951,positive regulation of establishment of protein localization,7,0.0,1.0,1.0,4
6826,GO:1904956,regulation of midbrain dopaminergic neuron differentiation,7,0.0,1.0,1.0,2
6827,GO:1904965,regulation of vitamin E biosynthetic process,7,0.0,1.0,1.0,1
6828,GO:1904967,regulation of spindle attachment to meiosis I kinetochore,7,0.0,1.0,1.0,1
6829,GO:1904979,negative regulation of endosome organization,7,0.0,1.0,1.0,1
6830,GO:1904980,positive regulation of endosome organization,7,0.0,1.0,1.0,1
6831,GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,7,0.0,1.0,1.0,4
6832,GO:1905000,regulation of membrane repolarization during atrial cardiac muscle cell action potential,7,0.0,1.0,1.0,2
6833,GO:1905005,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,7,0.0,1.0,1.0,2
6834,GO:1905024,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,7,0.0,1.0,1.0,2
6835,GO:1905027,regulation of membrane depolarization during AV node cell action potential,7,0.0,1.0,1.0,2
6836,GO:1905032,negative regulation of membrane repolarization during cardiac muscle cell action potential,7,0.0,1.0,1.0,2
6837,GO:1905033,positive regulation of membrane repolarization during cardiac muscle cell action potential,7,0.0,1.0,1.0,2
6838,GO:1905034,regulation of antifungal innate immune response,7,0.0,1.0,1.0,2
6839,GO:1905038,regulation of membrane lipid metabolic process,7,0.0,1.0,1.0,3
6840,GO:1905044,regulation of Schwann cell proliferation involved in axon regeneration,7,0.0,1.0,1.0,2
6841,GO:1905063,regulation of vascular associated smooth muscle cell differentiation,7,0.0,1.0,1.0,5
6842,GO:1905071,tight junction disassembly,7,0.0,1.0,1.0,1
6843,GO:1905098,negative regulation of guanyl-nucleotide exchange factor activity,7,0.0,1.0,1.0,1
6844,GO:1905099,positive regulation of guanyl-nucleotide exchange factor activity,7,0.0,1.0,1.0,1
6845,GO:1905147,regulation of smooth muscle hypertrophy,7,0.0,1.0,1.0,2
6846,GO:1905278,positive regulation of epithelial tube formation,7,0.0,1.0,1.0,2
6847,GO:1905293,negative regulation of neural crest cell differentiation,7,0.0,1.0,1.0,1
6848,GO:1905294,positive regulation of neural crest cell differentiation,7,0.0,1.0,1.0,1
6849,GO:1905295,regulation of neural crest cell fate specification,7,0.0,1.0,1.0,2
6850,GO:1905323,telomerase holoenzyme complex assembly,7,0.0,1.0,1.0,1
6851,GO:1905342,positive regulation of protein localization to kinetochore,7,0.0,1.0,1.0,1
6852,GO:1905364,regulation of endosomal vesicle fusion,7,0.0,1.0,1.0,2
6853,GO:1905365,regulation of intralumenal vesicle formation,7,0.0,1.0,1.0,2
6854,GO:1905371,ceramide phosphoethanolamine metabolic process,7,0.0,1.0,1.0,2
6855,GO:1905377,response to D-galactose,7,0.0,1.0,1.0,1
6856,GO:1905383,protein localization to presynapse,7,0.0,1.0,1.0,2
6857,GO:1905384,regulation of protein localization to presynapse,7,0.0,1.0,1.0,2
6858,GO:1905407,regulation of creatine transmembrane transporter activity,7,0.0,1.0,1.0,1
6859,GO:1905449,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,7,0.0,1.0,1.0,2
6860,GO:1905457,negative regulation of lymphoid progenitor cell differentiation,7,0.0,1.0,1.0,2
6861,GO:1905458,positive regulation of lymphoid progenitor cell differentiation,7,0.0,1.0,1.0,2
6862,GO:1905462,regulation of DNA duplex unwinding,7,0.0,1.0,1.0,3
6863,GO:1905465,regulation of G-quadruplex DNA unwinding,7,0.0,1.0,1.0,2
6864,GO:1905476,negative regulation of protein localization to membrane,7,0.0,1.0,1.0,7
6865,GO:1905477,positive regulation of protein localization to membrane,7,0.0,1.0,1.0,7
6866,GO:1905483,regulation of motor neuron migration,7,0.0,1.0,1.0,3
6867,GO:1905553,regulation of blood vessel branching,7,0.0,1.0,1.0,2
6868,GO:1905562,regulation of vascular endothelial cell proliferation,7,0.0,1.0,1.0,2
6869,GO:1905578,regulation of ERBB3 signaling pathway,7,0.0,1.0,1.0,2
6870,GO:1905582,response to mannose,7,0.0,1.0,1.0,1
6871,GO:1905585,regulation of outer hair cell apoptotic process,7,0.0,1.0,1.0,2
6872,GO:1905606,regulation of presynapse assembly,7,0.0,1.0,1.0,2
6873,GO:1905668,positive regulation of protein localization to endosome,7,0.0,1.0,1.0,1
6874,GO:1905671,regulation of lysosome organization,7,0.0,1.0,1.0,2
6875,GO:1905680,regulation of innate immunity memory response,7,0.0,1.0,1.0,2
6876,GO:1905702,regulation of inhibitory synapse assembly,7,0.0,1.0,1.0,2
6877,GO:1905777,regulation of exonuclease activity,7,0.0,1.0,1.0,5
6878,GO:1905787,regulation of detection of mechanical stimulus involved in sensory perception of touch,7,0.0,1.0,1.0,2
6879,GO:1905807,negative regulation of synapse pruning,7,0.0,1.0,1.0,1
6880,GO:1905810,regulation of excitatory synapse pruning,7,0.0,1.0,1.0,1
6881,GO:1905818,regulation of chromosome separation,7,0.0,1.0,1.0,4
6882,GO:1905825,regulation of selenocysteine metabolic process,7,0.0,1.0,1.0,2
6883,GO:1905874,regulation of postsynaptic density organization,7,0.0,1.0,1.0,4
6884,GO:1905883,regulation of triglyceride transport,7,0.0,1.0,1.0,2
6885,GO:1905898,positive regulation of response to endoplasmic reticulum stress,7,0.0,1.0,1.0,3
6886,GO:1905906,regulation of amyloid fibril formation,7,0.0,1.0,1.0,2
6887,GO:1905921,regulation of acetylcholine biosynthetic process,7,0.0,1.0,1.0,2
6888,GO:1905934,negative regulation of cell fate determination,7,0.0,1.0,1.0,1
6889,GO:1990005,granular vesicle,7,0.0,1.0,1.0,1
6890,GO:1990173,protein localization to nucleoplasm,7,0.0,1.0,1.0,1
6891,GO:1990238,double-stranded DNA endonuclease activity,7,0.0,1.0,1.0,1
6892,GO:1990266,neutrophil migration,7,0.0,1.0,1.0,3
6893,GO:1990470,piRNA cluster binding,7,0.0,1.0,1.0,2
6894,GO:1990896,protein localization to cell cortex of cell tip,7,0.0,1.0,1.0,1
6895,GO:2000023,regulation of lateral root development,7,0.0,1.0,1.0,2
6896,GO:2000034,regulation of seed maturation,7,0.0,1.0,1.0,3
6897,GO:2000050,regulation of non-canonical Wnt signaling pathway,7,0.0,1.0,1.0,5
6898,GO:2000061,regulation of ureter smooth muscle cell differentiation,7,0.0,1.0,1.0,2
6899,GO:2000073,"regulation of cytokinesis, site selection",7,0.0,1.0,1.0,3
6900,GO:2000084,regulation of mesenchymal to epithelial transition involved in mesonephros morphogenesis,7,0.0,1.0,1.0,2
6901,GO:2000090,regulation of mesonephric glomerular mesangial cell proliferation,7,0.0,1.0,1.0,2
6902,GO:2000097,regulation of smooth muscle cell-matrix adhesion,7,0.0,1.0,1.0,2
6903,GO:2000107,negative regulation of leukocyte apoptotic process,7,0.0,1.0,1.0,5
6904,GO:2000108,positive regulation of leukocyte apoptotic process,7,0.0,1.0,1.0,5
6905,GO:2000109,regulation of macrophage apoptotic process,7,0.0,1.0,1.0,2
6906,GO:2000121,regulation of removal of superoxide radicals,7,0.0,1.0,1.0,2
6907,GO:2000125,regulation of octopamine or tyramine signaling pathway,7,0.0,1.0,1.0,4
6908,GO:2000181,negative regulation of blood vessel morphogenesis,7,0.0,1.0,1.0,3
6909,GO:2000185,regulation of phosphate transmembrane transport,7,0.0,1.0,1.0,2
6910,GO:2000192,negative regulation of fatty acid transport,7,0.0,1.0,1.0,2
6911,GO:2000193,positive regulation of fatty acid transport,7,0.0,1.0,1.0,2
6912,GO:2000200,regulation of ribosomal subunit export from nucleus,7,0.0,1.0,1.0,4
6913,GO:2000217,regulation of invasive growth in response to glucose limitation,7,0.0,1.0,1.0,2
6914,GO:2000220,regulation of pseudohyphal growth,7,0.0,1.0,1.0,2
6915,GO:2000244,regulation of FtsZ-dependent cytokinesis,7,0.0,1.0,1.0,2
6916,GO:2000272,negative regulation of signaling receptor activity,7,0.0,1.0,1.0,6
6917,GO:2000273,positive regulation of signaling receptor activity,7,0.0,1.0,1.0,7
6918,GO:2000282,regulation of amino acid biosynthetic process,7,0.0,1.0,1.0,12
6919,GO:2000292,regulation of defecation,7,0.0,1.0,1.0,3
6920,GO:2000295,regulation of hydrogen peroxide catabolic process,7,0.0,1.0,1.0,2
6921,GO:2000313,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,7,0.0,1.0,1.0,2
6922,GO:2000316,regulation of T-helper 17 type immune response,7,0.0,1.0,1.0,3
6923,GO:2000331,regulation of terminal button organization,7,0.0,1.0,1.0,2
6924,GO:2000356,regulation of kidney smooth muscle cell differentiation,7,0.0,1.0,1.0,2
6925,GO:2000398,regulation of thymocyte aggregation,7,0.0,1.0,1.0,2
6926,GO:2000416,regulation of eosinophil migration,7,0.0,1.0,1.0,4
6927,GO:2000428,regulation of neutrophil aggregation,7,0.0,1.0,1.0,2
6928,GO:2000446,regulation of macrophage migration inhibitory factor signaling pathway,7,0.0,1.0,1.0,2
6929,GO:2000458,regulation of astrocyte chemotaxis,7,0.0,1.0,1.0,2
6930,GO:2000474,regulation of opioid receptor signaling pathway,7,0.0,1.0,1.0,3
6931,GO:2000485,regulation of glutamine transport,7,0.0,1.0,1.0,3
6932,GO:2000492,regulation of interleukin-18-mediated signaling pathway,7,0.0,1.0,1.0,2
6933,GO:2000520,regulation of immunological synapse formation,7,0.0,1.0,1.0,2
6934,GO:2000583,regulation of platelet-derived growth factor receptor-alpha signaling pathway,7,0.0,1.0,1.0,2
6935,GO:2000586,regulation of platelet-derived growth factor receptor-beta signaling pathway,7,0.0,1.0,1.0,2
6936,GO:2000591,positive regulation of metanephric mesenchymal cell migration,7,0.0,1.0,1.0,1
6937,GO:2000607,negative regulation of cell proliferation involved in mesonephros development,7,0.0,1.0,1.0,1
6938,GO:2000608,positive regulation of cell proliferation involved in mesonephros development,7,0.0,1.0,1.0,1
6939,GO:2000638,regulation of SREBP signaling pathway,7,0.0,1.0,1.0,2
6940,GO:2000645,negative regulation of receptor catabolic process,7,0.0,1.0,1.0,1
6941,GO:2000646,positive regulation of receptor catabolic process,7,0.0,1.0,1.0,1
6942,GO:2000659,regulation of interleukin-1-mediated signaling pathway,7,0.0,1.0,1.0,2
6943,GO:2000668,regulation of dendritic cell apoptotic process,7,0.0,1.0,1.0,2
6944,GO:2000671,regulation of motor neuron apoptotic process,7,0.0,1.0,1.0,2
6945,GO:2000674,regulation of type B pancreatic cell apoptotic process,7,0.0,1.0,1.0,2
6946,GO:2000690,regulation of cardiac muscle cell myoblast differentiation,7,0.0,1.0,1.0,2
6947,GO:2000697,negative regulation of epithelial cell differentiation involved in kidney development,7,0.0,1.0,1.0,3
6948,GO:2000698,positive regulation of epithelial cell differentiation involved in kidney development,7,0.0,1.0,1.0,3
6949,GO:2000702,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,7,0.0,1.0,1.0,2
6950,GO:2000725,regulation of cardiac muscle cell differentiation,7,0.0,1.0,1.0,3
6951,GO:2000740,negative regulation of mesenchymal stem cell differentiation,7,0.0,1.0,1.0,1
6952,GO:2000741,positive regulation of mesenchymal stem cell differentiation,7,0.0,1.0,1.0,1
6953,GO:2000769,regulation of establishment or maintenance of cell polarity regulating cell shape,7,0.0,1.0,1.0,4
6954,GO:2000785,regulation of autophagosome assembly,7,0.0,1.0,1.0,2
6955,GO:2000797,regulation of amniotic stem cell differentiation,7,0.0,1.0,1.0,2
6956,GO:2000874,regulation of glyoxylate cycle,7,0.0,1.0,1.0,2
6957,GO:2000877,negative regulation of oligopeptide transport,7,0.0,1.0,1.0,1
6958,GO:2000878,positive regulation of oligopeptide transport,7,0.0,1.0,1.0,1
6959,GO:2000889,cellodextrin metabolic process,7,0.0,1.0,1.0,1
6960,GO:2000891,cellobiose metabolic process,7,0.0,1.0,1.0,1
6961,GO:2000900,cyclodextrin metabolic process,7,0.0,1.0,1.0,1
6962,GO:2000909,regulation of sterol import,7,0.0,1.0,1.0,2
6963,GO:2000930,regulation of cellobiose metabolic process,7,0.0,1.0,1.0,3
6964,GO:2000943,negative regulation of amylopectin metabolic process,7,0.0,1.0,1.0,1
6965,GO:2000944,positive regulation of amylopectin metabolic process,7,0.0,1.0,1.0,1
6966,GO:2000945,regulation of amylopectin catabolic process,7,0.0,1.0,1.0,2
6967,GO:2000960,regulation of cellooligosaccharide metabolic process,7,0.0,1.0,1.0,3
6968,GO:2000973,regulation of pro-B cell differentiation,7,0.0,1.0,1.0,2
6969,GO:2000980,regulation of inner ear receptor cell differentiation,7,0.0,1.0,1.0,3
6970,GO:2001018,negative regulation of retrograde axon cargo transport,7,0.0,1.0,1.0,1
6971,GO:2001019,positive regulation of retrograde axon cargo transport,7,0.0,1.0,1.0,1
6972,GO:2001026,regulation of endothelial cell chemotaxis,7,0.0,1.0,1.0,3
6973,GO:2001029,regulation of cellular glucuronidation,7,0.0,1.0,1.0,2
6974,GO:2001054,negative regulation of mesenchymal cell apoptotic process,7,0.0,1.0,1.0,2
6975,GO:2001055,positive regulation of mesenchymal cell apoptotic process,7,0.0,1.0,1.0,2
6976,GO:2001118,tetrahydromethanopterin biosynthetic process,7,0.0,1.0,1.0,2
6977,GO:2001136,negative regulation of endocytic recycling,7,0.0,1.0,1.0,1
6978,GO:2001137,positive regulation of endocytic recycling,7,0.0,1.0,1.0,1
6979,GO:2001139,negative regulation of phospholipid transport,7,0.0,1.0,1.0,2
6980,GO:2001140,positive regulation of phospholipid transport,7,0.0,1.0,1.0,2
6981,GO:2001204,regulation of osteoclast development,7,0.0,1.0,1.0,2
6982,GO:2001223,negative regulation of neuron migration,7,0.0,1.0,1.0,1
6983,GO:2001224,positive regulation of neuron migration,7,0.0,1.0,1.0,1
6984,GO:2001225,regulation of chloride transport,7,0.0,1.0,1.0,2
6985,GO:2001234,negative regulation of apoptotic signaling pathway,7,0.0,1.0,1.0,5
6986,GO:2001235,positive regulation of apoptotic signaling pathway,7,0.0,1.0,1.0,2
6987,GO:2001236,regulation of extrinsic apoptotic signaling pathway,7,0.0,1.0,1.0,4
6988,GO:2001242,regulation of intrinsic apoptotic signaling pathway,7,0.0,1.0,1.0,9
6989,GO:2001251,negative regulation of chromosome organization,7,0.0,1.0,1.0,8
6990,GO:2001252,positive regulation of chromosome organization,7,0.0,1.0,1.0,10
6991,GO:2001262,positive regulation of semaphorin-plexin signaling pathway,7,0.0,1.0,1.0,1
6992,GO:2001286,regulation of caveolin-mediated endocytosis,7,0.0,1.0,1.0,2
6993,GO:2001301,lipoxin biosynthetic process,7,0.0,1.0,1.0,2
6994,GO:2001311,lysobisphosphatidic acid metabolic process,7,0.0,1.0,1.0,1
27,GO:0034370,triglyceride-rich lipoprotein particle remodeling,8,6727.26,1441.55,7.012738290522253e-44,3
57,GO:0019376,galactolipid catabolic process,8,1922.07,1922.07,4.846683615800979e-19,1
11,GO:0019433,triglyceride catabolic process,8,1774.22,1774.22,1.9046441725464945e-72,0
31,GO:0034375,high-density lipoprotein particle remodeling,8,961.04,961.04,1.2051986860389742e-35,1
162,GO:0001817,regulation of cytokine production,8,820.4,15.3,3.059543580579957e-06,52
214,GO:0010628,positive regulation of gene expression,8,820.4,6.0,0.0005193589713344,17
87,GO:0034638,phosphatidylcholine catabolic process,8,509.64,509.64,5.688084055625789e-13,0
112,GO:0034374,low-density lipoprotein particle remodeling,8,427.13,427.13,2.6823603137578855e-10,0
232,GO:0036150,phosphatidylserine acyl-chain remodeling,8,354.07,354.07,0.0028206019375102,0
156,GO:0032376,positive regulation of cholesterol transport,8,134.55,134.55,1.717786429448706e-06,4
206,GO:0006654,phosphatidic acid biosynthetic process,8,92.79,92.79,0.0002247483078426,0
254,GO:0015012,heparan sulfate proteoglycan biosynthetic process,8,73.12,73.12,0.0135847374961065,0
290,GO:0019432,triglyceride biosynthetic process,8,24.03,24.03,0.0407805027897787,0
183,GO:0005769,early endosome,8,21.07,21.07,4.330230930852493e-05,1
76,GO:0006631,fatty acid metabolic process,8,17.18,14.02,4.971672690014945e-15,15
107,GO:0072330,monocarboxylic acid biosynthetic process,8,17.18,9.86,1.5804360123001086e-10,51
322,GO:0005770,late endosome,8,7.05,7.05,0.1323304659302319,1
2932,GO:0000012,single strand break repair,8,0.0,1.0,1.0,2
2933,GO:0000018,regulation of DNA recombination,8,0.0,1.0,1.0,9
2934,GO:0000052,citrulline metabolic process,8,0.0,1.0,1.0,2
2935,GO:0000054,ribosomal subunit export from nucleus,8,0.0,1.0,1.0,2
2936,GO:0000075,cell cycle checkpoint signaling,8,0.0,1.0,1.0,4
2937,GO:0000097,sulfur amino acid biosynthetic process,8,0.0,1.0,1.0,4
2938,GO:0000098,sulfur amino acid catabolic process,8,0.0,1.0,1.0,4
2939,GO:0000175,3'-5'-RNA exonuclease activity,8,0.0,1.0,1.0,4
2940,GO:0000179,"rRNA (adenine-N6,N6-)-dimethyltransferase activity",8,0.0,1.0,1.0,2
2941,GO:0000212,meiotic spindle organization,8,0.0,1.0,1.0,2
2942,GO:0000235,astral microtubule,8,0.0,1.0,1.0,2
2943,GO:0000389,mRNA 3'-splice site recognition,8,0.0,1.0,1.0,1
2944,GO:0000395,mRNA 5'-splice site recognition,8,0.0,1.0,1.0,1
2945,GO:0000706,meiotic DNA double-strand break processing,8,0.0,1.0,1.0,2
2946,GO:0000707,meiotic DNA recombinase assembly,8,0.0,1.0,1.0,3
2947,GO:0000708,meiotic strand invasion,8,0.0,1.0,1.0,2
2948,GO:0000714,meiotic strand displacement,8,0.0,1.0,1.0,1
2949,GO:0000725,recombinational repair,8,0.0,1.0,1.0,4
2950,GO:0000731,DNA synthesis involved in DNA repair,8,0.0,1.0,1.0,5
2951,GO:0000921,septin ring assembly,8,0.0,1.0,1.0,1
2952,GO:0000948,amino acid catabolic process to carboxylic acid via Ehrlich pathway,8,0.0,1.0,1.0,3
2953,GO:0000957,mitochondrial RNA catabolic process,8,0.0,1.0,1.0,2
2954,GO:0000960,regulation of mitochondrial RNA catabolic process,8,0.0,1.0,1.0,3
2955,GO:0000964,mitochondrial RNA 5'-end processing,8,0.0,1.0,1.0,1
2956,GO:0000965,mitochondrial RNA 3'-end processing,8,0.0,1.0,1.0,2
2957,GO:0000977,RNA polymerase II transcription regulatory region sequence-specific DNA binding,8,0.0,1.0,1.0,3
2958,GO:0000987,cis-regulatory region sequence-specific DNA binding,8,0.0,1.0,1.0,2
2959,GO:0001016,RNA polymerase III transcription regulatory region sequence-specific DNA binding,8,0.0,1.0,1.0,1
2960,GO:0001046,core promoter sequence-specific DNA binding,8,0.0,1.0,1.0,2
2961,GO:0001064,single subunit type RNA polymerase activity,8,0.0,1.0,1.0,2
2962,GO:0001109,promoter clearance during DNA-templated transcription,8,0.0,1.0,1.0,3
2963,GO:0001161,intronic transcription regulatory region sequence-specific DNA binding,8,0.0,1.0,1.0,1
2964,GO:0001163,RNA polymerase I transcription regulatory region sequence-specific DNA binding,8,0.0,1.0,1.0,2
2965,GO:0001172,RNA-templated transcription,8,0.0,1.0,1.0,1
2966,GO:0001173,DNA-templated transcriptional start site selection,8,0.0,1.0,1.0,2
2967,GO:0001192,maintenance of transcriptional fidelity during transcription elongation,8,0.0,1.0,1.0,2
2968,GO:0001408,guanine nucleotide transport,8,0.0,1.0,1.0,2
2969,GO:0001510,RNA methylation,8,0.0,1.0,1.0,5
2970,GO:0001522,pseudouridine synthesis,8,0.0,1.0,1.0,4
2971,GO:0001523,retinoid metabolic process,8,0.0,1.0,1.0,4
2972,GO:0001573,ganglioside metabolic process,8,0.0,1.0,1.0,2
2973,GO:0001575,globoside metabolic process,8,0.0,1.0,1.0,1
2974,GO:0001845,phagolysosome assembly,8,0.0,1.0,1.0,1
2975,GO:0001866,NK T cell proliferation,8,0.0,1.0,1.0,1
2976,GO:0001914,regulation of T cell mediated cytotoxicity,8,0.0,1.0,1.0,4
2977,GO:0001932,regulation of protein phosphorylation,8,0.0,1.0,1.0,12
2978,GO:0001956,positive regulation of neurotransmitter secretion,8,0.0,1.0,1.0,6
2979,GO:0002012,vasoconstriction of artery involved in chemoreceptor response to lowering of systemic arterial blood pressure,8,0.0,1.0,1.0,2
2980,GO:0002016,regulation of blood volume by renin-angiotensin,8,0.0,1.0,1.0,2
2981,GO:0002031,G protein-coupled receptor internalization,8,0.0,1.0,1.0,1
2982,GO:0002082,regulation of oxidative phosphorylation,8,0.0,1.0,1.0,2
2983,GO:0002090,regulation of receptor internalization,8,0.0,1.0,1.0,4
2984,GO:0002218,activation of innate immune response,8,0.0,1.0,1.0,3
2985,GO:0002228,natural killer cell mediated immunity,8,0.0,1.0,1.0,3
2986,GO:0002288,NK T cell activation involved in immune response,8,0.0,1.0,1.0,1
2987,GO:0002292,T cell differentiation involved in immune response,8,0.0,1.0,1.0,3
2988,GO:0002310,alpha-beta T cell proliferation involved in immune response,8,0.0,1.0,1.0,1
2989,GO:0002327,immature B cell differentiation,8,0.0,1.0,1.0,2
2990,GO:0002335,mature B cell differentiation,8,0.0,1.0,1.0,2
2991,GO:0002369,T cell cytokine production,8,0.0,1.0,1.0,1
2992,GO:0002371,dendritic cell cytokine production,8,0.0,1.0,1.0,2
2993,GO:0002381,immunoglobulin production involved in immunoglobulin-mediated immune response,8,0.0,1.0,1.0,1
2994,GO:0002401,tolerance induction in mucosal-associated lymphoid tissue,8,0.0,1.0,1.0,3
2995,GO:0002408,myeloid dendritic cell chemotaxis,8,0.0,1.0,1.0,1
2996,GO:0002429,immune response-activating cell surface receptor signaling pathway,8,0.0,1.0,1.0,4
2997,GO:0002441,histamine secretion involved in inflammatory response,8,0.0,1.0,1.0,4
2998,GO:0002442,serotonin secretion involved in inflammatory response,8,0.0,1.0,1.0,3
2999,GO:0002445,type II hypersensitivity,8,0.0,1.0,1.0,2
3000,GO:0002516,B cell deletion,8,0.0,1.0,1.0,2
3001,GO:0002518,lymphocyte chemotaxis across high endothelial venule,8,0.0,1.0,1.0,1
3002,GO:0002622,regulation of B cell antigen processing and presentation,8,0.0,1.0,1.0,2
3003,GO:0002625,regulation of T cell antigen processing and presentation,8,0.0,1.0,1.0,2
3004,GO:0002631,regulation of granuloma formation,8,0.0,1.0,1.0,2
3005,GO:0002653,negative regulation of tolerance induction dependent upon immune response,8,0.0,1.0,1.0,2
3006,GO:0002654,positive regulation of tolerance induction dependent upon immune response,8,0.0,1.0,1.0,2
3007,GO:0002655,regulation of tolerance induction to nonself antigen,8,0.0,1.0,1.0,2
3008,GO:0002658,regulation of peripheral tolerance induction,8,0.0,1.0,1.0,6
3009,GO:0002674,negative regulation of acute inflammatory response,8,0.0,1.0,1.0,4
3010,GO:0002675,positive regulation of acute inflammatory response,8,0.0,1.0,1.0,4
3011,GO:0002677,negative regulation of chronic inflammatory response,8,0.0,1.0,1.0,3
3012,GO:0002678,positive regulation of chronic inflammatory response,8,0.0,1.0,1.0,3
3013,GO:0002689,negative regulation of leukocyte chemotaxis,8,0.0,1.0,1.0,6
3014,GO:0002690,positive regulation of leukocyte chemotaxis,8,0.0,1.0,1.0,6
3015,GO:0002692,negative regulation of cellular extravasation,8,0.0,1.0,1.0,5
3016,GO:0002693,positive regulation of cellular extravasation,8,0.0,1.0,1.0,4
3017,GO:0002700,regulation of production of molecular mediator of immune response,8,0.0,1.0,1.0,7
3018,GO:0002710,negative regulation of T cell mediated immunity,8,0.0,1.0,1.0,6
3019,GO:0002711,positive regulation of T cell mediated immunity,8,0.0,1.0,1.0,7
3020,GO:0002713,negative regulation of B cell mediated immunity,8,0.0,1.0,1.0,5
3021,GO:0002714,positive regulation of B cell mediated immunity,8,0.0,1.0,1.0,5
3022,GO:0002716,negative regulation of natural killer cell mediated immunity,8,0.0,1.0,1.0,3
3023,GO:0002717,positive regulation of natural killer cell mediated immunity,8,0.0,1.0,1.0,3
3024,GO:0002761,regulation of myeloid leukocyte differentiation,8,0.0,1.0,1.0,7
3025,GO:0002776,antimicrobial peptide secretion,8,0.0,1.0,1.0,2
3026,GO:0002826,negative regulation of T-helper 1 type immune response,8,0.0,1.0,1.0,2
3027,GO:0002827,positive regulation of T-helper 1 type immune response,8,0.0,1.0,1.0,1
3028,GO:0002840,regulation of T cell mediated immune response to tumor cell,8,0.0,1.0,1.0,4
3029,GO:0002855,regulation of natural killer cell mediated immune response to tumor cell,8,0.0,1.0,1.0,3
3030,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,8,0.0,1.0,1.0,2
3031,GO:0002863,positive regulation of inflammatory response to antigenic stimulus,8,0.0,1.0,1.0,2
3032,GO:0002864,regulation of acute inflammatory response to antigenic stimulus,8,0.0,1.0,1.0,3
3033,GO:0002874,regulation of chronic inflammatory response to antigenic stimulus,8,0.0,1.0,1.0,2
3034,GO:0002877,regulation of acute inflammatory response to non-antigenic stimulus,8,0.0,1.0,1.0,2
3035,GO:0002880,regulation of chronic inflammatory response to non-antigenic stimulus,8,0.0,1.0,1.0,2
3036,GO:0002889,regulation of immunoglobulin mediated immune response,8,0.0,1.0,1.0,8
3037,GO:0002902,regulation of B cell apoptotic process,8,0.0,1.0,1.0,4
3038,GO:0003053,circadian regulation of heart rate,8,0.0,1.0,1.0,1
3039,GO:0003056,regulation of vascular associated smooth muscle contraction,8,0.0,1.0,1.0,4
3040,GO:0003057,regulation of the force of heart contraction by chemical signal,8,0.0,1.0,1.0,3
3041,GO:0003062,regulation of heart rate by chemical signal,8,0.0,1.0,1.0,4
3042,GO:0003096,renal sodium ion transport,8,0.0,1.0,1.0,1
3043,GO:0003115,regulation of vasoconstriction by epinephrine,8,0.0,1.0,1.0,2
3044,GO:0003116,regulation of vasoconstriction by norepinephrine,8,0.0,1.0,1.0,2
3045,GO:0003363,lamellipodium assembly involved in ameboidal cell migration,8,0.0,1.0,1.0,1
3046,GO:0003380,establishment or maintenance of cytoskeleton polarity involved in gastrulation,8,0.0,1.0,1.0,1
3047,GO:0003390,dendrite development by retrograde extension,8,0.0,1.0,1.0,1
3048,GO:0003880,protein C-terminal carboxyl O-methyltransferase activity,8,0.0,1.0,1.0,2
3049,GO:0004032,aldose reductase (NADPH) activity,8,0.0,1.0,1.0,2
3050,GO:0004115,"3',5'-cyclic-AMP phosphodiesterase activity",8,0.0,1.0,1.0,2
3051,GO:0004445,inositol-polyphosphate 5-phosphatase activity,8,0.0,1.0,1.0,2
3052,GO:0004596,peptide alpha-N-acetyltransferase activity,8,0.0,1.0,1.0,5
3053,GO:0004723,calcium-dependent protein serine/threonine phosphatase activity,8,0.0,1.0,1.0,1
3054,GO:0005003,ephrin receptor activity,8,0.0,1.0,1.0,2
3055,GO:0005017,platelet-derived growth factor receptor activity,8,0.0,1.0,1.0,2
3056,GO:0005024,transforming growth factor beta receptor activity,8,0.0,1.0,1.0,3
3057,GO:0005217,intracellularly ligand-gated monoatomic ion channel activity,8,0.0,1.0,1.0,4
3058,GO:0005230,extracellular ligand-gated monoatomic ion channel activity,8,0.0,1.0,1.0,5
3059,GO:0005248,voltage-gated sodium channel activity,8,0.0,1.0,1.0,2
3060,GO:0005280,amino acid:proton symporter activity,8,0.0,1.0,1.0,4
3061,GO:0005283,amino acid:sodium symporter activity,8,0.0,1.0,1.0,7
3062,GO:0005343,organic acid:sodium symporter activity,8,0.0,1.0,1.0,11
3063,GO:0005351,carbohydrate:proton symporter activity,8,0.0,1.0,1.0,9
3064,GO:0005388,P-type calcium transporter activity,8,0.0,1.0,1.0,3
3065,GO:0005412,D-glucose:sodium symporter activity,8,0.0,1.0,1.0,1
3066,GO:0005415,nucleoside:sodium symporter activity,8,0.0,1.0,1.0,1
3067,GO:0005432,calcium:sodium antiporter activity,8,0.0,1.0,1.0,2
3068,GO:0005436,sodium:phosphate symporter activity,8,0.0,1.0,1.0,1
3069,GO:0005766,primary lysosome,8,0.0,1.0,1.0,1
3070,GO:0005767,secondary lysosome,8,0.0,1.0,1.0,2
3071,GO:0005827,polar microtubule,8,0.0,1.0,1.0,1
3072,GO:0005828,kinetochore microtubule,8,0.0,1.0,1.0,1
3073,GO:0005879,axonemal microtubule,8,0.0,1.0,1.0,4
3074,GO:0005980,glycogen catabolic process,8,0.0,1.0,1.0,1
3075,GO:0005987,sucrose catabolic process,8,0.0,1.0,1.0,4
3076,GO:0005990,lactose catabolic process,8,0.0,1.0,1.0,3
3077,GO:0005992,trehalose biosynthetic process,8,0.0,1.0,1.0,1
3078,GO:0005993,trehalose catabolic process,8,0.0,1.0,1.0,1
3079,GO:0006001,fructose catabolic process,8,0.0,1.0,1.0,5
3080,GO:0006007,glucose catabolic process,8,0.0,1.0,1.0,4
3081,GO:0006011,UDP-alpha-D-glucose metabolic process,8,0.0,1.0,1.0,3
3082,GO:0006047,UDP-N-acetylglucosamine metabolic process,8,0.0,1.0,1.0,2
3083,GO:0006060,sorbitol metabolic process,8,0.0,1.0,1.0,2
3084,GO:0006063,uronic acid metabolic process,8,0.0,1.0,1.0,2
3085,GO:0006074,(1->3)-beta-D-glucan metabolic process,8,0.0,1.0,1.0,3
3086,GO:0006077,(1->6)-beta-D-glucan metabolic process,8,0.0,1.0,1.0,2
3087,GO:0006083,acetate metabolic process,8,0.0,1.0,1.0,11
3088,GO:0006084,acetyl-CoA metabolic process,8,0.0,1.0,1.0,7
3089,GO:0006089,lactate metabolic process,8,0.0,1.0,1.0,7
3090,GO:0006090,pyruvate metabolic process,8,0.0,1.0,1.0,12
3091,GO:0006101,citrate metabolic process,8,0.0,1.0,1.0,1
3092,GO:0006103,2-oxoglutarate metabolic process,8,0.0,1.0,1.0,5
3093,GO:0006104,succinyl-CoA metabolic process,8,0.0,1.0,1.0,5
3094,GO:0006105,succinate metabolic process,8,0.0,1.0,1.0,4
3095,GO:0006106,fumarate metabolic process,8,0.0,1.0,1.0,2
3096,GO:0006107,oxaloacetate metabolic process,8,0.0,1.0,1.0,3
3097,GO:0006111,regulation of gluconeogenesis,8,0.0,1.0,1.0,2
3098,GO:0006114,glycerol biosynthetic process,8,0.0,1.0,1.0,1
3099,GO:0006145,purine nucleobase catabolic process,8,0.0,1.0,1.0,5
3100,GO:0006152,purine nucleoside catabolic process,8,0.0,1.0,1.0,2
3101,GO:0006163,purine nucleotide metabolic process,8,0.0,1.0,1.0,8
3102,GO:0006208,pyrimidine nucleobase catabolic process,8,0.0,1.0,1.0,4
3103,GO:0006220,pyrimidine nucleotide metabolic process,8,0.0,1.0,1.0,5
3104,GO:0006261,DNA-templated DNA replication,8,0.0,1.0,1.0,6
3105,GO:0006271,DNA strand elongation involved in DNA replication,8,0.0,1.0,1.0,3
3106,GO:0006275,regulation of DNA replication,8,0.0,1.0,1.0,3
3107,GO:0006277,DNA amplification,8,0.0,1.0,1.0,1
3108,GO:0006278,RNA-templated DNA biosynthetic process,8,0.0,1.0,1.0,2
3109,GO:0006282,regulation of DNA repair,8,0.0,1.0,1.0,8
3110,GO:0006284,base-excision repair,8,0.0,1.0,1.0,1
3111,GO:0006289,nucleotide-excision repair,8,0.0,1.0,1.0,4
3112,GO:0006290,pyrimidine dimer repair,8,0.0,1.0,1.0,2
3113,GO:0006298,mismatch repair,8,0.0,1.0,1.0,2
3114,GO:0006301,postreplication repair,8,0.0,1.0,1.0,2
3115,GO:0006302,double-strand break repair,8,0.0,1.0,1.0,5
3116,GO:0006312,mitotic recombination,8,0.0,1.0,1.0,2
3117,GO:0006313,DNA transposition,8,0.0,1.0,1.0,2
3118,GO:0006314,intron homing,8,0.0,1.0,1.0,2
3119,GO:0006351,DNA-templated transcription,8,0.0,1.0,1.0,17
3120,GO:0006352,DNA-templated transcription initiation,8,0.0,1.0,1.0,4
3121,GO:0006353,DNA-templated transcription termination,8,0.0,1.0,1.0,4
3122,GO:0006354,DNA-templated transcription elongation,8,0.0,1.0,1.0,4
3123,GO:0006364,rRNA processing,8,0.0,1.0,1.0,16
3124,GO:0006397,mRNA processing,8,0.0,1.0,1.0,7
3125,GO:0006404,RNA import into nucleus,8,0.0,1.0,1.0,2
3126,GO:0006405,RNA export from nucleus,8,0.0,1.0,1.0,5
3127,GO:0006474,N-terminal protein amino acid acetylation,8,0.0,1.0,1.0,5
3128,GO:0006475,internal protein amino acid acetylation,8,0.0,1.0,1.0,1
3129,GO:0006480,N-terminal protein amino acid methylation,8,0.0,1.0,1.0,4
3130,GO:0006499,N-terminal protein myristoylation,8,0.0,1.0,1.0,1
3131,GO:0006500,N-terminal protein palmitoylation,8,0.0,1.0,1.0,1
3132,GO:0006501,C-terminal protein lipidation,8,0.0,1.0,1.0,1
3133,GO:0006505,GPI anchor metabolic process,8,0.0,1.0,1.0,2
3134,GO:0006511,ubiquitin-dependent protein catabolic process,8,0.0,1.0,1.0,2
3135,GO:0006522,alanine metabolic process,8,0.0,1.0,1.0,5
3136,GO:0006525,arginine metabolic process,8,0.0,1.0,1.0,5
3137,GO:0006534,cysteine metabolic process,8,0.0,1.0,1.0,6
3138,GO:0006549,isoleucine metabolic process,8,0.0,1.0,1.0,2
3139,GO:0006553,lysine metabolic process,8,0.0,1.0,1.0,4
3140,GO:0006573,valine metabolic process,8,0.0,1.0,1.0,3
3141,GO:0006591,ornithine metabolic process,8,0.0,1.0,1.0,8
3142,GO:0006600,creatine metabolic process,8,0.0,1.0,1.0,2
3143,GO:0006606,protein import into nucleus,8,0.0,1.0,1.0,2
3144,GO:0006613,cotranslational protein targeting to membrane,8,0.0,1.0,1.0,1
3145,GO:0006623,protein targeting to vacuole,8,0.0,1.0,1.0,5
3146,GO:0006646,phosphatidylethanolamine biosynthetic process,8,0.0,1.0,1.0,2
3147,GO:0006655,phosphatidylglycerol biosynthetic process,8,0.0,1.0,1.0,1
3148,GO:0006656,phosphatidylcholine biosynthetic process,8,0.0,1.0,1.0,7
3149,GO:0006661,phosphatidylinositol biosynthetic process,8,0.0,1.0,1.0,2
3150,GO:0006667,sphinganine metabolic process,8,0.0,1.0,1.0,1
3151,GO:0006670,sphingosine metabolic process,8,0.0,1.0,1.0,2
3152,GO:0006671,phytosphingosine metabolic process,8,0.0,1.0,1.0,1
3153,GO:0006675,mannosyl-inositol phosphorylceramide metabolic process,8,0.0,1.0,1.0,1
3154,GO:0006677,glycosylceramide metabolic process,8,0.0,1.0,1.0,4
3155,GO:0006688,glycosphingolipid biosynthetic process,8,0.0,1.0,1.0,6
3156,GO:0006691,leukotriene metabolic process,8,0.0,1.0,1.0,5
3157,GO:0006695,cholesterol biosynthetic process,8,0.0,1.0,1.0,3
3158,GO:0006700,C21-steroid hormone biosynthetic process,8,0.0,1.0,1.0,2
3159,GO:0006704,glucocorticoid biosynthetic process,8,0.0,1.0,1.0,1
3160,GO:0006705,mineralocorticoid biosynthetic process,8,0.0,1.0,1.0,1
3161,GO:0006716,juvenile hormone metabolic process,8,0.0,1.0,1.0,2
3162,GO:0006768,biotin metabolic process,8,0.0,1.0,1.0,2
3163,GO:0006825,copper ion transport,8,0.0,1.0,1.0,4
3164,GO:0006826,iron ion transport,8,0.0,1.0,1.0,6
3165,GO:0006828,manganese ion transport,8,0.0,1.0,1.0,1
3166,GO:0006829,zinc ion transport,8,0.0,1.0,1.0,1
3167,GO:0007019,microtubule depolymerization,8,0.0,1.0,1.0,5
3168,GO:0007052,mitotic spindle organization,8,0.0,1.0,1.0,5
3169,GO:0007096,regulation of exit from mitosis,8,0.0,1.0,1.0,2
3170,GO:0007127,meiosis I,8,0.0,1.0,1.0,3
3171,GO:0007135,meiosis II,8,0.0,1.0,1.0,2
3172,GO:0007140,male meiotic nuclear division,8,0.0,1.0,1.0,2
3173,GO:0007143,female meiotic nuclear division,8,0.0,1.0,1.0,2
3174,GO:0007266,Rho protein signal transduction,8,0.0,1.0,1.0,1
3175,GO:0007268,chemical synaptic transmission,8,0.0,1.0,1.0,13
3176,GO:0007269,neurotransmitter secretion,8,0.0,1.0,1.0,18
3177,GO:0007409,axonogenesis,8,0.0,1.0,1.0,4
3178,GO:0007411,axon guidance,8,0.0,1.0,1.0,19
3179,GO:0007413,axonal fasciculation,8,0.0,1.0,1.0,2
3180,GO:0007553,regulation of ecdysteroid metabolic process,8,0.0,1.0,1.0,3
3181,GO:0007556,regulation of juvenile hormone metabolic process,8,0.0,1.0,1.0,4
3182,GO:0007558,regulation of juvenile hormone secretion,8,0.0,1.0,1.0,2
3183,GO:0008033,tRNA processing,8,0.0,1.0,1.0,5
3184,GO:0008206,bile acid metabolic process,8,0.0,1.0,1.0,3
3185,GO:0008296,3'-5'-DNA exonuclease activity,8,0.0,1.0,1.0,2
3186,GO:0008297,single-stranded DNA exodeoxyribonuclease activity,8,0.0,1.0,1.0,2
3187,GO:0008308,voltage-gated monoatomic anion channel activity,8,0.0,1.0,1.0,1
3188,GO:0008309,double-stranded DNA exodeoxyribonuclease activity,8,0.0,1.0,1.0,2
3189,GO:0008334,histone mRNA metabolic process,8,0.0,1.0,1.0,2
3190,GO:0008420,RNA polymerase II CTD heptapeptide repeat phosphatase activity,8,0.0,1.0,1.0,5
3191,GO:0008512,sulfate:proton symporter activity,8,0.0,1.0,1.0,2
3192,GO:0008543,fibroblast growth factor receptor signaling pathway,8,0.0,1.0,1.0,15
3193,GO:0008553,P-type proton-exporting transporter activity,8,0.0,1.0,1.0,1
3194,GO:0008554,P-type sodium transporter activity,8,0.0,1.0,1.0,1
3195,GO:0008556,P-type potassium transmembrane transporter activity,8,0.0,1.0,1.0,2
3196,GO:0008591,"regulation of Wnt signaling pathway, calcium modulating pathway",8,0.0,1.0,1.0,2
3197,GO:0008988,rRNA (adenine-N6-)-methyltransferase activity,8,0.0,1.0,1.0,3
3198,GO:0008989,rRNA (guanine-N1-)-methyltransferase activity,8,0.0,1.0,1.0,2
3199,GO:0008990,rRNA (guanine-N2-)-methyltransferase activity,8,0.0,1.0,1.0,5
3200,GO:0009073,aromatic amino acid family biosynthetic process,8,0.0,1.0,1.0,5
3201,GO:0009074,aromatic amino acid family catabolic process,8,0.0,1.0,1.0,8
3202,GO:0009082,branched-chain amino acid biosynthetic process,8,0.0,1.0,1.0,4
3203,GO:0009083,branched-chain amino acid catabolic process,8,0.0,1.0,1.0,6
3204,GO:0009113,purine nucleobase biosynthetic process,8,0.0,1.0,1.0,5
3205,GO:0009124,nucleoside monophosphate biosynthetic process,8,0.0,1.0,1.0,4
3206,GO:0009125,nucleoside monophosphate catabolic process,8,0.0,1.0,1.0,4
3207,GO:0009126,purine nucleoside monophosphate metabolic process,8,0.0,1.0,1.0,4
3208,GO:0009129,pyrimidine nucleoside monophosphate metabolic process,8,0.0,1.0,1.0,4
3209,GO:0009133,nucleoside diphosphate biosynthetic process,8,0.0,1.0,1.0,4
3210,GO:0009134,nucleoside diphosphate catabolic process,8,0.0,1.0,1.0,4
3211,GO:0009135,purine nucleoside diphosphate metabolic process,8,0.0,1.0,1.0,4
3212,GO:0009138,pyrimidine nucleoside diphosphate metabolic process,8,0.0,1.0,1.0,4
3213,GO:0009142,nucleoside triphosphate biosynthetic process,8,0.0,1.0,1.0,4
3214,GO:0009143,nucleoside triphosphate catabolic process,8,0.0,1.0,1.0,4
3215,GO:0009144,purine nucleoside triphosphate metabolic process,8,0.0,1.0,1.0,4
3216,GO:0009147,pyrimidine nucleoside triphosphate metabolic process,8,0.0,1.0,1.0,4
3217,GO:0009161,ribonucleoside monophosphate metabolic process,8,0.0,1.0,1.0,5
3218,GO:0009162,deoxyribonucleoside monophosphate metabolic process,8,0.0,1.0,1.0,4
3219,GO:0009165,nucleotide biosynthetic process,8,0.0,1.0,1.0,12
3220,GO:0009166,nucleotide catabolic process,8,0.0,1.0,1.0,9
3221,GO:0009185,ribonucleoside diphosphate metabolic process,8,0.0,1.0,1.0,4
3222,GO:0009186,deoxyribonucleoside diphosphate metabolic process,8,0.0,1.0,1.0,4
3223,GO:0009187,cyclic nucleotide metabolic process,8,0.0,1.0,1.0,3
3224,GO:0009199,ribonucleoside triphosphate metabolic process,8,0.0,1.0,1.0,4
3225,GO:0009200,deoxyribonucleoside triphosphate metabolic process,8,0.0,1.0,1.0,3
3226,GO:0009226,nucleotide-sugar biosynthetic process,8,0.0,1.0,1.0,20
3227,GO:0009227,nucleotide-sugar catabolic process,8,0.0,1.0,1.0,4
3228,GO:0009228,thiamine biosynthetic process,8,0.0,1.0,1.0,1
3229,GO:0009256,10-formyltetrahydrofolate metabolic process,8,0.0,1.0,1.0,2
3230,GO:0009259,ribonucleotide metabolic process,8,0.0,1.0,1.0,5
3231,GO:0009262,deoxyribonucleotide metabolic process,8,0.0,1.0,1.0,3
3232,GO:0009441,glycolate metabolic process,8,0.0,1.0,1.0,2
3233,GO:0009448,gamma-aminobutyric acid metabolic process,8,0.0,1.0,1.0,2
3234,GO:0009669,sucrose:monoatomic cation symporter activity,8,0.0,1.0,1.0,1
3235,GO:0009670,triose-phosphate:phosphate antiporter activity,8,0.0,1.0,1.0,1
3236,GO:0009674,potassium:sodium symporter activity,8,0.0,1.0,1.0,1
3237,GO:0009683,indoleacetic acid metabolic process,8,0.0,1.0,1.0,4
3238,GO:0009685,gibberellin metabolic process,8,0.0,1.0,1.0,3
3239,GO:0009687,abscisic acid metabolic process,8,0.0,1.0,1.0,2
3240,GO:0009696,salicylic acid metabolic process,8,0.0,1.0,1.0,2
3241,GO:0009803,cinnamic acid metabolic process,8,0.0,1.0,1.0,2
3242,GO:0009828,plant-type cell wall loosening,8,0.0,1.0,1.0,1
3243,GO:0009830,cell wall modification involved in abscission,8,0.0,1.0,1.0,2
3244,GO:0010017,red or far-red light signaling pathway,8,0.0,1.0,1.0,2
3245,GO:0010104,regulation of ethylene-activated signaling pathway,8,0.0,1.0,1.0,1
3246,GO:0010110,"regulation of photosynthesis, dark reaction",8,0.0,1.0,1.0,1
3247,GO:0010115,regulation of abscisic acid biosynthetic process,8,0.0,1.0,1.0,2
3248,GO:0010155,regulation of proton transport,8,0.0,1.0,1.0,7
3249,GO:0010264,myo-inositol hexakisphosphate biosynthetic process,8,0.0,1.0,1.0,2
3250,GO:0010359,regulation of anion channel activity,8,0.0,1.0,1.0,4
3251,GO:0010371,regulation of gibberellin biosynthetic process,8,0.0,1.0,1.0,2
3252,GO:0010389,regulation of G2/M transition of mitotic cell cycle,8,0.0,1.0,1.0,2
3253,GO:0010404,cell wall hydroxyproline-rich glycoprotein metabolic process,8,0.0,1.0,1.0,2
3254,GO:0010411,xyloglucan metabolic process,8,0.0,1.0,1.0,2
3255,GO:0010459,negative regulation of heart rate,8,0.0,1.0,1.0,3
3256,GO:0010460,positive regulation of heart rate,8,0.0,1.0,1.0,4
3257,GO:0010559,regulation of glycoprotein biosynthetic process,8,0.0,1.0,1.0,11
3258,GO:0010587,miRNA catabolic process,8,0.0,1.0,1.0,1
3259,GO:0010591,regulation of lamellipodium assembly,8,0.0,1.0,1.0,2
3260,GO:0010608,post-transcriptional regulation of gene expression,8,0.0,1.0,1.0,4
3261,GO:0010613,positive regulation of cardiac muscle hypertrophy,8,0.0,1.0,1.0,2
3262,GO:0010614,negative regulation of cardiac muscle hypertrophy,8,0.0,1.0,1.0,2
3263,GO:0010615,positive regulation of cardiac muscle adaptation,8,0.0,1.0,1.0,1
3264,GO:0010616,negative regulation of cardiac muscle adaptation,8,0.0,1.0,1.0,1
3265,GO:0010629,negative regulation of gene expression,8,0.0,1.0,1.0,17
3266,GO:0010663,positive regulation of striated muscle cell apoptotic process,8,0.0,1.0,1.0,1
3267,GO:0010664,negative regulation of striated muscle cell apoptotic process,8,0.0,1.0,1.0,1
3268,GO:0010665,regulation of cardiac muscle cell apoptotic process,8,0.0,1.0,1.0,2
3269,GO:0010683,tricyclic triterpenoid metabolic process,8,0.0,1.0,1.0,3
3270,GO:0010685,tetracyclic triterpenoid metabolic process,8,0.0,1.0,1.0,2
3271,GO:0010732,regulation of protein glutathionylation,8,0.0,1.0,1.0,2
3272,GO:0010746,regulation of long-chain fatty acid import across plasma membrane,8,0.0,1.0,1.0,2
3273,GO:0010750,positive regulation of nitric oxide mediated signal transduction,8,0.0,1.0,1.0,1
3274,GO:0010751,negative regulation of nitric oxide mediated signal transduction,8,0.0,1.0,1.0,1
3275,GO:0010753,positive regulation of cGMP-mediated signaling,8,0.0,1.0,1.0,1
3276,GO:0010754,negative regulation of cGMP-mediated signaling,8,0.0,1.0,1.0,1
3277,GO:0010765,positive regulation of sodium ion transport,8,0.0,1.0,1.0,1
3278,GO:0010766,negative regulation of sodium ion transport,8,0.0,1.0,1.0,1
3279,GO:0010793,regulation of mRNA export from nucleus,8,0.0,1.0,1.0,1
3280,GO:0010818,T cell chemotaxis,8,0.0,1.0,1.0,4
3281,GO:0010831,positive regulation of myotube differentiation,8,0.0,1.0,1.0,1
3282,GO:0010832,negative regulation of myotube differentiation,8,0.0,1.0,1.0,1
3283,GO:0010833,telomere maintenance via telomere lengthening,8,0.0,1.0,1.0,1
3284,GO:0010866,regulation of triglyceride biosynthetic process,8,0.0,1.0,1.0,2
3285,GO:0010874,regulation of cholesterol efflux,8,0.0,1.0,1.0,2
3286,GO:0010896,regulation of triglyceride catabolic process,8,0.0,1.0,1.0,2
3287,GO:0010904,regulation of UDP-glucose catabolic process,8,0.0,1.0,1.0,1
3288,GO:0010907,positive regulation of glucose metabolic process,8,0.0,1.0,1.0,4
3289,GO:0010919,regulation of inositol phosphate biosynthetic process,8,0.0,1.0,1.0,3
3290,GO:0010921,regulation of phosphatase activity,8,0.0,1.0,1.0,9
3291,GO:0010958,regulation of amino acid import across plasma membrane,8,0.0,1.0,1.0,11
3292,GO:0010965,regulation of mitotic sister chromatid separation,8,0.0,1.0,1.0,4
3293,GO:0010976,positive regulation of neuron projection development,8,0.0,1.0,1.0,4
3294,GO:0010977,negative regulation of neuron projection development,8,0.0,1.0,1.0,5
3295,GO:0014014,negative regulation of gliogenesis,8,0.0,1.0,1.0,3
3296,GO:0014015,positive regulation of gliogenesis,8,0.0,1.0,1.0,3
3297,GO:0014042,positive regulation of neuron maturation,8,0.0,1.0,1.0,1
3298,GO:0014043,negative regulation of neuron maturation,8,0.0,1.0,1.0,1
3299,GO:0014046,dopamine secretion,8,0.0,1.0,1.0,2
3300,GO:0014049,positive regulation of glutamate secretion,8,0.0,1.0,1.0,1
3301,GO:0014050,negative regulation of glutamate secretion,8,0.0,1.0,1.0,1
3302,GO:0014056,"regulation of acetylcholine secretion, neurotransmission",8,0.0,1.0,1.0,2
3303,GO:0014059,regulation of dopamine secretion,8,0.0,1.0,1.0,2
3304,GO:0014060,regulation of epinephrine secretion,8,0.0,1.0,1.0,2
3305,GO:0014061,regulation of norepinephrine secretion,8,0.0,1.0,1.0,2
3306,GO:0014721,twitch skeletal muscle contraction,8,0.0,1.0,1.0,2
3307,GO:0014819,regulation of skeletal muscle contraction,8,0.0,1.0,1.0,7
3308,GO:0014828,distal stomach smooth muscle contraction,8,0.0,1.0,1.0,2
3309,GO:0014829,vascular associated smooth muscle contraction,8,0.0,1.0,1.0,2
3310,GO:0014847,proximal stomach smooth muscle contraction,8,0.0,1.0,1.0,1
3311,GO:0014880,regulation of muscle filament sliding involved in regulation of the velocity of shortening in skeletal muscle contraction,8,0.0,1.0,1.0,3
3312,GO:0015091,ferric iron transmembrane transporter activity,8,0.0,1.0,1.0,3
3313,GO:0015093,ferrous iron transmembrane transporter activity,8,0.0,1.0,1.0,1
3314,GO:0015147,L-arabinose transmembrane transporter activity,8,0.0,1.0,1.0,1
3315,GO:0015275,"stretch-activated, monoatomic cation-selective, calcium channel activity",8,0.0,1.0,1.0,1
3316,GO:0015373,monoatomic anion:sodium symporter activity,8,0.0,1.0,1.0,2
3317,GO:0015377,chloride:monoatomic cation symporter activity,8,0.0,1.0,1.0,2
3318,GO:0015385,sodium:proton antiporter activity,8,0.0,1.0,1.0,5
3319,GO:0015407,ABC-type monosaccharide transporter activity,8,0.0,1.0,1.0,6
3320,GO:0015422,ABC-type oligosaccharide transporter activity,8,0.0,1.0,1.0,2
3321,GO:0015426,ATPase-coupled polar amino acid-transporter activity,8,0.0,1.0,1.0,2
3322,GO:0015486,glycoside-pentoside-hexuronide:cation symporter activity,8,0.0,1.0,1.0,1
3323,GO:0015487,melibiose:monoatomic cation symporter activity,8,0.0,1.0,1.0,1
3324,GO:0015494,aromatic amino acid:proton symporter activity,8,0.0,1.0,1.0,1
3325,GO:0015506,nucleoside:proton symporter activity,8,0.0,1.0,1.0,2
3326,GO:0015526,hexose-phosphate:phosphate antiporter activity,8,0.0,1.0,1.0,1
3327,GO:0015552,propionate transmembrane transporter activity,8,0.0,1.0,1.0,1
3328,GO:0015652,quaternary ammonium group:proton symporter activity,8,0.0,1.0,1.0,1
3329,GO:0015673,silver ion transport,8,0.0,1.0,1.0,1
3330,GO:0015675,nickel cation transport,8,0.0,1.0,1.0,1
3331,GO:0015691,cadmium ion transport,8,0.0,1.0,1.0,1
3332,GO:0015729,oxaloacetate transport,8,0.0,1.0,1.0,1
3333,GO:0015732,prostaglandin transport,8,0.0,1.0,1.0,2
3334,GO:0015736,hexuronate transmembrane transport,8,0.0,1.0,1.0,2
3335,GO:0015743,malate transport,8,0.0,1.0,1.0,2
3336,GO:0015744,succinate transport,8,0.0,1.0,1.0,1
3337,GO:0015751,arabinose transmembrane transport,8,0.0,1.0,1.0,1
3338,GO:0015755,fructose transmembrane transport,8,0.0,1.0,1.0,2
3339,GO:0015757,galactose transmembrane transport,8,0.0,1.0,1.0,1
3340,GO:0015783,GDP-fucose transmembrane transport,8,0.0,1.0,1.0,2
3341,GO:0015786,UDP-glucose transmembrane transport,8,0.0,1.0,1.0,1
3342,GO:0015810,aspartate transmembrane transport,8,0.0,1.0,1.0,3
3343,GO:0015813,L-glutamate transmembrane transport,8,0.0,1.0,1.0,4
3344,GO:0015819,lysine transport,8,0.0,1.0,1.0,1
3345,GO:0015868,purine ribonucleotide transport,8,0.0,1.0,1.0,9
3346,GO:0015909,long-chain fatty acid transport,8,0.0,1.0,1.0,4
3347,GO:0015912,short-chain fatty acid transport,8,0.0,1.0,1.0,1
3348,GO:0015939,pantothenate metabolic process,8,0.0,1.0,1.0,3
3349,GO:0015942,formate metabolic process,8,0.0,1.0,1.0,7
3350,GO:0015956,bis(5'-nucleosidyl) oligophosphate metabolic process,8,0.0,1.0,1.0,2
3351,GO:0015959,diadenosine polyphosphate metabolic process,8,0.0,1.0,1.0,6
3352,GO:0015985,"energy coupled proton transport, down electrochemical gradient",8,0.0,1.0,1.0,1
3353,GO:0015988,"energy coupled proton transmembrane transport, against electrochemical gradient",8,0.0,1.0,1.0,1
3354,GO:0016059,negative regulation of opsin-mediated signaling pathway,8,0.0,1.0,1.0,1
3355,GO:0016068,type I hypersensitivity,8,0.0,1.0,1.0,2
3356,GO:0016075,rRNA catabolic process,8,0.0,1.0,1.0,2
3357,GO:0016076,snRNA catabolic process,8,0.0,1.0,1.0,1
3358,GO:0016077,sno(s)RNA catabolic process,8,0.0,1.0,1.0,1
3359,GO:0016078,tRNA decay,8,0.0,1.0,1.0,1
3360,GO:0016079,synaptic vesicle exocytosis,8,0.0,1.0,1.0,2
3361,GO:0016099,monoterpenoid biosynthetic process,8,0.0,1.0,1.0,4
3362,GO:0016100,monoterpenoid catabolic process,8,0.0,1.0,1.0,3
3363,GO:0016102,diterpenoid biosynthetic process,8,0.0,1.0,1.0,12
3364,GO:0016103,diterpenoid catabolic process,8,0.0,1.0,1.0,5
3365,GO:0016104,triterpenoid biosynthetic process,8,0.0,1.0,1.0,4
3366,GO:0016105,triterpenoid catabolic process,8,0.0,1.0,1.0,4
3367,GO:0016106,sesquiterpenoid biosynthetic process,8,0.0,1.0,1.0,11
3368,GO:0016107,sesquiterpenoid catabolic process,8,0.0,1.0,1.0,5
3369,GO:0016109,tetraterpenoid biosynthetic process,8,0.0,1.0,1.0,1
3370,GO:0016110,tetraterpenoid catabolic process,8,0.0,1.0,1.0,1
3371,GO:0016116,carotenoid metabolic process,8,0.0,1.0,1.0,8
3372,GO:0016120,carotene biosynthetic process,8,0.0,1.0,1.0,6
3373,GO:0016121,carotene catabolic process,8,0.0,1.0,1.0,6
3374,GO:0016180,snRNA processing,8,0.0,1.0,1.0,3
3375,GO:0016239,positive regulation of macroautophagy,8,0.0,1.0,1.0,7
3376,GO:0016242,negative regulation of macroautophagy,8,0.0,1.0,1.0,6
3377,GO:0016266,O-glycan processing,8,0.0,1.0,1.0,3
3378,GO:0016444,somatic cell DNA recombination,8,0.0,1.0,1.0,2
3379,GO:0016486,peptide hormone processing,8,0.0,1.0,1.0,9
3380,GO:0016487,farnesol metabolic process,8,0.0,1.0,1.0,2
3381,GO:0016525,negative regulation of angiogenesis,8,0.0,1.0,1.0,3
3382,GO:0016553,base conversion or substitution editing,8,0.0,1.0,1.0,3
3383,GO:0016556,mRNA modification,8,0.0,1.0,1.0,3
3384,GO:0017002,activin receptor activity,8,0.0,1.0,1.0,2
3385,GO:0017121,plasma membrane phospholipid scrambling,8,0.0,1.0,1.0,4
3386,GO:0017156,calcium-ion regulated exocytosis,8,0.0,1.0,1.0,6
3387,GO:0017185,peptidyl-lysine hydroxylation,8,0.0,1.0,1.0,1
3388,GO:0018006,N-terminal protein amino acid glucuronylation,8,0.0,1.0,1.0,1
3389,GO:0018021,peptidyl-histidine methylation,8,0.0,1.0,1.0,1
3390,GO:0018022,peptidyl-lysine methylation,8,0.0,1.0,1.0,3
3391,GO:0018105,peptidyl-serine phosphorylation,8,0.0,1.0,1.0,2
3392,GO:0018107,peptidyl-threonine phosphorylation,8,0.0,1.0,1.0,2
3393,GO:0018108,peptidyl-tyrosine phosphorylation,8,0.0,1.0,1.0,3
3394,GO:0018119,peptidyl-cysteine S-nitrosylation,8,0.0,1.0,1.0,1
3395,GO:0018216,peptidyl-arginine methylation,8,0.0,1.0,1.0,1
3396,GO:0018217,peptidyl-aspartic acid phosphorylation,8,0.0,1.0,1.0,1
3397,GO:0018231,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,8,0.0,1.0,1.0,1
3398,GO:0018243,protein O-linked glycosylation via threonine,8,0.0,1.0,1.0,1
3399,GO:0018317,protein C-linked glycosylation via tryptophan,8,0.0,1.0,1.0,1
3400,GO:0018394,peptidyl-lysine acetylation,8,0.0,1.0,1.0,2
3401,GO:0018871,1-aminocyclopropane-1-carboxylate metabolic process,8,0.0,1.0,1.0,2
3402,GO:0018874,benzoate metabolic process,8,0.0,1.0,1.0,4
3403,GO:0018882,(+)-camphor metabolic process,8,0.0,1.0,1.0,2
3404,GO:0018898,"2,4-dichlorobenzoate metabolic process",8,0.0,1.0,1.0,1
3405,GO:0018901,"2,4-dichlorophenoxyacetic acid metabolic process",8,0.0,1.0,1.0,1
3406,GO:0018923,limonene metabolic process,8,0.0,1.0,1.0,2
3407,GO:0018924,mandelate metabolic process,8,0.0,1.0,1.0,2
3408,GO:0018934,nitrilotriacetate metabolic process,8,0.0,1.0,1.0,2
3409,GO:0018953,p-cymene metabolic process,8,0.0,1.0,1.0,1
3410,GO:0018962,3-phenylpropionate metabolic process,8,0.0,1.0,1.0,1
3411,GO:0018975,"anaerobic 2,4,6-trinitrotoluene metabolic process",8,0.0,1.0,1.0,1
3412,GO:0018980,"2,4,5-trichlorophenoxyacetic acid metabolic process",8,0.0,1.0,1.0,1
3413,GO:0019252,starch biosynthetic process,8,0.0,1.0,1.0,1
3414,GO:0019276,UDP-N-acetylgalactosamine metabolic process,8,0.0,1.0,1.0,2
3415,GO:0019288,"isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway",8,0.0,1.0,1.0,1
3416,GO:0019297,coenzyme B metabolic process,8,0.0,1.0,1.0,1
3417,GO:0019301,rhamnose catabolic process,8,0.0,1.0,1.0,1
3418,GO:0019309,mannose catabolic process,8,0.0,1.0,1.0,2
3419,GO:0019312,L-sorbose metabolic process,8,0.0,1.0,1.0,2
3420,GO:0019317,fucose catabolic process,8,0.0,1.0,1.0,2
3421,GO:0019349,ribitol metabolic process,8,0.0,1.0,1.0,2
3422,GO:0019362,pyridine nucleotide metabolic process,8,0.0,1.0,1.0,4
3423,GO:0019375,galactolipid biosynthetic process,8,0.0,1.0,1.0,1
3424,GO:0019387,"methanogenesis, from methanol",8,0.0,1.0,1.0,1
3425,GO:0019388,galactose catabolic process,8,0.0,1.0,1.0,4
3426,GO:0019402,galactitol metabolic process,8,0.0,1.0,1.0,2
3427,GO:0019406,hexitol biosynthetic process,8,0.0,1.0,1.0,3
3428,GO:0019407,hexitol catabolic process,8,0.0,1.0,1.0,3
3429,GO:0019471,4-hydroxyproline metabolic process,8,0.0,1.0,1.0,3
3430,GO:0019482,beta-alanine metabolic process,8,0.0,1.0,1.0,2
3431,GO:0019489,methylgallate metabolic process,8,0.0,1.0,1.0,2
3432,GO:0019511,peptidyl-proline hydroxylation,8,0.0,1.0,1.0,3
3433,GO:0019520,aldonic acid metabolic process,8,0.0,1.0,1.0,7
3434,GO:0019526,pentitol biosynthetic process,8,0.0,1.0,1.0,1
3435,GO:0019527,pentitol catabolic process,8,0.0,1.0,1.0,3
3436,GO:0019563,glycerol catabolic process,8,0.0,1.0,1.0,3
3437,GO:0019567,arabinose biosynthetic process,8,0.0,1.0,1.0,1
3438,GO:0019568,arabinose catabolic process,8,0.0,1.0,1.0,2
3439,GO:0019577,aldaric acid metabolic process,8,0.0,1.0,1.0,5
3440,GO:0019594,mannitol metabolic process,8,0.0,1.0,1.0,2
3441,GO:0019609,3-hydroxyphenylacetate metabolic process,8,0.0,1.0,1.0,1
3442,GO:0019611,4-toluenecarboxylate metabolic process,8,0.0,1.0,1.0,1
3443,GO:0019630,quinate metabolic process,8,0.0,1.0,1.0,2
3444,GO:0019632,shikimate metabolic process,8,0.0,1.0,1.0,1
3445,GO:0019638,6-hydroxycineole metabolic process,8,0.0,1.0,1.0,1
3446,GO:0019673,GDP-mannose metabolic process,8,0.0,1.0,1.0,2
3447,GO:0019686,purine nucleoside interconversion,8,0.0,1.0,1.0,1
3448,GO:0019689,pyrimidine nucleoside interconversion,8,0.0,1.0,1.0,1
3449,GO:0019731,antibacterial humoral response,8,0.0,1.0,1.0,2
3450,GO:0019742,pentacyclic triterpenoid metabolic process,8,0.0,1.0,1.0,4
3451,GO:0019744,hopanoid metabolic process,8,0.0,1.0,1.0,2
3452,GO:0019853,L-ascorbic acid biosynthetic process,8,0.0,1.0,1.0,2
3453,GO:0019856,pyrimidine nucleobase biosynthetic process,8,0.0,1.0,1.0,5
3454,GO:0019858,cytosine metabolic process,8,0.0,1.0,1.0,2
3455,GO:0019859,thymine metabolic process,8,0.0,1.0,1.0,2
3456,GO:0019860,uracil metabolic process,8,0.0,1.0,1.0,2
3457,GO:0019908,nuclear cyclin-dependent protein kinase holoenzyme complex,8,0.0,1.0,1.0,3
3458,GO:0019991,septate junction assembly,8,0.0,1.0,1.0,1
3459,GO:0021801,cerebral cortex radial glia-guided migration,8,0.0,1.0,1.0,1
3460,GO:0021825,substrate-dependent cerebral cortex tangential migration,8,0.0,1.0,1.0,2
3461,GO:0021830,interneuron migration from the subpallium to the cortex,8,0.0,1.0,1.0,1
3462,GO:0022843,voltage-gated monoatomic cation channel activity,8,0.0,1.0,1.0,3
3463,GO:0022883,zinc efflux transmembrane transporter activity,8,0.0,1.0,1.0,1
3464,GO:0030038,contractile actin filament bundle assembly,8,0.0,1.0,1.0,1
3465,GO:0030046,parallel actin filament bundle assembly,8,0.0,1.0,1.0,2
3466,GO:0030072,peptide hormone secretion,8,0.0,1.0,1.0,16
3467,GO:0030136,clathrin-coated vesicle,8,0.0,1.0,1.0,4
3468,GO:0030137,COPI-coated vesicle,8,0.0,1.0,1.0,2
3469,GO:0030141,secretory granule,8,0.0,1.0,1.0,16
3470,GO:0030194,positive regulation of blood coagulation,8,0.0,1.0,1.0,6
3471,GO:0030195,negative regulation of blood coagulation,8,0.0,1.0,1.0,6
3472,GO:0030205,dermatan sulfate metabolic process,8,0.0,1.0,1.0,2
3473,GO:0030239,myofibril assembly,8,0.0,1.0,1.0,2
3474,GO:0030243,cellulose metabolic process,8,0.0,1.0,1.0,3
3475,GO:0030300,regulation of intestinal cholesterol absorption,8,0.0,1.0,1.0,2
3476,GO:0030417,nicotianamine metabolic process,8,0.0,1.0,1.0,2
3477,GO:0030473,nuclear migration along microtubule,8,0.0,1.0,1.0,4
3478,GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,8,0.0,1.0,1.0,1
3479,GO:0030514,negative regulation of BMP signaling pathway,8,0.0,1.0,1.0,2
3480,GO:0030518,nuclear receptor-mediated steroid hormone signaling pathway,8,0.0,1.0,1.0,6
3481,GO:0030669,clathrin-coated endocytic vesicle membrane,8,0.0,1.0,1.0,1
3482,GO:0030808,regulation of nucleotide biosynthetic process,8,0.0,1.0,1.0,4
3483,GO:0030811,regulation of nucleotide catabolic process,8,0.0,1.0,1.0,4
3484,GO:0030832,regulation of actin filament length,8,0.0,1.0,1.0,1
3485,GO:0030888,regulation of B cell proliferation,8,0.0,1.0,1.0,2
3486,GO:0030920,peptidyl-serine acetylation,8,0.0,1.0,1.0,1
3487,GO:0030953,astral microtubule organization,8,0.0,1.0,1.0,2
3488,GO:0030979,alpha-glucan biosynthetic process,8,0.0,1.0,1.0,3
3489,GO:0031028,septation initiation signaling,8,0.0,1.0,1.0,1
3490,GO:0031029,regulation of septation initiation signaling,8,0.0,1.0,1.0,2
3491,GO:0031034,myosin filament assembly,8,0.0,1.0,1.0,2
3492,GO:0031035,myosin filament disassembly,8,0.0,1.0,1.0,1
3493,GO:0031038,myosin II filament organization,8,0.0,1.0,1.0,2
3494,GO:0031103,axon regeneration,8,0.0,1.0,1.0,4
3495,GO:0031110,regulation of microtubule polymerization or depolymerization,8,0.0,1.0,1.0,4
3496,GO:0031151,histone H3K79 methyltransferase activity,8,0.0,1.0,1.0,3
3497,GO:0031161,phosphatidylinositol catabolic process,8,0.0,1.0,1.0,2
3498,GO:0031169,ferrichrome biosynthetic process,8,0.0,1.0,1.0,1
3499,GO:0031272,regulation of pseudopodium assembly,8,0.0,1.0,1.0,2
3500,GO:0031294,lymphocyte costimulation,8,0.0,1.0,1.0,2
3501,GO:0031297,replication fork processing,8,0.0,1.0,1.0,2
3502,GO:0031383,regulation of mating projection assembly,8,0.0,1.0,1.0,3
3503,GO:0031400,negative regulation of protein modification process,8,0.0,1.0,1.0,14
3504,GO:0031401,positive regulation of protein modification process,8,0.0,1.0,1.0,13
3505,GO:0031445,regulation of heterochromatin formation,8,0.0,1.0,1.0,7
3506,GO:0031524,menthol metabolic process,8,0.0,1.0,1.0,1
3507,GO:0031620,regulation of fever generation,8,0.0,1.0,1.0,4
3508,GO:0031632,positive regulation of synaptic vesicle fusion to presynaptic active zone membrane,8,0.0,1.0,1.0,1
3509,GO:0031914,negative regulation of synaptic plasticity,8,0.0,1.0,1.0,1
3510,GO:0031915,positive regulation of synaptic plasticity,8,0.0,1.0,1.0,2
3511,GO:0031916,regulation of synaptic metaplasticity,8,0.0,1.0,1.0,2
3512,GO:0031943,regulation of glucocorticoid metabolic process,8,0.0,1.0,1.0,4
3513,GO:0032007,negative regulation of TOR signaling,8,0.0,1.0,1.0,2
3514,GO:0032008,positive regulation of TOR signaling,8,0.0,1.0,1.0,2
3515,GO:0032012,regulation of ARF protein signal transduction,8,0.0,1.0,1.0,2
3516,GO:0032048,cardiolipin metabolic process,8,0.0,1.0,1.0,2
3517,GO:0032070,regulation of deoxyribonuclease activity,8,0.0,1.0,1.0,4
3518,GO:0032074,negative regulation of nuclease activity,8,0.0,1.0,1.0,3
3519,GO:0032075,positive regulation of nuclease activity,8,0.0,1.0,1.0,3
3520,GO:0032138,single base insertion or deletion binding,8,0.0,1.0,1.0,4
3521,GO:0032139,dinucleotide insertion or deletion binding,8,0.0,1.0,1.0,1
3522,GO:0032201,telomere maintenance via semi-conservative replication,8,0.0,1.0,1.0,2
3523,GO:0032204,regulation of telomere maintenance,8,0.0,1.0,1.0,10
3524,GO:0032223,"negative regulation of synaptic transmission, cholinergic",8,0.0,1.0,1.0,1
3525,GO:0032224,"positive regulation of synaptic transmission, cholinergic",8,0.0,1.0,1.0,1
3526,GO:0032247,negative regulation of purine nucleoside transport,8,0.0,1.0,1.0,2
3527,GO:0032248,positive regulation of purine nucleoside transport,8,0.0,1.0,1.0,2
3528,GO:0032249,regulation of adenosine transport,8,0.0,1.0,1.0,2
3529,GO:0032276,regulation of gonadotropin secretion,8,0.0,1.0,1.0,4
3530,GO:0032304,negative regulation of icosanoid secretion,8,0.0,1.0,1.0,2
3531,GO:0032305,positive regulation of icosanoid secretion,8,0.0,1.0,1.0,2
3532,GO:0032306,regulation of prostaglandin secretion,8,0.0,1.0,1.0,3
3533,GO:0032335,regulation of activin secretion,8,0.0,1.0,1.0,2
3534,GO:0032338,regulation of inhibin secretion,8,0.0,1.0,1.0,2
3535,GO:0032344,regulation of aldosterone metabolic process,8,0.0,1.0,1.0,3
3536,GO:0032375,negative regulation of cholesterol transport,8,0.0,1.0,1.0,4
3537,GO:0032381,negative regulation of intracellular sterol transport,8,0.0,1.0,1.0,1
3538,GO:0032382,positive regulation of intracellular sterol transport,8,0.0,1.0,1.0,1
3539,GO:0032383,regulation of intracellular cholesterol transport,8,0.0,1.0,1.0,2
3540,GO:0032413,negative regulation of ion transmembrane transporter activity,8,0.0,1.0,1.0,7
3541,GO:0032414,positive regulation of ion transmembrane transporter activity,8,0.0,1.0,1.0,9
3542,GO:0032430,positive regulation of phospholipase A2 activity,8,0.0,1.0,1.0,1
3543,GO:0032446,protein modification by small protein conjugation,8,0.0,1.0,1.0,7
3544,GO:0032463,negative regulation of protein homooligomerization,8,0.0,1.0,1.0,1
3545,GO:0032464,positive regulation of protein homooligomerization,8,0.0,1.0,1.0,1
3546,GO:0032470,positive regulation of endoplasmic reticulum calcium ion concentration,8,0.0,1.0,1.0,1
3547,GO:0032471,negative regulation of endoplasmic reticulum calcium ion concentration,8,0.0,1.0,1.0,1
3548,GO:0032472,Golgi calcium ion transport,8,0.0,1.0,1.0,1
3549,GO:0032508,DNA duplex unwinding,8,0.0,1.0,1.0,2
3550,GO:0032510,endosome to lysosome transport via multivesicular body sorting pathway,8,0.0,1.0,1.0,1
3551,GO:0032527,protein exit from endoplasmic reticulum,8,0.0,1.0,1.0,1
3552,GO:0032531,regulation of follicle cell microvillus organization,8,0.0,1.0,1.0,1
3553,GO:0032532,regulation of microvillus length,8,0.0,1.0,1.0,3
3554,GO:0032534,regulation of microvillus assembly,8,0.0,1.0,1.0,2
3555,GO:0032594,protein transport within lipid bilayer,8,0.0,1.0,1.0,6
3556,GO:0032803,regulation of low-density lipoprotein particle receptor catabolic process,8,0.0,1.0,1.0,2
3557,GO:0032815,negative regulation of natural killer cell activation,8,0.0,1.0,1.0,2
3558,GO:0032816,positive regulation of natural killer cell activation,8,0.0,1.0,1.0,2
3559,GO:0032817,regulation of natural killer cell proliferation,8,0.0,1.0,1.0,3
3560,GO:0032847,regulation of cellular pH reduction,8,0.0,1.0,1.0,3
3561,GO:0032872,regulation of stress-activated MAPK cascade,8,0.0,1.0,1.0,3
3562,GO:0032882,regulation of chitin metabolic process,8,0.0,1.0,1.0,1
3563,GO:0032885,regulation of polysaccharide biosynthetic process,8,0.0,1.0,1.0,6
3564,GO:0032926,negative regulation of activin receptor signaling pathway,8,0.0,1.0,1.0,1
3565,GO:0032927,positive regulation of activin receptor signaling pathway,8,0.0,1.0,1.0,1
3566,GO:0032948,regulation of alpha-glucan metabolic process,8,0.0,1.0,1.0,2
3567,GO:0032950,regulation of beta-glucan metabolic process,8,0.0,1.0,1.0,4
3568,GO:0032955,regulation of division septum assembly,8,0.0,1.0,1.0,3
3569,GO:0032972,regulation of muscle filament sliding speed,8,0.0,1.0,1.0,1
3570,GO:0032978,protein insertion into membrane from inner side,8,0.0,1.0,1.0,1
3571,GO:0033046,negative regulation of sister chromatid segregation,8,0.0,1.0,1.0,1
3572,GO:0033047,regulation of mitotic sister chromatid segregation,8,0.0,1.0,1.0,4
3573,GO:0033049,clavulanic acid metabolic process,8,0.0,1.0,1.0,1
3574,GO:0033052,cyanoamino acid metabolic process,8,0.0,1.0,1.0,1
3575,GO:0033073,pinene metabolic process,8,0.0,1.0,1.0,2
3576,GO:0033077,T cell differentiation in thymus,8,0.0,1.0,1.0,3
3577,GO:0033100,NuA3 histone acetyltransferase complex,8,0.0,1.0,1.0,2
3578,GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway,8,0.0,1.0,1.0,4
3579,GO:0033145,positive regulation of intracellular steroid hormone receptor signaling pathway,8,0.0,1.0,1.0,4
3580,GO:0033146,regulation of intracellular estrogen receptor signaling pathway,8,0.0,1.0,1.0,2
3581,GO:0033157,regulation of intracellular protein transport,8,0.0,1.0,1.0,12
3582,GO:0033285,ATPase-coupled monocarboxylic acid transmembrane transporter activity,8,0.0,1.0,1.0,3
3583,GO:0033299,secretion of lysosomal enzymes,8,0.0,1.0,1.0,1
3584,GO:0033306,phytol metabolic process,8,0.0,1.0,1.0,1
3585,GO:0033319,UDP-D-xylose metabolic process,8,0.0,1.0,1.0,1
3586,GO:0033351,UDP-D-apiose metabolic process,8,0.0,1.0,1.0,1
3587,GO:0033356,UDP-L-arabinose metabolic process,8,0.0,1.0,1.0,1
3588,GO:0033369,establishment of protein localization to mast cell secretory granule,8,0.0,1.0,1.0,1
3589,GO:0033375,protease localization to T cell secretory granule,8,0.0,1.0,1.0,1
3590,GO:0033376,establishment of protein localization to T cell secretory granule,8,0.0,1.0,1.0,1
3591,GO:0033467,CMP-keto-3-deoxy-D-manno-octulosonic acid metabolic process,8,0.0,1.0,1.0,1
3592,GO:0033471,GDP-L-galactose metabolic process,8,0.0,1.0,1.0,1
3593,GO:0033478,UDP-rhamnose metabolic process,8,0.0,1.0,1.0,1
3594,GO:0033479,UDP-D-galacturonate metabolic process,8,0.0,1.0,1.0,1
3595,GO:0033494,ferulate metabolic process,8,0.0,1.0,1.0,2
3596,GO:0033496,sinapate metabolic process,8,0.0,1.0,1.0,1
3597,GO:0033536,ajugose biosynthetic process,8,0.0,1.0,1.0,2
3598,GO:0033604,negative regulation of catecholamine secretion,8,0.0,1.0,1.0,3
3599,GO:0033605,positive regulation of catecholamine secretion,8,0.0,1.0,1.0,3
3600,GO:0033609,oxalate metabolic process,8,0.0,1.0,1.0,2
3601,GO:0033652,host cell chloroplast,8,0.0,1.0,1.0,1
3602,GO:0033866,nucleoside bisphosphate biosynthetic process,8,0.0,1.0,1.0,2
3603,GO:0033869,nucleoside bisphosphate catabolic process,8,0.0,1.0,1.0,2
3604,GO:0033875,ribonucleoside bisphosphate metabolic process,8,0.0,1.0,1.0,3
3605,GO:0033892,deoxyribonuclease (pyrimidine dimer) activity,8,0.0,1.0,1.0,1
3606,GO:0033967,box C/D sno(s)RNA metabolic process,8,0.0,1.0,1.0,1
3607,GO:0033979,box H/ACA sno(s)RNA metabolic process,8,0.0,1.0,1.0,1
3608,GO:0034032,purine nucleoside bisphosphate metabolic process,8,0.0,1.0,1.0,3
3609,GO:0034077,butanediol metabolic process,8,0.0,1.0,1.0,3
3610,GO:0034091,regulation of maintenance of sister chromatid cohesion,8,0.0,1.0,1.0,4
3611,GO:0034121,regulation of toll-like receptor signaling pathway,8,0.0,1.0,1.0,5
3612,GO:0034131,regulation of toll-like receptor 1 signaling pathway,8,0.0,1.0,1.0,2
3613,GO:0034135,regulation of toll-like receptor 2 signaling pathway,8,0.0,1.0,1.0,2
3614,GO:0034143,regulation of toll-like receptor 4 signaling pathway,8,0.0,1.0,1.0,2
3615,GO:0034147,regulation of toll-like receptor 5 signaling pathway,8,0.0,1.0,1.0,2
3616,GO:0034151,regulation of toll-like receptor 6 signaling pathway,8,0.0,1.0,1.0,2
3617,GO:0034167,regulation of toll-like receptor 10 signaling pathway,8,0.0,1.0,1.0,2
3618,GO:0034215,thiamine:proton symporter activity,8,0.0,1.0,1.0,1
3619,GO:0034275,kynurenic acid metabolic process,8,0.0,1.0,1.0,1
3620,GO:0034307,regulation of ascospore formation,8,0.0,1.0,1.0,2
3621,GO:0034392,negative regulation of smooth muscle cell apoptotic process,8,0.0,1.0,1.0,1
3622,GO:0034393,positive regulation of smooth muscle cell apoptotic process,8,0.0,1.0,1.0,1
3623,GO:0034406,cell wall beta-glucan metabolic process,8,0.0,1.0,1.0,4
3624,GO:0034442,regulation of lipoprotein oxidation,8,0.0,1.0,1.0,2
3625,GO:0034501,protein localization to kinetochore,8,0.0,1.0,1.0,4
3626,GO:0034757,negative regulation of iron ion transport,8,0.0,1.0,1.0,1
3627,GO:0034758,positive regulation of iron ion transport,8,0.0,1.0,1.0,1
3628,GO:0034759,regulation of iron ion transmembrane transport,8,0.0,1.0,1.0,5
3629,GO:0035006,melanization defense response,8,0.0,1.0,1.0,1
3630,GO:0035009,negative regulation of melanization defense response,8,0.0,1.0,1.0,1
3631,GO:0035020,regulation of Rac protein signal transduction,8,0.0,1.0,1.0,2
3632,GO:0035023,regulation of Rho protein signal transduction,8,0.0,1.0,1.0,3
3633,GO:0035082,axoneme assembly,8,0.0,1.0,1.0,1
3634,GO:0035305,negative regulation of dephosphorylation,8,0.0,1.0,1.0,1
3635,GO:0035306,positive regulation of dephosphorylation,8,0.0,1.0,1.0,1
3636,GO:0035312,5'-3' DNA exonuclease activity,8,0.0,1.0,1.0,3
3637,GO:0035337,fatty-acyl-CoA metabolic process,8,0.0,1.0,1.0,10
3638,GO:0035341,regulation of inosine transport,8,0.0,1.0,1.0,2
3639,GO:0035350,FAD transmembrane transport,8,0.0,1.0,1.0,1
3640,GO:0035372,protein localization to microtubule,8,0.0,1.0,1.0,3
3641,GO:0035397,helper T cell enhancement of adaptive immune response,8,0.0,1.0,1.0,2
3642,GO:0035429,gluconate transmembrane transport,8,0.0,1.0,1.0,1
3643,GO:0035433,acetate transmembrane transport,8,0.0,1.0,1.0,1
3644,GO:0035581,sequestering of extracellular ligand from receptor,8,0.0,1.0,1.0,5
3645,GO:0035608,protein deglutamylation,8,0.0,1.0,1.0,3
3646,GO:0035672,oligopeptide transmembrane transport,8,0.0,1.0,1.0,7
3647,GO:0035685,helper T cell diapedesis,8,0.0,1.0,1.0,1
3648,GO:0035725,sodium ion transmembrane transport,8,0.0,1.0,1.0,2
3649,GO:0035739,"CD4-positive, alpha-beta T cell proliferation",8,0.0,1.0,1.0,1
3650,GO:0035740,"CD8-positive, alpha-beta T cell proliferation",8,0.0,1.0,1.0,1
3651,GO:0035747,natural killer cell chemotaxis,8,0.0,1.0,1.0,1
3652,GO:0035751,regulation of lysosomal lumen pH,8,0.0,1.0,1.0,2
3653,GO:0035754,B cell chemotaxis,8,0.0,1.0,1.0,1
3654,GO:0035794,positive regulation of mitochondrial membrane permeability,8,0.0,1.0,1.0,2
3655,GO:0035795,negative regulation of mitochondrial membrane permeability,8,0.0,1.0,1.0,2
3656,GO:0035814,negative regulation of renal sodium excretion,8,0.0,1.0,1.0,1
3657,GO:0035815,positive regulation of renal sodium excretion,8,0.0,1.0,1.0,1
3658,GO:0035825,homologous recombination,8,0.0,1.0,1.0,2
3659,GO:0035837,ergot alkaloid biosynthetic process,8,0.0,1.0,1.0,2
3660,GO:0035860,glial cell-derived neurotrophic factor receptor signaling pathway,8,0.0,1.0,1.0,2
3661,GO:0035873,lactate transmembrane transport,8,0.0,1.0,1.0,1
3662,GO:0035892,perturbation of platelet aggregation in another organism,8,0.0,1.0,1.0,2
3663,GO:0035927,RNA import into mitochondrion,8,0.0,1.0,1.0,2
3664,GO:0036032,neural crest cell delamination,8,0.0,1.0,1.0,1
3665,GO:0036041,long-chain fatty acid binding,8,0.0,1.0,1.0,8
3666,GO:0036103,Kdo2-lipid A metabolic process,8,0.0,1.0,1.0,1
3667,GO:0036290,protein trans-autophosphorylation,8,0.0,1.0,1.0,1
3668,GO:0036297,interstrand cross-link repair,8,0.0,1.0,1.0,2
3669,GO:0036300,B cell receptor internalization,8,0.0,1.0,1.0,1
3670,GO:0036394,amylase secretion,8,0.0,1.0,1.0,1
3671,GO:0036409,histone H3-K14 acetyltransferase complex,8,0.0,1.0,1.0,1
3672,GO:0036480,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,8,0.0,1.0,1.0,1
3673,GO:0036481,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,8,0.0,1.0,1.0,1
3674,GO:0036503,ERAD pathway,8,0.0,1.0,1.0,1
3675,GO:0036508,"protein alpha-1,2-demannosylation",8,0.0,1.0,1.0,3
3676,GO:0038009,regulation of signal transduction by receptor internalization,8,0.0,1.0,1.0,2
3677,GO:0038016,insulin receptor internalization,8,0.0,1.0,1.0,2
3678,GO:0038084,vascular endothelial growth factor signaling pathway,8,0.0,1.0,1.0,3
3679,GO:0038094,Fc-gamma receptor signaling pathway,8,0.0,1.0,1.0,1
3680,GO:0038095,Fc-epsilon receptor signaling pathway,8,0.0,1.0,1.0,1
3681,GO:0038115,chemokine (C-C motif) ligand 19 signaling pathway,8,0.0,1.0,1.0,1
3682,GO:0038116,chemokine (C-C motif) ligand 21 signaling pathway,8,0.0,1.0,1.0,1
3683,GO:0038118,C-C chemokine receptor CCR7 signaling pathway,8,0.0,1.0,1.0,2
3684,GO:0038127,ERBB signaling pathway,8,0.0,1.0,1.0,4
3685,GO:0038146,chemokine (C-X-C motif) ligand 12 signaling pathway,8,0.0,1.0,1.0,1
3686,GO:0038148,chemokine (C-C motif) ligand 2 signaling pathway,8,0.0,1.0,1.0,2
3687,GO:0038150,C-C chemokine receptor CCR2 signaling pathway,8,0.0,1.0,1.0,1
3688,GO:0038152,C-C chemokine receptor CCR4 signaling pathway,8,0.0,1.0,1.0,1
3689,GO:0038159,C-X-C chemokine receptor CXCR4 signaling pathway,8,0.0,1.0,1.0,1
3690,GO:0039008,pronephric nephron tubule morphogenesis,8,0.0,1.0,1.0,2
3691,GO:0039020,pronephric nephron tubule development,8,0.0,1.0,1.0,2
3692,GO:0039514,symbiont-mediated suppression of host JAK-STAT cascade,8,0.0,1.0,1.0,4
3693,GO:0039531,regulation of cytoplasmic pattern recognition receptor signaling pathway,8,0.0,1.0,1.0,13
3694,GO:0039671,evasion by virus of host natural killer cell activity,8,0.0,1.0,1.0,1
3695,GO:0039693,viral DNA genome replication,8,0.0,1.0,1.0,4
3696,GO:0039694,viral RNA genome replication,8,0.0,1.0,1.0,4
3697,GO:0040001,establishment of mitotic spindle localization,8,0.0,1.0,1.0,1
3698,GO:0040029,epigenetic regulation of gene expression,8,0.0,1.0,1.0,4
3699,GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,8,0.0,1.0,1.0,3
3700,GO:0042129,regulation of T cell proliferation,8,0.0,1.0,1.0,7
3701,GO:0042177,negative regulation of protein catabolic process,8,0.0,1.0,1.0,7
3702,GO:0042269,regulation of natural killer cell mediated cytotoxicity,8,0.0,1.0,1.0,4
3703,GO:0042304,regulation of fatty acid biosynthetic process,8,0.0,1.0,1.0,7
3704,GO:0042316,penicillin metabolic process,8,0.0,1.0,1.0,3
3705,GO:0042326,negative regulation of phosphorylation,8,0.0,1.0,1.0,2
3706,GO:0042327,positive regulation of phosphorylation,8,0.0,1.0,1.0,2
3707,GO:0042353,fucose biosynthetic process,8,0.0,1.0,1.0,1
3708,GO:0042354,L-fucose metabolic process,8,0.0,1.0,1.0,2
3709,GO:0042399,ectoine metabolic process,8,0.0,1.0,1.0,2
3710,GO:0042416,dopamine biosynthetic process,8,0.0,1.0,1.0,1
3711,GO:0042419,epinephrine catabolic process,8,0.0,1.0,1.0,1
3712,GO:0042451,purine nucleoside biosynthetic process,8,0.0,1.0,1.0,2
3713,GO:0042454,ribonucleoside catabolic process,8,0.0,1.0,1.0,3
3714,GO:0042455,ribonucleoside biosynthetic process,8,0.0,1.0,1.0,3
3715,GO:0042479,positive regulation of eye photoreceptor cell development,8,0.0,1.0,1.0,1
3716,GO:0042480,negative regulation of eye photoreceptor cell development,8,0.0,1.0,1.0,1
3717,GO:0042488,positive regulation of odontogenesis of dentin-containing tooth,8,0.0,1.0,1.0,1
3718,GO:0042492,gamma-delta T cell differentiation,8,0.0,1.0,1.0,2
3719,GO:0042662,negative regulation of mesodermal cell fate specification,8,0.0,1.0,1.0,4
3720,GO:0042783,evasion of host immune response,8,0.0,1.0,1.0,4
3721,GO:0042799,histone H4K20 methyltransferase activity,8,0.0,1.0,1.0,3
3722,GO:0042800,histone H3K4 methyltransferase activity,8,0.0,1.0,1.0,3
3723,GO:0042823,pyridoxal phosphate biosynthetic process,8,0.0,1.0,1.0,2
3724,GO:0042843,D-xylose catabolic process,8,0.0,1.0,1.0,1
3725,GO:0042845,glycol biosynthetic process,8,0.0,1.0,1.0,2
3726,GO:0042846,glycol catabolic process,8,0.0,1.0,1.0,2
3727,GO:0042847,sorbose biosynthetic process,8,0.0,1.0,1.0,1
3728,GO:0042848,sorbose catabolic process,8,0.0,1.0,1.0,1
3729,GO:0042938,dipeptide transport,8,0.0,1.0,1.0,3
3730,GO:0042939,tripeptide transport,8,0.0,1.0,1.0,2
3731,GO:0042996,regulation of Golgi to plasma membrane protein transport,8,0.0,1.0,1.0,2
3732,GO:0043007,maintenance of rDNA,8,0.0,1.0,1.0,2
3733,GO:0043039,tRNA aminoacylation,8,0.0,1.0,1.0,4
3734,GO:0043077,initiation of acetate catabolic process,8,0.0,1.0,1.0,1
3735,GO:0043102,amino acid salvage,8,0.0,1.0,1.0,2
3736,GO:0043110,rDNA spacer replication fork barrier binding,8,0.0,1.0,1.0,1
3737,GO:0043134,regulation of hindgut contraction,8,0.0,1.0,1.0,2
3738,GO:0043137,"DNA replication, removal of RNA primer",8,0.0,1.0,1.0,1
3739,GO:0043144,sno(s)RNA processing,8,0.0,1.0,1.0,6
3740,GO:0043174,nucleoside salvage,8,0.0,1.0,1.0,4
3741,GO:0043189,H4/H2A histone acetyltransferase complex,8,0.0,1.0,1.0,1
3742,GO:0043247,telomere maintenance in response to DNA damage,8,0.0,1.0,1.0,2
3743,GO:0043267,negative regulation of potassium ion transport,8,0.0,1.0,1.0,1
3744,GO:0043268,positive regulation of potassium ion transport,8,0.0,1.0,1.0,1
3745,GO:0043299,leukocyte degranulation,8,0.0,1.0,1.0,6
3746,GO:0043409,negative regulation of MAPK cascade,8,0.0,1.0,1.0,7
3747,GO:0043410,positive regulation of MAPK cascade,8,0.0,1.0,1.0,8
3748,GO:0043417,negative regulation of skeletal muscle tissue regeneration,8,0.0,1.0,1.0,1
3749,GO:0043420,anthranilate metabolic process,8,0.0,1.0,1.0,2
3750,GO:0043469,regulation of D-xylose catabolic process,8,0.0,1.0,1.0,1
3751,GO:0043484,regulation of RNA splicing,8,0.0,1.0,1.0,3
3752,GO:0043516,"regulation of DNA damage response, signal transduction by p53 class mediator",8,0.0,1.0,1.0,3
3753,GO:0043519,regulation of myosin II filament organization,8,0.0,1.0,1.0,4
3754,GO:0043536,positive regulation of blood vessel endothelial cell migration,8,0.0,1.0,1.0,1
3755,GO:0043537,negative regulation of blood vessel endothelial cell migration,8,0.0,1.0,1.0,1
3756,GO:0043549,regulation of kinase activity,8,0.0,1.0,1.0,6
3757,GO:0043633,polyadenylation-dependent RNA catabolic process,8,0.0,1.0,1.0,2
3758,GO:0043649,dicarboxylic acid catabolic process,8,0.0,1.0,1.0,12
3759,GO:0043650,dicarboxylic acid biosynthetic process,8,0.0,1.0,1.0,18
3760,GO:0043659,symbiosome,8,0.0,1.0,1.0,1
3761,GO:0043693,monoterpene biosynthetic process,8,0.0,1.0,1.0,2
3762,GO:0043694,monoterpene catabolic process,8,0.0,1.0,1.0,3
3763,GO:0043855,cyclic nucleotide-activated monoatomic ion channel activity,8,0.0,1.0,1.0,1
3764,GO:0043941,positive regulation of sexual sporulation resulting in formation of a cellular spore,8,0.0,1.0,1.0,4
3765,GO:0043942,negative regulation of sexual sporulation resulting in formation of a cellular spore,8,0.0,1.0,1.0,4
3766,GO:0044082,symbiont-mediated perturbation of host small GTPase-mediated signal transduction,8,0.0,1.0,1.0,2
3767,GO:0044184,host cell late endosome,8,0.0,1.0,1.0,1
3768,GO:0044352,pinosome,8,0.0,1.0,1.0,2
3769,GO:0044355,clearance of foreign intracellular DNA,8,0.0,1.0,1.0,1
3770,GO:0044414,symbiont-mediated suppression of host defenses,8,0.0,1.0,1.0,8
3771,GO:0044458,motile cilium assembly,8,0.0,1.0,1.0,2
3772,GO:0044465,modulation of sensory perception of pain in another organism,8,0.0,1.0,1.0,1
3773,GO:0044554,modulation of heart rate in another organism,8,0.0,1.0,1.0,1
3774,GO:0044617,modulation of relaxation of smooth muscle in another organism,8,0.0,1.0,1.0,1
3775,GO:0044743,protein transmembrane import into intracellular organelle,8,0.0,1.0,1.0,4
3776,GO:0044784,metaphase/anaphase transition of cell cycle,8,0.0,1.0,1.0,2
3777,GO:0044837,actomyosin contractile ring organization,8,0.0,1.0,1.0,2
3778,GO:0044866,modulation by host of viral exo-alpha-sialidase activity,8,0.0,1.0,1.0,1
3779,GO:0045006,DNA deamination,8,0.0,1.0,1.0,1
3780,GO:0045047,protein targeting to ER,8,0.0,1.0,1.0,2
3781,GO:0045048,protein insertion into ER membrane,8,0.0,1.0,1.0,5
3782,GO:0045065,cytotoxic T cell differentiation,8,0.0,1.0,1.0,1
3783,GO:0045066,regulatory T cell differentiation,8,0.0,1.0,1.0,2
3784,GO:0045110,intermediate filament bundle assembly,8,0.0,1.0,1.0,1
3785,GO:0045115,regulation of beta 2 integrin biosynthetic process,8,0.0,1.0,1.0,2
3786,GO:0045314,regulation of compound eye photoreceptor development,8,0.0,1.0,1.0,2
3787,GO:0045335,phagocytic vesicle,8,0.0,1.0,1.0,4
3788,GO:0045337,farnesyl diphosphate biosynthetic process,8,0.0,1.0,1.0,1
3789,GO:0045489,pectin biosynthetic process,8,0.0,1.0,1.0,2
3790,GO:0045490,pectin catabolic process,8,0.0,1.0,1.0,1
3791,GO:0045491,xylan metabolic process,8,0.0,1.0,1.0,5
3792,GO:0045607,regulation of inner ear auditory receptor cell differentiation,8,0.0,1.0,1.0,3
3793,GO:0045619,regulation of lymphocyte differentiation,8,0.0,1.0,1.0,5
3794,GO:0045638,negative regulation of myeloid cell differentiation,8,0.0,1.0,1.0,4
3795,GO:0045639,positive regulation of myeloid cell differentiation,8,0.0,1.0,1.0,4
3796,GO:0045646,regulation of erythrocyte differentiation,8,0.0,1.0,1.0,4
3797,GO:0045652,regulation of megakaryocyte differentiation,8,0.0,1.0,1.0,2
3798,GO:0045676,regulation of R7 cell differentiation,8,0.0,1.0,1.0,3
3799,GO:0045679,regulation of R8 cell differentiation,8,0.0,1.0,1.0,2
3800,GO:0045720,negative regulation of integrin biosynthetic process,8,0.0,1.0,1.0,1
3801,GO:0045726,positive regulation of integrin biosynthetic process,8,0.0,1.0,1.0,1
3802,GO:0045732,positive regulation of protein catabolic process,8,0.0,1.0,1.0,7
3803,GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,8,0.0,1.0,1.0,1
3804,GO:0045827,negative regulation of isoprenoid metabolic process,8,0.0,1.0,1.0,9
3805,GO:0045828,positive regulation of isoprenoid metabolic process,8,0.0,1.0,1.0,9
3806,GO:0045835,negative regulation of meiotic nuclear division,8,0.0,1.0,1.0,4
3807,GO:0045836,positive regulation of meiotic nuclear division,8,0.0,1.0,1.0,3
3808,GO:0045839,negative regulation of mitotic nuclear division,8,0.0,1.0,1.0,1
3809,GO:0045840,positive regulation of mitotic nuclear division,8,0.0,1.0,1.0,1
3810,GO:0045861,negative regulation of proteolysis,8,0.0,1.0,1.0,4
3811,GO:0045862,positive regulation of proteolysis,8,0.0,1.0,1.0,4
3812,GO:0045875,negative regulation of sister chromatid cohesion,8,0.0,1.0,1.0,1
3813,GO:0045876,positive regulation of sister chromatid cohesion,8,0.0,1.0,1.0,1
3814,GO:0045906,negative regulation of vasoconstriction,8,0.0,1.0,1.0,1
3815,GO:0045907,positive regulation of vasoconstriction,8,0.0,1.0,1.0,1
3816,GO:0045920,negative regulation of exocytosis,8,0.0,1.0,1.0,4
3817,GO:0045921,positive regulation of exocytosis,8,0.0,1.0,1.0,3
3818,GO:0045922,negative regulation of fatty acid metabolic process,8,0.0,1.0,1.0,5
3819,GO:0045923,positive regulation of fatty acid metabolic process,8,0.0,1.0,1.0,5
3820,GO:0045939,negative regulation of steroid metabolic process,8,0.0,1.0,1.0,6
3821,GO:0045940,positive regulation of steroid metabolic process,8,0.0,1.0,1.0,6
3822,GO:0045963,negative regulation of dopamine metabolic process,8,0.0,1.0,1.0,1
3823,GO:0045964,positive regulation of dopamine metabolic process,8,0.0,1.0,1.0,1
3824,GO:0045980,negative regulation of nucleotide metabolic process,8,0.0,1.0,1.0,3
3825,GO:0045981,positive regulation of nucleotide metabolic process,8,0.0,1.0,1.0,3
3826,GO:0045986,negative regulation of smooth muscle contraction,8,0.0,1.0,1.0,7
3827,GO:0045987,positive regulation of smooth muscle contraction,8,0.0,1.0,1.0,5
3828,GO:0045988,negative regulation of striated muscle contraction,8,0.0,1.0,1.0,5
3829,GO:0045989,positive regulation of striated muscle contraction,8,0.0,1.0,1.0,5
3830,GO:0046083,adenine metabolic process,8,0.0,1.0,1.0,2
3831,GO:0046098,guanine metabolic process,8,0.0,1.0,1.0,3
3832,GO:0046100,hypoxanthine metabolic process,8,0.0,1.0,1.0,2
3833,GO:0046110,xanthine metabolic process,8,0.0,1.0,1.0,2
3834,GO:0046116,queuosine metabolic process,8,0.0,1.0,1.0,2
3835,GO:0046120,deoxyribonucleoside biosynthetic process,8,0.0,1.0,1.0,2
3836,GO:0046121,deoxyribonucleoside catabolic process,8,0.0,1.0,1.0,2
3837,GO:0046122,purine deoxyribonucleoside metabolic process,8,0.0,1.0,1.0,6
3838,GO:0046125,pyrimidine deoxyribonucleoside metabolic process,8,0.0,1.0,1.0,6
3839,GO:0046128,purine ribonucleoside metabolic process,8,0.0,1.0,1.0,9
3840,GO:0046131,pyrimidine ribonucleoside metabolic process,8,0.0,1.0,1.0,4
3841,GO:0046134,pyrimidine nucleoside biosynthetic process,8,0.0,1.0,1.0,4
3842,GO:0046135,pyrimidine nucleoside catabolic process,8,0.0,1.0,1.0,3
3843,GO:0046256,"2,4,6-trinitrotoluene catabolic process",8,0.0,1.0,1.0,1
3844,GO:0046278,"3,4-dihydroxybenzoate metabolic process",8,0.0,1.0,1.0,2
3845,GO:0046320,regulation of fatty acid oxidation,8,0.0,1.0,1.0,3
3846,GO:0046328,regulation of JNK cascade,8,0.0,1.0,1.0,2
3847,GO:0046354,mannan biosynthetic process,8,0.0,1.0,1.0,1
3848,GO:0046368,GDP-L-fucose metabolic process,8,0.0,1.0,1.0,1
3849,GO:0046369,galactose biosynthetic process,8,0.0,1.0,1.0,1
3850,GO:0046371,dTDP-mannose metabolic process,8,0.0,1.0,1.0,1
3851,GO:0046372,D-arabinose metabolic process,8,0.0,1.0,1.0,1
3852,GO:0046373,L-arabinose metabolic process,8,0.0,1.0,1.0,2
3853,GO:0046381,CMP-N-acetylneuraminate metabolic process,8,0.0,1.0,1.0,1
3854,GO:0046382,GDP-D-rhamnose metabolic process,8,0.0,1.0,1.0,1
3855,GO:0046383,dTDP-rhamnose metabolic process,8,0.0,1.0,1.0,1
3856,GO:0046398,UDP-glucuronate metabolic process,8,0.0,1.0,1.0,1
3857,GO:0046416,D-amino acid metabolic process,8,0.0,1.0,1.0,13
3858,GO:0046417,chorismate metabolic process,8,0.0,1.0,1.0,6
3859,GO:0046426,negative regulation of receptor signaling pathway via JAK-STAT,8,0.0,1.0,1.0,1
3860,GO:0046430,non-phosphorylated glucose metabolic process,8,0.0,1.0,1.0,1
3861,GO:0046431,(R)-4-hydroxymandelate metabolic process,8,0.0,1.0,1.0,1
3862,GO:0046435,3-(3-hydroxy)phenylpropionate metabolic process,8,0.0,1.0,1.0,1
3863,GO:0046442,aerobactin metabolic process,8,0.0,1.0,1.0,1
3864,GO:0046450,dethiobiotin metabolic process,8,0.0,1.0,1.0,1
3865,GO:0046451,diaminopimelate metabolic process,8,0.0,1.0,1.0,2
3866,GO:0046452,dihydrofolate metabolic process,8,0.0,1.0,1.0,1
3867,GO:0046456,icosanoid biosynthetic process,8,0.0,1.0,1.0,2
3868,GO:0046468,phosphatidyl-N-monomethylethanolamine metabolic process,8,0.0,1.0,1.0,1
3869,GO:0046478,lactosylceramide metabolic process,8,0.0,1.0,1.0,1
3870,GO:0046479,glycosphingolipid catabolic process,8,0.0,1.0,1.0,2
3871,GO:0046482,para-aminobenzoic acid metabolic process,8,0.0,1.0,1.0,1
3872,GO:0046487,glyoxylate metabolic process,8,0.0,1.0,1.0,2
3873,GO:0046491,L-methylmalonyl-CoA metabolic process,8,0.0,1.0,1.0,1
3874,GO:0046495,nicotinamide riboside metabolic process,8,0.0,1.0,1.0,2
3875,GO:0046513,ceramide biosynthetic process,8,0.0,1.0,1.0,5
3876,GO:0046514,ceramide catabolic process,8,0.0,1.0,1.0,2
3877,GO:0046520,sphingoid biosynthetic process,8,0.0,1.0,1.0,3
3878,GO:0046521,sphingoid catabolic process,8,0.0,1.0,1.0,1
3879,GO:0046578,regulation of Ras protein signal transduction,8,0.0,1.0,1.0,2
3880,GO:0046599,regulation of centriole replication,8,0.0,1.0,1.0,2
3881,GO:0046606,negative regulation of centrosome cycle,8,0.0,1.0,1.0,1
3882,GO:0046632,alpha-beta T cell differentiation,8,0.0,1.0,1.0,5
3883,GO:0046634,regulation of alpha-beta T cell activation,8,0.0,1.0,1.0,7
3884,GO:0046643,regulation of gamma-delta T cell activation,8,0.0,1.0,1.0,5
3885,GO:0046655,folic acid metabolic process,8,0.0,1.0,1.0,2
3886,GO:0046832,negative regulation of RNA export from nucleus,8,0.0,1.0,1.0,1
3887,GO:0046833,positive regulation of RNA export from nucleus,8,0.0,1.0,1.0,1
3888,GO:0046874,quinolinate metabolic process,8,0.0,1.0,1.0,2
3889,GO:0046887,positive regulation of hormone secretion,8,0.0,1.0,1.0,12
3890,GO:0046888,negative regulation of hormone secretion,8,0.0,1.0,1.0,12
3891,GO:0046889,positive regulation of lipid biosynthetic process,8,0.0,1.0,1.0,18
3892,GO:0046929,negative regulation of neurotransmitter secretion,8,0.0,1.0,1.0,5
3893,GO:0046974,histone H3K9 methyltransferase activity,8,0.0,1.0,1.0,4
3894,GO:0046975,histone H3K36 methyltransferase activity,8,0.0,1.0,1.0,2
3895,GO:0046976,histone H3K27 methyltransferase activity,8,0.0,1.0,1.0,3
3896,GO:0047496,vesicle transport along microtubule,8,0.0,1.0,1.0,5
3897,GO:0047497,mitochondrion transport along microtubule,8,0.0,1.0,1.0,2
3898,GO:0047555,"3',5'-cyclic-GMP phosphodiesterase activity",8,0.0,1.0,1.0,2
3899,GO:0048008,platelet-derived growth factor receptor signaling pathway,8,0.0,1.0,1.0,3
3900,GO:0048010,vascular endothelial growth factor receptor signaling pathway,8,0.0,1.0,1.0,5
3901,GO:0048168,regulation of neuronal synaptic plasticity,8,0.0,1.0,1.0,3
3902,GO:0048202,clathrin coating of Golgi vesicle,8,0.0,1.0,1.0,2
3903,GO:0048205,COPI coating of Golgi vesicle,8,0.0,1.0,1.0,2
3904,GO:0048210,Golgi vesicle fusion to target membrane,8,0.0,1.0,1.0,4
3905,GO:0048242,epinephrine secretion,8,0.0,1.0,1.0,1
3906,GO:0048243,norepinephrine secretion,8,0.0,1.0,1.0,1
3907,GO:0048260,positive regulation of receptor-mediated endocytosis,8,0.0,1.0,1.0,3
3908,GO:0048261,negative regulation of receptor-mediated endocytosis,8,0.0,1.0,1.0,4
3909,GO:0048279,vesicle fusion with endoplasmic reticulum,8,0.0,1.0,1.0,1
3910,GO:0048280,vesicle fusion with Golgi apparatus,8,0.0,1.0,1.0,6
3911,GO:0048335,negative regulation of mesodermal cell fate determination,8,0.0,1.0,1.0,4
3912,GO:0048337,positive regulation of mesodermal cell fate specification,8,0.0,1.0,1.0,4
3913,GO:0048363,mucilage pectin metabolic process,8,0.0,1.0,1.0,1
3914,GO:0048549,positive regulation of pinocytosis,8,0.0,1.0,1.0,1
3915,GO:0048550,negative regulation of pinocytosis,8,0.0,1.0,1.0,1
3916,GO:0048690,regulation of axon extension involved in regeneration,8,0.0,1.0,1.0,2
3917,GO:0048742,regulation of skeletal muscle fiber development,8,0.0,1.0,1.0,2
3918,GO:0048813,dendrite morphogenesis,8,0.0,1.0,1.0,3
3919,GO:0048841,regulation of axon extension involved in axon guidance,8,0.0,1.0,1.0,2
3920,GO:0048893,afferent axon development in lateral line nerve,8,0.0,1.0,1.0,2
3921,GO:0050309,sugar-terminal-phosphatase activity,8,0.0,1.0,1.0,1
3922,GO:0050667,homocysteine metabolic process,8,0.0,1.0,1.0,3
3923,GO:0050671,positive regulation of lymphocyte proliferation,8,0.0,1.0,1.0,3
3924,GO:0050672,negative regulation of lymphocyte proliferation,8,0.0,1.0,1.0,3
3925,GO:0050708,regulation of protein secretion,8,0.0,1.0,1.0,11
3926,GO:0050747,positive regulation of lipoprotein metabolic process,8,0.0,1.0,1.0,1
3927,GO:0050748,negative regulation of lipoprotein metabolic process,8,0.0,1.0,1.0,2
3928,GO:0050765,negative regulation of phagocytosis,8,0.0,1.0,1.0,3
3929,GO:0050766,positive regulation of phagocytosis,8,0.0,1.0,1.0,4
3930,GO:0050770,regulation of axonogenesis,8,0.0,1.0,1.0,4
3931,GO:0050773,regulation of dendrite development,8,0.0,1.0,1.0,3
3932,GO:0050810,regulation of steroid biosynthetic process,8,0.0,1.0,1.0,11
3933,GO:0050812,regulation of acyl-CoA biosynthetic process,8,0.0,1.0,1.0,2
3934,GO:0050849,negative regulation of calcium-mediated signaling,8,0.0,1.0,1.0,2
3935,GO:0050850,positive regulation of calcium-mediated signaling,8,0.0,1.0,1.0,4
3936,GO:0050860,negative regulation of T cell receptor signaling pathway,8,0.0,1.0,1.0,1
3937,GO:0050868,negative regulation of T cell activation,8,0.0,1.0,1.0,6
3938,GO:0050869,negative regulation of B cell activation,8,0.0,1.0,1.0,3
3939,GO:0050870,positive regulation of T cell activation,8,0.0,1.0,1.0,9
3940,GO:0050871,positive regulation of B cell activation,8,0.0,1.0,1.0,4
3941,GO:0050995,negative regulation of lipid catabolic process,8,0.0,1.0,1.0,10
3942,GO:0050996,positive regulation of lipid catabolic process,8,0.0,1.0,1.0,10
3943,GO:0051028,mRNA transport,8,0.0,1.0,1.0,1
3944,GO:0051029,rRNA transport,8,0.0,1.0,1.0,2
3945,GO:0051030,snRNA transport,8,0.0,1.0,1.0,2
3946,GO:0051031,tRNA transport,8,0.0,1.0,1.0,3
3947,GO:0051043,regulation of membrane protein ectodomain proteolysis,8,0.0,1.0,1.0,2
3948,GO:0051053,negative regulation of DNA metabolic process,8,0.0,1.0,1.0,12
3949,GO:0051054,positive regulation of DNA metabolic process,8,0.0,1.0,1.0,16
3950,GO:0051055,negative regulation of lipid biosynthetic process,8,0.0,1.0,1.0,16
3951,GO:0051057,positive regulation of small GTPase mediated signal transduction,8,0.0,1.0,1.0,5
3952,GO:0051058,negative regulation of small GTPase mediated signal transduction,8,0.0,1.0,1.0,5
3953,GO:0051103,DNA ligation involved in DNA repair,8,0.0,1.0,1.0,1
3954,GO:0051104,DNA-dependent DNA replication DNA ligation,8,0.0,1.0,1.0,1
3955,GO:0051105,regulation of DNA ligation,8,0.0,1.0,1.0,3
3956,GO:0051143,propanediol metabolic process,8,0.0,1.0,1.0,3
3957,GO:0051161,arabitol metabolic process,8,0.0,1.0,1.0,3
3958,GO:0051164,xylitol metabolic process,8,0.0,1.0,1.0,1
3959,GO:0051202,phytochromobilin metabolic process,8,0.0,1.0,1.0,1
3960,GO:0051222,positive regulation of protein transport,8,0.0,1.0,1.0,7
3961,GO:0051224,negative regulation of protein transport,8,0.0,1.0,1.0,6
3962,GO:0051225,spindle assembly,8,0.0,1.0,1.0,3
3963,GO:0051230,spindle disassembly,8,0.0,1.0,1.0,2
3964,GO:0051253,negative regulation of RNA metabolic process,8,0.0,1.0,1.0,9
3965,GO:0051254,positive regulation of RNA metabolic process,8,0.0,1.0,1.0,9
3966,GO:0051274,beta-glucan biosynthetic process,8,0.0,1.0,1.0,4
3967,GO:0051275,beta-glucan catabolic process,8,0.0,1.0,1.0,3
3968,GO:0051278,fungal-type cell wall polysaccharide biosynthetic process,8,0.0,1.0,1.0,5
3969,GO:0051294,establishment of spindle orientation,8,0.0,1.0,1.0,2
3970,GO:0051295,establishment of meiotic spindle localization,8,0.0,1.0,1.0,1
3971,GO:0051403,stress-activated MAPK cascade,8,0.0,1.0,1.0,2
3972,GO:0051418,microtubule nucleation by microtubule organizing center,8,0.0,1.0,1.0,4
3973,GO:0051452,intracellular pH reduction,8,0.0,1.0,1.0,5
3974,GO:0051454,intracellular pH elevation,8,0.0,1.0,1.0,2
3975,GO:0051489,regulation of filopodium assembly,8,0.0,1.0,1.0,2
3976,GO:0051501,diterpene phytoalexin metabolic process,8,0.0,1.0,1.0,1
3977,GO:0051503,adenine nucleotide transport,8,0.0,1.0,1.0,9
3978,GO:0051511,negative regulation of unidimensional cell growth,8,0.0,1.0,1.0,2
3979,GO:0051512,positive regulation of unidimensional cell growth,8,0.0,1.0,1.0,2
3980,GO:0051563,smooth endoplasmic reticulum calcium ion homeostasis,8,0.0,1.0,1.0,2
3981,GO:0051584,regulation of dopamine uptake involved in synaptic transmission,8,0.0,1.0,1.0,2
3982,GO:0051609,inhibition of neurotransmitter uptake,8,0.0,1.0,1.0,6
3983,GO:0051612,negative regulation of serotonin uptake,8,0.0,1.0,1.0,1
3984,GO:0051617,negative regulation of histamine uptake,8,0.0,1.0,1.0,1
3985,GO:0051762,sesquiterpene biosynthetic process,8,0.0,1.0,1.0,6
3986,GO:0051763,sesquiterpene catabolic process,8,0.0,1.0,1.0,5
3987,GO:0051913,regulation of synaptic plasticity by chemical substance,8,0.0,1.0,1.0,1
3988,GO:0051917,regulation of fibrinolysis,8,0.0,1.0,1.0,2
3989,GO:0051926,negative regulation of calcium ion transport,8,0.0,1.0,1.0,4
3990,GO:0051928,positive regulation of calcium ion transport,8,0.0,1.0,1.0,4
3991,GO:0051934,catecholamine uptake involved in synaptic transmission,8,0.0,1.0,1.0,1
3992,GO:0051942,negative regulation of amino acid uptake involved in synaptic transmission,8,0.0,1.0,1.0,2
3993,GO:0051943,positive regulation of amino acid uptake involved in synaptic transmission,8,0.0,1.0,1.0,2
3994,GO:0051944,positive regulation of catecholamine uptake involved in synaptic transmission,8,0.0,1.0,1.0,1
3995,GO:0051945,negative regulation of catecholamine uptake involved in synaptic transmission,8,0.0,1.0,1.0,1
3996,GO:0051947,regulation of gamma-aminobutyric acid uptake involved in transmission of nerve impulse,8,0.0,1.0,1.0,2
3997,GO:0051967,"negative regulation of synaptic transmission, glutamatergic",8,0.0,1.0,1.0,1
3998,GO:0051968,"positive regulation of synaptic transmission, glutamatergic",8,0.0,1.0,1.0,1
3999,GO:0051981,copper chelate transmembrane transporter activity,8,0.0,1.0,1.0,1
4000,GO:0051986,negative regulation of attachment of spindle microtubules to kinetochore,8,0.0,1.0,1.0,1
4001,GO:0051987,positive regulation of attachment of spindle microtubules to kinetochore,8,0.0,1.0,1.0,2
4002,GO:0052322,positive regulation of phytoalexin biosynthetic process,8,0.0,1.0,1.0,2
4003,GO:0052482,defense response by cell wall thickening,8,0.0,1.0,1.0,1
4004,GO:0052543,callose deposition in cell wall,8,0.0,1.0,1.0,1
4005,GO:0052546,cell wall pectin metabolic process,8,0.0,1.0,1.0,2
4006,GO:0052547,regulation of peptidase activity,8,0.0,1.0,1.0,7
4007,GO:0052573,UDP-D-galactose metabolic process,8,0.0,1.0,1.0,1
4008,GO:0052649,coenzyme gamma-F420-2 metabolic process,8,0.0,1.0,1.0,1
4009,GO:0052698,ergothioneine metabolic process,8,0.0,1.0,1.0,2
4010,GO:0052713,inositol phosphorylceramide phospholipase activity,8,0.0,1.0,1.0,2
4011,GO:0052783,reuteran metabolic process,8,0.0,1.0,1.0,1
4012,GO:0055018,regulation of cardiac muscle fiber development,8,0.0,1.0,1.0,2
4013,GO:0055022,negative regulation of cardiac muscle tissue growth,8,0.0,1.0,1.0,2
4014,GO:0055023,positive regulation of cardiac muscle tissue growth,8,0.0,1.0,1.0,2
4015,GO:0055028,cortical microtubule,8,0.0,1.0,1.0,1
4016,GO:0055037,recycling endosome,8,0.0,1.0,1.0,4
4017,GO:0055117,regulation of cardiac muscle contraction,8,0.0,1.0,1.0,4
4018,GO:0060043,regulation of cardiac muscle cell proliferation,8,0.0,1.0,1.0,2
4019,GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",8,0.0,1.0,1.0,2
4020,GO:0060093,"negative regulation of synaptic transmission, glycinergic",8,0.0,1.0,1.0,1
4021,GO:0060094,"positive regulation of synaptic transmission, glycinergic",8,0.0,1.0,1.0,2
4022,GO:0060099,"regulation of phagocytosis, engulfment",8,0.0,1.0,1.0,3
4023,GO:0060147,regulation of post-transcriptional gene silencing,8,0.0,1.0,1.0,3
4024,GO:0060160,negative regulation of dopamine receptor signaling pathway,8,0.0,1.0,1.0,2
4025,GO:0060161,positive regulation of dopamine receptor signaling pathway,8,0.0,1.0,1.0,1
4026,GO:0060226,negative regulation of retinal cone cell fate commitment,8,0.0,1.0,1.0,1
4027,GO:0060296,regulation of cilium beat frequency involved in ciliary motility,8,0.0,1.0,1.0,1
4028,GO:0060302,negative regulation of cytokine activity,8,0.0,1.0,1.0,1
4029,GO:0060310,regulation of elastin catabolic process,8,0.0,1.0,1.0,2
4030,GO:0060331,negative regulation of response to type II interferon,8,0.0,1.0,1.0,1
4031,GO:0060332,positive regulation of response to type II interferon,8,0.0,1.0,1.0,1
4032,GO:0060334,regulation of type II interferon-mediated signaling pathway,8,0.0,1.0,1.0,2
4033,GO:0060382,regulation of DNA strand elongation,8,0.0,1.0,1.0,1
4034,GO:0060396,growth hormone receptor signaling pathway,8,0.0,1.0,1.0,1
4035,GO:0060542,regulation of strand invasion,8,0.0,1.0,1.0,2
4036,GO:0060620,regulation of cholesterol import,8,0.0,1.0,1.0,2
4037,GO:0060631,regulation of meiosis I,8,0.0,1.0,1.0,3
4038,GO:0060696,regulation of phospholipid catabolic process,8,0.0,1.0,1.0,4
4039,GO:0060700,regulation of ribonuclease activity,8,0.0,1.0,1.0,3
4040,GO:0060753,regulation of mast cell chemotaxis,8,0.0,1.0,1.0,2
4041,GO:0060765,regulation of androgen receptor signaling pathway,8,0.0,1.0,1.0,2
4042,GO:0060966,regulation of gene silencing by regulatory ncRNA,8,0.0,1.0,1.0,4
4043,GO:0060986,endocrine hormone secretion,8,0.0,1.0,1.0,7
4044,GO:0061001,regulation of dendritic spine morphogenesis,8,0.0,1.0,1.0,2
4045,GO:0061050,regulation of cell growth involved in cardiac muscle cell development,8,0.0,1.0,1.0,2
4046,GO:0061058,regulation of peptidoglycan recognition protein signaling pathway,8,0.0,1.0,1.0,2
4047,GO:0061067,negative regulation of dauer larval development,8,0.0,1.0,1.0,1
4048,GO:0061082,myeloid leukocyte cytokine production,8,0.0,1.0,1.0,3
4049,GO:0061092,positive regulation of phospholipid translocation,8,0.0,1.0,1.0,1
4050,GO:0061093,negative regulation of phospholipid translocation,8,0.0,1.0,1.0,1
4051,GO:0061119,regulation of positive chemotaxis to cAMP by chlorinated alkylphenone,8,0.0,1.0,1.0,4
4052,GO:0061122,positive regulation of positive chemotaxis to cAMP,8,0.0,1.0,1.0,1
4053,GO:0061123,negative regulation of positive chemotaxis to cAMP,8,0.0,1.0,1.0,1
4054,GO:0061182,negative regulation of chondrocyte development,8,0.0,1.0,1.0,1
4055,GO:0061242,mesonephric nephron tubule development,8,0.0,1.0,1.0,3
4056,GO:0061246,establishment or maintenance of bipolar cell polarity regulating cell shape,8,0.0,1.0,1.0,1
4057,GO:0061341,non-canonical Wnt signaling pathway involved in heart development,8,0.0,1.0,1.0,1
4058,GO:0061528,aspartate secretion,8,0.0,1.0,1.0,1
4059,GO:0061536,glycine secretion,8,0.0,1.0,1.0,1
4060,GO:0061584,orexin secretion,8,0.0,1.0,1.0,1
4061,GO:0061733,peptide-lysine-N-acetyltransferase activity,8,0.0,1.0,1.0,2
4062,GO:0061791,GTPase motor activity,8,0.0,1.0,1.0,1
4063,GO:0061884,regulation of mini excitatory postsynaptic potential,8,0.0,1.0,1.0,2
4064,GO:0062125,regulation of mitochondrial gene expression,8,0.0,1.0,1.0,2
4065,GO:0062132,regulation of L-glutamine biosynthetic process,8,0.0,1.0,1.0,2
4066,GO:0062208,positive regulation of pattern recognition receptor signaling pathway,8,0.0,1.0,1.0,21
4067,GO:0062232,prostanoid catabolic process,8,0.0,1.0,1.0,1
4068,GO:0065002,intracellular protein transmembrane transport,8,0.0,1.0,1.0,4
4069,GO:0070100,negative regulation of chemokine-mediated signaling pathway,8,0.0,1.0,1.0,1
4070,GO:0070101,positive regulation of chemokine-mediated signaling pathway,8,0.0,1.0,1.0,1
4071,GO:0070135,"beta-1,2-oligomannoside metabolic process",8,0.0,1.0,1.0,1
4072,GO:0070189,kynurenine metabolic process,8,0.0,1.0,1.0,2
4073,GO:0070203,regulation of establishment of protein localization to telomere,8,0.0,1.0,1.0,2
4074,GO:0070229,negative regulation of lymphocyte apoptotic process,8,0.0,1.0,1.0,3
4075,GO:0070230,positive regulation of lymphocyte apoptotic process,8,0.0,1.0,1.0,3
4076,GO:0070232,regulation of T cell apoptotic process,8,0.0,1.0,1.0,7
4077,GO:0070247,regulation of natural killer cell apoptotic process,8,0.0,1.0,1.0,2
4078,GO:0070296,sarcoplasmic reticulum calcium ion transport,8,0.0,1.0,1.0,2
4079,GO:0070298,negative regulation of phosphorelay signal transduction system,8,0.0,1.0,1.0,1
4080,GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,8,0.0,1.0,1.0,1
4081,GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,8,0.0,1.0,1.0,1
4082,GO:0070372,regulation of ERK1 and ERK2 cascade,8,0.0,1.0,1.0,2
4083,GO:0070376,regulation of ERK5 cascade,8,0.0,1.0,1.0,2
4084,GO:0070382,exocytic vesicle,8,0.0,1.0,1.0,3
4085,GO:0070413,trehalose metabolism in response to stress,8,0.0,1.0,1.0,3
4086,GO:0070456,galactose-1-phosphate phosphatase activity,8,0.0,1.0,1.0,2
4087,GO:0070472,regulation of uterine smooth muscle contraction,8,0.0,1.0,1.0,2
4088,GO:0070509,calcium ion import,8,0.0,1.0,1.0,1
4089,GO:0070525,tRNA threonylcarbamoyladenosine metabolic process,8,0.0,1.0,1.0,2
4090,GO:0070570,regulation of neuron projection regeneration,8,0.0,1.0,1.0,3
4091,GO:0070588,calcium ion transmembrane transport,8,0.0,1.0,1.0,8
4092,GO:0070595,(1->3)-alpha-glucan metabolic process,8,0.0,1.0,1.0,2
4093,GO:0070602,regulation of centromeric sister chromatid cohesion,8,0.0,1.0,1.0,2
4094,GO:0070629,(1->4)-alpha-glucan metabolic process,8,0.0,1.0,1.0,1
4095,GO:0070638,pyridine nucleoside catabolic process,8,0.0,1.0,1.0,1
4096,GO:0070646,protein modification by small protein removal,8,0.0,1.0,1.0,3
4097,GO:0070705,RNA nucleotide insertion,8,0.0,1.0,1.0,4
4098,GO:0070706,RNA nucleotide deletion,8,0.0,1.0,1.0,1
4099,GO:0070843,misfolded protein transport,8,0.0,1.0,1.0,1
4100,GO:0070844,polyubiquitinated protein transport,8,0.0,1.0,1.0,1
4101,GO:0070873,regulation of glycogen metabolic process,8,0.0,1.0,1.0,4
4102,GO:0070943,neutrophil-mediated killing of symbiont cell,8,0.0,1.0,1.0,2
4103,GO:0070949,regulation of neutrophil mediated killing of symbiont cell,8,0.0,1.0,1.0,4
4104,GO:0070954,negative regulation of neutrophil mediated cytotoxicity,8,0.0,1.0,1.0,1
4105,GO:0070960,positive regulation of neutrophil mediated cytotoxicity,8,0.0,1.0,1.0,1
4106,GO:0071025,RNA surveillance,8,0.0,1.0,1.0,3
4107,GO:0071034,CUT catabolic process,8,0.0,1.0,1.0,1
4108,GO:0071071,regulation of phospholipid biosynthetic process,8,0.0,1.0,1.0,9
4109,GO:0071169,establishment of protein localization to chromatin,8,0.0,1.0,1.0,1
4110,GO:0071170,site-specific DNA replication termination,8,0.0,1.0,1.0,2
4111,GO:0071210,protein insertion into membrane raft,8,0.0,1.0,1.0,1
4112,GO:0071271,1-butanol biosynthetic process,8,0.0,1.0,1.0,1
4113,GO:0071485,cellular response to absence of light,8,0.0,1.0,1.0,1
4114,GO:0071490,cellular response to far red light,8,0.0,1.0,1.0,1
4115,GO:0071491,cellular response to red light,8,0.0,1.0,1.0,1
4116,GO:0071519,actomyosin contractile ring actin filament bundle assembly,8,0.0,1.0,1.0,1
4117,GO:0071525,pyrrolysine metabolic process,8,0.0,1.0,1.0,1
4118,GO:0071580,regulation of zinc ion transmembrane transport,8,0.0,1.0,1.0,2
4119,GO:0071582,negative regulation of zinc ion transport,8,0.0,1.0,1.0,1
4120,GO:0071589,pyridine nucleoside biosynthetic process,8,0.0,1.0,1.0,2
4121,GO:0071591,nicotinic acid riboside metabolic process,8,0.0,1.0,1.0,1
4122,GO:0071616,acyl-CoA biosynthetic process,8,0.0,1.0,1.0,7
4123,GO:0071622,regulation of granulocyte chemotaxis,8,0.0,1.0,1.0,5
4124,GO:0071676,negative regulation of mononuclear cell migration,8,0.0,1.0,1.0,5
4125,GO:0071677,positive regulation of mononuclear cell migration,8,0.0,1.0,1.0,5
4126,GO:0071717,thromboxane transport,8,0.0,1.0,1.0,1
4127,GO:0071805,potassium ion transmembrane transport,8,0.0,1.0,1.0,3
4128,GO:0071879,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,8,0.0,1.0,1.0,1
4129,GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway,8,0.0,1.0,1.0,1
4130,GO:0071995,phytochelatin import into vacuole,8,0.0,1.0,1.0,3
4131,GO:0072011,glomerular endothelium development,8,0.0,1.0,1.0,1
4132,GO:0072014,proximal tubule development,8,0.0,1.0,1.0,3
4133,GO:0072017,distal tubule development,8,0.0,1.0,1.0,3
4134,GO:0072019,proximal convoluted tubule development,8,0.0,1.0,1.0,1
4135,GO:0072020,proximal straight tubule development,8,0.0,1.0,1.0,1
4136,GO:0072021,ascending thin limb development,8,0.0,1.0,1.0,1
4137,GO:0072023,thick ascending limb development,8,0.0,1.0,1.0,1
4138,GO:0072025,distal convoluted tubule development,8,0.0,1.0,1.0,1
4139,GO:0072027,connecting tubule development,8,0.0,1.0,1.0,2
4140,GO:0072039,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,8,0.0,1.0,1.0,4
4141,GO:0072070,loop of Henle development,8,0.0,1.0,1.0,1
4142,GO:0072156,distal tubule morphogenesis,8,0.0,1.0,1.0,3
4143,GO:0072158,proximal tubule morphogenesis,8,0.0,1.0,1.0,3
4144,GO:0072171,mesonephric tubule morphogenesis,8,0.0,1.0,1.0,3
4145,GO:0072183,negative regulation of nephron tubule epithelial cell differentiation,8,0.0,1.0,1.0,2
4146,GO:0072234,metanephric nephron tubule development,8,0.0,1.0,1.0,9
4147,GO:0072244,metanephric glomerular epithelium development,8,0.0,1.0,1.0,1
4148,GO:0072282,metanephric nephron tubule morphogenesis,8,0.0,1.0,1.0,2
4149,GO:0072307,regulation of metanephric nephron tubule epithelial cell differentiation,8,0.0,1.0,1.0,1
4150,GO:0072318,clathrin coat disassembly,8,0.0,1.0,1.0,1
4151,GO:0072329,monocarboxylic acid catabolic process,8,0.0,1.0,1.0,53
4152,GO:0072334,UDP-galactose transmembrane transport,8,0.0,1.0,1.0,1
4153,GO:0072351,tricarboxylic acid biosynthetic process,8,0.0,1.0,1.0,6
4154,GO:0072352,tricarboxylic acid catabolic process,8,0.0,1.0,1.0,3
4155,GO:0072385,minus-end-directed organelle transport along microtubule,8,0.0,1.0,1.0,1
4156,GO:0072386,plus-end-directed organelle transport along microtubule,8,0.0,1.0,1.0,1
4157,GO:0072387,flavin adenine dinucleotide metabolic process,8,0.0,1.0,1.0,4
4158,GO:0072393,microtubule anchoring at microtubule organizing center,8,0.0,1.0,1.0,2
4159,GO:0072514,trehalose transport in response to water deprivation,8,0.0,1.0,1.0,1
4160,GO:0072679,thymocyte migration,8,0.0,1.0,1.0,1
4161,GO:0072683,T cell extravasation,8,0.0,1.0,1.0,3
4162,GO:0072699,protein localization to cortical microtubule cytoskeleton,8,0.0,1.0,1.0,1
4163,GO:0075118,symbiont-mediated perturbation of host G protein-coupled receptor signal transduction pathway,8,0.0,1.0,1.0,2
4164,GO:0075240,regulation of zoospore formation,8,0.0,1.0,1.0,2
4165,GO:0075244,regulation of oospore formation,8,0.0,1.0,1.0,2
4166,GO:0075287,positive regulation of sporangiospore formation,8,0.0,1.0,1.0,2
4167,GO:0075288,negative regulation of sporangiospore formation,8,0.0,1.0,1.0,2
4168,GO:0075290,regulation of aplanospore formation,8,0.0,1.0,1.0,2
4169,GO:0075298,regulation of zygospore formation,8,0.0,1.0,1.0,2
4170,GO:0075302,regulation of basidiospore formation,8,0.0,1.0,1.0,2
4171,GO:0075528,perturbation by virus of host immune response,8,0.0,1.0,1.0,2
4172,GO:0080084,5S rDNA binding,8,0.0,1.0,1.0,1
4173,GO:0080140,regulation of jasmonic acid metabolic process,8,0.0,1.0,1.0,1
4174,GO:0086075,gap junction channel activity involved in cardiac conduction electrical coupling,8,0.0,1.0,1.0,5
4175,GO:0086093,G protein-coupled acetylcholine receptor signaling pathway involved in heart process,8,0.0,1.0,1.0,1
4176,GO:0089709,L-histidine transmembrane transport,8,0.0,1.0,1.0,4
4177,GO:0089722,phosphoenolpyruvate transmembrane transport,8,0.0,1.0,1.0,1
4178,GO:0090006,regulation of linear element assembly,8,0.0,1.0,1.0,1
4179,GO:0090025,regulation of monocyte chemotaxis,8,0.0,1.0,1.0,2
4180,GO:0090049,regulation of cell migration involved in sprouting angiogenesis,8,0.0,1.0,1.0,2
4181,GO:0090119,vesicle-mediated cholesterol transport,8,0.0,1.0,1.0,2
4182,GO:0090151,establishment of protein localization to mitochondrial membrane,8,0.0,1.0,1.0,4
4183,GO:0090153,regulation of sphingolipid biosynthetic process,8,0.0,1.0,1.0,3
4184,GO:0090181,regulation of cholesterol metabolic process,8,0.0,1.0,1.0,3
4185,GO:0090208,positive regulation of triglyceride metabolic process,8,0.0,1.0,1.0,2
4186,GO:0090209,negative regulation of triglyceride metabolic process,8,0.0,1.0,1.0,2
4187,GO:0090224,regulation of spindle organization,8,0.0,1.0,1.0,3
4188,GO:0090231,regulation of spindle checkpoint,8,0.0,1.0,1.0,4
4189,GO:0090234,regulation of kinetochore assembly,8,0.0,1.0,1.0,2
4190,GO:0090237,regulation of arachidonate secretion,8,0.0,1.0,1.0,2
4191,GO:0090276,regulation of peptide hormone secretion,8,0.0,1.0,1.0,11
4192,GO:0090279,regulation of calcium ion import,8,0.0,1.0,1.0,3
4193,GO:0090311,regulation of protein deacetylation,8,0.0,1.0,1.0,2
4194,GO:0090313,regulation of protein targeting to membrane,8,0.0,1.0,1.0,3
4195,GO:0090358,positive regulation of tryptophan metabolic process,8,0.0,1.0,1.0,1
4196,GO:0090385,phagosome-lysosome fusion,8,0.0,1.0,1.0,1
4197,GO:0090394,negative regulation of excitatory postsynaptic potential,8,0.0,1.0,1.0,1
4198,GO:0090426,actin filament bundle convergence,8,0.0,1.0,1.0,1
4199,GO:0090452,lithium ion transmembrane transport,8,0.0,1.0,1.0,1
4200,GO:0090494,dopamine uptake,8,0.0,1.0,1.0,1
4201,GO:0090495,low-density lipoprotein particle disassembly,8,0.0,1.0,1.0,1
4202,GO:0090592,DNA synthesis involved in DNA replication,8,0.0,1.0,1.0,2
4203,GO:0090657,telomeric loop disassembly,8,0.0,1.0,1.0,1
4204,GO:0097170,ADP-L-glycero-beta-D-manno-heptose metabolic process,8,0.0,1.0,1.0,1
4205,GO:0097174,"1,6-anhydro-N-acetyl-beta-muramic acid metabolic process",8,0.0,1.0,1.0,1
4206,GO:0097355,protein localization to heterochromatin,8,0.0,1.0,1.0,4
4207,GO:0097497,blood vessel endothelial cell delamination,8,0.0,1.0,1.0,1
4208,GO:0097688,glutamate receptor clustering,8,0.0,1.0,1.0,1
4209,GO:0097720,calcineurin-mediated signaling,8,0.0,1.0,1.0,1
4210,GO:0097742,de novo centriole assembly,8,0.0,1.0,1.0,2
4211,GO:0098596,imitative learning,8,0.0,1.0,1.0,1
4212,GO:0098670,entry receptor-mediated virion attachment to host cell,8,0.0,1.0,1.0,1
4213,GO:0098671,adhesion receptor-mediated virion attachment to host cell,8,0.0,1.0,1.0,1
4214,GO:0098737,protein insertion into plasma membrane,8,0.0,1.0,1.0,1
4215,GO:0098776,protein transport across the cell outer membrane,8,0.0,1.0,1.0,3
4216,GO:0098838,folate transmembrane transport,8,0.0,1.0,1.0,2
4217,GO:0098840,protein transport along microtubule,8,0.0,1.0,1.0,5
4218,GO:0098845,postsynaptic endosome,8,0.0,1.0,1.0,2
4219,GO:0098877,neurotransmitter receptor transport to plasma membrane,8,0.0,1.0,1.0,2
4220,GO:0098920,retrograde trans-synaptic signaling by lipid,8,0.0,1.0,1.0,1
4221,GO:0098923,retrograde trans-synaptic signaling by soluble gas,8,0.0,1.0,1.0,1
4222,GO:0098930,axonal transport,8,0.0,1.0,1.0,4
4223,GO:0098935,dendritic transport,8,0.0,1.0,1.0,5
4224,GO:0098962,regulation of postsynaptic neurotransmitter receptor activity,8,0.0,1.0,1.0,1
4225,GO:0098980,presynaptic density,8,0.0,1.0,1.0,1
4226,GO:0099082,retrograde trans-synaptic signaling by neuropeptide,8,0.0,1.0,1.0,1
4227,GO:0099094,ligand-gated monoatomic cation channel activity,8,0.0,1.0,1.0,14
4228,GO:0099095,ligand-gated monoatomic anion channel activity,8,0.0,1.0,1.0,8
4229,GO:0099101,G-protein gated potassium channel activity,8,0.0,1.0,1.0,1
4230,GO:0099112,microtubule polymerization based protein transport,8,0.0,1.0,1.0,1
4231,GO:0099151,regulation of postsynaptic density assembly,8,0.0,1.0,1.0,2
4232,GO:0099500,vesicle fusion to plasma membrane,8,0.0,1.0,1.0,2
4233,GO:0099542,trans-synaptic signaling by endocannabinoid,8,0.0,1.0,1.0,2
4234,GO:0099548,trans-synaptic signaling by nitric oxide,8,0.0,1.0,1.0,3
4235,GO:0099549,trans-synaptic signaling by carbon monoxide,8,0.0,1.0,1.0,1
4236,GO:0099551,"trans-synaptic signaling by neuropeptide, modulating synaptic transmission",8,0.0,1.0,1.0,1
4237,GO:0099552,"trans-synaptic signaling by lipid, modulating synaptic transmission",8,0.0,1.0,1.0,1
4238,GO:0099554,"trans-synaptic signaling by soluble gas, modulating synaptic transmission",8,0.0,1.0,1.0,2
4239,GO:0099590,neurotransmitter receptor internalization,8,0.0,1.0,1.0,1
4240,GO:0099627,neurotransmitter receptor cycle,8,0.0,1.0,1.0,1
4241,GO:0099638,endosome to plasma membrane protein transport,8,0.0,1.0,1.0,1
4242,GO:0106011,regulation of protein localization to medial cortex,8,0.0,1.0,1.0,3
4243,GO:0106017,"phosphatidylinositol-3,4-bisphosphate phosphatase activity",8,0.0,1.0,1.0,2
4244,GO:0106018,"phosphatidylinositol-3,5-bisphosphate phosphatase activity",8,0.0,1.0,1.0,2
4245,GO:0106019,"phosphatidylinositol-4,5-bisphosphate phosphatase activity",8,0.0,1.0,1.0,2
4246,GO:0106044,guanine deglycation,8,0.0,1.0,1.0,2
4247,GO:0106056,regulation of calcineurin-mediated signaling,8,0.0,1.0,1.0,3
4248,GO:0106060,regulation of exit from meiosis,8,0.0,1.0,1.0,2
4249,GO:0106071,positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,8,0.0,1.0,1.0,1
4250,GO:0106072,negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway,8,0.0,1.0,1.0,2
4251,GO:0106104,regulation of glutamate receptor clustering,8,0.0,1.0,1.0,1
4252,GO:0106393,regulation of palmitic acid catabolic process,8,0.0,1.0,1.0,2
4253,GO:0110020,regulation of actomyosin structure organization,8,0.0,1.0,1.0,4
4254,GO:0110026,regulation of DNA strand resection involved in replication fork processing,8,0.0,1.0,1.0,2
4255,GO:0110030,regulation of G2/MI transition of meiotic cell cycle,8,0.0,1.0,1.0,2
4256,GO:0110033,regulation of adenylate cyclase-activating glucose-activated G protein-coupled receptor signaling pathway,8,0.0,1.0,1.0,1
4257,GO:0110053,regulation of actin filament organization,8,0.0,1.0,1.0,4
4258,GO:0110058,positive regulation of blood vessel endothelial cell differentiation,8,0.0,1.0,1.0,1
4259,GO:0110059,negative regulation of blood vessel endothelial cell differentiation,8,0.0,1.0,1.0,1
4260,GO:0110117,positive regulation of compound eye photoreceptor cell differentiation,8,0.0,1.0,1.0,2
4261,GO:0110118,negative regulation of compound eye photoreceptor cell differentiation,8,0.0,1.0,1.0,2
4262,GO:0110156,mRNA methylguanosine-cap decapping,8,0.0,1.0,1.0,2
4263,GO:0120033,negative regulation of plasma membrane bounded cell projection assembly,8,0.0,1.0,1.0,8
4264,GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,8,0.0,1.0,1.0,9
4265,GO:0120093,regulation of peptidyl-lysine crotonylation,8,0.0,1.0,1.0,1
4266,GO:0120141,regulation of ecdysone receptor signaling pathway,8,0.0,1.0,1.0,2
4267,GO:0120213,regulation of histidine biosynthetic process,8,0.0,1.0,1.0,2
4268,GO:0120257,peptidyl-threonine acetylation,8,0.0,1.0,1.0,1
4269,GO:0140050,negative regulation of endocardial cushion to mesenchymal transition,8,0.0,1.0,1.0,1
4270,GO:0140051,positive regulation of endocardial cushion to mesenchymal transition,8,0.0,1.0,1.0,1
4271,GO:0140058,neuron projection arborization,8,0.0,1.0,1.0,2
4272,GO:0140075,regulation of lipoprotein transport,8,0.0,1.0,1.0,2
4273,GO:0140213,negative regulation of long-chain fatty acid import into cell,8,0.0,1.0,1.0,1
4274,GO:0140214,positive regulation of long-chain fatty acid import into cell,8,0.0,1.0,1.0,1
4275,GO:0140271,hexose import across plasma membrane,8,0.0,1.0,1.0,4
4276,GO:0140404,effector-mediated perturbation of host innate immune response by symbiont,8,0.0,1.0,1.0,3
4277,GO:0140412,zinc:bicarbonate symporter activity,8,0.0,1.0,1.0,1
4278,GO:0140455,cytoplasm protein quality control,8,0.0,1.0,1.0,1
4279,GO:0140500,regulation of reticulophagy,8,0.0,1.0,1.0,1
4280,GO:0140539,regulation of melanotic encapsulation of foreign target,8,0.0,1.0,1.0,1
4281,GO:0140667,regulation of oxytocin production,8,0.0,1.0,1.0,2
4282,GO:0140710,regulation of Frizzled Nuclear Import pathway,8,0.0,1.0,1.0,2
4283,GO:0140852,histone ubiquitin ligase activity,8,0.0,1.0,1.0,4
4284,GO:0140886,symbiont-mediated suppression of host interferon-mediated signaling pathway,8,0.0,1.0,1.0,3
4285,GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,8,0.0,1.0,1.0,3
4286,GO:0141149,regulation of nitric oxide-cGMP mediated signal transduction,8,0.0,1.0,1.0,2
4287,GO:0150078,positive regulation of neuroinflammatory response,8,0.0,1.0,1.0,2
4288,GO:0150079,negative regulation of neuroinflammatory response,8,0.0,1.0,1.0,2
4289,GO:0150172,regulation of phosphatidylcholine metabolic process,8,0.0,1.0,1.0,4
4290,GO:0150175,regulation of phosphatidylethanolamine metabolic process,8,0.0,1.0,1.0,2
4291,GO:0150178,regulation of phosphatidylserine metabolic process,8,0.0,1.0,1.0,3
4292,GO:0160128,pH-gated monoatomic ion channel activity,8,0.0,1.0,1.0,3
4293,GO:0170021,ionotropic taste receptor activity,8,0.0,1.0,1.0,3
4294,GO:0170033,L-amino acid metabolic process,8,0.0,1.0,1.0,22
4295,GO:0170038,proteinogenic amino acid biosynthetic process,8,0.0,1.0,1.0,7
4296,GO:0170040,proteinogenic amino acid catabolic process,8,0.0,1.0,1.0,6
4297,GO:0170043,non-proteinogenic amino acid biosynthetic process,8,0.0,1.0,1.0,18
4298,GO:0170044,non-proteinogenic amino acid catabolic process,8,0.0,1.0,1.0,19
4299,GO:0180039,regulation of pheromone response MAPK cascade,8,0.0,1.0,1.0,2
4300,GO:1900027,regulation of ruffle assembly,8,0.0,1.0,1.0,2
4301,GO:1900052,regulation of retinoic acid biosynthetic process,8,0.0,1.0,1.0,2
4302,GO:1900079,regulation of arginine biosynthetic process,8,0.0,1.0,1.0,1
4303,GO:1900081,regulation of arginine catabolic process,8,0.0,1.0,1.0,1
4304,GO:1900091,regulation of raffinose biosynthetic process,8,0.0,1.0,1.0,2
4305,GO:1900102,negative regulation of endoplasmic reticulum unfolded protein response,8,0.0,1.0,1.0,3
4306,GO:1900103,positive regulation of endoplasmic reticulum unfolded protein response,8,0.0,1.0,1.0,3
4307,GO:1900107,regulation of nodal signaling pathway,8,0.0,1.0,1.0,2
4308,GO:1900136,regulation of chemokine activity,8,0.0,1.0,1.0,1
4309,GO:1900148,negative regulation of Schwann cell migration,8,0.0,1.0,1.0,1
4310,GO:1900149,positive regulation of Schwann cell migration,8,0.0,1.0,1.0,1
4311,GO:1900161,regulation of phospholipid scramblase activity,8,0.0,1.0,1.0,1
4312,GO:1900184,negative regulation of xanthone-containing compound biosynthetic process,8,0.0,1.0,1.0,1
4313,GO:1900185,positive regulation of xanthone-containing compound biosynthetic process,8,0.0,1.0,1.0,1
4314,GO:1900194,negative regulation of oocyte maturation,8,0.0,1.0,1.0,1
4315,GO:1900208,regulation of cardiolipin metabolic process,8,0.0,1.0,1.0,2
4316,GO:1900212,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,8,0.0,1.0,1.0,1
4317,GO:1900213,positive regulation of mesenchymal cell apoptotic process involved in metanephros development,8,0.0,1.0,1.0,1
4318,GO:1900243,negative regulation of synaptic vesicle endocytosis,8,0.0,1.0,1.0,1
4319,GO:1900271,regulation of long-term synaptic potentiation,8,0.0,1.0,1.0,2
4320,GO:1900282,regulation of cellobiose catabolic process,8,0.0,1.0,1.0,2
4321,GO:1900333,regulation of methane biosynthetic process from 3-(methylthio)propionic acid,8,0.0,1.0,1.0,2
4322,GO:1900452,regulation of long-term synaptic depression,8,0.0,1.0,1.0,2
4323,GO:1900480,regulation of diacylglycerol biosynthetic process,8,0.0,1.0,1.0,2
4324,GO:1900497,regulation of butyryl-CoA catabolic process to butanol,8,0.0,1.0,1.0,2
4325,GO:1900542,regulation of purine nucleotide metabolic process,8,0.0,1.0,1.0,7
4326,GO:1900582,o-orsellinic acid metabolic process,8,0.0,1.0,1.0,2
4327,GO:1900637,regulation of asperfuranone biosynthetic process,8,0.0,1.0,1.0,2
4328,GO:1900646,regulation of chanoclavine-I aldehyde biosynthetic process,8,0.0,1.0,1.0,2
4329,GO:1900658,regulation of emericellamide biosynthetic process,8,0.0,1.0,1.0,3
4330,GO:1900670,regulation of F-9775A biosynthetic process,8,0.0,1.0,1.0,2
4331,GO:1900675,regulation of F-9775B biosynthetic process,8,0.0,1.0,1.0,2
4332,GO:1900705,negative regulation of siderophore biosynthetic process,8,0.0,1.0,1.0,1
4333,GO:1900706,positive regulation of siderophore biosynthetic process,8,0.0,1.0,1.0,1
4334,GO:1900719,regulation of uterine smooth muscle relaxation,8,0.0,1.0,1.0,3
4335,GO:1900722,regulation of protein adenylylation,8,0.0,1.0,1.0,2
4336,GO:1900729,regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway,8,0.0,1.0,1.0,2
4337,GO:1900733,negative regulation of polyketide biosynthetic process,8,0.0,1.0,1.0,4
4338,GO:1900734,positive regulation of polyketide biosynthetic process,8,0.0,1.0,1.0,6
4339,GO:1900737,negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway,8,0.0,1.0,1.0,2
4340,GO:1900744,regulation of p38MAPK cascade,8,0.0,1.0,1.0,2
4341,GO:1900749,(R)-carnitine transport,8,0.0,1.0,1.0,1
4342,GO:1900816,ochratoxin A metabolic process,8,0.0,1.0,1.0,2
4343,GO:1900823,negative regulation of ergot alkaloid biosynthetic process,8,0.0,1.0,1.0,2
4344,GO:1900824,positive regulation of ergot alkaloid biosynthetic process,8,0.0,1.0,1.0,2
4345,GO:1900834,regulation of emericellin biosynthetic process,8,0.0,1.0,1.0,2
4346,GO:1900837,regulation of fumigaclavine C biosynthetic process,8,0.0,1.0,1.0,2
4347,GO:1900864,mitochondrial RNA modification,8,0.0,1.0,1.0,2
4348,GO:1900865,chloroplast RNA modification,8,0.0,1.0,1.0,1
4349,GO:1900867,sarcinapterin metabolic process,8,0.0,1.0,1.0,1
4350,GO:1900944,regulation of isoprene metabolic process,8,0.0,1.0,1.0,3
4351,GO:1900969,negative regulation of sarcinapterin metabolic process,8,0.0,1.0,1.0,1
4352,GO:1900970,positive regulation of sarcinapterin metabolic process,8,0.0,1.0,1.0,1
4353,GO:1900971,regulation of sarcinapterin biosynthetic process,8,0.0,1.0,1.0,2
4354,GO:1901022,4-hydroxyphenylacetate metabolic process,8,0.0,1.0,1.0,2
4355,GO:1901027,dextrin catabolic process,8,0.0,1.0,1.0,2
4356,GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,8,0.0,1.0,1.0,2
4357,GO:1901052,sarcosine metabolic process,8,0.0,1.0,1.0,2
4358,GO:1901081,negative regulation of relaxation of smooth muscle,8,0.0,1.0,1.0,1
4359,GO:1901082,positive regulation of relaxation of smooth muscle,8,0.0,1.0,1.0,1
4360,GO:1901091,negative regulation of protein tetramerization,8,0.0,1.0,1.0,1
4361,GO:1901092,positive regulation of protein tetramerization,8,0.0,1.0,1.0,1
4362,GO:1901093,regulation of protein homotetramerization,8,0.0,1.0,1.0,2
4363,GO:1901096,regulation of autophagosome maturation,8,0.0,1.0,1.0,2
4364,GO:1901110,actinorhodin metabolic process,8,0.0,1.0,1.0,2
4365,GO:1901172,phytoene metabolic process,8,0.0,1.0,1.0,2
4366,GO:1901175,lycopene metabolic process,8,0.0,1.0,1.0,2
4367,GO:1901182,regulation of camalexin biosynthetic process,8,0.0,1.0,1.0,1
4368,GO:1901221,positive regulation of cardiac chamber morphogenesis,8,0.0,1.0,1.0,1
4369,GO:1901272,2-dehydro-3-deoxy-D-gluconic acid metabolic process,8,0.0,1.0,1.0,2
4370,GO:1901283,"5,6,7,8-tetrahydromethanopterin metabolic process",8,0.0,1.0,1.0,2
4371,GO:1901317,regulation of flagellated sperm motility,8,0.0,1.0,1.0,2
4372,GO:1901356,beta-D-galactofuranose metabolic process,8,0.0,1.0,1.0,2
4373,GO:1901379,regulation of potassium ion transmembrane transport,8,0.0,1.0,1.0,5
4374,GO:1901428,regulation of syringal lignin biosynthetic process,8,0.0,1.0,1.0,2
4375,GO:1901475,pyruvate transmembrane transport,8,0.0,1.0,1.0,2
4376,GO:1901524,regulation of mitophagy,8,0.0,1.0,1.0,3
4377,GO:1901542,"regulation of ent-pimara-8(14),15-diene biosynthetic process",8,0.0,1.0,1.0,2
4378,GO:1901551,negative regulation of endothelial cell development,8,0.0,1.0,1.0,1
4379,GO:1901552,positive regulation of endothelial cell development,8,0.0,1.0,1.0,1
4380,GO:1901553,malonic acid transmembrane transport,8,0.0,1.0,1.0,2
4381,GO:1901600,strigolactone metabolic process,8,0.0,1.0,1.0,1
4382,GO:1901606,alpha-amino acid catabolic process,8,0.0,1.0,1.0,14
4383,GO:1901607,alpha-amino acid biosynthetic process,8,0.0,1.0,1.0,12
4384,GO:1901609,negative regulation of vesicle transport along microtubule,8,0.0,1.0,1.0,3
4385,GO:1901610,positive regulation of vesicle transport along microtubule,8,0.0,1.0,1.0,3
4386,GO:1901710,regulation of homoserine biosynthetic process,8,0.0,1.0,1.0,2
4387,GO:1901735,(R)-mevalonic acid metabolic process,8,0.0,1.0,1.0,2
4388,GO:1901745,prephenate(2-) metabolic process,8,0.0,1.0,1.0,2
4389,GO:1901778,pentalenolactone metabolic process,8,0.0,1.0,1.0,2
4390,GO:1901781,p-cumate metabolic process,8,0.0,1.0,1.0,2
4391,GO:1901787,benzoyl-CoA metabolic process,8,0.0,1.0,1.0,2
4392,GO:1901790,"3-(2,3-dihydroxyphenyl)propanoate metabolic process",8,0.0,1.0,1.0,2
4393,GO:1901793,3-(3-hydroxyphenyl)propanoate metabolic process,8,0.0,1.0,1.0,2
4394,GO:1901797,negative regulation of signal transduction by p53 class mediator,8,0.0,1.0,1.0,2
4395,GO:1901798,positive regulation of signal transduction by p53 class mediator,8,0.0,1.0,1.0,2
4396,GO:1901847,nicotinate metabolic process,8,0.0,1.0,1.0,2
4397,GO:1901853,"5,6,7,8-tetrahydrosarcinapterin metabolic process",8,0.0,1.0,1.0,2
4398,GO:1901858,regulation of mitochondrial DNA metabolic process,8,0.0,1.0,1.0,3
4399,GO:1901873,regulation of post-translational protein modification,8,0.0,1.0,1.0,3
4400,GO:1901885,2-hydroxybenzoyl-CoA metabolic process,8,0.0,1.0,1.0,2
4401,GO:1901892,negative regulation of cell septum assembly,8,0.0,1.0,1.0,1
4402,GO:1901893,positive regulation of cell septum assembly,8,0.0,1.0,1.0,1
4403,GO:1901926,cadinene metabolic process,8,0.0,1.0,1.0,2
4404,GO:1901929,alpha-copaene metabolic process,8,0.0,1.0,1.0,2
4405,GO:1901932,bicyclogermacrene metabolic process,8,0.0,1.0,1.0,2
4406,GO:1901935,beta-caryophyllene metabolic process,8,0.0,1.0,1.0,2
4407,GO:1901938,(-)-exo-alpha-bergamotene metabolic process,8,0.0,1.0,1.0,2
4408,GO:1901941,(+)-epi-alpha-bisabolol metabolic process,8,0.0,1.0,1.0,2
4409,GO:1901947,"5alpha,9alpha,10beta-labda-8(20),13-dien-15-yl diphosphate metabolic process",8,0.0,1.0,1.0,2
4410,GO:1901951,regulation of anterograde dense core granule transport,8,0.0,1.0,1.0,2
4411,GO:1901954,regulation of retrograde dense core granule transport,8,0.0,1.0,1.0,2
4412,GO:1901977,negative regulation of cell cycle checkpoint,8,0.0,1.0,1.0,2
4413,GO:1901978,positive regulation of cell cycle checkpoint,8,0.0,1.0,1.0,2
4414,GO:1901983,regulation of protein acetylation,8,0.0,1.0,1.0,4
4415,GO:1901991,negative regulation of mitotic cell cycle phase transition,8,0.0,1.0,1.0,5
4416,GO:1901992,positive regulation of mitotic cell cycle phase transition,8,0.0,1.0,1.0,4
4417,GO:1901994,negative regulation of meiotic cell cycle phase transition,8,0.0,1.0,1.0,3
4418,GO:1901995,positive regulation of meiotic cell cycle phase transition,8,0.0,1.0,1.0,3
4419,GO:1901996,regulation of indoleacetic acid biosynthetic process via tryptophan,8,0.0,1.0,1.0,1
4420,GO:1901999,homogentisate metabolic process,8,0.0,1.0,1.0,1
4421,GO:1902001,fatty acid transmembrane transport,8,0.0,1.0,1.0,4
4422,GO:1902003,regulation of amyloid-beta formation,8,0.0,1.0,1.0,2
4423,GO:1902017,regulation of cilium assembly,8,0.0,1.0,1.0,4
4424,GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,8,0.0,1.0,1.0,3
4425,GO:1902053,regulation of neosartoricin biosynthetic process,8,0.0,1.0,1.0,2
4426,GO:1902076,regulation of lateral motor column neuron migration,8,0.0,1.0,1.0,2
4427,GO:1902080,regulation of calcium ion import into sarcoplasmic reticulum,8,0.0,1.0,1.0,2
4428,GO:1902084,fumagillin metabolic process,8,0.0,1.0,1.0,2
4429,GO:1902099,regulation of metaphase/anaphase transition of cell cycle,8,0.0,1.0,1.0,4
4430,GO:1902106,negative regulation of leukocyte differentiation,8,0.0,1.0,1.0,3
4431,GO:1902107,positive regulation of leukocyte differentiation,8,0.0,1.0,1.0,3
4432,GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,8,0.0,1.0,1.0,2
4433,GO:1902154,positive regulation of response to DNA damage checkpoint signaling,8,0.0,1.0,1.0,2
4434,GO:1902155,regulation of response to G1 DNA damage checkpoint signaling,8,0.0,1.0,1.0,1
4435,GO:1902157,regulation of response to G2 DNA damage checkpoint signaling,8,0.0,1.0,1.0,1
4436,GO:1902159,regulation of cyclic nucleotide-gated ion channel activity,8,0.0,1.0,1.0,1
4437,GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,8,0.0,1.0,1.0,4
4438,GO:1902218,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,8,0.0,1.0,1.0,3
4439,GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,8,0.0,1.0,1.0,3
4440,GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,8,0.0,1.0,1.0,3
4441,GO:1902241,copal-8-ol diphosphate(3-) metabolic process,8,0.0,1.0,1.0,2
4442,GO:1902244,cis-abienol metabolic process,8,0.0,1.0,1.0,2
4443,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,8,0.0,1.0,1.0,4
4444,GO:1902256,regulation of apoptotic process involved in outflow tract morphogenesis,8,0.0,1.0,1.0,2
4445,GO:1902292,cell cycle DNA replication initiation,8,0.0,1.0,1.0,2
4446,GO:1902294,cell cycle DNA replication termination,8,0.0,1.0,1.0,2
4447,GO:1902298,cell cycle DNA replication maintenance of fidelity,8,0.0,1.0,1.0,1
4448,GO:1902299,pre-replicative complex assembly involved in cell cycle DNA replication,8,0.0,1.0,1.0,2
4449,GO:1902305,regulation of sodium ion transmembrane transport,8,0.0,1.0,1.0,5
4450,GO:1902311,regulation of copper ion transmembrane transport,8,0.0,1.0,1.0,2
4451,GO:1902338,negative regulation of apoptotic process involved in morphogenesis,8,0.0,1.0,1.0,2
4452,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,8,0.0,1.0,1.0,3
4453,GO:1902340,negative regulation of chromosome condensation,8,0.0,1.0,1.0,1
4454,GO:1902357,2-isopropylmalate(2-) transmembrane transport,8,0.0,1.0,1.0,1
4455,GO:1902374,regulation of rRNA catabolic process,8,0.0,1.0,1.0,1
4456,GO:1902413,negative regulation of mitotic cytokinesis,8,0.0,1.0,1.0,1
4457,GO:1902480,protein localization to mitotic spindle,8,0.0,1.0,1.0,1
4458,GO:1902603,carnitine transmembrane transport,8,0.0,1.0,1.0,1
4459,GO:1902623,negative regulation of neutrophil migration,8,0.0,1.0,1.0,2
4460,GO:1902624,positive regulation of neutrophil migration,8,0.0,1.0,1.0,2
4461,GO:1902633,"1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process",8,0.0,1.0,1.0,2
4462,GO:1902656,calcium ion import into cytosol,8,0.0,1.0,1.0,1
4463,GO:1902667,regulation of axon guidance,8,0.0,1.0,1.0,8
4464,GO:1902744,negative regulation of lamellipodium organization,8,0.0,1.0,1.0,2
4465,GO:1902745,positive regulation of lamellipodium organization,8,0.0,1.0,1.0,2
4466,GO:1902750,negative regulation of cell cycle G2/M phase transition,8,0.0,1.0,1.0,2
4467,GO:1902751,positive regulation of cell cycle G2/M phase transition,8,0.0,1.0,1.0,2
4468,GO:1902759,Mo(VI)-molybdopterin cytosine dinucleotide metabolic process,8,0.0,1.0,1.0,1
4469,GO:1902761,positive regulation of chondrocyte development,8,0.0,1.0,1.0,1
4470,GO:1902799,regulation of phosphodiesterase I activity,8,0.0,1.0,1.0,1
4471,GO:1902807,negative regulation of cell cycle G1/S phase transition,8,0.0,1.0,1.0,1
4472,GO:1902808,positive regulation of cell cycle G1/S phase transition,8,0.0,1.0,1.0,1
4473,GO:1902809,regulation of skeletal muscle fiber differentiation,8,0.0,1.0,1.0,3
4474,GO:1902839,negative regulation of nuclear migration along microtubule,8,0.0,1.0,1.0,1
4475,GO:1902840,positive regulation of nuclear migration along microtubule,8,0.0,1.0,1.0,1
4476,GO:1902845,negative regulation of mitotic spindle elongation,8,0.0,1.0,1.0,1
4477,GO:1902852,regulation of nuclear migration during mitotic telophase,8,0.0,1.0,1.0,2
4478,GO:1902937,inward rectifier potassium channel complex,8,0.0,1.0,1.0,2
4479,GO:1902956,"regulation of mitochondrial electron transport, NADH to ubiquinone",8,0.0,1.0,1.0,2
4480,GO:1902986,regulation of lysine biosynthetic process via aminoadipic acid,8,0.0,1.0,1.0,2
4481,GO:1902992,negative regulation of amyloid precursor protein catabolic process,8,0.0,1.0,1.0,2
4482,GO:1902993,positive regulation of amyloid precursor protein catabolic process,8,0.0,1.0,1.0,2
4483,GO:1903019,negative regulation of glycoprotein metabolic process,8,0.0,1.0,1.0,3
4484,GO:1903020,positive regulation of glycoprotein metabolic process,8,0.0,1.0,1.0,2
4485,GO:1903041,regulation of chondrocyte hypertrophy,8,0.0,1.0,1.0,2
4486,GO:1903050,regulation of proteolysis involved in protein catabolic process,8,0.0,1.0,1.0,5
4487,GO:1903059,regulation of protein lipidation,8,0.0,1.0,1.0,4
4488,GO:1903062,regulation of reverse cholesterol transport,8,0.0,1.0,1.0,2
4489,GO:1903077,negative regulation of protein localization to plasma membrane,8,0.0,1.0,1.0,3
4490,GO:1903078,positive regulation of protein localization to plasma membrane,8,0.0,1.0,1.0,3
4491,GO:1903080,regulation of C-C chemokine receptor CCR7 signaling pathway,8,0.0,1.0,1.0,2
4492,GO:1903084,protein localization to condensed nuclear chromosome,8,0.0,1.0,1.0,1
4493,GO:1903100,"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process",8,0.0,1.0,1.0,2
4494,GO:1903140,regulation of establishment of endothelial barrier,8,0.0,1.0,1.0,2
4495,GO:1903147,negative regulation of autophagy of mitochondrion,8,0.0,1.0,1.0,1
4496,GO:1903169,regulation of calcium ion transmembrane transport,8,0.0,1.0,1.0,9
4497,GO:1903179,regulation of dopamine biosynthetic process,8,0.0,1.0,1.0,2
4498,GO:1903195,regulation of L-dopa biosynthetic process,8,0.0,1.0,1.0,2
4499,GO:1903214,regulation of protein targeting to mitochondrion,8,0.0,1.0,1.0,3
4500,GO:1903221,regulation of mitotic recombination-dependent replication fork processing,8,0.0,1.0,1.0,2
4501,GO:1903236,regulation of leukocyte tethering or rolling,8,0.0,1.0,1.0,2
4502,GO:1903242,regulation of cardiac muscle hypertrophy in response to stress,8,0.0,1.0,1.0,2
4503,GO:1903248,regulation of citrulline biosynthetic process,8,0.0,1.0,1.0,2
4504,GO:1903266,regulation of ornithine catabolic process,8,0.0,1.0,1.0,2
4505,GO:1903294,"regulation of glutamate secretion, neurotransmission",8,0.0,1.0,1.0,2
4506,GO:1903297,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,8,0.0,1.0,1.0,1
4507,GO:1903305,regulation of regulated secretory pathway,8,0.0,1.0,1.0,5
4508,GO:1903311,regulation of mRNA metabolic process,8,0.0,1.0,1.0,6
4509,GO:1903317,regulation of protein maturation,8,0.0,1.0,1.0,6
4510,GO:1903323,regulation of snoRNA metabolic process,8,0.0,1.0,1.0,3
4511,GO:1903326,regulation of tRNA metabolic process,8,0.0,1.0,1.0,4
4512,GO:1903341,regulation of meiotic DNA double-strand break formation,8,0.0,1.0,1.0,3
4513,GO:1903344,regulation of protein polyglycylation,8,0.0,1.0,1.0,2
4514,GO:1903352,L-ornithine transmembrane transport,8,0.0,1.0,1.0,3
4515,GO:1903379,regulation of mitotic chromosome condensation,8,0.0,1.0,1.0,2
4516,GO:1903401,L-lysine transmembrane transport,8,0.0,1.0,1.0,3
4517,GO:1903405,protein localization to nuclear body,8,0.0,1.0,1.0,1
4518,GO:1903432,regulation of TORC1 signaling,8,0.0,1.0,1.0,2
4519,GO:1903433,regulation of constitutive secretory pathway,8,0.0,1.0,1.0,2
4520,GO:1903436,regulation of mitotic cytokinetic process,8,0.0,1.0,1.0,7
4521,GO:1903446,geraniol metabolic process,8,0.0,1.0,1.0,2
4522,GO:1903490,positive regulation of mitotic cytokinesis,8,0.0,1.0,1.0,1
4523,GO:1903534,regulation of lactose biosynthetic process,8,0.0,1.0,1.0,2
4524,GO:1903539,protein localization to postsynaptic membrane,8,0.0,1.0,1.0,2
4525,GO:1903541,regulation of exosomal secretion,8,0.0,1.0,1.0,2
4526,GO:1903593,regulation of histamine secretion by mast cell,8,0.0,1.0,1.0,2
4527,GO:1903599,positive regulation of autophagy of mitochondrion,8,0.0,1.0,1.0,1
4528,GO:1903624,regulation of DNA catabolic process,8,0.0,1.0,1.0,3
4529,GO:1903692,methionine import across plasma membrane,8,0.0,1.0,1.0,1
4530,GO:1903712,cysteine transmembrane transport,8,0.0,1.0,1.0,1
4531,GO:1903714,isoleucine transmembrane transport,8,0.0,1.0,1.0,1
4532,GO:1903716,guanine transmembrane transport,8,0.0,1.0,1.0,2
4533,GO:1903726,negative regulation of phospholipid metabolic process,8,0.0,1.0,1.0,6
4534,GO:1903727,positive regulation of phospholipid metabolic process,8,0.0,1.0,1.0,6
4535,GO:1903742,regulation of anterograde synaptic vesicle transport,8,0.0,1.0,1.0,2
4536,GO:1903748,negative regulation of establishment of protein localization to mitochondrion,8,0.0,1.0,1.0,1
4537,GO:1903749,positive regulation of establishment of protein localization to mitochondrion,8,0.0,1.0,1.0,1
4538,GO:1903785,L-valine transmembrane transport,8,0.0,1.0,1.0,2
4539,GO:1903791,uracil transmembrane transport,8,0.0,1.0,1.0,1
4540,GO:1903826,L-arginine transmembrane transport,8,0.0,1.0,1.0,1
4541,GO:1903830,magnesium ion transmembrane transport,8,0.0,1.0,1.0,2
4542,GO:1903891,regulation of ATF6-mediated unfolded protein response,8,0.0,1.0,1.0,2
4543,GO:1903894,regulation of IRE1-mediated unfolded protein response,8,0.0,1.0,1.0,2
4544,GO:1903897,regulation of PERK-mediated unfolded protein response,8,0.0,1.0,1.0,2
4545,GO:1903910,negative regulation of receptor clustering,8,0.0,1.0,1.0,2
4546,GO:1903911,positive regulation of receptor clustering,8,0.0,1.0,1.0,2
4547,GO:1903939,regulation of TORC2 signaling,8,0.0,1.0,1.0,2
4548,GO:1903960,negative regulation of anion transmembrane transport,8,0.0,1.0,1.0,2
4549,GO:1903961,positive regulation of anion transmembrane transport,8,0.0,1.0,1.0,2
4550,GO:1903978,regulation of microglial cell activation,8,0.0,1.0,1.0,2
4551,GO:1904023,regulation of glucose catabolic process to lactate via pyruvate,8,0.0,1.0,1.0,2
4552,GO:1904048,regulation of spontaneous neurotransmitter secretion,8,0.0,1.0,1.0,2
4553,GO:1904063,negative regulation of cation transmembrane transport,8,0.0,1.0,1.0,9
4554,GO:1904064,positive regulation of cation transmembrane transport,8,0.0,1.0,1.0,7
4555,GO:1904170,regulation of bleb assembly,8,0.0,1.0,1.0,2
4556,GO:1904202,negative regulation of iodide transport,8,0.0,1.0,1.0,1
4557,GO:1904203,positive regulation of iodide transport,8,0.0,1.0,1.0,1
4558,GO:1904204,regulation of skeletal muscle hypertrophy,8,0.0,1.0,1.0,2
4559,GO:1904212,regulation of iodide transmembrane transport,8,0.0,1.0,1.0,2
4560,GO:1904215,regulation of protein import into chloroplast stroma,8,0.0,1.0,1.0,1
4561,GO:1904251,regulation of bile acid metabolic process,8,0.0,1.0,1.0,3
4562,GO:1904266,regulation of Schwann cell chemotaxis,8,0.0,1.0,1.0,2
4563,GO:1904276,regulation of wax biosynthetic process,8,0.0,1.0,1.0,2
4564,GO:1904285,regulation of protein-pyridoxal-5-phosphate linkage,8,0.0,1.0,1.0,2
4565,GO:1904304,regulation of gastro-intestinal system smooth muscle contraction,8,0.0,1.0,1.0,6
4566,GO:1904318,regulation of smooth muscle contraction involved in micturition,8,0.0,1.0,1.0,2
4567,GO:1904350,regulation of protein catabolic process in the vacuole,8,0.0,1.0,1.0,3
4568,GO:1904370,regulation of protein localization to actin cortical patch,8,0.0,1.0,1.0,2
4569,GO:1904393,regulation of skeletal muscle acetylcholine-gated channel clustering,8,0.0,1.0,1.0,2
4570,GO:1904415,regulation of xenophagy,8,0.0,1.0,1.0,2
4571,GO:1904502,regulation of lipophagy,8,0.0,1.0,1.0,2
4572,GO:1904555,L-proline transmembrane transport,8,0.0,1.0,1.0,1
4573,GO:1904556,L-tryptophan transmembrane transport,8,0.0,1.0,1.0,1
4574,GO:1904557,L-alanine transmembrane transport,8,0.0,1.0,1.0,2
4575,GO:1904562,phosphatidylinositol 5-phosphate metabolic process,8,0.0,1.0,1.0,1
4576,GO:1904589,regulation of protein import,8,0.0,1.0,1.0,2
4577,GO:1904624,"regulation of glycine secretion, neurotransmission",8,0.0,1.0,1.0,2
4578,GO:1904659,D-glucose transmembrane transport,8,0.0,1.0,1.0,3
4579,GO:1904714,regulation of chaperone-mediated autophagy,8,0.0,1.0,1.0,2
4580,GO:1904730,negative regulation of intestinal lipid absorption,8,0.0,1.0,1.0,2
4581,GO:1904731,positive regulation of intestinal lipid absorption,8,0.0,1.0,1.0,1
4582,GO:1904777,negative regulation of protein localization to cell cortex,8,0.0,1.0,1.0,2
4583,GO:1904778,positive regulation of protein localization to cell cortex,8,0.0,1.0,1.0,2
4584,GO:1904799,regulation of neuron remodeling,8,0.0,1.0,1.0,2
4585,GO:1904806,regulation of protein oxidation,8,0.0,1.0,1.0,2
4586,GO:1904829,regulation of aortic smooth muscle cell differentiation,8,0.0,1.0,1.0,2
4587,GO:1904832,negative regulation of removal of superoxide radicals,8,0.0,1.0,1.0,1
4588,GO:1904963,regulation of phytol biosynthetic process,8,0.0,1.0,1.0,1
4589,GO:1904981,maltose transmembrane transport,8,0.0,1.0,1.0,1
4590,GO:1904982,sucrose transmembrane transport,8,0.0,1.0,1.0,1
4591,GO:1904990,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,8,0.0,1.0,1.0,2
4592,GO:1904995,negative regulation of leukocyte adhesion to vascular endothelial cell,8,0.0,1.0,1.0,2
4593,GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,8,0.0,1.0,1.0,2
4594,GO:1904997,regulation of leukocyte adhesion to arterial endothelial cell,8,0.0,1.0,1.0,2
4595,GO:1905003,picolinic acid metabolic process,8,0.0,1.0,1.0,1
4596,GO:1905026,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,8,0.0,1.0,1.0,1
4597,GO:1905064,negative regulation of vascular associated smooth muscle cell differentiation,8,0.0,1.0,1.0,3
4598,GO:1905065,positive regulation of vascular associated smooth muscle cell differentiation,8,0.0,1.0,1.0,3
4599,GO:1905129,endocannabinoid signaling pathway involved in trans-synaptic signaling,8,0.0,1.0,1.0,1
4600,GO:1905132,regulation of meiotic chromosome separation,8,0.0,1.0,1.0,3
4601,GO:1905219,regulation of platelet formation,8,0.0,1.0,1.0,2
4602,GO:1905258,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,8,0.0,1.0,1.0,2
4603,GO:1905264,blasticidin S metabolic process,8,0.0,1.0,1.0,2
4604,GO:1905269,positive regulation of chromatin organization,8,0.0,1.0,1.0,3
4605,GO:1905282,regulation of epidermal growth factor receptor signaling pathway involved in heart process,8,0.0,1.0,1.0,2
4606,GO:1905289,regulation of CAMKK-AMPK signaling cascade,8,0.0,1.0,1.0,2
4607,GO:1905301,regulation of macropinocytosis,8,0.0,1.0,1.0,2
4608,GO:1905335,regulation of aggrephagy,8,0.0,1.0,1.0,2
4609,GO:1905356,regulation of snRNA pseudouridine synthesis,8,0.0,1.0,1.0,2
4610,GO:1905359,protein localization to meiotic spindle,8,0.0,1.0,1.0,1
4611,GO:1905459,regulation of vascular associated smooth muscle cell apoptotic process,8,0.0,1.0,1.0,2
4612,GO:1905464,positive regulation of DNA duplex unwinding,8,0.0,1.0,1.0,1
4613,GO:1905484,negative regulation of motor neuron migration,8,0.0,1.0,1.0,1
4614,GO:1905485,positive regulation of motor neuron migration,8,0.0,1.0,1.0,1
4615,GO:1905508,protein localization to microtubule organizing center,8,0.0,1.0,1.0,4
4616,GO:1905512,regulation of short-term synaptic potentiation,8,0.0,1.0,1.0,2
4617,GO:1905521,regulation of macrophage migration,8,0.0,1.0,1.0,4
4618,GO:1905568,regulation of ferrichrome biosynthetic process,8,0.0,1.0,1.0,3
4619,GO:1905600,regulation of receptor-mediated endocytosis involved in cholesterol transport,8,0.0,1.0,1.0,2
4620,GO:1905607,negative regulation of presynapse assembly,8,0.0,1.0,1.0,1
4621,GO:1905608,positive regulation of presynapse assembly,8,0.0,1.0,1.0,1
4622,GO:1905632,protein localization to euchromatin,8,0.0,1.0,1.0,1
4623,GO:1905647,proline import across plasma membrane,8,0.0,1.0,1.0,1
4624,GO:1905652,negative regulation of artery morphogenesis,8,0.0,1.0,1.0,2
4625,GO:1905774,regulation of DNA helicase activity,8,0.0,1.0,1.0,1
4626,GO:1905780,regulation of phosphatidylserine exposure on apoptotic cell surface,8,0.0,1.0,1.0,2
4627,GO:1905819,negative regulation of chromosome separation,8,0.0,1.0,1.0,2
4628,GO:1905820,positive regulation of chromosome separation,8,0.0,1.0,1.0,2
4629,GO:1905821,positive regulation of chromosome condensation,8,0.0,1.0,1.0,1
4630,GO:1905828,regulation of prostaglandin catabolic process,8,0.0,1.0,1.0,2
4631,GO:1905875,negative regulation of postsynaptic density organization,8,0.0,1.0,1.0,1
4632,GO:1905876,positive regulation of postsynaptic density organization,8,0.0,1.0,1.0,1
4633,GO:1905909,regulation of dauer entry,8,0.0,1.0,1.0,2
4634,GO:1905930,regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching,8,0.0,1.0,1.0,2
4635,GO:1905942,regulation of formation of growth cone in injured axon,8,0.0,1.0,1.0,2
4636,GO:1990179,protein localization to actomyosin contractile ring,8,0.0,1.0,1.0,1
4637,GO:1990428,miRNA transport,8,0.0,1.0,1.0,1
4638,GO:1990498,mitotic spindle microtubule,8,0.0,1.0,1.0,2
4639,GO:1990546,mitochondrial tricarboxylic acid transmembrane transport,8,0.0,1.0,1.0,1
4640,GO:1990668,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,8,0.0,1.0,1.0,2
4641,GO:1990670,vesicle fusion with Golgi cis cisterna membrane,8,0.0,1.0,1.0,1
4642,GO:1990818,L-arginine transmembrane export from vacuole,8,0.0,1.0,1.0,1
4643,GO:1990884,RNA acetylation,8,0.0,1.0,1.0,2
4644,GO:1990895,regulation of protein localization to cell cortex of cell tip,8,0.0,1.0,1.0,1
4645,GO:2000001,regulation of DNA damage checkpoint,8,0.0,1.0,1.0,3
4646,GO:2000033,regulation of seed dormancy process,8,0.0,1.0,1.0,2
4647,GO:2000044,negative regulation of cardiac cell fate specification,8,0.0,1.0,1.0,1
4648,GO:2000045,regulation of G1/S transition of mitotic cell cycle,8,0.0,1.0,1.0,2
4649,GO:2000051,negative regulation of non-canonical Wnt signaling pathway,8,0.0,1.0,1.0,3
4650,GO:2000052,positive regulation of non-canonical Wnt signaling pathway,8,0.0,1.0,1.0,3
4651,GO:2000076,"positive regulation of cytokinesis, site selection",8,0.0,1.0,1.0,1
4652,GO:2000082,regulation of L-ascorbic acid biosynthetic process,8,0.0,1.0,1.0,1
4653,GO:2000093,regulation of mesonephric nephron tubule epithelial cell differentiation,8,0.0,1.0,1.0,1
4654,GO:2000095,"regulation of Wnt signaling pathway, planar cell polarity pathway",8,0.0,1.0,1.0,2
4655,GO:2000100,regulation of establishment or maintenance of bipolar cell polarity regulating cell shape,8,0.0,1.0,1.0,4
4656,GO:2000126,negative regulation of octopamine or tyramine signaling pathway,8,0.0,1.0,1.0,2
4657,GO:2000127,positive regulation of octopamine or tyramine signaling pathway,8,0.0,1.0,1.0,2
4658,GO:2000128,regulation of octopamine signaling pathway,8,0.0,1.0,1.0,3
4659,GO:2000131,regulation of tyramine signaling pathway,8,0.0,1.0,1.0,2
4660,GO:2000169,regulation of peptidyl-cysteine S-nitrosylation,8,0.0,1.0,1.0,2
4661,GO:2000201,negative regulation of ribosomal subunit export from nucleus,8,0.0,1.0,1.0,2
4662,GO:2000202,positive regulation of ribosomal subunit export from nucleus,8,0.0,1.0,1.0,2
4663,GO:2000203,regulation of ribosomal large subunit export from nucleus,8,0.0,1.0,1.0,2
4664,GO:2000206,regulation of ribosomal small subunit export from nucleus,8,0.0,1.0,1.0,2
4665,GO:2000211,regulation of glutamate metabolic process,8,0.0,1.0,1.0,5
4666,GO:2000214,regulation of proline metabolic process,8,0.0,1.0,1.0,4
4667,GO:2000222,positive regulation of pseudohyphal growth,8,0.0,1.0,1.0,1
4668,GO:2000232,regulation of rRNA processing,8,0.0,1.0,1.0,2
4669,GO:2000238,regulation of tRNA export from nucleus,8,0.0,1.0,1.0,2
4670,GO:2000278,regulation of DNA biosynthetic process,8,0.0,1.0,1.0,7
4671,GO:2000283,negative regulation of amino acid biosynthetic process,8,0.0,1.0,1.0,8
4672,GO:2000284,positive regulation of amino acid biosynthetic process,8,0.0,1.0,1.0,8
4673,GO:2000293,negative regulation of defecation,8,0.0,1.0,1.0,1
4674,GO:2000294,positive regulation of defecation,8,0.0,1.0,1.0,1
4675,GO:2000310,regulation of NMDA receptor activity,8,0.0,1.0,1.0,2
4676,GO:2000311,regulation of AMPA receptor activity,8,0.0,1.0,1.0,2
4677,GO:2000317,negative regulation of T-helper 17 type immune response,8,0.0,1.0,1.0,1
4678,GO:2000318,positive regulation of T-helper 17 type immune response,8,0.0,1.0,1.0,1
4679,GO:2000322,regulation of glucocorticoid receptor signaling pathway,8,0.0,1.0,1.0,2
4680,GO:2000369,regulation of clathrin-dependent endocytosis,8,0.0,1.0,1.0,2
4681,GO:2000389,regulation of neutrophil extravasation,8,0.0,1.0,1.0,2
4682,GO:2000392,regulation of lamellipodium morphogenesis,8,0.0,1.0,1.0,2
4683,GO:2000395,regulation of ubiquitin-dependent endocytosis,8,0.0,1.0,1.0,2
4684,GO:2000401,regulation of lymphocyte migration,8,0.0,1.0,1.0,4
4685,GO:2000417,negative regulation of eosinophil migration,8,0.0,1.0,1.0,2
4686,GO:2000418,positive regulation of eosinophil migration,8,0.0,1.0,1.0,2
4687,GO:2000419,regulation of eosinophil extravasation,8,0.0,1.0,1.0,2
4688,GO:2000425,regulation of apoptotic cell clearance,8,0.0,1.0,1.0,2
4689,GO:2000437,regulation of monocyte extravasation,8,0.0,1.0,1.0,2
4690,GO:2000440,regulation of toll-like receptor 15 signaling pathway,8,0.0,1.0,1.0,2
4691,GO:2000463,positive regulation of excitatory postsynaptic potential,8,0.0,1.0,1.0,1
4692,GO:2000475,negative regulation of opioid receptor signaling pathway,8,0.0,1.0,1.0,1
4693,GO:2000476,positive regulation of opioid receptor signaling pathway,8,0.0,1.0,1.0,1
4694,GO:2000486,negative regulation of glutamine transport,8,0.0,1.0,1.0,1
4695,GO:2000487,positive regulation of glutamine transport,8,0.0,1.0,1.0,1
4696,GO:2000508,regulation of dendritic cell chemotaxis,8,0.0,1.0,1.0,3
4697,GO:2000523,regulation of T cell costimulation,8,0.0,1.0,1.0,3
4698,GO:2000539,regulation of protein geranylgeranylation,8,0.0,1.0,1.0,2
4699,GO:2000544,regulation of endothelial cell chemotaxis to fibroblast growth factor,8,0.0,1.0,1.0,2
4700,GO:2000547,regulation of dendritic cell dendrite assembly,8,0.0,1.0,1.0,2
4701,GO:2000567,regulation of memory T cell activation,8,0.0,1.0,1.0,1
4702,GO:2000628,regulation of miRNA metabolic process,8,0.0,1.0,1.0,4
4703,GO:2000639,negative regulation of SREBP signaling pathway,8,0.0,1.0,1.0,2
4704,GO:2000640,positive regulation of SREBP signaling pathway,8,0.0,1.0,1.0,1
4705,GO:2000722,regulation of cardiac vascular smooth muscle cell differentiation,8,0.0,1.0,1.0,2
4706,GO:2000726,negative regulation of cardiac muscle cell differentiation,8,0.0,1.0,1.0,1
4707,GO:2000727,positive regulation of cardiac muscle cell differentiation,8,0.0,1.0,1.0,1
4708,GO:2000746,regulation of defecation rhythm,8,0.0,1.0,1.0,2
4709,GO:2000752,regulation of glucosylceramide catabolic process,8,0.0,1.0,1.0,1
4710,GO:2000770,negative regulation of establishment or maintenance of cell polarity regulating cell shape,8,0.0,1.0,1.0,2
4711,GO:2000771,positive regulation of establishment or maintenance of cell polarity regulating cell shape,8,0.0,1.0,1.0,2
4712,GO:2000782,regulation of establishment of cell polarity regulating cell shape,8,0.0,1.0,1.0,2
4713,GO:2000787,regulation of venous endothelial cell fate commitment,8,0.0,1.0,1.0,2
4714,GO:2000800,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,8,0.0,1.0,1.0,2
4715,GO:2000828,regulation of parathyroid hormone secretion,8,0.0,1.0,1.0,2
4716,GO:2000831,regulation of steroid hormone secretion,8,0.0,1.0,1.0,9
4717,GO:2000837,regulation of androstenedione secretion,8,0.0,1.0,1.0,2
4718,GO:2000840,regulation of dehydroepiandrosterone secretion,8,0.0,1.0,1.0,2
4719,GO:2000843,regulation of testosterone secretion,8,0.0,1.0,1.0,2
4720,GO:2000879,negative regulation of dipeptide transport,8,0.0,1.0,1.0,1
4721,GO:2000880,positive regulation of dipeptide transport,8,0.0,1.0,1.0,1
4722,GO:2000895,hemicellulose catabolic process,8,0.0,1.0,1.0,2
4723,GO:2000898,regulation of glucomannan catabolic process,8,0.0,1.0,1.0,2
4724,GO:2000904,regulation of starch metabolic process,8,0.0,1.0,1.0,4
4725,GO:2000912,regulation of galactoglucomannan catabolic process,8,0.0,1.0,1.0,2
4726,GO:2000924,regulation of cellodextrin metabolic process,8,0.0,1.0,1.0,5
4727,GO:2000931,negative regulation of cellobiose metabolic process,8,0.0,1.0,1.0,1
4728,GO:2000932,positive regulation of cellobiose metabolic process,8,0.0,1.0,1.0,1
4729,GO:2000933,regulation of cellotriose metabolic process,8,0.0,1.0,1.0,3
4730,GO:2000948,regulation of xyloglucan metabolic process,8,0.0,1.0,1.0,3
4731,GO:2000954,regulation of cyclodextrin metabolic process,8,0.0,1.0,1.0,3
4732,GO:2000961,negative regulation of cellooligosaccharide metabolic process,8,0.0,1.0,1.0,1
4733,GO:2000962,positive regulation of cellooligosaccharide metabolic process,8,0.0,1.0,1.0,1
4734,GO:2000963,regulation of cellooligosaccharide catabolic process,8,0.0,1.0,1.0,2
4735,GO:2000966,regulation of cell wall polysaccharide catabolic process,8,0.0,1.0,1.0,5
4736,GO:2000981,negative regulation of inner ear receptor cell differentiation,8,0.0,1.0,1.0,1
4737,GO:2000982,positive regulation of inner ear receptor cell differentiation,8,0.0,1.0,1.0,1
4738,GO:2000991,regulation of galactomannan catabolic process,8,0.0,1.0,1.0,2
4739,GO:2001003,regulation of pectin catabolic process,8,0.0,1.0,1.0,2
4740,GO:2001027,negative regulation of endothelial cell chemotaxis,8,0.0,1.0,1.0,1
4741,GO:2001028,positive regulation of endothelial cell chemotaxis,8,0.0,1.0,1.0,2
4742,GO:2001141,regulation of RNA biosynthetic process,8,0.0,1.0,1.0,6
4743,GO:2001148,regulation of dipeptide transmembrane transport,8,0.0,1.0,1.0,2
4744,GO:2001154,regulation of glycolytic fermentation to ethanol,8,0.0,1.0,1.0,2
4745,GO:2001188,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,8,0.0,1.0,1.0,2
4746,GO:2001198,regulation of dendritic cell differentiation,8,0.0,1.0,1.0,2
4747,GO:2001231,regulation of protein localization to prospore membrane,8,0.0,1.0,1.0,1
4748,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,8,0.0,1.0,1.0,3
4749,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,8,0.0,1.0,1.0,2
4750,GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,8,0.0,1.0,1.0,2
4751,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,8,0.0,1.0,1.0,7
4752,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,8,0.0,1.0,1.0,6
4753,GO:2001256,regulation of store-operated calcium entry,8,0.0,1.0,1.0,2
4754,GO:2001257,regulation of cation channel activity,8,0.0,1.0,1.0,16
4755,GO:2001276,regulation of L-leucine biosynthetic process,8,0.0,1.0,1.0,2
4756,GO:2001293,malonyl-CoA metabolic process,8,0.0,1.0,1.0,2
4757,GO:2001313,UDP-4-deoxy-4-formamido-beta-L-arabinopyranose metabolic process,8,0.0,1.0,1.0,2
201,GO:0034373,intermediate-density lipoprotein particle remodeling,9,6727.26,6727.26,0.0001486490161076,0
29,GO:0034371,chylomicron remodeling,9,5692.29,5692.29,3.0285076797892027e-41,0
22,GO:0034372,very-low-density lipoprotein particle remodeling,9,2102.27,2102.27,1.0653062873917695e-46,0
98,GO:0032642,regulation of chemokine production,9,820.4,135.9,7.832750798947285e-12,15
146,GO:0001819,positive regulation of cytokine production,9,820.4,23.43,2.6320933273494153e-07,49
130,GO:0032652,regulation of interleukin-1 production,9,152.89,82.85,5.486810663768789e-09,4
139,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,9,100.11,60.17,2.685173456420739e-08,6
136,GO:0032675,regulation of interleukin-6 production,9,98.93,64.93,1.8408275054308295e-08,2
83,GO:0006633,fatty acid biosynthetic process,9,17.18,17.18,1.051625206426511e-13,12
1667,GO:0000019,regulation of mitotic recombination,9,0.0,1.0,1.0,3
1668,GO:0000038,very long-chain fatty acid metabolic process,9,0.0,1.0,1.0,2
1669,GO:0000132,establishment of mitotic spindle orientation,9,0.0,1.0,1.0,1
1670,GO:0000154,rRNA modification,9,0.0,1.0,1.0,4
1671,GO:0000398,"mRNA splicing, via spliceosome",9,0.0,1.0,1.0,4
1672,GO:0000449,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 5S)",9,0.0,1.0,1.0,2
1673,GO:0000460,maturation of 5.8S rRNA,9,0.0,1.0,1.0,2
1674,GO:0000470,maturation of LSU-rRNA,9,0.0,1.0,1.0,4
1675,GO:0000479,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",9,0.0,1.0,1.0,7
1676,GO:0000481,maturation of 5S rRNA,9,0.0,1.0,1.0,2
1677,GO:0000483,"endonucleolytic cleavage of tetracistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, 2S rRNA, LSU-rRNA)",9,0.0,1.0,1.0,3
1678,GO:0000710,meiotic mismatch repair,9,0.0,1.0,1.0,2
1679,GO:0000711,meiotic DNA repair synthesis,9,0.0,1.0,1.0,2
1680,GO:0000722,telomere maintenance via recombination,9,0.0,1.0,1.0,1
1681,GO:0000724,double-strand break repair via homologous recombination,9,0.0,1.0,1.0,4
1682,GO:0000915,actomyosin contractile ring assembly,9,0.0,1.0,1.0,1
1683,GO:0000962,positive regulation of mitochondrial RNA catabolic process,9,0.0,1.0,1.0,1
1684,GO:0000967,rRNA 5'-end processing,9,0.0,1.0,1.0,3
1685,GO:0000978,RNA polymerase II cis-regulatory region sequence-specific DNA binding,9,0.0,1.0,1.0,12
1686,GO:0000992,RNA polymerase III cis-regulatory region sequence-specific DNA binding,9,0.0,1.0,1.0,4
1687,GO:0001100,negative regulation of exit from mitosis,9,0.0,1.0,1.0,1
1688,GO:0001574,ganglioside biosynthetic process,9,0.0,1.0,1.0,1
1689,GO:0001576,globoside biosynthetic process,9,0.0,1.0,1.0,1
1690,GO:0001676,long-chain fatty acid metabolic process,9,0.0,1.0,1.0,13
1691,GO:0001794,type IIa hypersensitivity,9,0.0,1.0,1.0,1
1692,GO:0001818,negative regulation of cytokine production,9,0.0,1.0,1.0,47
1693,GO:0001915,negative regulation of T cell mediated cytotoxicity,9,0.0,1.0,1.0,2
1694,GO:0001916,positive regulation of T cell mediated cytotoxicity,9,0.0,1.0,1.0,3
1695,GO:0001923,B-1 B cell differentiation,9,0.0,1.0,1.0,2
1696,GO:0001933,negative regulation of protein phosphorylation,9,0.0,1.0,1.0,8
1697,GO:0001934,positive regulation of protein phosphorylation,9,0.0,1.0,1.0,7
1698,GO:0002019,regulation of renal output by angiotensin,9,0.0,1.0,1.0,1
1699,GO:0002036,regulation of L-glutamate import across plasma membrane,9,0.0,1.0,1.0,3
1700,GO:0002091,negative regulation of receptor internalization,9,0.0,1.0,1.0,1
1701,GO:0002092,positive regulation of receptor internalization,9,0.0,1.0,1.0,1
1702,GO:0002103,"endonucleolytic cleavage of tetracistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 4.5S-rRNA, 5S-rRNA)",9,0.0,1.0,1.0,3
1703,GO:0002293,alpha-beta T cell differentiation involved in immune response,9,0.0,1.0,1.0,2
1704,GO:0002299,alpha-beta intraepithelial T cell differentiation,9,0.0,1.0,1.0,2
1705,GO:0002304,gamma-delta intraepithelial T cell differentiation,9,0.0,1.0,1.0,2
1706,GO:0002313,mature B cell differentiation involved in immune response,9,0.0,1.0,1.0,5
1707,GO:0002332,transitional stage B cell differentiation,9,0.0,1.0,1.0,2
1708,GO:0002394,tolerance induction in gut-associated lymphoid tissue,9,0.0,1.0,1.0,2
1709,GO:0002423,natural killer cell mediated immune response to tumor cell,9,0.0,1.0,1.0,1
1710,GO:0002430,complement receptor mediated signaling pathway,9,0.0,1.0,1.0,1
1711,GO:0002431,Fc receptor mediated stimulatory signaling pathway,9,0.0,1.0,1.0,2
1712,GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,9,0.0,1.0,1.0,3
1713,GO:0002565,somatic diversification of immune receptors via gene conversion,9,0.0,1.0,1.0,1
1714,GO:0002628,regulation of proteolysis associated with antigen processing and presentation,9,0.0,1.0,1.0,2
1715,GO:0002637,regulation of immunoglobulin production,9,0.0,1.0,1.0,4
1716,GO:0002659,negative regulation of peripheral tolerance induction,9,0.0,1.0,1.0,4
1717,GO:0002660,positive regulation of peripheral tolerance induction,9,0.0,1.0,1.0,4
1718,GO:0002701,negative regulation of production of molecular mediator of immune response,9,0.0,1.0,1.0,5
1719,GO:0002702,positive regulation of production of molecular mediator of immune response,9,0.0,1.0,1.0,5
1720,GO:0002718,regulation of cytokine production involved in immune response,9,0.0,1.0,1.0,8
1721,GO:0002758,innate immune response-activating signaling pathway,9,0.0,1.0,1.0,2
1722,GO:0002762,negative regulation of myeloid leukocyte differentiation,9,0.0,1.0,1.0,5
1723,GO:0002763,positive regulation of myeloid leukocyte differentiation,9,0.0,1.0,1.0,5
1724,GO:0002784,regulation of antimicrobial peptide production,9,0.0,1.0,1.0,6
1725,GO:0002841,negative regulation of T cell mediated immune response to tumor cell,9,0.0,1.0,1.0,2
1726,GO:0002842,positive regulation of T cell mediated immune response to tumor cell,9,0.0,1.0,1.0,2
1727,GO:0002843,regulation of tolerance induction to tumor cell,9,0.0,1.0,1.0,3
1728,GO:0002849,regulation of peripheral T cell tolerance induction,9,0.0,1.0,1.0,3
1729,GO:0002852,regulation of T cell mediated cytotoxicity directed against tumor cell target,9,0.0,1.0,1.0,2
1730,GO:0002856,negative regulation of natural killer cell mediated immune response to tumor cell,9,0.0,1.0,1.0,1
1731,GO:0002857,positive regulation of natural killer cell mediated immune response to tumor cell,9,0.0,1.0,1.0,1
1732,GO:0002858,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,9,0.0,1.0,1.0,2
1733,GO:0002865,negative regulation of acute inflammatory response to antigenic stimulus,9,0.0,1.0,1.0,1
1734,GO:0002866,positive regulation of acute inflammatory response to antigenic stimulus,9,0.0,1.0,1.0,1
1735,GO:0002867,regulation of B cell deletion,9,0.0,1.0,1.0,4
1736,GO:0002883,regulation of hypersensitivity,9,0.0,1.0,1.0,6
1737,GO:0002890,negative regulation of immunoglobulin mediated immune response,9,0.0,1.0,1.0,5
1738,GO:0002891,positive regulation of immunoglobulin mediated immune response,9,0.0,1.0,1.0,6
1739,GO:0002903,negative regulation of B cell apoptotic process,9,0.0,1.0,1.0,2
1740,GO:0002904,positive regulation of B cell apoptotic process,9,0.0,1.0,1.0,2
1741,GO:0002905,regulation of mature B cell apoptotic process,9,0.0,1.0,1.0,2
1742,GO:0002917,regulation of peripheral B cell anergy,9,0.0,1.0,1.0,2
1743,GO:0002923,regulation of humoral immune response mediated by circulating immunoglobulin,9,0.0,1.0,1.0,3
1744,GO:0003065,positive regulation of heart rate by epinephrine,9,0.0,1.0,1.0,2
1745,GO:0003066,positive regulation of heart rate by norepinephrine,9,0.0,1.0,1.0,2
1746,GO:0003099,positive regulation of the force of heart contraction by chemical signal,9,0.0,1.0,1.0,3
1747,GO:0003108,negative regulation of the force of heart contraction by chemical signal,9,0.0,1.0,1.0,1
1748,GO:0004402,histone acetyltransferase activity,9,0.0,1.0,1.0,4
1749,GO:0005221,intracellularly cyclic nucleotide-activated monoatomic cation channel activity,9,0.0,1.0,1.0,2
1750,GO:0005227,calcium-activated cation channel activity,9,0.0,1.0,1.0,1
1751,GO:0005231,excitatory extracellular ligand-gated monoatomic ion channel activity,9,0.0,1.0,1.0,4
1752,GO:0005237,inhibitory extracellular ligand-gated monoatomic ion channel activity,9,0.0,1.0,1.0,1
1753,GO:0005245,voltage-gated calcium channel activity,9,0.0,1.0,1.0,7
1754,GO:0005247,voltage-gated chloride channel activity,9,0.0,1.0,1.0,1
1755,GO:0005249,voltage-gated potassium channel activity,9,0.0,1.0,1.0,6
1756,GO:0005295,neutral L-amino acid:sodium symporter activity,9,0.0,1.0,1.0,3
1757,GO:0005391,P-type sodium:potassium-exchanging transporter activity,9,0.0,1.0,1.0,1
1758,GO:0005981,regulation of glycogen catabolic process,9,0.0,1.0,1.0,2
1759,GO:0006075,(1->3)-beta-D-glucan biosynthetic process,9,0.0,1.0,1.0,1
1760,GO:0006085,acetyl-CoA biosynthetic process,9,0.0,1.0,1.0,5
1761,GO:0006164,purine nucleotide biosynthetic process,9,0.0,1.0,1.0,5
1762,GO:0006195,purine nucleotide catabolic process,9,0.0,1.0,1.0,4
1763,GO:0006221,pyrimidine nucleotide biosynthetic process,9,0.0,1.0,1.0,3
1764,GO:0006244,pyrimidine nucleotide catabolic process,9,0.0,1.0,1.0,2
1765,GO:0006264,mitochondrial DNA replication,9,0.0,1.0,1.0,1
1766,GO:0006267,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,9,0.0,1.0,1.0,2
1767,GO:0006268,DNA unwinding involved in DNA replication,9,0.0,1.0,1.0,1
1768,GO:0006272,leading strand elongation,9,0.0,1.0,1.0,1
1769,GO:0006273,lagging strand elongation,9,0.0,1.0,1.0,1
1770,GO:0006303,double-strand break repair via nonhomologous end joining,9,0.0,1.0,1.0,2
1771,GO:0006355,regulation of DNA-templated transcription,9,0.0,1.0,1.0,19
1772,GO:0006360,transcription by RNA polymerase I,9,0.0,1.0,1.0,1
1773,GO:0006366,transcription by RNA polymerase II,9,0.0,1.0,1.0,3
1774,GO:0006369,termination of RNA polymerase II transcription,9,0.0,1.0,1.0,2
1775,GO:0006382,adenosine to inosine editing,9,0.0,1.0,1.0,1
1776,GO:0006383,transcription by RNA polymerase III,9,0.0,1.0,1.0,4
1777,GO:0006400,tRNA modification,9,0.0,1.0,1.0,17
1778,GO:0006402,mRNA catabolic process,9,0.0,1.0,1.0,5
1779,GO:0006406,mRNA export from nucleus,9,0.0,1.0,1.0,2
1780,GO:0006409,tRNA export from nucleus,9,0.0,1.0,1.0,1
1781,GO:0006417,regulation of translation,9,0.0,1.0,1.0,17
1782,GO:0006418,tRNA aminoacylation for protein translation,9,0.0,1.0,1.0,21
1783,GO:0006523,alanine biosynthetic process,9,0.0,1.0,1.0,2
1784,GO:0006524,alanine catabolic process,9,0.0,1.0,1.0,2
1785,GO:0006547,L-histidine metabolic process,9,0.0,1.0,1.0,2
1786,GO:0006554,lysine catabolic process,9,0.0,1.0,1.0,2
1787,GO:0006569,tryptophan catabolic process,9,0.0,1.0,1.0,4
1788,GO:0006574,valine catabolic process,9,0.0,1.0,1.0,2
1789,GO:0006593,ornithine catabolic process,9,0.0,1.0,1.0,2
1790,GO:0006604,phosphoarginine metabolic process,9,0.0,1.0,1.0,2
1791,GO:0006622,protein targeting to lysosome,9,0.0,1.0,1.0,1
1792,GO:0006678,glucosylceramide metabolic process,9,0.0,1.0,1.0,2
1793,GO:0006681,galactosylceramide metabolic process,9,0.0,1.0,1.0,2
1794,GO:0006776,vitamin A metabolic process,9,0.0,1.0,1.0,1
1795,GO:0006851,mitochondrial calcium ion transmembrane transport,9,0.0,1.0,1.0,2
1796,GO:0007035,vacuolar acidification,9,0.0,1.0,1.0,1
1797,GO:0007093,mitotic cell cycle checkpoint signaling,9,0.0,1.0,1.0,8
1798,GO:0007146,meiotic recombination nodule assembly,9,0.0,1.0,1.0,2
1799,GO:0007173,epidermal growth factor receptor signaling pathway,9,0.0,1.0,1.0,5
1800,GO:0007274,neuromuscular synaptic transmission,9,0.0,1.0,1.0,1
1801,GO:0007549,sex-chromosome dosage compensation,9,0.0,1.0,1.0,3
1802,GO:0007555,regulation of ecdysteroid secretion,9,0.0,1.0,1.0,2
1803,GO:0007557,regulation of juvenile hormone biosynthetic process,9,0.0,1.0,1.0,2
1804,GO:0008021,synaptic vesicle,9,0.0,1.0,1.0,3
1805,GO:0008024,cyclin/CDK positive transcription elongation factor complex,9,0.0,1.0,1.0,2
1806,GO:0008045,motor neuron axon guidance,9,0.0,1.0,1.0,1
1807,GO:0008064,regulation of actin polymerization or depolymerization,9,0.0,1.0,1.0,2
1808,GO:0008089,anterograde axonal transport,9,0.0,1.0,1.0,5
1809,GO:0008090,retrograde axonal transport,9,0.0,1.0,1.0,4
1810,GO:0008156,negative regulation of DNA replication,9,0.0,1.0,1.0,1
1811,GO:0008616,queuosine biosynthetic process,9,0.0,1.0,1.0,1
1812,GO:0009062,fatty acid catabolic process,9,0.0,1.0,1.0,10
1813,GO:0009064,glutamine family amino acid metabolic process,9,0.0,1.0,1.0,5
1814,GO:0009066,aspartate family amino acid metabolic process,9,0.0,1.0,1.0,8
1815,GO:0009069,serine family amino acid metabolic process,9,0.0,1.0,1.0,7
1816,GO:0009078,pyruvate family amino acid metabolic process,9,0.0,1.0,1.0,4
1817,GO:0009093,cysteine catabolic process,9,0.0,1.0,1.0,2
1818,GO:0009095,"aromatic amino acid family biosynthetic process, prephenate pathway",9,0.0,1.0,1.0,2
1819,GO:0009097,isoleucine biosynthetic process,9,0.0,1.0,1.0,1
1820,GO:0009106,lipoate metabolic process,9,0.0,1.0,1.0,2
1821,GO:0009127,purine nucleoside monophosphate biosynthetic process,9,0.0,1.0,1.0,2
1822,GO:0009128,purine nucleoside monophosphate catabolic process,9,0.0,1.0,1.0,2
1823,GO:0009130,pyrimidine nucleoside monophosphate biosynthetic process,9,0.0,1.0,1.0,2
1824,GO:0009131,pyrimidine nucleoside monophosphate catabolic process,9,0.0,1.0,1.0,2
1825,GO:0009136,purine nucleoside diphosphate biosynthetic process,9,0.0,1.0,1.0,2
1826,GO:0009137,purine nucleoside diphosphate catabolic process,9,0.0,1.0,1.0,2
1827,GO:0009139,pyrimidine nucleoside diphosphate biosynthetic process,9,0.0,1.0,1.0,2
1828,GO:0009140,pyrimidine nucleoside diphosphate catabolic process,9,0.0,1.0,1.0,2
1829,GO:0009145,purine nucleoside triphosphate biosynthetic process,9,0.0,1.0,1.0,2
1830,GO:0009146,purine nucleoside triphosphate catabolic process,9,0.0,1.0,1.0,2
1831,GO:0009148,pyrimidine nucleoside triphosphate biosynthetic process,9,0.0,1.0,1.0,2
1832,GO:0009149,pyrimidine nucleoside triphosphate catabolic process,9,0.0,1.0,1.0,2
1833,GO:0009150,purine ribonucleotide metabolic process,9,0.0,1.0,1.0,20
1834,GO:0009156,ribonucleoside monophosphate biosynthetic process,9,0.0,1.0,1.0,4
1835,GO:0009157,deoxyribonucleoside monophosphate biosynthetic process,9,0.0,1.0,1.0,2
1836,GO:0009158,ribonucleoside monophosphate catabolic process,9,0.0,1.0,1.0,3
1837,GO:0009159,deoxyribonucleoside monophosphate catabolic process,9,0.0,1.0,1.0,2
1838,GO:0009167,purine ribonucleoside monophosphate metabolic process,9,0.0,1.0,1.0,6
1839,GO:0009170,purine deoxyribonucleoside monophosphate metabolic process,9,0.0,1.0,1.0,4
1840,GO:0009173,pyrimidine ribonucleoside monophosphate metabolic process,9,0.0,1.0,1.0,5
1841,GO:0009176,pyrimidine deoxyribonucleoside monophosphate metabolic process,9,0.0,1.0,1.0,5
1842,GO:0009179,purine ribonucleoside diphosphate metabolic process,9,0.0,1.0,1.0,5
1843,GO:0009182,purine deoxyribonucleoside diphosphate metabolic process,9,0.0,1.0,1.0,4
1844,GO:0009188,ribonucleoside diphosphate biosynthetic process,9,0.0,1.0,1.0,2
1845,GO:0009189,deoxyribonucleoside diphosphate biosynthetic process,9,0.0,1.0,1.0,2
1846,GO:0009190,cyclic nucleotide biosynthetic process,9,0.0,1.0,1.0,3
1847,GO:0009191,ribonucleoside diphosphate catabolic process,9,0.0,1.0,1.0,2
1848,GO:0009192,deoxyribonucleoside diphosphate catabolic process,9,0.0,1.0,1.0,2
1849,GO:0009193,pyrimidine ribonucleoside diphosphate metabolic process,9,0.0,1.0,1.0,5
1850,GO:0009196,pyrimidine deoxyribonucleoside diphosphate metabolic process,9,0.0,1.0,1.0,5
1851,GO:0009201,ribonucleoside triphosphate biosynthetic process,9,0.0,1.0,1.0,2
1852,GO:0009202,deoxyribonucleoside triphosphate biosynthetic process,9,0.0,1.0,1.0,1
1853,GO:0009203,ribonucleoside triphosphate catabolic process,9,0.0,1.0,1.0,2
1854,GO:0009204,deoxyribonucleoside triphosphate catabolic process,9,0.0,1.0,1.0,1
1855,GO:0009205,purine ribonucleoside triphosphate metabolic process,9,0.0,1.0,1.0,5
1856,GO:0009208,pyrimidine ribonucleoside triphosphate metabolic process,9,0.0,1.0,1.0,5
1857,GO:0009211,pyrimidine deoxyribonucleoside triphosphate metabolic process,9,0.0,1.0,1.0,5
1858,GO:0009214,cyclic nucleotide catabolic process,9,0.0,1.0,1.0,2
1859,GO:0009215,purine deoxyribonucleoside triphosphate metabolic process,9,0.0,1.0,1.0,5
1860,GO:0009218,pyrimidine ribonucleotide metabolic process,9,0.0,1.0,1.0,12
1861,GO:0009260,ribonucleotide biosynthetic process,9,0.0,1.0,1.0,4
1862,GO:0009261,ribonucleotide catabolic process,9,0.0,1.0,1.0,3
1863,GO:0009263,deoxyribonucleotide biosynthetic process,9,0.0,1.0,1.0,1
1864,GO:0009264,deoxyribonucleotide catabolic process,9,0.0,1.0,1.0,2
1865,GO:0009298,GDP-mannose biosynthetic process,9,0.0,1.0,1.0,3
1866,GO:0009299,mRNA transcription,9,0.0,1.0,1.0,1
1867,GO:0009301,snRNA transcription,9,0.0,1.0,1.0,2
1868,GO:0009302,sno(s)RNA transcription,9,0.0,1.0,1.0,2
1869,GO:0009303,rRNA transcription,9,0.0,1.0,1.0,3
1870,GO:0009304,tRNA transcription,9,0.0,1.0,1.0,1
1871,GO:0009394,2'-deoxyribonucleotide metabolic process,9,0.0,1.0,1.0,3
1872,GO:0009443,pyridoxal 5'-phosphate salvage,9,0.0,1.0,1.0,1
1873,GO:0009679,hexose:proton symporter activity,9,0.0,1.0,1.0,6
1874,GO:0009684,indoleacetic acid biosynthetic process,9,0.0,1.0,1.0,2
1875,GO:0009686,gibberellin biosynthetic process,9,0.0,1.0,1.0,1
1876,GO:0010322,"regulation of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway",9,0.0,1.0,1.0,1
1877,GO:0010395,rhamnogalacturonan I metabolic process,9,0.0,1.0,1.0,3
1878,GO:0010405,arabinogalactan protein metabolic process,9,0.0,1.0,1.0,3
1879,GO:0010413,glucuronoxylan metabolic process,9,0.0,1.0,1.0,3
1880,GO:0010416,arabinoxylan-containing compound metabolic process,9,0.0,1.0,1.0,2
1881,GO:0010466,negative regulation of peptidase activity,9,0.0,1.0,1.0,5
1882,GO:0010510,regulation of acetyl-CoA biosynthetic process from pyruvate,9,0.0,1.0,1.0,1
1883,GO:0010511,regulation of phosphatidylinositol biosynthetic process,9,0.0,1.0,1.0,3
1884,GO:0010520,regulation of reciprocal meiotic recombination,9,0.0,1.0,1.0,2
1885,GO:0010522,regulation of calcium ion transport into cytosol,9,0.0,1.0,1.0,2
1886,GO:0010544,negative regulation of platelet activation,9,0.0,1.0,1.0,1
1887,GO:0010560,positive regulation of glycoprotein biosynthetic process,9,0.0,1.0,1.0,10
1888,GO:0010561,negative regulation of glycoprotein biosynthetic process,9,0.0,1.0,1.0,8
1889,GO:0010574,regulation of vascular endothelial growth factor production,9,0.0,1.0,1.0,2
1890,GO:0010686,tetracyclic triterpenoid biosynthetic process,9,0.0,1.0,1.0,1
1891,GO:0010692,regulation of alkaline phosphatase activity,9,0.0,1.0,1.0,2
1892,GO:0010758,regulation of macrophage chemotaxis,9,0.0,1.0,1.0,2
1893,GO:0010799,regulation of peptidyl-threonine phosphorylation,9,0.0,1.0,1.0,2
1894,GO:0010826,negative regulation of centrosome duplication,9,0.0,1.0,1.0,1
1895,GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling,9,0.0,1.0,1.0,1
1896,GO:0010893,positive regulation of steroid biosynthetic process,9,0.0,1.0,1.0,9
1897,GO:0010894,negative regulation of steroid biosynthetic process,9,0.0,1.0,1.0,10
1898,GO:0010899,regulation of phosphatidylcholine catabolic process,9,0.0,1.0,1.0,1
1899,GO:0010908,regulation of heparan sulfate proteoglycan biosynthetic process,9,0.0,1.0,1.0,1
1900,GO:0010920,negative regulation of inositol phosphate biosynthetic process,9,0.0,1.0,1.0,1
1901,GO:0010922,positive regulation of phosphatase activity,9,0.0,1.0,1.0,3
1902,GO:0010923,negative regulation of phosphatase activity,9,0.0,1.0,1.0,2
1903,GO:0010924,regulation of inositol-polyphosphate 5-phosphatase activity,9,0.0,1.0,1.0,1
1904,GO:0010938,cytoplasmic microtubule depolymerization,9,0.0,1.0,1.0,1
1905,GO:0010952,positive regulation of peptidase activity,9,0.0,1.0,1.0,6
1906,GO:0010962,regulation of glucan biosynthetic process,9,0.0,1.0,1.0,4
1907,GO:0010964,regulation of regulatory ncRNA-mediated heterochromatin formation,9,0.0,1.0,1.0,2
1908,GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,9,0.0,1.0,1.0,1
1909,GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,9,0.0,1.0,1.0,3
1910,GO:0010973,positive regulation of division septum assembly,9,0.0,1.0,1.0,2
1911,GO:0010974,negative regulation of division septum assembly,9,0.0,1.0,1.0,2
1912,GO:0014722,regulation of skeletal muscle contraction by calcium ion signaling,9,0.0,1.0,1.0,2
1913,GO:0014724,regulation of twitch skeletal muscle contraction,9,0.0,1.0,1.0,2
1914,GO:0014746,regulation of tonic skeletal muscle contraction,9,0.0,1.0,1.0,2
1915,GO:0014824,artery smooth muscle contraction,9,0.0,1.0,1.0,1
1916,GO:0014862,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,9,0.0,1.0,1.0,2
1917,GO:0015280,ligand-gated sodium channel activity,9,0.0,1.0,1.0,2
1918,GO:0015378,sodium:chloride symporter activity,9,0.0,1.0,1.0,7
1919,GO:0015379,potassium:chloride symporter activity,9,0.0,1.0,1.0,1
1920,GO:0015501,glutamate:sodium symporter activity,9,0.0,1.0,1.0,1
1921,GO:0015655,alanine:sodium symporter activity,9,0.0,1.0,1.0,2
1922,GO:0015738,glucuronate transmembrane transport,9,0.0,1.0,1.0,1
1923,GO:0015814,p-aminobenzoyl-glutamate transport,9,0.0,1.0,1.0,1
1924,GO:0015866,ADP transport,9,0.0,1.0,1.0,1
1925,GO:0015867,ATP transport,9,0.0,1.0,1.0,2
1926,GO:0015913,short-chain fatty acid transmembrane transport,9,0.0,1.0,1.0,1
1927,GO:0015950,purine nucleotide interconversion,9,0.0,1.0,1.0,2
1928,GO:0015953,pyrimidine nucleotide interconversion,9,0.0,1.0,1.0,2
1929,GO:0015960,diadenosine polyphosphate biosynthetic process,9,0.0,1.0,1.0,2
1930,GO:0015961,diadenosine polyphosphate catabolic process,9,0.0,1.0,1.0,4
1931,GO:0015962,diadenosine triphosphate metabolic process,9,0.0,1.0,1.0,2
1932,GO:0015965,diadenosine tetraphosphate metabolic process,9,0.0,1.0,1.0,2
1933,GO:0016117,carotenoid biosynthetic process,9,0.0,1.0,1.0,6
1934,GO:0016118,carotenoid catabolic process,9,0.0,1.0,1.0,6
1935,GO:0016122,xanthophyll metabolic process,9,0.0,1.0,1.0,10
1936,GO:0016441,post-transcriptional gene silencing,9,0.0,1.0,1.0,3
1937,GO:0016567,protein ubiquitination,9,0.0,1.0,1.0,4
1938,GO:0016579,protein deubiquitination,9,0.0,1.0,1.0,10
1939,GO:0016925,protein sumoylation,9,0.0,1.0,1.0,1
1940,GO:0017153,sodium:dicarboxylate symporter activity,9,0.0,1.0,1.0,4
1941,GO:0017158,regulation of calcium ion-dependent exocytosis,9,0.0,1.0,1.0,5
1942,GO:0018011,N-terminal peptidyl-alanine methylation,9,0.0,1.0,1.0,1
1943,GO:0018393,internal peptidyl-lysine acetylation,9,0.0,1.0,1.0,2
1944,GO:0018867,alpha-pinene metabolic process,9,0.0,1.0,1.0,2
1945,GO:0018875,anaerobic benzoate metabolic process,9,0.0,1.0,1.0,2
1946,GO:0019090,mitochondrial rRNA export from mitochondrion,9,0.0,1.0,1.0,2
1947,GO:0019249,lactate biosynthetic process,9,0.0,1.0,1.0,3
1948,GO:0019287,"isopentenyl diphosphate biosynthetic process, mevalonate pathway",9,0.0,1.0,1.0,1
1949,GO:0019363,pyridine nucleotide biosynthetic process,9,0.0,1.0,1.0,3
1950,GO:0019364,pyridine nucleotide catabolic process,9,0.0,1.0,1.0,3
1951,GO:0019370,leukotriene biosynthetic process,9,0.0,1.0,1.0,3
1952,GO:0019372,lipoxygenase pathway,9,0.0,1.0,1.0,1
1953,GO:0019392,glucarate metabolic process,9,0.0,1.0,1.0,3
1954,GO:0019395,fatty acid oxidation,9,0.0,1.0,1.0,3
1955,GO:0019396,gallate catabolic process,9,0.0,1.0,1.0,2
1956,GO:0019413,acetate biosynthetic process,9,0.0,1.0,1.0,1
1957,GO:0019478,D-amino acid catabolic process,9,0.0,1.0,1.0,7
1958,GO:0019483,beta-alanine biosynthetic process,9,0.0,1.0,1.0,3
1959,GO:0019484,beta-alanine catabolic process,9,0.0,1.0,1.0,2
1960,GO:0019502,L-proline betaine metabolic process,9,0.0,1.0,1.0,2
1961,GO:0019521,D-gluconate metabolic process,9,0.0,1.0,1.0,2
1962,GO:0019522,ketogluconate metabolic process,9,0.0,1.0,1.0,3
1963,GO:0019523,L-idonate metabolic process,9,0.0,1.0,1.0,2
1964,GO:0019571,D-arabinose catabolic process,9,0.0,1.0,1.0,1
1965,GO:0019572,L-arabinose catabolic process,9,0.0,1.0,1.0,2
1966,GO:0019578,aldaric acid biosynthetic process,9,0.0,1.0,1.0,2
1967,GO:0019579,aldaric acid catabolic process,9,0.0,1.0,1.0,3
1968,GO:0019580,galactarate metabolic process,9,0.0,1.0,1.0,2
1969,GO:0019583,galactonate metabolic process,9,0.0,1.0,1.0,3
1970,GO:0019585,glucuronate metabolic process,9,0.0,1.0,1.0,5
1971,GO:0019586,galacturonate metabolic process,9,0.0,1.0,1.0,3
1972,GO:0019588,anaerobic glycerol catabolic process,9,0.0,1.0,1.0,1
1973,GO:0019595,non-phosphorylated glucose catabolic process,9,0.0,1.0,1.0,1
1974,GO:0019596,mandelate catabolic process,9,0.0,1.0,1.0,2
1975,GO:0019619,"3,4-dihydroxybenzoate catabolic process",9,0.0,1.0,1.0,2
1976,GO:0019659,glucose catabolic process to lactate,9,0.0,1.0,1.0,3
1977,GO:0019741,pentacyclic triterpenoid catabolic process,9,0.0,1.0,1.0,2
1978,GO:0019745,pentacyclic triterpenoid biosynthetic process,9,0.0,1.0,1.0,2
1979,GO:0019896,axonal transport of mitochondrion,9,0.0,1.0,1.0,2
1980,GO:0019985,translesion synthesis,9,0.0,1.0,1.0,2
1981,GO:0021823,cerebral cortex tangential migration using cell-cell interactions,9,0.0,1.0,1.0,1
1982,GO:0021955,central nervous system neuron axonogenesis,9,0.0,1.0,1.0,3
1983,GO:0022824,transmitter-gated monoatomic ion channel activity,9,0.0,1.0,1.0,7
1984,GO:0030071,regulation of mitotic metaphase/anaphase transition,9,0.0,1.0,1.0,3
1985,GO:0030073,insulin secretion,9,0.0,1.0,1.0,1
1986,GO:0030103,vasopressin secretion,9,0.0,1.0,1.0,1
1987,GO:0030244,cellulose biosynthetic process,9,0.0,1.0,1.0,2
1988,GO:0030245,cellulose catabolic process,9,0.0,1.0,1.0,2
1989,GO:0030490,maturation of SSU-rRNA,9,0.0,1.0,1.0,4
1990,GO:0030809,negative regulation of nucleotide biosynthetic process,9,0.0,1.0,1.0,2
1991,GO:0030810,positive regulation of nucleotide biosynthetic process,9,0.0,1.0,1.0,2
1992,GO:0030812,negative regulation of nucleotide catabolic process,9,0.0,1.0,1.0,1
1993,GO:0030813,positive regulation of nucleotide catabolic process,9,0.0,1.0,1.0,1
1994,GO:0030852,regulation of granulocyte differentiation,9,0.0,1.0,1.0,5
1995,GO:0031045,dense core granule,9,0.0,1.0,1.0,1
1996,GO:0031047,regulatory ncRNA-mediated gene silencing,9,0.0,1.0,1.0,3
1997,GO:0031049,programmed DNA elimination,9,0.0,1.0,1.0,2
1998,GO:0031070,intronic snoRNA processing,9,0.0,1.0,1.0,2
1999,GO:0031087,deadenylation-independent decapping of nuclear-transcribed mRNA,9,0.0,1.0,1.0,1
2000,GO:0031111,negative regulation of microtubule polymerization or depolymerization,9,0.0,1.0,1.0,2
2001,GO:0031112,positive regulation of microtubule polymerization or depolymerization,9,0.0,1.0,1.0,2
2002,GO:0031113,regulation of microtubule polymerization,9,0.0,1.0,1.0,3
2003,GO:0031114,regulation of microtubule depolymerization,9,0.0,1.0,1.0,3
2004,GO:0031124,mRNA 3'-end processing,9,0.0,1.0,1.0,4
2005,GO:0031125,rRNA 3'-end processing,9,0.0,1.0,1.0,4
2006,GO:0031126,sno(s)RNA 3'-end processing,9,0.0,1.0,1.0,4
2007,GO:0031295,T cell costimulation,9,0.0,1.0,1.0,1
2008,GO:0031426,polycistronic mRNA processing,9,0.0,1.0,1.0,1
2009,GO:0031452,negative regulation of heterochromatin formation,9,0.0,1.0,1.0,4
2010,GO:0031453,positive regulation of heterochromatin formation,9,0.0,1.0,1.0,3
2011,GO:0031554,regulation of termination of DNA-templated transcription,9,0.0,1.0,1.0,4
2012,GO:0031566,actomyosin contractile ring maturation,9,0.0,1.0,1.0,1
2013,GO:0031570,DNA integrity checkpoint signaling,9,0.0,1.0,1.0,4
2014,GO:0031577,spindle checkpoint signaling,9,0.0,1.0,1.0,3
2015,GO:0031622,positive regulation of fever generation,9,0.0,1.0,1.0,2
2016,GO:0031944,negative regulation of glucocorticoid metabolic process,9,0.0,1.0,1.0,2
2017,GO:0031945,positive regulation of glucocorticoid metabolic process,9,0.0,1.0,1.0,2
2018,GO:0031949,regulation of glucocorticoid catabolic process,9,0.0,1.0,1.0,2
2019,GO:0031952,regulation of protein autophosphorylation,9,0.0,1.0,1.0,3
2020,GO:0031958,nuclear receptor-mediated corticosteroid signaling pathway,9,0.0,1.0,1.0,2
2021,GO:0031998,regulation of fatty acid beta-oxidation,9,0.0,1.0,1.0,3
2022,GO:0032010,phagolysosome,9,0.0,1.0,1.0,1
2023,GO:0032071,regulation of endodeoxyribonuclease activity,9,0.0,1.0,1.0,3
2024,GO:0032076,negative regulation of deoxyribonuclease activity,9,0.0,1.0,1.0,1
2025,GO:0032077,positive regulation of deoxyribonuclease activity,9,0.0,1.0,1.0,1
2026,GO:0032113,regulation of carbohydrate phosphatase activity,9,0.0,1.0,1.0,1
2027,GO:0032205,negative regulation of telomere maintenance,9,0.0,1.0,1.0,7
2028,GO:0032206,positive regulation of telomere maintenance,9,0.0,1.0,1.0,8
2029,GO:0032213,regulation of telomere maintenance via semi-conservative replication,9,0.0,1.0,1.0,2
2030,GO:0032231,regulation of actin filament bundle assembly,9,0.0,1.0,1.0,4
2031,GO:0032274,gonadotropin secretion,9,0.0,1.0,1.0,2
2032,GO:0032277,negative regulation of gonadotropin secretion,9,0.0,1.0,1.0,2
2033,GO:0032278,positive regulation of gonadotropin secretion,9,0.0,1.0,1.0,2
2034,GO:0032308,positive regulation of prostaglandin secretion,9,0.0,1.0,1.0,2
2035,GO:0032310,prostaglandin secretion,9,0.0,1.0,1.0,2
2036,GO:0032345,negative regulation of aldosterone metabolic process,9,0.0,1.0,1.0,1
2037,GO:0032346,positive regulation of aldosterone metabolic process,9,0.0,1.0,1.0,1
2038,GO:0032384,negative regulation of intracellular cholesterol transport,9,0.0,1.0,1.0,1
2039,GO:0032385,positive regulation of intracellular cholesterol transport,9,0.0,1.0,1.0,1
2040,GO:0032423,regulation of mismatch repair,9,0.0,1.0,1.0,2
2041,GO:0032479,regulation of type I interferon production,9,0.0,1.0,1.0,4
2042,GO:0032595,B cell receptor transport within lipid bilayer,9,0.0,1.0,1.0,1
2043,GO:0032596,protein transport into membrane raft,9,0.0,1.0,1.0,2
2044,GO:0032599,protein transport out of membrane raft,9,0.0,1.0,1.0,2
2045,GO:0032643,regulation of connective tissue growth factor production,9,0.0,1.0,1.0,2
2046,GO:0032645,regulation of granulocyte macrophage colony-stimulating factor production,9,0.0,1.0,1.0,2
2047,GO:0032646,regulation of hepatocyte growth factor production,9,0.0,1.0,1.0,2
2048,GO:0032649,regulation of type II interferon production,9,0.0,1.0,1.0,2
2049,GO:0032653,regulation of interleukin-10 production,9,0.0,1.0,1.0,2
2050,GO:0032654,regulation of interleukin-11 production,9,0.0,1.0,1.0,2
2051,GO:0032655,regulation of interleukin-12 production,9,0.0,1.0,1.0,2
2052,GO:0032656,regulation of interleukin-13 production,9,0.0,1.0,1.0,2
2053,GO:0032658,regulation of interleukin-15 production,9,0.0,1.0,1.0,2
2054,GO:0032659,regulation of interleukin-16 production,9,0.0,1.0,1.0,2
2055,GO:0032660,regulation of interleukin-17 production,9,0.0,1.0,1.0,3
2056,GO:0032661,regulation of interleukin-18 production,9,0.0,1.0,1.0,2
2057,GO:0032662,regulation of interleukin-19 production,9,0.0,1.0,1.0,2
2058,GO:0032663,regulation of interleukin-2 production,9,0.0,1.0,1.0,2
2059,GO:0032664,regulation of interleukin-20 production,9,0.0,1.0,1.0,2
2060,GO:0032665,regulation of interleukin-21 production,9,0.0,1.0,1.0,2
2061,GO:0032666,regulation of interleukin-22 production,9,0.0,1.0,1.0,2
2062,GO:0032667,regulation of interleukin-23 production,9,0.0,1.0,1.0,2
2063,GO:0032668,regulation of interleukin-24 production,9,0.0,1.0,1.0,2
2064,GO:0032669,regulation of interleukin-25 production,9,0.0,1.0,1.0,2
2065,GO:0032670,regulation of interleukin-26 production,9,0.0,1.0,1.0,2
2066,GO:0032671,regulation of interleukin-27 production,9,0.0,1.0,1.0,2
2067,GO:0032672,regulation of interleukin-3 production,9,0.0,1.0,1.0,2
2068,GO:0032673,regulation of interleukin-4 production,9,0.0,1.0,1.0,2
2069,GO:0032674,regulation of interleukin-5 production,9,0.0,1.0,1.0,2
2070,GO:0032676,regulation of interleukin-7 production,9,0.0,1.0,1.0,2
2071,GO:0032677,regulation of interleukin-8 production,9,0.0,1.0,1.0,2
2072,GO:0032678,regulation of interleukin-9 production,9,0.0,1.0,1.0,2
2073,GO:0032818,negative regulation of natural killer cell proliferation,9,0.0,1.0,1.0,1
2074,GO:0032819,positive regulation of natural killer cell proliferation,9,0.0,1.0,1.0,1
2075,GO:0032820,regulation of natural killer cell proliferation involved in immune response,9,0.0,1.0,1.0,2
2076,GO:0032823,regulation of natural killer cell differentiation,9,0.0,1.0,1.0,3
2077,GO:0032848,negative regulation of cellular pH reduction,9,0.0,1.0,1.0,1
2078,GO:0032849,positive regulation of cellular pH reduction,9,0.0,1.0,1.0,1
2079,GO:0032873,negative regulation of stress-activated MAPK cascade,9,0.0,1.0,1.0,1
2080,GO:0032874,positive regulation of stress-activated MAPK cascade,9,0.0,1.0,1.0,1
2081,GO:0032924,activin receptor signaling pathway,9,0.0,1.0,1.0,1
2082,GO:0032952,regulation of (1->3)-beta-D-glucan metabolic process,9,0.0,1.0,1.0,1
2083,GO:0032960,regulation of inositol trisphosphate biosynthetic process,9,0.0,1.0,1.0,2
2084,GO:0033048,negative regulation of mitotic sister chromatid segregation,9,0.0,1.0,1.0,1
2085,GO:0033074,pinene catabolic process,9,0.0,1.0,1.0,1
2086,GO:0033083,regulation of immature T cell proliferation,9,0.0,1.0,1.0,3
2087,GO:0033119,negative regulation of RNA splicing,9,0.0,1.0,1.0,2
2088,GO:0033120,positive regulation of RNA splicing,9,0.0,1.0,1.0,1
2089,GO:0033121,regulation of purine nucleotide catabolic process,9,0.0,1.0,1.0,3
2090,GO:0033135,regulation of peptidyl-serine phosphorylation,9,0.0,1.0,1.0,3
2091,GO:0033212,iron import into cell,9,0.0,1.0,1.0,5
2092,GO:0033313,meiotic cell cycle checkpoint signaling,9,0.0,1.0,1.0,3
2093,GO:0033378,establishment of protease localization to T cell secretory granule,9,0.0,1.0,1.0,1
2094,GO:0033388,putrescine biosynthetic process from arginine,9,0.0,1.0,1.0,2
2095,GO:0033469,gibberellin 12 metabolic process,9,0.0,1.0,1.0,1
2096,GO:0033473,indoleacetic acid conjugate metabolic process,9,0.0,1.0,1.0,1
2097,GO:0033520,phytol biosynthetic process,9,0.0,1.0,1.0,1
2098,GO:0033545,"myo-inositol hexakisphosphate biosynthetic process, lipid-dependent",9,0.0,1.0,1.0,1
2099,GO:0033559,unsaturated fatty acid metabolic process,9,0.0,1.0,1.0,7
2100,GO:0033564,anterior/posterior axon guidance,9,0.0,1.0,1.0,2
2101,GO:0033606,chemokine receptor transport within lipid bilayer,9,0.0,1.0,1.0,1
2102,GO:0033653,host cell chloroplast part,9,0.0,1.0,1.0,1
2103,GO:0033673,negative regulation of kinase activity,9,0.0,1.0,1.0,3
2104,GO:0033674,positive regulation of kinase activity,9,0.0,1.0,1.0,3
2105,GO:0033684,regulation of luteinizing hormone secretion,9,0.0,1.0,1.0,2
2106,GO:0034030,ribonucleoside bisphosphate biosynthetic process,9,0.0,1.0,1.0,1
2107,GO:0034031,ribonucleoside bisphosphate catabolic process,9,0.0,1.0,1.0,1
2108,GO:0034033,purine nucleoside bisphosphate biosynthetic process,9,0.0,1.0,1.0,1
2109,GO:0034034,purine nucleoside bisphosphate catabolic process,9,0.0,1.0,1.0,1
2110,GO:0034035,purine ribonucleoside bisphosphate metabolic process,9,0.0,1.0,1.0,5
2111,GO:0034092,negative regulation of maintenance of sister chromatid cohesion,9,0.0,1.0,1.0,2
2112,GO:0034093,positive regulation of maintenance of sister chromatid cohesion,9,0.0,1.0,1.0,2
2113,GO:0034094,regulation of maintenance of meiotic sister chromatid cohesion,9,0.0,1.0,1.0,3
2114,GO:0034122,negative regulation of toll-like receptor signaling pathway,9,0.0,1.0,1.0,3
2115,GO:0034123,positive regulation of toll-like receptor signaling pathway,9,0.0,1.0,1.0,3
2116,GO:0034124,regulation of MyD88-dependent toll-like receptor signaling pathway,9,0.0,1.0,1.0,2
2117,GO:0034127,regulation of MyD88-independent toll-like receptor signaling pathway,9,0.0,1.0,1.0,2
2118,GO:0034139,regulation of toll-like receptor 3 signaling pathway,9,0.0,1.0,1.0,2
2119,GO:0034155,regulation of toll-like receptor 7 signaling pathway,9,0.0,1.0,1.0,2
2120,GO:0034159,regulation of toll-like receptor 8 signaling pathway,9,0.0,1.0,1.0,2
2121,GO:0034163,regulation of toll-like receptor 9 signaling pathway,9,0.0,1.0,1.0,2
2122,GO:0034171,regulation of toll-like receptor 11 signaling pathway,9,0.0,1.0,1.0,2
2123,GO:0034175,regulation of toll-like receptor 12 signaling pathway,9,0.0,1.0,1.0,2
2124,GO:0034179,regulation of toll-like receptor 13 signaling pathway,9,0.0,1.0,1.0,2
2125,GO:0034182,regulation of maintenance of mitotic sister chromatid cohesion,9,0.0,1.0,1.0,5
2126,GO:0034267,discadenine metabolic process,9,0.0,1.0,1.0,2
2127,GO:0034344,regulation of type III interferon production,9,0.0,1.0,1.0,2
2128,GO:0034407,cell wall (1->3)-beta-D-glucan metabolic process,9,0.0,1.0,1.0,2
2129,GO:0034410,cell wall beta-glucan biosynthetic process,9,0.0,1.0,1.0,3
2130,GO:0034443,negative regulation of lipoprotein oxidation,9,0.0,1.0,1.0,1
2131,GO:0034472,snRNA 3'-end processing,9,0.0,1.0,1.0,5
2132,GO:0034631,microtubule anchoring at spindle pole body,9,0.0,1.0,1.0,2
2133,GO:0034635,glutathione transport,9,0.0,1.0,1.0,1
2134,GO:0034755,iron ion transmembrane transport,9,0.0,1.0,1.0,7
2135,GO:0034760,negative regulation of iron ion transmembrane transport,9,0.0,1.0,1.0,2
2136,GO:0034761,positive regulation of iron ion transmembrane transport,9,0.0,1.0,1.0,2
2137,GO:0034963,box C/D sno(s)RNA processing,9,0.0,1.0,1.0,3
2138,GO:0034964,box H/ACA sno(s)RNA processing,9,0.0,1.0,1.0,2
2139,GO:0035246,peptidyl-arginine N-methylation,9,0.0,1.0,1.0,1
2140,GO:0035336,long-chain fatty-acyl-CoA metabolic process,9,0.0,1.0,1.0,2
2141,GO:0035434,copper ion transmembrane transport,9,0.0,1.0,1.0,5
2142,GO:0035442,dipeptide transmembrane transport,9,0.0,1.0,1.0,2
2143,GO:0035443,tripeptide transmembrane transport,9,0.0,1.0,1.0,2
2144,GO:0035444,nickel cation transmembrane transport,9,0.0,1.0,1.0,1
2145,GO:0035568,N-terminal peptidyl-proline methylation,9,0.0,1.0,1.0,1
2146,GO:0035570,N-terminal peptidyl-serine methylation,9,0.0,1.0,1.0,2
2147,GO:0035684,helper T cell extravasation,9,0.0,1.0,1.0,2
2148,GO:0035697,"CD8-positive, alpha-beta T cell extravasation",9,0.0,1.0,1.0,3
2149,GO:0035743,"CD4-positive, alpha-beta T cell cytokine production",9,0.0,1.0,1.0,2
2150,GO:0035790,platelet-derived growth factor receptor-alpha signaling pathway,9,0.0,1.0,1.0,1
2151,GO:0035791,platelet-derived growth factor receptor-beta signaling pathway,9,0.0,1.0,1.0,2
2152,GO:0035822,gene conversion,9,0.0,1.0,1.0,5
2153,GO:0035879,plasma membrane lactate transport,9,0.0,1.0,1.0,1
2154,GO:0035929,steroid hormone secretion,9,0.0,1.0,1.0,7
2155,GO:0036036,cardiac neural crest cell delamination,9,0.0,1.0,1.0,1
2156,GO:0036100,leukotriene catabolic process,9,0.0,1.0,1.0,3
2157,GO:0036111,very long-chain fatty-acyl-CoA metabolic process,9,0.0,1.0,1.0,1
2158,GO:0036112,medium-chain fatty-acyl-CoA metabolic process,9,0.0,1.0,1.0,1
2159,GO:0036115,fatty-acyl-CoA catabolic process,9,0.0,1.0,1.0,9
2160,GO:0036265,RNA (guanine-N7)-methylation,9,0.0,1.0,1.0,3
2161,GO:0036289,peptidyl-serine autophosphorylation,9,0.0,1.0,1.0,1
2162,GO:0038010,positive regulation of signal transduction by receptor internalization,9,0.0,1.0,1.0,2
2163,GO:0038011,negative regulation of signal transduction by receptor internalization,9,0.0,1.0,1.0,1
2164,GO:0038086,VEGF-activated platelet-derived growth factor receptor signaling pathway,9,0.0,1.0,1.0,4
2165,GO:0038089,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,9,0.0,1.0,1.0,2
2166,GO:0038128,ERBB2 signaling pathway,9,0.0,1.0,1.0,3
2167,GO:0038129,ERBB3 signaling pathway,9,0.0,1.0,1.0,2
2168,GO:0038130,ERBB4 signaling pathway,9,0.0,1.0,1.0,4
2169,GO:0038190,VEGF-activated neuropilin signaling pathway,9,0.0,1.0,1.0,1
2170,GO:0039532,negative regulation of cytoplasmic pattern recognition receptor signaling pathway,9,0.0,1.0,1.0,12
2171,GO:0039533,regulation of MDA-5 signaling pathway,9,0.0,1.0,1.0,2
2172,GO:0039535,regulation of RIG-I signaling pathway,9,0.0,1.0,1.0,2
2173,GO:0039562,symbiont-mediated suppression of host JAK-STAT cascade via inhibition of STAT activity,9,0.0,1.0,1.0,2
2174,GO:0039687,viral DNA strand displacement replication,9,0.0,1.0,1.0,1
2175,GO:0040031,snRNA modification,9,0.0,1.0,1.0,3
2176,GO:0042102,positive regulation of T cell proliferation,9,0.0,1.0,1.0,5
2177,GO:0042130,negative regulation of T cell proliferation,9,0.0,1.0,1.0,5
2178,GO:0042267,natural killer cell mediated cytotoxicity,9,0.0,1.0,1.0,1
2179,GO:0042275,error-free postreplication DNA repair,9,0.0,1.0,1.0,1
2180,GO:0042306,regulation of protein import into nucleus,9,0.0,1.0,1.0,2
2181,GO:0042317,penicillin catabolic process,9,0.0,1.0,1.0,1
2182,GO:0042318,penicillin biosynthetic process,9,0.0,1.0,1.0,1
2183,GO:0042350,GDP-L-fucose biosynthetic process,9,0.0,1.0,1.0,2
2184,GO:0042453,deoxyguanosine metabolic process,9,0.0,1.0,1.0,2
2185,GO:0042573,retinoic acid metabolic process,9,0.0,1.0,1.0,4
2186,GO:0042574,retinal metabolic process,9,0.0,1.0,1.0,1
2187,GO:0042599,lamellar body,9,0.0,1.0,1.0,3
2188,GO:0042669,regulation of inner ear auditory receptor cell fate specification,9,0.0,1.0,1.0,1
2189,GO:0042780,tRNA 3'-end processing,9,0.0,1.0,1.0,2
2190,GO:0042793,plastid transcription,9,0.0,1.0,1.0,1
2191,GO:0042866,pyruvate biosynthetic process,9,0.0,1.0,1.0,1
2192,GO:0042867,pyruvate catabolic process,9,0.0,1.0,1.0,1
2193,GO:0042984,regulation of amyloid precursor protein biosynthetic process,9,0.0,1.0,1.0,2
2194,GO:0043045,epigenetic programming of gene expression,9,0.0,1.0,1.0,2
2195,GO:0043096,purine nucleobase salvage,9,0.0,1.0,1.0,3
2196,GO:0043097,pyrimidine nucleoside salvage,9,0.0,1.0,1.0,2
2197,GO:0043100,pyrimidine nucleobase salvage,9,0.0,1.0,1.0,1
2198,GO:0043132,NAD transport,9,0.0,1.0,1.0,1
2199,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,9,0.0,1.0,1.0,10
2200,GO:0043173,nucleotide salvage,9,0.0,1.0,1.0,4
2201,GO:0043300,regulation of leukocyte degranulation,9,0.0,1.0,1.0,8
2202,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",9,0.0,1.0,1.0,3
2203,GO:0043374,"CD8-positive, alpha-beta T cell differentiation",9,0.0,1.0,1.0,4
2204,GO:0043397,regulation of corticotropin-releasing hormone secretion,9,0.0,1.0,1.0,2
2205,GO:0043487,regulation of RNA stability,9,0.0,1.0,1.0,5
2206,GO:0043517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",9,0.0,1.0,1.0,1
2207,GO:0043518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",9,0.0,1.0,1.0,1
2208,GO:0043520,regulation of myosin II filament assembly,9,0.0,1.0,1.0,2
2209,GO:0043550,regulation of lipid kinase activity,9,0.0,1.0,1.0,3
2210,GO:0043634,polyadenylation-dependent ncRNA catabolic process,9,0.0,1.0,1.0,1
2211,GO:0043637,puromycin metabolic process,9,0.0,1.0,1.0,1
2212,GO:0043639,benzoate catabolic process,9,0.0,1.0,1.0,2
2213,GO:0043660,bacteroid-containing symbiosome,9,0.0,1.0,1.0,1
2214,GO:0044539,long-chain fatty acid import into cell,9,0.0,1.0,1.0,1
2215,GO:0044618,modulation of relaxation of uterine smooth muscle in another organism,9,0.0,1.0,1.0,1
2216,GO:0044785,metaphase/anaphase transition of meiotic cell cycle,9,0.0,1.0,1.0,2
2217,GO:0044786,cell cycle DNA replication,9,0.0,1.0,1.0,3
2218,GO:0044831,modulation by virus of host cytokine production,9,0.0,1.0,1.0,1
2219,GO:0045016,mitochondrial magnesium ion transmembrane transport,9,0.0,1.0,1.0,1
2220,GO:0045091,regulation of single stranded viral RNA replication via double stranded DNA intermediate,9,0.0,1.0,1.0,2
2221,GO:0045219,regulation of FasL production,9,0.0,1.0,1.0,2
2222,GO:0045223,regulation of CD4 production,9,0.0,1.0,1.0,2
2223,GO:0045334,clathrin-coated endocytic vesicle,9,0.0,1.0,1.0,1
2224,GO:0045492,xylan biosynthetic process,9,0.0,1.0,1.0,1
2225,GO:0045493,xylan catabolic process,9,0.0,1.0,1.0,2
2226,GO:0045501,regulation of sevenless signaling pathway,9,0.0,1.0,1.0,2
2227,GO:0045577,regulation of B cell differentiation,9,0.0,1.0,1.0,6
2228,GO:0045580,regulation of T cell differentiation,9,0.0,1.0,1.0,10
2229,GO:0045608,negative regulation of inner ear auditory receptor cell differentiation,9,0.0,1.0,1.0,1
2230,GO:0045620,negative regulation of lymphocyte differentiation,9,0.0,1.0,1.0,3
2231,GO:0045621,positive regulation of lymphocyte differentiation,9,0.0,1.0,1.0,3
2232,GO:0045649,regulation of macrophage differentiation,9,0.0,1.0,1.0,3
2233,GO:0045655,regulation of monocyte differentiation,9,0.0,1.0,1.0,2
2234,GO:0045670,regulation of osteoclast differentiation,9,0.0,1.0,1.0,2
2235,GO:0045677,negative regulation of R7 cell differentiation,9,0.0,1.0,1.0,1
2236,GO:0045686,negative regulation of glial cell differentiation,9,0.0,1.0,1.0,4
2237,GO:0045687,positive regulation of glial cell differentiation,9,0.0,1.0,1.0,4
2238,GO:0045717,negative regulation of fatty acid biosynthetic process,9,0.0,1.0,1.0,4
2239,GO:0045723,positive regulation of fatty acid biosynthetic process,9,0.0,1.0,1.0,4
2240,GO:0045724,positive regulation of cilium assembly,9,0.0,1.0,1.0,2
2241,GO:0045738,negative regulation of DNA repair,9,0.0,1.0,1.0,5
2242,GO:0045739,positive regulation of DNA repair,9,0.0,1.0,1.0,5
2243,GO:0045740,positive regulation of DNA replication,9,0.0,1.0,1.0,1
2244,GO:0045814,"negative regulation of gene expression, epigenetic",9,0.0,1.0,1.0,3
2245,GO:0045859,regulation of protein kinase activity,9,0.0,1.0,1.0,6
2246,GO:0045910,negative regulation of DNA recombination,9,0.0,1.0,1.0,9
2247,GO:0045911,positive regulation of DNA recombination,9,0.0,1.0,1.0,8
2248,GO:0045928,negative regulation of juvenile hormone metabolic process,9,0.0,1.0,1.0,2
2249,GO:0045929,positive regulation of juvenile hormone metabolic process,9,0.0,1.0,1.0,2
2250,GO:0045952,regulation of juvenile hormone catabolic process,9,0.0,1.0,1.0,2
2251,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,9,0.0,1.0,1.0,3
2252,GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,9,0.0,1.0,1.0,3
2253,GO:0045965,negative regulation of ecdysteroid metabolic process,9,0.0,1.0,1.0,1
2254,GO:0045966,positive regulation of ecdysteroid metabolic process,9,0.0,1.0,1.0,1
2255,GO:0046006,regulation of activated T cell proliferation,9,0.0,1.0,1.0,2
2256,GO:0046013,regulation of T cell homeostatic proliferation,9,0.0,1.0,1.0,2
2257,GO:0046084,adenine biosynthetic process,9,0.0,1.0,1.0,1
2258,GO:0046085,adenosine metabolic process,9,0.0,1.0,1.0,2
2259,GO:0046087,cytidine metabolic process,9,0.0,1.0,1.0,2
2260,GO:0046090,deoxyadenosine metabolic process,9,0.0,1.0,1.0,2
2261,GO:0046092,deoxycytidine metabolic process,9,0.0,1.0,1.0,2
2262,GO:0046094,deoxyinosine metabolic process,9,0.0,1.0,1.0,2
2263,GO:0046096,deoxyuridine metabolic process,9,0.0,1.0,1.0,2
2264,GO:0046099,guanine biosynthetic process,9,0.0,1.0,1.0,1
2265,GO:0046101,hypoxanthine biosynthetic process,9,0.0,1.0,1.0,1
2266,GO:0046102,inosine metabolic process,9,0.0,1.0,1.0,2
2267,GO:0046104,thymidine metabolic process,9,0.0,1.0,1.0,2
2268,GO:0046107,uracil biosynthetic process,9,0.0,1.0,1.0,1
2269,GO:0046108,uridine metabolic process,9,0.0,1.0,1.0,2
2270,GO:0046123,purine deoxyribonucleoside biosynthetic process,9,0.0,1.0,1.0,4
2271,GO:0046124,purine deoxyribonucleoside catabolic process,9,0.0,1.0,1.0,3
2272,GO:0046126,pyrimidine deoxyribonucleoside biosynthetic process,9,0.0,1.0,1.0,4
2273,GO:0046127,pyrimidine deoxyribonucleoside catabolic process,9,0.0,1.0,1.0,3
2274,GO:0046129,purine ribonucleoside biosynthetic process,9,0.0,1.0,1.0,6
2275,GO:0046130,purine ribonucleoside catabolic process,9,0.0,1.0,1.0,5
2276,GO:0046132,pyrimidine ribonucleoside biosynthetic process,9,0.0,1.0,1.0,2
2277,GO:0046133,pyrimidine ribonucleoside catabolic process,9,0.0,1.0,1.0,2
2278,GO:0046175,aldonic acid biosynthetic process,9,0.0,1.0,1.0,3
2279,GO:0046176,aldonic acid catabolic process,9,0.0,1.0,1.0,4
2280,GO:0046295,glycolate biosynthetic process,9,0.0,1.0,1.0,1
2281,GO:0046321,positive regulation of fatty acid oxidation,9,0.0,1.0,1.0,1
2282,GO:0046322,negative regulation of fatty acid oxidation,9,0.0,1.0,1.0,1
2283,GO:0046323,D-glucose import,9,0.0,1.0,1.0,1
2284,GO:0046329,negative regulation of JNK cascade,9,0.0,1.0,1.0,1
2285,GO:0046356,acetyl-CoA catabolic process,9,0.0,1.0,1.0,1
2286,GO:0046363,ribitol catabolic process,9,0.0,1.0,1.0,1
2287,GO:0046436,D-alanine metabolic process,9,0.0,1.0,1.0,2
2288,GO:0046437,D-amino acid biosynthetic process,9,0.0,1.0,1.0,3
2289,GO:0046438,D-cysteine metabolic process,9,0.0,1.0,1.0,1
2290,GO:0046441,D-lysine metabolic process,9,0.0,1.0,1.0,1
2291,GO:0046443,FAD metabolic process,9,0.0,1.0,1.0,1
2292,GO:0046444,FMN metabolic process,9,0.0,1.0,1.0,2
2293,GO:0046459,short-chain fatty acid metabolic process,9,0.0,1.0,1.0,7
2294,GO:0046476,glycosylceramide biosynthetic process,9,0.0,1.0,1.0,2
2295,GO:0046477,glycosylceramide catabolic process,9,0.0,1.0,1.0,2
2296,GO:0046496,nicotinamide nucleotide metabolic process,9,0.0,1.0,1.0,4
2297,GO:0046497,nicotinate nucleotide metabolic process,9,0.0,1.0,1.0,1
2298,GO:0046498,S-adenosylhomocysteine metabolic process,9,0.0,1.0,1.0,1
2299,GO:0046601,positive regulation of centriole replication,9,0.0,1.0,1.0,1
2300,GO:0046635,positive regulation of alpha-beta T cell activation,9,0.0,1.0,1.0,5
2301,GO:0046636,negative regulation of alpha-beta T cell activation,9,0.0,1.0,1.0,5
2302,GO:0046640,regulation of alpha-beta T cell proliferation,9,0.0,1.0,1.0,5
2303,GO:0046644,negative regulation of gamma-delta T cell activation,9,0.0,1.0,1.0,3
2304,GO:0046645,positive regulation of gamma-delta T cell activation,9,0.0,1.0,1.0,3
2305,GO:0046646,regulation of gamma-delta T cell proliferation,9,0.0,1.0,1.0,2
2306,GO:0046825,regulation of protein export from nucleus,9,0.0,1.0,1.0,2
2307,GO:0046854,phosphatidylinositol phosphate biosynthetic process,9,0.0,1.0,1.0,4
2308,GO:0046880,regulation of follicle-stimulating hormone secretion,9,0.0,1.0,1.0,2
2309,GO:0046940,nucleoside monophosphate phosphorylation,9,0.0,1.0,1.0,4
2310,GO:0046949,fatty-acyl-CoA biosynthetic process,9,0.0,1.0,1.0,7
2311,GO:0046963,3'-phosphoadenosine 5'-phosphosulfate transport,9,0.0,1.0,1.0,1
2312,GO:0048169,regulation of long-term neuronal synaptic plasticity,9,0.0,1.0,1.0,2
2313,GO:0048172,regulation of short-term neuronal synaptic plasticity,9,0.0,1.0,1.0,2
2314,GO:0048670,regulation of collateral sprouting,9,0.0,1.0,1.0,5
2315,GO:0048679,regulation of axon regeneration,9,0.0,1.0,1.0,4
2316,GO:0048791,calcium ion-regulated exocytosis of neurotransmitter,9,0.0,1.0,1.0,3
2317,GO:0048814,regulation of dendrite morphogenesis,9,0.0,1.0,1.0,2
2318,GO:0050543,icosatetraenoic acid binding,9,0.0,1.0,1.0,1
2319,GO:0050684,regulation of mRNA processing,9,0.0,1.0,1.0,4
2320,GO:0050709,negative regulation of protein secretion,9,0.0,1.0,1.0,10
2321,GO:0050714,positive regulation of protein secretion,9,0.0,1.0,1.0,10
2322,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,9,0.0,1.0,1.0,5
2323,GO:0050771,negative regulation of axonogenesis,9,0.0,1.0,1.0,2
2324,GO:0050772,positive regulation of axonogenesis,9,0.0,1.0,1.0,2
2325,GO:0050796,regulation of insulin secretion,9,0.0,1.0,1.0,3
2326,GO:0050851,antigen receptor-mediated signaling pathway,9,0.0,1.0,1.0,2
2327,GO:0051106,positive regulation of DNA ligation,9,0.0,1.0,1.0,1
2328,GO:0051125,regulation of actin nucleation,9,0.0,1.0,1.0,3
2329,GO:0051133,regulation of NK T cell activation,9,0.0,1.0,1.0,3
2330,GO:0051157,arabitol catabolic process,9,0.0,1.0,1.0,2
2331,GO:0051160,xylitol catabolic process,9,0.0,1.0,1.0,1
2332,GO:0051162,L-arabitol metabolic process,9,0.0,1.0,1.0,1
2333,GO:0051163,D-arabitol metabolic process,9,0.0,1.0,1.0,1
2334,GO:0051204,protein insertion into mitochondrial membrane,9,0.0,1.0,1.0,1
2335,GO:0051279,regulation of release of sequestered calcium ion into cytosol,9,0.0,1.0,1.0,6
2336,GO:0051459,regulation of corticotropin secretion,9,0.0,1.0,1.0,2
2337,GO:0051514,negative regulation of monopolar cell growth,9,0.0,1.0,1.0,1
2338,GO:0051515,positive regulation of monopolar cell growth,9,0.0,1.0,1.0,1
2339,GO:0051517,negative regulation of bipolar cell growth,9,0.0,1.0,1.0,1
2340,GO:0051518,positive regulation of bipolar cell growth,9,0.0,1.0,1.0,1
2341,GO:0051543,regulation of elastin biosynthetic process,9,0.0,1.0,1.0,2
2342,GO:0051585,negative regulation of dopamine uptake involved in synaptic transmission,9,0.0,1.0,1.0,1
2343,GO:0051791,medium-chain fatty acid metabolic process,9,0.0,1.0,1.0,3
2344,GO:0051914,positive regulation of synaptic plasticity by chemical substance,9,0.0,1.0,1.0,1
2345,GO:0052003,symbiont-mediated suppression of defense-related host salicylic acid-mediated signal transduction pathway,9,0.0,1.0,1.0,1
2346,GO:0052165,symbiont defense to host-produced phytoalexin,9,0.0,1.0,1.0,1
2347,GO:0052170,symbiont-mediated suppression of host innate immune response,9,0.0,1.0,1.0,10
2348,GO:0052325,cell wall pectin biosynthetic process,9,0.0,1.0,1.0,2
2349,GO:0052541,plant-type cell wall cellulose metabolic process,9,0.0,1.0,1.0,2
2350,GO:0052548,regulation of endopeptidase activity,9,0.0,1.0,1.0,6
2351,GO:0052652,cyclic purine nucleotide metabolic process,9,0.0,1.0,1.0,3
2352,GO:0052699,ergothioneine biosynthetic process,9,0.0,1.0,1.0,2
2353,GO:0052708,"N-alpha,N-alpha,N-alpha-trimethyl-L-histidine metabolic process",9,0.0,1.0,1.0,2
2354,GO:0055003,cardiac myofibril assembly,9,0.0,1.0,1.0,2
2355,GO:0055048,anastral spindle assembly,9,0.0,1.0,1.0,1
2356,GO:0055118,negative regulation of cardiac muscle contraction,9,0.0,1.0,1.0,1
2357,GO:0060049,regulation of protein glycosylation,9,0.0,1.0,1.0,3
2358,GO:0060100,"positive regulation of phagocytosis, engulfment",9,0.0,1.0,1.0,1
2359,GO:0060101,"negative regulation of phagocytosis, engulfment",9,0.0,1.0,1.0,1
2360,GO:0060123,regulation of growth hormone secretion,9,0.0,1.0,1.0,2
2361,GO:0060148,positive regulation of post-transcriptional gene silencing,9,0.0,1.0,1.0,1
2362,GO:0060149,negative regulation of post-transcriptional gene silencing,9,0.0,1.0,1.0,1
2363,GO:0060198,clathrin-sculpted vesicle,9,0.0,1.0,1.0,4
2364,GO:0060236,regulation of mitotic spindle organization,9,0.0,1.0,1.0,4
2365,GO:0060252,positive regulation of glial cell proliferation,9,0.0,1.0,1.0,1
2366,GO:0060253,negative regulation of glial cell proliferation,9,0.0,1.0,1.0,1
2367,GO:0060254,regulation of N-terminal protein palmitoylation,9,0.0,1.0,1.0,1
2368,GO:0060297,regulation of sarcomere organization,9,0.0,1.0,1.0,2
2369,GO:0060375,regulation of mast cell differentiation,9,0.0,1.0,1.0,2
2370,GO:0060556,regulation of vitamin D biosynthetic process,9,0.0,1.0,1.0,2
2371,GO:0060587,regulation of lipoprotein lipid oxidation,9,0.0,1.0,1.0,1
2372,GO:0060697,positive regulation of phospholipid catabolic process,9,0.0,1.0,1.0,2
2373,GO:0060699,regulation of endoribonuclease activity,9,0.0,1.0,1.0,2
2374,GO:0060701,negative regulation of ribonuclease activity,9,0.0,1.0,1.0,2
2375,GO:0060732,positive regulation of inositol phosphate biosynthetic process,9,0.0,1.0,1.0,1
2376,GO:0060825,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,9,0.0,1.0,1.0,1
2377,GO:0060967,negative regulation of gene silencing by regulatory ncRNA,9,0.0,1.0,1.0,2
2378,GO:0061013,regulation of mRNA catabolic process,9,0.0,1.0,1.0,8
2379,GO:0061120,regulation of positive chemotaxis to cAMP by DIF-1,9,0.0,1.0,1.0,2
2380,GO:0061121,regulation of positive chemotaxis to cAMP by DIF-2,9,0.0,1.0,1.0,2
2381,GO:0061124,positive regulation of positive chemotaxis to cAMP by chlorinated alkylphenone,9,0.0,1.0,1.0,2
2382,GO:0061125,negative regulation of positive chemotaxis to cAMP by chlorinated alkylphenone,9,0.0,1.0,1.0,2
2383,GO:0061136,regulation of proteasomal protein catabolic process,9,0.0,1.0,1.0,4
2384,GO:0061160,regulation of establishment of bipolar cell polarity regulating cell shape,9,0.0,1.0,1.0,1
2385,GO:0061187,regulation of rDNA heterochromatin formation,9,0.0,1.0,1.0,2
2386,GO:0061240,mesonephric nephron tubule morphogenesis,9,0.0,1.0,1.0,2
2387,GO:0061295,regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,9,0.0,1.0,1.0,2
2388,GO:0061356,regulation of Wnt protein secretion,9,0.0,1.0,1.0,2
2389,GO:0061532,"primary amine secretion, neurotransmission",9,0.0,1.0,1.0,1
2390,GO:0061544,"peptide secretion, neurotransmission",9,0.0,1.0,1.0,1
2391,GO:0061588,calcium activated phospholipid scrambling,9,0.0,1.0,1.0,3
2392,GO:0061678,Entner-Doudoroff pathway,9,0.0,1.0,1.0,2
2393,GO:0061718,glucose catabolic process to pyruvate,9,0.0,1.0,1.0,4
2394,GO:0061727,methylglyoxal catabolic process to lactate,9,0.0,1.0,1.0,2
2395,GO:0061806,regulation of DNA recombination at centromere,9,0.0,1.0,1.0,2
2396,GO:0061856,Golgi calcium ion transmembrane transport,9,0.0,1.0,1.0,1
2397,GO:0062033,positive regulation of mitotic sister chromatid segregation,9,0.0,1.0,1.0,2
2398,GO:0062084,regulation of capsule polysaccharide biosynthetic process,9,0.0,1.0,1.0,1
2399,GO:0062086,regulation of vein smooth muscle contraction,9,0.0,1.0,1.0,2
2400,GO:0070092,regulation of glucagon secretion,9,0.0,1.0,1.0,2
2401,GO:0070163,regulation of adiponectin secretion,9,0.0,1.0,1.0,2
2402,GO:0070178,D-serine metabolic process,9,0.0,1.0,1.0,2
2403,GO:0070233,negative regulation of T cell apoptotic process,9,0.0,1.0,1.0,5
2404,GO:0070234,positive regulation of T cell apoptotic process,9,0.0,1.0,1.0,5
2405,GO:0070235,regulation of activation-induced cell death of T cells,9,0.0,1.0,1.0,2
2406,GO:0070239,regulation of activated T cell autonomous cell death,9,0.0,1.0,1.0,2
2407,GO:0070243,regulation of thymocyte apoptotic process,9,0.0,1.0,1.0,2
2408,GO:0070294,renal sodium ion absorption,9,0.0,1.0,1.0,1
2409,GO:0070414,trehalose metabolism in response to heat stress,9,0.0,1.0,1.0,2
2410,GO:0070424,"regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",9,0.0,1.0,1.0,4
2411,GO:0070571,negative regulation of neuron projection regeneration,9,0.0,1.0,1.0,1
2412,GO:0070572,positive regulation of neuron projection regeneration,9,0.0,1.0,1.0,1
2413,GO:0070574,cadmium ion transmembrane transport,9,0.0,1.0,1.0,1
2414,GO:0070596,(1->3)-alpha-glucan biosynthetic process,9,0.0,1.0,1.0,1
2415,GO:0070597,cell wall (1->3)-alpha-glucan metabolic process,9,0.0,1.0,1.0,2
2416,GO:0070605,regulation of (1->3)-alpha-glucan metabolic process,9,0.0,1.0,1.0,2
2417,GO:0070613,regulation of protein processing,9,0.0,1.0,1.0,6
2418,GO:0070707,RNA dinucleotide insertion,9,0.0,1.0,1.0,4
2419,GO:0070716,mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication,9,0.0,1.0,1.0,1
2420,GO:0070754,regulation of interleukin-35 production,9,0.0,1.0,1.0,2
2421,GO:0070777,D-aspartate transmembrane transport,9,0.0,1.0,1.0,1
2422,GO:0070778,L-aspartate transmembrane transport,9,0.0,1.0,1.0,2
2423,GO:0070857,regulation of bile acid biosynthetic process,9,0.0,1.0,1.0,2
2424,GO:0070861,regulation of protein exit from endoplasmic reticulum,9,0.0,1.0,1.0,3
2425,GO:0070874,negative regulation of glycogen metabolic process,9,0.0,1.0,1.0,2
2426,GO:0070875,positive regulation of glycogen metabolic process,9,0.0,1.0,1.0,2
2427,GO:0070879,fungal-type cell wall beta-glucan metabolic process,9,0.0,1.0,1.0,3
2428,GO:0070884,regulation of calcineurin-NFAT signaling cascade,9,0.0,1.0,1.0,2
2429,GO:0070920,regulation of regulatory ncRNA processing,9,0.0,1.0,1.0,2
2430,GO:0070944,neutrophil-mediated killing of bacterium,9,0.0,1.0,1.0,2
2431,GO:0070950,regulation of neutrophil mediated killing of bacterium,9,0.0,1.0,1.0,4
2432,GO:0070953,regulation of neutrophil mediated killing of fungus,9,0.0,1.0,1.0,2
2433,GO:0070955,negative regulation of neutrophil mediated killing of symbiont cell,9,0.0,1.0,1.0,2
2434,GO:0070961,positive regulation of neutrophil mediated killing of symbiont cell,9,0.0,1.0,1.0,2
2435,GO:0071026,cytoplasmic RNA surveillance,9,0.0,1.0,1.0,1
2436,GO:0071027,nuclear RNA surveillance,9,0.0,1.0,1.0,9
2437,GO:0071072,negative regulation of phospholipid biosynthetic process,9,0.0,1.0,1.0,7
2438,GO:0071073,positive regulation of phospholipid biosynthetic process,9,0.0,1.0,1.0,6
2439,GO:0071211,protein targeting to vacuole involved in autophagy,9,0.0,1.0,1.0,1
2440,GO:0071268,homocysteine biosynthetic process,9,0.0,1.0,1.0,1
2441,GO:0071421,manganese ion transmembrane transport,9,0.0,1.0,1.0,3
2442,GO:0071422,succinate transmembrane transport,9,0.0,1.0,1.0,1
2443,GO:0071423,malate transmembrane transport,9,0.0,1.0,1.0,1
2444,GO:0071539,protein localization to centrosome,9,0.0,1.0,1.0,2
2445,GO:0071569,protein ufmylation,9,0.0,1.0,1.0,1
2446,GO:0071577,zinc ion transmembrane transport,9,0.0,1.0,1.0,4
2447,GO:0071581,regulation of zinc ion transmembrane import,9,0.0,1.0,1.0,1
2448,GO:0071583,negative regulation of zinc ion transmembrane transport,9,0.0,1.0,1.0,1
2449,GO:0071623,negative regulation of granulocyte chemotaxis,9,0.0,1.0,1.0,2
2450,GO:0071624,positive regulation of granulocyte chemotaxis,9,0.0,1.0,1.0,2
2451,GO:0071634,regulation of transforming growth factor beta production,9,0.0,1.0,1.0,5
2452,GO:0071661,regulation of granzyme B production,9,0.0,1.0,1.0,2
2453,GO:0071688,striated muscle myosin thick filament assembly,9,0.0,1.0,1.0,2
2454,GO:0071767,mycolic acid metabolic process,9,0.0,1.0,1.0,1
2455,GO:0071834,mating pheromone secretion,9,0.0,1.0,1.0,2
2456,GO:0071878,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,9,0.0,1.0,1.0,1
2457,GO:0071988,protein localization to spindle pole body,9,0.0,1.0,1.0,4
2458,GO:0072040,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,9,0.0,1.0,1.0,2
2459,GO:0072041,positive regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,9,0.0,1.0,1.0,2
2460,GO:0072180,mesonephric duct morphogenesis,9,0.0,1.0,1.0,1
2461,GO:0072304,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,9,0.0,1.0,1.0,2
2462,GO:0072383,plus-end-directed vesicle transport along microtubule,9,0.0,1.0,1.0,1
2463,GO:0072388,flavin adenine dinucleotide biosynthetic process,9,0.0,1.0,1.0,1
2464,GO:0072680,extracellular matrix-dependent thymocyte migration,9,0.0,1.0,1.0,1
2465,GO:0072695,regulation of DNA recombination at telomere,9,0.0,1.0,1.0,3
2466,GO:0075120,symbiont-mediated suppression of host G protein-coupled receptor signal transduction,9,0.0,1.0,1.0,1
2467,GO:0075296,positive regulation of ascospore formation,9,0.0,1.0,1.0,1
2468,GO:0080152,regulation of reductive pentose-phosphate cycle,9,0.0,1.0,1.0,1
2469,GO:0086004,regulation of cardiac muscle cell contraction,9,0.0,1.0,1.0,4
2470,GO:0086006,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,9,0.0,1.0,1.0,4
2471,GO:0086023,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,9,0.0,1.0,1.0,1
2472,GO:0089707,L-lysine transmembrane export from vacuole,9,0.0,1.0,1.0,1
2473,GO:0090022,regulation of neutrophil chemotaxis,9,0.0,1.0,1.0,2
2474,GO:0090030,regulation of steroid hormone biosynthetic process,9,0.0,1.0,1.0,6
2475,GO:0090043,regulation of tubulin deacetylation,9,0.0,1.0,1.0,3
2476,GO:0090052,regulation of pericentric heterochromatin formation,9,0.0,1.0,1.0,1
2477,GO:0090054,regulation of silent mating-type cassette heterochromatin formation,9,0.0,1.0,1.0,2
2478,GO:0090154,positive regulation of sphingolipid biosynthetic process,9,0.0,1.0,1.0,1
2479,GO:0090155,negative regulation of sphingolipid biosynthetic process,9,0.0,1.0,1.0,1
2480,GO:0090169,regulation of spindle assembly,9,0.0,1.0,1.0,3
2481,GO:0090182,regulation of secretion of lysosomal enzymes,9,0.0,1.0,1.0,2
2482,GO:0090205,positive regulation of cholesterol metabolic process,9,0.0,1.0,1.0,1
2483,GO:0090206,negative regulation of cholesterol metabolic process,9,0.0,1.0,1.0,1
2484,GO:0090232,positive regulation of spindle checkpoint,9,0.0,1.0,1.0,2
2485,GO:0090233,negative regulation of spindle checkpoint,9,0.0,1.0,1.0,1
2486,GO:0090259,regulation of retinal ganglion cell axon guidance,9,0.0,1.0,1.0,2
2487,GO:0090270,regulation of fibroblast growth factor production,9,0.0,1.0,1.0,2
2488,GO:0090273,regulation of somatostatin secretion,9,0.0,1.0,1.0,2
2489,GO:0090277,positive regulation of peptide hormone secretion,9,0.0,1.0,1.0,10
2490,GO:0090278,negative regulation of peptide hormone secretion,9,0.0,1.0,1.0,10
2491,GO:0090280,positive regulation of calcium ion import,9,0.0,1.0,1.0,1
2492,GO:0090281,negative regulation of calcium ion import,9,0.0,1.0,1.0,1
2493,GO:0090306,meiotic spindle assembly,9,0.0,1.0,1.0,3
2494,GO:0090307,mitotic spindle assembly,9,0.0,1.0,1.0,1
2495,GO:0090312,positive regulation of protein deacetylation,9,0.0,1.0,1.0,1
2496,GO:0090314,positive regulation of protein targeting to membrane,9,0.0,1.0,1.0,1
2497,GO:0090315,negative regulation of protein targeting to membrane,9,0.0,1.0,1.0,1
2498,GO:0090316,positive regulation of intracellular protein transport,9,0.0,1.0,1.0,8
2499,GO:0090317,negative regulation of intracellular protein transport,9,0.0,1.0,1.0,9
2500,GO:0090324,negative regulation of oxidative phosphorylation,9,0.0,1.0,1.0,1
2501,GO:0090329,regulation of DNA-templated DNA replication,9,0.0,1.0,1.0,9
2502,GO:0090361,regulation of platelet-derived growth factor production,9,0.0,1.0,1.0,1
2503,GO:0090365,regulation of mRNA modification,9,0.0,1.0,1.0,2
2504,GO:0090383,phagosome acidification,9,0.0,1.0,1.0,1
2505,GO:0090427,activation of meiosis,9,0.0,1.0,1.0,1
2506,GO:0090517,L-lysine transmembrane import into vacuole,9,0.0,1.0,1.0,1
2507,GO:0090615,mitochondrial mRNA processing,9,0.0,1.0,1.0,3
2508,GO:0090646,mitochondrial tRNA processing,9,0.0,1.0,1.0,3
2509,GO:0097052,L-kynurenine metabolic process,9,0.0,1.0,1.0,1
2510,GO:0097089,methyl-branched fatty acid metabolic process,9,0.0,1.0,1.0,2
2511,GO:0097280,histamine secretion mediated by immunoglobulin,9,0.0,1.0,1.0,1
2512,GO:0097364,"stretch-activated, monoatomic cation-selective, calcium channel activity involved in regulation of action potential",9,0.0,1.0,1.0,1
2513,GO:0097374,sensory neuron axon guidance,9,0.0,1.0,1.0,1
2514,GO:0097376,interneuron axon guidance,9,0.0,1.0,1.0,1
2515,GO:0097551,mitochondrial double-strand break repair,9,0.0,1.0,1.0,1
2516,GO:0097553,calcium ion transmembrane import into cytosol,9,0.0,1.0,1.0,3
2517,GO:0098712,L-glutamate import across plasma membrane,9,0.0,1.0,1.0,1
2518,GO:0098777,protein secretion by the type VIII secretion system,9,0.0,1.0,1.0,1
2519,GO:0098924,retrograde trans-synaptic signaling by nitric oxide,9,0.0,1.0,1.0,1
2520,GO:0098937,anterograde dendritic transport,9,0.0,1.0,1.0,3
2521,GO:0098939,dendritic transport of mitochondrion,9,0.0,1.0,1.0,2
2522,GO:0099116,tRNA 5'-end processing,9,0.0,1.0,1.0,2
2523,GO:0099124,axonal dopamine secretion,9,0.0,1.0,1.0,1
2524,GO:0099142,intracellularly ATP-gated ion channel activity,9,0.0,1.0,1.0,1
2525,GO:0099517,synaptic vesicle transport along microtubule,9,0.0,1.0,1.0,2
2526,GO:0099555,"trans-synaptic signaling by nitric oxide, modulating synaptic transmission",9,0.0,1.0,1.0,1
2527,GO:0099604,ligand-gated calcium channel activity,9,0.0,1.0,1.0,3
2528,GO:0099632,protein transport within plasma membrane,9,0.0,1.0,1.0,1
2529,GO:0099633,protein localization to postsynaptic specialization membrane,9,0.0,1.0,1.0,1
2530,GO:0099639,"neurotransmitter receptor transport, endosome to plasma membrane",9,0.0,1.0,1.0,1
2531,GO:0099640,axo-dendritic protein transport,9,0.0,1.0,1.0,2
2532,GO:0106012,positive regulation of protein localization to medial cortex,9,0.0,1.0,1.0,1
2533,GO:0106057,negative regulation of calcineurin-mediated signaling,9,0.0,1.0,1.0,1
2534,GO:0106058,positive regulation of calcineurin-mediated signaling,9,0.0,1.0,1.0,1
2535,GO:0106118,regulation of sterol biosynthetic process,9,0.0,1.0,1.0,4
2536,GO:0106354,tRNA surveillance,9,0.0,1.0,1.0,2
2537,GO:0110029,negative regulation of meiosis I,9,0.0,1.0,1.0,1
2538,GO:0110031,negative regulation of G2/MI transition of meiotic cell cycle,9,0.0,1.0,1.0,1
2539,GO:0110054,regulation of actin filament annealing,9,0.0,1.0,1.0,2
2540,GO:0110097,regulation of calcium import into the mitochondrion,9,0.0,1.0,1.0,2
2541,GO:0120046,regulation of protein localization to medial cortical node,9,0.0,1.0,1.0,1
2542,GO:0120064,stomach pylorus smooth muscle contraction,9,0.0,1.0,1.0,3
2543,GO:0120068,regulation of stomach fundus smooth muscle contraction,9,0.0,1.0,1.0,2
2544,GO:0120071,regulation of pyloric antrum smooth muscle contraction,9,0.0,1.0,1.0,2
2545,GO:0120235,"regulation of post-translational protein targeting to membrane, translocation",9,0.0,1.0,1.0,1
2546,GO:0140059,dendrite arborization,9,0.0,1.0,1.0,2
2547,GO:0140161,monocarboxylate:sodium symporter activity,9,0.0,1.0,1.0,2
2548,GO:0140205,oligopeptide import across plasma membrane,9,0.0,1.0,1.0,3
2549,GO:0140215,regulation of D-aspartate import across plasma membrane,9,0.0,1.0,1.0,2
2550,GO:0140279,regulation of mitotic division septum assembly,9,0.0,1.0,1.0,3
2551,GO:0140527,reciprocal homologous recombination,9,0.0,1.0,1.0,1
2552,GO:0140590,effector-mediated suppression of host defense response,9,0.0,1.0,1.0,1
2553,GO:0140731,regulation of amphiregulin production,9,0.0,1.0,1.0,1
2554,GO:0140845,regulation of promoter clearance from RNA polymerase II promoter,9,0.0,1.0,1.0,2
2555,GO:0141043,symbiont-mediated evasion of host innate immune response,9,0.0,1.0,1.0,2
2556,GO:0141053,histone H2A ubiquitin ligase activity,9,0.0,1.0,1.0,5
2557,GO:0141054,histone H2B ubiquitin ligase activity,9,0.0,1.0,1.0,1
2558,GO:0141055,histone H3 ubiquitin ligase activity,9,0.0,1.0,1.0,1
2559,GO:0141056,histone H4 ubiquitin ligase activity,9,0.0,1.0,1.0,1
2560,GO:0141085,regulation of inflammasome-mediated signaling pathway,9,0.0,1.0,1.0,2
2561,GO:0141137,"positive regulation of gene expression, epigenetic",9,0.0,1.0,1.0,2
2562,GO:0150019,basal dendrite morphogenesis,9,0.0,1.0,1.0,1
2563,GO:0150021,apical dendrite morphogenesis,9,0.0,1.0,1.0,1
2564,GO:0150127,regulation of interleukin-33 production,9,0.0,1.0,1.0,2
2565,GO:0150136,regulation of interleukin-37 production,9,0.0,1.0,1.0,2
2566,GO:0150140,regulation of CD86 production,9,0.0,1.0,1.0,2
2567,GO:0150143,regulation of CD80 production,9,0.0,1.0,1.0,2
2568,GO:0150157,regulation of interleukin-34 production,9,0.0,1.0,1.0,2
2569,GO:0150173,positive regulation of phosphatidylcholine metabolic process,9,0.0,1.0,1.0,1
2570,GO:0150174,negative regulation of phosphatidylcholine metabolic process,9,0.0,1.0,1.0,2
2571,GO:0150179,positive regulation of phosphatidylserine metabolic process,9,0.0,1.0,1.0,1
2572,GO:0150180,negative regulation of phosphatidylserine metabolic process,9,0.0,1.0,1.0,1
2573,GO:0150189,regulation of interleukin-32 production,9,0.0,1.0,1.0,2
2574,GO:0160043,"catecholamine secretion, neurotransmission",9,0.0,1.0,1.0,3
2575,GO:0170034,L-amino acid biosynthetic process,9,0.0,1.0,1.0,14
2576,GO:0170035,L-amino acid catabolic process,9,0.0,1.0,1.0,15
2577,GO:0180018,cytoplasmic polyadenylation-dependent RNA catabolic process,9,0.0,1.0,1.0,1
2578,GO:0180031,"snoRNA 2,2,7-trimethylguanosine (TMG) capping",9,0.0,1.0,1.0,1
2579,GO:1900015,regulation of cytokine production involved in inflammatory response,9,0.0,1.0,1.0,2
2580,GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,9,0.0,1.0,1.0,1
2581,GO:1900125,regulation of hyaluronan biosynthetic process,9,0.0,1.0,1.0,2
2582,GO:1900133,regulation of renin secretion into blood stream,9,0.0,1.0,1.0,2
2583,GO:1900166,regulation of glial cell-derived neurotrophic factor production,9,0.0,1.0,1.0,2
2584,GO:1900268,regulation of reverse transcription,9,0.0,1.0,1.0,2
2585,GO:1900368,regulation of post-transcriptional gene silencing by regulatory ncRNA,9,0.0,1.0,1.0,3
2586,GO:1900371,regulation of purine nucleotide biosynthetic process,9,0.0,1.0,1.0,5
2587,GO:1900397,regulation of pyrimidine nucleotide biosynthetic process,9,0.0,1.0,1.0,3
2588,GO:1900468,regulation of phosphatidylserine biosynthetic process,9,0.0,1.0,1.0,2
2589,GO:1900483,regulation of protein targeting to vacuolar membrane,9,0.0,1.0,1.0,2
2590,GO:1900494,regulation of butyryl-CoA biosynthetic process from acetyl-CoA,9,0.0,1.0,1.0,2
2591,GO:1900500,regulation of butyryl-CoA catabolic process to butyrate,9,0.0,1.0,1.0,2
2592,GO:1900515,regulation of xylose catabolic process to ethanol,9,0.0,1.0,1.0,2
2593,GO:1900543,negative regulation of purine nucleotide metabolic process,9,0.0,1.0,1.0,5
2594,GO:1900544,positive regulation of purine nucleotide metabolic process,9,0.0,1.0,1.0,5
2595,GO:1900579,"(17Z)-protosta-17(20),24-dien-3beta-ol metabolic process",9,0.0,1.0,1.0,2
2596,GO:1900659,negative regulation of emericellamide biosynthetic process,9,0.0,1.0,1.0,1
2597,GO:1900660,positive regulation of emericellamide biosynthetic process,9,0.0,1.0,1.0,1
2598,GO:1900661,regulation of emericellamide A biosynthetic process,9,0.0,1.0,1.0,2
2599,GO:1900678,regulation of ferricrocin biosynthetic process,9,0.0,1.0,1.0,2
2600,GO:1900721,positive regulation of uterine smooth muscle relaxation,9,0.0,1.0,1.0,1
2601,GO:1900828,D-tyrosine metabolic process,9,0.0,1.0,1.0,1
2602,GO:1900831,D-leucine metabolic process,9,0.0,1.0,1.0,2
2603,GO:1900840,regulation of helvolic acid biosynthetic process,9,0.0,1.0,1.0,2
2604,GO:1900923,regulation of glycine import across plasma membrane,9,0.0,1.0,1.0,2
2605,GO:1900926,regulation of L-threonine import across plasma membrane,9,0.0,1.0,1.0,2
2606,GO:1900929,regulation of L-tyrosine import across plasma membrane,9,0.0,1.0,1.0,2
2607,GO:1900945,negative regulation of isoprene metabolic process,9,0.0,1.0,1.0,1
2608,GO:1900946,positive regulation of isoprene metabolic process,9,0.0,1.0,1.0,1
2609,GO:1900947,regulation of isoprene biosynthetic process,9,0.0,1.0,1.0,2
2610,GO:1901016,regulation of potassium ion transmembrane transporter activity,9,0.0,1.0,1.0,10
2611,GO:1901019,regulation of calcium ion transmembrane transporter activity,9,0.0,1.0,1.0,8
2612,GO:1901034,regulation of L-glutamine import across plasma membrane,9,0.0,1.0,1.0,2
2613,GO:1901068,guanosine-containing compound metabolic process,9,0.0,1.0,1.0,6
2614,GO:1901074,regulation of engulfment of apoptotic cell,9,0.0,1.0,1.0,2
2615,GO:1901086,benzylpenicillin metabolic process,9,0.0,1.0,1.0,2
2616,GO:1901212,positive regulation of cardiac chamber formation,9,0.0,1.0,1.0,1
2617,GO:1901256,regulation of macrophage colony-stimulating factor production,9,0.0,1.0,1.0,3
2618,GO:1901351,regulation of phosphatidylglycerol biosynthetic process,9,0.0,1.0,1.0,2
2619,GO:1901380,negative regulation of potassium ion transmembrane transport,9,0.0,1.0,1.0,3
2620,GO:1901381,positive regulation of potassium ion transmembrane transport,9,0.0,1.0,1.0,3
2621,GO:1901410,regulation of tetrapyrrole biosynthetic process from glutamate,9,0.0,1.0,1.0,2
2622,GO:1901525,negative regulation of mitophagy,9,0.0,1.0,1.0,1
2623,GO:1901526,positive regulation of mitophagy,9,0.0,1.0,1.0,1
2624,GO:1901529,positive regulation of anion channel activity,9,0.0,1.0,1.0,1
2625,GO:1901546,regulation of synaptic vesicle lumen acidification,9,0.0,1.0,1.0,2
2626,GO:1901623,regulation of lymphocyte chemotaxis,9,0.0,1.0,1.0,5
2627,GO:1901678,iron coordination entity transport,9,0.0,1.0,1.0,4
2628,GO:1901748,leukotriene D4 metabolic process,9,0.0,1.0,1.0,2
2629,GO:1901810,beta-carotene metabolic process,9,0.0,1.0,1.0,2
2630,GO:1901816,beta-zeacarotene metabolic process,9,0.0,1.0,1.0,2
2631,GO:1901819,alpha-zeacarotene metabolic process,9,0.0,1.0,1.0,2
2632,GO:1901822,delta-carotene metabolic process,9,0.0,1.0,1.0,2
2633,GO:1901828,zeaxanthin bis(beta-D-glucoside) metabolic process,9,0.0,1.0,1.0,2
2634,GO:1901834,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,9,0.0,1.0,1.0,1
2635,GO:1901859,negative regulation of mitochondrial DNA metabolic process,9,0.0,1.0,1.0,1
2636,GO:1901860,positive regulation of mitochondrial DNA metabolic process,9,0.0,1.0,1.0,1
2637,GO:1901874,negative regulation of post-translational protein modification,9,0.0,1.0,1.0,1
2638,GO:1901875,positive regulation of post-translational protein modification,9,0.0,1.0,1.0,1
2639,GO:1901906,diadenosine pentaphosphate metabolic process,9,0.0,1.0,1.0,1
2640,GO:1901908,diadenosine hexaphosphate metabolic process,9,0.0,1.0,1.0,1
2641,GO:1901917,regulation of exoribonuclease activity,9,0.0,1.0,1.0,3
2642,GO:1901970,positive regulation of mitotic sister chromatid separation,9,0.0,1.0,1.0,2
2643,GO:1901984,negative regulation of protein acetylation,9,0.0,1.0,1.0,2
2644,GO:1901985,positive regulation of protein acetylation,9,0.0,1.0,1.0,2
2645,GO:1902005,regulation of proline biosynthetic process,9,0.0,1.0,1.0,1
2646,GO:1902018,negative regulation of cilium assembly,9,0.0,1.0,1.0,2
2647,GO:1902031,regulation of NADP metabolic process,9,0.0,1.0,1.0,1
2648,GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,9,0.0,1.0,1.0,1
2649,GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,9,0.0,1.0,1.0,1
2650,GO:1902093,positive regulation of flagellated sperm motility,9,0.0,1.0,1.0,1
2651,GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,9,0.0,1.0,1.0,2
2652,GO:1902101,positive regulation of metaphase/anaphase transition of cell cycle,9,0.0,1.0,1.0,2
2653,GO:1902102,regulation of metaphase/anaphase transition of meiotic cell cycle,9,0.0,1.0,1.0,5
2654,GO:1902114,D-valine metabolic process,9,0.0,1.0,1.0,1
2655,GO:1902162,"regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",9,0.0,1.0,1.0,2
2656,GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,9,0.0,1.0,1.0,2
2657,GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,9,0.0,1.0,1.0,2
2658,GO:1902177,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,9,0.0,1.0,1.0,2
2659,GO:1902189,2-methylbutanoyl-CoA(4-) metabolic process,9,0.0,1.0,1.0,2
2660,GO:1902192,2-methylbut-2-enoyl-CoA(4-) metabolic process,9,0.0,1.0,1.0,2
2661,GO:1902195,isovaleryl-CoA(4-) metabolic process,9,0.0,1.0,1.0,2
2662,GO:1902198,3-methylbut-2-enoyl-CoA(4-) metabolic process,9,0.0,1.0,1.0,2
2663,GO:1902219,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,9,0.0,1.0,1.0,1
2664,GO:1902220,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,9,0.0,1.0,1.0,1
2665,GO:1902221,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,9,0.0,1.0,1.0,5
2666,GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,9,0.0,1.0,1.0,1
2667,GO:1902231,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,9,0.0,1.0,1.0,1
2668,GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,9,0.0,1.0,1.0,1
2669,GO:1902238,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,9,0.0,1.0,1.0,2
2670,GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,9,0.0,1.0,1.0,2
2671,GO:1902255,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,9,0.0,1.0,1.0,2
2672,GO:1902276,regulation of pancreatic amylase secretion,9,0.0,1.0,1.0,2
2673,GO:1902291,cell cycle DNA replication DNA ligation,9,0.0,1.0,1.0,2
2674,GO:1902296,DNA strand elongation involved in cell cycle DNA replication,9,0.0,1.0,1.0,1
2675,GO:1902306,negative regulation of sodium ion transmembrane transport,9,0.0,1.0,1.0,3
2676,GO:1902307,positive regulation of sodium ion transmembrane transport,9,0.0,1.0,1.0,3
2677,GO:1902315,nuclear cell cycle DNA replication initiation,9,0.0,1.0,1.0,2
2678,GO:1902317,nuclear DNA replication termination,9,0.0,1.0,1.0,2
2679,GO:1902322,regulation of methyl-branched fatty acid biosynthetic process,9,0.0,1.0,1.0,2
2680,GO:1902356,oxaloacetate(2-) transmembrane transport,9,0.0,1.0,1.0,1
2681,GO:1902369,negative regulation of RNA catabolic process,9,0.0,1.0,1.0,5
2682,GO:1902370,regulation of tRNA catabolic process,9,0.0,1.0,1.0,3
2683,GO:1902381,11-oxo-beta-amyrin metabolic process,9,0.0,1.0,1.0,2
2684,GO:1902384,glycyrrhetinate metabolic process,9,0.0,1.0,1.0,2
2685,GO:1902423,regulation of attachment of mitotic spindle microtubules to kinetochore,9,0.0,1.0,1.0,3
2686,GO:1902472,"regulation of mitotic cytokinesis, division site positioning",9,0.0,1.0,1.0,1
2687,GO:1902510,regulation of apoptotic DNA fragmentation,9,0.0,1.0,1.0,2
2688,GO:1902514,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,9,0.0,1.0,1.0,2
2689,GO:1902558,5'-adenylyl sulfate transmembrane transport,9,0.0,1.0,1.0,1
2690,GO:1902571,regulation of serine-type peptidase activity,9,0.0,1.0,1.0,3
2691,GO:1902641,"regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process",9,0.0,1.0,1.0,2
2692,GO:1902662,regulation of peptidyl-L-cysteine S-palmitoylation,9,0.0,1.0,1.0,2
2693,GO:1902668,negative regulation of axon guidance,9,0.0,1.0,1.0,5
2694,GO:1902669,positive regulation of axon guidance,9,0.0,1.0,1.0,5
2695,GO:1902679,negative regulation of RNA biosynthetic process,9,0.0,1.0,1.0,3
2696,GO:1902680,positive regulation of RNA biosynthetic process,9,0.0,1.0,1.0,4
2697,GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,9,0.0,1.0,1.0,1
2698,GO:1902688,regulation of NAD metabolic process,9,0.0,1.0,1.0,3
2699,GO:1902796,regulation of snoRNA processing,9,0.0,1.0,1.0,2
2700,GO:1902810,negative regulation of skeletal muscle fiber differentiation,9,0.0,1.0,1.0,1
2701,GO:1902811,positive regulation of skeletal muscle fiber differentiation,9,0.0,1.0,1.0,1
2702,GO:1902834,regulation of proline import across plasma membrane,9,0.0,1.0,1.0,3
2703,GO:1902855,regulation of non-motile cilium assembly,9,0.0,1.0,1.0,2
2704,GO:1902858,propionyl-CoA metabolic process,9,0.0,1.0,1.0,2
2705,GO:1902889,protein localization to spindle microtubule,9,0.0,1.0,1.0,2
2706,GO:1902941,regulation of voltage-gated chloride channel activity,9,0.0,1.0,1.0,1
2707,GO:1902987,negative regulation of lysine biosynthetic process via aminoadipic acid,9,0.0,1.0,1.0,1
2708,GO:1903051,negative regulation of proteolysis involved in protein catabolic process,9,0.0,1.0,1.0,3
2709,GO:1903052,positive regulation of proteolysis involved in protein catabolic process,9,0.0,1.0,1.0,3
2710,GO:1903060,negative regulation of protein lipidation,9,0.0,1.0,1.0,2
2711,GO:1903061,positive regulation of protein lipidation,9,0.0,1.0,1.0,1
2712,GO:1903121,regulation of TRAIL-activated apoptotic signaling pathway,9,0.0,1.0,1.0,2
2713,GO:1903137,regulation of cell integrity MAPK cascade,9,0.0,1.0,1.0,2
2714,GO:1903170,negative regulation of calcium ion transmembrane transport,9,0.0,1.0,1.0,7
2715,GO:1903184,L-dopa metabolic process,9,0.0,1.0,1.0,1
2716,GO:1903215,negative regulation of protein targeting to mitochondrion,9,0.0,1.0,1.0,1
2717,GO:1903227,xanthosine metabolic process,9,0.0,1.0,1.0,2
2718,GO:1903276,regulation of sodium ion export across plasma membrane,9,0.0,1.0,1.0,2
2719,GO:1903286,regulation of potassium ion import,9,0.0,1.0,1.0,2
2720,GO:1903296,"positive regulation of glutamate secretion, neurotransmission",9,0.0,1.0,1.0,1
2721,GO:1903299,regulation of hexokinase activity,9,0.0,1.0,1.0,3
2722,GO:1903306,negative regulation of regulated secretory pathway,9,0.0,1.0,1.0,3
2723,GO:1903307,positive regulation of regulated secretory pathway,9,0.0,1.0,1.0,3
2724,GO:1903312,negative regulation of mRNA metabolic process,9,0.0,1.0,1.0,3
2725,GO:1903313,positive regulation of mRNA metabolic process,9,0.0,1.0,1.0,3
2726,GO:1903318,negative regulation of protein maturation,9,0.0,1.0,1.0,4
2727,GO:1903319,positive regulation of protein maturation,9,0.0,1.0,1.0,4
2728,GO:1903320,regulation of protein modification by small protein conjugation or removal,9,0.0,1.0,1.0,8
2729,GO:1903324,negative regulation of snoRNA metabolic process,9,0.0,1.0,1.0,1
2730,GO:1903325,positive regulation of snoRNA metabolic process,9,0.0,1.0,1.0,1
2731,GO:1903327,negative regulation of tRNA metabolic process,9,0.0,1.0,1.0,2
2732,GO:1903328,positive regulation of tRNA metabolic process,9,0.0,1.0,1.0,2
2733,GO:1903342,negative regulation of meiotic DNA double-strand break formation,9,0.0,1.0,1.0,1
2734,GO:1903343,positive regulation of meiotic DNA double-strand break formation,9,0.0,1.0,1.0,1
2735,GO:1903376,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,9,0.0,1.0,1.0,3
2736,GO:1903381,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,9,0.0,1.0,1.0,1
2737,GO:1903395,regulation of secondary cell septum biogenesis,9,0.0,1.0,1.0,2
2738,GO:1903437,negative regulation of mitotic cytokinetic process,9,0.0,1.0,1.0,3
2739,GO:1903438,positive regulation of mitotic cytokinetic process,9,0.0,1.0,1.0,5
2740,GO:1903454,"regulation of androst-4-ene-3,17-dione biosynthetic process",9,0.0,1.0,1.0,2
2741,GO:1903457,lactate catabolic process,9,0.0,1.0,1.0,2
2742,GO:1903471,regulation of mitotic actomyosin contractile ring contraction,9,0.0,1.0,1.0,2
2743,GO:1903504,regulation of mitotic spindle checkpoint,9,0.0,1.0,1.0,1
2744,GO:1903516,regulation of single strand break repair,9,0.0,1.0,1.0,3
2745,GO:1903540,establishment of protein localization to postsynaptic membrane,9,0.0,1.0,1.0,1
2746,GO:1903558,3-cyano-L-alanine metabolic process,9,0.0,1.0,1.0,2
2747,GO:1903578,regulation of ATP metabolic process,9,0.0,1.0,1.0,4
2748,GO:1903625,negative regulation of DNA catabolic process,9,0.0,1.0,1.0,1
2749,GO:1903626,positive regulation of DNA catabolic process,9,0.0,1.0,1.0,1
2750,GO:1903636,regulation of protein insertion into mitochondrial outer membrane,9,0.0,1.0,1.0,2
2751,GO:1903662,L-altrarate metabolic process,9,0.0,1.0,1.0,1
2752,GO:1903671,negative regulation of sprouting angiogenesis,9,0.0,1.0,1.0,1
2753,GO:1903719,regulation of I-kappaB phosphorylation,9,0.0,1.0,1.0,2
2754,GO:1903750,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,9,0.0,1.0,1.0,3
2755,GO:1903764,regulation of potassium ion export across plasma membrane,9,0.0,1.0,1.0,2
2756,GO:1903782,regulation of sodium ion import across plasma membrane,9,0.0,1.0,1.0,2
2757,GO:1903790,guanine nucleotide transmembrane transport,9,0.0,1.0,1.0,1
2758,GO:1903955,positive regulation of protein targeting to mitochondrion,9,0.0,1.0,1.0,1
2759,GO:1903963,arachidonate transport,9,0.0,1.0,1.0,1
2760,GO:1903964,monounsaturated fatty acid metabolic process,9,0.0,1.0,1.0,2
2761,GO:1904020,regulation of G protein-coupled receptor internalization,9,0.0,1.0,1.0,2
2762,GO:1904038,regulation of iron export across plasma membrane,9,0.0,1.0,1.0,2
2763,GO:1904051,regulation of protein targeting to vacuole involved in autophagy,9,0.0,1.0,1.0,2
2764,GO:1904076,regulation of estrogen biosynthetic process,9,0.0,1.0,1.0,2
2765,GO:1904139,regulation of microglial cell migration,9,0.0,1.0,1.0,2
2766,GO:1904242,regulation of pancreatic trypsinogen secretion,9,0.0,1.0,1.0,2
2767,GO:1904252,negative regulation of bile acid metabolic process,9,0.0,1.0,1.0,1
2768,GO:1904253,positive regulation of bile acid metabolic process,9,0.0,1.0,1.0,1
2769,GO:1904289,regulation of mitotic DNA damage checkpoint,9,0.0,1.0,1.0,2
2770,GO:1904305,negative regulation of gastro-intestinal system smooth muscle contraction,9,0.0,1.0,1.0,4
2771,GO:1904306,positive regulation of gastro-intestinal system smooth muscle contraction,9,0.0,1.0,1.0,4
2772,GO:1904323,regulation of inhibitory G protein-coupled receptor phosphorylation,9,0.0,1.0,1.0,2
2773,GO:1904331,regulation of error-prone translesion synthesis,9,0.0,1.0,1.0,2
2774,GO:1904341,regulation of colon smooth muscle contraction,9,0.0,1.0,1.0,2
2775,GO:1904347,regulation of small intestine smooth muscle contraction,9,0.0,1.0,1.0,2
2776,GO:1904351,negative regulation of protein catabolic process in the vacuole,9,0.0,1.0,1.0,1
2777,GO:1904352,positive regulation of protein catabolic process in the vacuole,9,0.0,1.0,1.0,1
2778,GO:1904353,regulation of telomere capping,9,0.0,1.0,1.0,3
2779,GO:1904356,regulation of telomere maintenance via telomere lengthening,9,0.0,1.0,1.0,3
2780,GO:1904362,regulation of calcitonin secretion,9,0.0,1.0,1.0,2
2781,GO:1904380,endoplasmic reticulum mannose trimming,9,0.0,1.0,1.0,1
2782,GO:1904418,regulation of telomeric loop formation,9,0.0,1.0,1.0,2
2783,GO:1904427,positive regulation of calcium ion transmembrane transport,9,0.0,1.0,1.0,7
2784,GO:1904429,regulation of t-circle formation,9,0.0,1.0,1.0,2
2785,GO:1904438,regulation of iron ion import across plasma membrane,9,0.0,1.0,1.0,2
2786,GO:1904458,regulation of substance P secretion,9,0.0,1.0,1.0,3
2787,GO:1904464,regulation of matrix metallopeptidase secretion,9,0.0,1.0,1.0,2
2788,GO:1904470,regulation of endothelin production,9,0.0,1.0,1.0,2
2789,GO:1904505,regulation of telomere maintenance in response to DNA damage,9,0.0,1.0,1.0,3
2790,GO:1904523,regulation of DNA amplification,9,0.0,1.0,1.0,2
2791,GO:1904533,regulation of telomeric loop disassembly,9,0.0,1.0,1.0,3
2792,GO:1904663,regulation of N-terminal peptidyl-methionine acetylation,9,0.0,1.0,1.0,2
2793,GO:1904694,negative regulation of vascular associated smooth muscle contraction,9,0.0,1.0,1.0,2
2794,GO:1904695,positive regulation of vascular associated smooth muscle contraction,9,0.0,1.0,1.0,2
2795,GO:1904717,regulation of AMPA glutamate receptor clustering,9,0.0,1.0,1.0,2
2796,GO:1904875,regulation of DNA ligase activity,9,0.0,1.0,1.0,1
2797,GO:1904900,negative regulation of myosin II filament organization,9,0.0,1.0,1.0,1
2798,GO:1904901,positive regulation of myosin II filament organization,9,0.0,1.0,1.0,1
2799,GO:1904959,regulation of cytochrome-c oxidase activity,9,0.0,1.0,1.0,1
2800,GO:1905008,regulation of L-lysine import across plasma membrane,9,0.0,1.0,1.0,2
2801,GO:1905048,regulation of metallopeptidase activity,9,0.0,1.0,1.0,3
2802,GO:1905051,regulation of base-excision repair,9,0.0,1.0,1.0,2
2803,GO:1905089,regulation of type 2 mitophagy,9,0.0,1.0,1.0,2
2804,GO:1905126,regulation of axo-dendritic protein transport,9,0.0,1.0,1.0,2
2805,GO:1905133,negative regulation of meiotic chromosome separation,9,0.0,1.0,1.0,1
2806,GO:1905134,positive regulation of meiotic chromosome separation,9,0.0,1.0,1.0,2
2807,GO:1905165,regulation of lysosomal protein catabolic process,9,0.0,1.0,1.0,2
2808,GO:1905245,regulation of aspartic-type peptidase activity,9,0.0,1.0,1.0,3
2809,GO:1905261,regulation of meiotic DNA double-strand break formation involved in reciprocal meiotic recombination,9,0.0,1.0,1.0,3
2810,GO:1905271,"regulation of proton-transporting ATP synthase activity, rotational mechanism",9,0.0,1.0,1.0,1
2811,GO:1905304,regulation of cardiac myofibril assembly,9,0.0,1.0,1.0,2
2812,GO:1905399,"regulation of activated CD4-positive, alpha-beta T cell apoptotic process",9,0.0,1.0,1.0,2
2813,GO:1905402,"regulation of activated CD8-positive, alpha-beta T cell apoptotic process",9,0.0,1.0,1.0,2
2814,GO:1905486,regulation of anterior/posterior axon guidance,9,0.0,1.0,1.0,2
2815,GO:1905489,regulation of sensory neuron axon guidance,9,0.0,1.0,1.0,2
2816,GO:1905503,regulation of motile cilium assembly,9,0.0,1.0,1.0,2
2817,GO:1905522,negative regulation of macrophage migration,9,0.0,1.0,1.0,2
2818,GO:1905523,positive regulation of macrophage migration,9,0.0,1.0,1.0,2
2819,GO:1905526,regulation of Golgi lumen acidification,9,0.0,1.0,1.0,2
2820,GO:1905532,regulation of L-leucine import across plasma membrane,9,0.0,1.0,1.0,2
2821,GO:1905541,regulation of L-arginine import across plasma membrane,9,0.0,1.0,1.0,2
2822,GO:1905569,negative regulation of ferrichrome biosynthetic process,9,0.0,1.0,1.0,2
2823,GO:1905570,positive regulation of ferrichrome biosynthetic process,9,0.0,1.0,1.0,1
2824,GO:1905624,regulation of L-methionine import across plasma membrane,9,0.0,1.0,1.0,2
2825,GO:1905654,regulation of artery smooth muscle contraction,9,0.0,1.0,1.0,2
2826,GO:1905664,regulation of calcium ion import across plasma membrane,9,0.0,1.0,1.0,2
2827,GO:1905693,regulation of phosphatidic acid biosynthetic process,9,0.0,1.0,1.0,2
2828,GO:1905725,protein localization to microtubule end,9,0.0,1.0,1.0,2
2829,GO:1905749,regulation of endosome to plasma membrane protein transport,9,0.0,1.0,1.0,3
2830,GO:1905755,protein localization to cytoplasmic microtubule,9,0.0,1.0,1.0,2
2831,GO:1905778,negative regulation of exonuclease activity,9,0.0,1.0,1.0,1
2832,GO:1905779,positive regulation of exonuclease activity,9,0.0,1.0,1.0,2
2833,GO:1905812,regulation of motor neuron axon guidance,9,0.0,1.0,1.0,2
2834,GO:1905815,regulation of dorsal/ventral axon guidance,9,0.0,1.0,1.0,2
2835,GO:1905822,regulation of mitotic sister chromatid arm separation,9,0.0,1.0,1.0,2
2836,GO:1905912,regulation of calcium ion export across plasma membrane,9,0.0,1.0,1.0,2
2837,GO:1990504,dense core granule exocytosis,9,0.0,1.0,1.0,1
2838,GO:1990505,mitotic DNA replication maintenance of fidelity,9,0.0,1.0,1.0,1
2839,GO:1990772,substance P secretion,9,0.0,1.0,1.0,1
2840,GO:2000002,negative regulation of DNA damage checkpoint,9,0.0,1.0,1.0,1
2841,GO:2000003,positive regulation of DNA damage checkpoint,9,0.0,1.0,1.0,1
2842,GO:2000058,regulation of ubiquitin-dependent protein catabolic process,9,0.0,1.0,1.0,3
2843,GO:2000115,regulation of maintenance of bipolar cell polarity regulating cell shape,9,0.0,1.0,1.0,2
2844,GO:2000129,negative regulation of octopamine signaling pathway,9,0.0,1.0,1.0,1
2845,GO:2000130,positive regulation of octopamine signaling pathway,9,0.0,1.0,1.0,1
2846,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,9,0.0,1.0,1.0,2
2847,GO:2000139,regulation of octopamine signaling pathway involved in response to food,9,0.0,1.0,1.0,2
2848,GO:2000152,regulation of ubiquitin-specific protease activity,9,0.0,1.0,1.0,2
2849,GO:2000182,regulation of progesterone biosynthetic process,9,0.0,1.0,1.0,2
2850,GO:2000212,negative regulation of glutamate metabolic process,9,0.0,1.0,1.0,3
2851,GO:2000213,positive regulation of glutamate metabolic process,9,0.0,1.0,1.0,3
2852,GO:2000215,negative regulation of proline metabolic process,9,0.0,1.0,1.0,2
2853,GO:2000216,positive regulation of proline metabolic process,9,0.0,1.0,1.0,1
2854,GO:2000224,regulation of testosterone biosynthetic process,9,0.0,1.0,1.0,1
2855,GO:2000235,regulation of tRNA processing,9,0.0,1.0,1.0,3
2856,GO:2000247,positive regulation of establishment or maintenance of bipolar cell polarity regulating cell shape,9,0.0,1.0,1.0,2
2857,GO:2000257,regulation of protein activation cascade,9,0.0,1.0,1.0,7
2858,GO:2000275,regulation of oxidative phosphorylation uncoupler activity,9,0.0,1.0,1.0,2
2859,GO:2000279,negative regulation of DNA biosynthetic process,9,0.0,1.0,1.0,4
2860,GO:2000300,regulation of synaptic vesicle exocytosis,9,0.0,1.0,1.0,3
2861,GO:2000303,regulation of ceramide biosynthetic process,9,0.0,1.0,1.0,3
2862,GO:2000402,negative regulation of lymphocyte migration,9,0.0,1.0,1.0,2
2863,GO:2000403,positive regulation of lymphocyte migration,9,0.0,1.0,1.0,2
2864,GO:2000404,regulation of T cell migration,9,0.0,1.0,1.0,5
2865,GO:2000422,regulation of eosinophil chemotaxis,9,0.0,1.0,1.0,2
2866,GO:2000426,negative regulation of apoptotic cell clearance,9,0.0,1.0,1.0,1
2867,GO:2000427,positive regulation of apoptotic cell clearance,9,0.0,1.0,1.0,1
2868,GO:2000431,"regulation of cytokinesis, actomyosin contractile ring assembly",9,0.0,1.0,1.0,3
2869,GO:2000443,regulation of toll-like receptor 21 signaling pathway,9,0.0,1.0,1.0,2
2870,GO:2000509,negative regulation of dendritic cell chemotaxis,9,0.0,1.0,1.0,1
2871,GO:2000510,positive regulation of dendritic cell chemotaxis,9,0.0,1.0,1.0,1
2872,GO:2000511,regulation of granzyme A production,9,0.0,1.0,1.0,2
2873,GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",9,0.0,1.0,1.0,7
2874,GO:2000524,negative regulation of T cell costimulation,9,0.0,1.0,1.0,1
2875,GO:2000525,positive regulation of T cell costimulation,9,0.0,1.0,1.0,1
2876,GO:2000527,regulation of myeloid dendritic cell chemotaxis,9,0.0,1.0,1.0,2
2877,GO:2000559,regulation of CD24 production,9,0.0,1.0,1.0,1
2878,GO:2000573,positive regulation of DNA biosynthetic process,9,0.0,1.0,1.0,5
2879,GO:2000612,regulation of thyroid-stimulating hormone secretion,9,0.0,1.0,1.0,2
2880,GO:2000625,regulation of miRNA catabolic process,9,0.0,1.0,1.0,2
2881,GO:2000629,negative regulation of miRNA metabolic process,9,0.0,1.0,1.0,2
2882,GO:2000630,positive regulation of miRNA metabolic process,9,0.0,1.0,1.0,2
2883,GO:2000649,regulation of sodium ion transmembrane transporter activity,9,0.0,1.0,1.0,7
2884,GO:2000750,negative regulation of establishment or maintenance of bipolar cell polarity regulating cell shape,9,0.0,1.0,1.0,1
2885,GO:2000754,regulation of sphingomyelin catabolic process,9,0.0,1.0,1.0,1
2886,GO:2000756,regulation of peptidyl-lysine acetylation,9,0.0,1.0,1.0,3
2887,GO:2000779,regulation of double-strand break repair,9,0.0,1.0,1.0,5
2888,GO:2000819,regulation of nucleotide-excision repair,9,0.0,1.0,1.0,1
2889,GO:2000832,negative regulation of steroid hormone secretion,9,0.0,1.0,1.0,7
2890,GO:2000833,positive regulation of steroid hormone secretion,9,0.0,1.0,1.0,7
2891,GO:2000834,regulation of androgen secretion,9,0.0,1.0,1.0,2
2892,GO:2000846,regulation of corticosteroid hormone secretion,9,0.0,1.0,1.0,4
2893,GO:2000861,regulation of estrogen secretion,9,0.0,1.0,1.0,2
2894,GO:2000864,regulation of estradiol secretion,9,0.0,1.0,1.0,2
2895,GO:2000867,regulation of estrone secretion,9,0.0,1.0,1.0,2
2896,GO:2000870,regulation of progesterone secretion,9,0.0,1.0,1.0,2
2897,GO:2000881,regulation of starch catabolic process,9,0.0,1.0,1.0,2
2898,GO:2000905,negative regulation of starch metabolic process,9,0.0,1.0,1.0,1
2899,GO:2000906,positive regulation of starch metabolic process,9,0.0,1.0,1.0,1
2900,GO:2000925,negative regulation of cellodextrin metabolic process,9,0.0,1.0,1.0,3
2901,GO:2000926,positive regulation of cellodextrin metabolic process,9,0.0,1.0,1.0,3
2902,GO:2000927,regulation of cellodextrin catabolic process,9,0.0,1.0,1.0,2
2903,GO:2000934,negative regulation of cellotriose metabolic process,9,0.0,1.0,1.0,1
2904,GO:2000935,positive regulation of cellotriose metabolic process,9,0.0,1.0,1.0,1
2905,GO:2000936,regulation of cellotriose catabolic process,9,0.0,1.0,1.0,2
2906,GO:2000939,regulation of plant-type cell wall cellulose catabolic process,9,0.0,1.0,1.0,2
2907,GO:2000949,negative regulation of xyloglucan metabolic process,9,0.0,1.0,1.0,1
2908,GO:2000950,positive regulation of xyloglucan metabolic process,9,0.0,1.0,1.0,1
2909,GO:2000955,negative regulation of cyclodextrin metabolic process,9,0.0,1.0,1.0,1
2910,GO:2000956,positive regulation of cyclodextrin metabolic process,9,0.0,1.0,1.0,1
2911,GO:2000957,regulation of cyclodextrin catabolic process,9,0.0,1.0,1.0,2
2912,GO:2000967,negative regulation of cell wall polysaccharide catabolic process,9,0.0,1.0,1.0,3
2913,GO:2000968,positive regulation of cell wall polysaccharide catabolic process,9,0.0,1.0,1.0,3
2914,GO:2000988,regulation of hemicellulose catabolic process,9,0.0,1.0,1.0,4
2915,GO:2000994,regulation of mannan catabolic process,9,0.0,1.0,1.0,2
2916,GO:2000997,regulation of cellulose catabolic process,9,0.0,1.0,1.0,2
2917,GO:2001035,regulation of tongue muscle cell differentiation,9,0.0,1.0,1.0,2
2918,GO:2001144,"regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity",9,0.0,1.0,1.0,1
2919,GO:2001156,regulation of proline catabolic process to glutamate,9,0.0,1.0,1.0,2
2920,GO:2001185,"regulation of CD8-positive, alpha-beta T cell activation",9,0.0,1.0,1.0,4
2921,GO:2001191,regulation of gamma-delta T cell activation involved in immune response,9,0.0,1.0,1.0,2
2922,GO:2001194,regulation of lysine biosynthetic process via alpha-aminoadipate and saccharopine,9,0.0,1.0,1.0,2
2923,GO:2001210,"regulation of isopentenyl diphosphate biosynthetic process, mevalonate pathway",9,0.0,1.0,1.0,2
2924,GO:2001245,regulation of phosphatidylcholine biosynthetic process,9,0.0,1.0,1.0,2
2925,GO:2001248,regulation of ammonia assimilation cycle,9,0.0,1.0,1.0,2
2926,GO:2001258,negative regulation of cation channel activity,9,0.0,1.0,1.0,6
2927,GO:2001259,positive regulation of cation channel activity,9,0.0,1.0,1.0,8
2928,GO:2001279,regulation of unsaturated fatty acid biosynthetic process,9,0.0,1.0,1.0,2
2929,GO:2001284,regulation of BMP secretion,9,0.0,1.0,1.0,2
2930,GO:2001296,N(omega)-methyl-L-arginine metabolic process,9,0.0,1.0,1.0,1
2931,GO:2001298,"N(omega),N(omega)-dimethyl-L-arginine metabolic process",9,0.0,1.0,1.0,1
86,GO:2000341,regulation of chemokine (C-X-C motif) ligand 2 production,10,820.4,551.41,3.788654700193995e-13,2
92,GO:0032722,positive regulation of chemokine production,10,820.4,181.82,1.3546293025815599e-12,13
115,GO:0032732,positive regulation of interleukin-1 production,10,152.89,132.43,5.273144689811135e-10,2
124,GO:0032651,regulation of interleukin-1 beta production,10,152.89,99.22,2.233261175618903e-09,2
126,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,10,100.11,96.93,2.5088947337430595e-09,4
138,GO:0032680,regulation of tumor necrosis factor production,10,100.11,61.6,2.3897180047003195e-08,2
125,GO:0032755,positive regulation of interleukin-6 production,10,98.93,98.93,2.2663299349187988e-09,0
892,GO:0000076,DNA replication checkpoint signaling,10,0.0,1.0,1.0,2
893,GO:0000077,DNA damage checkpoint signaling,10,0.0,1.0,1.0,1
894,GO:0000209,protein polyubiquitination,10,0.0,1.0,1.0,9
895,GO:0000365,"mRNA trans splicing, via spliceosome",10,0.0,1.0,1.0,2
896,GO:0000380,"alternative mRNA splicing, via spliceosome",10,0.0,1.0,1.0,1
897,GO:0000409,regulation of transcription by galactose,10,0.0,1.0,1.0,3
898,GO:0000956,nuclear-transcribed mRNA catabolic process,10,0.0,1.0,1.0,10
899,GO:0000958,mitochondrial mRNA catabolic process,10,0.0,1.0,1.0,1
900,GO:0000961,negative regulation of mitochondrial RNA catabolic process,10,0.0,1.0,1.0,1
901,GO:0001803,regulation of type III hypersensitivity,10,0.0,1.0,1.0,2
902,GO:0001807,regulation of type IV hypersensitivity,10,0.0,1.0,1.0,2
903,GO:0001810,regulation of type I hypersensitivity,10,0.0,1.0,1.0,2
904,GO:0001924,regulation of B-1 B cell differentiation,10,0.0,1.0,1.0,2
905,GO:0001997,positive regulation of the force of heart contraction by epinephrine-norepinephrine,10,0.0,1.0,1.0,2
906,GO:0002037,negative regulation of L-glutamate import across plasma membrane,10,0.0,1.0,1.0,1
907,GO:0002038,positive regulation of L-glutamate import across plasma membrane,10,0.0,1.0,1.0,1
908,GO:0002097,tRNA wobble base modification,10,0.0,1.0,1.0,4
909,GO:0002138,retinoic acid biosynthetic process,10,0.0,1.0,1.0,1
910,GO:0002206,gene conversion of immunoglobulin genes,10,0.0,1.0,1.0,1
911,GO:0002220,innate immune response activating cell surface receptor signaling pathway,10,0.0,1.0,1.0,3
912,GO:0002221,pattern recognition receptor signaling pathway,10,0.0,1.0,1.0,5
913,GO:0002225,positive regulation of antimicrobial peptide production,10,0.0,1.0,1.0,4
914,GO:0002256,regulation of kinin cascade,10,0.0,1.0,1.0,4
915,GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",10,0.0,1.0,1.0,2
916,GO:0002361,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",10,0.0,1.0,1.0,1
917,GO:0002638,negative regulation of immunoglobulin production,10,0.0,1.0,1.0,1
918,GO:0002639,positive regulation of immunoglobulin production,10,0.0,1.0,1.0,2
919,GO:0002681,somatic recombination of T cell receptor gene segments,10,0.0,1.0,1.0,1
920,GO:0002719,negative regulation of cytokine production involved in immune response,10,0.0,1.0,1.0,6
921,GO:0002720,positive regulation of cytokine production involved in immune response,10,0.0,1.0,1.0,5
922,GO:0002721,regulation of B cell cytokine production,10,0.0,1.0,1.0,2
923,GO:0002724,regulation of T cell cytokine production,10,0.0,1.0,1.0,4
924,GO:0002727,regulation of natural killer cell cytokine production,10,0.0,1.0,1.0,2
925,GO:0002730,regulation of dendritic cell cytokine production,10,0.0,1.0,1.0,4
926,GO:0002785,negative regulation of antimicrobial peptide production,10,0.0,1.0,1.0,4
927,GO:0002786,regulation of antibacterial peptide production,10,0.0,1.0,1.0,4
928,GO:0002788,regulation of antifungal peptide production,10,0.0,1.0,1.0,4
929,GO:0002794,regulation of antimicrobial peptide secretion,10,0.0,1.0,1.0,4
930,GO:0002805,regulation of antimicrobial peptide biosynthetic process,10,0.0,1.0,1.0,4
931,GO:0002844,negative regulation of tolerance induction to tumor cell,10,0.0,1.0,1.0,1
932,GO:0002845,positive regulation of tolerance induction to tumor cell,10,0.0,1.0,1.0,1
933,GO:0002846,regulation of T cell tolerance induction to tumor cell,10,0.0,1.0,1.0,2
934,GO:0002850,negative regulation of peripheral T cell tolerance induction,10,0.0,1.0,1.0,1
935,GO:0002851,positive regulation of peripheral T cell tolerance induction,10,0.0,1.0,1.0,1
936,GO:0002868,negative regulation of B cell deletion,10,0.0,1.0,1.0,2
937,GO:0002869,positive regulation of B cell deletion,10,0.0,1.0,1.0,2
938,GO:0002884,negative regulation of hypersensitivity,10,0.0,1.0,1.0,4
939,GO:0002885,positive regulation of hypersensitivity,10,0.0,1.0,1.0,4
940,GO:0002892,regulation of type II hypersensitivity,10,0.0,1.0,1.0,4
941,GO:0002898,regulation of central B cell deletion,10,0.0,1.0,1.0,2
942,GO:0002908,regulation of peripheral B cell deletion,10,0.0,1.0,1.0,2
943,GO:0002914,regulation of central B cell anergy,10,0.0,1.0,1.0,2
944,GO:0002924,negative regulation of humoral immune response mediated by circulating immunoglobulin,10,0.0,1.0,1.0,1
945,GO:0002925,positive regulation of humoral immune response mediated by circulating immunoglobulin,10,0.0,1.0,1.0,1
946,GO:0002949,tRNA threonylcarbamoyladenosine modification,10,0.0,1.0,1.0,1
947,GO:0003059,positive regulation of the force of heart contraction by epinephrine,10,0.0,1.0,1.0,2
948,GO:0003061,positive regulation of the force of heart contraction by norepinephrine,10,0.0,1.0,1.0,2
949,GO:0003083,negative regulation of renal output by angiotensin,10,0.0,1.0,1.0,2
950,GO:0004970,glutamate-gated receptor activity,10,0.0,1.0,1.0,4
951,GO:0005222,intracellularly cAMP-activated cation channel activity,10,0.0,1.0,1.0,2
952,GO:0005234,extracellularly glutamate-gated ion channel activity,10,0.0,1.0,1.0,1
953,GO:0005242,inward rectifier potassium channel activity,10,0.0,1.0,1.0,2
954,GO:0005356,D-glucose:proton symporter activity,10,0.0,1.0,1.0,3
955,GO:0005979,regulation of glycogen biosynthetic process,10,0.0,1.0,1.0,2
956,GO:0006064,glucuronate catabolic process,10,0.0,1.0,1.0,1
957,GO:0006110,regulation of glycolytic process,10,0.0,1.0,1.0,3
958,GO:0006166,purine ribonucleoside salvage,10,0.0,1.0,1.0,3
959,GO:0006216,cytidine catabolic process,10,0.0,1.0,1.0,1
960,GO:0006356,regulation of transcription by RNA polymerase I,10,0.0,1.0,1.0,5
961,GO:0006357,regulation of transcription by RNA polymerase II,10,0.0,1.0,1.0,8
962,GO:0006359,regulation of transcription by RNA polymerase III,10,0.0,1.0,1.0,3
963,GO:0006419,alanyl-tRNA aminoacylation,10,0.0,1.0,1.0,2
964,GO:0006420,arginyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
965,GO:0006421,asparaginyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
966,GO:0006422,aspartyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
967,GO:0006423,cysteinyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
968,GO:0006424,glutamyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
969,GO:0006425,glutaminyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
970,GO:0006426,glycyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
971,GO:0006427,histidyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
972,GO:0006428,isoleucyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
973,GO:0006429,leucyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
974,GO:0006430,lysyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
975,GO:0006431,methionyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
976,GO:0006432,phenylalanyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
977,GO:0006433,prolyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
978,GO:0006434,seryl-tRNA aminoacylation,10,0.0,1.0,1.0,1
979,GO:0006435,threonyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
980,GO:0006436,tryptophanyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
981,GO:0006437,tyrosyl-tRNA aminoacylation,10,0.0,1.0,1.0,1
982,GO:0006438,valyl-tRNA aminoacylation,10,0.0,1.0,1.0,2
983,GO:0006446,regulation of translational initiation,10,0.0,1.0,1.0,11
984,GO:0006448,regulation of translational elongation,10,0.0,1.0,1.0,6
985,GO:0006449,regulation of translational termination,10,0.0,1.0,1.0,3
986,GO:0006451,translational readthrough,10,0.0,1.0,1.0,3
987,GO:0006469,negative regulation of protein kinase activity,10,0.0,1.0,1.0,4
988,GO:0006528,asparagine metabolic process,10,0.0,1.0,1.0,4
989,GO:0006531,aspartate metabolic process,10,0.0,1.0,1.0,4
990,GO:0006536,glutamate metabolic process,10,0.0,1.0,1.0,9
991,GO:0006541,glutamine metabolic process,10,0.0,1.0,1.0,5
992,GO:0006544,glycine metabolic process,10,0.0,1.0,1.0,6
993,GO:0006548,L-histidine catabolic process,10,0.0,1.0,1.0,5
994,GO:0006551,L-leucine metabolic process,10,0.0,1.0,1.0,2
995,GO:0006555,methionine metabolic process,10,0.0,1.0,1.0,2
996,GO:0006558,L-phenylalanine metabolic process,10,0.0,1.0,1.0,2
997,GO:0006560,proline metabolic process,10,0.0,1.0,1.0,4
998,GO:0006563,L-serine metabolic process,10,0.0,1.0,1.0,4
999,GO:0006566,threonine metabolic process,10,0.0,1.0,1.0,2
1000,GO:0006568,tryptophan metabolic process,10,0.0,1.0,1.0,3
1001,GO:0006570,tyrosine metabolic process,10,0.0,1.0,1.0,5
1002,GO:0006635,fatty acid beta-oxidation,10,0.0,1.0,1.0,4
1003,GO:0006636,unsaturated fatty acid biosynthetic process,10,0.0,1.0,1.0,4
1004,GO:0006692,prostanoid metabolic process,10,0.0,1.0,1.0,2
1005,GO:0006739,NADP metabolic process,10,0.0,1.0,1.0,4
1006,GO:0007026,negative regulation of microtubule depolymerization,10,0.0,1.0,1.0,2
1007,GO:0007053,spindle assembly involved in male meiosis,10,0.0,1.0,1.0,3
1008,GO:0007056,spindle assembly involved in female meiosis,10,0.0,1.0,1.0,2
1009,GO:0007532,"regulation of mating-type specific transcription, DNA-templated",10,0.0,1.0,1.0,2
1010,GO:0007554,regulation of ecdysteroid biosynthetic process,10,0.0,1.0,1.0,2
1011,GO:0008617,guanosine metabolic process,10,0.0,1.0,1.0,2
1012,GO:0008618,7-methylguanosine metabolic process,10,0.0,1.0,1.0,2
1013,GO:0009065,glutamine family amino acid catabolic process,10,0.0,1.0,1.0,5
1014,GO:0009067,aspartate family amino acid biosynthetic process,10,0.0,1.0,1.0,7
1015,GO:0009068,aspartate family amino acid catabolic process,10,0.0,1.0,1.0,6
1016,GO:0009070,serine family amino acid biosynthetic process,10,0.0,1.0,1.0,6
1017,GO:0009071,serine family amino acid catabolic process,10,0.0,1.0,1.0,5
1018,GO:0009079,pyruvate family amino acid biosynthetic process,10,0.0,1.0,1.0,3
1019,GO:0009080,pyruvate family amino acid catabolic process,10,0.0,1.0,1.0,2
1020,GO:0009084,glutamine family amino acid biosynthetic process,10,0.0,1.0,1.0,4
1021,GO:0009092,homoserine metabolic process,10,0.0,1.0,1.0,4
1022,GO:0009151,purine deoxyribonucleotide metabolic process,10,0.0,1.0,1.0,10
1023,GO:0009152,purine ribonucleotide biosynthetic process,10,0.0,1.0,1.0,18
1024,GO:0009154,purine ribonucleotide catabolic process,10,0.0,1.0,1.0,12
1025,GO:0009168,purine ribonucleoside monophosphate biosynthetic process,10,0.0,1.0,1.0,4
1026,GO:0009169,purine ribonucleoside monophosphate catabolic process,10,0.0,1.0,1.0,3
1027,GO:0009171,purine deoxyribonucleoside monophosphate biosynthetic process,10,0.0,1.0,1.0,3
1028,GO:0009172,purine deoxyribonucleoside monophosphate catabolic process,10,0.0,1.0,1.0,2
1029,GO:0009174,pyrimidine ribonucleoside monophosphate biosynthetic process,10,0.0,1.0,1.0,3
1030,GO:0009175,pyrimidine ribonucleoside monophosphate catabolic process,10,0.0,1.0,1.0,3
1031,GO:0009177,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,10,0.0,1.0,1.0,3
1032,GO:0009178,pyrimidine deoxyribonucleoside monophosphate catabolic process,10,0.0,1.0,1.0,3
1033,GO:0009180,purine ribonucleoside diphosphate biosynthetic process,10,0.0,1.0,1.0,3
1034,GO:0009181,purine ribonucleoside diphosphate catabolic process,10,0.0,1.0,1.0,3
1035,GO:0009183,purine deoxyribonucleoside diphosphate biosynthetic process,10,0.0,1.0,1.0,2
1036,GO:0009184,purine deoxyribonucleoside diphosphate catabolic process,10,0.0,1.0,1.0,2
1037,GO:0009194,pyrimidine ribonucleoside diphosphate biosynthetic process,10,0.0,1.0,1.0,3
1038,GO:0009195,pyrimidine ribonucleoside diphosphate catabolic process,10,0.0,1.0,1.0,3
1039,GO:0009197,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,10,0.0,1.0,1.0,3
1040,GO:0009198,pyrimidine deoxyribonucleoside diphosphate catabolic process,10,0.0,1.0,1.0,3
1041,GO:0009206,purine ribonucleoside triphosphate biosynthetic process,10,0.0,1.0,1.0,3
1042,GO:0009207,purine ribonucleoside triphosphate catabolic process,10,0.0,1.0,1.0,1
1043,GO:0009209,pyrimidine ribonucleoside triphosphate biosynthetic process,10,0.0,1.0,1.0,3
1044,GO:0009210,pyrimidine ribonucleoside triphosphate catabolic process,10,0.0,1.0,1.0,3
1045,GO:0009212,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,10,0.0,1.0,1.0,3
1046,GO:0009213,pyrimidine deoxyribonucleoside triphosphate catabolic process,10,0.0,1.0,1.0,3
1047,GO:0009216,purine deoxyribonucleoside triphosphate biosynthetic process,10,0.0,1.0,1.0,2
1048,GO:0009217,purine deoxyribonucleoside triphosphate catabolic process,10,0.0,1.0,1.0,3
1049,GO:0009219,pyrimidine deoxyribonucleotide metabolic process,10,0.0,1.0,1.0,12
1050,GO:0009220,pyrimidine ribonucleotide biosynthetic process,10,0.0,1.0,1.0,10
1051,GO:0009222,pyrimidine ribonucleotide catabolic process,10,0.0,1.0,1.0,9
1052,GO:0009265,2'-deoxyribonucleotide biosynthetic process,10,0.0,1.0,1.0,2
1053,GO:0009694,jasmonic acid metabolic process,10,0.0,1.0,1.0,1
1054,GO:0010400,rhamnogalacturonan I side chain metabolic process,10,0.0,1.0,1.0,3
1055,GO:0010414,glucuronoarabinoxylan metabolic process,10,0.0,1.0,1.0,1
1056,GO:0010422,regulation of brassinosteroid biosynthetic process,10,0.0,1.0,1.0,2
1057,GO:0010484,histone H3 acetyltransferase activity,10,0.0,1.0,1.0,9
1058,GO:0010485,histone H4 acetyltransferase activity,10,0.0,1.0,1.0,4
1059,GO:0010512,negative regulation of phosphatidylinositol biosynthetic process,10,0.0,1.0,1.0,1
1060,GO:0010513,positive regulation of phosphatidylinositol biosynthetic process,10,0.0,1.0,1.0,1
1061,GO:0010523,negative regulation of calcium ion transport into cytosol,10,0.0,1.0,1.0,1
1062,GO:0010524,positive regulation of calcium ion transport into cytosol,10,0.0,1.0,1.0,2
1063,GO:0010526,transposable element silencing,10,0.0,1.0,1.0,2
1064,GO:0010569,regulation of double-strand break repair via homologous recombination,10,0.0,1.0,1.0,3
1065,GO:0010625,positive regulation of Schwann cell proliferation,10,0.0,1.0,1.0,1
1066,GO:0010626,negative regulation of Schwann cell proliferation,10,0.0,1.0,1.0,1
1067,GO:0010755,regulation of plasminogen activation,10,0.0,1.0,1.0,2
1068,GO:0010819,regulation of T cell chemotaxis,10,0.0,1.0,1.0,1
1069,GO:0010845,positive regulation of reciprocal meiotic recombination,10,0.0,1.0,1.0,1
1070,GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,10,0.0,1.0,1.0,2
1071,GO:0010935,regulation of macrophage cytokine production,10,0.0,1.0,1.0,2
1072,GO:0010937,regulation of cytoplasmic microtubule depolymerization,10,0.0,1.0,1.0,1
1073,GO:0010950,positive regulation of endopeptidase activity,10,0.0,1.0,1.0,4
1074,GO:0010951,negative regulation of endopeptidase activity,10,0.0,1.0,1.0,4
1075,GO:0010954,positive regulation of protein processing,10,0.0,1.0,1.0,4
1076,GO:0010955,negative regulation of protein processing,10,0.0,1.0,1.0,5
1077,GO:0010957,negative regulation of vitamin D biosynthetic process,10,0.0,1.0,1.0,1
1078,GO:0010968,regulation of microtubule nucleation,10,0.0,1.0,1.0,2
1079,GO:0014006,regulation of microglia differentiation,10,0.0,1.0,1.0,2
1080,GO:0015269,calcium-activated potassium channel activity,10,0.0,1.0,1.0,3
1081,GO:0015271,outward rectifier potassium channel activity,10,0.0,1.0,1.0,1
1082,GO:0015278,intracellularly gated calcium channel activity,10,0.0,1.0,1.0,5
1083,GO:0015679,plasma membrane copper ion transport,10,0.0,1.0,1.0,1
1084,GO:0015886,heme transport,10,0.0,1.0,1.0,3
1085,GO:0015891,siderophore transport,10,0.0,1.0,1.0,4
1086,GO:0015969,guanosine tetraphosphate metabolic process,10,0.0,1.0,1.0,2
1087,GO:0015972,guanosine pentaphosphate metabolic process,10,0.0,1.0,1.0,2
1088,GO:0016123,xanthophyll biosynthetic process,10,0.0,1.0,1.0,7
1089,GO:0016124,xanthophyll catabolic process,10,0.0,1.0,1.0,8
1090,GO:0016259,selenocysteine metabolic process,10,0.0,1.0,1.0,2
1091,GO:0016447,somatic recombination of immunoglobulin gene segments,10,0.0,1.0,1.0,3
1092,GO:0016933,extracellularly glycine-gated ion channel activity,10,0.0,1.0,1.0,1
1093,GO:0017148,negative regulation of translation,10,0.0,1.0,1.0,11
1094,GO:0019244,lactate biosynthetic process from pyruvate,10,0.0,1.0,1.0,2
1095,GO:0019357,nicotinate nucleotide biosynthetic process,10,0.0,1.0,1.0,2
1096,GO:0019359,nicotinamide nucleotide biosynthetic process,10,0.0,1.0,1.0,3
1097,GO:0019365,pyridine nucleotide salvage,10,0.0,1.0,1.0,2
1098,GO:0019369,arachidonate metabolic process,10,0.0,1.0,1.0,3
1099,GO:0019393,glucarate biosynthetic process,10,0.0,1.0,1.0,1
1100,GO:0019394,glucarate catabolic process,10,0.0,1.0,1.0,1
1101,GO:0019525,keto-D-gluconate metabolic process,10,0.0,1.0,1.0,2
1102,GO:0019541,propionate metabolic process,10,0.0,1.0,1.0,8
1103,GO:0019584,galactonate catabolic process,10,0.0,1.0,1.0,2
1104,GO:0019605,butyrate metabolic process,10,0.0,1.0,1.0,4
1105,GO:0019626,short-chain fatty acid catabolic process,10,0.0,1.0,1.0,4
1106,GO:0019674,NAD metabolic process,10,0.0,1.0,1.0,3
1107,GO:0019988,charged-tRNA amino acid modification,10,0.0,1.0,1.0,6
1108,GO:0021785,branchiomotor neuron axon guidance,10,0.0,1.0,1.0,2
1109,GO:0021952,central nervous system projection neuron axonogenesis,10,0.0,1.0,1.0,15
1110,GO:0030174,regulation of DNA-templated DNA replication initiation,10,0.0,1.0,1.0,5
1111,GO:0030450,"regulation of complement activation, classical pathway",10,0.0,1.0,1.0,2
1112,GO:0030488,tRNA methylation,10,0.0,1.0,1.0,9
1113,GO:0030497,fatty acid elongation,10,0.0,1.0,1.0,2
1114,GO:0030517,negative regulation of axon extension,10,0.0,1.0,1.0,2
1115,GO:0030833,regulation of actin filament polymerization,10,0.0,1.0,1.0,3
1116,GO:0030834,regulation of actin filament depolymerization,10,0.0,1.0,1.0,3
1117,GO:0030853,negative regulation of granulocyte differentiation,10,0.0,1.0,1.0,3
1118,GO:0030854,positive regulation of granulocyte differentiation,10,0.0,1.0,1.0,3
1119,GO:0031115,negative regulation of microtubule polymerization,10,0.0,1.0,1.0,1
1120,GO:0031116,positive regulation of microtubule polymerization,10,0.0,1.0,1.0,1
1121,GO:0031118,rRNA pseudouridine synthesis,10,0.0,1.0,1.0,2
1122,GO:0031119,tRNA pseudouridine synthesis,10,0.0,1.0,1.0,1
1123,GO:0031167,rRNA methylation,10,0.0,1.0,1.0,2
1124,GO:0031282,regulation of guanylate cyclase activity,10,0.0,1.0,1.0,2
1125,GO:0031392,regulation of prostaglandin biosynthetic process,10,0.0,1.0,1.0,3
1126,GO:0031396,regulation of protein ubiquitination,10,0.0,1.0,1.0,5
1127,GO:0031440,regulation of mRNA 3'-end processing,10,0.0,1.0,1.0,3
1128,GO:0031446,regulation of fast-twitch skeletal muscle fiber contraction,10,0.0,1.0,1.0,2
1129,GO:0031449,regulation of slow-twitch skeletal muscle fiber contraction,10,0.0,1.0,1.0,2
1130,GO:0031507,heterochromatin formation,10,0.0,1.0,1.0,5
1131,GO:0031567,mitotic cell size control checkpoint signaling,10,0.0,1.0,1.0,2
1132,GO:0031585,"regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity",10,0.0,1.0,1.0,1
1133,GO:0031946,regulation of glucocorticoid biosynthetic process,10,0.0,1.0,1.0,3
1134,GO:0031953,negative regulation of protein autophosphorylation,10,0.0,1.0,1.0,1
1135,GO:0031954,positive regulation of protein autophosphorylation,10,0.0,1.0,1.0,1
1136,GO:0031999,negative regulation of fatty acid beta-oxidation,10,0.0,1.0,1.0,1
1137,GO:0032000,positive regulation of fatty acid beta-oxidation,10,0.0,1.0,1.0,3
1138,GO:0032024,positive regulation of insulin secretion,10,0.0,1.0,1.0,1
1139,GO:0032072,regulation of restriction endodeoxyribonuclease activity,10,0.0,1.0,1.0,5
1140,GO:0032078,negative regulation of endodeoxyribonuclease activity,10,0.0,1.0,1.0,1
1141,GO:0032207,regulation of telomere maintenance via recombination,10,0.0,1.0,1.0,2
1142,GO:0032210,regulation of telomere maintenance via telomerase,10,0.0,1.0,1.0,2
1143,GO:0032232,negative regulation of actin filament bundle assembly,10,0.0,1.0,1.0,2
1144,GO:0032233,positive regulation of actin filament bundle assembly,10,0.0,1.0,1.0,2
1145,GO:0032261,purine nucleotide salvage,10,0.0,1.0,1.0,3
1146,GO:0032262,pyrimidine nucleotide salvage,10,0.0,1.0,1.0,2
1147,GO:0032347,regulation of aldosterone biosynthetic process,10,0.0,1.0,1.0,2
1148,GO:0032415,regulation of sodium:proton antiporter activity,10,0.0,1.0,1.0,2
1149,GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,10,0.0,1.0,1.0,4
1150,GO:0032443,regulation of ergosterol biosynthetic process,10,0.0,1.0,1.0,2
1151,GO:0032480,negative regulation of type I interferon production,10,0.0,1.0,1.0,3
1152,GO:0032481,positive regulation of type I interferon production,10,0.0,1.0,1.0,2
1153,GO:0032597,B cell receptor transport into membrane raft,10,0.0,1.0,1.0,1
1154,GO:0032644,regulation of fractalkine production,10,0.0,1.0,1.0,2
1155,GO:0032647,regulation of interferon-alpha production,10,0.0,1.0,1.0,2
1156,GO:0032648,regulation of interferon-beta production,10,0.0,1.0,1.0,2
1157,GO:0032650,regulation of interleukin-1 alpha production,10,0.0,1.0,1.0,2
1158,GO:0032679,regulation of TRAIL production,10,0.0,1.0,1.0,2
1159,GO:0032681,regulation of lymphotoxin A production,10,0.0,1.0,1.0,2
1160,GO:0032682,negative regulation of chemokine production,10,0.0,1.0,1.0,13
1161,GO:0032692,negative regulation of interleukin-1 production,10,0.0,1.0,1.0,2
1162,GO:0032700,negative regulation of interleukin-17 production,10,0.0,1.0,1.0,1
1163,GO:0032740,positive regulation of interleukin-17 production,10,0.0,1.0,1.0,1
1164,GO:0032763,regulation of mast cell cytokine production,10,0.0,1.0,1.0,2
1165,GO:0032784,regulation of DNA-templated transcription elongation,10,0.0,1.0,1.0,4
1166,GO:0032824,negative regulation of natural killer cell differentiation,10,0.0,1.0,1.0,1
1167,GO:0032825,positive regulation of natural killer cell differentiation,10,0.0,1.0,1.0,1
1168,GO:0032826,regulation of natural killer cell differentiation involved in immune response,10,0.0,1.0,1.0,2
1169,GO:0032875,regulation of DNA endoreduplication,10,0.0,1.0,1.0,2
1170,GO:0032908,regulation of transforming growth factor beta1 production,10,0.0,1.0,1.0,2
1171,GO:0032909,regulation of transforming growth factor beta2 production,10,0.0,1.0,1.0,2
1172,GO:0032910,regulation of transforming growth factor beta3 production,10,0.0,1.0,1.0,2
1173,GO:0032949,regulation of alpha-glucan biosynthetic process,10,0.0,1.0,1.0,1
1174,GO:0032951,regulation of beta-glucan biosynthetic process,10,0.0,1.0,1.0,4
1175,GO:0033081,regulation of T cell differentiation in thymus,10,0.0,1.0,1.0,3
1176,GO:0033082,regulation of extrathymic T cell differentiation,10,0.0,1.0,1.0,2
1177,GO:0033084,regulation of immature T cell proliferation in thymus,10,0.0,1.0,1.0,2
1178,GO:0033087,negative regulation of immature T cell proliferation,10,0.0,1.0,1.0,1
1179,GO:0033091,positive regulation of immature T cell proliferation,10,0.0,1.0,1.0,1
1180,GO:0033122,negative regulation of purine nucleotide catabolic process,10,0.0,1.0,1.0,1
1181,GO:0033123,positive regulation of purine nucleotide catabolic process,10,0.0,1.0,1.0,1
1182,GO:0033131,regulation of glucokinase activity,10,0.0,1.0,1.0,2
1183,GO:0033137,negative regulation of peptidyl-serine phosphorylation,10,0.0,1.0,1.0,1
1184,GO:0033138,positive regulation of peptidyl-serine phosphorylation,10,0.0,1.0,1.0,1
1185,GO:0033139,regulation of peptidyl-serine phosphorylation of STAT protein,10,0.0,1.0,1.0,2
1186,GO:0033151,V(D)J recombination,10,0.0,1.0,1.0,2
1187,GO:0033214,siderophore-dependent iron import into cell,10,0.0,1.0,1.0,3
1188,GO:0033233,regulation of protein sumoylation,10,0.0,1.0,1.0,3
1189,GO:0033260,nuclear DNA replication,10,0.0,1.0,1.0,2
1190,GO:0033262,regulation of nuclear cell cycle DNA replication,10,0.0,1.0,1.0,4
1191,GO:0033474,indoleacetic acid conjugate biosynthetic process,10,0.0,1.0,1.0,2
1192,GO:0033481,galacturonate biosynthetic process,10,0.0,1.0,1.0,1
1193,GO:0034036,purine ribonucleoside bisphosphate biosynthetic process,10,0.0,1.0,1.0,3
1194,GO:0034037,purine ribonucleoside bisphosphate catabolic process,10,0.0,1.0,1.0,2
1195,GO:0034095,negative regulation of maintenance of meiotic sister chromatid cohesion,10,0.0,1.0,1.0,1
1196,GO:0034096,positive regulation of maintenance of meiotic sister chromatid cohesion,10,0.0,1.0,1.0,1
1197,GO:0034165,positive regulation of toll-like receptor 9 signaling pathway,10,0.0,1.0,1.0,1
1198,GO:0034183,negative regulation of maintenance of mitotic sister chromatid cohesion,10,0.0,1.0,1.0,3
1199,GO:0034184,positive regulation of maintenance of mitotic sister chromatid cohesion,10,0.0,1.0,1.0,3
1200,GO:0034192,D-galactonate metabolic process,10,0.0,1.0,1.0,1
1201,GO:0034193,L-galactonate metabolic process,10,0.0,1.0,1.0,1
1202,GO:0034227,tRNA thio-modification,10,0.0,1.0,1.0,3
1203,GO:0034315,regulation of Arp2/3 complex-mediated actin nucleation,10,0.0,1.0,1.0,2
1204,GO:0034408,ascospore wall beta-glucan metabolic process,10,0.0,1.0,1.0,2
1205,GO:0034411,cell wall (1->3)-beta-D-glucan biosynthetic process,10,0.0,1.0,1.0,1
1206,GO:0034775,glutathione transmembrane transport,10,0.0,1.0,1.0,3
1207,GO:0035194,regulatory ncRNA-mediated post-transcriptional gene silencing,10,0.0,1.0,1.0,7
1208,GO:0035247,peptidyl-arginine omega-N-methylation,10,0.0,1.0,1.0,2
1209,GO:0035352,NAD transmembrane transport,10,0.0,1.0,1.0,1
1210,GO:0035394,regulation of chemokine (C-X-C motif) ligand 9 production,10,0.0,1.0,1.0,2
1211,GO:0035531,regulation of chemokine (C-C motif) ligand 6 production,10,0.0,1.0,1.0,2
1212,GO:0035930,corticosteroid hormone secretion,10,0.0,1.0,1.0,2
1213,GO:0036102,leukotriene B4 metabolic process,10,0.0,1.0,1.0,2
1214,GO:0036234,deglucuronidation,10,0.0,1.0,1.0,1
1215,GO:0036415,regulation of tRNA stability,10,0.0,1.0,1.0,2
1216,GO:0036444,calcium import into the mitochondrion,10,0.0,1.0,1.0,1
1217,GO:0039682,rolling circle viral DNA replication,10,0.0,1.0,1.0,2
1218,GO:0042195,aerobic gallate catabolic process,10,0.0,1.0,1.0,2
1219,GO:0042452,deoxyguanosine biosynthetic process,10,0.0,1.0,1.0,1
1220,GO:0042509,regulation of tyrosine phosphorylation of STAT protein,10,0.0,1.0,1.0,2
1221,GO:0042758,long-chain fatty acid catabolic process,10,0.0,1.0,1.0,3
1222,GO:0042759,long-chain fatty acid biosynthetic process,10,0.0,1.0,1.0,9
1223,GO:0042760,very long-chain fatty acid catabolic process,10,0.0,1.0,1.0,1
1224,GO:0042784,symbiont-mediated suppression of host complement activation,10,0.0,1.0,1.0,4
1225,GO:0042836,D-glucarate metabolic process,10,0.0,1.0,1.0,2
1226,GO:0042839,D-glucuronate metabolic process,10,0.0,1.0,1.0,2
1227,GO:0042851,L-alanine metabolic process,10,0.0,1.0,1.0,3
1228,GO:0042905,9-cis-retinoic acid metabolic process,10,0.0,1.0,1.0,1
1229,GO:0043098,purine deoxyribonucleoside salvage,10,0.0,1.0,1.0,2
1230,GO:0043099,pyrimidine deoxyribonucleoside salvage,10,0.0,1.0,1.0,1
1231,GO:0043301,negative regulation of leukocyte degranulation,10,0.0,1.0,1.0,6
1232,GO:0043302,positive regulation of leukocyte degranulation,10,0.0,1.0,1.0,6
1233,GO:0043304,regulation of mast cell degranulation,10,0.0,1.0,1.0,3
1234,GO:0043309,regulation of eosinophil degranulation,10,0.0,1.0,1.0,2
1235,GO:0043313,regulation of neutrophil degranulation,10,0.0,1.0,1.0,2
1236,GO:0043317,regulation of cytotoxic T cell degranulation,10,0.0,1.0,1.0,2
1237,GO:0043321,regulation of natural killer cell degranulation,10,0.0,1.0,1.0,2
1238,GO:0043380,regulation of memory T cell differentiation,10,0.0,1.0,1.0,2
1239,GO:0043438,acetoacetic acid metabolic process,10,0.0,1.0,1.0,2
1240,GO:0043456,regulation of pentose-phosphate shunt,10,0.0,1.0,1.0,2
1241,GO:0043488,regulation of mRNA stability,10,0.0,1.0,1.0,7
1242,GO:0043489,RNA stabilization,10,0.0,1.0,1.0,3
1243,GO:0043555,regulation of translation in response to stress,10,0.0,1.0,1.0,6
1244,GO:0043998,histone H2A acetyltransferase activity,10,0.0,1.0,1.0,2
1245,GO:0044013,histone H2B acetyltransferase activity,10,0.0,1.0,1.0,2
1246,GO:0044357,regulation of rRNA stability,10,0.0,1.0,1.0,1
1247,GO:0044578,butyryl-CoA biosynthetic process,10,0.0,1.0,1.0,1
1248,GO:0044580,butyryl-CoA catabolic process,10,0.0,1.0,1.0,2
1249,GO:0044725,epigenetic programming in the zygotic pronuclei,10,0.0,1.0,1.0,3
1250,GO:0044774,mitotic DNA integrity checkpoint signaling,10,0.0,1.0,1.0,2
1251,GO:0044778,meiotic DNA integrity checkpoint signaling,10,0.0,1.0,1.0,1
1252,GO:0044818,mitotic G2/M transition checkpoint,10,0.0,1.0,1.0,2
1253,GO:0044819,mitotic G1/S transition checkpoint signaling,10,0.0,1.0,1.0,1
1254,GO:0045191,regulation of isotype switching,10,0.0,1.0,1.0,6
1255,GO:0045540,regulation of cholesterol biosynthetic process,10,0.0,1.0,1.0,2
1256,GO:0045578,negative regulation of B cell differentiation,10,0.0,1.0,1.0,4
1257,GO:0045579,positive regulation of B cell differentiation,10,0.0,1.0,1.0,4
1258,GO:0045581,negative regulation of T cell differentiation,10,0.0,1.0,1.0,8
1259,GO:0045582,positive regulation of T cell differentiation,10,0.0,1.0,1.0,8
1260,GO:0045583,regulation of cytotoxic T cell differentiation,10,0.0,1.0,1.0,2
1261,GO:0045586,regulation of gamma-delta T cell differentiation,10,0.0,1.0,1.0,2
1262,GO:0045589,regulation of regulatory T cell differentiation,10,0.0,1.0,1.0,3
1263,GO:0045640,regulation of basophil differentiation,10,0.0,1.0,1.0,2
1264,GO:0045643,regulation of eosinophil differentiation,10,0.0,1.0,1.0,2
1265,GO:0045650,negative regulation of macrophage differentiation,10,0.0,1.0,1.0,1
1266,GO:0045651,positive regulation of macrophage differentiation,10,0.0,1.0,1.0,1
1267,GO:0045658,regulation of neutrophil differentiation,10,0.0,1.0,1.0,2
1268,GO:0045671,negative regulation of osteoclast differentiation,10,0.0,1.0,1.0,1
1269,GO:0045672,positive regulation of osteoclast differentiation,10,0.0,1.0,1.0,1
1270,GO:0045727,positive regulation of translation,10,0.0,1.0,1.0,9
1271,GO:0045773,positive regulation of axon extension,10,0.0,1.0,1.0,2
1272,GO:0045815,transcription initiation-coupled chromatin remodeling,10,0.0,1.0,1.0,1
1273,GO:0045842,positive regulation of mitotic metaphase/anaphase transition,10,0.0,1.0,1.0,1
1274,GO:0045860,positive regulation of protein kinase activity,10,0.0,1.0,1.0,4
1275,GO:0045892,negative regulation of DNA-templated transcription,10,0.0,1.0,1.0,16
1276,GO:0045893,positive regulation of DNA-templated transcription,10,0.0,1.0,1.0,16
1277,GO:0045950,negative regulation of mitotic recombination,10,0.0,1.0,1.0,1
1278,GO:0045951,positive regulation of mitotic recombination,10,0.0,1.0,1.0,1
1279,GO:0045955,negative regulation of calcium ion-dependent exocytosis,10,0.0,1.0,1.0,2
1280,GO:0045956,positive regulation of calcium ion-dependent exocytosis,10,0.0,1.0,1.0,4
1281,GO:0045974,"regulation of translation, ncRNA-mediated",10,0.0,1.0,1.0,1
1282,GO:0045990,carbon catabolite regulation of transcription,10,0.0,1.0,1.0,3
1283,GO:0046011,regulation of oskar mRNA translation,10,0.0,1.0,1.0,2
1284,GO:0046015,regulation of transcription by glucose,10,0.0,1.0,1.0,3
1285,GO:0046031,ADP metabolic process,10,0.0,1.0,1.0,3
1286,GO:0046033,AMP metabolic process,10,0.0,1.0,1.0,3
1287,GO:0046034,ATP metabolic process,10,0.0,1.0,1.0,4
1288,GO:0046035,CMP metabolic process,10,0.0,1.0,1.0,2
1289,GO:0046036,CTP metabolic process,10,0.0,1.0,1.0,2
1290,GO:0046037,GMP metabolic process,10,0.0,1.0,1.0,2
1291,GO:0046039,GTP metabolic process,10,0.0,1.0,1.0,1
1292,GO:0046040,IMP metabolic process,10,0.0,1.0,1.0,3
1293,GO:0046041,ITP metabolic process,10,0.0,1.0,1.0,2
1294,GO:0046043,TDP metabolic process,10,0.0,1.0,1.0,2
1295,GO:0046044,TMP metabolic process,10,0.0,1.0,1.0,2
1296,GO:0046046,TTP metabolic process,10,0.0,1.0,1.0,2
1297,GO:0046048,UDP metabolic process,10,0.0,1.0,1.0,2
1298,GO:0046049,UMP metabolic process,10,0.0,1.0,1.0,2
1299,GO:0046051,UTP metabolic process,10,0.0,1.0,1.0,2
1300,GO:0046058,cAMP metabolic process,10,0.0,1.0,1.0,2
1301,GO:0046068,cGMP metabolic process,10,0.0,1.0,1.0,2
1302,GO:0046086,adenosine biosynthetic process,10,0.0,1.0,1.0,1
1303,GO:0046088,cytidine biosynthetic process,10,0.0,1.0,1.0,1
1304,GO:0046093,deoxycytidine biosynthetic process,10,0.0,1.0,1.0,1
1305,GO:0046095,deoxyinosine biosynthetic process,10,0.0,1.0,1.0,1
1306,GO:0046103,inosine biosynthetic process,10,0.0,1.0,1.0,1
1307,GO:0046180,ketogluconate biosynthetic process,10,0.0,1.0,1.0,1
1308,GO:0046181,ketogluconate catabolic process,10,0.0,1.0,1.0,1
1309,GO:0046317,regulation of glucosylceramide biosynthetic process,10,0.0,1.0,1.0,2
1310,GO:0046361,2-oxobutyrate metabolic process,10,0.0,1.0,1.0,2
1311,GO:0046396,D-galacturonate metabolic process,10,0.0,1.0,1.0,2
1312,GO:0046397,galacturonate catabolic process,10,0.0,1.0,1.0,1
1313,GO:0046399,glucuronate biosynthetic process,10,0.0,1.0,1.0,1
1314,GO:0046432,2'-(5''-triphosphoribosyl)-3'-dephospho-CoA metabolic process,10,0.0,1.0,1.0,1
1315,GO:0046439,L-cysteine metabolic process,10,0.0,1.0,1.0,1
1316,GO:0046440,L-lysine metabolic process,10,0.0,1.0,1.0,1
1317,GO:0046637,regulation of alpha-beta T cell differentiation,10,0.0,1.0,1.0,5
1318,GO:0046641,positive regulation of alpha-beta T cell proliferation,10,0.0,1.0,1.0,3
1319,GO:0046642,negative regulation of alpha-beta T cell proliferation,10,0.0,1.0,1.0,3
1320,GO:0046676,negative regulation of insulin secretion,10,0.0,1.0,1.0,1
1321,GO:0046704,CDP metabolic process,10,0.0,1.0,1.0,2
1322,GO:0046707,IDP metabolic process,10,0.0,1.0,1.0,2
1323,GO:0046710,GDP metabolic process,10,0.0,1.0,1.0,2
1324,GO:0046827,positive regulation of protein export from nucleus,10,0.0,1.0,1.0,2
1325,GO:0046946,hydroxylysine metabolic process,10,0.0,1.0,1.0,2
1326,GO:0048024,"regulation of mRNA splicing, via spliceosome",10,0.0,1.0,1.0,4
1327,GO:0048239,negative regulation of DNA recombination at telomere,10,0.0,1.0,1.0,1
1328,GO:0048671,negative regulation of collateral sprouting,10,0.0,1.0,1.0,3
1329,GO:0048672,positive regulation of collateral sprouting,10,0.0,1.0,1.0,3
1330,GO:0048680,positive regulation of axon regeneration,10,0.0,1.0,1.0,3
1331,GO:0048681,negative regulation of axon regeneration,10,0.0,1.0,1.0,3
1332,GO:0048683,regulation of collateral sprouting of intact axon in response to injury,10,0.0,1.0,1.0,2
1333,GO:0048693,regulation of collateral sprouting of injured axon,10,0.0,1.0,1.0,2
1334,GO:0048696,regulation of collateral sprouting in absence of injury,10,0.0,1.0,1.0,2
1335,GO:0048711,positive regulation of astrocyte differentiation,10,0.0,1.0,1.0,1
1336,GO:0048712,negative regulation of astrocyte differentiation,10,0.0,1.0,1.0,1
1337,GO:0048894,efferent axon development in a lateral line nerve,10,0.0,1.0,1.0,2
1338,GO:0050427,3'-phosphoadenosine 5'-phosphosulfate metabolic process,10,0.0,1.0,1.0,1
1339,GO:0050685,positive regulation of mRNA processing,10,0.0,1.0,1.0,3
1340,GO:0050686,negative regulation of mRNA processing,10,0.0,1.0,1.0,2
1341,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,10,0.0,1.0,1.0,3
1342,GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,10,0.0,1.0,1.0,3
1343,GO:0050775,positive regulation of dendrite morphogenesis,10,0.0,1.0,1.0,1
1344,GO:0050779,RNA destabilization,10,0.0,1.0,1.0,2
1345,GO:0050853,B cell receptor signaling pathway,10,0.0,1.0,1.0,1
1346,GO:0051090,regulation of DNA-binding transcription factor activity,10,0.0,1.0,1.0,3
1347,GO:0051121,hepoxilin metabolic process,10,0.0,1.0,1.0,1
1348,GO:0051126,negative regulation of actin nucleation,10,0.0,1.0,1.0,1
1349,GO:0051127,positive regulation of actin nucleation,10,0.0,1.0,1.0,1
1350,GO:0051134,negative regulation of NK T cell activation,10,0.0,1.0,1.0,1
1351,GO:0051135,positive regulation of NK T cell activation,10,0.0,1.0,1.0,1
1352,GO:0051140,regulation of NK T cell proliferation,10,0.0,1.0,1.0,2
1353,GO:0051158,L-arabitol catabolic process,10,0.0,1.0,1.0,1
1354,GO:0051159,D-arabitol catabolic process,10,0.0,1.0,1.0,1
1355,GO:0051209,release of sequestered calcium ion into cytosol,10,0.0,1.0,1.0,5
1356,GO:0051280,negative regulation of release of sequestered calcium ion into cytosol,10,0.0,1.0,1.0,1
1357,GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,10,0.0,1.0,1.0,2
1358,GO:0051492,regulation of stress fiber assembly,10,0.0,1.0,1.0,2
1359,GO:0051790,short-chain fatty acid biosynthetic process,10,0.0,1.0,1.0,4
1360,GO:0051946,regulation of glutamate uptake involved in transmission of nerve impulse,10,0.0,1.0,1.0,2
1361,GO:0052078,symbiont-mediated suppression of host pathogen-associated molecular pattern receptor signaling pathway,10,0.0,1.0,1.0,1
1362,GO:0052695,cellular glucuronidation,10,0.0,1.0,1.0,3
1363,GO:0060050,positive regulation of protein glycosylation,10,0.0,1.0,1.0,1
1364,GO:0060051,negative regulation of protein glycosylation,10,0.0,1.0,1.0,1
1365,GO:0060188,regulation of protein desumoylation,10,0.0,1.0,1.0,2
1366,GO:0060194,regulation of antisense RNA transcription,10,0.0,1.0,1.0,2
1367,GO:0060211,regulation of nuclear-transcribed mRNA poly(A) tail shortening,10,0.0,1.0,1.0,2
1368,GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,10,0.0,1.0,1.0,2
1369,GO:0060549,"regulation of fructose 1,6-bisphosphate 1-phosphatase activity",10,0.0,1.0,1.0,1
1370,GO:0060568,regulation of peptide hormone processing,10,0.0,1.0,1.0,2
1371,GO:0060964,regulation of miRNA-mediated gene silencing,10,0.0,1.0,1.0,2
1372,GO:0061014,positive regulation of mRNA catabolic process,10,0.0,1.0,1.0,8
1373,GO:0061097,regulation of protein tyrosine kinase activity,10,0.0,1.0,1.0,5
1374,GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,10,0.0,1.0,1.0,2
1375,GO:0061492,asymmetric protein localization to old or new spindle pole body,10,0.0,1.0,1.0,2
1376,GO:0061679,Entner-Doudoroff pathway through gluconate,10,0.0,1.0,1.0,2
1377,GO:0062111,zinc ion import into organelle,10,0.0,1.0,1.0,6
1378,GO:0062170,lutein metabolic process,10,0.0,1.0,1.0,2
1379,GO:0070127,tRNA aminoacylation for mitochondrial protein translation,10,0.0,1.0,1.0,20
1380,GO:0070129,regulation of mitochondrial translation,10,0.0,1.0,1.0,3
1381,GO:0070425,"negative regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",10,0.0,1.0,1.0,2
1382,GO:0070426,"positive regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",10,0.0,1.0,1.0,2
1383,GO:0070428,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,10,0.0,1.0,1.0,2
1384,GO:0070432,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,10,0.0,1.0,1.0,2
1385,GO:0070598,cell wall (1->3)-alpha-glucan biosynthetic process,10,0.0,1.0,1.0,1
1386,GO:0070599,fungal-type cell wall (1->3)-alpha-glucan metabolic process,10,0.0,1.0,1.0,1
1387,GO:0070607,regulation of cell wall (1->3)-alpha-glucan metabolic process,10,0.0,1.0,1.0,2
1388,GO:0070862,negative regulation of protein exit from endoplasmic reticulum,10,0.0,1.0,1.0,1
1389,GO:0070863,positive regulation of protein exit from endoplasmic reticulum,10,0.0,1.0,1.0,1
1390,GO:0070880,fungal-type cell wall beta-glucan biosynthetic process,10,0.0,1.0,1.0,2
1391,GO:0070900,mitochondrial tRNA modification,10,0.0,1.0,1.0,5
1392,GO:0070921,regulation of siRNA processing,10,0.0,1.0,1.0,2
1393,GO:0070951,regulation of neutrophil mediated killing of gram-negative bacterium,10,0.0,1.0,1.0,2
1394,GO:0070952,regulation of neutrophil mediated killing of gram-positive bacterium,10,0.0,1.0,1.0,2
1395,GO:0070956,negative regulation of neutrophil mediated killing of bacterium,10,0.0,1.0,1.0,2
1396,GO:0070962,positive regulation of neutrophil mediated killing of bacterium,10,0.0,1.0,1.0,2
1397,GO:0071041,antisense RNA transcript catabolic process,10,0.0,1.0,1.0,1
1398,GO:0071173,spindle assembly checkpoint signaling,10,0.0,1.0,1.0,2
1399,GO:0071174,mitotic spindle checkpoint signaling,10,0.0,1.0,1.0,2
1400,GO:0071514,genomic imprinting,10,0.0,1.0,1.0,3
1401,GO:0071630,nuclear protein quality control by the ubiquitin-proteasome system,10,0.0,1.0,1.0,1
1402,GO:0071635,negative regulation of transforming growth factor beta production,10,0.0,1.0,1.0,3
1403,GO:0071636,positive regulation of transforming growth factor beta production,10,0.0,1.0,1.0,3
1404,GO:0071637,regulation of monocyte chemotactic protein-1 production,10,0.0,1.0,1.0,2
1405,GO:0071640,regulation of macrophage inflammatory protein 1 alpha production,10,0.0,1.0,1.0,2
1406,GO:0071643,regulation of chemokine (C-C motif) ligand 4 production,10,0.0,1.0,1.0,2
1407,GO:0071646,regulation of macrophage inflammatory protein-1 gamma production,10,0.0,1.0,1.0,2
1408,GO:0071649,regulation of chemokine (C-C motif) ligand 5 production,10,0.0,1.0,1.0,2
1409,GO:0071652,regulation of chemokine (C-C motif) ligand 1 production,10,0.0,1.0,1.0,2
1410,GO:0071655,regulation of granulocyte colony-stimulating factor production,10,0.0,1.0,1.0,2
1411,GO:0071658,regulation of IP-10 production,10,0.0,1.0,1.0,2
1412,GO:0071900,regulation of protein serine/threonine kinase activity,10,0.0,1.0,1.0,9
1413,GO:0071969,fungal-type cell wall (1->3)-beta-D-glucan metabolic process,10,0.0,1.0,1.0,2
1414,GO:0071989,establishment of protein localization to spindle pole body,10,0.0,1.0,1.0,1
1415,GO:0072696,positive regulation of DNA recombination at telomere,10,0.0,1.0,1.0,1
1416,GO:0086007,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,10,0.0,1.0,1.0,4
1417,GO:0086008,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,10,0.0,1.0,1.0,6
1418,GO:0090031,positive regulation of steroid hormone biosynthetic process,10,0.0,1.0,1.0,3
1419,GO:0090032,negative regulation of steroid hormone biosynthetic process,10,0.0,1.0,1.0,4
1420,GO:0090085,regulation of protein deubiquitination,10,0.0,1.0,1.0,4
1421,GO:0090218,positive regulation of lipid kinase activity,10,0.0,1.0,1.0,1
1422,GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint,10,0.0,1.0,1.0,2
1423,GO:0090293,nitrogen catabolite regulation of transcription,10,0.0,1.0,1.0,3
1424,GO:0090296,regulation of mitochondrial DNA replication,10,0.0,1.0,1.0,2
1425,GO:0090337,regulation of formin-nucleated actin cable assembly,10,0.0,1.0,1.0,2
1426,GO:0097292,XMP metabolic process,10,0.0,1.0,1.0,1
1427,GO:0097377,spinal cord interneuron axon guidance,10,0.0,1.0,1.0,1
1428,GO:0098711,iron ion import across plasma membrane,10,0.0,1.0,1.0,1
1429,GO:0098910,regulation of atrial cardiac muscle cell action potential,10,0.0,1.0,1.0,2
1430,GO:0098911,regulation of ventricular cardiac muscle cell action potential,10,0.0,1.0,1.0,2
1431,GO:0098969,neurotransmitter receptor transport to postsynaptic membrane,10,0.0,1.0,1.0,1
1432,GO:0099011,neuronal dense core vesicle exocytosis,10,0.0,1.0,1.0,2
1433,GO:0099511,voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels,10,0.0,1.0,1.0,2
1434,GO:0099641,anterograde axonal protein transport,10,0.0,1.0,1.0,1
1435,GO:0100009,regulation of fever generation by prostaglandin secretion,10,0.0,1.0,1.0,1
1436,GO:0106119,negative regulation of sterol biosynthetic process,10,0.0,1.0,1.0,2
1437,GO:0106120,positive regulation of sterol biosynthetic process,10,0.0,1.0,1.0,2
1438,GO:0106134,positive regulation of cardiac muscle cell contraction,10,0.0,1.0,1.0,1
1439,GO:0106135,negative regulation of cardiac muscle cell contraction,10,0.0,1.0,1.0,2
1440,GO:0106288,regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA,10,0.0,1.0,1.0,1
1441,GO:0106349,snRNA methylation,10,0.0,1.0,1.0,1
1442,GO:0110002,regulation of tRNA methylation,10,0.0,1.0,1.0,2
1443,GO:0110028,positive regulation of mitotic spindle organization,10,0.0,1.0,1.0,3
1444,GO:0110162,regulation of mitotic spindle elongation (spindle phase three),10,0.0,1.0,1.0,2
1445,GO:0120270,"regulation of nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts",10,0.0,1.0,1.0,2
1446,GO:0140131,positive regulation of lymphocyte chemotaxis,10,0.0,1.0,1.0,3
1447,GO:0140133,symbiont-mediated suppression of host cytokine production,10,0.0,1.0,1.0,1
1448,GO:0140207,tripeptide import across plasma membrane,10,0.0,1.0,1.0,1
1449,GO:0140243,regulation of translation at synapse,10,0.0,1.0,1.0,3
1450,GO:0140280,negative regulation of mitotic division septum assembly,10,0.0,1.0,1.0,2
1451,GO:0140281,positive regulation of mitotic division septum assembly,10,0.0,1.0,1.0,1
1452,GO:0140298,endocytic iron import into cell,10,0.0,1.0,1.0,1
1453,GO:0140403,effector-mediated suppression of host innate immune response,10,0.0,1.0,1.0,1
1454,GO:0140542,regulation of piRNA transcription,10,0.0,1.0,1.0,1
1455,GO:0140743,regulation of lncRNA transcription,10,0.0,1.0,1.0,1
1456,GO:0141177,symbiont-mediated evasion of recognition by host innate immune effector,10,0.0,1.0,1.0,5
1457,GO:0150151,regulation of interleukin-17A production,10,0.0,1.0,1.0,2
1458,GO:0160033,regulation of Toll receptor ligand protein activation cascade,10,0.0,1.0,1.0,2
1459,GO:1900003,regulation of serine-type endopeptidase activity,10,0.0,1.0,1.0,2
1460,GO:1900060,negative regulation of ceramide biosynthetic process,10,0.0,1.0,1.0,1
1461,GO:1900084,regulation of peptidyl-tyrosine autophosphorylation,10,0.0,1.0,1.0,2
1462,GO:1900098,regulation of plasma cell differentiation,10,0.0,1.0,1.0,2
1463,GO:1900238,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,10,0.0,1.0,1.0,1
1464,GO:1900262,regulation of DNA-directed DNA polymerase activity,10,0.0,1.0,1.0,1
1465,GO:1900279,"regulation of CD4-positive, alpha-beta T cell costimulation",10,0.0,1.0,1.0,2
1466,GO:1900369,negative regulation of post-transcriptional gene silencing by regulatory ncRNA,10,0.0,1.0,1.0,1
1467,GO:1900370,positive regulation of post-transcriptional gene silencing by RNA,10,0.0,1.0,1.0,1
1468,GO:1900372,negative regulation of purine nucleotide biosynthetic process,10,0.0,1.0,1.0,3
1469,GO:1900373,positive regulation of purine nucleotide biosynthetic process,10,0.0,1.0,1.0,3
1470,GO:1900398,negative regulation of pyrimidine nucleotide biosynthetic process,10,0.0,1.0,1.0,1
1471,GO:1900533,palmitic acid metabolic process,10,0.0,1.0,1.0,2
1472,GO:1901017,negative regulation of potassium ion transmembrane transporter activity,10,0.0,1.0,1.0,3
1473,GO:1901018,positive regulation of potassium ion transmembrane transporter activity,10,0.0,1.0,1.0,3
1474,GO:1901020,negative regulation of calcium ion transmembrane transporter activity,10,0.0,1.0,1.0,4
1475,GO:1901021,positive regulation of calcium ion transmembrane transporter activity,10,0.0,1.0,1.0,6
1476,GO:1901069,guanosine-containing compound catabolic process,10,0.0,1.0,1.0,2
1477,GO:1901070,guanosine-containing compound biosynthetic process,10,0.0,1.0,1.0,2
1478,GO:1901178,spheroidene metabolic process,10,0.0,1.0,1.0,2
1479,GO:1901257,negative regulation of macrophage colony-stimulating factor production,10,0.0,1.0,1.0,1
1480,GO:1901258,positive regulation of macrophage colony-stimulating factor production,10,0.0,1.0,1.0,1
1481,GO:1901339,regulation of store-operated calcium channel activity,10,0.0,1.0,1.0,2
1482,GO:1901385,regulation of voltage-gated calcium channel activity,10,0.0,1.0,1.0,3
1483,GO:1901624,negative regulation of lymphocyte chemotaxis,10,0.0,1.0,1.0,2
1484,GO:1901673,regulation of mitotic spindle assembly,10,0.0,1.0,1.0,1
1485,GO:1901751,leukotriene A4 metabolic process,10,0.0,1.0,1.0,2
1486,GO:1901799,negative regulation of proteasomal protein catabolic process,10,0.0,1.0,1.0,2
1487,GO:1901800,positive regulation of proteasomal protein catabolic process,10,0.0,1.0,1.0,2
1488,GO:1901807,capsanthin metabolic process,10,0.0,1.0,1.0,2
1489,GO:1901813,astaxanthin metabolic process,10,0.0,1.0,1.0,2
1490,GO:1901825,zeaxanthin metabolic process,10,0.0,1.0,1.0,2
1491,GO:1901831,all-trans-neoxanthin metabolic process,10,0.0,1.0,1.0,2
1492,GO:1901864,capsorubin metabolic process,10,0.0,1.0,1.0,2
1493,GO:1901894,regulation of ATPase-coupled calcium transmembrane transporter activity,10,0.0,1.0,1.0,2
1494,GO:1901910,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,10,0.0,1.0,1.0,1
1495,GO:1901979,regulation of inward rectifier potassium channel activity,10,0.0,1.0,1.0,3
1496,GO:1902103,negative regulation of metaphase/anaphase transition of meiotic cell cycle,10,0.0,1.0,1.0,3
1497,GO:1902104,positive regulation of metaphase/anaphase transition of meiotic cell cycle,10,0.0,1.0,1.0,2
1498,GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,10,0.0,1.0,1.0,1
1499,GO:1902222,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,10,0.0,1.0,1.0,2
1500,GO:1902223,erythrose 4-phosphate/phosphoenolpyruvate family amino acid biosynthetic process,10,0.0,1.0,1.0,2
1501,GO:1902259,regulation of delayed rectifier potassium channel activity,10,0.0,1.0,1.0,2
1502,GO:1902278,positive regulation of pancreatic amylase secretion,10,0.0,1.0,1.0,1
1503,GO:1902297,cell cycle DNA replication DNA unwinding,10,0.0,1.0,1.0,2
1504,GO:1902319,DNA strand elongation involved in nuclear cell cycle DNA replication,10,0.0,1.0,1.0,2
1505,GO:1902333,nuclear DNA replication DNA ligation,10,0.0,1.0,1.0,2
1506,GO:1902371,negative regulation of tRNA catabolic process,10,0.0,1.0,1.0,1
1507,GO:1902372,positive regulation of tRNA catabolic process,10,0.0,1.0,1.0,1
1508,GO:1902373,negative regulation of mRNA catabolic process,10,0.0,1.0,1.0,6
1509,GO:1902425,positive regulation of attachment of mitotic spindle microtubules to kinetochore,10,0.0,1.0,1.0,2
1510,GO:1902440,protein localization to mitotic spindle pole body,10,0.0,1.0,1.0,3
1511,GO:1902497,iron-sulfur cluster transmembrane transport,10,0.0,1.0,1.0,1
1512,GO:1902559,3'-phospho-5'-adenylyl sulfate transmembrane transport,10,0.0,1.0,1.0,1
1513,GO:1902572,negative regulation of serine-type peptidase activity,10,0.0,1.0,1.0,1
1514,GO:1902573,positive regulation of serine-type peptidase activity,10,0.0,1.0,1.0,1
1515,GO:1902606,regulation of large conductance calcium-activated potassium channel activity,10,0.0,1.0,1.0,2
1516,GO:1902646,"regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process",10,0.0,1.0,1.0,2
1517,GO:1902689,negative regulation of NAD metabolic process,10,0.0,1.0,1.0,1
1518,GO:1902690,positive regulation of NAD metabolic process,10,0.0,1.0,1.0,1
1519,GO:1902730,positive regulation of proteoglycan biosynthetic process,10,0.0,1.0,1.0,1
1520,GO:1902835,negative regulation of proline import across plasma membrane,10,0.0,1.0,1.0,1
1521,GO:1902836,positive regulation of proline import across plasma membrane,10,0.0,1.0,1.0,1
1522,GO:1902846,positive regulation of mitotic spindle elongation,10,0.0,1.0,1.0,1
1523,GO:1902893,regulation of miRNA transcription,10,0.0,1.0,1.0,2
1524,GO:1902959,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,10,0.0,1.0,1.0,2
1525,GO:1903108,regulation of mitochondrial transcription,10,0.0,1.0,1.0,1
1526,GO:1903110,regulation of single-strand break repair via homologous recombination,10,0.0,1.0,1.0,2
1527,GO:1903216,regulation of protein processing involved in protein targeting to mitochondrion,10,0.0,1.0,1.0,1
1528,GO:1903233,regulation of calcium ion-dependent exocytosis of neurotransmitter,10,0.0,1.0,1.0,3
1529,GO:1903279,regulation of calcium:sodium antiporter activity,10,0.0,1.0,1.0,1
1530,GO:1903300,negative regulation of hexokinase activity,10,0.0,1.0,1.0,1
1531,GO:1903301,positive regulation of hexokinase activity,10,0.0,1.0,1.0,1
1532,GO:1903321,negative regulation of protein modification by small protein conjugation or removal,10,0.0,1.0,1.0,5
1533,GO:1903322,positive regulation of protein modification by small protein conjugation or removal,10,0.0,1.0,1.0,5
1534,GO:1903377,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,10,0.0,1.0,1.0,1
1535,GO:1903383,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,10,0.0,1.0,1.0,1
1536,GO:1903406,regulation of P-type sodium:potassium-exchanging transporter activity,10,0.0,1.0,1.0,2
1537,GO:1903499,regulation of mitotic actomyosin contractile ring assembly,10,0.0,1.0,1.0,2
1538,GO:1903517,negative regulation of single strand break repair,10,0.0,1.0,1.0,2
1539,GO:1903518,positive regulation of single strand break repair,10,0.0,1.0,1.0,1
1540,GO:1903528,regulation of dCDP biosynthetic process,10,0.0,1.0,1.0,1
1541,GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production,10,0.0,1.0,1.0,4
1542,GO:1903579,negative regulation of ATP metabolic process,10,0.0,1.0,1.0,2
1543,GO:1903580,positive regulation of ATP metabolic process,10,0.0,1.0,1.0,2
1544,GO:1903581,regulation of basophil degranulation,10,0.0,1.0,1.0,2
1545,GO:1903751,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,10,0.0,1.0,1.0,1
1546,GO:1903760,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,10,0.0,1.0,1.0,1
1547,GO:1903798,regulation of miRNA processing,10,0.0,1.0,1.0,4
1548,GO:1903884,regulation of chemokine (C-C motif) ligand 20 production,10,0.0,1.0,1.0,2
1549,GO:1903921,regulation of protein processing in phagocytic vesicle,10,0.0,1.0,1.0,2
1550,GO:1904029,regulation of cyclin-dependent protein kinase activity,10,0.0,1.0,1.0,3
1551,GO:1904098,regulation of protein O-linked glycosylation,10,0.0,1.0,1.0,2
1552,GO:1904152,"regulation of retrograde protein transport, ER to cytosol",10,0.0,1.0,1.0,2
1553,GO:1904279,regulation of transcription by RNA polymerase V,10,0.0,1.0,1.0,2
1554,GO:1904292,regulation of ERAD pathway,10,0.0,1.0,1.0,2
1555,GO:1904315,transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential,10,0.0,1.0,1.0,1
1556,GO:1904354,negative regulation of telomere capping,10,0.0,1.0,1.0,1
1557,GO:1904357,negative regulation of telomere maintenance via telomere lengthening,10,0.0,1.0,1.0,1
1558,GO:1904358,positive regulation of telomere maintenance via telomere lengthening,10,0.0,1.0,1.0,1
1559,GO:1904459,negative regulation of substance P secretion,10,0.0,1.0,1.0,1
1560,GO:1904460,positive regulation of substance P secretion,10,0.0,1.0,1.0,1
1561,GO:1904494,"regulation of substance P secretion, neurotransmission",10,0.0,1.0,1.0,2
1562,GO:1904506,negative regulation of telomere maintenance in response to DNA damage,10,0.0,1.0,1.0,1
1563,GO:1904507,positive regulation of telomere maintenance in response to DNA damage,10,0.0,1.0,1.0,1
1564,GO:1904534,negative regulation of telomeric loop disassembly,10,0.0,1.0,1.0,1
1565,GO:1904535,positive regulation of telomeric loop disassembly,10,0.0,1.0,1.0,1
1566,GO:1904594,regulation of termination of RNA polymerase II transcription,10,0.0,1.0,1.0,3
1567,GO:1904683,regulation of metalloendopeptidase activity,10,0.0,1.0,1.0,3
1568,GO:1904686,regulation of mitotic spindle disassembly,10,0.0,1.0,1.0,1
1569,GO:1904735,regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase,10,0.0,1.0,1.0,2
1570,GO:1904825,protein localization to microtubule plus-end,10,0.0,1.0,1.0,1
1571,GO:1904907,"regulation of maintenance of mitotic sister chromatid cohesion, telomeric",10,0.0,1.0,1.0,2
1572,GO:1905012,regulation of 'de novo' NAD biosynthetic process from tryptophan,10,0.0,1.0,1.0,2
1573,GO:1905049,negative regulation of metallopeptidase activity,10,0.0,1.0,1.0,1
1574,GO:1905050,positive regulation of metallopeptidase activity,10,0.0,1.0,1.0,1
1575,GO:1905115,regulation of lateral attachment of mitotic spindle microtubules to kinetochore,10,0.0,1.0,1.0,1
1576,GO:1905150,regulation of voltage-gated sodium channel activity,10,0.0,1.0,1.0,2
1577,GO:1905186,regulation of metaphase/anaphase transition of meiosis I,10,0.0,1.0,1.0,2
1578,GO:1905189,regulation of metaphase/anaphase transition of meiosis II,10,0.0,1.0,1.0,2
1579,GO:1905246,negative regulation of aspartic-type peptidase activity,10,0.0,1.0,1.0,1
1580,GO:1905247,positive regulation of aspartic-type peptidase activity,10,0.0,1.0,1.0,1
1581,GO:1905325,regulation of meiosis I spindle assembly checkpoint,10,0.0,1.0,1.0,1
1582,GO:1905413,regulation of dense core granule exocytosis,10,0.0,1.0,1.0,4
1583,GO:1905447,negative regulation of mitochondrial ATP synthesis coupled electron transport,10,0.0,1.0,1.0,1
1584,GO:1905533,negative regulation of L-leucine import across plasma membrane,10,0.0,1.0,1.0,1
1585,GO:1905591,regulation of optical nerve axon regeneration,10,0.0,1.0,1.0,2
1586,GO:1905637,regulation of mitochondrial mRNA catabolic process,10,0.0,1.0,1.0,2
1587,GO:1905687,regulation of diacylglycerol kinase activity,10,0.0,1.0,1.0,1
1588,GO:1905735,regulation of L-proline import across plasma membrane,10,0.0,1.0,1.0,2
1589,GO:1905756,regulation of primary cell septum biogenesis,10,0.0,1.0,1.0,2
1590,GO:1905764,regulation of protection from non-homologous end joining at telomere,10,0.0,1.0,1.0,2
1591,GO:1905831,negative regulation of spindle assembly,10,0.0,1.0,1.0,1
1592,GO:1905832,positive regulation of spindle assembly,10,0.0,1.0,1.0,1
1593,GO:1905838,regulation of telomeric D-loop disassembly,10,0.0,1.0,1.0,2
1594,GO:1990564,protein polyufmylation,10,0.0,1.0,1.0,1
1595,GO:1990882,rRNA acetylation,10,0.0,1.0,1.0,1
1596,GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,10,0.0,1.0,1.0,1
1597,GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,10,0.0,1.0,1.0,1
1598,GO:2000104,negative regulation of DNA-templated DNA replication,10,0.0,1.0,1.0,6
1599,GO:2000105,positive regulation of DNA-templated DNA replication,10,0.0,1.0,1.0,4
1600,GO:2000116,regulation of cysteine-type endopeptidase activity,10,0.0,1.0,1.0,2
1601,GO:2000142,regulation of DNA-templated transcription initiation,10,0.0,1.0,1.0,4
1602,GO:2000174,regulation of pro-T cell differentiation,10,0.0,1.0,1.0,2
1603,GO:2000183,negative regulation of progesterone biosynthetic process,10,0.0,1.0,1.0,1
1604,GO:2000237,positive regulation of tRNA processing,10,0.0,1.0,1.0,1
1605,GO:2000258,negative regulation of protein activation cascade,10,0.0,1.0,1.0,5
1606,GO:2000259,positive regulation of protein activation cascade,10,0.0,1.0,1.0,5
1607,GO:2000260,"regulation of blood coagulation, common pathway",10,0.0,1.0,1.0,2
1608,GO:2000263,"regulation of blood coagulation, extrinsic pathway",10,0.0,1.0,1.0,2
1609,GO:2000266,"regulation of blood coagulation, intrinsic pathway",10,0.0,1.0,1.0,2
1610,GO:2000301,negative regulation of synaptic vesicle exocytosis,10,0.0,1.0,1.0,3
1611,GO:2000302,positive regulation of synaptic vesicle exocytosis,10,0.0,1.0,1.0,2
1612,GO:2000304,positive regulation of ceramide biosynthetic process,10,0.0,1.0,1.0,1
1613,GO:2000307,regulation of tumor necrosis factor (ligand) superfamily member 11 production,10,0.0,1.0,1.0,2
1614,GO:2000338,regulation of chemokine (C-X-C motif) ligand 1 production,10,0.0,1.0,1.0,2
1615,GO:2000367,regulation of acrosomal vesicle exocytosis,10,0.0,1.0,1.0,1
1616,GO:2000405,negative regulation of T cell migration,10,0.0,1.0,1.0,2
1617,GO:2000406,positive regulation of T cell migration,10,0.0,1.0,1.0,3
1618,GO:2000407,regulation of T cell extravasation,10,0.0,1.0,1.0,3
1619,GO:2000410,regulation of thymocyte migration,10,0.0,1.0,1.0,3
1620,GO:2000432,"negative regulation of cytokinesis, actomyosin contractile ring assembly",10,0.0,1.0,1.0,1
1621,GO:2000433,"positive regulation of cytokinesis, actomyosin contractile ring assembly",10,0.0,1.0,1.0,1
1622,GO:2000434,regulation of protein neddylation,10,0.0,1.0,1.0,2
1623,GO:2000501,regulation of natural killer cell chemotaxis,10,0.0,1.0,1.0,2
1624,GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation",10,0.0,1.0,1.0,3
1625,GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",10,0.0,1.0,1.0,6
1626,GO:2000517,regulation of T-helper 1 cell activation,10,0.0,1.0,1.0,2
1627,GO:2000537,regulation of B cell chemotaxis,10,0.0,1.0,1.0,2
1628,GO:2000557,regulation of immunoglobulin production in mucosal tissue,10,0.0,1.0,1.0,1
1629,GO:2000561,"regulation of CD4-positive, alpha-beta T cell proliferation",10,0.0,1.0,1.0,2
1630,GO:2000564,"regulation of CD8-positive, alpha-beta T cell proliferation",10,0.0,1.0,1.0,2
1631,GO:2000569,regulation of T-helper 2 cell activation,10,0.0,1.0,1.0,1
1632,GO:2000621,regulation of DNA replication termination,10,0.0,1.0,1.0,1
1633,GO:2000622,"regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",10,0.0,1.0,1.0,2
1634,GO:2000650,negative regulation of sodium ion transmembrane transporter activity,10,0.0,1.0,1.0,3
1635,GO:2000651,positive regulation of sodium ion transmembrane transporter activity,10,0.0,1.0,1.0,4
1636,GO:2000709,"regulation of maintenance of meiotic sister chromatid cohesion, centromeric",10,0.0,1.0,1.0,2
1637,GO:2000715,"regulation of maintenance of mitotic sister chromatid cohesion, arms",10,0.0,1.0,1.0,2
1638,GO:2000718,"regulation of maintenance of mitotic sister chromatid cohesion, centromeric",10,0.0,1.0,1.0,2
1639,GO:2000757,negative regulation of peptidyl-lysine acetylation,10,0.0,1.0,1.0,1
1640,GO:2000758,positive regulation of peptidyl-lysine acetylation,10,0.0,1.0,1.0,1
1641,GO:2000759,regulation of N-terminal peptidyl-lysine acetylation,10,0.0,1.0,1.0,2
1642,GO:2000765,regulation of cytoplasmic translation,10,0.0,1.0,1.0,5
1643,GO:2000780,negative regulation of double-strand break repair,10,0.0,1.0,1.0,3
1644,GO:2000781,positive regulation of double-strand break repair,10,0.0,1.0,1.0,2
1645,GO:2000816,negative regulation of mitotic sister chromatid separation,10,0.0,1.0,1.0,2
1646,GO:2000827,mitochondrial RNA surveillance,10,0.0,1.0,1.0,2
1647,GO:2000847,negative regulation of corticosteroid hormone secretion,10,0.0,1.0,1.0,2
1648,GO:2000848,positive regulation of corticosteroid hormone secretion,10,0.0,1.0,1.0,2
1649,GO:2000849,regulation of glucocorticoid secretion,10,0.0,1.0,1.0,4
1650,GO:2000855,regulation of mineralocorticoid secretion,10,0.0,1.0,1.0,3
1651,GO:2000882,negative regulation of starch catabolic process,10,0.0,1.0,1.0,1
1652,GO:2000883,positive regulation of starch catabolic process,10,0.0,1.0,1.0,1
1653,GO:2000886,glucuronoxylan catabolic process,10,0.0,1.0,1.0,1
1654,GO:2000888,arabinoxylan-containing compound catabolic process,10,0.0,1.0,1.0,1
1655,GO:2000951,regulation of xyloglucan catabolic process,10,0.0,1.0,1.0,2
1656,GO:2000989,negative regulation of hemicellulose catabolic process,10,0.0,1.0,1.0,2
1657,GO:2000990,positive regulation of hemicellulose catabolic process,10,0.0,1.0,1.0,2
1658,GO:2000996,positive regulation of mannan catabolic process,10,0.0,1.0,1.0,1
1659,GO:2001000,regulation of xylan catabolic process,10,0.0,1.0,1.0,4
1660,GO:2001032,regulation of double-strand break repair via nonhomologous end joining,10,0.0,1.0,1.0,2
1661,GO:2001169,regulation of ATP biosynthetic process,10,0.0,1.0,1.0,3
1662,GO:2001186,"negative regulation of CD8-positive, alpha-beta T cell activation",10,0.0,1.0,1.0,2
1663,GO:2001187,"positive regulation of CD8-positive, alpha-beta T cell activation",10,0.0,1.0,1.0,2
1664,GO:2001280,positive regulation of unsaturated fatty acid biosynthetic process,10,0.0,1.0,1.0,1
1665,GO:2001302,lipoxin A4 metabolic process,10,0.0,1.0,1.0,1
1666,GO:2001304,lipoxin B4 metabolic process,10,0.0,1.0,1.0,1
80,GO:2000343,positive regulation of chemokine (C-X-C motif) ligand 2 production,11,820.4,820.4,4.7835816524833266e-14,0
110,GO:0032731,positive regulation of interleukin-1 beta production,11,152.89,152.89,2.564808569709895e-10,0
122,GO:0032760,positive regulation of tumor necrosis factor production,11,100.11,100.11,2.136355255963959e-09,0
558,GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,11,0.0,1.0,1.0,2
559,GO:0000122,negative regulation of transcription by RNA polymerase II,11,0.0,1.0,1.0,5
560,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",11,0.0,1.0,1.0,2
561,GO:0000429,carbon catabolite regulation of transcription from RNA polymerase II promoter,11,0.0,1.0,1.0,5
562,GO:0000451,rRNA 2'-O-methylation,11,0.0,1.0,1.0,1
563,GO:0001079,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,11,0.0,1.0,1.0,2
564,GO:0001796,regulation of type IIa hypersensitivity,11,0.0,1.0,1.0,3
565,GO:0001799,regulation of type IIb hypersensitivity,11,0.0,1.0,1.0,2
566,GO:0002098,tRNA wobble uridine modification,11,0.0,1.0,1.0,3
567,GO:0002101,tRNA wobble cytosine modification,11,0.0,1.0,1.0,2
568,GO:0002128,tRNA nucleoside ribose methylation,11,0.0,1.0,1.0,2
569,GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,11,0.0,1.0,1.0,1
570,GO:0002224,toll-like receptor signaling pathway,11,0.0,1.0,1.0,6
571,GO:0002257,negative regulation of kinin cascade,11,0.0,1.0,1.0,2
572,GO:0002258,positive regulation of kinin cascade,11,0.0,1.0,1.0,2
573,GO:0002382,regulation of tissue kallikrein-kinin cascade,11,0.0,1.0,1.0,2
574,GO:0002452,B cell receptor editing,11,0.0,1.0,1.0,2
575,GO:0002529,regulation of plasma kallikrein-kinin cascade,11,0.0,1.0,1.0,2
576,GO:0002725,negative regulation of T cell cytokine production,11,0.0,1.0,1.0,2
577,GO:0002726,positive regulation of T cell cytokine production,11,0.0,1.0,1.0,2
578,GO:0002731,negative regulation of dendritic cell cytokine production,11,0.0,1.0,1.0,2
579,GO:0002732,positive regulation of dendritic cell cytokine production,11,0.0,1.0,1.0,2
580,GO:0002733,regulation of myeloid dendritic cell cytokine production,11,0.0,1.0,1.0,2
581,GO:0002736,regulation of plasmacytoid dendritic cell cytokine production,11,0.0,1.0,1.0,2
582,GO:0002752,cell surface pattern recognition receptor signaling pathway,11,0.0,1.0,1.0,2
583,GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,11,0.0,1.0,1.0,7
584,GO:0002787,negative regulation of antibacterial peptide production,11,0.0,1.0,1.0,2
585,GO:0002789,negative regulation of antifungal peptide production,11,0.0,1.0,1.0,2
586,GO:0002795,negative regulation of antimicrobial peptide secretion,11,0.0,1.0,1.0,2
587,GO:0002796,positive regulation of antimicrobial peptide secretion,11,0.0,1.0,1.0,2
588,GO:0002797,regulation of antibacterial peptide secretion,11,0.0,1.0,1.0,2
589,GO:0002800,regulation of antifungal peptide secretion,11,0.0,1.0,1.0,2
590,GO:0002803,positive regulation of antibacterial peptide production,11,0.0,1.0,1.0,2
591,GO:0002804,positive regulation of antifungal peptide production,11,0.0,1.0,1.0,2
592,GO:0002806,negative regulation of antimicrobial peptide biosynthetic process,11,0.0,1.0,1.0,2
593,GO:0002807,positive regulation of antimicrobial peptide biosynthetic process,11,0.0,1.0,1.0,2
594,GO:0002808,regulation of antibacterial peptide biosynthetic process,11,0.0,1.0,1.0,4
595,GO:0002810,regulation of antifungal peptide biosynthetic process,11,0.0,1.0,1.0,2
596,GO:0002893,negative regulation of type II hypersensitivity,11,0.0,1.0,1.0,2
597,GO:0002894,positive regulation of type II hypersensitivity,11,0.0,1.0,1.0,2
598,GO:0002946,tRNA C5-cytosine methylation,11,0.0,1.0,1.0,1
599,GO:0005220,"inositol 1,4,5-trisphosphate-gated calcium channel activity",11,0.0,1.0,1.0,1
600,GO:0006167,AMP biosynthetic process,11,0.0,1.0,1.0,2
601,GO:0006177,GMP biosynthetic process,11,0.0,1.0,1.0,2
602,GO:0006188,IMP biosynthetic process,11,0.0,1.0,1.0,2
603,GO:0006222,UMP biosynthetic process,11,0.0,1.0,1.0,2
604,GO:0006241,CTP biosynthetic process,11,0.0,1.0,1.0,2
605,GO:0006447,regulation of translational initiation by iron,11,0.0,1.0,1.0,2
606,GO:0006527,arginine catabolic process,11,0.0,1.0,1.0,7
607,GO:0006529,asparagine biosynthetic process,11,0.0,1.0,1.0,3
608,GO:0006530,asparagine catabolic process,11,0.0,1.0,1.0,2
609,GO:0006537,glutamate biosynthetic process,11,0.0,1.0,1.0,1
610,GO:0006538,glutamate catabolic process,11,0.0,1.0,1.0,9
611,GO:0006542,glutamine biosynthetic process,11,0.0,1.0,1.0,1
612,GO:0006545,glycine biosynthetic process,11,0.0,1.0,1.0,2
613,GO:0006546,glycine catabolic process,11,0.0,1.0,1.0,4
614,GO:0006559,L-phenylalanine catabolic process,11,0.0,1.0,1.0,1
615,GO:0006561,proline biosynthetic process,11,0.0,1.0,1.0,2
616,GO:0006562,proline catabolic process,11,0.0,1.0,1.0,2
617,GO:0006567,threonine catabolic process,11,0.0,1.0,1.0,4
618,GO:0006571,tyrosine biosynthetic process,11,0.0,1.0,1.0,3
619,GO:0006572,tyrosine catabolic process,11,0.0,1.0,1.0,1
620,GO:0006693,prostaglandin metabolic process,11,0.0,1.0,1.0,1
621,GO:0006734,NADH metabolic process,11,0.0,1.0,1.0,3
622,GO:0006740,NADPH regeneration,11,0.0,1.0,1.0,3
623,GO:0006754,ATP biosynthetic process,11,0.0,1.0,1.0,2
624,GO:0007176,regulation of epidermal growth factor-activated receptor activity,11,0.0,1.0,1.0,2
625,GO:0009048,dosage compensation by inactivation of X chromosome,11,0.0,1.0,1.0,2
626,GO:0009085,lysine biosynthetic process,11,0.0,1.0,1.0,2
627,GO:0009086,methionine biosynthetic process,11,0.0,1.0,1.0,1
628,GO:0009087,methionine catabolic process,11,0.0,1.0,1.0,4
629,GO:0009094,L-phenylalanine biosynthetic process,11,0.0,1.0,1.0,2
630,GO:0009153,purine deoxyribonucleotide biosynthetic process,11,0.0,1.0,1.0,7
631,GO:0009155,purine deoxyribonucleotide catabolic process,11,0.0,1.0,1.0,7
632,GO:0009221,pyrimidine deoxyribonucleotide biosynthetic process,11,0.0,1.0,1.0,10
633,GO:0009223,pyrimidine deoxyribonucleotide catabolic process,11,0.0,1.0,1.0,10
634,GO:0009224,CMP biosynthetic process,11,0.0,1.0,1.0,1
635,GO:0009435,NAD biosynthetic process,11,0.0,1.0,1.0,3
636,GO:0009616,RNAi-mediated antiviral immune response,11,0.0,1.0,1.0,2
637,GO:0010138,pyrimidine ribonucleotide salvage,11,0.0,1.0,1.0,3
638,GO:0010571,positive regulation of nuclear cell cycle DNA replication,11,0.0,1.0,1.0,2
639,GO:0010610,regulation of mRNA stability involved in response to stress,11,0.0,1.0,1.0,1
640,GO:0014809,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,11,0.0,1.0,1.0,2
641,GO:0015687,ferric-hydroxamate import into cell,11,0.0,1.0,1.0,1
642,GO:0016479,negative regulation of transcription by RNA polymerase I,11,0.0,1.0,1.0,3
643,GO:0016480,negative regulation of transcription by RNA polymerase III,11,0.0,1.0,1.0,1
644,GO:0019344,cysteine biosynthetic process,11,0.0,1.0,1.0,3
645,GO:0019368,"fatty acid elongation, unsaturated fatty acid",11,0.0,1.0,1.0,2
646,GO:0019448,L-cysteine catabolic process,11,0.0,1.0,1.0,4
647,GO:0019477,L-lysine catabolic process,11,0.0,1.0,1.0,3
648,GO:0019543,propionate catabolic process,11,0.0,1.0,1.0,1
649,GO:0019677,NAD catabolic process,11,0.0,1.0,1.0,1
650,GO:0021786,branchiomotor neuron axon guidance in neural tube,11,0.0,1.0,1.0,2
651,GO:0021789,branchiomotor neuron axon guidance in branchial arch mesenchyme,11,0.0,1.0,1.0,2
652,GO:0030835,negative regulation of actin filament depolymerization,11,0.0,1.0,1.0,1
653,GO:0030836,positive regulation of actin filament depolymerization,11,0.0,1.0,1.0,2
654,GO:0030837,negative regulation of actin filament polymerization,11,0.0,1.0,1.0,2
655,GO:0030838,positive regulation of actin filament polymerization,11,0.0,1.0,1.0,1
656,GO:0031048,regulatory ncRNA-mediated heterochromatin formation,11,0.0,1.0,1.0,2
657,GO:0031394,positive regulation of prostaglandin biosynthetic process,11,0.0,1.0,1.0,1
658,GO:0031397,negative regulation of protein ubiquitination,11,0.0,1.0,1.0,4
659,GO:0031398,positive regulation of protein ubiquitination,11,0.0,1.0,1.0,4
660,GO:0031442,positive regulation of mRNA 3'-end processing,11,0.0,1.0,1.0,1
661,GO:0031947,negative regulation of glucocorticoid biosynthetic process,11,0.0,1.0,1.0,1
662,GO:0031948,positive regulation of glucocorticoid biosynthetic process,11,0.0,1.0,1.0,1
663,GO:0032055,negative regulation of translation in response to stress,11,0.0,1.0,1.0,6
664,GO:0032056,positive regulation of translation in response to stress,11,0.0,1.0,1.0,5
665,GO:0032147,activation of protein kinase activity,11,0.0,1.0,1.0,6
666,GO:0032297,negative regulation of DNA-templated DNA replication initiation,11,0.0,1.0,1.0,3
667,GO:0032298,positive regulation of DNA-templated DNA replication initiation,11,0.0,1.0,1.0,2
668,GO:0032435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,11,0.0,1.0,1.0,2
669,GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,11,0.0,1.0,1.0,2
670,GO:0032785,"negative regulation of DNA-templated transcription, elongation",11,0.0,1.0,1.0,2
671,GO:0032786,"positive regulation of DNA-templated transcription, elongation",11,0.0,1.0,1.0,2
672,GO:0032953,regulation of (1->3)-beta-D-glucan biosynthetic process,11,0.0,1.0,1.0,3
673,GO:0033085,negative regulation of T cell differentiation in thymus,11,0.0,1.0,1.0,2
674,GO:0033089,positive regulation of T cell differentiation in thymus,11,0.0,1.0,1.0,1
675,GO:0033152,immunoglobulin V(D)J recombination,11,0.0,1.0,1.0,2
676,GO:0033526,tetrapyrrole biosynthetic process from glutamate,11,0.0,1.0,1.0,1
677,GO:0033540,fatty acid beta-oxidation using acyl-CoA oxidase,11,0.0,1.0,1.0,1
678,GO:0033542,"fatty acid beta-oxidation, unsaturated, even number",11,0.0,1.0,1.0,2
679,GO:0034243,regulation of transcription elongation by RNA polymerase II,11,0.0,1.0,1.0,2
680,GO:0034409,ascospore wall (1->3)-beta-D-glucan metabolic process,11,0.0,1.0,1.0,1
681,GO:0034412,ascospore wall beta-glucan biosynthetic process,11,0.0,1.0,1.0,1
682,GO:0035195,miRNA-mediated post-transcriptional gene silencing,11,0.0,1.0,1.0,2
683,GO:0035351,heme transmembrane transport,11,0.0,1.0,1.0,2
684,GO:0035504,regulation of myosin light chain kinase activity,11,0.0,1.0,1.0,1
685,GO:0035862,dITP metabolic process,11,0.0,1.0,1.0,1
686,GO:0035895,modulation of mast cell degranulation in another organism,11,0.0,1.0,1.0,1
687,GO:0035931,mineralocorticoid secretion,11,0.0,1.0,1.0,1
688,GO:0035933,glucocorticoid secretion,11,0.0,1.0,1.0,2
689,GO:0036453,transitive RNA interference,11,0.0,1.0,1.0,2
690,GO:0036490,regulation of translation in response to endoplasmic reticulum stress,11,0.0,1.0,1.0,3
691,GO:0039537,symbiont-mediated suppression of cytoplasmic pattern recognition receptor signaling pathway,11,0.0,1.0,1.0,9
692,GO:0042093,T-helper cell differentiation,11,0.0,1.0,1.0,4
693,GO:0042840,D-glucuronate catabolic process,11,0.0,1.0,1.0,1
694,GO:0042852,L-alanine biosynthetic process,11,0.0,1.0,1.0,2
695,GO:0042853,L-alanine catabolic process,11,0.0,1.0,1.0,4
696,GO:0043111,replication fork arrest,11,0.0,1.0,1.0,4
697,GO:0043306,positive regulation of mast cell degranulation,11,0.0,1.0,1.0,2
698,GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",11,0.0,1.0,1.0,4
699,GO:0043376,"regulation of CD8-positive, alpha-beta T cell differentiation",11,0.0,1.0,1.0,2
700,GO:0043405,regulation of MAP kinase activity,11,0.0,1.0,1.0,3
701,GO:0043433,negative regulation of DNA-binding transcription factor activity,11,0.0,1.0,1.0,3
702,GO:0043557,regulation of translation in response to osmotic stress,11,0.0,1.0,1.0,3
703,GO:0043558,regulation of translational initiation in response to stress,11,0.0,1.0,1.0,7
704,GO:0044773,mitotic DNA damage checkpoint signaling,11,0.0,1.0,1.0,3
705,GO:0044779,meiotic spindle checkpoint signaling,11,0.0,1.0,1.0,1
706,GO:0045013,carbon catabolite repression of transcription,11,0.0,1.0,1.0,3
707,GO:0045590,negative regulation of regulatory T cell differentiation,11,0.0,1.0,1.0,1
708,GO:0045591,positive regulation of regulatory T cell differentiation,11,0.0,1.0,1.0,1
709,GO:0045820,negative regulation of glycolytic process,11,0.0,1.0,1.0,1
710,GO:0045821,positive regulation of glycolytic process,11,0.0,1.0,1.0,1
711,GO:0045829,negative regulation of isotype switching,11,0.0,1.0,1.0,4
712,GO:0045830,positive regulation of isotype switching,11,0.0,1.0,1.0,4
713,GO:0045841,negative regulation of mitotic metaphase/anaphase transition,11,0.0,1.0,1.0,1
714,GO:0045900,negative regulation of translational elongation,11,0.0,1.0,1.0,4
715,GO:0045901,positive regulation of translational elongation,11,0.0,1.0,1.0,4
716,GO:0045943,positive regulation of transcription by RNA polymerase I,11,0.0,1.0,1.0,3
717,GO:0045944,positive regulation of transcription by RNA polymerase II,11,0.0,1.0,1.0,7
718,GO:0045947,negative regulation of translational initiation,11,0.0,1.0,1.0,5
719,GO:0045948,positive regulation of translational initiation,11,0.0,1.0,1.0,4
720,GO:0045991,carbon catabolite activation of transcription,11,0.0,1.0,1.0,3
721,GO:0046032,ADP catabolic process,11,0.0,1.0,1.0,1
722,GO:0046038,GMP catabolic process,11,0.0,1.0,1.0,2
723,GO:0046053,dAMP metabolic process,11,0.0,1.0,1.0,2
724,GO:0046054,dGMP metabolic process,11,0.0,1.0,1.0,2
725,GO:0046056,dADP metabolic process,11,0.0,1.0,1.0,2
726,GO:0046060,dATP metabolic process,11,0.0,1.0,1.0,2
727,GO:0046062,dCDP metabolic process,11,0.0,1.0,1.0,2
728,GO:0046063,dCMP metabolic process,11,0.0,1.0,1.0,2
729,GO:0046065,dCTP metabolic process,11,0.0,1.0,1.0,2
730,GO:0046066,dGDP metabolic process,11,0.0,1.0,1.0,3
731,GO:0046070,dGTP metabolic process,11,0.0,1.0,1.0,2
732,GO:0046072,dTDP metabolic process,11,0.0,1.0,1.0,2
733,GO:0046073,dTMP metabolic process,11,0.0,1.0,1.0,2
734,GO:0046075,dTTP metabolic process,11,0.0,1.0,1.0,2
735,GO:0046077,dUDP metabolic process,11,0.0,1.0,1.0,2
736,GO:0046078,dUMP metabolic process,11,0.0,1.0,1.0,2
737,GO:0046080,dUTP metabolic process,11,0.0,1.0,1.0,2
738,GO:0046114,guanosine biosynthetic process,11,0.0,1.0,1.0,1
739,GO:0046358,butyrate biosynthetic process,11,0.0,1.0,1.0,1
740,GO:0046457,prostanoid biosynthetic process,11,0.0,1.0,1.0,1
741,GO:0046638,positive regulation of alpha-beta T cell differentiation,11,0.0,1.0,1.0,3
742,GO:0046639,negative regulation of alpha-beta T cell differentiation,11,0.0,1.0,1.0,3
743,GO:0046775,suppression by virus of host cytokine production,11,0.0,1.0,1.0,1
744,GO:0048025,"negative regulation of mRNA splicing, via spliceosome",11,0.0,1.0,1.0,1
745,GO:0048026,"positive regulation of mRNA splicing, via spliceosome",11,0.0,1.0,1.0,1
746,GO:0048255,mRNA stabilization,11,0.0,1.0,1.0,2
747,GO:0048293,regulation of isotype switching to IgE isotypes,11,0.0,1.0,1.0,3
748,GO:0048296,regulation of isotype switching to IgA isotypes,11,0.0,1.0,1.0,2
749,GO:0048299,regulation of isotype switching to IgD isotypes,11,0.0,1.0,1.0,2
750,GO:0048302,regulation of isotype switching to IgG isotypes,11,0.0,1.0,1.0,2
751,GO:0048687,positive regulation of sprouting of injured axon,11,0.0,1.0,1.0,3
752,GO:0048688,negative regulation of sprouting of injured axon,11,0.0,1.0,1.0,3
753,GO:0048763,calcium-induced calcium release activity,11,0.0,1.0,1.0,3
754,GO:0051091,positive regulation of DNA-binding transcription factor activity,11,0.0,1.0,1.0,3
755,GO:0051136,regulation of NK T cell differentiation,11,0.0,1.0,1.0,2
756,GO:0051462,regulation of cortisol secretion,11,0.0,1.0,1.0,2
757,GO:0052034,effector-mediated suppression of host pattern-triggered immunity,11,0.0,1.0,1.0,1
758,GO:0060260,regulation of transcription initiation by RNA polymerase II,11,0.0,1.0,1.0,4
759,GO:0060566,positive regulation of termination of DNA-templated transcription,11,0.0,1.0,1.0,3
760,GO:0060567,negative regulation of termination of DNA-templated transcription,11,0.0,1.0,1.0,3
761,GO:0060909,regulation of DNA replication initiation involved in plasmid copy number maintenance,11,0.0,1.0,1.0,1
762,GO:0060962,regulation of ribosomal protein gene transcription by RNA polymerase II,11,0.0,1.0,1.0,2
763,GO:0060965,negative regulation of miRNA-mediated gene silencing,11,0.0,1.0,1.0,2
764,GO:0061081,positive regulation of myeloid leukocyte cytokine production involved in immune response,11,0.0,1.0,1.0,3
765,GO:0061098,positive regulation of protein tyrosine kinase activity,11,0.0,1.0,1.0,2
766,GO:0061099,negative regulation of protein tyrosine kinase activity,11,0.0,1.0,1.0,2
767,GO:0061157,mRNA destabilization,11,0.0,1.0,1.0,8
768,GO:0061986,negative regulation of transcription by glucose,11,0.0,1.0,1.0,2
769,GO:0062025,regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,11,0.0,1.0,1.0,2
770,GO:0070130,negative regulation of mitochondrial translation,11,0.0,1.0,1.0,1
771,GO:0070131,positive regulation of mitochondrial translation,11,0.0,1.0,1.0,2
772,GO:0070132,regulation of mitochondrial translational initiation,11,0.0,1.0,1.0,2
773,GO:0070475,rRNA base methylation,11,0.0,1.0,1.0,1
774,GO:0070606,regulation of (1->3)-alpha-glucan biosynthetic process,11,0.0,1.0,1.0,1
775,GO:0070609,regulation of fungal-type cell wall (1->3)-alpha-glucan metabolic process,11,0.0,1.0,1.0,1
776,GO:0070903,mitochondrial tRNA thio-modification,11,0.0,1.0,1.0,1
777,GO:0070982,L-asparagine metabolic process,11,0.0,1.0,1.0,1
778,GO:0071028,nuclear mRNA surveillance,11,0.0,1.0,1.0,4
779,GO:0071044,histone mRNA catabolic process,11,0.0,1.0,1.0,1
780,GO:0071901,negative regulation of protein serine/threonine kinase activity,11,0.0,1.0,1.0,5
781,GO:0071902,positive regulation of protein serine/threonine kinase activity,11,0.0,1.0,1.0,6
782,GO:0071970,fungal-type cell wall (1->3)-beta-D-glucan biosynthetic process,11,0.0,1.0,1.0,1
783,GO:0090063,positive regulation of microtubule nucleation,11,0.0,1.0,1.0,1
784,GO:0090086,negative regulation of protein deubiquitination,11,0.0,1.0,1.0,2
785,GO:0090093,regulation of fungal-type cell wall beta-glucan biosynthetic process,11,0.0,1.0,1.0,1
786,GO:0090267,positive regulation of mitotic cell cycle spindle assembly checkpoint,11,0.0,1.0,1.0,1
787,GO:0090294,nitrogen catabolite activation of transcription,11,0.0,1.0,1.0,1
788,GO:0090295,nitrogen catabolite repression of transcription,11,0.0,1.0,1.0,1
789,GO:0097293,XMP biosynthetic process,11,0.0,1.0,1.0,2
790,GO:0097341,zymogen inhibition,11,0.0,1.0,1.0,1
791,GO:0097378,dorsal spinal cord interneuron axon guidance,11,0.0,1.0,1.0,2
792,GO:0099093,calcium export from the mitochondrion,11,0.0,1.0,1.0,1
793,GO:0099525,presynaptic dense core vesicle exocytosis,11,0.0,1.0,1.0,1
794,GO:0099547,"regulation of translation at synapse, modulating synaptic transmission",11,0.0,1.0,1.0,2
795,GO:0106295,resolvin biosynthetic process,11,0.0,1.0,1.0,3
796,GO:0106380,purine ribonucleotide salvage,11,0.0,1.0,1.0,4
797,GO:0110003,regulation of tRNA C5-cytosine methylation,11,0.0,1.0,1.0,1
798,GO:0110004,positive regulation of tRNA methylation,11,0.0,1.0,1.0,1
799,GO:0110159,regulation of mitotic spindle formation (spindle phase one),11,0.0,1.0,1.0,2
800,GO:0140244,regulation of translation at presynapse,11,0.0,1.0,1.0,1
801,GO:0140245,regulation of translation at postsynapse,11,0.0,1.0,1.0,1
802,GO:0140408,regulation of mRNA alternative polyadenylation,11,0.0,1.0,1.0,1
803,GO:0140420,heme import into cell,11,0.0,1.0,1.0,2
804,GO:0140499,negative regulation of mitotic spindle assembly checkpoint signaling,11,0.0,1.0,1.0,1
805,GO:0140718,facultative heterochromatin formation,11,0.0,1.0,1.0,3
806,GO:0140719,constitutive heterochromatin formation,11,0.0,1.0,1.0,5
807,GO:0140766,siRNA-mediated post-transcriptional gene silencing,11,0.0,1.0,1.0,2
808,GO:0140914,zinc ion import into secretory vesicle,11,0.0,1.0,1.0,1
809,GO:1900019,regulation of protein kinase C activity,11,0.0,1.0,1.0,1
810,GO:1900128,regulation of G-protein activated inward rectifier potassium channel activity,11,0.0,1.0,1.0,1
811,GO:1900151,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",11,0.0,1.0,1.0,2
812,GO:1900247,regulation of cytoplasmic translational elongation,11,0.0,1.0,1.0,4
813,GO:1901341,positive regulation of store-operated calcium channel activity,11,0.0,1.0,1.0,1
814,GO:1901386,negative regulation of voltage-gated calcium channel activity,11,0.0,1.0,1.0,1
815,GO:1901387,positive regulation of voltage-gated calcium channel activity,11,0.0,1.0,1.0,1
816,GO:1901591,regulation of double-strand break repair via break-induced replication,11,0.0,1.0,1.0,1
817,GO:1901836,regulation of transcription of nucleolar large rRNA by RNA polymerase I,11,0.0,1.0,1.0,2
818,GO:1901841,regulation of high voltage-gated calcium channel activity,11,0.0,1.0,1.0,2
819,GO:1902232,regulation of positive thymic T cell selection,11,0.0,1.0,1.0,2
820,GO:1902320,nuclear DNA replication DNA duplex unwinding,11,0.0,1.0,1.0,2
821,GO:1902498,regulation of protein autoubiquitination,11,0.0,1.0,1.0,2
822,GO:1902525,regulation of protein monoubiquitination,11,0.0,1.0,1.0,2
823,GO:1902576,negative regulation of nuclear cell cycle DNA replication,11,0.0,1.0,1.0,2
824,GO:1902914,regulation of protein polyubiquitination,11,0.0,1.0,1.0,5
825,GO:1902947,regulation of tau-protein kinase activity,11,0.0,1.0,1.0,2
826,GO:1902969,mitotic DNA replication,11,0.0,1.0,1.0,1
827,GO:1902983,DNA strand elongation involved in mitotic DNA replication,11,0.0,1.0,1.0,2
828,GO:1903003,positive regulation of protein deubiquitination,11,0.0,1.0,1.0,1
829,GO:1903004,regulation of protein K63-linked deubiquitination,11,0.0,1.0,1.0,2
830,GO:1903093,regulation of protein K48-linked deubiquitination,11,0.0,1.0,1.0,1
831,GO:1903182,regulation of SUMO transferase activity,11,0.0,1.0,1.0,1
832,GO:1903463,regulation of mitotic cell cycle DNA replication,11,0.0,1.0,1.0,3
833,GO:1903500,negative regulation of mitotic actomyosin contractile ring assembly,11,0.0,1.0,1.0,1
834,GO:1903514,release of sequestered calcium ion into cytosol by endoplasmic reticulum,11,0.0,1.0,1.0,1
835,GO:1903622,regulation of RNA polymerase III activity,11,0.0,1.0,1.0,1
836,GO:1903817,negative regulation of voltage-gated potassium channel activity,11,0.0,1.0,1.0,2
837,GO:1903818,positive regulation of voltage-gated potassium channel activity,11,0.0,1.0,1.0,3
838,GO:1903995,regulation of non-membrane spanning protein tyrosine kinase activity,11,0.0,1.0,1.0,2
839,GO:1904030,negative regulation of cyclin-dependent protein kinase activity,11,0.0,1.0,1.0,1
840,GO:1904031,positive regulation of cyclin-dependent protein kinase activity,11,0.0,1.0,1.0,1
841,GO:1904512,regulation of initiation of premeiotic DNA replication,11,0.0,1.0,1.0,2
842,GO:1904538,regulation of glycolytic process through fructose-6-phosphate,11,0.0,1.0,1.0,2
843,GO:1904569,regulation of selenocysteine incorporation,11,0.0,1.0,1.0,2
844,GO:1904688,regulation of cytoplasmic translational initiation,11,0.0,1.0,1.0,6
845,GO:1905082,regulation of mitochondrial translational elongation,11,0.0,1.0,1.0,2
846,GO:1905326,positive regulation of meiosis I spindle assembly checkpoint,11,0.0,1.0,1.0,1
847,GO:1905380,regulation of snRNA transcription by RNA polymerase II,11,0.0,1.0,1.0,2
848,GO:1905706,regulation of mitochondrial ATP synthesis coupled proton transport,11,0.0,1.0,1.0,1
849,GO:1905744,"regulation of mRNA cis splicing, via spliceosome",11,0.0,1.0,1.0,2
850,GO:1905784,regulation of anaphase-promoting complex-dependent catabolic process,11,0.0,1.0,1.0,2
851,GO:1905868,regulation of 3'-UTR-mediated mRNA stabilization,11,0.0,1.0,1.0,2
852,GO:1990437,snRNA 2'-O-methylation,11,0.0,1.0,1.0,1
853,GO:1990497,regulation of cytoplasmic translation in response to stress,11,0.0,1.0,1.0,1
854,GO:1990852,protein transport along microtubule to spindle pole body,11,0.0,1.0,1.0,1
855,GO:2000042,negative regulation of double-strand break repair via homologous recombination,11,0.0,1.0,1.0,1
856,GO:2000064,regulation of cortisol biosynthetic process,11,0.0,1.0,1.0,2
857,GO:2000117,negative regulation of cysteine-type endopeptidase activity,11,0.0,1.0,1.0,1
858,GO:2000143,negative regulation of DNA-templated transcription initiation,11,0.0,1.0,1.0,1
859,GO:2000144,positive regulation of DNA-templated transcription initiation,11,0.0,1.0,1.0,1
860,GO:2000298,regulation of Rho-dependent protein serine/threonine kinase activity,11,0.0,1.0,1.0,1
861,GO:2000408,negative regulation of T cell extravasation,11,0.0,1.0,1.0,1
862,GO:2000409,positive regulation of T cell extravasation,11,0.0,1.0,1.0,1
863,GO:2000411,negative regulation of thymocyte migration,11,0.0,1.0,1.0,1
864,GO:2000412,positive regulation of thymocyte migration,11,0.0,1.0,1.0,1
865,GO:2000413,regulation of fibronectin-dependent thymocyte migration,11,0.0,1.0,1.0,2
866,GO:2000449,"regulation of CD8-positive, alpha-beta T cell extravasation",11,0.0,1.0,1.0,4
867,GO:2000479,regulation of cAMP-dependent protein kinase activity,11,0.0,1.0,1.0,2
868,GO:2000551,regulation of T-helper 2 cell cytokine production,11,0.0,1.0,1.0,2
869,GO:2000554,regulation of T-helper 1 cell cytokine production,11,0.0,1.0,1.0,2
870,GO:2000631,regulation of pre-miRNA processing,11,0.0,1.0,1.0,2
871,GO:2000634,regulation of primary miRNA processing,11,0.0,1.0,1.0,2
872,GO:2000637,positive regulation of miRNA-mediated gene silencing,11,0.0,1.0,1.0,1
873,GO:2000730,regulation of termination of RNA polymerase I transcription,11,0.0,1.0,1.0,2
874,GO:2000766,negative regulation of cytoplasmic translation,11,0.0,1.0,1.0,1
875,GO:2000804,"regulation of termination of RNA polymerase II transcription, poly(A)-coupled",11,0.0,1.0,1.0,2
876,GO:2000812,regulation of barbed-end actin filament capping,11,0.0,1.0,1.0,2
877,GO:2000850,negative regulation of glucocorticoid secretion,11,0.0,1.0,1.0,2
878,GO:2000851,positive regulation of glucocorticoid secretion,11,0.0,1.0,1.0,2
879,GO:2000852,regulation of corticosterone secretion,11,0.0,1.0,1.0,2
880,GO:2000856,negative regulation of mineralocorticoid secretion,11,0.0,1.0,1.0,1
881,GO:2000857,positive regulation of mineralocorticoid secretion,11,0.0,1.0,1.0,1
882,GO:2000858,regulation of aldosterone secretion,11,0.0,1.0,1.0,3
883,GO:2000915,regulation of glucuronoxylan catabolic process,11,0.0,1.0,1.0,3
884,GO:2000921,regulation of arabinoxylan-containing compound catabolic process,11,0.0,1.0,1.0,3
885,GO:2001001,negative regulation of xylan catabolic process,11,0.0,1.0,1.0,2
886,GO:2001002,positive regulation of xylan catabolic process,11,0.0,1.0,1.0,2
887,GO:2001006,regulation of cellulose biosynthetic process,11,0.0,1.0,1.0,3
888,GO:2001056,positive regulation of cysteine-type endopeptidase activity,11,0.0,1.0,1.0,1
889,GO:2001124,regulation of translational frameshifting,11,0.0,1.0,1.0,2
890,GO:2001170,negative regulation of ATP biosynthetic process,11,0.0,1.0,1.0,1
891,GO:2001207,regulation of transcription elongation by RNA polymerase I,11,0.0,1.0,1.0,2
424,GO:0000410,carbon catabolite repression of transcription by galactose,12,0.0,1.0,1.0,1
425,GO:0000411,positive regulation of transcription by galactose,12,0.0,1.0,1.0,1
426,GO:0000430,regulation of transcription from RNA polymerase II promoter by glucose,12,0.0,1.0,1.0,2
427,GO:0000431,regulation of transcription from RNA polymerase II promoter by galactose,12,0.0,1.0,1.0,2
428,GO:0000436,carbon catabolite activation of transcription from RNA polymerase II promoter,12,0.0,1.0,1.0,4
429,GO:0000437,carbon catabolite repression of transcription from RNA polymerase II promoter,12,0.0,1.0,1.0,2
430,GO:0001516,prostaglandin biosynthetic process,12,0.0,1.0,1.0,1
431,GO:0001797,negative regulation of type IIa hypersensitivity,12,0.0,1.0,1.0,1
432,GO:0001798,positive regulation of type IIa hypersensitivity,12,0.0,1.0,1.0,1
433,GO:0001813,regulation of antibody-dependent cellular cytotoxicity,12,0.0,1.0,1.0,2
434,GO:0002130,wobble position ribose methylation,12,0.0,1.0,1.0,3
435,GO:0002143,tRNA wobble position uridine thiolation,12,0.0,1.0,1.0,1
436,GO:0002755,MyD88-dependent toll-like receptor signaling pathway,12,0.0,1.0,1.0,2
437,GO:0002756,MyD88-independent toll-like receptor signaling pathway,12,0.0,1.0,1.0,2
438,GO:0002809,negative regulation of antibacterial peptide biosynthetic process,12,0.0,1.0,1.0,2
439,GO:0002813,regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria,12,0.0,1.0,1.0,2
440,GO:0002816,regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,12,0.0,1.0,1.0,2
441,GO:0002938,tRNA guanine ribose methylation,12,0.0,1.0,1.0,1
442,GO:0005219,ryanodine-sensitive calcium-release channel activity,12,0.0,1.0,1.0,1
443,GO:0006096,glycolytic process,12,0.0,1.0,1.0,5
444,GO:0006116,NADH oxidation,12,0.0,1.0,1.0,1
445,GO:0006170,dAMP biosynthetic process,12,0.0,1.0,1.0,1
446,GO:0006175,dATP biosynthetic process,12,0.0,1.0,1.0,1
447,GO:0006181,dGMP biosynthetic process,12,0.0,1.0,1.0,1
448,GO:0006231,dTMP biosynthetic process,12,0.0,1.0,1.0,1
449,GO:0006346,DNA methylation-dependent constitutive heterochromatin formation,12,0.0,1.0,1.0,2
450,GO:0006735,NADH regeneration,12,0.0,1.0,1.0,1
451,GO:0006963,positive regulation of antibacterial peptide biosynthetic process,12,0.0,1.0,1.0,2
452,GO:0009089,lysine biosynthetic process via diaminopimelate,12,0.0,1.0,1.0,4
453,GO:0010139,pyrimidine deoxyribonucleotide salvage,12,0.0,1.0,1.0,2
454,GO:0010688,negative regulation of ribosomal protein gene transcription by RNA polymerase II,12,0.0,1.0,1.0,3
455,GO:0010998,regulation of translational initiation by eIF2 alpha phosphorylation,12,0.0,1.0,1.0,1
456,GO:0015986,proton motive force-driven ATP synthesis,12,0.0,1.0,1.0,2
457,GO:0019450,L-cysteine catabolic process to pyruvate,12,0.0,1.0,1.0,1
458,GO:0019453,L-cysteine catabolic process via cystine,12,0.0,1.0,1.0,3
459,GO:0019474,L-lysine catabolic process to acetyl-CoA,12,0.0,1.0,1.0,4
460,GO:0019493,arginine catabolic process to proline,12,0.0,1.0,1.0,1
461,GO:0019670,anaerobic glutamate catabolic process,12,0.0,1.0,1.0,1
462,GO:0019878,lysine biosynthetic process via aminoadipic acid,12,0.0,1.0,1.0,2
463,GO:0031508,pericentric heterochromatin formation,12,0.0,1.0,1.0,1
464,GO:0031555,transcriptional attenuation,12,0.0,1.0,1.0,1
465,GO:0031571,mitotic G1 DNA damage checkpoint signaling,12,0.0,1.0,1.0,1
466,GO:0032057,negative regulation of translational initiation in response to stress,12,0.0,1.0,1.0,5
467,GO:0032058,positive regulation of translational initiation in response to stress,12,0.0,1.0,1.0,3
468,GO:0032061,negative regulation of translation in response to osmotic stress,12,0.0,1.0,1.0,1
469,GO:0032062,positive regulation of translation in response to osmotic stress,12,0.0,1.0,1.0,1
470,GO:0032088,negative regulation of NF-kappaB transcription factor activity,12,0.0,1.0,1.0,1
471,GO:0032829,"regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",12,0.0,1.0,1.0,3
472,GO:0033316,meiotic spindle assembly checkpoint signaling,12,0.0,1.0,1.0,1
473,GO:0034627,'de novo' NAD biosynthetic process,12,0.0,1.0,1.0,2
474,GO:0035664,TIRAP-dependent toll-like receptor signaling pathway,12,0.0,1.0,1.0,1
475,GO:0035872,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",12,0.0,1.0,1.0,2
476,GO:0036491,regulation of translation initiation in response to endoplasmic reticulum stress,12,0.0,1.0,1.0,4
477,GO:0036493,positive regulation of translation in response to endoplasmic reticulum stress,12,0.0,1.0,1.0,1
478,GO:0036496,regulation of translational initiation by eIF2 alpha dephosphorylation,12,0.0,1.0,1.0,1
479,GO:0042994,cytoplasmic sequestering of transcription factor,12,0.0,1.0,1.0,1
480,GO:0043371,"negative regulation of CD4-positive, alpha-beta T cell differentiation",12,0.0,1.0,1.0,2
481,GO:0043372,"positive regulation of CD4-positive, alpha-beta T cell differentiation",12,0.0,1.0,1.0,2
482,GO:0043406,positive regulation of MAP kinase activity,12,0.0,1.0,1.0,1
483,GO:0043407,negative regulation of MAP kinase activity,12,0.0,1.0,1.0,1
484,GO:0043506,regulation of JUN kinase activity,12,0.0,1.0,1.0,2
485,GO:0043556,regulation of translation in response to oxidative stress,12,0.0,1.0,1.0,1
486,GO:0043561,regulation of translational initiation in response to osmotic stress,12,0.0,1.0,1.0,2
487,GO:0045014,carbon catabolite repression of transcription by glucose,12,0.0,1.0,1.0,1
488,GO:0045190,isotype switching,12,0.0,1.0,1.0,4
489,GO:0045622,regulation of T-helper cell differentiation,12,0.0,1.0,1.0,5
490,GO:0045898,regulation of RNA polymerase II transcription preinitiation complex assembly,12,0.0,1.0,1.0,2
491,GO:0046016,positive regulation of transcription by glucose,12,0.0,1.0,1.0,1
492,GO:0046064,dCMP biosynthetic process,12,0.0,1.0,1.0,1
493,GO:0046071,dGTP biosynthetic process,12,0.0,1.0,1.0,1
494,GO:0048295,positive regulation of isotype switching to IgE isotypes,12,0.0,1.0,1.0,1
495,GO:0051443,positive regulation of ubiquitin-protein transferase activity,12,0.0,1.0,1.0,1
496,GO:0051444,negative regulation of ubiquitin-protein transferase activity,12,0.0,1.0,1.0,1
497,GO:0051693,actin filament capping,12,0.0,1.0,1.0,2
498,GO:0051695,actin filament uncapping,12,0.0,1.0,1.0,2
499,GO:0060261,positive regulation of transcription initiation by RNA polymerase II,12,0.0,1.0,1.0,1
500,GO:0060622,regulation of ascospore wall beta-glucan biosynthetic process,12,0.0,1.0,1.0,1
501,GO:0060633,negative regulation of transcription initiation by RNA polymerase II,12,0.0,1.0,1.0,1
502,GO:0060635,positive regulation of (1->3)-beta-D-glucan biosynthetic process,12,0.0,1.0,1.0,1
503,GO:0061413,regulation of transcription from RNA polymerase II promoter by a nonfermentable carbon source,12,0.0,1.0,1.0,2
504,GO:0061945,regulation of protein K48-linked ubiquitination,12,0.0,1.0,1.0,2
505,GO:0070608,regulation of cell wall (1->3)-alpha-glucan biosynthetic process,12,0.0,1.0,1.0,1
506,GO:0070899,mitochondrial tRNA wobble uridine modification,12,0.0,1.0,1.0,1
507,GO:0071047,polyadenylation-dependent mRNA catabolic process,12,0.0,1.0,1.0,1
508,GO:0071262,regulation of translational initiation in response to starvation,12,0.0,1.0,1.0,2
509,GO:0071265,L-methionine biosynthetic process,12,0.0,1.0,1.0,2
510,GO:0090334,regulation of cell wall (1->3)-beta-D-glucan biosynthetic process,12,0.0,1.0,1.0,1
511,GO:0090625,siRNA-mediated gene silencing by mRNA destabilization,12,0.0,1.0,1.0,1
512,GO:0106381,purine deoxyribonucleotide salvage,12,0.0,1.0,1.0,3
513,GO:0120191,negative regulation of termination of RNA polymerase II transcription,12,0.0,1.0,1.0,1
514,GO:0140894,endolysosomal toll-like receptor signaling pathway,12,0.0,1.0,1.0,7
515,GO:0140895,cell surface toll-like receptor signaling pathway,12,0.0,1.0,1.0,6
516,GO:0140966,piRNA-mediated heterochromatin formation,12,0.0,1.0,1.0,2
517,GO:0140991,piRNA-mediated gene silencing by mRNA destabilization,12,0.0,1.0,1.0,1
518,GO:0141005,transposable element silencing by heterochromatin formation,12,0.0,1.0,1.0,4
519,GO:0141008,transposable element silencing by mRNA destabilization,12,0.0,1.0,1.0,2
520,GO:0141194,siRNA-mediated heterochromatin formation,12,0.0,1.0,1.0,4
521,GO:1900044,regulation of protein K63-linked ubiquitination,12,0.0,1.0,1.0,2
522,GO:1900152,"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",12,0.0,1.0,1.0,1
523,GO:1900248,negative regulation of cytoplasmic translational elongation,12,0.0,1.0,1.0,1
524,GO:1900249,positive regulation of cytoplasmic translational elongation,12,0.0,1.0,1.0,1
525,GO:1901193,regulation of formation of translation preinitiation complex,12,0.0,1.0,1.0,2
526,GO:1901980,positive regulation of inward rectifier potassium channel activity,12,0.0,1.0,1.0,1
527,GO:1902010,negative regulation of translation in response to endoplasmic reticulum stress,12,0.0,1.0,1.0,1
528,GO:1902528,regulation of protein linear polyubiquitination,12,0.0,1.0,1.0,2
529,GO:1902915,negative regulation of protein polyubiquitination,12,0.0,1.0,1.0,3
530,GO:1902916,positive regulation of protein polyubiquitination,12,0.0,1.0,1.0,3
531,GO:1903006,positive regulation of protein K63-linked deubiquitination,12,0.0,1.0,1.0,1
532,GO:1903270,regulation of cytoplasmic translational elongation through polyproline stretches,12,0.0,1.0,1.0,2
533,GO:1903464,negative regulation of mitotic cell cycle DNA replication,12,0.0,1.0,1.0,1
534,GO:1903465,positive regulation of mitotic cell cycle DNA replication,12,0.0,1.0,1.0,1
535,GO:1903466,regulation of mitotic DNA replication initiation,12,0.0,1.0,1.0,4
536,GO:1903674,regulation of cap-dependent translational initiation,12,0.0,1.0,1.0,2
537,GO:1903677,regulation of cap-independent translational initiation,12,0.0,1.0,1.0,2
538,GO:1903799,negative regulation of miRNA processing,12,0.0,1.0,1.0,2
539,GO:1903800,positive regulation of miRNA processing,12,0.0,1.0,1.0,2
540,GO:1904595,positive regulation of termination of RNA polymerase II transcription,12,0.0,1.0,1.0,1
541,GO:1904689,negative regulation of cytoplasmic translational initiation,12,0.0,1.0,1.0,4
542,GO:1904690,positive regulation of cytoplasmic translational initiation,12,0.0,1.0,1.0,2
543,GO:1905058,calcium-induced calcium release activity involved in regulation of postsynaptic cytosolic calcium ion concentration,12,0.0,1.0,1.0,1
544,GO:1990611,regulation of cytoplasmic translational initiation in response to stress,12,0.0,1.0,1.0,1
545,GO:2000450,"negative regulation of CD8-positive, alpha-beta T cell extravasation",12,0.0,1.0,1.0,2
546,GO:2000451,"positive regulation of CD8-positive, alpha-beta T cell extravasation",12,0.0,1.0,1.0,2
547,GO:2000452,"regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation",12,0.0,1.0,1.0,2
548,GO:2000455,regulation of T-helper 17 cell extravasation,12,0.0,1.0,1.0,2
549,GO:2000571,regulation of interleukin-4-dependent isotype switching to IgE isotypes,12,0.0,1.0,1.0,1
550,GO:2000916,negative regulation of glucuronoxylan catabolic process,12,0.0,1.0,1.0,1
551,GO:2000917,positive regulation of glucuronoxylan catabolic process,12,0.0,1.0,1.0,1
552,GO:2000918,regulation of glucuronoarabinoxylan catabolic process,12,0.0,1.0,1.0,2
553,GO:2000922,negative regulation of arabinoxylan-containing compound catabolic process,12,0.0,1.0,1.0,1
554,GO:2000923,positive regulation of arabinoxylan-containing compound catabolic process,12,0.0,1.0,1.0,1
555,GO:2001007,negative regulation of cellulose biosynthetic process,12,0.0,1.0,1.0,1
556,GO:2001008,positive regulation of cellulose biosynthetic process,12,0.0,1.0,1.0,1
557,GO:2001009,regulation of plant-type cell wall cellulose biosynthetic process,12,0.0,1.0,1.0,2
400,GO:0032830,"negative regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",13,0.0,1.0,1.0,1
401,GO:0032831,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",13,0.0,1.0,1.0,1
402,GO:0032832,"regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response",13,0.0,1.0,1.0,2
403,GO:0034134,toll-like receptor 2 signaling pathway,13,0.0,1.0,1.0,1
404,GO:0034142,toll-like receptor 4 signaling pathway,13,0.0,1.0,1.0,4
405,GO:0035666,TRIF-dependent toll-like receptor signaling pathway,13,0.0,1.0,1.0,1
406,GO:0035668,TRAM-dependent toll-like receptor signaling pathway,13,0.0,1.0,1.0,1
407,GO:0045623,negative regulation of T-helper cell differentiation,13,0.0,1.0,1.0,3
408,GO:0045624,positive regulation of T-helper cell differentiation,13,0.0,1.0,1.0,3
409,GO:0045625,regulation of T-helper 1 cell differentiation,13,0.0,1.0,1.0,2
410,GO:0045628,regulation of T-helper 2 cell differentiation,13,0.0,1.0,1.0,2
411,GO:0048289,isotype switching to IgE isotypes,13,0.0,1.0,1.0,1
412,GO:0060624,regulation of ascospore wall (1->3)-beta-D-glucan biosynthetic process,13,0.0,1.0,1.0,1
413,GO:0061615,glycolytic process through fructose-6-phosphate,13,0.0,1.0,1.0,4
414,GO:0061704,glycolytic process from sucrose,13,0.0,1.0,1.0,1
415,GO:0061987,negative regulation of transcription from RNA polymerase II promoter by glucose,13,0.0,1.0,1.0,1
416,GO:0071266,'de novo' L-methionine biosynthetic process,13,0.0,1.0,1.0,2
417,GO:0071267,L-methionine salvage,13,0.0,1.0,1.0,3
418,GO:0080188,gene silencing by siRNA-directed DNA methylation,13,0.0,1.0,1.0,1
419,GO:0100008,regulation of fever generation by prostaglandin biosynthetic process,13,0.0,1.0,1.0,1
420,GO:0101017,regulation of mitotic DNA replication initiation from late origin,13,0.0,1.0,1.0,1
421,GO:0141176,gene silencing by piRNA-directed DNA methylation,13,0.0,1.0,1.0,1
422,GO:1903467,negative regulation of mitotic DNA replication initiation,13,0.0,1.0,1.0,1
423,GO:2000319,regulation of T-helper 17 cell differentiation,13,0.0,1.0,1.0,3
395,GO:0019279,L-methionine biosynthetic process from L-homoserine via cystathionine,14,0.0,1.0,1.0,3
396,GO:0061620,glycolytic process through glucose-6-phosphate,14,0.0,1.0,1.0,3
397,GO:2000320,negative regulation of T-helper 17 cell differentiation,14,0.0,1.0,1.0,1
398,GO:2000321,positive regulation of T-helper 17 cell differentiation,14,0.0,1.0,1.0,1
399,GO:2000328,regulation of T-helper 17 cell lineage commitment,14,0.0,1.0,1.0,2
394,GO:0061622,glycolytic process through glucose-1-phosphate,15,0.0,1.0,1.0,2
